data_2m7s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m7s _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.236 0.369 0 N-CA-C 108.953 -0.758 . . . . 74.21 108.953 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -72.28 37.98 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.371 -0.831 . . . . 72.21 112.295 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.64 28.75 2.41 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 119.349 -2.094 . . . . 75.44 109.797 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.13 143.03 51.03 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.867 -1.145 . . . . 74.03 112.395 -167.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 m -140.51 167.69 17.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 124.491 1.117 . . . . 62.14 110.527 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.2 t -129.72 153.67 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.15 -1.796 . . . . 75.13 106.15 170.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -121.98 136.58 58.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 105.821 -1.918 . . . . 74.23 105.821 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 p -134.53 145.08 48.4 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.927 0.785 . . . . 61.34 111.678 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.9 27.66 23.25 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 125.147 1.356 . . . . 74.45 112.619 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 152.7 45.82 Favored Pre-proline 0 N--CA 1.467 0.419 0 CA-C-N 118.443 1.121 . . . . 64.22 110.393 -177.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.07 168.59 17.01 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.813 2.342 . . . . 73.41 110.882 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.02 -12.6 35.43 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.65 2.234 . . . . 75.45 113.831 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -151.16 57.03 0.89 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.379 1.445 . . . . 72.14 111.92 -171.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.19 -166.51 32.7 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.273 1.416 . . . . 72.15 111.11 172.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.8 p -157.69 173.85 16.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.402 1.081 . . . . 63.34 109.718 169.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -70.06 -18.4 63.27 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.97 0.908 . . . . 75.45 111.38 171.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.44 -54.11 10.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.834 -1.173 . . . . 75.31 107.834 -177.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.51 -32.84 74.41 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 118.55 -0.738 . . . . 71.12 110.249 172.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.35 -57.08 13.8 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.558 1.072 . . . . 73.45 110.57 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -61.81 -42.99 99.71 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 118.785 0.72 . . . . 74.24 110.087 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.25 -25.66 64.39 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.224 1.01 . . . . 75.42 111.92 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.445 ' CE1' ' HG1' ' A' ' 73' ' ' THR . 20.3 t-160 -81.39 -60.04 2.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.589 0.756 . . . . 72.32 110.046 174.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.0 ttt -68.09 -8.8 41.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.791 1.636 . . . . 62.01 114.348 -159.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.18 20.97 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 131.218 3.807 . . . . 75.54 115.848 175.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -100.59 0.79 39.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.98 1.712 . . . . 74.34 112.604 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.92 17.08 6.79 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 125.846 1.658 . . . . 74.32 112.797 -167.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 -107.73 1.04 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 125.762 1.648 . . . . 75.24 109.304 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -143.96 139.61 29.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 117.764 0.782 . . . . 71.24 109.922 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 t -128.44 81.13 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 126.451 1.9 . . . . 75.5 107.167 -170.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.7 t -72.66 -15.12 61.71 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.277 0.473 . . . . 53.34 112.277 -174.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -132.83 135.14 45.47 Favored 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 121.038 -1.039 . . . . 74.25 108.413 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.42 138.83 41.93 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.218 -1.03 . . . . 74.32 108.218 166.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -145.92 156.68 43.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.843 -1.169 . . . . 74.42 107.843 169.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.35 -178.41 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 O-C-N 120.826 -1.171 . . . . 72.43 108.162 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -103.34 -163.09 0.96 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.417 1.487 . . . . 74.31 107.283 166.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 mtm-85 -52.71 -53.98 40.08 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.975 -1.011 . . . . 72.25 109.885 159.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -170.68 -179.91 3.05 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.083 0.856 . . . . 63.13 112.82 -171.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.69 -39.85 2.73 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 127.147 2.308 . . . . 72.44 113.445 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.01 170.58 16.82 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.759 1.279 . . . . 71.35 109.429 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.86 159.66 28.09 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.543 -1.823 . . . . 60.41 108.543 165.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.3 p -130.23 131.3 65.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.396 1.098 . . . . 72.42 109.292 -170.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.7 t -144.32 151.83 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.632 -0.877 . . . . 75.43 108.632 -157.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -135.13 133.7 39.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.5 -1.296 . . . . 73.41 107.5 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -101.6 -176.77 3.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.117 1.767 . . . . 75.21 108.626 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.2 t -81.72 -50.96 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 118.256 -0.878 . . . . 61.3 110.57 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.1 ttt85 -145.17 164.5 31.1 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 120.526 1.512 . . . . 75.3 111.79 -171.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -62.7 -30.31 71.31 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 117.867 -1.063 . . . . 64.24 111.673 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -65.38 -50.98 63.47 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.645 -0.872 . . . . 71.34 108.645 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -59.36 -53.11 61.99 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 126.786 2.034 . . . . 75.12 109.25 176.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -51.94 -51.56 56.18 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.485 -0.759 . . . . 75.02 112.457 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.7 m -55.29 -53.56 54.53 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.536 -0.745 . . . . 74.14 109.584 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -56.96 -32.43 66.02 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.321 1.048 . . . . 72.3 111.588 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.25 -42.77 77.91 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.438 1.017 . . . . 74.01 110.863 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t -69.3 -14.31 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.951 -0.468 . . . . 64.12 111.091 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -100.58 -33.55 10.26 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.314 -1.492 . . . . 73.41 112.349 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.7 9.01 2.85 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.844 0.858 . . . . 71.03 113.19 -165.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.36 3.24 3.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.798 0.726 . . . . 75.33 111.132 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.85 162.16 13.7 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 119.315 -2.116 . . . . 75.23 114.501 171.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.4 t30 66.2 15.38 10.07 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.007 2.523 . . . . 75.44 113.003 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.445 ' HG1' ' CE1' ' A' ' 35' ' ' HIS . 31.1 p -78.46 171.21 15.43 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.495 -0.753 . . . . 75.12 109.747 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.08 151.65 21.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.029 1.332 . . . . 75.21 109.034 166.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -125.15 130.18 51.66 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 127.709 2.404 . . . . 75.3 108.896 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -87.03 153.83 21.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.108 0.963 . . . . 73.12 110.541 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.7 p -124.39 176.73 6.28 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.077 0.951 . . . . 74.45 110.451 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -85.6 5.15 33.01 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.569 1.148 . . . . 75.41 111.268 167.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.74 13.42 14.17 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.729 2.012 . . . . 64.54 112.595 -162.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.24 12.85 81.7 Favored Glycine 0 C--N 1.336 0.561 0 O-C-N 121.762 -0.586 . . . . 74.55 113.489 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -134.59 162.99 30.74 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.227 1.011 . . . . 52.24 109.593 -173.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.6 p -148.75 119.61 7.6 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.678 -0.86 . . . . 71.21 108.678 -172.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.23 165.01 13.68 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.418 0.687 . . . . 72.15 110.033 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -84.65 157.23 21.21 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.569 -0.9 . . . . 64.22 108.569 160.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.3 pt -137.47 152.94 27.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.895 0.855 . . . . 74.21 109.364 175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -123.9 119.19 28.92 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.043 -1.836 . . . . 72.05 106.043 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -75.62 163.25 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.262 -0.644 . . . . 75.2 109.262 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.49 163.84 39.48 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.922 1.689 . . . . 75.04 107.42 164.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.07 155.44 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.23 -1.767 . . . . 64.1 106.23 165.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 58.8 t0 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 124.567 1.147 . . . . 74.31 109.971 176.372 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 107.408 -1.33 . . . . 61.12 107.408 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -80.41 40.69 0.51 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.251 1.021 . . . . 62.42 111.976 173.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.94 15.05 1.91 Allowed 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.431 -1.418 . . . . 72.31 111.968 -178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.56 144.57 39.22 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.028 -1.045 . . . . 75.43 110.203 -171.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.423 ' CG1' ' HG3' ' A' ' 63' ' ' MET . 27.3 m -141.4 166.36 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.249 1.02 . . . . 74.14 110.496 -171.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.79 124.02 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 106.75 -1.574 . . . . 73.54 106.75 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.23 148.99 4.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.059 1.344 . . . . 62.51 107.601 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -136.6 163.1 31.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.591 -0.693 . . . . 74.13 109.635 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.5 9.87 68.66 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.062 -0.854 . . . . 52.41 113.81 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.81 150.99 45.29 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.481 1.141 . . . . 72.41 112.509 -172.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -71.52 169.65 20.42 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 125.163 3.909 . . . . 74.15 113.259 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.47 -4.23 11.56 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.576 3.517 . . . . 63.31 114.167 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.73 71.03 1.37 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.081 2.152 . . . . 71.24 106.579 171.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.18 127.08 6.66 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 125.344 1.449 . . . . 23.5 109.596 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.4 m -134.78 166.64 22.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.935 0.894 . . . . 71.13 110.644 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -65.05 -22.84 67.04 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.407 1.083 . . . . 74.44 111.711 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -58.38 -60.45 3.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.436 -1.269 . . . . 71.51 109.742 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.84 -42.69 94.13 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 108.875 -0.787 . . . . 60.22 108.875 176.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.78 -50.98 62.48 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.846 0.748 . . . . 71.32 111.072 -176.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -67.48 -31.88 72.33 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.263 -0.898 . . . . 74.43 112.406 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.78 -2.58 57.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.34 1.456 . . . . 74.42 112.003 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -122.17 -56.08 1.84 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.278 1.431 . . . . 52.52 110.45 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 17.2 ttt -75.74 72.11 2.64 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.435 -1.415 . . . . 64.42 108.473 171.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.3 ptm85 -136.81 -13.4 1.68 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.271 1.428 . . . . 71.42 111.734 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -76.39 3.41 11.13 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.423 -0.798 . . . . 72.42 112.315 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.7 64.29 0.74 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.814 1.645 . . . . 74.33 107.055 172.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.58 -136.38 33.87 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.249 -0.887 . . . . 74.35 111.528 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -109.43 117.87 35.16 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.212 0.53 . . . . 74.35 111.096 -159.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.23 95.99 4.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.092 0.957 . . . . 72.23 108.929 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.4 t -69.78 -29.58 66.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.003 -0.998 . . . . 51.43 112.064 -175.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -122.04 149.76 43.06 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.144 1.338 . . . . 73.51 110.916 -168.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.62 133.52 20.18 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.827 1.251 . . . . 65.32 109.231 169.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -151.63 125.28 8.99 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 107.5 -1.296 . . . . 71.14 107.5 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.9 t -142.62 96.9 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.018 -2.216 . . . . 74.54 105.018 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -64.89 -176.13 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.137 1.775 . . . . 74.14 108.818 161.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -115.15 78.51 1.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 O-C-N 120.585 -1.322 . . . . 75.54 107.793 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -158.41 42.0 0.26 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.945 1.298 . . . . 62.51 110.227 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.15 9.3 14.61 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.525 1.536 . . . . 73.11 116.385 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.2 p -134.7 168.13 19.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.977 1.889 . . . . 61.52 109.95 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -146.41 151.94 24.13 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 107.454 -2.258 . . . . 75.32 107.454 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.87 121.4 58.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.771 -1.566 . . . . 72.23 106.771 -172.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.4 t -135.81 147.84 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.387 -1.709 . . . . 74.53 106.387 -159.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -136.58 113.81 10.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 105.47 -2.048 . . . . 75.22 105.47 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -86.42 172.22 10.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.741 1.217 . . . . 72.23 108.424 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.7 t -70.65 -56.7 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 118.588 -0.72 . . . . 73.33 110.635 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -139.26 168.26 20.23 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 119.556 1.071 . . . . 74.42 111.034 -171.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -56.04 -36.34 67.89 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 117.479 -1.248 . . . . 71.41 110.343 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -67.01 -47.53 71.15 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.168 1.349 . . . . 73.33 109.847 -171.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.67 -51.67 68.59 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.837 1.655 . . . . 75.12 109.3 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.423 ' HG3' ' CG1' ' A' ' 18' ' ' VAL . 62.8 ttp -55.57 -50.57 69.73 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.825 0.85 . . . . 73.11 111.767 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.6 m -54.56 -53.53 53.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.963 -1.018 . . . . 74.45 109.258 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -49.84 -32.77 15.03 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.311 0.96 . . . . 75.42 111.527 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.2 -45.9 91.56 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.916 0.886 . . . . 73.32 111.033 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -68.52 -16.66 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.381 -0.824 . . . . 72.45 110.902 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -108.89 -19.58 13.35 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.216 -0.927 . . . . 72.43 113.147 -167.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -136.21 -9.03 2.0 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.579 1.151 . . . . 74.24 111.75 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.7 17.49 6.33 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.851 1.26 . . . . 75.34 110.385 -167.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.58 150.79 28.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.628 1.171 . . . . 73.42 112.099 -171.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.06 32.3 0.86 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.726 2.01 . . . . 71.15 113.202 -167.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.3 p -75.02 177.06 6.63 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.05 0.94 . . . . 72.43 109.631 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -72.97 176.49 5.68 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.564 0.345 . . . . 73.21 111.078 162.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -151.55 128.46 10.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 128.212 2.605 . . . . 74.12 108.639 168.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -75.84 124.45 27.33 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.378 1.071 . . . . 73.22 109.576 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.44 157.41 17.66 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.241 0.616 . . . . 72.12 110.475 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -80.63 -0.39 37.78 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.218 1.007 . . . . 55.12 112.097 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -86.1 4.67 37.21 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.573 1.949 . . . . 55.52 111.569 170.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.38 20.1 74.98 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 119.037 0.835 . . . . 65.43 111.886 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -120.91 177.85 4.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 127.302 2.241 . . . . 64.51 107.749 170.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.6 p -140.58 134.36 30.42 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.247 -1.39 . . . . 63.12 107.247 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.96 173.19 6.78 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.922 -1.111 . . . . 71.53 110.07 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -87.67 161.89 17.41 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.499 -0.926 . . . . 75.11 108.499 158.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.9 pt -137.93 141.46 38.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.414 1.086 . . . . 74.15 109.245 173.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -96.95 120.92 38.2 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.415 -1.698 . . . . 74.24 106.415 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.2 t -89.32 137.03 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.611 -1.255 . . . . 74.24 107.611 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -145.48 157.52 43.99 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.379 1.472 . . . . 72.33 109.545 169.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.21 143.41 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 126.19 1.796 . . . . 75.13 106.347 170.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 C--O 1.255 1.379 0 C-N-CA 124.281 1.032 . . . . 72.14 108.447 167.154 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 108.283 -1.006 . . . . 74.05 108.283 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -68.22 26.45 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.086 2.554 . . . . 71.32 114.925 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.9 23.35 3.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.29 1.436 . . . . 72.32 109.488 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.27 143.75 47.16 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.568 1.147 . . . . 74.03 111.16 -168.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.97 156.47 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.877 1.271 . . . . 73.34 109.045 -165.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -141.3 120.4 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.992 1.269 . . . . 74.15 109.742 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.54 155.01 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.85 1.66 . . . . 73.12 109.867 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -143.87 167.58 21.98 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.379 1.072 . . . . 72.35 109.366 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.0 14.41 64.67 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.27 0.462 . . . . 55.53 112.778 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.96 148.68 87.12 Favored Pre-proline 0 CA--C 1.537 0.461 0 O-C-N 121.991 -0.711 . . . . 71.34 110.355 -168.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.18 167.44 23.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 124.996 3.798 . . . . 74.21 111.733 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.05 -21.19 56.6 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.791 2.327 . . . . 72.42 113.229 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.15 35.98 4.73 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.5 1.12 . . . . 75.32 111.314 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.99 156.42 51.65 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 107.503 -2.239 . . . . 63.25 107.503 158.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.4 m -152.47 173.24 15.37 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.771 0.828 . . . . 75.02 110.541 165.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -63.48 -21.8 66.52 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.227 1.011 . . . . 65.22 111.894 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -65.74 -63.83 1.0 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.383 1.073 . . . . 74.41 108.95 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -34.62 78.82 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 118.606 -1.238 . . . . 71.24 110.482 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -47.78 64.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.484 1.038 . . . . 73.22 111.017 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -66.94 -32.23 73.34 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.882 1.219 . . . . 72.14 111.557 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.23 -7.01 59.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.018 0.927 . . . . 65.02 113.194 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -106.09 -58.06 1.96 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.361 1.864 . . . . 73.44 108.1 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.6 ttt -79.23 73.05 5.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.312 1.445 . . . . 72.24 109.079 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -139.01 -0.32 1.88 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.892 0.877 . . . . 74.21 113.21 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -91.45 -1.11 57.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.5 1.52 . . . . 73.35 112.286 -169.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.2 -6.26 14.59 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.38 -0.825 . . . . 72.02 112.617 -170.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.3 -111.4 0.47 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.936 -1.48 . . . . 70.21 112.182 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -136.37 139.46 42.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.169 1.485 . . . . 74.12 109.817 169.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.7 t -124.13 97.77 4.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 124.847 1.259 . . . . 70.22 107.686 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 t -67.39 -54.84 16.92 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.119 -0.363 . . . . 73.03 110.054 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -83.8 175.92 9.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.316 1.846 . . . . 72.44 111.816 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -167.08 130.73 1.86 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.542 1.137 . . . . 73.41 111.398 166.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -157.36 136.99 12.2 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.793 1.178 . . . . 72.25 112.514 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.9 t -147.59 135.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.642 1.577 . . . . 75.25 107.492 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -112.12 152.85 27.81 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.241 1.416 . . . . 63.24 109.203 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -80.45 65.86 5.75 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.34 0.656 . . . . 73.0 110.338 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -130.45 -11.65 4.0 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.363 0.665 . . . . 75.02 112.361 168.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.86 17.36 7.96 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.756 -1.024 . . . . 63.13 112.531 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.97 158.46 43.87 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.939 1.37 . . . . 71.2 110.007 -171.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.67 107.98 0.34 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.42 -1.072 . . . . 74.03 110.42 -170.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.19 147.98 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 118.006 0.903 . . . . 71.43 109.634 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 t -139.37 163.94 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 106.981 -1.488 . . . . 74.04 106.981 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -146.74 126.42 13.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.163 -1.421 . . . . 74.04 107.163 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.3 170.49 8.62 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.183 -1.414 . . . . 72.45 107.183 172.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.93 -60.26 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.908 -0.775 . . . . 72.23 108.908 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -131.69 167.01 20.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.366 0.603 . . . . 74.23 110.155 -168.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -65.81 -27.38 68.22 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 118.138 -0.934 . . . . 71.34 110.377 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -57.46 -50.31 73.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.602 1.092 . . . . 70.41 109.745 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -67.68 -51.42 49.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.943 2.097 . . . . 74.34 107.833 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -57.33 -45.09 84.64 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.389 1.076 . . . . 74.32 112.755 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.6 m -59.15 -46.26 88.83 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.739 -1.226 . . . . 73.31 111.292 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -60.81 -29.95 69.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.07 0.548 . . . . 72.12 110.438 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.24 91.87 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.018 0.927 . . . . 74.21 111.519 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 83.6 t -72.69 -19.28 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 120.705 -1.247 . . . . 74.44 110.36 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -77.17 -57.55 3.77 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.018 -1.051 . . . . 73.45 109.56 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -100.21 -12.51 19.51 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.159 0.984 . . . . 72.23 113.225 -164.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.51 8.91 3.13 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.558 1.143 . . . . 73.45 111.899 -155.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -106.0 163.1 13.03 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.158 1.383 . . . . 72.34 110.017 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.321 6.8 p30 53.92 37.44 26.63 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 119.439 1.018 . . . . 72.44 110.808 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -93.77 172.55 8.18 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 131.625 3.97 . . . . 65.31 111.756 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -85.06 174.72 9.5 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.503 1.121 . . . . 74.14 109.881 160.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -155.81 133.43 11.07 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.756 1.222 . . . . 73.14 110.977 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -72.84 141.47 47.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.114 0.87 . . . . 73.14 110.988 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.79 171.79 7.54 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.961 0.886 . . . . 74.35 110.814 156.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -67.59 -22.66 65.36 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 113.613 -1.63 . . . . 75.14 112.33 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -87.69 14.2 8.99 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.176 0.99 . . . . 75.51 111.787 -169.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.11 30.77 74.06 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.454 -1.058 . . . . 72.32 110.454 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -132.13 159.34 39.23 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 127.076 2.15 . . . . 71.23 106.548 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.6 p -142.63 113.71 7.65 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.045 0.926 . . . . 73.44 110.405 -171.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.75 177.4 8.91 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 125.909 1.683 . . . . 71.25 110.417 -173.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -106.31 144.78 32.51 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.488 -0.93 . . . . 74.43 108.488 158.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.2 pt -131.28 170.05 20.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 124.554 1.142 . . . . 73.11 108.94 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -125.02 151.87 45.01 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.966 -1.124 . . . . 73.01 107.966 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.1 t -114.9 114.8 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 128.341 2.656 . . . . 72.23 105.925 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -123.87 164.69 18.73 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 121.757 -0.589 . . . . 74.32 110.116 164.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.9 t -67.1 154.95 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 106.74 -1.578 . . . . 74.45 106.74 170.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.276 -1.009 . . . . 72.13 108.276 170.234 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.1 m . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 108.591 -0.892 . . . . 74.5 108.591 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -72.35 26.9 0.05 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.949 2.1 . . . . 71.3 113.664 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.43 41.18 3.49 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.925 -1.509 . . . . 62.22 106.925 174.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.19 136.43 49.23 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.848 1.259 . . . . 74.51 109.133 -172.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.439 ' CG1' ' HG3' ' A' ' 63' ' ' MET . 33.7 m -137.61 169.08 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.008 0.923 . . . . 74.12 111.324 -169.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 40.8 t -132.44 156.31 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 104.604 -2.369 . . . . 73.14 104.604 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.3 t -130.89 151.27 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.047 -1.464 . . . . 73.33 107.047 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.4 p -136.56 167.89 20.53 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.542 1.064 . . . . 73.14 109.174 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.58 4.43 70.35 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.576 1.56 . . . . 72.11 113.557 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.58 148.1 67.53 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 119.528 1.664 . . . . 73.24 112.298 -169.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.58 163.22 36.43 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.142 1.894 . . . . 73.15 109.917 174.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.1 -8.49 20.29 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.898 3.066 . . . . 65.31 115.633 -165.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.53 19.64 2.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.781 1.232 . . . . 74.24 110.829 -175.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.87 103.52 2.0 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 108.594 -1.802 . . . . 65.21 108.594 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.9 m -85.9 169.73 13.01 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.128 0.964 . . . . 72.14 110.773 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -64.06 -24.46 67.71 Favored 'General case' 0 C--O 1.226 -0.136 0 O-C-N 121.86 -0.525 . . . . 73.35 110.77 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -50.45 72.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.472 1.509 . . . . 74.15 108.347 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.26 -41.91 80.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.249 0.477 . . . . 61.23 110.547 176.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -52.74 47.24 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.991 0.814 . . . . 72.31 109.884 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -65.14 -33.57 76.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.835 0.854 . . . . 74.33 110.827 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -80.01 -10.72 59.79 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.667 1.187 . . . . 74.33 113.263 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -112.68 -46.1 3.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.619 0.767 . . . . 74.34 109.866 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 17.2 ttt -67.04 -12.81 60.96 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.046 1.128 . . . . 74.41 114.046 -173.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -60.25 -11.5 6.51 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.893 1.277 . . . . 74.31 114.023 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -58.75 -27.92 65.4 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.47 1.032 . . . . 72.0 112.002 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.38 -9.83 59.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 113.822 1.045 . . . . 70.31 113.822 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.25 -148.83 17.39 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 119.941 1.246 . . . . 52.12 110.3 -171.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.45 91.65 8.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.579 1.657 . . . . 71.54 110.08 -166.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.45 144.61 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 113.524 -1.671 . . . . 74.4 106.608 161.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 2.3 t -138.13 -2.47 1.85 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.282 1.215 . . . . 73.53 114.282 172.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -138.25 145.43 41.32 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 121.125 1.784 . . . . 73.32 106.8 168.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.45 145.16 38.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.376 -0.972 . . . . 74.31 108.376 165.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -151.73 141.96 22.34 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.548 1.139 . . . . 74.42 109.238 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.9 m -144.33 176.11 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.368 1.467 . . . . 73.41 108.123 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -146.64 -177.24 5.54 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.704 1.202 . . . . 74.12 108.151 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -83.03 51.4 1.94 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.111 0.869 . . . . 64.25 109.083 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -139.65 176.24 8.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.405 -1.331 . . . . 73.25 107.405 167.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.75 53.61 4.86 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.331 -1.108 . . . . 70.31 110.331 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.03 154.56 32.67 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.354 1.077 . . . . 73.41 110.523 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.96 170.53 32.58 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.481 1.515 . . . . 71.44 110.394 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 33.7 t -146.13 142.93 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.094 1.757 . . . . 71.01 107.309 -176.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.6 t -145.21 164.02 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.113 -1.069 . . . . 73.33 108.113 -161.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -138.4 144.69 40.33 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.806 -1.553 . . . . 54.23 106.806 172.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -115.7 167.89 10.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.809 2.043 . . . . 74.42 107.638 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.4 m -73.42 -33.06 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.649 0.611 . . . . 74.13 112.649 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -156.95 159.74 38.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.74 0.7 . . . . 74.54 109.592 -171.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -64.85 -20.75 66.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 118.138 -0.934 . . . . 74.23 112.287 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.18 -64.14 0.94 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.391 1.076 . . . . 74.1 108.797 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.34 -42.18 81.43 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.881 0.872 . . . . 73.5 110.146 177.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.439 ' HG3' ' CG1' ' A' ' 18' ' ' VAL . 47.9 ttp -51.63 -57.94 7.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.541 0.336 . . . . 74.31 110.647 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.5 m -61.17 -38.33 86.1 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.96 0.904 . . . . 72.5 112.817 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -54.36 -34.97 62.23 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.224 0.92 . . . . 71.11 111.394 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.69 -43.43 76.39 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.657 -0.652 . . . . 74.04 112.08 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.33 -19.36 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.929 -1.107 . . . . 71.42 109.934 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -86.91 -36.46 18.36 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.513 1.125 . . . . 72.43 111.493 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.7 mmtm -132.72 0.95 3.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.648 0.981 . . . . 75.0 113.648 -160.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -143.34 16.64 1.87 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.386 1.075 . . . . 75.04 110.369 -167.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.25 156.32 17.65 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 119.294 -2.129 . . . . 74.31 112.561 173.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.2 t30 55.22 19.78 3.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.58 1.952 . . . . 75.24 114.059 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.5 p -70.31 173.32 6.93 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.958 1.703 . . . . 70.15 110.766 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -78.39 178.11 7.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.401 -0.592 . . . . 73.44 109.401 163.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -156.03 141.08 17.34 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.486 1.514 . . . . 74.43 112.102 168.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -94.5 109.48 21.36 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.133 2.173 . . . . 73.12 111.529 -170.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -93.39 165.5 12.74 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.53 1.514 . . . . 45.41 110.935 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.58 -17.56 44.44 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.085 -1.009 . . . . 72.43 113.112 176.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -80.97 22.94 0.58 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.233 1.413 . . . . 72.41 112.123 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.62 33.07 83.37 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.687 -0.633 . . . . 74.33 111.818 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.53 169.13 20.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.288 1.435 . . . . 72.01 110.275 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.6 p -148.87 131.06 15.48 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.331 1.052 . . . . 74.12 108.673 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.04 -178.94 3.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.653 0.781 . . . . 71.01 109.277 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -90.81 160.7 15.63 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.152 -0.684 . . . . 72.45 109.152 163.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.1 pt -136.54 167.1 24.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.546 1.138 . . . . 73.44 109.856 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -137.57 122.11 18.45 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.585 -1.265 . . . . 75.41 107.585 -170.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -84.86 148.79 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 118.47 0.577 . . . . 62.1 109.708 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.89 177.2 10.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.565 0.746 . . . . 73.31 109.896 162.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.02 153.95 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.503 -1.666 . . . . 75.43 106.503 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.4 t0 . . . . . 0 C--O 1.252 1.187 0 N-CA-C 105.959 -1.867 . . . . 72.32 105.959 158.843 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 106.56 -1.644 . . . . 64.4 106.56 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -84.52 24.3 1.02 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.901 1.68 . . . . 75.22 112.27 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.32 23.75 5.94 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 119.997 -1.689 . . . . 63.14 110.971 -169.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.2 122.02 40.04 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 121.376 -0.827 . . . . 74.44 111.132 -159.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.07 159.96 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.24 1.816 . . . . 73.4 108.972 174.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 24.3 m -136.77 176.85 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 127.117 2.167 . . . . 74.13 108.139 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 m -135.89 159.11 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.925 -1.139 . . . . 72.1 107.925 -162.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.88 169.52 22.63 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 123.912 0.885 . . . . 64.12 110.192 -176.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.09 11.1 69.96 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.008 0.813 . . . . 44.34 113.831 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mt -60.31 148.83 78.49 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 118.845 1.323 . . . . 72.3 111.193 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -75.13 170.01 21.32 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.23 2.62 . . . . 72.0 110.39 168.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.93 -36.91 21.26 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.677 2.251 . . . . 73.4 113.969 -175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.6 32.67 3.26 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 119.841 1.201 . . . . 74.44 110.918 -173.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.07 173.94 44.59 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-O 123.033 1.352 . . . . 65.11 109.776 164.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.4 p -159.43 168.88 25.18 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.063 1.745 . . . . 64.42 107.883 171.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -62.19 -27.34 68.9 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 122.116 -0.365 . . . . 74.3 111.26 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -65.02 -50.02 67.89 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.983 0.913 . . . . 73.01 109.807 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -67.45 -26.32 66.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.356 1.063 . . . . 74.31 111.02 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.08 -55.97 8.12 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.172 -1.047 . . . . 74.4 108.172 171.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -63.61 -35.75 81.56 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.299 -0.875 . . . . 75.34 111.85 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -75.3 -5.75 46.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.81 0.844 . . . . 64.32 113.244 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.467 ' CG ' HH21 ' A' ' 76' ' ' ARG . 2.2 t-160 -119.05 -43.7 2.63 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.262 1.025 . . . . 75.23 112.828 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 8.8 ttt -76.27 41.83 0.25 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.452 -0.78 . . . . 74.1 110.752 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.2 ptm85 -111.28 -16.5 13.38 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.074 -1.641 . . . . 74.15 112.372 -170.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -84.58 -5.28 59.29 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.666 1.358 . . . . 55.24 114.666 -168.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.12 -13.73 24.82 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.755 0.822 . . . . 64.04 112.388 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.18 -176.23 24.33 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.767 -0.933 . . . . 72.31 110.767 -170.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.21 127.25 32.48 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.241 -0.564 . . . . 72.03 111.696 -166.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.2 t -118.05 123.29 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 C-N-CA 124.252 1.021 . . . . 74.43 108.948 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.82 -19.88 19.26 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 117.993 -1.003 . . . . 74.43 112.362 -177.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -130.02 166.98 19.0 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.362 1.437 . . . . 72.22 111.798 -170.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -163.29 139.73 7.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.412 1.085 . . . . 71.11 111.617 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -146.84 143.34 28.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.559 1.144 . . . . 64.13 109.741 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.4 t -144.41 148.4 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.074 1.35 . . . . 74.33 107.982 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -139.87 168.47 19.73 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.859 1.263 . . . . 72.42 110.554 175.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -84.06 40.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 127.294 2.237 . . . . 74.02 111.327 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -130.2 43.19 3.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.59 1.186 . . . . 71.24 109.205 170.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.14 12.34 30.16 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.357 -1.246 . . . . 65.44 114.523 172.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.3 p -143.12 157.45 44.51 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 120.429 2.115 . . . . 73.31 109.282 -169.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.79 178.26 27.41 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 107.553 -2.219 . . . . 71.31 107.553 -172.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 31.0 t -155.96 137.79 5.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 105.393 -2.076 . . . . 74.04 105.393 -170.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.62 170.53 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.381 -1.34 . . . . 74.21 107.381 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -146.88 125.41 12.44 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.328 -2.101 . . . . 51.22 105.328 162.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -100.35 164.59 11.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.185 -1.783 . . . . 75.22 106.185 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.8 m -73.39 -29.5 27.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.307 -0.957 . . . . 73.21 112.266 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -151.82 165.41 34.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.526 0.603 . . . . 75.41 112.488 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -61.81 -28.38 69.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.884 -1.055 . . . . 74.33 110.944 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.13 -59.76 4.33 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.17 0.896 . . . . 74.24 108.729 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.31 -46.52 86.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.586 1.555 . . . . 73.43 109.139 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -50.38 -55.46 15.6 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.253 1.021 . . . . 74.55 111.344 172.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.7 m -54.04 -44.2 70.84 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.779 0.718 . . . . 73.42 110.956 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -62.08 -40.88 97.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.11 -0.33 . . . . 75.44 110.11 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.95 -41.0 86.38 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.949 -0.469 . . . . 75.24 111.364 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.49 -10.24 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 121.497 -0.752 . . . . 61.2 110.975 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -119.12 -1.49 10.89 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.468 1.031 . . . . 71.44 113.721 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.0 -5.05 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.163 0.985 . . . . 75.25 112.586 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.99 24.24 3.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.633 1.173 . . . . 74.23 109.28 -171.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.34 156.83 17.59 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.796 -1.19 . . . . 71.13 110.361 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.13 20.96 1.96 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.389 2.276 . . . . 74.32 113.351 -174.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.3 p -74.31 174.62 8.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.528 1.931 . . . . 62.23 111.582 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -77.15 162.82 27.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.082 0.953 . . . . 74.13 110.116 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -148.18 121.13 8.77 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.726 1.611 . . . . 74.44 108.469 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.467 HH21 ' CG ' ' A' ' 35' ' ' HIS . 6.7 ptp180 -74.75 157.24 35.58 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.839 0.856 . . . . 72.42 109.747 173.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.9 p -141.42 163.26 33.42 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.13 0.572 . . . . 73.12 111.124 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -71.41 -12.43 61.41 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.579 1.551 . . . . 74.13 112.169 -174.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.75 8.58 2.32 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.755 1.222 . . . . 73.22 111.701 169.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.12 21.09 76.94 Favored Glycine 0 C--N 1.337 0.634 0 O-C-N 121.096 -1.002 . . . . 73.42 112.008 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -127.37 167.99 15.44 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.115 1.366 . . . . 74.34 109.065 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -140.27 145.6 37.51 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.387 -0.968 . . . . 73.1 108.387 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -127.26 -168.92 1.95 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.499 1.92 . . . . 72.2 107.022 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -103.72 161.94 13.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.785 -0.82 . . . . 74.1 108.785 165.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.8 pt -132.65 162.97 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-O 121.189 0.519 . . . . 73.2 109.793 169.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -120.09 103.01 8.92 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.543 1.537 . . . . 74.4 108.086 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 t -70.0 139.27 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.623 -1.251 . . . . 75.2 107.623 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -138.05 168.02 20.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.327 0.967 . . . . 74.32 110.467 159.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.7 t -78.57 140.8 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.047 -1.464 . . . . 75.5 107.047 170.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 44.5 t0 . . . . . 0 C--O 1.248 1.003 0 N-CA-C 107.273 -1.38 . . . . 65.54 107.273 167.521 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 107.43 -1.322 . . . . 75.41 107.43 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.56 25.72 0.05 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.229 2.612 . . . . 75.45 113.212 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.52 35.77 3.81 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.485 1.514 . . . . 75.23 108.326 -177.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -115.77 124.43 50.75 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.771 1.628 . . . . 73.34 108.436 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.55 166.26 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.336 1.854 . . . . 74.05 110.05 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -137.0 141.11 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.275 1.83 . . . . 75.12 106.506 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.7 t -112.99 152.16 14.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.792 1.237 . . . . 75.43 107.725 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.99 164.34 32.37 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.585 -1.265 . . . . 72.14 107.585 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.88 14.33 82.26 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.815 -0.992 . . . . 62.25 113.07 -173.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.61 145.27 98.67 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 119.762 1.781 . . . . 72.24 110.94 -166.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.33 169.86 10.29 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.095 2.53 . . . . 73.22 110.717 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.16 -13.92 39.28 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.761 1.641 . . . . 72.14 113.108 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -138.37 17.65 2.75 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.429 1.27 . . . . 64.01 114.429 -155.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.74 97.7 1.18 Allowed Glycine 0 C--N 1.335 0.507 0 N-CA-C 108.51 -1.836 . . . . 62.14 108.51 170.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.92 179.2 4.43 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.833 0.816 . . . . 71.33 110.876 172.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -61.93 -28.09 69.29 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.723 -1.235 . . . . 73.45 114.272 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.33 -51.8 64.47 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.245 -1.391 . . . . 74.11 107.245 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.3 -47.52 83.42 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.137 1.375 . . . . 73.03 110.056 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.43 -58.22 4.95 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.638 0.775 . . . . 75.25 110.024 177.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.02 -37.86 78.87 Favored 'General case' 0 C--N 1.338 0.08 0 O-C-N 122.101 -0.374 . . . . 74.02 111.017 -171.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -7.71 14.2 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.284 0.846 . . . . 73.12 113.284 176.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -112.29 -49.32 2.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.173 0.989 . . . . 75.14 111.858 174.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.1 ttt -70.53 25.25 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.774 1.629 . . . . 64.32 112.945 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.51 -7.42 41.3 Favored 'General case' 0 C--O 1.222 -0.392 0 O-C-N 120.175 -1.578 . . . . 73.23 113.292 167.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.69 -23.05 67.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.83 1.65 . . . . 72.45 113.801 -172.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.48 -8.39 58.38 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.486 1.515 . . . . 61.22 113.951 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.21 -110.28 0.43 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 119.852 1.206 . . . . 71.13 111.448 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.99 138.31 22.86 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.34 1.067 . . . . 74.14 108.229 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.455 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.4 p -122.34 135.81 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 C-N-CA 127.42 2.288 . . . . 71.42 109.595 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.1 p -103.17 -25.88 13.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.386 -0.825 . . . . 61.11 110.104 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -130.67 136.9 49.26 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.74 1.616 . . . . 73.02 109.071 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.92 150.05 46.73 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.003 0.921 . . . . 74.24 108.635 158.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -148.05 132.69 17.82 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.458 1.903 . . . . 73.2 107.494 172.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.1 t -137.98 137.61 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.599 -2.0 . . . . 72.31 105.599 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.29 -163.83 0.22 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.0 1.72 . . . . 74.1 109.833 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 ptm85 -43.54 -57.49 3.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.532 -1.667 . . . . 70.33 111.118 159.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -172.7 168.76 5.12 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.803 1.638 . . . . 61.34 114.443 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.28 -39.95 3.06 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 128.152 2.787 . . . . 74.13 114.822 168.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.96 168.47 19.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.997 1.399 . . . . 61.21 109.242 -173.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.71 152.29 23.38 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.063 -1.615 . . . . 62.13 109.063 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -118.4 139.96 43.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.731 -1.211 . . . . 74.14 107.731 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.4 t -140.92 146.51 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.486 -1.672 . . . . 62.11 106.486 -168.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -138.29 106.97 5.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 120.815 -1.178 . . . . 65.25 108.085 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.455 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 1.3 m-85 -76.51 163.76 26.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.201 1.801 . . . . 75.25 108.943 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.6 m -74.47 -39.17 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 120.955 -1.091 . . . . 63.35 112.499 -172.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -143.09 159.27 42.58 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.195 0.598 . . . . 75.42 110.412 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -67.26 -26.89 66.79 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 117.609 -1.186 . . . . 75.42 111.698 -174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -51.72 -63.56 1.1 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 122.341 1.067 . . . . 75.01 108.429 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -73.2 -41.36 63.9 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.999 1.719 . . . . 72.44 108.446 -167.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -52.62 -49.85 64.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.443 1.097 . . . . 75.43 111.245 170.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.4 m -61.19 -43.31 99.08 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.461 -0.774 . . . . 73.11 110.523 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -56.44 -41.31 76.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.93 0.786 . . . . 74.14 110.328 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.58 -43.49 68.56 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 123.729 0.812 . . . . 75.15 111.876 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.96 -34.94 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 120.596 1.543 . . . . 75.22 110.375 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.8 ptt85 -92.49 -16.32 25.96 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.145 1.165 . . . . 74.22 114.145 -170.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -117.18 -37.43 3.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.248 1.019 . . . . 74.24 111.482 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.04 22.57 12.05 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.367 1.467 . . . . 75.34 110.095 -167.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -101.16 154.96 18.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.306 1.412 . . . . 74.14 111.841 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.0 t30 63.7 14.88 8.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.148 2.579 . . . . 75.42 112.981 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.5 p -76.13 175.17 9.21 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.746 1.218 . . . . 73.43 110.832 -169.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -66.92 170.92 5.95 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.3 -0.875 . . . . 75.35 108.954 155.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -149.67 126.7 11.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.432 1.093 . . . . 74.04 109.553 166.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.5 mtt-85 -82.98 120.38 25.64 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.442 1.497 . . . . 75.43 111.511 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.8 p -76.25 -172.19 2.0 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.597 -0.89 . . . . 72.01 108.597 154.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -89.24 -8.16 54.02 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.006 -1.059 . . . . 71.32 110.99 165.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -76.82 5.55 7.59 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.84 -1.163 . . . . 73.34 113.64 -167.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.36 17.06 67.46 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 124.309 0.956 . . . . 74.15 110.845 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.6 167.14 20.58 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.139 1.376 . . . . 74.34 108.763 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.9 p -146.55 128.48 15.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.352 -0.981 . . . . 63.45 108.352 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.51 175.69 8.22 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.155 -1.054 . . . . 61.14 108.155 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -92.08 156.54 17.31 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.092 -1.818 . . . . 75.32 106.092 144.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.5 pt -131.64 173.74 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.558 -1.275 . . . . 74.25 107.558 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -128.94 150.4 50.4 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.231 -1.396 . . . . 75.25 107.231 168.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.8 t -122.62 137.21 56.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 126.081 1.752 . . . . 75.44 107.664 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.61 158.84 43.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.04 1.336 . . . . 75.53 108.902 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.3 t -70.43 149.89 10.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.45 -1.685 . . . . 72.34 106.45 162.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.3 t70 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.813 -1.089 . . . . 75.41 110.369 172.445 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 108.509 -0.922 . . . . 72.21 108.509 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -73.42 44.65 0.16 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.446 1.898 . . . . 73.51 111.9 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.23 22.3 3.22 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.125 -1.609 . . . . 75.13 110.861 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -121.61 136.79 54.93 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.937 -1.102 . . . . 74.42 109.285 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.51 155.99 16.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.112 -0.699 . . . . 71.54 109.112 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.97 141.26 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 124.893 1.277 . . . . 72.41 107.671 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.0 t -101.88 147.27 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 126.727 2.011 . . . . 75.35 107.805 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.08 156.45 48.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.726 0.694 . . . . 74.44 110.632 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.94 3.53 70.3 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.674 1.13 . . . . 74.23 114.084 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.9 mt -58.26 147.12 68.23 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.449 1.1 . . . . 72.41 113.448 -164.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.22 165.6 31.91 Favored 'Trans proline' 0 CA--C 1.538 0.694 1 C-N-CA 126.051 4.501 . . . . 74.22 112.841 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -67.61 -15.76 45.43 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.669 2.913 . . . . 62.53 114.754 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.04 22.72 9.48 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.536 1.134 . . . . 73.2 110.023 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.45 72.75 2.71 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.56 -1.016 . . . . 74.24 110.56 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -69.68 162.8 26.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 124.423 0.72 . . . . 72.13 111.126 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.0 p-90 -61.55 -19.54 62.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.714 0.806 . . . . 74.24 111.467 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -60.49 3.28 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 117.093 -1.432 . . . . 74.15 109.385 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -64.46 -39.9 94.69 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.128 0.893 . . . . 54.42 109.544 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -48.6 52.37 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 123.247 0.619 . . . . 64.51 110.866 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -67.77 -44.15 78.14 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.708 0.685 . . . . 75.23 110.81 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.41 -13.07 62.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.767 1.227 . . . . 63.22 112.499 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -108.74 -43.85 4.16 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.986 1.314 . . . . 75.43 112.455 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.5 ttt -77.59 42.72 0.37 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.59 -1.319 . . . . 75.32 111.198 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.5 -5.65 12.83 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.092 -1.63 . . . . 75.05 113.366 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -63.19 -22.55 66.94 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.565 1.529 . . . . 73.34 113.833 -172.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.47 -5.44 59.16 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.06 1.504 . . . . 74.35 115.06 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.27 -98.6 0.21 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-O 118.349 -1.251 . . . . 64.04 111.034 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.15 149.53 31.19 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.579 1.189 . . . . 71.43 112.188 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.4 t -130.55 148.22 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.79 1.636 . . . . 75.34 109.509 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.9 t -129.76 8.19 5.29 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.525 0.73 . . . . 64.44 112.293 -170.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -154.08 162.88 40.89 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.593 1.557 . . . . 74.12 108.81 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -162.04 129.9 4.04 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.867 0.867 . . . . 73.01 109.583 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -155.75 128.61 7.99 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.268 0.94 . . . . 72.14 111.184 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.01 177.38 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 O-C-N 120.522 -1.361 . . . . 71.33 107.398 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.21 161.04 42.27 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.312 -1.366 . . . . 72.14 107.312 168.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.5 ' HG3' ' H ' ' A' ' 50' ' ' ASP . 21.0 ptt180 42.36 -86.87 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.426 1 C-N-CA 132.116 4.166 . . . . 74.4 112.114 162.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.5 ' H ' ' HG3' ' A' ' 49' ' ' ARG . 1.1 p30 -165.48 -178.02 4.73 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 128.002 2.521 . . . . 74.54 110.209 153.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.74 -21.12 31.47 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-O 117.879 -1.512 . . . . 74.1 114.293 161.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.02 164.82 37.28 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 120.154 1.977 . . . . 73.43 108.448 168.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.0 143.05 8.17 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 107.816 -2.114 . . . . 74.13 107.816 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.7 p -107.99 144.9 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.726 1.263 . . . . 75.53 109.567 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.2 t -142.81 156.58 18.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 107.152 -1.425 . . . . 74.55 107.152 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -136.49 112.85 9.91 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.93 -1.507 . . . . 73.22 106.93 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -80.0 177.81 8.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.977 -1.465 . . . . 73.53 107.237 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.54 -60.99 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.046 -0.979 . . . . 71.45 110.399 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -139.19 169.17 18.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 124.24 1.016 . . . . 75.31 109.671 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -59.45 -29.73 68.0 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 116.875 -1.536 . . . . 74.33 111.791 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -60.55 -60.01 4.48 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.086 1.312 . . . . 73.15 109.877 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.64 -42.45 98.15 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.904 0.882 . . . . 71.54 109.695 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -58.31 -50.61 73.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.282 1.033 . . . . 70.44 110.721 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.9 m -57.57 -52.76 64.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.255 -0.646 . . . . 75.12 109.255 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -56.57 -32.13 64.89 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.627 0.771 . . . . 75.42 112.077 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.54 93.64 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 123.304 0.641 . . . . 63.33 110.024 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 t -70.29 -12.99 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.229 -0.919 . . . . 52.22 110.84 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -105.35 -33.1 8.29 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 120.875 -1.141 . . . . 74.11 111.957 -174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -121.51 -12.42 8.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.377 1.071 . . . . 74.54 112.759 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.1 18.24 10.81 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.246 1.818 . . . . 73.55 109.434 -172.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -112.57 148.71 33.97 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.725 -1.234 . . . . 74.24 110.836 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.77 27.84 16.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.395 1.078 . . . . 72.33 111.032 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.1 p -90.44 175.93 6.9 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.85 1.26 . . . . 73.52 109.807 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.86 167.82 21.11 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.831 -0.803 . . . . 73.53 108.831 158.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -146.05 160.79 41.4 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 127.328 2.251 . . . . 74.24 110.656 173.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -114.93 126.18 54.49 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.313 0.96 . . . . 72.52 109.16 -173.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.7 t -93.33 163.58 13.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.874 -0.787 . . . . 75.5 108.874 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.52 -8.37 56.56 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 119.112 -0.47 . . . . 73.2 111.749 166.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -78.43 -12.99 60.04 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.927 1.239 . . . . 73.22 113.339 -169.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.65 31.69 4.77 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 124.327 0.965 . . . . 74.24 111.864 -173.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.1 168.29 26.41 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.036 0.934 . . . . 73.11 110.936 -169.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.5 p -145.2 122.53 11.59 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.566 -1.197 . . . . 73.44 108.565 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.02 -174.17 2.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.603 1.961 . . . . 61.4 108.392 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -105.1 156.37 18.14 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 120.477 1.489 . . . . 72.43 110.59 172.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.6 pt -129.8 170.37 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 122.115 0.96 . . . . 71.44 108.987 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -130.61 155.51 46.42 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 104.791 -2.299 . . . . 71.21 104.791 172.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.8 t -125.97 137.33 58.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.982 -1.118 . . . . 74.34 107.982 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -130.41 147.7 52.14 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 123.853 0.861 . . . . 65.51 110.592 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.66 127.61 24.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 105.722 -1.955 . . . . 74.42 105.722 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 127.678 2.391 . . . . 61.31 111.09 -172.992 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 106.97 -1.493 . . . . 74.02 106.97 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -76.34 37.15 0.16 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.709 1.603 . . . . 74.2 112.301 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.8 14.94 3.63 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.465 1.906 . . . . 74.03 110.746 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.33 121.39 42.66 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.512 1.525 . . . . 73.02 107.526 -162.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.8 m -115.14 166.12 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 118.504 0.593 . . . . 72.21 111.455 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.3 t -132.74 153.01 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.092 -1.818 . . . . 72.34 106.092 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 t -134.11 141.03 44.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 106.955 -1.498 . . . . 74.42 106.955 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.3 m -137.31 141.81 41.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 123.127 1.442 . . . . 74.33 113.266 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.19 37.43 48.8 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 128.578 2.99 . . . . 73.24 112.773 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.63 160.77 3.67 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.853 1.661 . . . . 74.42 113.021 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.83 171.02 14.13 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.612 3.541 . . . . 73.11 112.014 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.76 -4.89 16.18 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.739 2.293 . . . . 73.23 114.239 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.8 t -141.58 51.66 1.55 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.615 1.166 . . . . 73.34 109.08 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.95 164.55 13.22 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.365 -1.494 . . . . 74.2 109.365 168.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 m -151.66 168.41 25.09 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.405 1.482 . . . . 73.2 108.426 167.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -53.0 -29.3 28.39 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.203 0.816 . . . . 70.31 113.203 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -62.79 -58.24 8.11 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.424 1.089 . . . . 72.44 108.911 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.3 -30.6 67.64 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.453 -0.573 . . . . 70.13 109.453 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -51.29 -56.05 15.05 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.33 -0.856 . . . . 72.5 109.78 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -70.47 -35.62 73.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.919 1.288 . . . . 65.53 110.034 -175.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -59.63 -23.04 62.68 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.245 1.018 . . . . 73.33 112.953 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -102.59 -42.89 5.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.153 0.981 . . . . 74.51 111.431 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.19 -20.42 65.4 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.154 -0.966 . . . . 74.43 113.244 -174.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -52.55 -26.2 12.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.827 1.417 . . . . 74.4 114.827 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -71.06 3.08 3.69 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.687 1.736 . . . . 65.43 115.687 -161.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.75 -0.96 28.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.642 1.177 . . . . 74.44 111.955 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.47 -97.95 0.16 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.617 -1.793 . . . . 50.02 108.617 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -157.76 162.53 38.51 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.795 1.283 . . . . 62.52 107.789 166.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.442 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -131.81 129.73 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 126.738 2.015 . . . . 64.33 109.818 -175.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.7 t -86.85 -32.62 20.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.577 -1.192 . . . . 74.32 109.341 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -138.47 137.16 36.9 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.156 -0.965 . . . . 74.32 110.638 -160.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.76 149.43 37.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.203 1.001 . . . . 74.31 110.771 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -161.63 106.97 1.3 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.879 2.072 . . . . 63.11 108.821 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.93 -176.71 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.282 -1.511 . . . . 73.13 107.985 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -143.16 155.17 44.5 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.892 -0.781 . . . . 74.52 108.892 156.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 43.37 -86.13 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 130.666 3.587 . . . . 64.13 111.838 166.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -159.38 173.97 15.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 125.231 1.582 . . . . 72.24 107.52 147.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.08 -8.92 63.27 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 118.605 -1.108 . . . . 71.44 113.343 161.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.56 164.84 33.93 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.635 1.717 . . . . 74.1 108.294 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -155.8 163.21 31.65 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.174 -1.17 . . . . 72.53 110.174 167.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.6 147.54 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.493 1.917 . . . . 73.32 108.23 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.1 t -144.0 166.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.943 -1.132 . . . . 73.44 107.943 -165.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -135.81 109.68 8.16 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.249 -1.389 . . . . 74.44 107.249 165.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.442 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -79.12 167.11 21.49 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.495 1.518 . . . . 70.33 108.336 172.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.71 -29.98 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.212 1.19 . . . . 70.13 114.212 -166.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -156.31 164.39 38.38 Favored 'General case' 0 CA--C 1.515 -0.381 0 O-C-N 121.262 -0.899 . . . . 74.34 109.894 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -61.72 -31.95 72.15 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 117.448 -1.263 . . . . 74.43 111.632 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.29 -51.92 65.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 120.379 1.445 . . . . 72.42 109.724 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.46 -40.69 66.8 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.258 1.423 . . . . 61.22 108.706 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.2 ttp -52.25 -53.82 38.95 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 123.338 0.655 . . . . 65.04 109.98 169.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.4 m -55.31 -47.46 75.57 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.306 -0.854 . . . . 73.0 109.977 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -57.53 -28.34 63.4 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.866 1.212 . . . . 71.51 112.113 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.1 -44.91 83.0 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.469 1.108 . . . . 72.23 109.227 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.8 t -65.09 -21.76 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 121.192 -0.942 . . . . 73.33 110.778 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -91.9 -43.78 9.29 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 120.964 -1.085 . . . . 74.41 111.317 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -114.44 -15.62 12.05 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.069 1.348 . . . . 74.11 111.998 -165.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.32 22.15 9.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.478 1.911 . . . . 63.3 108.95 -171.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -111.83 154.53 24.98 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.45 -1.407 . . . . 72.42 110.87 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.269 5.8 p-10 45.25 41.67 6.31 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.103 2.161 . . . . 72.42 112.327 -170.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.0 p -95.97 175.15 6.59 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.545 1.138 . . . . 73.23 111.668 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 171.78 4.09 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.078 0.551 . . . . 74.1 109.541 158.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -150.97 124.78 9.14 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.104 1.361 . . . . 74.2 109.328 166.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -70.46 142.2 51.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.84 1.2 . . . . 74.24 110.47 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -109.11 -170.97 1.75 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.17 1.788 . . . . 71.52 107.507 176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -99.6 -3.21 33.74 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.303 0.853 . . . . 71.24 113.303 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.73 41.46 1.39 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.494 1.117 . . . . 62.44 111.465 -171.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.41 18.48 55.78 Favored Glycine 0 N--CA 1.464 0.538 0 C-N-CA 124.924 1.249 . . . . 51.21 113.408 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -142.99 174.09 10.98 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 125.492 1.517 . . . . 74.51 108.894 -166.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.5 p -147.19 143.35 28.14 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.813 -0.81 . . . . 71.54 108.813 -172.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.21 176.81 8.13 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.619 0.768 . . . . 70.51 110.565 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -104.13 154.79 19.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.984 -1.487 . . . . 73.53 106.984 141.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 pt -133.4 166.43 29.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 124.828 1.251 . . . . 74.52 108.603 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -126.51 133.5 51.13 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 105.822 -1.918 . . . . 74.23 105.822 165.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.5 t -84.44 165.96 2.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 125.779 1.632 . . . . 72.11 107.703 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.77 156.43 31.55 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.552 1.541 . . . . 73.33 107.967 162.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.78 138.51 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 105.18 -2.156 . . . . 63.1 105.18 156.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--O 1.245 0.853 0 C-N-CA 124.044 0.938 . . . . 65.31 110.568 177.361 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 108.319 -0.993 . . . . 74.5 108.319 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -70.53 24.35 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.054 2.541 . . . . 74.14 113.949 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.51 18.24 5.3 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.473 -1.392 . . . . 65.4 110.465 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.93 146.56 34.98 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.057 1.743 . . . . 71.34 111.106 -170.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.0 m -142.01 171.92 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 118.956 0.798 . . . . 74.43 111.012 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 39.5 t -140.96 148.15 21.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.188 -2.153 . . . . 72.23 105.188 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 t -118.83 154.88 21.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 125.006 1.322 . . . . 74.43 107.683 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.6 m -149.45 158.49 44.22 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 119.955 -1.716 . . . . 73.31 110.525 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.39 61.42 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.889 0.757 . . . . 71.35 112.895 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.1 154.85 37.49 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 124.866 1.267 . . . . 73.05 112.238 -175.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.63 174.54 12.06 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.45 3.434 . . . . 73.11 112.8 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.89 -8.08 21.74 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.625 2.217 . . . . 64.01 114.676 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.68 59.84 1.65 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.997 1.726 . . . . 70.33 109.685 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.97 149.12 16.87 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 108.199 -1.96 . . . . 70.11 108.199 172.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.1 m -137.6 -179.69 5.89 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 122.513 1.149 . . . . 72.14 108.144 168.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.3 p-90 -63.56 -18.53 63.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.92 1.288 . . . . 70.41 112.239 -176.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -69.89 -57.18 5.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.082 -1.081 . . . . 71.12 108.082 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -64.39 -26.91 68.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.548 0.69 . . . . 71.32 110.455 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -64.74 -54.05 37.46 Favored 'General case' 0 C--O 1.224 -0.264 0 O-C-N 120.235 -1.54 . . . . 65.32 110.653 174.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -65.51 -25.83 67.63 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.864 0.866 . . . . 73.41 110.865 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -31.89 64.97 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.808 -0.812 . . . . 74.31 108.808 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -83.82 -53.41 5.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.231 1.813 . . . . 72.51 112.088 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.9 ttt -81.64 39.42 0.54 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.64 1.176 . . . . 72.14 112.069 -167.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.81 2.28 14.33 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.229 1.412 . . . . 74.34 111.874 -175.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -85.78 -8.56 58.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.418 1.487 . . . . 72.13 113.174 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.61 25.22 11.88 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.979 1.312 . . . . 62.43 112.926 -166.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.51 -104.03 0.82 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 108.818 -1.713 . . . . 73.1 108.818 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -139.73 133.9 31.13 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.812 0.845 . . . . 64.33 110.64 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.6 t -127.97 136.04 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 126.195 1.798 . . . . 73.14 107.587 173.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.2 t -110.08 -26.13 9.86 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.462 0.541 . . . . 72.14 112.462 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -116.01 146.13 42.4 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.238 1.015 . . . . 72.42 109.721 -173.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.74 152.19 43.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.112 0.965 . . . . 71.25 108.463 163.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -148.58 144.66 27.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.569 0.748 . . . . 74.51 109.557 160.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -147.4 144.91 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 105.768 -1.938 . . . . 73.22 105.768 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -138.22 178.79 6.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.599 1.16 . . . . 74.43 109.343 -171.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -89.42 66.47 7.43 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.203 -1.036 . . . . 73.43 108.203 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -151.49 31.68 0.58 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.625 0.77 . . . . 70.11 110.414 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.75 18.75 40.22 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.062 -1.024 . . . . 74.31 113.616 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.7 p -146.93 170.22 17.52 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.222 1.511 . . . . 63.05 110.242 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.42 164.01 34.27 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.841 1.21 . . . . 72.23 110.469 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 28.7 t -131.4 156.01 42.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.572 1.549 . . . . 70.15 109.025 172.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.5 t -147.1 158.4 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.093 -1.447 . . . . 71.33 107.093 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -145.0 114.45 7.14 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.325 -0.991 . . . . 65.42 108.325 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.78 174.77 7.01 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.822 2.449 . . . . 73.43 107.941 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.81 -49.25 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 117.606 -1.188 . . . . 63.31 111.11 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -137.09 157.84 45.79 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 120.471 1.487 . . . . 74.42 110.721 -167.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -62.88 -25.85 68.5 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 118.303 -0.856 . . . . 70.54 111.133 -170.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.66 -42.76 40.67 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 119.242 0.928 . . . . 73.11 111.299 -174.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -67.84 -44.44 77.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.082 0.855 . . . . 64.52 109.104 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.9 tmm? -50.6 -50.94 52.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.926 0.491 . . . . 72.52 110.938 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.9 m -56.58 -52.84 63.28 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.715 -0.659 . . . . 74.51 110.344 172.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -49.52 -40.84 39.26 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.489 1.515 . . . . 75.02 111.158 -174.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.39 93.35 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.102 1.361 . . . . 75.12 111.259 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.5 t -58.67 -25.77 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 121.413 -0.804 . . . . 75.12 110.269 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -106.87 -9.85 16.2 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.399 1.479 . . . . 75.12 111.852 -167.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -20.23 1.54 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 117.283 -1.341 . . . . 71.01 113.587 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.0 18.83 10.08 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.882 1.673 . . . . 74.42 109.737 -164.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -104.12 159.0 16.04 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.921 -1.112 . . . . 73.32 111.91 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 44.98 43.24 7.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.782 2.433 . . . . 74.43 112.044 -168.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.2 p -86.54 164.35 16.95 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.509 0.723 . . . . 75.45 110.731 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -88.07 157.62 18.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.553 1.141 . . . . 75.12 108.99 169.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -140.29 133.1 29.09 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.65 1.58 . . . . 74.05 109.519 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -81.82 112.28 18.81 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 123.692 0.797 . . . . 75.34 110.52 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.15 156.66 29.77 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.961 -1.125 . . . . 73.35 107.961 165.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -72.77 -11.36 60.58 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.94 -0.475 . . . . 74.54 111.196 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -70.05 3.64 2.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.778 2.031 . . . . 74.13 113.545 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.19 15.97 78.67 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 119.121 0.873 . . . . 50.54 111.525 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.13 170.88 14.36 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 126.841 2.056 . . . . 75.42 108.011 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 30.6 p -137.54 154.71 49.78 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.295 -1.743 . . . . 63.13 106.295 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.07 -179.09 5.2 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.871 -0.789 . . . . 73.03 108.871 166.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -95.56 156.53 16.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.453 -0.573 . . . . 75.33 109.453 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.1 pt -124.95 168.83 17.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.552 1.141 . . . . 74.34 108.873 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -125.39 147.18 49.28 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.154 -1.424 . . . . 72.41 107.154 165.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.1 t -104.79 146.39 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 125.909 1.684 . . . . 74.41 108.794 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 160.61 43.77 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.211 1.805 . . . . 75.3 108.815 173.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.9 150.49 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 105.688 -1.967 . . . . 75.1 105.688 167.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t70 . . . . . 0 C--O 1.248 1.005 0 C-N-CA 125.477 1.511 . . . . 74.13 109.854 171.022 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.447 -0.597 0 CA-C-O 123.053 1.406 . . . . 70.13 111.156 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -62.34 15.26 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 131.138 3.775 . . . . 71.52 113.17 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.43 14.85 3.46 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 119.093 -2.254 . . . . 70.12 111.314 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -104.49 142.61 34.32 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.63 1.172 . . . . 71.21 111.3 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.7 169.41 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.095 1.358 . . . . 71.32 111.601 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.7 t -133.86 151.3 32.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.948 2.099 . . . . 73.54 106.008 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.42 153.9 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.379 -0.971 . . . . 70.22 108.379 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.0 p -132.14 168.83 17.31 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 121.286 -0.884 . . . . 72.33 109.04 168.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.69 -6.45 58.88 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.713 -1.049 . . . . 72.23 113.644 168.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.83 152.58 26.56 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 125.082 1.353 . . . . 74.53 113.892 -165.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.26 173.55 12.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.763 2.975 . . . . 64.11 111.788 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.45 -7.55 12.7 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.071 3.181 . . . . 73.23 115.329 168.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.29 68.16 1.23 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 121.25 1.841 . . . . 70.31 110.787 172.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.92 115.51 3.49 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.35 -1.5 . . . . 64.32 109.35 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 m -111.06 164.05 13.23 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.324 1.05 . . . . 54.23 109.83 -174.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -66.48 -25.26 66.62 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.171 -0.956 . . . . 74.43 112.097 -168.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -68.75 -52.08 34.43 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.729 -0.841 . . . . 73.44 108.729 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -58.56 -41.32 85.36 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.772 -0.825 . . . . 73.25 108.772 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.95 -60.75 2.94 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-O 117.707 -1.139 . . . . 73.53 110.264 174.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -65.86 -32.83 74.58 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 120.904 1.683 . . . . 72.54 111.758 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.31 -30.02 71.24 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.458 1.103 . . . . 74.13 111.351 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.34 -48.56 6.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.774 0.43 . . . . 74.31 110.803 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.4 ttt -72.25 30.64 0.06 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.454 2.302 . . . . 70.42 112.843 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -108.92 -10.07 15.09 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 120.125 -1.609 . . . . 74.14 112.091 172.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -72.3 -9.75 58.89 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.269 -1.52 . . . . 74.32 113.828 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.03 8.34 43.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.335 1.054 . . . . 71.52 113.048 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.44 -127.25 3.28 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 109.334 -1.507 . . . . 71.44 109.334 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -142.02 131.82 24.26 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.247 0.523 . . . . 73.51 109.92 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.433 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -127.57 138.76 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 C-N-CA 126.095 1.758 . . . . 74.51 112.37 -175.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.1 t -112.51 -35.57 5.51 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.929 -1.032 . . . . 73.31 111.46 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -109.55 136.35 49.07 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.499 1.045 . . . . 73.33 108.887 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.69 143.88 31.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.256 -1.387 . . . . 52.12 107.256 166.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -158.6 129.44 6.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.482 -1.303 . . . . 64.24 107.482 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.82 163.02 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 120.798 -1.189 . . . . 74.14 109.286 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -149.38 169.23 21.32 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.437 0.637 . . . . 70.13 110.151 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -74.61 48.8 0.37 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.869 2.468 . . . . 72.31 113.059 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -138.56 15.78 2.73 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.851 -1.155 . . . . 63.23 112.283 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.55 20.46 66.3 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 120.761 -1.212 . . . . 45.34 113.016 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 p -138.45 177.43 7.89 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 119.036 1.418 . . . . 72.14 111.963 -169.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.6 168.53 40.16 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.817 1.198 . . . . 72.33 111.007 167.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 p -133.97 139.38 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.497 1.519 . . . . 72.32 108.115 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.2 t -146.41 148.36 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 107.78 -1.192 . . . . 72.33 107.78 -161.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -137.37 109.5 7.26 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.686 1.232 . . . . 72.4 108.979 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.433 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 3.6 m-30 -69.19 -179.52 1.6 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.952 1.701 . . . . 74.21 109.666 171.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.92 -50.55 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 O-C-N 121.238 -0.914 . . . . 72.55 110.068 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -142.6 159.07 42.95 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 119.281 0.946 . . . . 74.34 111.447 -169.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -59.31 -30.91 68.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.211 -0.9 . . . . 74.21 111.458 -173.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.6 -29.65 68.22 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.886 1.221 . . . . 70.31 112.296 -174.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -85.12 -40.83 16.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.725 0.81 . . . . 73.41 108.907 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -52.79 -51.94 58.74 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.769 -0.582 . . . . 74.2 110.626 171.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.6 m -48.64 -46.55 40.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.475 1.51 . . . . 45.44 110.728 171.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -59.46 -40.32 86.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.223 0.609 . . . . 71.31 110.221 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.53 -39.01 78.95 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.054 0.843 . . . . 73.52 111.677 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.79 -27.76 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.812 0.733 . . . . 72.5 109.897 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -106.39 -9.1 16.87 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 114.101 1.148 . . . . 74.23 114.101 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -133.78 -1.74 3.03 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 117.673 -1.156 . . . . 73.54 113.195 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.89 17.81 1.61 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 120.067 1.303 . . . . 72.31 111.97 -165.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.48 153.1 18.65 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.705 1.593 . . . . 62.42 114.432 173.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 52.68 33.09 13.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 128.488 2.715 . . . . 74.53 114.494 -173.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.2 p -82.38 172.78 12.69 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.4 -0.813 . . . . 74.22 110.748 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.74 171.23 15.41 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.66 1.184 . . . . 74.54 109.356 168.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -144.87 122.63 11.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.746 2.018 . . . . 72.55 109.489 167.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -69.64 122.22 18.68 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.814 1.646 . . . . 71.33 109.436 170.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.0 p -87.45 172.87 9.48 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.752 0.705 . . . . 70.11 109.565 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -73.28 -9.87 59.16 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.336 -0.393 . . . . 71.25 111.919 165.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.62 23.33 10.54 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.539 1.536 . . . . 74.3 112.78 -164.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.43 4.5 38.27 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 123.344 0.497 . . . . 72.54 113.313 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -119.71 165.87 13.95 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.302 1.441 . . . . 64.12 108.752 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.2 p -140.77 142.05 34.76 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.561 -1.644 . . . . 51.02 106.561 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.09 169.08 12.04 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.915 1.686 . . . . 54.42 107.392 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -93.25 158.0 15.97 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.65 1.114 . . . . 74.23 109.256 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 pt -126.89 168.92 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.677 0.791 . . . . 74.5 110.644 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -129.28 120.32 25.48 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 105.162 -2.162 . . . . 74.21 105.162 163.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.5 t -67.66 149.18 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.575 -1.269 . . . . 74.43 107.575 162.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -144.28 165.72 27.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 123.872 0.869 . . . . 73.31 109.93 156.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 t -73.36 149.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.728 -1.582 . . . . 62.43 106.728 166.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.0 t0 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 124.785 1.234 . . . . 72.54 108.399 167.543 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 C--O 1.235 0.319 0 N-CA-C 108.144 -1.058 . . . . 72.35 108.144 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -80.74 33.87 0.33 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.439 1.895 . . . . 74.24 112.039 -170.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.38 29.08 3.33 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.158 -1.589 . . . . 74.25 108.948 175.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.77 145.2 44.67 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.746 -1.221 . . . . 74.04 109.77 -167.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 m -141.18 175.37 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.554 0.741 . . . . 74.45 110.326 -173.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.1 t -135.08 155.48 37.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 107.674 -1.232 . . . . 74.25 107.674 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.7 140.44 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.903 1.681 . . . . 73.31 106.528 170.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -135.58 165.03 26.47 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.874 -0.787 . . . . 74.13 108.874 170.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.58 7.04 72.5 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.616 -0.547 . . . . 71.22 113.04 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.9 mt -63.85 156.52 72.66 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 119.136 1.468 . . . . 73.41 111.189 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.99 170.46 19.75 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.049 3.166 . . . . 65.24 110.534 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.28 -5.11 16.26 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.04 2.493 . . . . 72.32 114.932 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.53 34.78 4.75 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.886 1.221 . . . . 72.14 111.398 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.9 146.66 21.44 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.265 -1.134 . . . . 74.31 110.265 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 t -137.75 168.08 20.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.61 1.195 . . . . 64.33 113.428 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -67.19 -26.1 66.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.989 1.716 . . . . 74.03 111.455 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -61.82 2.35 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.6 -1.259 . . . . 73.31 107.6 175.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -63.73 -35.46 80.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.1 0.875 . . . . 64.0 109.72 -176.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -54.38 46.95 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.48 0.582 . . . . 75.35 109.834 175.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -67.57 -27.51 67.0 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 111.563 0.208 . . . . 75.42 111.563 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.01 -20.53 52.37 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.729 -0.607 . . . . 75.02 112.069 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -88.33 -60.6 1.92 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.628 1.571 . . . . 73.3 111.171 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -69.44 -13.4 62.34 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.372 1.249 . . . . 62.44 114.372 -160.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -8.9 0.06 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.848 2.859 . . . . 75.22 113.757 170.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -58.75 -30.55 67.6 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.489 1.04 . . . . 73.41 112.256 173.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.35 0.94 57.44 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.28 1.215 . . . . 64.35 114.28 -170.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.71 -104.21 0.33 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 108.855 -1.698 . . . . 64.01 108.855 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -147.03 152.31 38.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.661 0.73 . . . . 74.24 109.451 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.2 t -141.74 120.36 9.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 127.245 2.218 . . . . 73.34 106.273 -165.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -102.43 -44.43 5.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.96 0.8 . . . . 72.41 110.926 -175.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -73.22 160.26 32.2 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.596 0.759 . . . . 73.34 110.607 174.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.94 128.35 5.56 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.269 0.94 . . . . 75.02 112.105 166.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -158.17 127.02 5.58 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.342 1.057 . . . . 61.04 111.309 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.8 t -143.81 158.89 16.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.467 -1.679 . . . . 63.13 106.467 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -138.51 171.01 14.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.735 0.814 . . . . 65.45 109.908 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -75.32 68.66 2.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.707 1.603 . . . . 75.0 108.245 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -148.61 174.03 12.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.978 2.911 . . . . 74.21 106.354 166.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.07 22.81 0.45 Allowed Glycine 0 CA--C 1.537 1.458 0 CA-C-O 117.379 -1.789 . . . . 74.44 114.597 165.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.3 p -133.46 158.08 43.97 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 121.01 2.405 . . . . 74.42 112.504 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.41 151.95 23.69 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 105.676 -2.97 . . . . 65.34 105.676 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.09 148.97 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.705 -1.961 . . . . 74.34 105.705 168.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.9 t -137.47 160.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.112 -1.44 . . . . 74.11 107.112 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -140.99 149.92 42.4 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.826 -1.916 . . . . 74.22 105.826 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -122.3 176.77 5.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.251 1.82 . . . . 74.41 108.573 -168.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -82.7 -39.21 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.314 -0.857 . . . . 75.25 111.36 -174.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -151.88 163.99 38.05 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.744 0.702 . . . . 71.03 110.1 -176.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -68.97 -27.41 65.69 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 117.773 -1.108 . . . . 75.42 110.944 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -58.68 -51.84 68.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.941 1.246 . . . . 75.13 109.39 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.31 -47.83 75.19 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.541 1.936 . . . . 74.43 109.012 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -54.54 -58.47 7.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.453 0.701 . . . . 64.42 112.061 176.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.4 m -55.3 -44.93 76.22 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 118.013 -0.994 . . . . 73.34 110.31 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.1 -32.83 71.35 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.245 0.929 . . . . 73.43 111.211 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.35 -41.64 85.12 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.813 0.845 . . . . 72.34 110.739 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.04 -18.77 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 O-C-N 121.008 -1.058 . . . . 71.35 109.842 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.08 -16.16 14.34 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.807 1.643 . . . . 73.42 114.129 -173.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -144.72 12.94 1.49 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.034 1.124 . . . . 74.12 114.034 -174.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -149.69 -1.66 0.44 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.874 1.216 . . . . 73.45 112.735 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.86 156.23 19.95 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 119.134 -2.229 . . . . 65.2 112.884 172.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.4 t30 57.82 58.19 3.79 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.109 1.764 . . . . 73.13 109.98 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.6 p -128.7 168.24 16.09 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.39 1.076 . . . . 74.12 110.436 -172.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -80.43 161.56 24.87 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.731 -0.605 . . . . 73.22 111.521 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -146.89 127.17 13.89 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.231 1.413 . . . . 75.14 111.457 171.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -78.75 125.39 29.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.192 2.197 . . . . 75.11 111.203 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.2 t -94.79 169.75 9.93 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.062 0.945 . . . . 74.23 109.442 172.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -65.36 -30.37 71.19 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 123.898 0.879 . . . . 73.4 112.498 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.64 9.7 3.21 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.762 0.825 . . . . 72.03 112.104 -173.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.17 4.93 57.74 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 120.866 -1.146 . . . . 75.1 113.577 -175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -88.04 172.22 9.71 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 124.709 1.204 . . . . 71.31 109.107 172.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.2 p -142.06 160.37 40.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.207 -1.405 . . . . 70.33 107.207 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.32 -177.44 4.24 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.644 -0.873 . . . . 74.31 108.644 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -108.88 148.75 30.17 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.046 -1.094 . . . . 72.12 108.046 165.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.6 pt -134.15 162.36 39.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 122.208 1.004 . . . . 73.23 111.331 -171.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -136.29 109.34 7.7 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.978 1.711 . . . . 73.44 107.509 -162.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.3 p -77.69 156.21 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 124.834 1.334 . . . . 71.21 108.815 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -152.16 161.66 42.29 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.567 -1.271 . . . . 74.14 107.567 160.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.0 141.49 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.826 -1.916 . . . . 71.14 105.826 168.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 59.2 t0 . . . . . 0 C--O 1.256 1.445 0 N-CA-C 107.465 -1.309 . . . . 73.44 107.465 168.144 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 108.539 -0.912 . . . . 51.51 108.539 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -75.44 21.07 0.14 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.29 1.436 . . . . 71.03 112.966 -173.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.69 17.94 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.316 -1.49 . . . . 64.33 110.853 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 124.9 50.33 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.414 1.086 . . . . 74.12 112.273 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.48 162.31 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.661 1.585 . . . . 63.1 109.592 171.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.28 171.09 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.782 1.633 . . . . 71.42 109.708 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.17 148.8 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.524 1.129 . . . . 73.31 108.102 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.92 164.96 25.78 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.53 1.932 . . . . 61.33 107.676 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.25 -2.12 47.05 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 124.892 1.234 . . . . 72.35 113.676 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.58 147.73 98.68 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 118.758 1.279 . . . . 71.32 111.666 -161.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.2 169.13 22.26 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.481 2.788 . . . . 75.41 110.24 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.63 -4.27 11.8 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.707 2.938 . . . . 73.04 114.173 174.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.29 41.7 3.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.081 1.353 . . . . 74.34 108.777 -174.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.44 106.36 1.31 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.756 1.646 . . . . 74.14 110.567 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 m -103.35 174.26 5.94 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.754 1.277 . . . . 73.13 111.683 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -67.33 -18.94 65.37 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.502 1.121 . . . . 74.32 112.688 -170.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -74.77 -53.82 8.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.346 -0.983 . . . . 73.31 108.346 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -58.09 -37.33 74.28 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.269 0.627 . . . . 65.31 110.187 173.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -56.76 17.63 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.92 0.888 . . . . 74.34 110.257 173.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -61.19 -37.8 84.23 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.692 1.133 . . . . 73.25 110.069 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.39 -8.29 56.29 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.035 0.934 . . . . 72.41 113.225 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.436 ' CE1' ' H ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -92.36 -54.49 3.78 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.764 1.226 . . . . 74.44 110.763 163.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -80.02 77.85 6.69 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.988 1.315 . . . . 72.32 108.656 -169.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.77 -21.47 0.46 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.293 1.437 . . . . 74.05 112.386 176.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.4 -14.09 61.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.064 0.946 . . . . 74.01 113.304 -172.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.13 -27.8 35.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.201 0.6 . . . . 71.04 112.414 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.35 -170.88 17.26 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.19 -0.764 . . . . 65.32 111.19 -154.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.76 127.94 33.92 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 113.183 0.809 . . . . 74.22 113.183 -146.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.33 130.45 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 125.278 1.431 . . . . 74.41 108.446 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.2 t -130.63 11.59 5.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.126 0.97 . . . . 71.0 111.243 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -152.99 139.63 18.83 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.076 2.15 . . . . 71.43 107.239 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.73 147.78 41.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.839 0.856 . . . . 72.15 109.471 163.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -162.16 142.38 10.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.946 2.098 . . . . 73.02 109.194 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.41 -172.35 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 125.849 1.66 . . . . 70.42 107.089 173.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -150.54 156.2 40.93 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.788 -1.56 . . . . 75.11 106.788 171.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.318 0.3 OUTLIER 41.45 -85.75 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 129.142 2.977 . . . . 73.32 112.654 152.152 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.94 174.73 14.52 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.181 0.991 . . . . 73.05 112.589 169.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.39 -41.33 3.06 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 125.677 1.608 . . . . 63.03 113.672 159.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.25 169.68 17.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.419 1.61 . . . . 73.04 110.285 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.55 167.98 35.9 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.578 1.561 . . . . 73.05 109.46 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.77 119.85 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 118.399 1.1 . . . . 73.15 110.303 -168.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -113.27 174.23 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.619 -0.882 . . . . 72.31 108.619 -166.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.39 125.99 11.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.609 1.55 . . . . 73.34 108.774 164.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -99.48 177.5 5.15 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.251 1.82 . . . . 73.01 108.874 -175.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.4 -64.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 O-C-N 122.14 -0.35 . . . . 73.34 110.206 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -133.49 168.53 18.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.358 0.599 . . . . 71.1 111.637 -169.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -54.18 -33.56 58.39 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 114.353 -1.294 . . . . 71.22 110.706 176.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -54.16 -64.12 0.93 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.76 0.824 . . . . 70.14 110.265 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.64 -41.45 79.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.594 1.558 . . . . 73.12 109.387 -173.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -53.47 -50.59 65.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.599 1.159 . . . . 74.31 111.198 174.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -66.42 -45.55 79.5 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.156 0.583 . . . . 73.31 110.602 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -56.7 -38.62 72.53 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.805 0.729 . . . . 74.42 110.134 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.62 -39.89 74.43 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.643 -0.694 . . . . 71.03 112.053 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.11 -26.3 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.102 1.319 . . . . 74.33 109.587 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -105.53 4.38 30.4 Favored 'General case' 0 C--N 1.343 0.305 0 N-CA-C 114.779 1.4 . . . . 72.43 114.779 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -148.4 -9.71 0.37 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.423 1.268 . . . . 74.04 114.423 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -130.71 11.88 5.26 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.684 -1.26 . . . . 75.2 109.928 -167.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.53 159.98 14.64 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 120.679 -1.263 . . . . 74.4 113.723 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.5 t30 60.58 14.4 4.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.854 1.662 . . . . 75.03 113.61 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.3 p -76.68 174.99 9.77 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.261 1.824 . . . . 75.05 112.298 -169.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -67.39 171.0 6.48 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.235 1.014 . . . . 73.04 110.798 167.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -145.3 124.35 12.82 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.759 1.624 . . . . 75.44 112.015 164.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.436 ' H ' ' CE1' ' A' ' 35' ' ' HIS . 7.3 ptp180 -72.08 126.32 29.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.486 1.115 . . . . 75.01 109.484 172.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.0 p -98.86 177.75 5.17 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.978 0.894 . . . . 71.35 110.303 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -76.17 -19.94 57.99 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.811 -0.556 . . . . 73.24 110.723 167.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -84.79 16.34 3.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.878 1.217 . . . . 64.01 113.429 -169.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.08 21.51 78.38 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.214 -0.754 . . . . 72.32 111.214 176.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.29 -175.01 3.91 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.176 1.79 . . . . 71.11 108.224 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 p -143.86 148.61 35.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.34 -0.615 . . . . 60.22 109.34 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -110.31 -163.69 0.87 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.407 1.083 . . . . 63.03 109.13 167.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -121.24 164.47 16.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.482 1.113 . . . . 74.15 108.681 164.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 pt -136.94 165.38 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.944 1.297 . . . . 73.14 110.547 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -132.29 128.62 38.17 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.625 1.97 . . . . 75.14 106.56 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.3 p -94.68 150.72 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.831 1.196 . . . . 74.14 108.593 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 164.61 34.3 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.83 1.196 . . . . 75.43 110.067 160.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.7 t -61.58 136.13 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 105.277 -2.12 . . . . 75.24 105.277 163.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.8 t0 . . . . . 0 C--O 1.26 1.615 0 N-CA-C 107.165 -1.421 . . . . 74.24 107.165 175.708 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 107.459 -1.312 . . . . 72.34 107.459 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 5.1 pt-20 -78.8 22.04 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.269 1.828 . . . . 64.55 113.088 176.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.64 50.82 1.99 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.286 -1.509 . . . . 74.33 107.046 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -130.06 137.49 50.25 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.667 1.587 . . . . 74.11 109.772 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.2 m -136.04 169.95 19.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 124.793 1.237 . . . . 73.54 110.952 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.8 144.3 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 125.891 1.676 . . . . 73.33 106.879 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.69 146.07 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.613 -1.625 . . . . 72.31 106.613 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -137.42 160.68 38.41 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.114 -0.991 . . . . 71.41 109.193 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.47 12.96 84.04 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.427 -0.652 . . . . 74.11 113.491 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 mt -59.27 144.63 83.16 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 117.643 0.722 . . . . 72.41 109.694 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -73.57 171.94 16.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.387 2.058 . . . . 73.33 108.907 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.12 -15.85 47.51 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 CA-C-N 119.923 1.008 . . . . 74.12 112.822 -168.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.64 21.02 13.23 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.404 1.482 . . . . 53.44 111.643 -170.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.47 99.5 1.93 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.207 1.384 . . . . 72.24 111.688 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -94.87 179.57 5.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.644 1.577 . . . . 75.43 111.599 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.9 p-90 -62.26 -33.65 75.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.511 1.124 . . . . 74.21 112.397 -175.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -46.64 63.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.885 -0.783 . . . . 75.14 108.885 -173.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.71 -33.16 75.31 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.718 -0.658 . . . . 74.04 109.764 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -53.51 56.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.481 1.037 . . . . 73.32 109.39 174.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -63.45 -39.4 94.38 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.344 1.058 . . . . 75.43 110.36 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.19 -12.24 60.25 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.921 1.082 . . . . 64.31 113.921 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -99.95 -59.27 1.74 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.149 1.78 . . . . 72.31 112.78 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.429 ' HE3' ' CE1' ' A' ' 57' ' ' PHE . 11.5 ttt -72.83 37.91 0.08 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.777 2.431 . . . . 75.33 110.579 -171.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -107.38 -9.75 15.93 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 119.087 -2.258 . . . . 74.32 111.006 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -79.06 -27.96 43.11 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.091 -1.005 . . . . 75.04 111.997 -163.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.42 -10.97 58.08 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.028 1.331 . . . . 51.21 112.224 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.48 173.69 13.25 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.495 -1.442 . . . . 55.43 109.495 -165.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -97.25 153.86 17.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.2 1.0 . . . . 74.3 111.508 -160.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.9 t -125.49 147.76 30.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 125.408 1.483 . . . . 74.24 107.831 -166.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.8 t -111.41 -53.29 2.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.418 -0.956 . . . . 73.22 108.418 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -86.45 150.01 24.58 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.505 0.722 . . . . 75.34 110.155 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.72 125.72 15.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.641 -0.874 . . . . 64.41 108.641 168.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -156.55 124.44 5.56 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.864 0.84 . . . . 71.14 110.599 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.28 156.95 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.886 -2.264 . . . . 74.32 104.886 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -124.64 162.83 23.29 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 127.126 2.17 . . . . 75.34 107.618 170.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 43.55 -86.6 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 130.768 3.627 . . . . 73.41 112.612 153.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -170.91 168.87 6.96 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 127.206 2.202 . . . . 71.45 110.625 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.85 -15.39 32.08 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.757 1.17 . . . . 62.01 115.432 156.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.77 168.52 22.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 120.022 1.911 . . . . 72.25 108.492 164.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.2 167.66 35.6 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 108.878 -1.689 . . . . 75.32 108.878 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.12 144.09 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.083 -1.08 . . . . 75.35 108.083 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.3 t -146.62 157.53 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 106.706 -1.59 . . . . 74.33 106.706 -163.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -143.46 129.51 19.63 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.165 -1.05 . . . . 72.55 108.165 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.429 ' CE1' ' HE3' ' A' ' 36' ' ' MET . 3.6 m-85 -100.54 170.19 8.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.869 1.668 . . . . 75.34 109.257 -175.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.0 m -75.85 -31.15 21.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 72.54 112.315 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 43.2 ttt85 -154.9 155.74 34.85 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.664 -0.495 . . . . 75.13 109.664 -172.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' A' ' 15' ' ' GLU . 14.6 ttmt -63.18 -26.46 68.81 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 117.723 -1.132 . . . . 73.51 110.931 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.0 -55.59 15.94 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 120.487 1.494 . . . . 74.23 109.285 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.15 -47.75 77.61 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.798 1.239 . . . . 72.21 109.525 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 59.7 ttp -54.04 -53.29 55.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.162 0.585 . . . . 72.35 112.047 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.7 m -54.33 -48.32 71.52 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.508 1.123 . . . . 75.15 109.102 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.53 ' CZ ' ' HE3' ' A' ' 69' ' ' LYS . 16.4 t80 -53.59 -38.98 64.47 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.315 1.046 . . . . 75.22 111.641 -175.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.04 -33.04 75.09 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.75 0.82 . . . . 72.32 110.832 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.4 t -70.09 -14.15 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 O-C-N 120.532 -1.355 . . . . 75.34 110.813 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -108.41 -37.73 5.89 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.04 -1.037 . . . . 73.43 111.469 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.53 ' HE3' ' CZ ' ' A' ' 65' ' ' TYR . 3.6 mptp? -108.87 -16.9 14.06 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.278 1.031 . . . . 71.04 111.743 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.9 7.53 8.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.24 -0.886 . . . . 74.44 111.17 -164.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.26 153.72 19.38 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 121.088 1.767 . . . . 75.03 111.164 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 t30 57.5 40.29 27.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.953 1.701 . . . . 71.12 111.591 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.4 p -103.39 -179.22 3.89 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.883 2.073 . . . . 71.02 111.287 -169.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.13 158.63 15.38 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.436 1.016 . . . . 65.41 110.305 171.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -137.26 146.22 44.48 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 125.588 1.555 . . . . 61.34 110.417 167.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -112.95 118.0 33.64 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.545 1.538 . . . . 75.03 110.908 -173.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 m -78.3 156.5 29.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 119.079 0.854 . . . . 63.2 109.3 167.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -62.61 -13.14 28.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.36 0.874 . . . . 75.3 113.36 168.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.87 12.23 0.72 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.944 1.697 . . . . 64.11 112.104 172.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.85 26.33 74.67 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 121.118 -0.989 . . . . 65.32 111.258 170.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -139.14 160.97 38.55 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 125.808 1.643 . . . . 63.3 108.684 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.8 p -145.84 149.81 34.98 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.154 -1.054 . . . . 74.03 108.154 -168.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.55 169.17 15.34 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.973 -1.121 . . . . 73.42 107.973 166.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -82.81 151.81 25.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.984 -1.117 . . . . 74.14 107.984 168.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.7 pt -125.16 166.27 21.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.418 1.487 . . . . 75.14 109.093 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -123.75 144.07 49.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.373 -2.084 . . . . 74.03 105.373 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.8 t -127.88 124.26 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.758 -1.571 . . . . 71.02 106.758 -172.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.38 153.33 51.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.446 1.098 . . . . 73.23 108.261 -170.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.1 t -71.34 153.18 8.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 106.08 -1.822 . . . . 71.41 106.08 162.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.881 1.272 . . . . 61.51 111.295 170.884 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 109.051 -0.722 . . . . 72.33 109.051 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -65.34 11.92 0.06 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.504 2.322 . . . . 52.53 114.802 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.72 26.7 7.07 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 119.729 -1.857 . . . . 72.4 109.199 -178.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -109.26 133.56 52.88 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.664 1.185 . . . . 74.22 109.107 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.32 168.81 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 126.009 1.724 . . . . 73.34 109.533 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.92 154.3 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.934 1.694 . . . . 75.02 106.809 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.3 t -130.12 152.07 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.229 -1.397 . . . . 75.31 107.229 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.6 154.97 48.71 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.268 1.027 . . . . 73.23 108.733 -175.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.75 6.4 52.53 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 117.905 -1.497 . . . . 42.24 114.176 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.46 149.87 91.06 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 120.037 1.918 . . . . 62.22 112.412 -160.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.07 170.03 13.88 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.966 3.111 . . . . 75.13 111.022 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.29 -8.3 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.675 2.25 . . . . 75.31 113.833 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.35 52.05 1.27 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.345 1.458 . . . . 73.02 109.204 -176.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.03 130.6 10.24 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 108.626 -1.79 . . . . 73.05 108.626 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -116.42 163.62 15.77 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.811 0.845 . . . . 71.23 111.221 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.3 p-90 -66.37 -23.96 66.42 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.838 0.681 . . . . 74.24 112.838 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -56.04 14.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.883 -0.784 . . . . 74.04 108.883 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -60.17 -35.61 75.73 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.847 0.859 . . . . 73.25 109.656 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -58.36 8.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 117.28 -1.343 . . . . 72.33 110.014 174.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -68.67 -37.62 79.74 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 120.066 1.303 . . . . 73.24 110.763 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.02 -24.78 64.77 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.562 1.545 . . . . 73.41 112.874 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -95.22 -46.64 6.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.636 0.374 . . . . 75.12 111.061 170.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.6 ttt -77.02 32.31 0.14 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.336 1.454 . . . . 75.12 113.086 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.2 -5.28 14.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 121.03 1.741 . . . . 73.22 114.308 171.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -61.27 -31.16 70.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.099 1.318 . . . . 72.43 113.874 -173.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.26 -0.88 13.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.839 1.256 . . . . 73.33 114.33 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.87 -100.97 0.21 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 108.153 -1.979 . . . . 71.4 108.153 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -154.11 163.57 39.88 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.021 0.928 . . . . 72.3 108.999 176.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.77 135.93 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.518 2.327 . . . . 73.32 109.822 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.3 t -90.81 -56.17 3.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.846 -0.798 . . . . 74.33 108.846 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -96.01 146.99 24.16 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.795 1.238 . . . . 74.2 109.588 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.55 136.18 21.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.846 -1.168 . . . . 54.2 107.846 168.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -148.86 131.2 15.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.436 -0.95 . . . . 74.31 108.436 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 91.9 t -140.75 140.73 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.086 -2.19 . . . . 72.44 105.086 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -77.32 -164.08 0.44 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.985 1.714 . . . . 71.33 109.996 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -44.4 -50.94 9.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.464 -1.698 . . . . 73.14 112.078 158.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -179.67 -179.11 0.49 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.195 1.398 . . . . 70.42 112.391 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.3 -34.39 3.46 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 128.226 2.822 . . . . 55.35 114.407 166.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.26 -179.05 6.75 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.772 1.286 . . . . 75.03 108.529 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.74 171.71 40.26 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 125.246 1.403 . . . . 63.3 109.67 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -141.75 135.11 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.738 0.78 . . . . 65.34 108.982 -173.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.52 145.13 25.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 108.405 -0.961 . . . . 73.32 108.405 -156.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -133.83 106.54 7.37 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.543 -1.651 . . . . 73.12 106.543 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.89 168.1 16.38 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 130.258 3.423 . . . . 72.14 109.876 -176.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -72.47 -42.3 64.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 121.305 -0.872 . . . . 73.12 111.573 -171.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -152.88 160.24 43.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.961 0.8 . . . . 74.22 109.462 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -63.96 -19.31 65.04 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.492 -1.242 . . . . 71.2 111.025 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -52.97 -65.95 0.47 Allowed 'General case' 0 C--N 1.345 0.407 0 C-N-CA 125.581 1.553 . . . . 62.43 108.684 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -75.33 -36.18 61.08 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.751 1.62 . . . . 73.3 108.836 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 39.2 ttp -51.33 -52.27 46.87 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.881 -0.414 . . . . 74.13 109.881 169.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.7 m -68.42 -12.16 60.74 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.939 -1.101 . . . . 71.4 113.359 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -79.95 -35.57 37.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 122.539 2.427 . . . . 74.24 110.083 169.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.65 -35.39 80.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.094 0.958 . . . . 75.2 110.198 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.73 -17.45 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.651 0.78 . . . . 73.0 111.163 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -120.24 -16.88 8.41 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.49 -1.381 . . . . 74.2 112.059 -163.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -132.35 -19.06 2.49 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.24 1.416 . . . . 64.23 113.807 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.23 11.99 16.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 120.081 1.31 . . . . 75.41 110.356 -168.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.48 161.44 13.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.893 1.224 . . . . 73.34 112.437 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.0 t30 56.96 17.86 3.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.523 3.129 . . . . 73.41 114.177 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.6 p -71.74 175.15 5.95 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.817 2.847 . . . . 74.43 112.731 -172.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.48 169.69 15.23 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.709 1.604 . . . . 71.13 109.656 171.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -150.58 135.16 17.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.972 1.709 . . . . 71.25 109.46 170.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -82.69 119.14 23.92 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 118.652 0.66 . . . . 72.25 109.977 176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 t -81.05 154.57 26.78 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.3 -1.0 . . . . 74.32 108.3 165.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -62.45 -16.68 56.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.892 -0.575 . . . . 63.01 111.644 164.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.58 17.41 0.11 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.248 1.419 . . . . 74.35 112.413 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.26 21.18 71.92 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 124.31 0.957 . . . . 71.33 112.496 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.93 175.4 10.46 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.327 1.851 . . . . 72.42 108.412 -172.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.0 p -137.07 148.86 47.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.689 -0.856 . . . . 75.34 108.689 -174.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.01 176.74 7.82 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.776 -1.194 . . . . 74.03 107.776 172.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -102.25 154.74 18.75 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.721 0.691 . . . . 74.15 109.932 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 pt -133.34 160.39 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 O-C-N 121.924 -0.485 . . . . 73.41 110.457 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -131.65 106.98 8.51 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.101 1.36 . . . . 75.44 107.697 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.53 154.46 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 124.219 0.949 . . . . 75.33 108.83 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -145.82 173.36 12.18 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.708 2.403 . . . . 74.21 107.505 162.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.81 151.18 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 125.624 1.57 . . . . 72.44 107.742 173.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.381 1.072 . . . . 64.23 108.788 167.133 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.446 -0.661 0 CA-C-O 121.038 0.447 . . . . 53.55 109.947 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.41 30.96 0.06 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.379 1.471 . . . . 71.31 113.093 -167.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.84 20.58 3.28 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.751 2.02 . . . . 75.42 108.754 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.09 139.25 47.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.768 1.227 . . . . 74.32 111.907 -171.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.94 170.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 126.078 1.751 . . . . 74.45 109.633 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 19.6 m -136.14 174.31 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.014 1.726 . . . . 74.41 108.386 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -137.26 162.35 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.024 1.329 . . . . 72.25 108.297 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.75 165.07 37.17 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.458 -1.401 . . . . 75.31 108.424 -174.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.84 9.37 86.95 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 119.156 0.889 . . . . 74.1 113.239 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.19 150.84 69.77 Favored Pre-proline 0 N--CA 1.445 -0.681 0 CA-C-N 119.097 1.448 . . . . 75.4 112.194 -175.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.54 161.07 36.76 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.358 2.705 . . . . 75.34 111.516 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.44 -34.22 44.13 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.233 1.955 . . . . 71.1 111.563 173.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.81 60.51 0.71 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 122.488 1.137 . . . . 71.11 110.549 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -132.3 159.53 23.39 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 107.565 -2.214 . . . . 72.22 107.565 159.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m -128.39 -175.86 3.64 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.295 1.038 . . . . 75.1 109.059 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -62.08 -21.39 64.92 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.958 1.303 . . . . 72.33 111.057 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -57.24 11.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.929 -1.137 . . . . 73.13 107.929 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.82 -32.38 73.88 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.394 0.434 . . . . 71.0 110.894 175.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.39 -54.9 37.97 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.867 0.758 . . . . 64.43 110.303 176.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -64.28 -33.61 76.23 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.553 0.615 . . . . 75.21 110.827 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -74.5 -25.62 59.48 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.834 1.254 . . . . 64.01 113.526 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -102.26 -41.43 6.37 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.599 1.56 . . . . 75.44 111.545 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.3 ttt -81.59 53.39 2.1 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.334 -1.479 . . . . 75.42 109.884 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.29 47.5 2.48 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.332 1.453 . . . . 75.01 110.604 -170.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -135.65 -5.77 2.22 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.258 1.207 . . . . 75.24 114.258 -172.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.94 45.88 1.99 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.792 1.637 . . . . 73.41 110.726 -170.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.11 -107.32 1.95 Allowed Glycine 0 N--CA 1.47 0.967 0 N-CA-C 108.581 -1.808 . . . . 73.32 108.581 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.9 167.09 25.72 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.426 1.613 . . . . 64.24 111.761 158.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.01 135.73 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.505 1.522 . . . . 72.31 109.775 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.9 t -113.88 -24.06 9.3 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.53 0.567 . . . . 63.21 112.53 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -123.66 143.35 50.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.816 1.189 . . . . 72.41 109.263 -173.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.61 133.96 15.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.228 0.922 . . . . 54.42 110.688 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -149.48 131.21 15.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.17 1.388 . . . . 75.04 108.881 -177.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.93 171.31 16.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.946 1.298 . . . . 72.31 109.137 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -154.3 -177.89 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.115 0.966 . . . . 62.12 109.768 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -81.58 40.1 0.57 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.88 2.072 . . . . 55.1 111.833 -164.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -117.62 -25.67 6.83 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.836 0.854 . . . . 73.13 112.309 -171.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.38 6.48 64.42 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.452 -0.659 . . . . 73.11 111.452 -162.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -119.26 165.58 14.07 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.989 1.394 . . . . 74.3 110.448 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.75 174.61 28.34 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.64 -1.784 . . . . 74.13 108.64 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 70.1 t -146.69 134.53 15.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.619 1.568 . . . . 74.12 107.964 -173.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 t -132.64 164.06 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.046 -0.724 . . . . 73.01 109.046 -169.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -142.5 124.51 15.29 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 120.433 -1.417 . . . . 73.05 107.45 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -94.11 174.64 7.05 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.604 1.562 . . . . 75.04 108.066 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.2 -64.01 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 118.69 -0.672 . . . . 63.24 110.901 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -139.85 172.13 13.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.628 1.104 . . . . 75.41 109.865 -166.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -62.85 -29.57 70.84 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.058 -1.026 . . . . 75.13 110.092 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 62' ' ' ASP . 3.5 pt-20 -52.7 -63.43 1.15 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.862 0.865 . . . . 75.22 109.497 173.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.405 ' H ' ' HG3' ' A' ' 61' ' ' GLU . 3.8 m-20 -60.1 -47.99 83.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.771 1.229 . . . . 63.43 108.336 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -57.32 -53.19 60.93 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.208 0.603 . . . . 71.14 110.914 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.4 m -59.3 -41.03 88.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.284 0.634 . . . . 51.22 110.282 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -56.96 -33.16 66.77 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 118.898 0.772 . . . . 74.13 111.741 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.61 83.16 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.392 -0.818 . . . . 73.42 109.971 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -71.81 -7.66 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 121.349 -0.845 . . . . 75.04 110.868 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.4 mtt180 -109.34 -31.96 7.35 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.855 0.862 . . . . 74.44 113.234 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -124.87 -6.16 7.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.843 1.257 . . . . 75.03 113.686 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.64 21.85 3.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.12 1.327 . . . . 72.21 110.86 -167.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.44 153.85 30.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.666 1.586 . . . . 75.45 109.777 170.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 62.27 11.35 4.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.572 2.749 . . . . 62.53 113.62 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.0 p -75.79 172.23 13.01 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.309 -0.869 . . . . 74.43 110.526 -172.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.443 ' HE3' ' OG1' ' A' ' 82' ' ' THR . 17.8 tttp -78.6 168.7 19.37 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 122.038 -0.414 . . . . 74.51 109.973 166.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -147.43 159.72 43.39 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 125.208 1.403 . . . . 73.04 111.866 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -116.46 148.04 41.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.747 1.158 . . . . 64.44 111.647 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.23 153.81 45.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.86 1.664 . . . . 74.1 109.284 -174.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -70.67 -12.54 61.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.175 1.176 . . . . 75.13 114.175 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.95 1.4 7.26 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.395 1.078 . . . . 75.4 112.728 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.26 9.1 63.79 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 124.08 0.848 . . . . 72.34 112.084 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -128.0 168.31 15.47 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 112.793 0.664 . . . . 64.43 112.793 -165.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.443 ' OG1' ' HE3' ' A' ' 74' ' ' LYS . 57.2 p -141.65 117.41 10.41 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.148 -0.933 . . . . 71.3 111.053 -175.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.83 173.19 7.8 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.584 1.953 . . . . 71.31 108.491 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -93.32 152.39 19.18 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.615 1.098 . . . . 72.42 108.478 159.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.5 pt -122.2 170.61 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.936 1.351 . . . . 74.11 108.839 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -125.33 143.19 51.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.751 -1.944 . . . . 74.51 105.751 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -110.8 146.34 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.325 -1.361 . . . . 55.53 107.325 168.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -142.98 159.94 41.29 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 122.109 -0.37 . . . . 75.44 111.156 163.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.4 t -61.16 138.96 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.603 -1.629 . . . . 72.32 106.603 165.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 43.1 t0 . . . . . 0 C--O 1.259 1.577 0 N-CA-C 105.257 -2.127 . . . . 75.43 105.257 166.22 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 108.13 -1.063 . . . . 73.31 108.13 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 31.44 0.07 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.992 2.117 . . . . 52.34 113.272 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -132.7 24.28 4.34 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 119.334 -2.104 . . . . 73.15 110.317 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.0 139.35 47.57 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.346 -1.471 . . . . 71.44 110.704 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.43 159.99 22.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 126.455 1.902 . . . . 72.34 108.881 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 95.4 t -132.8 140.85 46.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 127.232 2.213 . . . . 74.55 106.147 -170.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.9 t -104.73 145.37 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.782 1.633 . . . . 73.11 108.414 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -131.97 160.62 35.27 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.779 -1.201 . . . . 74.42 109.197 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.02 5.58 67.83 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.695 1.141 . . . . 73.43 113.866 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 mt -64.65 151.49 92.03 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.133 0.973 . . . . 74.14 112.304 -165.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -76.21 161.29 35.38 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.93 2.42 . . . . 70.24 110.662 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -67.55 -39.17 12.74 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.4 2.733 . . . . 50.15 110.567 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.0 p -67.19 -0.3 3.29 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.65 1.98 . . . . 74.43 112.303 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.42 121.42 7.08 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 126.078 1.799 . . . . 52.33 109.416 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.07 -179.6 6.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.855 1.262 . . . . 73.54 108.482 171.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -62.01 -29.44 70.27 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.181 -0.914 . . . . 74.55 111.974 -158.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -58.69 -62.1 2.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.809 -1.182 . . . . 74.51 107.809 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.71 -47.11 74.13 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.589 0.755 . . . . 73.43 109.867 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.03 -45.03 87.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.954 1.702 . . . . 72.34 111.537 -176.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -69.36 -30.25 68.22 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 74.24 111.15 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -92.52 1.44 57.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.565 1.146 . . . . 72.51 112.778 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -121.46 -56.55 1.88 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.664 1.586 . . . . 64.44 112.285 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.5 ttt -75.01 79.72 2.2 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.378 -1.342 . . . . 74.5 107.378 170.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.39 -7.71 0.78 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.423 1.889 . . . . 71.2 111.873 173.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.59 -3.08 25.71 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.585 0.63 . . . . 74.53 111.88 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.38 -0.41 41.06 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 119.322 0.965 . . . . 61.42 112.913 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.27 -156.52 15.58 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.444 -1.062 . . . . 53.2 110.444 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.37 114.91 21.15 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.32 1.057 . . . . 71.51 110.694 -163.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.3 t -101.9 151.52 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.458 -1.312 . . . . 73.2 107.458 171.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.7 t -131.37 0.93 4.11 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.033 0.753 . . . . 74.52 113.033 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -161.81 144.82 12.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.7 1.6 . . . . 65.44 107.7 -169.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.61 139.44 22.92 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.8 -0.815 . . . . 73.12 108.8 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -155.51 107.48 2.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.508 1.049 . . . . 72.11 109.202 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 p -135.71 144.82 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.228 1.811 . . . . 74.51 111.976 -171.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -135.27 156.57 48.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.429 1.092 . . . . 74.15 109.697 -164.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -81.37 35.38 0.39 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.996 1.318 . . . . 74.21 111.53 -169.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -115.42 9.58 15.57 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.959 1.703 . . . . 73.24 108.486 173.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.26 23.98 60.05 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 125.672 1.606 . . . . 73.44 112.886 174.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.96 162.91 34.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.28 1.04 . . . . 72.44 108.498 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.26 160.11 32.7 Favored Glycine 0 C--O 1.224 -0.469 0 N-CA-C 109.13 -1.588 . . . . 72.14 109.13 -169.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 88.7 t -132.53 155.36 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 125.595 1.558 . . . . 73.53 108.351 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.19 170.73 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 127.415 2.286 . . . . 73.25 106.032 -174.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -144.41 124.28 13.46 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.12 -1.808 . . . . 74.54 106.12 167.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -94.29 166.05 12.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.408 -0.96 . . . . 74.45 108.408 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -73.08 -37.86 54.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.378 -1.283 . . . . 64.5 111.835 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.4 ttm105 -154.04 156.69 37.81 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.328 0.651 . . . . 71.54 109.4 -168.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -61.12 -27.99 68.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 117.639 -1.172 . . . . 73.25 111.567 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.12 -50.32 74.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.839 1.2 . . . . 74.24 110.749 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -77.7 -41.58 37.46 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.539 -0.912 . . . . 74.3 108.539 -175.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -47.77 -50.86 24.41 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.615 1.166 . . . . 71.53 111.237 169.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.1 m -64.9 -47.47 77.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.369 -0.824 . . . . 70.54 111.216 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -54.84 -32.75 60.91 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.559 1.072 . . . . 74.31 111.324 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.34 -42.29 86.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.448 0.567 . . . . 70.51 111.681 178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.89 -25.21 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.281 -0.887 . . . . 72.5 110.248 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -79.49 -41.84 26.57 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 117.519 -1.229 . . . . 72.5 112.553 -177.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -124.27 -16.98 6.26 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.186 1.18 . . . . 73.33 114.186 -170.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.32 1.44 32.77 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.779 1.232 . . . . 73.21 110.151 -171.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.11 147.97 25.08 Favored 'General case' 0 CA--C 1.527 0.078 0 O-C-N 120.27 -1.519 . . . . 65.4 113.65 -172.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 69.68 11.15 7.83 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.034 2.134 . . . . 64.2 111.531 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.4 p -83.97 163.07 20.2 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.032 1.333 . . . . 71.3 110.161 -169.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -77.81 156.92 30.18 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 120.892 -1.13 . . . . 71.43 109.706 168.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -107.72 -175.73 2.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.215 2.206 . . . . 73.12 110.768 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.1 mtt-85 -146.65 146.54 30.42 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 124.85 1.26 . . . . 74.12 107.681 169.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 p -142.3 159.98 41.15 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.794 1.238 . . . . 72.42 110.537 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -73.76 37.9 0.1 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.218 1.807 . . . . 72.42 113.551 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.4 16.43 4.48 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.557 2.343 . . . . 74.42 110.617 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.39 29.41 69.05 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 124.284 0.945 . . . . 64.23 112.227 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.52 173.9 11.17 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 125.82 1.648 . . . . 73.2 111.002 -173.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.7 p -144.8 147.72 33.21 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.255 -1.017 . . . . 74.32 108.255 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.02 176.43 5.3 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.504 1.122 . . . . 74.41 108.495 161.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -109.0 150.15 28.18 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 120.256 1.389 . . . . 74.32 110.45 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 pt -124.91 158.76 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 122.08 0.943 . . . . 71.21 112.207 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.0 mmm-85 -117.27 136.91 52.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.46 -1.681 . . . . 74.24 106.46 165.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 89.7 t -108.4 131.12 59.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.053 -1.832 . . . . 74.23 106.053 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -138.33 168.06 20.56 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.182 1.393 . . . . 73.23 108.332 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.4 t -87.82 161.34 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.046 -1.464 . . . . 74.55 107.046 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.1 t0 . . . . . 0 C--O 1.252 1.197 0 N-CA-C 104.368 -2.456 . . . . 73.22 104.368 156.818 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 104.2 -2.519 . . . . 73.4 104.2 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -74.1 38.84 0.11 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.52 0.728 . . . . 74.21 111.748 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.6 28.27 2.71 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 119.52 -1.987 . . . . 71.21 110.053 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -130.2 154.85 47.13 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.954 -1.091 . . . . 75.0 112.704 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.1 m -144.01 168.49 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.296 1.438 . . . . 61.0 112.32 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.24 136.09 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.638 -1.615 . . . . 64.41 106.638 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 98.3 t -105.26 150.7 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.63 -1.248 . . . . 71.14 107.63 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 p -150.17 153.09 35.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.443 1.019 . . . . 73.31 109.714 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.11 6.97 38.89 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.301 1.429 . . . . 64.31 113.311 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 mt -65.91 156.44 83.73 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.347 1.059 . . . . 74.22 113.171 -164.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.09 175.7 8.03 Favored 'Trans proline' 0 CA--C 1.537 0.674 1 C-N-CA 125.493 4.129 . . . . 64.52 113.294 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.31 -7.96 15.43 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.766 2.977 . . . . 62.13 115.238 172.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 t -148.81 56.6 1.02 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 120.531 1.514 . . . . 73.1 110.296 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.38 79.5 0.58 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.319 -1.113 . . . . 74.11 110.319 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -74.8 155.46 37.57 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 119.395 -0.922 . . . . 44.42 110.32 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -60.08 -25.38 65.35 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.932 -1.105 . . . . 75.54 112.205 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -59.3 -46.03 89.69 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.59 1.556 . . . . 75.41 109.579 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -71.14 -37.5 72.26 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.032 0.933 . . . . 75.1 109.074 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.65 -52.16 65.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.863 0.756 . . . . 63.42 111.164 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -62.06 -39.67 93.2 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.154 -0.684 . . . . 72.32 109.154 -174.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.97 -17.38 64.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.569 1.548 . . . . 71.51 112.066 175.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.84 -45.03 8.6 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 104.817 -2.29 . . . . 74.53 104.817 -174.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.8 ttt -82.26 -14.1 55.99 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.238 0.459 . . . . 65.11 112.238 -150.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.6 -0.91 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 130.77 3.628 . . . . 74.14 116.446 174.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -81.65 -16.14 52.33 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 120.704 -1.247 . . . . 70.1 112.315 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.13 1.74 57.03 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.078 0.77 . . . . 53.43 113.078 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.19 -161.15 15.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.027 -2.029 . . . . 74.13 108.027 -157.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.83 145.3 32.84 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.593 0.357 . . . . 72.24 111.002 -165.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 t -130.33 131.01 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.397 -2.075 . . . . 74.51 105.397 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.5 t -116.69 5.61 13.2 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.748 0.647 . . . . 70.44 112.748 -167.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -162.94 158.21 22.09 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 126.435 1.894 . . . . 73.1 106.737 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.04 150.04 34.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 119.579 1.081 . . . . 73.31 108.396 163.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -158.89 129.7 6.1 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 117.965 0.348 . . . . 64.32 110.721 167.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -128.8 114.44 33.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.868 -2.271 . . . . 73.43 104.868 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -77.52 153.8 33.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.081 0.952 . . . . 74.41 109.143 161.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 43.63 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 130.948 3.699 . . . . 74.43 110.92 168.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 178.97 178.08 0.47 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.317 1.847 . . . . 71.5 111.233 155.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.78 -18.62 56.96 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.867 1.222 . . . . 64.14 114.202 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 m -148.97 -179.03 6.7 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.671 1.589 . . . . 74.43 108.719 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.9 164.21 35.52 Favored Glycine 0 N--CA 1.465 0.621 0 O-C-N 120.385 -1.447 . . . . 63.54 111.164 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.36 131.98 51.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 124.119 0.968 . . . . 75.41 108.518 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.6 t -144.0 154.98 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.328 -1.36 . . . . 71.4 107.328 -160.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -139.07 131.95 29.3 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.763 -1.569 . . . . 72.13 106.763 -172.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -101.8 -178.11 3.62 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.703 1.201 . . . . 70.3 108.056 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.47 -51.78 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.809 -1.182 . . . . 73.14 107.809 170.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.47 163.49 32.8 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 114.507 1.299 . . . . 71.1 114.507 -164.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -61.32 -33.18 73.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.586 -1.643 . . . . 73.0 112.076 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.87 -56.63 13.91 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.522 -0.918 . . . . 70.11 108.522 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -61.52 -45.31 94.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.533 0.733 . . . . 64.13 109.58 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -51.05 -55.43 17.58 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.772 -0.58 . . . . 74.03 112.259 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.1 m -57.11 -48.92 77.45 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.586 1.084 . . . . 74.31 110.347 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -55.16 -33.3 62.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.206 1.002 . . . . 74.31 111.494 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.11 -44.78 75.26 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.623 1.169 . . . . 73.31 110.498 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.78 -10.18 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.252 -0.905 . . . . 74.34 110.884 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -104.65 -31.95 9.14 Favored 'General case' 0 CA--C 1.527 0.089 0 O-C-N 121.413 -0.804 . . . . 73.32 110.914 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.03 -0.29 6.53 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.364 1.246 . . . . 72.54 114.364 -169.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -133.69 -4.87 2.87 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.284 1.402 . . . . 54.14 111.873 -172.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.04 161.17 21.78 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.356 -1.465 . . . . 74.2 111.998 165.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.8 t30 70.89 20.2 5.5 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.776 2.031 . . . . 74.53 112.26 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.6 p -85.35 142.18 29.5 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.06 -0.719 . . . . 73.22 109.06 -169.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -77.77 101.31 6.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.103 -1.443 . . . . 73.43 107.103 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -85.9 141.69 29.39 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.935 1.294 . . . . 74.34 113.134 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -99.42 139.24 35.36 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.66 1.984 . . . . 72.52 110.643 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.4 p -108.89 174.25 5.95 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.137 0.975 . . . . 73.42 109.609 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -92.34 18.18 8.73 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.841 -1.072 . . . . 75.2 111.095 165.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -98.8 18.11 17.8 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.537 -1.352 . . . . 63.1 110.599 169.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.02 7.1 75.6 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 126.406 1.955 . . . . 63.3 112.845 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -176.66 4.13 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 117.627 0.714 . . . . 64.31 110.209 -166.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 48.0 p -141.76 138.11 32.07 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 106.65 -1.611 . . . . 73.54 106.65 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.39 135.23 47.8 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.989 1.268 . . . . 64.11 109.326 172.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -69.93 156.51 38.99 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.982 0.81 . . . . 74.4 110.296 -168.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.96 166.46 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.711 0.767 . . . . 72.42 111.146 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -127.43 152.51 47.43 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.666 -1.235 . . . . 64.14 107.666 159.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 p -109.79 149.59 12.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.758 1.223 . . . . 73.21 109.142 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.92 166.69 23.96 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.661 1.184 . . . . 72.11 108.803 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.9 t -81.69 144.16 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.689 -1.967 . . . . 75.04 105.689 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 C--O 1.256 1.395 0 CA-C-O 117.853 -1.07 . . . . 73.21 109.726 169.517 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 108.597 -0.89 . . . . 70.1 108.597 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -72.62 25.79 0.06 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.418 2.287 . . . . 65.34 113.137 -170.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.52 14.49 2.96 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.075 -1.641 . . . . 72.21 110.292 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -95.78 145.07 25.62 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.644 -1.285 . . . . 65.53 110.676 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.0 m -133.75 160.26 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.834 -0.802 . . . . 73.54 108.834 164.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.97 149.0 27.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 106.557 -1.646 . . . . 72.54 106.557 164.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.01 153.65 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.705 -1.591 . . . . 74.51 106.705 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -144.45 162.36 36.71 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 120.119 -1.613 . . . . 43.43 112.244 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.14 12.52 80.76 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.733 1.635 . . . . 73.42 112.71 -177.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mt -63.89 144.3 98.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.023 -0.989 . . . . 74.14 111.789 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -71.88 165.13 33.49 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.238 3.292 . . . . 74.33 113.583 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.29 -32.89 25.39 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.978 2.452 . . . . 51.41 113.427 -172.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -97.85 41.39 1.13 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.991 0.916 . . . . 63.24 109.381 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.35 124.48 8.25 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 108.179 -1.968 . . . . 73.24 108.179 173.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.6 m -125.02 169.67 11.9 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.24 1.416 . . . . 73.15 109.48 167.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -61.95 -20.14 63.51 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 113.511 0.93 . . . . 73.23 113.511 -174.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -60.84 2.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.071 -0.966 . . . . 74.54 108.548 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.08 -34.78 73.91 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.837 0.744 . . . . 64.11 109.171 177.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.4 -53.43 36.72 Favored 'General case' 0 C--N 1.345 0.397 0 O-C-N 121.452 -0.78 . . . . 74.44 111.149 173.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.505 ' HE3' ' HB ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -80.18 -20.46 44.72 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.762 1.165 . . . . 72.12 112.343 -176.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.45 -29.92 66.62 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.645 -0.66 . . . . 70.35 110.911 169.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -93.52 -51.48 4.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.035 1.334 . . . . 74.43 110.131 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.8 ttt -79.92 66.8 5.51 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 128.546 2.738 . . . . 74.51 110.382 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.66 -1.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 120.709 -1.244 . . . . 74.52 113.712 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.06 -44.94 94.42 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 119.572 1.078 . . . . 72.15 108.89 168.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.05 16.65 0.22 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.935 2.494 . . . . 70.21 114.293 -171.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.22 -147.9 16.66 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.282 -0.727 . . . . 72.43 111.282 162.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.43 99.94 8.24 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.846 0.832 . . . . 74.31 109.714 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.505 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 44.0 t -98.7 96.38 5.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 105.586 -2.005 . . . . 74.13 105.586 171.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.5 t -75.13 -22.97 57.82 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.408 0.442 . . . . 71.31 112.038 -174.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -124.39 149.73 46.37 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 125.545 1.538 . . . . 74.03 109.506 -170.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.38 129.97 10.74 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.237 0.926 . . . . 70.13 109.082 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.68 147.45 28.09 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.138 0.881 . . . . 61.33 110.356 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.4 t -145.65 151.65 14.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.234 -1.765 . . . . 73.33 106.234 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.7 168.68 19.27 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.88 2.072 . . . . 73.31 109.193 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.495 ' HG3' ' H ' ' A' ' 50' ' ' ASP . 9.0 ptm180 42.86 -87.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 129.821 3.248 . . . . 74.33 112.674 163.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.495 ' H ' ' HG3' ' A' ' 49' ' ' ARG . 1.9 p-10 -178.61 -176.92 0.5 Allowed 'General case' 0 N--CA 1.436 -1.128 1 C-N-CA 132.684 4.394 . . . . 74.4 107.728 162.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.28 -24.65 5.37 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-O 119.214 -0.77 . . . . 71.33 113.452 163.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.93 165.08 35.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.854 1.327 . . . . 72.32 108.676 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.0 140.58 6.68 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.089 -2.404 . . . . 73.12 107.089 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -111.57 134.98 52.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 118.781 1.29 . . . . 73.4 108.04 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.0 161.87 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 105.98 -1.859 . . . . 74.54 105.98 -172.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -143.52 139.88 30.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.371 -2.085 . . . . 72.4 105.371 170.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -107.34 164.26 12.34 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.959 -1.867 . . . . 74.53 105.959 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.1 t -63.98 -44.64 97.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.177 0.806 . . . . 72.44 113.177 -173.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -144.87 168.13 20.96 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.833 0.742 . . . . 74.52 109.506 -173.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -55.26 -28.88 56.38 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.19 -0.909 . . . . 71.52 110.197 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -64.8 -63.1 1.2 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.874 0.761 . . . . 65.35 108.99 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.46 -43.49 88.91 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.032 0.378 . . . . 74.34 110.033 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -57.16 -50.04 74.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.283 0.633 . . . . 71.43 111.228 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -59.51 -35.98 75.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.176 0.898 . . . . 73.24 111.229 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -54.78 -45.95 74.34 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.621 1.555 . . . . 74.24 110.013 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.43 -46.88 63.11 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.31 0.644 . . . . 74.44 111.68 -175.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -74.05 -7.42 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.571 0.749 . . . . 74.23 111.019 -169.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -123.89 -3.24 8.17 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.665 1.186 . . . . 72.54 113.452 -177.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -142.37 -0.91 1.21 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.029 0.932 . . . . 64.13 112.784 -175.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -149.08 10.18 0.78 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.093 1.315 . . . . 72.31 111.339 -167.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.69 163.65 14.02 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 119.009 -2.307 . . . . 40.45 112.302 171.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.418 ' H ' ' CB ' ' A' ' 86' ' ' ARG . 0.7 OUTLIER 68.5 12.96 8.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.356 1.862 . . . . 75.35 113.794 171.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 31.1 p -75.21 164.04 26.89 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.51 1.524 . . . . 72.21 111.388 -170.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.66 162.87 28.72 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.245 -1.535 . . . . 73.23 108.169 166.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -147.85 151.23 35.59 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 125.047 1.339 . . . . 73.43 110.227 171.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -138.03 138.91 39.3 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.722 2.009 . . . . 74.23 106.33 -160.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -144.14 156.34 44.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.044 0.938 . . . . 73.33 110.554 -164.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -71.69 60.95 0.36 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.914 1.686 . . . . 73.35 113.242 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -146.14 -2.09 0.72 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.306 2.243 . . . . 74.55 111.088 169.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.89 15.26 54.87 Favored Glycine 0 C--N 1.34 0.773 0 O-C-N 120.298 -1.501 . . . . 74.14 112.201 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.8 171.7 12.83 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.151 0.98 . . . . 72.54 111.369 -172.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.5 p -143.04 153.98 43.5 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.536 -1.211 . . . . 75.52 108.145 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.46 177.07 5.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.118 2.167 . . . . 74.35 108.496 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -97.81 153.99 17.92 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.015 -1.053 . . . . 74.33 108.709 147.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.7 pt -130.82 171.6 17.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 125.871 1.668 . . . . 75.53 107.165 171.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.418 ' CB ' ' H ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -143.69 165.75 26.79 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 120.998 -1.063 . . . . 71.52 108.874 156.467 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.24 163.85 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.98 1.312 . . . . 75.52 109.019 169.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -154.6 158.22 39.42 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.704 2.002 . . . . 74.4 107.264 163.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.02 83.87 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.224 -2.139 . . . . 70.24 105.224 164.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 t0 . . . . . 0 C--O 1.256 1.439 0 C-N-CA 127.894 2.478 . . . . 73.23 113.817 159.417 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 122.059 0.933 . . . . 62.34 110.494 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -63.08 20.95 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 128.411 2.684 . . . . 73.14 113.095 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.04 28.4 4.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 119.328 -2.107 . . . . 73.24 108.481 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.618 HH21 ' CG1' ' A' ' 54' ' ' VAL . 42.1 ttt180 -112.83 129.56 56.4 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.753 1.221 . . . . 73.54 110.851 -177.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.7 159.86 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.703 -1.221 . . . . 71.42 107.703 168.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 12.5 m -124.3 -179.86 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.97 2.108 . . . . 75.11 107.042 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.11 155.15 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.496 1.918 . . . . 74.43 108.256 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.86 165.24 30.35 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.633 -1.292 . . . . 64.3 109.589 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.35 7.55 87.83 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.936 0.779 . . . . 72.52 113.003 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mt -60.82 155.02 55.1 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.065 1.346 . . . . 75.54 111.412 -173.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.58 167.54 23.92 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.913 3.742 . . . . 73.24 111.341 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.38 -27.87 39.78 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.358 2.038 . . . . 73.21 112.975 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.7 m -140.59 80.27 1.74 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 127.1 2.16 . . . . 72.43 107.445 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.22 138.96 10.47 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 105.112 -3.195 . . . . 64.54 105.112 157.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.78 179.23 4.18 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 117.747 0.774 . . . . 75.21 109.055 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -65.42 -19.18 65.83 Favored 'General case' 0 C--O 1.226 -0.153 0 O-C-N 121.606 -0.684 . . . . 75.51 110.648 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -59.5 4.2 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 117.775 -1.107 . . . . 64.23 108.555 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -35.9 78.82 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.598 -0.841 . . . . 54.34 109.477 177.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.97 -53.64 46.81 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.386 0.993 . . . . 74.31 110.708 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -69.74 -26.21 64.21 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.124 -0.985 . . . . 74.54 111.951 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -85.23 -12.91 51.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.938 0.895 . . . . 75.14 112.577 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -109.06 -57.61 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.522 1.129 . . . . 73.23 111.252 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.9 ttt -74.53 70.71 1.8 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.659 1.184 . . . . 71.22 108.588 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -140.64 -0.55 1.54 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.795 -1.191 . . . . 73.31 113.368 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -68.29 -21.57 64.77 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.602 0.637 . . . . 74.24 111.579 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.42 -6.88 58.82 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.359 1.244 . . . . 75.25 114.359 -171.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.26 -171.49 27.12 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 119.858 1.208 . . . . 71.11 111.357 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -86.19 85.03 7.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 106.965 -1.495 . . . . 73.42 106.965 -170.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.9 t -69.57 135.08 29.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.155 -1.054 . . . . 72.22 108.155 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.5 t -99.07 -11.55 21.35 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.076 -0.488 . . . . 75.13 111.954 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -159.45 146.79 17.01 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.555 1.071 . . . . 73.35 109.757 -162.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.7 143.25 32.21 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.727 -1.212 . . . . 73.14 107.727 165.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -152.47 134.24 14.71 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.488 0.715 . . . . 72.11 109.466 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 m -137.53 177.62 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.554 -1.276 . . . . 74.52 107.554 175.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -140.79 -169.24 2.76 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 126.167 1.787 . . . . 75.51 106.768 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -96.89 45.21 1.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.921 -1.112 . . . . 74.23 111.729 -176.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.93 -154.0 0.53 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.277 1.831 . . . . 63.13 107.324 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -111.02 28.65 9.58 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.772 2.13 . . . . 72.41 110.605 173.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 p -131.89 173.36 11.26 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.416 1.487 . . . . 74.23 109.508 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.86 172.66 44.4 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 107.743 -2.143 . . . . 75.51 107.743 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.618 ' CG1' HH21 ' A' ' 17' ' ' ARG . 37.5 t -145.59 144.34 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.483 -0.932 . . . . 72.4 108.483 -165.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.6 t -132.95 171.65 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.54 -0.911 . . . . 74.31 108.54 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -153.8 137.4 16.0 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 120.553 -1.342 . . . . 74.13 107.716 167.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.84 177.39 4.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.458 1.903 . . . . 75.24 108.104 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.3 m -86.38 -31.79 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.64 0.608 . . . . 75.21 112.64 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 ttm105 -156.37 160.32 39.56 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.362 0.665 . . . . 75.15 109.95 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -67.1 -22.92 65.8 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.568 1.147 . . . . 61.51 112.205 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.12 -54.01 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.112 0.869 . . . . 72.25 109.603 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.96 -41.21 87.25 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.563 -0.532 . . . . 63.33 109.563 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.3 ttp -53.22 -52.78 57.8 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 110.168 -0.308 . . . . 61.52 110.168 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -55.11 -40.26 70.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.537 -0.745 . . . . 73.43 111.08 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -55.84 -45.38 78.41 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.088 0.858 . . . . 60.12 109.446 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.5 -42.4 78.28 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.31 -0.869 . . . . 75.52 111.893 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 t -68.35 -18.18 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.503 0.721 . . . . 72.31 111.019 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -114.37 -15.81 12.06 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.833 1.049 . . . . 75.52 113.833 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm -134.1 -1.06 2.99 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.261 1.425 . . . . 72.35 112.681 -171.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.62 21.42 2.71 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.929 1.24 . . . . 74.45 110.753 -175.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.84 164.0 11.88 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.077 -1.64 . . . . 62.32 110.285 174.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 60.86 12.97 4.12 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.235 1.814 . . . . 75.43 112.202 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.3 p -74.06 168.2 20.01 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.883 -1.136 . . . . 71.12 110.724 -167.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -63.94 166.24 7.72 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 121.74 -0.6 . . . . 75.32 109.813 153.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -145.67 138.79 26.13 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.938 1.695 . . . . 75.41 107.791 166.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -96.09 136.61 36.33 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.822 -0.807 . . . . 75.32 108.822 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -109.9 174.39 5.89 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.086 -1.079 . . . . 60.1 108.086 -169.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.82 -11.3 55.98 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.839 -0.538 . . . . 72.31 111.882 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -102.02 34.24 2.77 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.079 1.351 . . . . 75.23 111.536 -166.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.08 15.99 68.11 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.782 1.182 . . . . 60.53 113.528 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -132.73 176.8 8.14 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.439 1.096 . . . . 60.24 110.252 -175.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.6 p -144.78 126.07 14.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.75 -1.204 . . . . 73.1 107.75 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.36 -176.49 4.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.861 0.865 . . . . 73.32 110.339 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -106.29 157.21 17.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.578 -0.897 . . . . 75.21 108.578 159.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 pt -141.61 163.78 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.551 1.141 . . . . 73.31 110.937 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -131.58 105.84 7.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.141 -1.429 . . . . 75.45 107.141 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.5 t -69.71 144.17 14.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.792 -1.188 . . . . 73.22 107.792 170.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.27 158.82 43.53 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.747 1.158 . . . . 71.21 111.724 166.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.75 137.37 22.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 106.184 -1.784 . . . . 64.24 106.184 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 C--O 1.25 1.119 0 C-N-CA 124.293 1.037 . . . . 74.43 110.487 175.656 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 16' ' ' ASN . 72.7 m . . . . . 0 C--O 1.238 0.459 0 CA-C-O 121.81 0.814 . . . . 74.13 112.101 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.71 31.32 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.043 2.537 . . . . 73.51 111.541 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.467 ' H ' ' C ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -143.01 14.72 1.89 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.101 2.16 . . . . 74.5 108.284 -173.475 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.27 116.22 31.59 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.522 1.929 . . . . 75.34 110.13 -174.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.58 174.07 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.606 0.762 . . . . 75.12 111.522 173.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 10.7 m -136.1 -179.1 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.727 1.611 . . . . 64.41 106.967 170.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.0 t -135.7 153.52 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.134 2.174 . . . . 75.41 107.006 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.87 155.31 48.2 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.146 1.378 . . . . 71.21 108.88 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.02 4.8 57.58 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.419 1.961 . . . . 71.4 113.346 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mt -66.56 154.45 91.14 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 120.99 -1.3 . . . . 74.43 113.163 -166.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.47 166.36 20.03 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.169 2.579 . . . . 75.2 112.573 175.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.07 -6.03 18.29 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 124.12 3.213 . . . . 71.42 114.013 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -146.75 54.06 1.11 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.505 2.322 . . . . 74.3 108.926 -172.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.96 112.02 2.03 Favored Glycine 0 C--N 1.34 0.761 0 O-C-N 120.126 -1.608 . . . . 54.42 111.564 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -76.24 155.35 34.47 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 118.835 1.318 . . . . 74.14 112.361 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -59.04 -26.03 64.23 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.828 0.851 . . . . 75.1 113.217 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -65.22 -52.2 56.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.251 -1.018 . . . . 71.1 108.251 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -62.76 -27.56 69.37 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.109 1.363 . . . . 73.11 111.326 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -64.28 -61.34 2.3 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.067 -1.086 . . . . 72.02 108.067 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -61.28 -39.57 90.91 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.825 -0.607 . . . . 73.22 109.851 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -17.46 52.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.85 1.26 . . . . 73.33 112.688 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -100.72 -45.36 5.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.266 0.626 . . . . 75.01 111.23 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.0 tpt -57.75 -32.86 67.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.15 1.38 . . . . 75.4 113.396 -174.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -19.17 59.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.208 1.929 . . . . 73.0 116.208 -166.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.67 1.02 1.39 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.991 1.478 . . . . 64.01 114.991 -169.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.26 -10.09 31.31 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.754 1.222 . . . . 55.52 112.993 175.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.58 -101.74 0.21 Allowed Glycine 0 C--N 1.335 0.498 0 CA-C-N 119.68 1.127 . . . . 41.22 111.386 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.2 144.35 29.85 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.533 1.166 . . . . 72.32 109.84 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.493 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -131.7 139.53 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 126.379 1.872 . . . . 75.24 113.382 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -127.51 18.88 6.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.837 1.255 . . . . 71.22 111.36 -170.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -170.73 144.48 2.3 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.108 1.763 . . . . 72.42 108.318 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.69 139.26 16.91 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.861 -1.162 . . . . 75.2 107.861 168.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -155.14 129.22 8.82 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.421 1.089 . . . . 71.13 110.615 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 t -140.27 165.8 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.966 1.706 . . . . 72.04 107.285 -175.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.66 -162.76 1.3 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.775 2.83 . . . . 72.12 107.723 -169.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -105.25 63.53 0.7 Allowed 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.283 -1.511 . . . . 73.11 109.55 170.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -144.74 -176.33 5.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.26 -0.9 . . . . 64.04 108.592 169.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.38 13.73 20.11 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-O 118.312 -1.271 . . . . 52.33 113.433 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.32 163.54 30.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.163 1.982 . . . . 73.41 110.084 -174.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.45 167.84 38.52 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 107.788 -2.125 . . . . 72.24 107.788 -171.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 59.0 t -143.8 144.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 119.929 1.864 . . . . 73.1 110.395 -163.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.9 t -145.19 154.33 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.112 0.482 . . . . 74.34 110.849 -173.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -137.08 101.36 4.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.885 -1.524 . . . . 75.1 106.885 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.493 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 3.0 m-30 -72.37 179.37 3.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.533 1.933 . . . . 75.42 110.625 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.0 t -77.5 -63.43 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.627 -0.671 . . . . 72.11 110.98 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -140.37 157.36 45.66 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.27 0.941 . . . . 73.2 112.053 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -53.53 -27.13 24.19 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.247 1.019 . . . . 71.51 112.138 -166.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -53.16 -61.92 1.99 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.218 1.407 . . . . 72.44 108.376 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.56 -37.5 71.08 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.05 1.34 . . . . 75.54 110.667 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -56.86 -54.85 41.8 Favored 'General case' 0 C--O 1.228 -0.047 0 CA-C-O 118.829 -0.605 . . . . 74.42 110.178 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.6 m -54.73 -40.64 69.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.634 -0.698 . . . . 74.42 110.508 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -60.02 -49.77 76.34 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.02 0.928 . . . . 72.24 110.661 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.46 -25.1 68.12 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.739 -1.226 . . . . 75.3 112.68 -176.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.3 t -76.77 -5.75 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 O-C-N 120.853 -1.155 . . . . 75.23 110.125 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -129.41 0.45 5.06 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.537 1.31 . . . . 44.34 114.537 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.39 5.26 0.82 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.499 1.519 . . . . 64.14 112.563 -171.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.01 4.05 0.62 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.404 1.082 . . . . 71.13 109.765 -173.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -99.42 157.69 16.24 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.079 1.751 . . . . 74.44 111.372 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.452 ' H ' ' CB ' ' A' ' 86' ' ' ARG . 0.6 OUTLIER 44.42 64.41 1.34 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.496 1.519 . . . . 75.44 110.359 -168.255 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.4 p -121.06 174.19 6.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.203 2.601 . . . . 73.02 109.278 -174.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.89 161.98 14.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.952 -1.093 . . . . 75.42 109.633 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -151.68 120.66 6.66 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 126.647 1.979 . . . . 64.23 111.483 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -102.74 119.82 39.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.665 -1.235 . . . . 64.44 107.665 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.54 168.41 16.45 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.799 1.64 . . . . 74.11 110.309 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -65.07 -14.17 59.81 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.33 1.233 . . . . 73.11 114.33 174.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -86.56 6.02 32.79 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.692 1.997 . . . . 72.2 112.51 -172.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.15 14.39 82.31 Favored Glycine 0 C--N 1.337 0.635 0 O-C-N 121.572 -0.705 . . . . 43.34 112.061 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -125.08 171.71 10.05 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 123.961 0.904 . . . . 74.14 110.566 -177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.5 p -139.42 146.03 39.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.967 1.307 . . . . 75.33 108.05 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.7 129.97 19.83 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.729 -1.582 . . . . 64.44 106.729 172.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -69.74 159.49 33.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.968 0.804 . . . . 75.23 110.126 -164.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.69 155.73 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 123.414 0.686 . . . . 74.2 109.165 -173.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.452 ' CB ' ' H ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -134.99 143.05 46.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.849 -1.157 . . . . 54.41 109.728 163.119 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.94 151.2 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.377 1.471 . . . . 73.04 108.347 166.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -146.3 161.61 39.93 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.423 -0.955 . . . . 73.12 108.423 152.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 t -70.18 143.93 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 106.358 -1.719 . . . . 74.33 106.358 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.604 -1.189 . . . . 63.4 110.487 -177.743 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.701 0 N-CA-C 109.956 -1.258 . . . . 75.22 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.91 155.13 33.82 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 123.843 0.857 . . . . 75.15 110.86 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.91 174.26 8.03 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.437 2.758 . . . . 74.55 112.187 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -137.52 -179.32 5.67 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.233 1.013 . . . . 71.22 110.089 -174.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.57 -179.51 24.7 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.616 1.579 . . . . 75.15 110.391 167.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.85 122.07 45.21 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.463 1.505 . . . . 75.22 108.99 -167.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -154.09 160.61 42.03 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.265 0.626 . . . . 75.12 110.479 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.21 67.35 0.23 Allowed Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.03 -0.872 . . . . 63.54 113.265 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.8 155.66 67.98 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 CA-C-N 120.953 2.377 . . . . 75.02 112.695 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.92 91.99 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.997 3.132 . . . . 53.42 111.377 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.4 m -103.36 172.23 6.93 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.197 2.199 . . . . 74.32 111.957 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 167.68 1.85 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.398 1.079 . . . . 73.24 110.943 169.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -127.73 110.32 12.52 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.205 -2.146 . . . . 75.31 105.205 174.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -68.61 174.4 4.26 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.953 -0.758 . . . . 74.21 108.953 168.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -72.28 37.98 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.371 -0.831 . . . . 72.21 112.295 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.64 28.75 2.41 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 119.349 -2.094 . . . . 75.44 109.797 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.13 143.03 51.03 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.867 -1.145 . . . . 74.03 112.395 -167.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 m -140.51 167.69 17.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 124.491 1.117 . . . . 62.14 110.527 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.2 t -129.72 153.67 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.15 -1.796 . . . . 75.13 106.15 170.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -121.98 136.58 58.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 105.821 -1.918 . . . . 74.23 105.821 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 p -134.53 145.08 48.4 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.927 0.785 . . . . 61.34 111.678 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.9 27.66 23.25 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 125.147 1.356 . . . . 74.45 112.619 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.71 152.7 45.82 Favored Pre-proline 0 N--CA 1.467 0.419 0 CA-C-N 118.443 1.121 . . . . 64.22 110.393 -177.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.07 168.59 17.01 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.813 2.342 . . . . 73.41 110.882 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.02 -12.6 35.43 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.65 2.234 . . . . 75.45 113.831 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -151.16 57.03 0.89 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.379 1.445 . . . . 72.14 111.92 -171.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.19 -166.51 32.7 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.273 1.416 . . . . 72.15 111.11 172.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.8 p -157.69 173.85 16.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.402 1.081 . . . . 63.34 109.718 169.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -70.06 -18.4 63.27 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.97 0.908 . . . . 75.45 111.38 171.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.44 -54.11 10.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.834 -1.173 . . . . 75.31 107.834 -177.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.51 -32.84 74.41 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 118.55 -0.738 . . . . 71.12 110.249 172.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.35 -57.08 13.8 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.558 1.072 . . . . 73.45 110.57 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -61.81 -42.99 99.71 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 118.785 0.72 . . . . 74.24 110.087 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.25 -25.66 64.39 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.224 1.01 . . . . 75.42 111.92 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.445 ' CE1' ' HG1' ' A' ' 73' ' ' THR . 20.3 t-160 -81.39 -60.04 2.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.589 0.756 . . . . 72.32 110.046 174.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 15.0 ttt -68.09 -8.8 41.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.791 1.636 . . . . 62.01 114.348 -159.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.18 20.97 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 131.218 3.807 . . . . 75.54 115.848 175.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -100.59 0.79 39.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.98 1.712 . . . . 74.34 112.604 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.92 17.08 6.79 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 125.846 1.658 . . . . 74.32 112.797 -167.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 -107.73 1.04 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 125.762 1.648 . . . . 75.24 109.304 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -143.96 139.61 29.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 117.764 0.782 . . . . 71.24 109.922 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 t -128.44 81.13 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 126.451 1.9 . . . . 75.5 107.167 -170.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.7 t -72.66 -15.12 61.71 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.277 0.473 . . . . 53.34 112.277 -174.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -132.83 135.14 45.47 Favored 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 121.038 -1.039 . . . . 74.25 108.413 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.42 138.83 41.93 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.218 -1.03 . . . . 74.32 108.218 166.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -145.92 156.68 43.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.843 -1.169 . . . . 74.42 107.843 169.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.35 -178.41 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 O-C-N 120.826 -1.171 . . . . 72.43 108.162 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -103.34 -163.09 0.96 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.417 1.487 . . . . 74.31 107.283 166.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 mtm-85 -52.71 -53.98 40.08 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.975 -1.011 . . . . 72.25 109.885 159.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -170.68 -179.91 3.05 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.083 0.856 . . . . 63.13 112.82 -171.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.69 -39.85 2.73 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 127.147 2.308 . . . . 72.44 113.445 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.01 170.58 16.82 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.759 1.279 . . . . 71.35 109.429 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.86 159.66 28.09 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.543 -1.823 . . . . 60.41 108.543 165.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.3 p -130.23 131.3 65.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.396 1.098 . . . . 72.42 109.292 -170.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.7 t -144.32 151.83 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.632 -0.877 . . . . 75.43 108.632 -157.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -135.13 133.7 39.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.5 -1.296 . . . . 73.41 107.5 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -101.6 -176.77 3.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.117 1.767 . . . . 75.21 108.626 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.2 t -81.72 -50.96 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 118.256 -0.878 . . . . 61.3 110.57 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.1 ttt85 -145.17 164.5 31.1 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 120.526 1.512 . . . . 75.3 111.79 -171.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -62.7 -30.31 71.31 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 117.867 -1.063 . . . . 64.24 111.673 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -65.38 -50.98 63.47 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.645 -0.872 . . . . 71.34 108.645 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -59.36 -53.11 61.99 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 126.786 2.034 . . . . 75.12 109.25 176.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -51.94 -51.56 56.18 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.485 -0.759 . . . . 75.02 112.457 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.7 m -55.29 -53.56 54.53 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.536 -0.745 . . . . 74.14 109.584 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -56.96 -32.43 66.02 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.321 1.048 . . . . 72.3 111.588 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.25 -42.77 77.91 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.438 1.017 . . . . 74.01 110.863 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t -69.3 -14.31 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.951 -0.468 . . . . 64.12 111.091 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -100.58 -33.55 10.26 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.314 -1.492 . . . . 73.41 112.349 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.7 9.01 2.85 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.844 0.858 . . . . 71.03 113.19 -165.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.36 3.24 3.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.798 0.726 . . . . 75.33 111.132 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.85 162.16 13.7 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 119.315 -2.116 . . . . 75.23 114.501 171.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.4 t30 66.2 15.38 10.07 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.007 2.523 . . . . 75.44 113.003 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.445 ' HG1' ' CE1' ' A' ' 35' ' ' HIS . 31.1 p -78.46 171.21 15.43 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.495 -0.753 . . . . 75.12 109.747 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.08 151.65 21.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.029 1.332 . . . . 75.21 109.034 166.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -125.15 130.18 51.66 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 127.709 2.404 . . . . 75.3 108.896 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -87.03 153.83 21.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.108 0.963 . . . . 73.12 110.541 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.7 p -124.39 176.73 6.28 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.077 0.951 . . . . 74.45 110.451 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -85.6 5.15 33.01 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.569 1.148 . . . . 75.41 111.268 167.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.74 13.42 14.17 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.729 2.012 . . . . 64.54 112.595 -162.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.24 12.85 81.7 Favored Glycine 0 C--N 1.336 0.561 0 O-C-N 121.762 -0.586 . . . . 74.55 113.489 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -134.59 162.99 30.74 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.227 1.011 . . . . 52.24 109.593 -173.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.6 p -148.75 119.61 7.6 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.678 -0.86 . . . . 71.21 108.678 -172.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.23 165.01 13.68 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.418 0.687 . . . . 72.15 110.033 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -84.65 157.23 21.21 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.569 -0.9 . . . . 64.22 108.569 160.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.3 pt -137.47 152.94 27.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.895 0.855 . . . . 74.21 109.364 175.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -123.9 119.19 28.92 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.043 -1.836 . . . . 72.05 106.043 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -75.62 163.25 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.262 -0.644 . . . . 75.2 109.262 175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.49 163.84 39.48 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.922 1.689 . . . . 75.04 107.42 164.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.07 155.44 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.23 -1.767 . . . . 64.1 106.23 165.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 58.8 t0 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 124.567 1.147 . . . . 74.31 109.971 176.372 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.504 0 N-CA-C 108.876 -1.69 . . . . 73.32 108.876 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.86 164.98 16.93 Favored Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 126.213 1.805 . . . . 74.24 106.323 170.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -67.41 156.1 67.57 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 CA-C-N 119.867 0.988 . . . . 62.31 110.011 169.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.31 136.03 41.26 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.022 2.129 . . . . 72.14 105.851 173.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.17 163.09 7.54 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.975 1.274 . . . . 64.23 114.886 173.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 38.32 0.76 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.581 1.152 . . . . 64.41 110.753 172.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -152.63 99.52 2.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.593 -2.003 . . . . 74.13 105.593 176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.45 -86.45 0.29 Allowed Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.117 -1.379 . . . . 60.41 111.574 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.72 167.73 16.68 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.442 2.761 . . . . 71.31 112.772 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.59 85.61 0.73 Allowed 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.178 2.585 . . . . 63.12 110.547 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.7 t -73.33 -158.86 0.06 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.761 2.025 . . . . 74.23 109.164 171.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 141.19 49.36 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.138 -1.601 . . . . 73.12 109.662 161.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.82 -88.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 130.553 3.541 . . . . 75.24 113.116 165.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.9 m -162.96 166.89 23.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.408 -1.33 . . . . 61.12 107.408 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -80.41 40.69 0.51 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.251 1.021 . . . . 62.42 111.976 173.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.94 15.05 1.91 Allowed 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.431 -1.418 . . . . 72.31 111.968 -178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.56 144.57 39.22 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.028 -1.045 . . . . 75.43 110.203 -171.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.423 ' CG1' ' HG3' ' A' ' 63' ' ' MET . 27.3 m -141.4 166.36 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.249 1.02 . . . . 74.14 110.496 -171.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.79 124.02 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 106.75 -1.574 . . . . 73.54 106.75 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.23 148.99 4.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.059 1.344 . . . . 62.51 107.601 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -136.6 163.1 31.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.591 -0.693 . . . . 74.13 109.635 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.5 9.87 68.66 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.062 -0.854 . . . . 52.41 113.81 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.81 150.99 45.29 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.481 1.141 . . . . 72.41 112.509 -172.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -71.52 169.65 20.42 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 125.163 3.909 . . . . 74.15 113.259 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.47 -4.23 11.56 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.576 3.517 . . . . 63.31 114.167 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.73 71.03 1.37 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.081 2.152 . . . . 71.24 106.579 171.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.18 127.08 6.66 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 125.344 1.449 . . . . 23.5 109.596 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.4 m -134.78 166.64 22.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.935 0.894 . . . . 71.13 110.644 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -65.05 -22.84 67.04 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.407 1.083 . . . . 74.44 111.711 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -58.38 -60.45 3.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.436 -1.269 . . . . 71.51 109.742 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.84 -42.69 94.13 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 108.875 -0.787 . . . . 60.22 108.875 176.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.78 -50.98 62.48 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.846 0.748 . . . . 71.32 111.072 -176.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -67.48 -31.88 72.33 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.263 -0.898 . . . . 74.43 112.406 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.78 -2.58 57.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.34 1.456 . . . . 74.42 112.003 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -122.17 -56.08 1.84 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.278 1.431 . . . . 52.52 110.45 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 17.2 ttt -75.74 72.11 2.64 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.435 -1.415 . . . . 64.42 108.473 171.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.3 ptm85 -136.81 -13.4 1.68 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.271 1.428 . . . . 71.42 111.734 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -76.39 3.41 11.13 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.423 -0.798 . . . . 72.42 112.315 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.7 64.29 0.74 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.814 1.645 . . . . 74.33 107.055 172.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.58 -136.38 33.87 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.249 -0.887 . . . . 74.35 111.528 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -109.43 117.87 35.16 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.212 0.53 . . . . 74.35 111.096 -159.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.23 95.99 4.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.092 0.957 . . . . 72.23 108.929 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.4 t -69.78 -29.58 66.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.003 -0.998 . . . . 51.43 112.064 -175.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -122.04 149.76 43.06 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.144 1.338 . . . . 73.51 110.916 -168.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.62 133.52 20.18 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.827 1.251 . . . . 65.32 109.231 169.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -151.63 125.28 8.99 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 107.5 -1.296 . . . . 71.14 107.5 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.9 t -142.62 96.9 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.018 -2.216 . . . . 74.54 105.018 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -64.89 -176.13 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.137 1.775 . . . . 74.14 108.818 161.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -115.15 78.51 1.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 O-C-N 120.585 -1.322 . . . . 75.54 107.793 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -158.41 42.0 0.26 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.945 1.298 . . . . 62.51 110.227 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.15 9.3 14.61 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.525 1.536 . . . . 73.11 116.385 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.2 p -134.7 168.13 19.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.977 1.889 . . . . 61.52 109.95 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -146.41 151.94 24.13 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 107.454 -2.258 . . . . 75.32 107.454 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.87 121.4 58.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.771 -1.566 . . . . 72.23 106.771 -172.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 76.4 t -135.81 147.84 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.387 -1.709 . . . . 74.53 106.387 -159.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -136.58 113.81 10.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 105.47 -2.048 . . . . 75.22 105.47 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -86.42 172.22 10.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.741 1.217 . . . . 72.23 108.424 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.7 t -70.65 -56.7 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 118.588 -0.72 . . . . 73.33 110.635 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -139.26 168.26 20.23 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 119.556 1.071 . . . . 74.42 111.034 -171.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -56.04 -36.34 67.89 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 117.479 -1.248 . . . . 71.41 110.343 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -67.01 -47.53 71.15 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.168 1.349 . . . . 73.33 109.847 -171.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.67 -51.67 68.59 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.837 1.655 . . . . 75.12 109.3 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.423 ' HG3' ' CG1' ' A' ' 18' ' ' VAL . 62.8 ttp -55.57 -50.57 69.73 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.825 0.85 . . . . 73.11 111.767 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.6 m -54.56 -53.53 53.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.963 -1.018 . . . . 74.45 109.258 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -49.84 -32.77 15.03 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.311 0.96 . . . . 75.42 111.527 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.2 -45.9 91.56 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.916 0.886 . . . . 73.32 111.033 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -68.52 -16.66 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.381 -0.824 . . . . 72.45 110.902 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -108.89 -19.58 13.35 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.216 -0.927 . . . . 72.43 113.147 -167.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -136.21 -9.03 2.0 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.579 1.151 . . . . 74.24 111.75 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.7 17.49 6.33 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.851 1.26 . . . . 75.34 110.385 -167.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.58 150.79 28.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.628 1.171 . . . . 73.42 112.099 -171.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.06 32.3 0.86 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.726 2.01 . . . . 71.15 113.202 -167.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.3 p -75.02 177.06 6.63 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.05 0.94 . . . . 72.43 109.631 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -72.97 176.49 5.68 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.564 0.345 . . . . 73.21 111.078 162.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -151.55 128.46 10.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 128.212 2.605 . . . . 74.12 108.639 168.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -75.84 124.45 27.33 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.378 1.071 . . . . 73.22 109.576 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.44 157.41 17.66 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.241 0.616 . . . . 72.12 110.475 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -80.63 -0.39 37.78 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.218 1.007 . . . . 55.12 112.097 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -86.1 4.67 37.21 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.573 1.949 . . . . 55.52 111.569 170.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.38 20.1 74.98 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 119.037 0.835 . . . . 65.43 111.886 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -120.91 177.85 4.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 127.302 2.241 . . . . 64.51 107.749 170.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.6 p -140.58 134.36 30.42 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.247 -1.39 . . . . 63.12 107.247 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.96 173.19 6.78 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.922 -1.111 . . . . 71.53 110.07 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -87.67 161.89 17.41 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.499 -0.926 . . . . 75.11 108.499 158.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.9 pt -137.93 141.46 38.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.414 1.086 . . . . 74.15 109.245 173.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -96.95 120.92 38.2 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.415 -1.698 . . . . 74.24 106.415 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.2 t -89.32 137.03 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.611 -1.255 . . . . 74.24 107.611 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -145.48 157.52 43.99 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.379 1.472 . . . . 72.33 109.545 169.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.21 143.41 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 126.19 1.796 . . . . 75.13 106.347 170.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 C--O 1.255 1.379 0 C-N-CA 124.281 1.032 . . . . 72.14 108.447 167.154 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.805 0 N-CA-C 110.927 -0.869 . . . . 75.44 110.927 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.5 155.15 94.07 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.111 0.964 . . . . 75.13 110.944 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.19 -168.63 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.102 3.201 . . . . 73.13 110.505 166.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -166.36 163.39 17.48 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 127.661 2.384 . . . . 75.44 107.486 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.63 -168.85 22.19 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 123.558 0.599 . . . . 72.11 111.864 173.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -135.76 148.33 48.74 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.392 -1.336 . . . . 73.12 107.392 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -129.9 155.71 45.59 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.518 1.127 . . . . 75.21 108.87 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.27 70.55 0.03 OUTLIER Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.107 -1.385 . . . . 74.0 112.333 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -67.43 166.17 24.59 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.693 2.928 . . . . 75.22 111.948 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.94 68.59 8.26 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.055 3.17 . . . . 64.34 112.65 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.5 t -156.83 164.16 38.39 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 120.591 -1.318 . . . . 63.43 110.681 152.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -124.95 155.06 40.19 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.452 1.501 . . . . 74.32 109.097 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -86.55 -86.2 0.15 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.14 -1.43 . . . . 72.34 107.14 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.5 m -161.37 174.17 13.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.035 2.134 . . . . 74.05 108.283 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -68.22 26.45 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.086 2.554 . . . . 71.32 114.925 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.9 23.35 3.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.29 1.436 . . . . 72.32 109.488 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.27 143.75 47.16 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.568 1.147 . . . . 74.03 111.16 -168.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -144.97 156.47 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.877 1.271 . . . . 73.34 109.045 -165.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -141.3 120.4 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.992 1.269 . . . . 74.15 109.742 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.54 155.01 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.85 1.66 . . . . 73.12 109.867 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -143.87 167.58 21.98 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.379 1.072 . . . . 72.35 109.366 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.0 14.41 64.67 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.27 0.462 . . . . 55.53 112.778 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.96 148.68 87.12 Favored Pre-proline 0 CA--C 1.537 0.461 0 O-C-N 121.991 -0.711 . . . . 71.34 110.355 -168.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.18 167.44 23.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 124.996 3.798 . . . . 74.21 111.733 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.05 -21.19 56.6 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.791 2.327 . . . . 72.42 113.229 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.15 35.98 4.73 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.5 1.12 . . . . 75.32 111.314 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.99 156.42 51.65 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 107.503 -2.239 . . . . 63.25 107.503 158.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.4 m -152.47 173.24 15.37 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.771 0.828 . . . . 75.02 110.541 165.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -63.48 -21.8 66.52 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.227 1.011 . . . . 65.22 111.894 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -65.74 -63.83 1.0 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.383 1.073 . . . . 74.41 108.95 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -34.62 78.82 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 118.606 -1.238 . . . . 71.24 110.482 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -47.78 64.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.484 1.038 . . . . 73.22 111.017 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -66.94 -32.23 73.34 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.882 1.219 . . . . 72.14 111.557 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.23 -7.01 59.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.018 0.927 . . . . 65.02 113.194 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -106.09 -58.06 1.96 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.361 1.864 . . . . 73.44 108.1 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.6 ttt -79.23 73.05 5.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.312 1.445 . . . . 72.24 109.079 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -139.01 -0.32 1.88 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.892 0.877 . . . . 74.21 113.21 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -91.45 -1.11 57.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.5 1.52 . . . . 73.35 112.286 -169.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.2 -6.26 14.59 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.38 -0.825 . . . . 72.02 112.617 -170.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.3 -111.4 0.47 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.936 -1.48 . . . . 70.21 112.182 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -136.37 139.46 42.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.169 1.485 . . . . 74.12 109.817 169.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.7 t -124.13 97.77 4.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 124.847 1.259 . . . . 70.22 107.686 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 t -67.39 -54.84 16.92 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.119 -0.363 . . . . 73.03 110.054 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -83.8 175.92 9.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.316 1.846 . . . . 72.44 111.816 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -167.08 130.73 1.86 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.542 1.137 . . . . 73.41 111.398 166.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -157.36 136.99 12.2 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.793 1.178 . . . . 72.25 112.514 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.9 t -147.59 135.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.642 1.577 . . . . 75.25 107.492 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -112.12 152.85 27.81 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.241 1.416 . . . . 63.24 109.203 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -80.45 65.86 5.75 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.34 0.656 . . . . 73.0 110.338 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -130.45 -11.65 4.0 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.363 0.665 . . . . 75.02 112.361 168.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.86 17.36 7.96 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.756 -1.024 . . . . 63.13 112.531 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.97 158.46 43.87 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.939 1.37 . . . . 71.2 110.007 -171.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.67 107.98 0.34 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.42 -1.072 . . . . 74.03 110.42 -170.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.19 147.98 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 118.006 0.903 . . . . 71.43 109.634 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 t -139.37 163.94 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 106.981 -1.488 . . . . 74.04 106.981 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -146.74 126.42 13.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.163 -1.421 . . . . 74.04 107.163 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -99.3 170.49 8.62 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.183 -1.414 . . . . 72.45 107.183 172.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.93 -60.26 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.908 -0.775 . . . . 72.23 108.908 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -131.69 167.01 20.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.366 0.603 . . . . 74.23 110.155 -168.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -65.81 -27.38 68.22 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 118.138 -0.934 . . . . 71.34 110.377 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -57.46 -50.31 73.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.602 1.092 . . . . 70.41 109.745 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -67.68 -51.42 49.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.943 2.097 . . . . 74.34 107.833 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -57.33 -45.09 84.64 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.389 1.076 . . . . 74.32 112.755 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.6 m -59.15 -46.26 88.83 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.739 -1.226 . . . . 73.31 111.292 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -60.81 -29.95 69.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.07 0.548 . . . . 72.12 110.438 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.24 91.87 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.018 0.927 . . . . 74.21 111.519 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 83.6 t -72.69 -19.28 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 120.705 -1.247 . . . . 74.44 110.36 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -77.17 -57.55 3.77 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.018 -1.051 . . . . 73.45 109.56 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -100.21 -12.51 19.51 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.159 0.984 . . . . 72.23 113.225 -164.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.51 8.91 3.13 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.558 1.143 . . . . 73.45 111.899 -155.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -106.0 163.1 13.03 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.158 1.383 . . . . 72.34 110.017 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.321 6.8 p30 53.92 37.44 26.63 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 119.439 1.018 . . . . 72.44 110.808 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -93.77 172.55 8.18 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 131.625 3.97 . . . . 65.31 111.756 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -85.06 174.72 9.5 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.503 1.121 . . . . 74.14 109.881 160.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -155.81 133.43 11.07 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.756 1.222 . . . . 73.14 110.977 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -72.84 141.47 47.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.114 0.87 . . . . 73.14 110.988 177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.79 171.79 7.54 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.961 0.886 . . . . 74.35 110.814 156.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -67.59 -22.66 65.36 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 113.613 -1.63 . . . . 75.14 112.33 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -87.69 14.2 8.99 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.176 0.99 . . . . 75.51 111.787 -169.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.11 30.77 74.06 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.454 -1.058 . . . . 72.32 110.454 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -132.13 159.34 39.23 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 127.076 2.15 . . . . 71.23 106.548 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.6 p -142.63 113.71 7.65 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.045 0.926 . . . . 73.44 110.405 -171.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.75 177.4 8.91 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 125.909 1.683 . . . . 71.25 110.417 -173.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -106.31 144.78 32.51 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.488 -0.93 . . . . 74.43 108.488 158.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.2 pt -131.28 170.05 20.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 124.554 1.142 . . . . 73.11 108.94 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -125.02 151.87 45.01 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.966 -1.124 . . . . 73.01 107.966 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.1 t -114.9 114.8 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 128.341 2.656 . . . . 72.23 105.925 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -123.87 164.69 18.73 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 121.757 -0.589 . . . . 74.32 110.116 164.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.9 t -67.1 154.95 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 106.74 -1.578 . . . . 74.45 106.74 170.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.276 -1.009 . . . . 72.13 108.276 170.234 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.665 0 N-CA-C 109.879 -1.289 . . . . 51.34 109.879 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.39 152.26 45.69 Favored Pre-proline 0 C--O 1.235 0.293 0 O-C-N 121.647 -0.914 . . . . 71.52 109.902 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.98 167.23 27.72 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.802 2.335 . . . . 53.42 110.55 167.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.48 -170.99 2.32 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.29 1.836 . . . . 73.52 112.638 -159.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.97 26.32 37.86 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.249 -0.75 . . . . 42.13 113.812 170.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.81 10.31 2.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.14 1.376 . . . . 61.42 113.6 -171.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -149.99 144.56 25.91 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.213 1.405 . . . . 72.34 109.081 -172.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.2 -76.18 0.28 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 109.449 -1.46 . . . . 62.21 109.449 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -65.2 166.49 18.86 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.522 2.148 . . . . 74.11 110.756 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.58 64.72 7.42 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.425 2.75 . . . . 71.44 112.38 -172.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.1 m -94.45 151.46 19.36 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.285 -1.005 . . . . 74.32 108.285 152.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.44 -173.88 0.62 Allowed 'General case' 0 C--O 1.234 0.288 0 O-C-N 124.084 0.865 . . . . 74.11 110.394 162.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -118.55 -85.16 0.65 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.839 -1.541 . . . . 74.2 106.839 174.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.1 m -165.12 162.1 19.97 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.458 1.903 . . . . 74.5 108.591 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -72.35 26.9 0.05 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.949 2.1 . . . . 71.3 113.664 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.43 41.18 3.49 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.925 -1.509 . . . . 62.22 106.925 174.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.19 136.43 49.23 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.848 1.259 . . . . 74.51 109.133 -172.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.439 ' CG1' ' HG3' ' A' ' 63' ' ' MET . 33.7 m -137.61 169.08 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.008 0.923 . . . . 74.12 111.324 -169.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 40.8 t -132.44 156.31 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 104.604 -2.369 . . . . 73.14 104.604 179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.3 t -130.89 151.27 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.047 -1.464 . . . . 73.33 107.047 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.4 p -136.56 167.89 20.53 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.542 1.064 . . . . 73.14 109.174 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.58 4.43 70.35 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.576 1.56 . . . . 72.11 113.557 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.58 148.1 67.53 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 119.528 1.664 . . . . 73.24 112.298 -169.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.58 163.22 36.43 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.142 1.894 . . . . 73.15 109.917 174.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.1 -8.49 20.29 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.898 3.066 . . . . 65.31 115.633 -165.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.53 19.64 2.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.781 1.232 . . . . 74.24 110.829 -175.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.87 103.52 2.0 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 108.594 -1.802 . . . . 65.21 108.594 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.9 m -85.9 169.73 13.01 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.128 0.964 . . . . 72.14 110.773 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -64.06 -24.46 67.71 Favored 'General case' 0 C--O 1.226 -0.136 0 O-C-N 121.86 -0.525 . . . . 73.35 110.77 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -50.45 72.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.472 1.509 . . . . 74.15 108.347 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.26 -41.91 80.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.249 0.477 . . . . 61.23 110.547 176.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -52.74 47.24 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.991 0.814 . . . . 72.31 109.884 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -65.14 -33.57 76.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.835 0.854 . . . . 74.33 110.827 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -80.01 -10.72 59.79 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.667 1.187 . . . . 74.33 113.263 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -112.68 -46.1 3.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.619 0.767 . . . . 74.34 109.866 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 17.2 ttt -67.04 -12.81 60.96 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.046 1.128 . . . . 74.41 114.046 -173.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -60.25 -11.5 6.51 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.893 1.277 . . . . 74.31 114.023 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -58.75 -27.92 65.4 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.47 1.032 . . . . 72.0 112.002 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.38 -9.83 59.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 113.822 1.045 . . . . 70.31 113.822 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.25 -148.83 17.39 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 119.941 1.246 . . . . 52.12 110.3 -171.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.45 91.65 8.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.579 1.657 . . . . 71.54 110.08 -166.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.45 144.61 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 113.524 -1.671 . . . . 74.4 106.608 161.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 2.3 t -138.13 -2.47 1.85 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.282 1.215 . . . . 73.53 114.282 172.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -138.25 145.43 41.32 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 121.125 1.784 . . . . 73.32 106.8 168.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.45 145.16 38.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.376 -0.972 . . . . 74.31 108.376 165.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -151.73 141.96 22.34 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.548 1.139 . . . . 74.42 109.238 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.9 m -144.33 176.11 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.368 1.467 . . . . 73.41 108.123 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -146.64 -177.24 5.54 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.704 1.202 . . . . 74.12 108.151 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -83.03 51.4 1.94 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.111 0.869 . . . . 64.25 109.083 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -139.65 176.24 8.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.405 -1.331 . . . . 73.25 107.405 167.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.75 53.61 4.86 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.331 -1.108 . . . . 70.31 110.331 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.03 154.56 32.67 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.354 1.077 . . . . 73.41 110.523 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.96 170.53 32.58 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.481 1.515 . . . . 71.44 110.394 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 33.7 t -146.13 142.93 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.094 1.757 . . . . 71.01 107.309 -176.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.6 t -145.21 164.02 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.113 -1.069 . . . . 73.33 108.113 -161.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -138.4 144.69 40.33 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.806 -1.553 . . . . 54.23 106.806 172.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -115.7 167.89 10.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.809 2.043 . . . . 74.42 107.638 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.4 m -73.42 -33.06 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.649 0.611 . . . . 74.13 112.649 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -156.95 159.74 38.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.74 0.7 . . . . 74.54 109.592 -171.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -64.85 -20.75 66.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 118.138 -0.934 . . . . 74.23 112.287 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.18 -64.14 0.94 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.391 1.076 . . . . 74.1 108.797 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.34 -42.18 81.43 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.881 0.872 . . . . 73.5 110.146 177.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.439 ' HG3' ' CG1' ' A' ' 18' ' ' VAL . 47.9 ttp -51.63 -57.94 7.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.541 0.336 . . . . 74.31 110.647 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.5 m -61.17 -38.33 86.1 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.96 0.904 . . . . 72.5 112.817 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -54.36 -34.97 62.23 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.224 0.92 . . . . 71.11 111.394 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.69 -43.43 76.39 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.657 -0.652 . . . . 74.04 112.08 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.33 -19.36 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.929 -1.107 . . . . 71.42 109.934 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -86.91 -36.46 18.36 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.513 1.125 . . . . 72.43 111.493 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.7 mmtm -132.72 0.95 3.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.648 0.981 . . . . 75.0 113.648 -160.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -143.34 16.64 1.87 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.386 1.075 . . . . 75.04 110.369 -167.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.25 156.32 17.65 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 119.294 -2.129 . . . . 74.31 112.561 173.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.2 t30 55.22 19.78 3.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.58 1.952 . . . . 75.24 114.059 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.5 p -70.31 173.32 6.93 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.958 1.703 . . . . 70.15 110.766 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -78.39 178.11 7.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.401 -0.592 . . . . 73.44 109.401 163.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -156.03 141.08 17.34 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.486 1.514 . . . . 74.43 112.102 168.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -94.5 109.48 21.36 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.133 2.173 . . . . 73.12 111.529 -170.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -93.39 165.5 12.74 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.53 1.514 . . . . 45.41 110.935 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.58 -17.56 44.44 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.085 -1.009 . . . . 72.43 113.112 176.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -80.97 22.94 0.58 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.233 1.413 . . . . 72.41 112.123 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.62 33.07 83.37 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.687 -0.633 . . . . 74.33 111.818 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.53 169.13 20.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.288 1.435 . . . . 72.01 110.275 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.6 p -148.87 131.06 15.48 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.331 1.052 . . . . 74.12 108.673 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.04 -178.94 3.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.653 0.781 . . . . 71.01 109.277 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -90.81 160.7 15.63 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.152 -0.684 . . . . 72.45 109.152 163.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.1 pt -136.54 167.1 24.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.546 1.138 . . . . 73.44 109.856 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -137.57 122.11 18.45 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.585 -1.265 . . . . 75.41 107.585 -170.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -84.86 148.79 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 118.47 0.577 . . . . 62.1 109.708 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.89 177.2 10.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.565 0.746 . . . . 73.31 109.896 162.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.02 153.95 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.503 -1.666 . . . . 75.43 106.503 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.4 t0 . . . . . 0 C--O 1.252 1.187 0 N-CA-C 105.959 -1.867 . . . . 72.32 105.959 158.843 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.901 0 N-CA-C 108.674 -1.77 . . . . 52.24 108.674 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.57 159.49 70.27 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 118.554 1.177 . . . . 74.4 110.233 -174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -70.89 161.36 46.34 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 N-CA-C 108.2 -1.5 . . . . 73.54 108.2 166.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -117.43 9.83 13.41 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 114.116 1.154 . . . . 73.34 114.116 -164.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.88 169.11 14.32 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 107.936 -2.066 . . . . 61.4 107.936 -157.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -151.08 129.44 12.04 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.302 -0.999 . . . . 73.13 108.302 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -150.98 146.48 26.26 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.195 -0.668 . . . . 73.34 109.195 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.3 -82.42 1.62 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.901 -1.28 . . . . 61.3 109.901 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -70.72 169.05 21.07 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.672 2.248 . . . . 71.52 112.974 -166.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.6 67.84 6.34 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.663 2.909 . . . . 72.3 111.339 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.5 m -132.48 152.76 51.42 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.415 1.486 . . . . 65.11 107.522 167.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -137.31 165.58 25.83 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.086 1.354 . . . . 73.12 108.851 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -82.43 -87.36 0.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.403 -0.962 . . . . 72.34 108.403 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -167.9 -178.55 3.83 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.661 2.384 . . . . 64.4 106.56 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -84.52 24.3 1.02 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.901 1.68 . . . . 75.22 112.27 -175.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.32 23.75 5.94 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 119.997 -1.689 . . . . 63.14 110.971 -169.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.2 122.02 40.04 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 121.376 -0.827 . . . . 74.44 111.132 -159.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.07 159.96 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.24 1.816 . . . . 73.4 108.972 174.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 24.3 m -136.77 176.85 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 127.117 2.167 . . . . 74.13 108.139 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 m -135.89 159.11 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.925 -1.139 . . . . 72.1 107.925 -162.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.88 169.52 22.63 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 123.912 0.885 . . . . 64.12 110.192 -176.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.09 11.1 69.96 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.008 0.813 . . . . 44.34 113.831 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mt -60.31 148.83 78.49 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 118.845 1.323 . . . . 72.3 111.193 -176.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -75.13 170.01 21.32 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.23 2.62 . . . . 72.0 110.39 168.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.93 -36.91 21.26 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.677 2.251 . . . . 73.4 113.969 -175.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.6 32.67 3.26 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 119.841 1.201 . . . . 74.44 110.918 -173.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.07 173.94 44.59 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-O 123.033 1.352 . . . . 65.11 109.776 164.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.4 p -159.43 168.88 25.18 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.063 1.745 . . . . 64.42 107.883 171.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -62.19 -27.34 68.9 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 122.116 -0.365 . . . . 74.3 111.26 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -65.02 -50.02 67.89 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.983 0.913 . . . . 73.01 109.807 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -67.45 -26.32 66.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.356 1.063 . . . . 74.31 111.02 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.08 -55.97 8.12 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.172 -1.047 . . . . 74.4 108.172 171.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -63.61 -35.75 81.56 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.299 -0.875 . . . . 75.34 111.85 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -75.3 -5.75 46.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.81 0.844 . . . . 64.32 113.244 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.467 ' CG ' HH21 ' A' ' 76' ' ' ARG . 2.2 t-160 -119.05 -43.7 2.63 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.262 1.025 . . . . 75.23 112.828 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 8.8 ttt -76.27 41.83 0.25 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.452 -0.78 . . . . 74.1 110.752 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.2 ptm85 -111.28 -16.5 13.38 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.074 -1.641 . . . . 74.15 112.372 -170.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -84.58 -5.28 59.29 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.666 1.358 . . . . 55.24 114.666 -168.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.12 -13.73 24.82 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.755 0.822 . . . . 64.04 112.388 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.18 -176.23 24.33 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.767 -0.933 . . . . 72.31 110.767 -170.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.21 127.25 32.48 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.241 -0.564 . . . . 72.03 111.696 -166.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.2 t -118.05 123.29 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 C-N-CA 124.252 1.021 . . . . 74.43 108.948 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.82 -19.88 19.26 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 117.993 -1.003 . . . . 74.43 112.362 -177.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -130.02 166.98 19.0 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.362 1.437 . . . . 72.22 111.798 -170.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -163.29 139.73 7.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.412 1.085 . . . . 71.11 111.617 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -146.84 143.34 28.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.559 1.144 . . . . 64.13 109.741 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 42.4 t -144.41 148.4 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.074 1.35 . . . . 74.33 107.982 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -139.87 168.47 19.73 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.859 1.263 . . . . 72.42 110.554 175.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -84.06 40.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 127.294 2.237 . . . . 74.02 111.327 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -130.2 43.19 3.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.59 1.186 . . . . 71.24 109.205 170.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.14 12.34 30.16 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.357 -1.246 . . . . 65.44 114.523 172.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.3 p -143.12 157.45 44.51 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 120.429 2.115 . . . . 73.31 109.282 -169.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -149.79 178.26 27.41 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 107.553 -2.219 . . . . 71.31 107.553 -172.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 31.0 t -155.96 137.79 5.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 105.393 -2.076 . . . . 74.04 105.393 -170.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.62 170.53 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.381 -1.34 . . . . 74.21 107.381 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -146.88 125.41 12.44 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.328 -2.101 . . . . 51.22 105.328 162.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -100.35 164.59 11.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.185 -1.783 . . . . 75.22 106.185 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.8 m -73.39 -29.5 27.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.307 -0.957 . . . . 73.21 112.266 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -151.82 165.41 34.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.526 0.603 . . . . 75.41 112.488 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.7 ttmt -61.81 -28.38 69.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.884 -1.055 . . . . 74.33 110.944 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.13 -59.76 4.33 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.17 0.896 . . . . 74.24 108.729 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.31 -46.52 86.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.586 1.555 . . . . 73.43 109.139 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -50.38 -55.46 15.6 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.253 1.021 . . . . 74.55 111.344 172.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.7 m -54.04 -44.2 70.84 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.779 0.718 . . . . 73.42 110.956 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -62.08 -40.88 97.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.11 -0.33 . . . . 75.44 110.11 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.95 -41.0 86.38 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.949 -0.469 . . . . 75.24 111.364 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.49 -10.24 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 121.497 -0.752 . . . . 61.2 110.975 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -119.12 -1.49 10.89 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.468 1.031 . . . . 71.44 113.721 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.0 -5.05 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.163 0.985 . . . . 75.25 112.586 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.99 24.24 3.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.633 1.173 . . . . 74.23 109.28 -171.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.34 156.83 17.59 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.796 -1.19 . . . . 71.13 110.361 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.13 20.96 1.96 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.389 2.276 . . . . 74.32 113.351 -174.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.3 p -74.31 174.62 8.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.528 1.931 . . . . 62.23 111.582 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -77.15 162.82 27.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.082 0.953 . . . . 74.13 110.116 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -148.18 121.13 8.77 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.726 1.611 . . . . 74.44 108.469 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.467 HH21 ' CG ' ' A' ' 35' ' ' HIS . 6.7 ptp180 -74.75 157.24 35.58 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.839 0.856 . . . . 72.42 109.747 173.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.9 p -141.42 163.26 33.42 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.13 0.572 . . . . 73.12 111.124 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -71.41 -12.43 61.41 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.579 1.551 . . . . 74.13 112.169 -174.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.75 8.58 2.32 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.755 1.222 . . . . 73.22 111.701 169.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.12 21.09 76.94 Favored Glycine 0 C--N 1.337 0.634 0 O-C-N 121.096 -1.002 . . . . 73.42 112.008 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -127.37 167.99 15.44 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.115 1.366 . . . . 74.34 109.065 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -140.27 145.6 37.51 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.387 -0.968 . . . . 73.1 108.387 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -127.26 -168.92 1.95 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.499 1.92 . . . . 72.2 107.022 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -103.72 161.94 13.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.785 -0.82 . . . . 74.1 108.785 165.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.8 pt -132.65 162.97 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-O 121.189 0.519 . . . . 73.2 109.793 169.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -120.09 103.01 8.92 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.543 1.537 . . . . 74.4 108.086 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 t -70.0 139.27 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.623 -1.251 . . . . 75.2 107.623 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -138.05 168.02 20.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.327 0.967 . . . . 74.32 110.467 159.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.7 t -78.57 140.8 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.047 -1.464 . . . . 75.5 107.047 170.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 44.5 t0 . . . . . 0 C--O 1.248 1.003 0 N-CA-C 107.273 -1.38 . . . . 65.54 107.273 167.521 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.815 0 N-CA-C 109.744 -1.342 . . . . 61.4 109.744 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.49 150.18 28.12 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 125.306 1.442 . . . . 74.33 107.934 165.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.42 158.2 56.51 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 121.98 1.786 . . . . 65.22 111.192 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.25 145.96 29.61 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.404 -0.962 . . . . 74.23 108.404 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.47 -157.69 53.44 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.404 -0.678 . . . . 52.32 111.404 175.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.02 -174.49 2.55 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.275 1.43 . . . . 73.02 109.416 -175.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -91.31 58.77 3.73 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.489 1.116 . . . . 74.42 108.346 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.49 175.05 47.03 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.879 1.228 . . . . 65.21 112.328 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -67.87 167.63 20.9 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.884 2.389 . . . . 74.33 110.047 170.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.51 66.48 5.55 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.849 3.033 . . . . 54.2 109.882 173.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.8 m -142.11 103.99 4.39 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.62 1.568 . . . . 73.24 107.107 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -70.54 177.84 3.27 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.128 -0.693 . . . . 73.33 109.128 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -136.88 -82.59 0.36 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.088 -1.078 . . . . 74.43 108.088 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.0 m -150.7 171.3 17.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.807 1.643 . . . . 75.41 107.43 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.56 25.72 0.05 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.229 2.612 . . . . 75.45 113.212 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.52 35.77 3.81 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.485 1.514 . . . . 75.23 108.326 -177.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -115.77 124.43 50.75 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.771 1.628 . . . . 73.34 108.436 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.55 166.26 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.336 1.854 . . . . 74.05 110.05 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -137.0 141.11 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.275 1.83 . . . . 75.12 106.506 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.7 t -112.99 152.16 14.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.792 1.237 . . . . 75.43 107.725 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.99 164.34 32.37 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.585 -1.265 . . . . 72.14 107.585 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.88 14.33 82.26 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.815 -0.992 . . . . 62.25 113.07 -173.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.61 145.27 98.67 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 119.762 1.781 . . . . 72.24 110.94 -166.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.33 169.86 10.29 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.095 2.53 . . . . 73.22 110.717 175.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.16 -13.92 39.28 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.761 1.641 . . . . 72.14 113.108 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -138.37 17.65 2.75 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.429 1.27 . . . . 64.01 114.429 -155.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.74 97.7 1.18 Allowed Glycine 0 C--N 1.335 0.507 0 N-CA-C 108.51 -1.836 . . . . 62.14 108.51 170.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.92 179.2 4.43 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.833 0.816 . . . . 71.33 110.876 172.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -61.93 -28.09 69.29 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.723 -1.235 . . . . 73.45 114.272 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.33 -51.8 64.47 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.245 -1.391 . . . . 74.11 107.245 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.3 -47.52 83.42 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.137 1.375 . . . . 73.03 110.056 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.43 -58.22 4.95 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.638 0.775 . . . . 75.25 110.024 177.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.02 -37.86 78.87 Favored 'General case' 0 C--N 1.338 0.08 0 O-C-N 122.101 -0.374 . . . . 74.02 111.017 -171.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -7.71 14.2 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.284 0.846 . . . . 73.12 113.284 176.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -112.29 -49.32 2.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.173 0.989 . . . . 75.14 111.858 174.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.1 ttt -70.53 25.25 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.774 1.629 . . . . 64.32 112.945 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.51 -7.42 41.3 Favored 'General case' 0 C--O 1.222 -0.392 0 O-C-N 120.175 -1.578 . . . . 73.23 113.292 167.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.69 -23.05 67.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.83 1.65 . . . . 72.45 113.801 -172.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.48 -8.39 58.38 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.486 1.515 . . . . 61.22 113.951 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.21 -110.28 0.43 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 119.852 1.206 . . . . 71.13 111.448 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.99 138.31 22.86 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.34 1.067 . . . . 74.14 108.229 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.455 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.4 p -122.34 135.81 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 C-N-CA 127.42 2.288 . . . . 71.42 109.595 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.1 p -103.17 -25.88 13.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.386 -0.825 . . . . 61.11 110.104 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -130.67 136.9 49.26 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.74 1.616 . . . . 73.02 109.071 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.92 150.05 46.73 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.003 0.921 . . . . 74.24 108.635 158.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -148.05 132.69 17.82 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.458 1.903 . . . . 73.2 107.494 172.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.1 t -137.98 137.61 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.599 -2.0 . . . . 72.31 105.599 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.29 -163.83 0.22 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.0 1.72 . . . . 74.1 109.833 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 ptm85 -43.54 -57.49 3.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.532 -1.667 . . . . 70.33 111.118 159.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -172.7 168.76 5.12 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.803 1.638 . . . . 61.34 114.443 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.28 -39.95 3.06 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 128.152 2.787 . . . . 74.13 114.822 168.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.96 168.47 19.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.997 1.399 . . . . 61.21 109.242 -173.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.71 152.29 23.38 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.063 -1.615 . . . . 62.13 109.063 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -118.4 139.96 43.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.731 -1.211 . . . . 74.14 107.731 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.4 t -140.92 146.51 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.486 -1.672 . . . . 62.11 106.486 -168.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -138.29 106.97 5.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 120.815 -1.178 . . . . 65.25 108.085 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.455 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 1.3 m-85 -76.51 163.76 26.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.201 1.801 . . . . 75.25 108.943 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.6 m -74.47 -39.17 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 120.955 -1.091 . . . . 63.35 112.499 -172.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -143.09 159.27 42.58 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.195 0.598 . . . . 75.42 110.412 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -67.26 -26.89 66.79 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 117.609 -1.186 . . . . 75.42 111.698 -174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -51.72 -63.56 1.1 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 122.341 1.067 . . . . 75.01 108.429 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -73.2 -41.36 63.9 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.999 1.719 . . . . 72.44 108.446 -167.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.5 tmm? -52.62 -49.85 64.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.443 1.097 . . . . 75.43 111.245 170.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.4 m -61.19 -43.31 99.08 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.461 -0.774 . . . . 73.11 110.523 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -56.44 -41.31 76.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.93 0.786 . . . . 74.14 110.328 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.58 -43.49 68.56 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 123.729 0.812 . . . . 75.15 111.876 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.96 -34.94 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 120.596 1.543 . . . . 75.22 110.375 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.8 ptt85 -92.49 -16.32 25.96 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.145 1.165 . . . . 74.22 114.145 -170.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -117.18 -37.43 3.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.248 1.019 . . . . 74.24 111.482 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.04 22.57 12.05 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.367 1.467 . . . . 75.34 110.095 -167.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -101.16 154.96 18.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.306 1.412 . . . . 74.14 111.841 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.0 t30 63.7 14.88 8.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.148 2.579 . . . . 75.42 112.981 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.5 p -76.13 175.17 9.21 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.746 1.218 . . . . 73.43 110.832 -169.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -66.92 170.92 5.95 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.3 -0.875 . . . . 75.35 108.954 155.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -149.67 126.7 11.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.432 1.093 . . . . 74.04 109.553 166.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.5 mtt-85 -82.98 120.38 25.64 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.442 1.497 . . . . 75.43 111.511 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.8 p -76.25 -172.19 2.0 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.597 -0.89 . . . . 72.01 108.597 154.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -89.24 -8.16 54.02 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.006 -1.059 . . . . 71.32 110.99 165.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -76.82 5.55 7.59 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.84 -1.163 . . . . 73.34 113.64 -167.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.36 17.06 67.46 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 124.309 0.956 . . . . 74.15 110.845 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.6 167.14 20.58 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.139 1.376 . . . . 74.34 108.763 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.9 p -146.55 128.48 15.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.352 -0.981 . . . . 63.45 108.352 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.51 175.69 8.22 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.155 -1.054 . . . . 61.14 108.155 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -92.08 156.54 17.31 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.092 -1.818 . . . . 75.32 106.092 144.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.5 pt -131.64 173.74 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.558 -1.275 . . . . 74.25 107.558 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -128.94 150.4 50.4 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.231 -1.396 . . . . 75.25 107.231 168.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.8 t -122.62 137.21 56.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 126.081 1.752 . . . . 75.44 107.664 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.61 158.84 43.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.04 1.336 . . . . 75.53 108.902 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.3 t -70.43 149.89 10.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.45 -1.685 . . . . 72.34 106.45 162.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.3 t70 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.813 -1.089 . . . . 75.41 110.369 172.445 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.948 0 N-CA-C 110.293 -1.123 . . . . 71.32 110.293 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.8 165.38 36.38 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.593 1.557 . . . . 64.45 108.733 -168.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.96 162.88 37.93 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.173 1.915 . . . . 75.23 110.903 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -146.89 104.57 3.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.235 -1.765 . . . . 75.04 106.235 -176.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.33 43.48 2.9 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.323 0.963 . . . . 54.12 112.569 -169.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.09 -176.3 5.04 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 125.162 1.385 . . . . 74.03 110.466 -173.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.72 -169.6 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.103 1.761 . . . . 75.13 109.952 165.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.33 -171.47 22.54 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 120.605 -1.309 . . . . 52.34 112.023 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.5 172.59 11.13 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 124.131 3.221 . . . . 65.22 112.955 -173.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -64.19 99.35 0.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.465 2.11 . . . . 74.24 109.202 160.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.57 166.12 12.47 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.548 1.539 . . . . 64.23 107.737 164.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.73 159.92 15.04 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.327 -0.62 . . . . 74.43 109.327 172.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -98.7 -79.28 0.48 Allowed 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.48 -1.304 . . . . 73.51 107.48 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.1 m -153.4 174.54 14.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.854 1.262 . . . . 72.21 108.509 165.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -73.42 44.65 0.16 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.446 1.898 . . . . 73.51 111.9 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.23 22.3 3.22 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.125 -1.609 . . . . 75.13 110.861 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -121.61 136.79 54.93 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.937 -1.102 . . . . 74.42 109.285 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.51 155.99 16.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.112 -0.699 . . . . 71.54 109.112 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.97 141.26 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 124.893 1.277 . . . . 72.41 107.671 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.0 t -101.88 147.27 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 126.727 2.011 . . . . 75.35 107.805 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.08 156.45 48.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.726 0.694 . . . . 74.44 110.632 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.94 3.53 70.3 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.674 1.13 . . . . 74.23 114.084 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.9 mt -58.26 147.12 68.23 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.449 1.1 . . . . 72.41 113.448 -164.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.22 165.6 31.91 Favored 'Trans proline' 0 CA--C 1.538 0.694 1 C-N-CA 126.051 4.501 . . . . 74.22 112.841 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -67.61 -15.76 45.43 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.669 2.913 . . . . 62.53 114.754 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.04 22.72 9.48 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.536 1.134 . . . . 73.2 110.023 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.45 72.75 2.71 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.56 -1.016 . . . . 74.24 110.56 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -69.68 162.8 26.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 124.423 0.72 . . . . 72.13 111.126 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.0 p-90 -61.55 -19.54 62.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.714 0.806 . . . . 74.24 111.467 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -60.49 3.28 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 117.093 -1.432 . . . . 74.15 109.385 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -64.46 -39.9 94.69 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.128 0.893 . . . . 54.42 109.544 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -48.6 52.37 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 123.247 0.619 . . . . 64.51 110.866 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -67.77 -44.15 78.14 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.708 0.685 . . . . 75.23 110.81 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.41 -13.07 62.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.767 1.227 . . . . 63.22 112.499 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -108.74 -43.85 4.16 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.986 1.314 . . . . 75.43 112.455 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.5 ttt -77.59 42.72 0.37 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.59 -1.319 . . . . 75.32 111.198 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.5 -5.65 12.83 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.092 -1.63 . . . . 75.05 113.366 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -63.19 -22.55 66.94 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.565 1.529 . . . . 73.34 113.833 -172.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.47 -5.44 59.16 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.06 1.504 . . . . 74.35 115.06 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.27 -98.6 0.21 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-O 118.349 -1.251 . . . . 64.04 111.034 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.15 149.53 31.19 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.579 1.189 . . . . 71.43 112.188 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.4 t -130.55 148.22 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.79 1.636 . . . . 75.34 109.509 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.9 t -129.76 8.19 5.29 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.525 0.73 . . . . 64.44 112.293 -170.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -154.08 162.88 40.89 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.593 1.557 . . . . 74.12 108.81 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -162.04 129.9 4.04 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.867 0.867 . . . . 73.01 109.583 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -155.75 128.61 7.99 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.268 0.94 . . . . 72.14 111.184 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.01 177.38 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 O-C-N 120.522 -1.361 . . . . 71.33 107.398 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.21 161.04 42.27 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.312 -1.366 . . . . 72.14 107.312 168.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.5 ' HG3' ' H ' ' A' ' 50' ' ' ASP . 21.0 ptt180 42.36 -86.87 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.426 1 C-N-CA 132.116 4.166 . . . . 74.4 112.114 162.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.5 ' H ' ' HG3' ' A' ' 49' ' ' ARG . 1.1 p30 -165.48 -178.02 4.73 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 128.002 2.521 . . . . 74.54 110.209 153.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.74 -21.12 31.47 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-O 117.879 -1.512 . . . . 74.1 114.293 161.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.02 164.82 37.28 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 120.154 1.977 . . . . 73.43 108.448 168.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.0 143.05 8.17 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 107.816 -2.114 . . . . 74.13 107.816 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.7 p -107.99 144.9 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.726 1.263 . . . . 75.53 109.567 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.2 t -142.81 156.58 18.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 107.152 -1.425 . . . . 74.55 107.152 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -136.49 112.85 9.91 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.93 -1.507 . . . . 73.22 106.93 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -80.0 177.81 8.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.977 -1.465 . . . . 73.53 107.237 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.54 -60.99 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.046 -0.979 . . . . 71.45 110.399 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -139.19 169.17 18.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 124.24 1.016 . . . . 75.31 109.671 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -59.45 -29.73 68.0 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 116.875 -1.536 . . . . 74.33 111.791 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -60.55 -60.01 4.48 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.086 1.312 . . . . 73.15 109.877 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.64 -42.45 98.15 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.904 0.882 . . . . 71.54 109.695 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -58.31 -50.61 73.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.282 1.033 . . . . 70.44 110.721 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.9 m -57.57 -52.76 64.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.255 -0.646 . . . . 75.12 109.255 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -56.57 -32.13 64.89 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.627 0.771 . . . . 75.42 112.077 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.54 93.64 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 123.304 0.641 . . . . 63.33 110.024 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 t -70.29 -12.99 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.229 -0.919 . . . . 52.22 110.84 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -105.35 -33.1 8.29 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 120.875 -1.141 . . . . 74.11 111.957 -174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -121.51 -12.42 8.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.377 1.071 . . . . 74.54 112.759 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.1 18.24 10.81 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.246 1.818 . . . . 73.55 109.434 -172.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -112.57 148.71 33.97 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.725 -1.234 . . . . 74.24 110.836 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.77 27.84 16.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.395 1.078 . . . . 72.33 111.032 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.1 p -90.44 175.93 6.9 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.85 1.26 . . . . 73.52 109.807 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.86 167.82 21.11 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.831 -0.803 . . . . 73.53 108.831 158.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -146.05 160.79 41.4 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 127.328 2.251 . . . . 74.24 110.656 173.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -114.93 126.18 54.49 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.313 0.96 . . . . 72.52 109.16 -173.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.7 t -93.33 163.58 13.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.874 -0.787 . . . . 75.5 108.874 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.52 -8.37 56.56 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 119.112 -0.47 . . . . 73.2 111.749 166.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -78.43 -12.99 60.04 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.927 1.239 . . . . 73.22 113.339 -169.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.65 31.69 4.77 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 124.327 0.965 . . . . 74.24 111.864 -173.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.1 168.29 26.41 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.036 0.934 . . . . 73.11 110.936 -169.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.5 p -145.2 122.53 11.59 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.566 -1.197 . . . . 73.44 108.565 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.02 -174.17 2.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.603 1.961 . . . . 61.4 108.392 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -105.1 156.37 18.14 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 120.477 1.489 . . . . 72.43 110.59 172.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.6 pt -129.8 170.37 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 122.115 0.96 . . . . 71.44 108.987 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -130.61 155.51 46.42 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 104.791 -2.299 . . . . 71.21 104.791 172.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.8 t -125.97 137.33 58.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.982 -1.118 . . . . 74.34 107.982 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -130.41 147.7 52.14 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 123.853 0.861 . . . . 65.51 110.592 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.66 127.61 24.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 105.722 -1.955 . . . . 74.42 105.722 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 127.678 2.391 . . . . 61.31 111.09 -172.992 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.694 0 N-CA-C 110.356 -1.098 . . . . 73.13 110.356 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.81 164.77 19.92 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.827 2.051 . . . . 63.53 107.526 172.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -82.24 165.69 16.65 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.316 2.011 . . . . 73.52 112.476 -171.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -150.94 178.24 9.35 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.186 2.194 . . . . 74.53 109.145 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.52 85.14 0.06 OUTLIER Glycine 0 C--N 1.336 0.549 0 N-CA-C 109.523 -1.431 . . . . 52.33 109.523 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.96 78.48 1.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.285 1.043 . . . . 74.51 109.965 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -157.61 124.25 4.94 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 120.866 -1.146 . . . . 74.34 109.059 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.19 177.18 29.22 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.923 1.249 . . . . 63.31 112.627 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.6 172.41 10.47 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.198 2.599 . . . . 73.42 109.976 164.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.78 78.51 2.8 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.337 2.691 . . . . 70.01 110.464 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.4 m -90.49 157.0 17.78 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.062 -0.718 . . . . 72.32 109.062 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.84 -175.54 3.76 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.959 1.304 . . . . 74.14 110.474 -175.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -146.07 -81.08 0.15 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.817 0.847 . . . . 72.14 110.205 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.2 m -154.48 159.0 40.76 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 128.696 2.798 . . . . 74.02 106.97 -163.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -76.34 37.15 0.16 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.709 1.603 . . . . 74.2 112.301 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.8 14.94 3.63 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.465 1.906 . . . . 74.03 110.746 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.33 121.39 42.66 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.512 1.525 . . . . 73.02 107.526 -162.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.8 m -115.14 166.12 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 118.504 0.593 . . . . 72.21 111.455 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.3 t -132.74 153.01 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.092 -1.818 . . . . 72.34 106.092 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 t -134.11 141.03 44.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 106.955 -1.498 . . . . 74.42 106.955 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.3 m -137.31 141.81 41.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 123.127 1.442 . . . . 74.33 113.266 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.19 37.43 48.8 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 128.578 2.99 . . . . 73.24 112.773 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.63 160.77 3.67 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.853 1.661 . . . . 74.42 113.021 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.83 171.02 14.13 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.612 3.541 . . . . 73.11 112.014 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.76 -4.89 16.18 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.739 2.293 . . . . 73.23 114.239 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.8 t -141.58 51.66 1.55 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.615 1.166 . . . . 73.34 109.08 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.95 164.55 13.22 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.365 -1.494 . . . . 74.2 109.365 168.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 m -151.66 168.41 25.09 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.405 1.482 . . . . 73.2 108.426 167.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -53.0 -29.3 28.39 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.203 0.816 . . . . 70.31 113.203 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -62.79 -58.24 8.11 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.424 1.089 . . . . 72.44 108.911 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.3 -30.6 67.64 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.453 -0.573 . . . . 70.13 109.453 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -51.29 -56.05 15.05 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.33 -0.856 . . . . 72.5 109.78 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -70.47 -35.62 73.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.919 1.288 . . . . 65.53 110.034 -175.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -59.63 -23.04 62.68 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.245 1.018 . . . . 73.33 112.953 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -102.59 -42.89 5.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.153 0.981 . . . . 74.51 111.431 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.19 -20.42 65.4 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.154 -0.966 . . . . 74.43 113.244 -174.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -52.55 -26.2 12.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.827 1.417 . . . . 74.4 114.827 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -71.06 3.08 3.69 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.687 1.736 . . . . 65.43 115.687 -161.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.75 -0.96 28.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.642 1.177 . . . . 74.44 111.955 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.47 -97.95 0.16 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.617 -1.793 . . . . 50.02 108.617 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -157.76 162.53 38.51 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.795 1.283 . . . . 62.52 107.789 166.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.442 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -131.81 129.73 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 126.738 2.015 . . . . 64.33 109.818 -175.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.7 t -86.85 -32.62 20.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.577 -1.192 . . . . 74.32 109.341 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -138.47 137.16 36.9 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.156 -0.965 . . . . 74.32 110.638 -160.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.76 149.43 37.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.203 1.001 . . . . 74.31 110.771 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -161.63 106.97 1.3 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.879 2.072 . . . . 63.11 108.821 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.93 -176.71 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.282 -1.511 . . . . 73.13 107.985 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -143.16 155.17 44.5 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.892 -0.781 . . . . 74.52 108.892 156.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 43.37 -86.13 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 130.666 3.587 . . . . 64.13 111.838 166.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -159.38 173.97 15.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 125.231 1.582 . . . . 72.24 107.52 147.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.08 -8.92 63.27 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 118.605 -1.108 . . . . 71.44 113.343 161.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.56 164.84 33.93 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.635 1.717 . . . . 74.1 108.294 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -155.8 163.21 31.65 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.174 -1.17 . . . . 72.53 110.174 167.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.6 147.54 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.493 1.917 . . . . 73.32 108.23 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 72.1 t -144.0 166.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.943 -1.132 . . . . 73.44 107.943 -165.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -135.81 109.68 8.16 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.249 -1.389 . . . . 74.44 107.249 165.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.442 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -79.12 167.11 21.49 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.495 1.518 . . . . 70.33 108.336 172.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.71 -29.98 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.212 1.19 . . . . 70.13 114.212 -166.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -156.31 164.39 38.38 Favored 'General case' 0 CA--C 1.515 -0.381 0 O-C-N 121.262 -0.899 . . . . 74.34 109.894 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -61.72 -31.95 72.15 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 117.448 -1.263 . . . . 74.43 111.632 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.29 -51.92 65.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 120.379 1.445 . . . . 72.42 109.724 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.46 -40.69 66.8 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.258 1.423 . . . . 61.22 108.706 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 36.2 ttp -52.25 -53.82 38.95 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 123.338 0.655 . . . . 65.04 109.98 169.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.4 m -55.31 -47.46 75.57 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.306 -0.854 . . . . 73.0 109.977 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -57.53 -28.34 63.4 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.866 1.212 . . . . 71.51 112.113 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.1 -44.91 83.0 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.469 1.108 . . . . 72.23 109.227 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.8 t -65.09 -21.76 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 121.192 -0.942 . . . . 73.33 110.778 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -91.9 -43.78 9.29 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 120.964 -1.085 . . . . 74.41 111.317 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -114.44 -15.62 12.05 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.069 1.348 . . . . 74.11 111.998 -165.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.32 22.15 9.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.478 1.911 . . . . 63.3 108.95 -171.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -111.83 154.53 24.98 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.45 -1.407 . . . . 72.42 110.87 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.269 5.8 p-10 45.25 41.67 6.31 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.103 2.161 . . . . 72.42 112.327 -170.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.0 p -95.97 175.15 6.59 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.545 1.138 . . . . 73.23 111.668 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 171.78 4.09 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.078 0.551 . . . . 74.1 109.541 158.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -150.97 124.78 9.14 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.104 1.361 . . . . 74.2 109.328 166.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -70.46 142.2 51.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.84 1.2 . . . . 74.24 110.47 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -109.11 -170.97 1.75 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.17 1.788 . . . . 71.52 107.507 176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -99.6 -3.21 33.74 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.303 0.853 . . . . 71.24 113.303 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.73 41.46 1.39 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.494 1.117 . . . . 62.44 111.465 -171.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.41 18.48 55.78 Favored Glycine 0 N--CA 1.464 0.538 0 C-N-CA 124.924 1.249 . . . . 51.21 113.408 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -142.99 174.09 10.98 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 125.492 1.517 . . . . 74.51 108.894 -166.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 52.5 p -147.19 143.35 28.14 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.813 -0.81 . . . . 71.54 108.813 -172.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.21 176.81 8.13 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.619 0.768 . . . . 70.51 110.565 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -104.13 154.79 19.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.984 -1.487 . . . . 73.53 106.984 141.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 pt -133.4 166.43 29.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 124.828 1.251 . . . . 74.52 108.603 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -126.51 133.5 51.13 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 105.822 -1.918 . . . . 74.23 105.822 165.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.5 t -84.44 165.96 2.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 125.779 1.632 . . . . 72.11 107.703 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.77 156.43 31.55 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.552 1.541 . . . . 73.33 107.967 162.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.78 138.51 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 105.18 -2.156 . . . . 63.1 105.18 156.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--O 1.245 0.853 0 C-N-CA 124.044 0.938 . . . . 65.31 110.568 177.361 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.771 0 N-CA-C 111.609 -0.596 . . . . 55.23 111.609 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.49 158.1 57.19 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 125.877 1.671 . . . . 75.21 109.061 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.34 -55.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.559 2.173 . . . . 73.04 112.544 -171.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -172.54 165.94 5.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.121 -1.066 . . . . 74.34 108.121 -157.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.65 177.41 48.33 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 108.063 -2.015 . . . . 73.33 108.063 170.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -156.13 165.77 35.42 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.993 0.396 . . . . 73.45 110.415 161.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -148.51 -164.64 2.07 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.985 -1.117 . . . . 74.41 107.985 160.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.17 62.27 0.55 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.41 1.481 . . . . 74.22 110.886 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.17 170.81 9.98 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.271 1.98 . . . . 74.14 109.662 166.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.7 79.25 1.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.9 2.4 . . . . 74.52 110.148 174.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.0 p -145.35 164.56 31.09 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.911 1.284 . . . . 71.43 109.68 165.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.1 179.52 6.58 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.148 1.779 . . . . 73.14 108.143 169.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -134.92 -84.97 0.41 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.942 -1.133 . . . . 71.14 107.942 165.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.4 m -149.32 167.72 25.32 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.372 1.869 . . . . 74.5 108.319 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -70.53 24.35 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.054 2.541 . . . . 74.14 113.949 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.51 18.24 5.3 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.473 -1.392 . . . . 65.4 110.465 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.93 146.56 34.98 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.057 1.743 . . . . 71.34 111.106 -170.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.0 m -142.01 171.92 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 118.956 0.798 . . . . 74.43 111.012 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 39.5 t -140.96 148.15 21.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.188 -2.153 . . . . 72.23 105.188 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 t -118.83 154.88 21.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 125.006 1.322 . . . . 74.43 107.683 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.6 m -149.45 158.49 44.22 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 119.955 -1.716 . . . . 73.31 110.525 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.39 61.42 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.889 0.757 . . . . 71.35 112.895 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -59.1 154.85 37.49 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 124.866 1.267 . . . . 73.05 112.238 -175.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.63 174.54 12.06 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.45 3.434 . . . . 73.11 112.8 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.89 -8.08 21.74 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.625 2.217 . . . . 64.01 114.676 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.68 59.84 1.65 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.997 1.726 . . . . 70.33 109.685 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.97 149.12 16.87 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 108.199 -1.96 . . . . 70.11 108.199 172.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.1 m -137.6 -179.69 5.89 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 122.513 1.149 . . . . 72.14 108.144 168.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.3 p-90 -63.56 -18.53 63.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.92 1.288 . . . . 70.41 112.239 -176.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -69.89 -57.18 5.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.082 -1.081 . . . . 71.12 108.082 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -64.39 -26.91 68.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.548 0.69 . . . . 71.32 110.455 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -64.74 -54.05 37.46 Favored 'General case' 0 C--O 1.224 -0.264 0 O-C-N 120.235 -1.54 . . . . 65.32 110.653 174.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -65.51 -25.83 67.63 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.864 0.866 . . . . 73.41 110.865 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -31.89 64.97 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.808 -0.812 . . . . 74.31 108.808 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -83.82 -53.41 5.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.231 1.813 . . . . 72.51 112.088 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.9 ttt -81.64 39.42 0.54 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.64 1.176 . . . . 72.14 112.069 -167.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.81 2.28 14.33 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.229 1.412 . . . . 74.34 111.874 -175.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -85.78 -8.56 58.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.418 1.487 . . . . 72.13 113.174 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.61 25.22 11.88 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.979 1.312 . . . . 62.43 112.926 -166.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.51 -104.03 0.82 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 108.818 -1.713 . . . . 73.1 108.818 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -139.73 133.9 31.13 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.812 0.845 . . . . 64.33 110.64 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.6 t -127.97 136.04 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 126.195 1.798 . . . . 73.14 107.587 173.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.2 t -110.08 -26.13 9.86 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.462 0.541 . . . . 72.14 112.462 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -116.01 146.13 42.4 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.238 1.015 . . . . 72.42 109.721 -173.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.74 152.19 43.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.112 0.965 . . . . 71.25 108.463 163.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -148.58 144.66 27.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.569 0.748 . . . . 74.51 109.557 160.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -147.4 144.91 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 105.768 -1.938 . . . . 73.22 105.768 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -138.22 178.79 6.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.599 1.16 . . . . 74.43 109.343 -171.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -89.42 66.47 7.43 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.203 -1.036 . . . . 73.43 108.203 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -151.49 31.68 0.58 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.625 0.77 . . . . 70.11 110.414 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.75 18.75 40.22 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.062 -1.024 . . . . 74.31 113.616 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.7 p -146.93 170.22 17.52 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.222 1.511 . . . . 63.05 110.242 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.42 164.01 34.27 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.841 1.21 . . . . 72.23 110.469 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 28.7 t -131.4 156.01 42.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.572 1.549 . . . . 70.15 109.025 172.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.5 t -147.1 158.4 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.093 -1.447 . . . . 71.33 107.093 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -145.0 114.45 7.14 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.325 -0.991 . . . . 65.42 108.325 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.78 174.77 7.01 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.822 2.449 . . . . 73.43 107.941 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.81 -49.25 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 117.606 -1.188 . . . . 63.31 111.11 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -137.09 157.84 45.79 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 120.471 1.487 . . . . 74.42 110.721 -167.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -62.88 -25.85 68.5 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 118.303 -0.856 . . . . 70.54 111.133 -170.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.66 -42.76 40.67 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 119.242 0.928 . . . . 73.11 111.299 -174.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -67.84 -44.44 77.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.082 0.855 . . . . 64.52 109.104 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.9 tmm? -50.6 -50.94 52.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.926 0.491 . . . . 72.52 110.938 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.9 m -56.58 -52.84 63.28 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.715 -0.659 . . . . 74.51 110.344 172.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -49.52 -40.84 39.26 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.489 1.515 . . . . 75.02 111.158 -174.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.39 93.35 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.102 1.361 . . . . 75.12 111.259 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.5 t -58.67 -25.77 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 121.413 -0.804 . . . . 75.12 110.269 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -106.87 -9.85 16.2 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.399 1.479 . . . . 75.12 111.852 -167.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -20.23 1.54 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 117.283 -1.341 . . . . 71.01 113.587 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.0 18.83 10.08 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.882 1.673 . . . . 74.42 109.737 -164.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -104.12 159.0 16.04 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.921 -1.112 . . . . 73.32 111.91 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 44.98 43.24 7.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.782 2.433 . . . . 74.43 112.044 -168.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.2 p -86.54 164.35 16.95 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.509 0.723 . . . . 75.45 110.731 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -88.07 157.62 18.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.553 1.141 . . . . 75.12 108.99 169.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -140.29 133.1 29.09 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.65 1.58 . . . . 74.05 109.519 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -81.82 112.28 18.81 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 123.692 0.797 . . . . 75.34 110.52 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.15 156.66 29.77 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.961 -1.125 . . . . 73.35 107.961 165.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -72.77 -11.36 60.58 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.94 -0.475 . . . . 74.54 111.196 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -70.05 3.64 2.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.778 2.031 . . . . 74.13 113.545 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.19 15.97 78.67 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 119.121 0.873 . . . . 50.54 111.525 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.13 170.88 14.36 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 126.841 2.056 . . . . 75.42 108.011 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 30.6 p -137.54 154.71 49.78 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.295 -1.743 . . . . 63.13 106.295 -177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.07 -179.09 5.2 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.871 -0.789 . . . . 73.03 108.871 166.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -95.56 156.53 16.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.453 -0.573 . . . . 75.33 109.453 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.1 pt -124.95 168.83 17.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.552 1.141 . . . . 74.34 108.873 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -125.39 147.18 49.28 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.154 -1.424 . . . . 72.41 107.154 165.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.1 t -104.79 146.39 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 125.909 1.684 . . . . 74.41 108.794 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 160.61 43.77 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.211 1.805 . . . . 75.3 108.815 173.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.9 150.49 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 105.688 -1.967 . . . . 75.1 105.688 167.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t70 . . . . . 0 C--O 1.248 1.005 0 C-N-CA 125.477 1.511 . . . . 74.13 109.854 171.022 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.141 0 N-CA-C 110.113 -1.195 . . . . 71.31 110.113 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.04 160.69 34.48 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 118.188 0.994 . . . . 65.13 109.963 170.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -68.98 -175.76 1.07 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.083 2.522 . . . . 61.1 110.968 164.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.48 161.31 42.37 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.269 1.027 . . . . 72.4 110.2 -170.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.64 -168.04 26.43 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.354 -1.098 . . . . 72.21 110.354 169.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.55 164.96 34.71 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.164 1.386 . . . . 74.22 108.163 166.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -156.6 162.73 39.86 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.315 0.507 . . . . 74.24 110.908 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.1 67.82 0.03 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.859 1.218 . . . . 63.32 110.112 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.63 163.89 25.82 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.552 2.168 . . . . 72.52 111.341 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.6 78.38 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.302 3.335 . . . . 72.41 111.09 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 p -145.58 167.79 22.2 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 126.403 1.881 . . . . 63.43 109.621 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.83 167.56 25.31 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 127.538 2.335 . . . . 71.52 105.269 169.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 mtp-105 -127.26 -75.95 0.57 Allowed 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.2 -1.407 . . . . 71.31 107.2 165.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.3 m -146.74 165.66 28.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 123.053 1.406 . . . . 70.13 111.156 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -62.34 15.26 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 131.138 3.775 . . . . 71.52 113.17 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.43 14.85 3.46 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 119.093 -2.254 . . . . 70.12 111.314 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -104.49 142.61 34.32 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.63 1.172 . . . . 71.21 111.3 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.7 169.41 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.095 1.358 . . . . 71.32 111.601 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.7 t -133.86 151.3 32.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.948 2.099 . . . . 73.54 106.008 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.42 153.9 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.379 -0.971 . . . . 70.22 108.379 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.0 p -132.14 168.83 17.31 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 121.286 -0.884 . . . . 72.33 109.04 168.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.69 -6.45 58.88 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.713 -1.049 . . . . 72.23 113.644 168.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.83 152.58 26.56 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 125.082 1.353 . . . . 74.53 113.892 -165.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.26 173.55 12.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.763 2.975 . . . . 64.11 111.788 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.45 -7.55 12.7 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.071 3.181 . . . . 73.23 115.329 168.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.29 68.16 1.23 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 121.25 1.841 . . . . 70.31 110.787 172.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.92 115.51 3.49 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.35 -1.5 . . . . 64.32 109.35 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 m -111.06 164.05 13.23 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.324 1.05 . . . . 54.23 109.83 -174.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -66.48 -25.26 66.62 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.171 -0.956 . . . . 74.43 112.097 -168.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -68.75 -52.08 34.43 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.729 -0.841 . . . . 73.44 108.729 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -58.56 -41.32 85.36 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.772 -0.825 . . . . 73.25 108.772 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.95 -60.75 2.94 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-O 117.707 -1.139 . . . . 73.53 110.264 174.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -65.86 -32.83 74.58 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 120.904 1.683 . . . . 72.54 111.758 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.31 -30.02 71.24 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.458 1.103 . . . . 74.13 111.351 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.34 -48.56 6.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.774 0.43 . . . . 74.31 110.803 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.4 ttt -72.25 30.64 0.06 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.454 2.302 . . . . 70.42 112.843 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -108.92 -10.07 15.09 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 120.125 -1.609 . . . . 74.14 112.091 172.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -72.3 -9.75 58.89 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.269 -1.52 . . . . 74.32 113.828 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.03 8.34 43.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.335 1.054 . . . . 71.52 113.048 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.44 -127.25 3.28 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 109.334 -1.507 . . . . 71.44 109.334 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -142.02 131.82 24.26 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.247 0.523 . . . . 73.51 109.92 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.433 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -127.57 138.76 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 C-N-CA 126.095 1.758 . . . . 74.51 112.37 -175.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.1 t -112.51 -35.57 5.51 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.929 -1.032 . . . . 73.31 111.46 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -109.55 136.35 49.07 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.499 1.045 . . . . 73.33 108.887 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.69 143.88 31.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.256 -1.387 . . . . 52.12 107.256 166.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -158.6 129.44 6.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.482 -1.303 . . . . 64.24 107.482 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.82 163.02 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 120.798 -1.189 . . . . 74.14 109.286 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -149.38 169.23 21.32 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.437 0.637 . . . . 70.13 110.151 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -74.61 48.8 0.37 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.869 2.468 . . . . 72.31 113.059 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -138.56 15.78 2.73 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.851 -1.155 . . . . 63.23 112.283 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.55 20.46 66.3 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 120.761 -1.212 . . . . 45.34 113.016 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 p -138.45 177.43 7.89 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 119.036 1.418 . . . . 72.14 111.963 -169.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.6 168.53 40.16 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.817 1.198 . . . . 72.33 111.007 167.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 p -133.97 139.38 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.497 1.519 . . . . 72.32 108.115 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.2 t -146.41 148.36 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 107.78 -1.192 . . . . 72.33 107.78 -161.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -137.37 109.5 7.26 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.686 1.232 . . . . 72.4 108.979 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.433 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 3.6 m-30 -69.19 -179.52 1.6 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.952 1.701 . . . . 74.21 109.666 171.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.92 -50.55 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 O-C-N 121.238 -0.914 . . . . 72.55 110.068 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -142.6 159.07 42.95 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 119.281 0.946 . . . . 74.34 111.447 -169.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -59.31 -30.91 68.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.211 -0.9 . . . . 74.21 111.458 -173.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.6 -29.65 68.22 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.886 1.221 . . . . 70.31 112.296 -174.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -85.12 -40.83 16.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.725 0.81 . . . . 73.41 108.907 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -52.79 -51.94 58.74 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.769 -0.582 . . . . 74.2 110.626 171.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.6 m -48.64 -46.55 40.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.475 1.51 . . . . 45.44 110.728 171.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -59.46 -40.32 86.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.223 0.609 . . . . 71.31 110.221 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.53 -39.01 78.95 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.054 0.843 . . . . 73.52 111.677 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.79 -27.76 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.812 0.733 . . . . 72.5 109.897 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -106.39 -9.1 16.87 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 114.101 1.148 . . . . 74.23 114.101 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -133.78 -1.74 3.03 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 117.673 -1.156 . . . . 73.54 113.195 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.89 17.81 1.61 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 120.067 1.303 . . . . 72.31 111.97 -165.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.48 153.1 18.65 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.705 1.593 . . . . 62.42 114.432 173.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 52.68 33.09 13.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 128.488 2.715 . . . . 74.53 114.494 -173.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.2 p -82.38 172.78 12.69 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.4 -0.813 . . . . 74.22 110.748 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.74 171.23 15.41 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.66 1.184 . . . . 74.54 109.356 168.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -144.87 122.63 11.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.746 2.018 . . . . 72.55 109.489 167.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -69.64 122.22 18.68 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.814 1.646 . . . . 71.33 109.436 170.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.0 p -87.45 172.87 9.48 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.752 0.705 . . . . 70.11 109.565 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -73.28 -9.87 59.16 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.336 -0.393 . . . . 71.25 111.919 165.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.62 23.33 10.54 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.539 1.536 . . . . 74.3 112.78 -164.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.43 4.5 38.27 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 123.344 0.497 . . . . 72.54 113.313 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -119.71 165.87 13.95 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.302 1.441 . . . . 64.12 108.752 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.2 p -140.77 142.05 34.76 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.561 -1.644 . . . . 51.02 106.561 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.09 169.08 12.04 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.915 1.686 . . . . 54.42 107.392 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -93.25 158.0 15.97 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.65 1.114 . . . . 74.23 109.256 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 pt -126.89 168.92 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.677 0.791 . . . . 74.5 110.644 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -129.28 120.32 25.48 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 105.162 -2.162 . . . . 74.21 105.162 163.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.5 t -67.66 149.18 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.575 -1.269 . . . . 74.43 107.575 162.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -144.28 165.72 27.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 123.872 0.869 . . . . 73.31 109.93 156.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 t -73.36 149.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.728 -1.582 . . . . 62.43 106.728 166.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.0 t0 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 124.785 1.234 . . . . 72.54 108.399 167.543 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.661 0 N-CA-C 111.777 -0.529 . . . . 64.11 111.777 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.25 161.96 50.24 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 126.321 1.848 . . . . 75.25 107.871 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.91 -57.05 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 120.648 1.267 . . . . 74.31 111.493 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 175.42 173.66 0.27 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.941 -1.133 . . . . 74.45 107.941 -157.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.2 -163.3 5.33 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.889 1.709 . . . . 73.04 112.022 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.62 169.51 24.14 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.505 1.522 . . . . 72.44 108.239 158.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.32 120.83 4.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 104.913 -2.254 . . . . 74.32 104.913 168.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.5 -170.05 24.07 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.453 -1.193 . . . . 72.32 111.909 -176.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -64.12 175.54 3.14 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.65 2.9 . . . . 74.32 113.105 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -55.66 -164.55 0.01 OUTLIER 'Trans proline' 0 CA--C 1.555 1.566 0 CA-C-O 124.726 1.886 . . . . 64.24 112.4 146.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 174.89 144.81 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 1 C-N-CA 132.565 4.346 . . . . 74.51 108.499 -168.127 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.95 178.02 8.32 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.548 1.139 . . . . 71.53 110.646 168.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -128.2 -83.2 0.59 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 118.774 -0.632 . . . . 75.03 109.687 162.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 m -152.39 173.25 15.32 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.812 1.645 . . . . 72.35 108.144 -169.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -80.74 33.87 0.33 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.439 1.895 . . . . 74.24 112.039 -170.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.38 29.08 3.33 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.158 -1.589 . . . . 74.25 108.948 175.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.77 145.2 44.67 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.746 -1.221 . . . . 74.04 109.77 -167.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.3 m -141.18 175.37 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.554 0.741 . . . . 74.45 110.326 -173.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.1 t -135.08 155.48 37.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 107.674 -1.232 . . . . 74.25 107.674 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.7 140.44 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.903 1.681 . . . . 73.31 106.528 170.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -135.58 165.03 26.47 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.874 -0.787 . . . . 74.13 108.874 170.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.58 7.04 72.5 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.616 -0.547 . . . . 71.22 113.04 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.9 mt -63.85 156.52 72.66 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 119.136 1.468 . . . . 73.41 111.189 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.99 170.46 19.75 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.049 3.166 . . . . 65.24 110.534 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.28 -5.11 16.26 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.04 2.493 . . . . 72.32 114.932 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.53 34.78 4.75 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.886 1.221 . . . . 72.14 111.398 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.9 146.66 21.44 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.265 -1.134 . . . . 74.31 110.265 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 t -137.75 168.08 20.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.61 1.195 . . . . 64.33 113.428 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -67.19 -26.1 66.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.989 1.716 . . . . 74.03 111.455 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -61.82 2.35 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.6 -1.259 . . . . 73.31 107.6 175.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -63.73 -35.46 80.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.1 0.875 . . . . 64.0 109.72 -176.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -54.38 46.95 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.48 0.582 . . . . 75.35 109.834 175.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -67.57 -27.51 67.0 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 111.563 0.208 . . . . 75.42 111.563 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.01 -20.53 52.37 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.729 -0.607 . . . . 75.02 112.069 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -88.33 -60.6 1.92 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.628 1.571 . . . . 73.3 111.171 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -69.44 -13.4 62.34 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.372 1.249 . . . . 62.44 114.372 -160.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -8.9 0.06 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.848 2.859 . . . . 75.22 113.757 170.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -58.75 -30.55 67.6 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.489 1.04 . . . . 73.41 112.256 173.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.35 0.94 57.44 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.28 1.215 . . . . 64.35 114.28 -170.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.71 -104.21 0.33 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 108.855 -1.698 . . . . 64.01 108.855 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -147.03 152.31 38.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.661 0.73 . . . . 74.24 109.451 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.2 t -141.74 120.36 9.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 127.245 2.218 . . . . 73.34 106.273 -165.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -102.43 -44.43 5.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.96 0.8 . . . . 72.41 110.926 -175.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -73.22 160.26 32.2 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.596 0.759 . . . . 73.34 110.607 174.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.94 128.35 5.56 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.269 0.94 . . . . 75.02 112.105 166.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -158.17 127.02 5.58 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.342 1.057 . . . . 61.04 111.309 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.8 t -143.81 158.89 16.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.467 -1.679 . . . . 63.13 106.467 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -138.51 171.01 14.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.735 0.814 . . . . 65.45 109.908 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -75.32 68.66 2.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.707 1.603 . . . . 75.0 108.245 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -148.61 174.03 12.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.978 2.911 . . . . 74.21 106.354 166.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.07 22.81 0.45 Allowed Glycine 0 CA--C 1.537 1.458 0 CA-C-O 117.379 -1.789 . . . . 74.44 114.597 165.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.3 p -133.46 158.08 43.97 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 121.01 2.405 . . . . 74.42 112.504 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.41 151.95 23.69 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 105.676 -2.97 . . . . 65.34 105.676 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.09 148.97 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.705 -1.961 . . . . 74.34 105.705 168.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.9 t -137.47 160.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.112 -1.44 . . . . 74.11 107.112 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -140.99 149.92 42.4 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.826 -1.916 . . . . 74.22 105.826 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -122.3 176.77 5.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.251 1.82 . . . . 74.41 108.573 -168.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -82.7 -39.21 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.314 -0.857 . . . . 75.25 111.36 -174.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -151.88 163.99 38.05 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.744 0.702 . . . . 71.03 110.1 -176.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -68.97 -27.41 65.69 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 117.773 -1.108 . . . . 75.42 110.944 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -58.68 -51.84 68.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.941 1.246 . . . . 75.13 109.39 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.31 -47.83 75.19 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.541 1.936 . . . . 74.43 109.012 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 12.0 tmm? -54.54 -58.47 7.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.453 0.701 . . . . 64.42 112.061 176.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.4 m -55.3 -44.93 76.22 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 118.013 -0.994 . . . . 73.34 110.31 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.1 -32.83 71.35 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.245 0.929 . . . . 73.43 111.211 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.35 -41.64 85.12 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.813 0.845 . . . . 72.34 110.739 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.04 -18.77 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 O-C-N 121.008 -1.058 . . . . 71.35 109.842 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.08 -16.16 14.34 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.807 1.643 . . . . 73.42 114.129 -173.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -144.72 12.94 1.49 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.034 1.124 . . . . 74.12 114.034 -174.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -149.69 -1.66 0.44 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.874 1.216 . . . . 73.45 112.735 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -86.86 156.23 19.95 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 119.134 -2.229 . . . . 65.2 112.884 172.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.4 t30 57.82 58.19 3.79 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.109 1.764 . . . . 73.13 109.98 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.6 p -128.7 168.24 16.09 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.39 1.076 . . . . 74.12 110.436 -172.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -80.43 161.56 24.87 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.731 -0.605 . . . . 73.22 111.521 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -146.89 127.17 13.89 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.231 1.413 . . . . 75.14 111.457 171.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -78.75 125.39 29.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.192 2.197 . . . . 75.11 111.203 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.2 t -94.79 169.75 9.93 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.062 0.945 . . . . 74.23 109.442 172.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -65.36 -30.37 71.19 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 123.898 0.879 . . . . 73.4 112.498 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.64 9.7 3.21 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.762 0.825 . . . . 72.03 112.104 -173.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.17 4.93 57.74 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 120.866 -1.146 . . . . 75.1 113.577 -175.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -88.04 172.22 9.71 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 124.709 1.204 . . . . 71.31 109.107 172.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.2 p -142.06 160.37 40.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.207 -1.405 . . . . 70.33 107.207 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.32 -177.44 4.24 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.644 -0.873 . . . . 74.31 108.644 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -108.88 148.75 30.17 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.046 -1.094 . . . . 72.12 108.046 165.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.6 pt -134.15 162.36 39.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 122.208 1.004 . . . . 73.23 111.331 -171.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -136.29 109.34 7.7 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.978 1.711 . . . . 73.44 107.509 -162.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.3 p -77.69 156.21 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 124.834 1.334 . . . . 71.21 108.815 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -152.16 161.66 42.29 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.567 -1.271 . . . . 74.14 107.567 160.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.0 141.49 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.826 -1.916 . . . . 71.14 105.826 168.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 59.2 t0 . . . . . 0 C--O 1.256 1.445 0 N-CA-C 107.465 -1.309 . . . . 73.44 107.465 168.144 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.757 0 N-CA-C 108.647 -1.781 . . . . 73.25 108.647 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.22 155.03 28.52 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 108.402 -0.962 . . . . 73.45 108.402 162.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.17 163.6 34.65 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.937 2.424 . . . . 71.12 111.434 175.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -145.12 133.11 21.34 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.126 0.97 . . . . 74.45 108.823 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.29 -135.3 20.86 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 108.954 -1.659 . . . . 72.23 108.954 -172.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.51 -178.93 5.28 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.291 1.436 . . . . 74.41 109.306 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -115.22 155.89 26.36 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.223 1.009 . . . . 75.44 108.662 167.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.75 -179.53 5.03 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.928 1.393 . . . . 64.11 113.39 171.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.33 157.53 49.6 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.162 1.908 . . . . 63.41 110.185 163.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.54 66.82 6.46 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.855 3.037 . . . . 75.0 109.398 164.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -85.88 157.19 20.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.268 -1.012 . . . . 71.11 108.268 166.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -139.51 165.55 26.95 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.425 0.69 . . . . 74.32 110.346 -172.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.67 -67.26 0.8 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.671 0.788 . . . . 74.2 110.78 -167.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.9 m -156.55 167.99 28.76 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.554 1.941 . . . . 51.51 108.539 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -75.44 21.07 0.14 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.29 1.436 . . . . 71.03 112.966 -173.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.69 17.94 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.316 -1.49 . . . . 64.33 110.853 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 124.9 50.33 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.414 1.086 . . . . 74.12 112.273 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.4 m -129.48 162.31 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.661 1.585 . . . . 63.1 109.592 171.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.28 171.09 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.782 1.633 . . . . 71.42 109.708 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.17 148.8 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.524 1.129 . . . . 73.31 108.102 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.92 164.96 25.78 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.53 1.932 . . . . 61.33 107.676 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.25 -2.12 47.05 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 124.892 1.234 . . . . 72.35 113.676 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.58 147.73 98.68 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 118.758 1.279 . . . . 71.32 111.666 -161.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.2 169.13 22.26 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.481 2.788 . . . . 75.41 110.24 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.63 -4.27 11.8 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.707 2.938 . . . . 73.04 114.173 174.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.29 41.7 3.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.081 1.353 . . . . 74.34 108.777 -174.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.44 106.36 1.31 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.756 1.646 . . . . 74.14 110.567 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 m -103.35 174.26 5.94 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.754 1.277 . . . . 73.13 111.683 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -67.33 -18.94 65.37 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.502 1.121 . . . . 74.32 112.688 -170.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -74.77 -53.82 8.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.346 -0.983 . . . . 73.31 108.346 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -58.09 -37.33 74.28 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.269 0.627 . . . . 65.31 110.187 173.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -56.76 17.63 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.92 0.888 . . . . 74.34 110.257 173.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -61.19 -37.8 84.23 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.692 1.133 . . . . 73.25 110.069 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.39 -8.29 56.29 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.035 0.934 . . . . 72.41 113.225 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.436 ' CE1' ' H ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -92.36 -54.49 3.78 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.764 1.226 . . . . 74.44 110.763 163.724 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -80.02 77.85 6.69 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.988 1.315 . . . . 72.32 108.656 -169.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.77 -21.47 0.46 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.293 1.437 . . . . 74.05 112.386 176.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.4 -14.09 61.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.064 0.946 . . . . 74.01 113.304 -172.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.13 -27.8 35.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.201 0.6 . . . . 71.04 112.414 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.35 -170.88 17.26 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.19 -0.764 . . . . 65.32 111.19 -154.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.76 127.94 33.92 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 113.183 0.809 . . . . 74.22 113.183 -146.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.5 t -119.33 130.45 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 125.278 1.431 . . . . 74.41 108.446 -178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.2 t -130.63 11.59 5.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.126 0.97 . . . . 71.0 111.243 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -152.99 139.63 18.83 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.076 2.15 . . . . 71.43 107.239 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.73 147.78 41.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.839 0.856 . . . . 72.15 109.471 163.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -162.16 142.38 10.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.946 2.098 . . . . 73.02 109.194 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.41 -172.35 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 125.849 1.66 . . . . 70.42 107.089 173.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -150.54 156.2 40.93 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.788 -1.56 . . . . 75.11 106.788 171.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.318 0.3 OUTLIER 41.45 -85.75 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 129.142 2.977 . . . . 73.32 112.654 152.152 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.94 174.73 14.52 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.181 0.991 . . . . 73.05 112.589 169.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.39 -41.33 3.06 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 125.677 1.608 . . . . 63.03 113.672 159.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.25 169.68 17.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.419 1.61 . . . . 73.04 110.285 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.55 167.98 35.9 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.578 1.561 . . . . 73.05 109.46 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.77 119.85 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 118.399 1.1 . . . . 73.15 110.303 -168.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -113.27 174.23 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.619 -0.882 . . . . 72.31 108.619 -166.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.39 125.99 11.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.609 1.55 . . . . 73.34 108.774 164.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -99.48 177.5 5.15 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.251 1.82 . . . . 73.01 108.874 -175.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.4 -64.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 O-C-N 122.14 -0.35 . . . . 73.34 110.206 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -133.49 168.53 18.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.358 0.599 . . . . 71.1 111.637 -169.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -54.18 -33.56 58.39 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 114.353 -1.294 . . . . 71.22 110.706 176.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -54.16 -64.12 0.93 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.76 0.824 . . . . 70.14 110.265 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.64 -41.45 79.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.594 1.558 . . . . 73.12 109.387 -173.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -53.47 -50.59 65.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.599 1.159 . . . . 74.31 111.198 174.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -66.42 -45.55 79.5 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.156 0.583 . . . . 73.31 110.602 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -56.7 -38.62 72.53 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.805 0.729 . . . . 74.42 110.134 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.62 -39.89 74.43 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.643 -0.694 . . . . 71.03 112.053 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.11 -26.3 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.102 1.319 . . . . 74.33 109.587 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -105.53 4.38 30.4 Favored 'General case' 0 C--N 1.343 0.305 0 N-CA-C 114.779 1.4 . . . . 72.43 114.779 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -148.4 -9.71 0.37 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.423 1.268 . . . . 74.04 114.423 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -130.71 11.88 5.26 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.684 -1.26 . . . . 75.2 109.928 -167.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.53 159.98 14.64 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 120.679 -1.263 . . . . 74.4 113.723 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.5 t30 60.58 14.4 4.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.854 1.662 . . . . 75.03 113.61 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.3 p -76.68 174.99 9.77 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.261 1.824 . . . . 75.05 112.298 -169.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -67.39 171.0 6.48 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.235 1.014 . . . . 73.04 110.798 167.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -145.3 124.35 12.82 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.759 1.624 . . . . 75.44 112.015 164.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.436 ' H ' ' CE1' ' A' ' 35' ' ' HIS . 7.3 ptp180 -72.08 126.32 29.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.486 1.115 . . . . 75.01 109.484 172.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.0 p -98.86 177.75 5.17 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.978 0.894 . . . . 71.35 110.303 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -76.17 -19.94 57.99 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.811 -0.556 . . . . 73.24 110.723 167.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -84.79 16.34 3.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.878 1.217 . . . . 64.01 113.429 -169.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.08 21.51 78.38 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.214 -0.754 . . . . 72.32 111.214 176.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.29 -175.01 3.91 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.176 1.79 . . . . 71.11 108.224 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 p -143.86 148.61 35.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.34 -0.615 . . . . 60.22 109.34 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -110.31 -163.69 0.87 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.407 1.083 . . . . 63.03 109.13 167.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -121.24 164.47 16.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.482 1.113 . . . . 74.15 108.681 164.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 pt -136.94 165.38 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.944 1.297 . . . . 73.14 110.547 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -132.29 128.62 38.17 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.625 1.97 . . . . 75.14 106.56 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.3 p -94.68 150.72 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.831 1.196 . . . . 74.14 108.593 177.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 164.61 34.3 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.83 1.196 . . . . 75.43 110.067 160.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 30.7 t -61.58 136.13 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 105.277 -2.12 . . . . 75.24 105.277 163.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.8 t0 . . . . . 0 C--O 1.26 1.615 0 N-CA-C 107.165 -1.421 . . . . 74.24 107.165 175.708 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.573 0 N-CA-C 108.256 -1.938 . . . . 70.03 108.256 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.58 165.76 18.01 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.712 1.205 . . . . 74.03 109.705 -169.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.43 -174.9 1.36 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.988 2.459 . . . . 73.22 111.946 172.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.07 160.56 39.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.009 2.124 . . . . 73.33 107.195 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.79 -174.67 47.22 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.946 -0.861 . . . . 71.21 110.946 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.03 153.24 23.77 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 127.776 2.43 . . . . 72.22 107.205 -176.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -156.71 171.34 20.53 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.51 1.05 . . . . 73.55 110.545 -176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.83 85.08 0.07 OUTLIER Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.248 0.927 . . . . 72.31 111.88 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.2 164.25 35.83 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.523 2.148 . . . . 75.35 111.025 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.21 73.91 5.8 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.852 2.368 . . . . 61.55 111.556 -173.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.9 m -152.21 160.57 43.35 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 119.962 -1.711 . . . . 73.13 110.466 171.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.85 171.0 14.98 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 128.348 2.659 . . . . 64.35 108.694 173.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -132.97 -74.67 0.49 Allowed 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.209 1.003 . . . . 72.53 108.32 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 m -145.38 -175.59 4.77 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.362 1.865 . . . . 72.34 107.459 166.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 5.1 pt-20 -78.8 22.04 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.269 1.828 . . . . 64.55 113.088 176.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.64 50.82 1.99 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.286 -1.509 . . . . 74.33 107.046 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -130.06 137.49 50.25 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.667 1.587 . . . . 74.11 109.772 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.2 m -136.04 169.95 19.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 124.793 1.237 . . . . 73.54 110.952 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.8 144.3 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 125.891 1.676 . . . . 73.33 106.879 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.69 146.07 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.613 -1.625 . . . . 72.31 106.613 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -137.42 160.68 38.41 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.114 -0.991 . . . . 71.41 109.193 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.47 12.96 84.04 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.427 -0.652 . . . . 74.11 113.491 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 mt -59.27 144.63 83.16 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 117.643 0.722 . . . . 72.41 109.694 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -73.57 171.94 16.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.387 2.058 . . . . 73.33 108.907 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.12 -15.85 47.51 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 CA-C-N 119.923 1.008 . . . . 74.12 112.822 -168.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.64 21.02 13.23 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.404 1.482 . . . . 53.44 111.643 -170.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.47 99.5 1.93 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.207 1.384 . . . . 72.24 111.688 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -94.87 179.57 5.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.644 1.577 . . . . 75.43 111.599 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.9 p-90 -62.26 -33.65 75.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.511 1.124 . . . . 74.21 112.397 -175.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -46.64 63.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.885 -0.783 . . . . 75.14 108.885 -173.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.71 -33.16 75.31 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.718 -0.658 . . . . 74.04 109.764 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -53.51 56.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.481 1.037 . . . . 73.32 109.39 174.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -63.45 -39.4 94.38 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.344 1.058 . . . . 75.43 110.36 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.19 -12.24 60.25 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.921 1.082 . . . . 64.31 113.921 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -99.95 -59.27 1.74 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.149 1.78 . . . . 72.31 112.78 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.429 ' HE3' ' CE1' ' A' ' 57' ' ' PHE . 11.5 ttt -72.83 37.91 0.08 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.777 2.431 . . . . 75.33 110.579 -171.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -107.38 -9.75 15.93 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 119.087 -2.258 . . . . 74.32 111.006 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -79.06 -27.96 43.11 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.091 -1.005 . . . . 75.04 111.997 -163.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.42 -10.97 58.08 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.028 1.331 . . . . 51.21 112.224 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.48 173.69 13.25 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.495 -1.442 . . . . 55.43 109.495 -165.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -97.25 153.86 17.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.2 1.0 . . . . 74.3 111.508 -160.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 64.9 t -125.49 147.76 30.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 125.408 1.483 . . . . 74.24 107.831 -166.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.8 t -111.41 -53.29 2.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.418 -0.956 . . . . 73.22 108.418 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -86.45 150.01 24.58 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.505 0.722 . . . . 75.34 110.155 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.72 125.72 15.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.641 -0.874 . . . . 64.41 108.641 168.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -156.55 124.44 5.56 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.864 0.84 . . . . 71.14 110.599 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.28 156.95 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.886 -2.264 . . . . 74.32 104.886 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -124.64 162.83 23.29 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 127.126 2.17 . . . . 75.34 107.618 170.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 43.55 -86.6 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 130.768 3.627 . . . . 73.41 112.612 153.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -170.91 168.87 6.96 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 127.206 2.202 . . . . 71.45 110.625 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.85 -15.39 32.08 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.757 1.17 . . . . 62.01 115.432 156.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.77 168.52 22.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 120.022 1.911 . . . . 72.25 108.492 164.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.2 167.66 35.6 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 108.878 -1.689 . . . . 75.32 108.878 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.12 144.09 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.083 -1.08 . . . . 75.35 108.083 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.3 t -146.62 157.53 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 106.706 -1.59 . . . . 74.33 106.706 -163.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -143.46 129.51 19.63 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.165 -1.05 . . . . 72.55 108.165 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.429 ' CE1' ' HE3' ' A' ' 36' ' ' MET . 3.6 m-85 -100.54 170.19 8.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.869 1.668 . . . . 75.34 109.257 -175.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.0 m -75.85 -31.15 21.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 72.54 112.315 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 43.2 ttt85 -154.9 155.74 34.85 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.664 -0.495 . . . . 75.13 109.664 -172.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' A' ' 15' ' ' GLU . 14.6 ttmt -63.18 -26.46 68.81 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 117.723 -1.132 . . . . 73.51 110.931 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.0 -55.59 15.94 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 120.487 1.494 . . . . 74.23 109.285 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.15 -47.75 77.61 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.798 1.239 . . . . 72.21 109.525 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 59.7 ttp -54.04 -53.29 55.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.162 0.585 . . . . 72.35 112.047 176.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.7 m -54.33 -48.32 71.52 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.508 1.123 . . . . 75.15 109.102 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.53 ' CZ ' ' HE3' ' A' ' 69' ' ' LYS . 16.4 t80 -53.59 -38.98 64.47 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.315 1.046 . . . . 75.22 111.641 -175.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.04 -33.04 75.09 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.75 0.82 . . . . 72.32 110.832 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.4 t -70.09 -14.15 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 O-C-N 120.532 -1.355 . . . . 75.34 110.813 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -108.41 -37.73 5.89 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.04 -1.037 . . . . 73.43 111.469 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.53 ' HE3' ' CZ ' ' A' ' 65' ' ' TYR . 3.6 mptp? -108.87 -16.9 14.06 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.278 1.031 . . . . 71.04 111.743 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.9 7.53 8.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.24 -0.886 . . . . 74.44 111.17 -164.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.26 153.72 19.38 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 121.088 1.767 . . . . 75.03 111.164 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 t30 57.5 40.29 27.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.953 1.701 . . . . 71.12 111.591 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.4 p -103.39 -179.22 3.89 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.883 2.073 . . . . 71.02 111.287 -169.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.13 158.63 15.38 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.436 1.016 . . . . 65.41 110.305 171.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -137.26 146.22 44.48 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 125.588 1.555 . . . . 61.34 110.417 167.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -112.95 118.0 33.64 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.545 1.538 . . . . 75.03 110.908 -173.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 m -78.3 156.5 29.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 119.079 0.854 . . . . 63.2 109.3 167.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -62.61 -13.14 28.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.36 0.874 . . . . 75.3 113.36 168.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.87 12.23 0.72 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.944 1.697 . . . . 64.11 112.104 172.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.85 26.33 74.67 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 121.118 -0.989 . . . . 65.32 111.258 170.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -139.14 160.97 38.55 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 125.808 1.643 . . . . 63.3 108.684 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.8 p -145.84 149.81 34.98 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.154 -1.054 . . . . 74.03 108.154 -168.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.55 169.17 15.34 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.973 -1.121 . . . . 73.42 107.973 166.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -82.81 151.81 25.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.984 -1.117 . . . . 74.14 107.984 168.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.7 pt -125.16 166.27 21.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.418 1.487 . . . . 75.14 109.093 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -123.75 144.07 49.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.373 -2.084 . . . . 74.03 105.373 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.8 t -127.88 124.26 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.758 -1.571 . . . . 71.02 106.758 -172.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.38 153.33 51.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.446 1.098 . . . . 73.23 108.261 -170.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.1 t -71.34 153.18 8.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 106.08 -1.822 . . . . 71.41 106.08 162.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.881 1.272 . . . . 61.51 111.295 170.884 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.068 0 N-CA-C 109.908 -1.277 . . . . 72.14 109.908 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.66 156.53 24.94 Favored Pre-proline 0 C--O 1.24 0.554 0 CA-C-N 118.608 1.204 . . . . 73.25 109.069 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.84 -56.93 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.913 1.742 . . . . 74.44 110.55 168.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 178.85 150.12 0.26 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.987 1.267 . . . . 75.12 111.391 -168.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -116.82 150.17 18.6 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.044 1.307 . . . . 65.34 110.992 166.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 -168.18 109.11 0.55 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.826 2.05 . . . . 70.42 107.934 169.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.42 ' CE1' ' HD3' ' A' ' 9' ' ' PRO . 9.8 t80 -164.73 -179.5 5.91 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.875 2.07 . . . . 71.3 106.557 168.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.21 85.62 0.73 Allowed Glycine 0 C--N 1.345 1.036 0 CA-C-O 118.138 -1.368 . . . . 72.21 113.206 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HD3' ' CE1' ' A' ' 7' ' ' TYR . 97.7 Cg_endo -74.99 154.39 42.52 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 121.215 2.507 . . . . 73.04 110.003 173.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.89 64.01 8.18 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.63 2.886 . . . . 64.2 111.149 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.0 m -125.37 108.86 12.1 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 128.176 2.59 . . . . 34.33 106.08 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -90.83 172.34 8.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.474 1.11 . . . . 74.23 110.768 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -125.69 -80.67 0.62 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.191 -1.04 . . . . 72.24 108.191 166.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -156.76 162.06 39.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 124.264 0.978 . . . . 72.33 109.051 -156.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -65.34 11.92 0.06 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.504 2.322 . . . . 52.53 114.802 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.72 26.7 7.07 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 119.729 -1.857 . . . . 72.4 109.199 -178.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -109.26 133.56 52.88 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.664 1.185 . . . . 74.22 109.107 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.32 168.81 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 126.009 1.724 . . . . 73.34 109.533 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.92 154.3 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.934 1.694 . . . . 75.02 106.809 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.3 t -130.12 152.07 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.229 -1.397 . . . . 75.31 107.229 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.6 154.97 48.71 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.268 1.027 . . . . 73.23 108.733 -175.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.75 6.4 52.53 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 117.905 -1.497 . . . . 42.24 114.176 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.46 149.87 91.06 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 120.037 1.918 . . . . 62.22 112.412 -160.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.07 170.03 13.88 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.966 3.111 . . . . 75.13 111.022 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.29 -8.3 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.675 2.25 . . . . 75.31 113.833 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.35 52.05 1.27 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.345 1.458 . . . . 73.02 109.204 -176.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.03 130.6 10.24 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 108.626 -1.79 . . . . 73.05 108.626 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -116.42 163.62 15.77 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.811 0.845 . . . . 71.23 111.221 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.3 p-90 -66.37 -23.96 66.42 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.838 0.681 . . . . 74.24 112.838 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -56.04 14.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.883 -0.784 . . . . 74.04 108.883 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -60.17 -35.61 75.73 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.847 0.859 . . . . 73.25 109.656 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -58.36 8.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 117.28 -1.343 . . . . 72.33 110.014 174.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -68.67 -37.62 79.74 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 120.066 1.303 . . . . 73.24 110.763 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.02 -24.78 64.77 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.562 1.545 . . . . 73.41 112.874 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -95.22 -46.64 6.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.636 0.374 . . . . 75.12 111.061 170.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.6 ttt -77.02 32.31 0.14 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.336 1.454 . . . . 75.12 113.086 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.2 -5.28 14.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 121.03 1.741 . . . . 73.22 114.308 171.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -61.27 -31.16 70.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.099 1.318 . . . . 72.43 113.874 -173.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.26 -0.88 13.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.839 1.256 . . . . 73.33 114.33 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.87 -100.97 0.21 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 108.153 -1.979 . . . . 71.4 108.153 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -154.11 163.57 39.88 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.021 0.928 . . . . 72.3 108.999 176.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.77 135.93 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.518 2.327 . . . . 73.32 109.822 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.3 t -90.81 -56.17 3.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.846 -0.798 . . . . 74.33 108.846 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -96.01 146.99 24.16 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.795 1.238 . . . . 74.2 109.588 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.55 136.18 21.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.846 -1.168 . . . . 54.2 107.846 168.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -148.86 131.2 15.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.436 -0.95 . . . . 74.31 108.436 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 91.9 t -140.75 140.73 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.086 -2.19 . . . . 72.44 105.086 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -77.32 -164.08 0.44 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.985 1.714 . . . . 71.33 109.996 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -44.4 -50.94 9.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.464 -1.698 . . . . 73.14 112.078 158.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -179.67 -179.11 0.49 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.195 1.398 . . . . 70.42 112.391 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.3 -34.39 3.46 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 128.226 2.822 . . . . 55.35 114.407 166.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.26 -179.05 6.75 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.772 1.286 . . . . 75.03 108.529 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.74 171.71 40.26 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 125.246 1.403 . . . . 63.3 109.67 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -141.75 135.11 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.738 0.78 . . . . 65.34 108.982 -173.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.52 145.13 25.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 108.405 -0.961 . . . . 73.32 108.405 -156.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -133.83 106.54 7.37 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.543 -1.651 . . . . 73.12 106.543 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.89 168.1 16.38 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 130.258 3.423 . . . . 72.14 109.876 -176.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -72.47 -42.3 64.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 121.305 -0.872 . . . . 73.12 111.573 -171.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -152.88 160.24 43.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.961 0.8 . . . . 74.22 109.462 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -63.96 -19.31 65.04 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.492 -1.242 . . . . 71.2 111.025 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -52.97 -65.95 0.47 Allowed 'General case' 0 C--N 1.345 0.407 0 C-N-CA 125.581 1.553 . . . . 62.43 108.684 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -75.33 -36.18 61.08 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.751 1.62 . . . . 73.3 108.836 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 39.2 ttp -51.33 -52.27 46.87 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.881 -0.414 . . . . 74.13 109.881 169.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.7 m -68.42 -12.16 60.74 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.939 -1.101 . . . . 71.4 113.359 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -79.95 -35.57 37.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 122.539 2.427 . . . . 74.24 110.083 169.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.65 -35.39 80.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.094 0.958 . . . . 75.2 110.198 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.73 -17.45 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.651 0.78 . . . . 73.0 111.163 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -120.24 -16.88 8.41 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.49 -1.381 . . . . 74.2 112.059 -163.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -132.35 -19.06 2.49 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.24 1.416 . . . . 64.23 113.807 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.23 11.99 16.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 120.081 1.31 . . . . 75.41 110.356 -168.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.48 161.44 13.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.893 1.224 . . . . 73.34 112.437 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.0 t30 56.96 17.86 3.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.523 3.129 . . . . 73.41 114.177 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.6 p -71.74 175.15 5.95 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.817 2.847 . . . . 74.43 112.731 -172.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.48 169.69 15.23 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.709 1.604 . . . . 71.13 109.656 171.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -150.58 135.16 17.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.972 1.709 . . . . 71.25 109.46 170.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -82.69 119.14 23.92 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 118.652 0.66 . . . . 72.25 109.977 176.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 t -81.05 154.57 26.78 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.3 -1.0 . . . . 74.32 108.3 165.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -62.45 -16.68 56.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.892 -0.575 . . . . 63.01 111.644 164.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.58 17.41 0.11 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.248 1.419 . . . . 74.35 112.413 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.26 21.18 71.92 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 124.31 0.957 . . . . 71.33 112.496 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.93 175.4 10.46 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.327 1.851 . . . . 72.42 108.412 -172.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.0 p -137.07 148.86 47.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.689 -0.856 . . . . 75.34 108.689 -174.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.01 176.74 7.82 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.776 -1.194 . . . . 74.03 107.776 172.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -102.25 154.74 18.75 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.721 0.691 . . . . 74.15 109.932 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 pt -133.34 160.39 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 O-C-N 121.924 -0.485 . . . . 73.41 110.457 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -131.65 106.98 8.51 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.101 1.36 . . . . 75.44 107.697 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.53 154.46 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 124.219 0.949 . . . . 75.33 108.83 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -145.82 173.36 12.18 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.708 2.403 . . . . 74.21 107.505 162.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.8 t -97.81 151.18 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 125.624 1.57 . . . . 72.44 107.742 173.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.381 1.072 . . . . 64.23 108.788 167.133 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.116 0 N-CA-C 111.063 -0.815 . . . . 44.15 111.063 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.71 154.18 58.95 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 124.341 1.057 . . . . 64.35 109.714 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -76.96 177.33 9.01 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.884 3.056 . . . . 75.04 110.86 174.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -146.05 164.55 31.77 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.9 0.88 . . . . 75.35 109.831 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.77 -161.95 36.63 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.212 1.386 . . . . 61.41 109.934 166.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 tpp85 -100.79 138.7 37.49 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.449 1.099 . . . . 73.14 108.818 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -156.1 -179.83 8.53 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.969 0.508 . . . . 75.44 110.085 148.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.32 70.45 0.46 Allowed Glycine 0 CA--C 1.536 1.396 0 CA-C-O 118.406 -1.219 . . . . 62.45 113.303 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.15 167.93 17.02 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.55 3.5 . . . . 60.33 115.079 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.48 91.82 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 125.016 3.811 . . . . 64.34 111.35 170.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.7 m -106.33 148.57 27.88 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.215 1.406 . . . . 71.45 110.19 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.76 174.2 9.48 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.559 0.744 . . . . 75.31 111.167 175.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.473 ' HG3' HH11 ' A' ' 17' ' ' ARG . 0.8 OUTLIER -118.45 77.81 1.2 Allowed 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 106.212 -1.774 . . . . 75.42 106.212 175.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.0 m -59.51 164.85 3.19 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.442 -1.254 . . . . 53.55 109.947 169.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.41 30.96 0.06 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.379 1.471 . . . . 71.31 113.093 -167.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.84 20.58 3.28 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.751 2.02 . . . . 75.42 108.754 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.473 HH11 ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -112.09 139.25 47.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.768 1.227 . . . . 74.32 111.907 -171.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.94 170.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 126.078 1.751 . . . . 74.45 109.633 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 19.6 m -136.14 174.31 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.014 1.726 . . . . 74.41 108.386 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -137.26 162.35 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.024 1.329 . . . . 72.25 108.297 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.75 165.07 37.17 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.458 -1.401 . . . . 75.31 108.424 -174.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.84 9.37 86.95 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 119.156 0.889 . . . . 74.1 113.239 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.19 150.84 69.77 Favored Pre-proline 0 N--CA 1.445 -0.681 0 CA-C-N 119.097 1.448 . . . . 75.4 112.194 -175.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.54 161.07 36.76 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.358 2.705 . . . . 75.34 111.516 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.44 -34.22 44.13 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.233 1.955 . . . . 71.1 111.563 173.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.81 60.51 0.71 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 122.488 1.137 . . . . 71.11 110.549 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -132.3 159.53 23.39 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 107.565 -2.214 . . . . 72.22 107.565 159.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m -128.39 -175.86 3.64 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.295 1.038 . . . . 75.1 109.059 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -62.08 -21.39 64.92 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.958 1.303 . . . . 72.33 111.057 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -57.24 11.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.929 -1.137 . . . . 73.13 107.929 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.82 -32.38 73.88 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.394 0.434 . . . . 71.0 110.894 175.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.39 -54.9 37.97 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.867 0.758 . . . . 64.43 110.303 176.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -64.28 -33.61 76.23 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.553 0.615 . . . . 75.21 110.827 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -74.5 -25.62 59.48 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.834 1.254 . . . . 64.01 113.526 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -102.26 -41.43 6.37 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.599 1.56 . . . . 75.44 111.545 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.3 ttt -81.59 53.39 2.1 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.334 -1.479 . . . . 75.42 109.884 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.29 47.5 2.48 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.332 1.453 . . . . 75.01 110.604 -170.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -135.65 -5.77 2.22 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.258 1.207 . . . . 75.24 114.258 -172.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.94 45.88 1.99 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.792 1.637 . . . . 73.41 110.726 -170.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.11 -107.32 1.95 Allowed Glycine 0 N--CA 1.47 0.967 0 N-CA-C 108.581 -1.808 . . . . 73.32 108.581 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.9 167.09 25.72 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.426 1.613 . . . . 64.24 111.761 158.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.01 135.73 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.505 1.522 . . . . 72.31 109.775 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.9 t -113.88 -24.06 9.3 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.53 0.567 . . . . 63.21 112.53 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -123.66 143.35 50.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.816 1.189 . . . . 72.41 109.263 -173.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.61 133.96 15.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.228 0.922 . . . . 54.42 110.688 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -149.48 131.21 15.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.17 1.388 . . . . 75.04 108.881 -177.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.93 171.31 16.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.946 1.298 . . . . 72.31 109.137 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -154.3 -177.89 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.115 0.966 . . . . 62.12 109.768 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -81.58 40.1 0.57 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.88 2.072 . . . . 55.1 111.833 -164.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -117.62 -25.67 6.83 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.836 0.854 . . . . 73.13 112.309 -171.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.38 6.48 64.42 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.452 -0.659 . . . . 73.11 111.452 -162.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -119.26 165.58 14.07 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.989 1.394 . . . . 74.3 110.448 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.75 174.61 28.34 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.64 -1.784 . . . . 74.13 108.64 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 70.1 t -146.69 134.53 15.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.619 1.568 . . . . 74.12 107.964 -173.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 t -132.64 164.06 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.046 -0.724 . . . . 73.01 109.046 -169.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -142.5 124.51 15.29 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 120.433 -1.417 . . . . 73.05 107.45 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -94.11 174.64 7.05 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.604 1.562 . . . . 75.04 108.066 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.2 -64.01 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 118.69 -0.672 . . . . 63.24 110.901 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -139.85 172.13 13.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.628 1.104 . . . . 75.41 109.865 -166.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -62.85 -29.57 70.84 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.058 -1.026 . . . . 75.13 110.092 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 62' ' ' ASP . 3.5 pt-20 -52.7 -63.43 1.15 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.862 0.865 . . . . 75.22 109.497 173.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.405 ' H ' ' HG3' ' A' ' 61' ' ' GLU . 3.8 m-20 -60.1 -47.99 83.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.771 1.229 . . . . 63.43 108.336 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -57.32 -53.19 60.93 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.208 0.603 . . . . 71.14 110.914 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.4 m -59.3 -41.03 88.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.284 0.634 . . . . 51.22 110.282 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -56.96 -33.16 66.77 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 118.898 0.772 . . . . 74.13 111.741 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.61 83.16 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.392 -0.818 . . . . 73.42 109.971 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -71.81 -7.66 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 121.349 -0.845 . . . . 75.04 110.868 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.4 mtt180 -109.34 -31.96 7.35 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.855 0.862 . . . . 74.44 113.234 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -124.87 -6.16 7.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.843 1.257 . . . . 75.03 113.686 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.64 21.85 3.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.12 1.327 . . . . 72.21 110.86 -167.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.44 153.85 30.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.666 1.586 . . . . 75.45 109.777 170.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 62.27 11.35 4.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.572 2.749 . . . . 62.53 113.62 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.0 p -75.79 172.23 13.01 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.309 -0.869 . . . . 74.43 110.526 -172.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.443 ' HE3' ' OG1' ' A' ' 82' ' ' THR . 17.8 tttp -78.6 168.7 19.37 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 122.038 -0.414 . . . . 74.51 109.973 166.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -147.43 159.72 43.39 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 125.208 1.403 . . . . 73.04 111.866 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -116.46 148.04 41.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.747 1.158 . . . . 64.44 111.647 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.23 153.81 45.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.86 1.664 . . . . 74.1 109.284 -174.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -70.67 -12.54 61.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.175 1.176 . . . . 75.13 114.175 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.95 1.4 7.26 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.395 1.078 . . . . 75.4 112.728 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.26 9.1 63.79 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 124.08 0.848 . . . . 72.34 112.084 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -128.0 168.31 15.47 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 112.793 0.664 . . . . 64.43 112.793 -165.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.443 ' OG1' ' HE3' ' A' ' 74' ' ' LYS . 57.2 p -141.65 117.41 10.41 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.148 -0.933 . . . . 71.3 111.053 -175.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.83 173.19 7.8 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.584 1.953 . . . . 71.31 108.491 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -93.32 152.39 19.18 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.615 1.098 . . . . 72.42 108.478 159.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.5 pt -122.2 170.61 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.936 1.351 . . . . 74.11 108.839 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -125.33 143.19 51.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.751 -1.944 . . . . 74.51 105.751 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -110.8 146.34 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.325 -1.361 . . . . 55.53 107.325 168.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -142.98 159.94 41.29 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 122.109 -0.37 . . . . 75.44 111.156 163.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.4 t -61.16 138.96 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.603 -1.629 . . . . 72.32 106.603 165.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 43.1 t0 . . . . . 0 C--O 1.259 1.577 0 N-CA-C 105.257 -2.127 . . . . 75.43 105.257 166.22 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.517 0 N-CA-C 110.253 -1.139 . . . . 71.32 110.253 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.78 156.66 43.4 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 124.665 1.186 . . . . 51.21 110.421 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -76.14 -164.18 0.24 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 124.708 3.605 . . . . 71.21 110.554 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -146.86 -176.14 5.08 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.363 1.065 . . . . 74.52 108.67 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.95 7.78 71.56 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 116.809 -2.106 . . . . 65.31 116.893 161.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.34 142.1 23.71 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 121.096 2.448 . . . . 72.23 110.18 -176.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -62.23 171.8 1.7 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 127.092 2.157 . . . . 74.44 112.857 176.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.58 84.76 0.16 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.861 1.696 . . . . 72.51 109.264 170.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.43 169.85 18.78 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.424 2.749 . . . . 72.54 112.765 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.48 101.82 0.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.882 2.388 . . . . 54.41 109.632 163.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 m -130.49 116.4 18.14 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.808 0.843 . . . . 74.21 109.983 170.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.417 HH21 ' C ' ' A' ' 90' ' ' ASP . 27.7 mmm-85 -75.59 -167.96 0.76 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.535 0.683 . . . . 73.25 109.232 169.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -123.57 -85.43 0.65 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.729 -1.211 . . . . 65.43 107.729 167.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -147.45 172.39 14.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.528 1.531 . . . . 73.31 108.13 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 31.44 0.07 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.992 2.117 . . . . 52.34 113.272 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -132.7 24.28 4.34 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 119.334 -2.104 . . . . 73.15 110.317 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.0 139.35 47.57 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.346 -1.471 . . . . 71.44 110.704 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.43 159.99 22.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 126.455 1.902 . . . . 72.34 108.881 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 95.4 t -132.8 140.85 46.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 127.232 2.213 . . . . 74.55 106.147 -170.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.9 t -104.73 145.37 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.782 1.633 . . . . 73.11 108.414 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -131.97 160.62 35.27 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.779 -1.201 . . . . 74.42 109.197 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.02 5.58 67.83 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.695 1.141 . . . . 73.43 113.866 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 mt -64.65 151.49 92.03 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.133 0.973 . . . . 74.14 112.304 -165.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -76.21 161.29 35.38 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.93 2.42 . . . . 70.24 110.662 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -67.55 -39.17 12.74 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.4 2.733 . . . . 50.15 110.567 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.0 p -67.19 -0.3 3.29 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.65 1.98 . . . . 74.43 112.303 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.42 121.42 7.08 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 126.078 1.799 . . . . 52.33 109.416 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.07 -179.6 6.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.855 1.262 . . . . 73.54 108.482 171.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -62.01 -29.44 70.27 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.181 -0.914 . . . . 74.55 111.974 -158.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -58.69 -62.1 2.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.809 -1.182 . . . . 74.51 107.809 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.71 -47.11 74.13 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.589 0.755 . . . . 73.43 109.867 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.03 -45.03 87.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.954 1.702 . . . . 72.34 111.537 -176.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -69.36 -30.25 68.22 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 74.24 111.15 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -92.52 1.44 57.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.565 1.146 . . . . 72.51 112.778 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -121.46 -56.55 1.88 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.664 1.586 . . . . 64.44 112.285 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.5 ttt -75.01 79.72 2.2 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.378 -1.342 . . . . 74.5 107.378 170.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.39 -7.71 0.78 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.423 1.889 . . . . 71.2 111.873 173.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.59 -3.08 25.71 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.585 0.63 . . . . 74.53 111.88 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.38 -0.41 41.06 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 119.322 0.965 . . . . 61.42 112.913 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.27 -156.52 15.58 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.444 -1.062 . . . . 53.2 110.444 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.37 114.91 21.15 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.32 1.057 . . . . 71.51 110.694 -163.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.3 t -101.9 151.52 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.458 -1.312 . . . . 73.2 107.458 171.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.7 t -131.37 0.93 4.11 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.033 0.753 . . . . 74.52 113.033 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -161.81 144.82 12.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.7 1.6 . . . . 65.44 107.7 -169.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.61 139.44 22.92 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.8 -0.815 . . . . 73.12 108.8 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -155.51 107.48 2.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.508 1.049 . . . . 72.11 109.202 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.3 p -135.71 144.82 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.228 1.811 . . . . 74.51 111.976 -171.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -135.27 156.57 48.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.429 1.092 . . . . 74.15 109.697 -164.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -81.37 35.38 0.39 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.996 1.318 . . . . 74.21 111.53 -169.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -115.42 9.58 15.57 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.959 1.703 . . . . 73.24 108.486 173.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.26 23.98 60.05 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 125.672 1.606 . . . . 73.44 112.886 174.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.96 162.91 34.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.28 1.04 . . . . 72.44 108.498 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.26 160.11 32.7 Favored Glycine 0 C--O 1.224 -0.469 0 N-CA-C 109.13 -1.588 . . . . 72.14 109.13 -169.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 88.7 t -132.53 155.36 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 125.595 1.558 . . . . 73.53 108.351 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.19 170.73 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 127.415 2.286 . . . . 73.25 106.032 -174.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -144.41 124.28 13.46 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.12 -1.808 . . . . 74.54 106.12 167.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -94.29 166.05 12.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.408 -0.96 . . . . 74.45 108.408 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -73.08 -37.86 54.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.378 -1.283 . . . . 64.5 111.835 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.4 ttm105 -154.04 156.69 37.81 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.328 0.651 . . . . 71.54 109.4 -168.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -61.12 -27.99 68.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 117.639 -1.172 . . . . 73.25 111.567 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.12 -50.32 74.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.839 1.2 . . . . 74.24 110.749 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -77.7 -41.58 37.46 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.539 -0.912 . . . . 74.3 108.539 -175.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -47.77 -50.86 24.41 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.615 1.166 . . . . 71.53 111.237 169.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.1 m -64.9 -47.47 77.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.369 -0.824 . . . . 70.54 111.216 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -54.84 -32.75 60.91 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.559 1.072 . . . . 74.31 111.324 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.34 -42.29 86.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.448 0.567 . . . . 70.51 111.681 178.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.89 -25.21 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.281 -0.887 . . . . 72.5 110.248 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -79.49 -41.84 26.57 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 117.519 -1.229 . . . . 72.5 112.553 -177.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -124.27 -16.98 6.26 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.186 1.18 . . . . 73.33 114.186 -170.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.32 1.44 32.77 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.779 1.232 . . . . 73.21 110.151 -171.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.11 147.97 25.08 Favored 'General case' 0 CA--C 1.527 0.078 0 O-C-N 120.27 -1.519 . . . . 65.4 113.65 -172.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 69.68 11.15 7.83 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.034 2.134 . . . . 64.2 111.531 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.4 p -83.97 163.07 20.2 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.032 1.333 . . . . 71.3 110.161 -169.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -77.81 156.92 30.18 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 120.892 -1.13 . . . . 71.43 109.706 168.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -107.72 -175.73 2.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.215 2.206 . . . . 73.12 110.768 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.1 mtt-85 -146.65 146.54 30.42 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 124.85 1.26 . . . . 74.12 107.681 169.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 p -142.3 159.98 41.15 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.794 1.238 . . . . 72.42 110.537 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -73.76 37.9 0.1 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.218 1.807 . . . . 72.42 113.551 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.4 16.43 4.48 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.557 2.343 . . . . 74.42 110.617 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.39 29.41 69.05 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 124.284 0.945 . . . . 64.23 112.227 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.52 173.9 11.17 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 125.82 1.648 . . . . 73.2 111.002 -173.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.7 p -144.8 147.72 33.21 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.255 -1.017 . . . . 74.32 108.255 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.02 176.43 5.3 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.504 1.122 . . . . 74.41 108.495 161.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -109.0 150.15 28.18 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 120.256 1.389 . . . . 74.32 110.45 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 pt -124.91 158.76 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 122.08 0.943 . . . . 71.21 112.207 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.0 mmm-85 -117.27 136.91 52.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.46 -1.681 . . . . 74.24 106.46 165.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 89.7 t -108.4 131.12 59.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.053 -1.832 . . . . 74.23 106.053 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -138.33 168.06 20.56 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.182 1.393 . . . . 73.23 108.332 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.4 t -87.82 161.34 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.046 -1.464 . . . . 74.55 107.046 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.417 ' C ' HH21 ' A' ' 12' ' ' ARG . 25.1 t0 . . . . . 0 C--O 1.252 1.197 0 N-CA-C 104.368 -2.456 . . . . 73.22 104.368 156.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.744 0 N-CA-C 110.5 -1.04 . . . . 64.33 110.5 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.33 155.28 28.72 Favored Pre-proline 0 C--O 1.237 0.443 0 CA-C-N 118.412 1.106 . . . . 75.0 111.85 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.05 -179.62 5.61 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.28 3.32 . . . . 73.03 111.847 163.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.4 mtm-85 -142.54 4.15 1.53 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.667 1.729 . . . . 75.21 115.667 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -123.76 -124.22 2.87 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 126.476 1.989 . . . . 63.34 110.777 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -139.72 136.84 34.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.469 1.634 . . . . 75.23 108.591 171.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -155.79 -174.88 5.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.273 1.829 . . . . 75.31 106.835 167.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.58 69.0 0.48 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 109.587 -1.405 . . . . 73.0 109.587 174.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -69.17 168.49 20.63 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.997 2.465 . . . . 64.4 110.705 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.55 83.01 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.534 2.823 . . . . 72.12 110.662 173.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -156.17 155.91 33.3 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.997 1.719 . . . . 72.01 106.59 170.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -53.76 166.51 0.32 Allowed 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.887 0.875 . . . . 75.42 110.066 156.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.4 mtt-85 -122.76 -83.12 0.66 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.234 -0.654 . . . . 74.43 109.234 167.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.6 m -151.48 152.46 33.03 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 104.2 -2.519 . . . . 73.4 104.2 -160.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -74.1 38.84 0.11 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.52 0.728 . . . . 74.21 111.748 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.6 28.27 2.71 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 119.52 -1.987 . . . . 71.21 110.053 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -130.2 154.85 47.13 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.954 -1.091 . . . . 75.0 112.704 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.1 m -144.01 168.49 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.296 1.438 . . . . 61.0 112.32 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.24 136.09 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.638 -1.615 . . . . 64.41 106.638 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 98.3 t -105.26 150.7 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.63 -1.248 . . . . 71.14 107.63 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 p -150.17 153.09 35.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.443 1.019 . . . . 73.31 109.714 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.11 6.97 38.89 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.301 1.429 . . . . 64.31 113.311 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 mt -65.91 156.44 83.73 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.347 1.059 . . . . 74.22 113.171 -164.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.09 175.7 8.03 Favored 'Trans proline' 0 CA--C 1.537 0.674 1 C-N-CA 125.493 4.129 . . . . 64.52 113.294 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.31 -7.96 15.43 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.766 2.977 . . . . 62.13 115.238 172.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 t -148.81 56.6 1.02 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 120.531 1.514 . . . . 73.1 110.296 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.38 79.5 0.58 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.319 -1.113 . . . . 74.11 110.319 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -74.8 155.46 37.57 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 119.395 -0.922 . . . . 44.42 110.32 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -60.08 -25.38 65.35 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.932 -1.105 . . . . 75.54 112.205 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -59.3 -46.03 89.69 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.59 1.556 . . . . 75.41 109.579 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -71.14 -37.5 72.26 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.032 0.933 . . . . 75.1 109.074 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.65 -52.16 65.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.863 0.756 . . . . 63.42 111.164 177.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -62.06 -39.67 93.2 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.154 -0.684 . . . . 72.32 109.154 -174.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.97 -17.38 64.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.569 1.548 . . . . 71.51 112.066 175.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.84 -45.03 8.6 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 104.817 -2.29 . . . . 74.53 104.817 -174.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.8 ttt -82.26 -14.1 55.99 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.238 0.459 . . . . 65.11 112.238 -150.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.6 -0.91 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 130.77 3.628 . . . . 74.14 116.446 174.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -81.65 -16.14 52.33 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 120.704 -1.247 . . . . 70.1 112.315 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.13 1.74 57.03 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.078 0.77 . . . . 53.43 113.078 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.19 -161.15 15.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.027 -2.029 . . . . 74.13 108.027 -157.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.83 145.3 32.84 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.593 0.357 . . . . 72.24 111.002 -165.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 t -130.33 131.01 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.397 -2.075 . . . . 74.51 105.397 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.5 t -116.69 5.61 13.2 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.748 0.647 . . . . 70.44 112.748 -167.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -162.94 158.21 22.09 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 126.435 1.894 . . . . 73.1 106.737 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.04 150.04 34.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 119.579 1.081 . . . . 73.31 108.396 163.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -158.89 129.7 6.1 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 117.965 0.348 . . . . 64.32 110.721 167.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -128.8 114.44 33.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.868 -2.271 . . . . 73.43 104.868 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -77.52 153.8 33.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.081 0.952 . . . . 74.41 109.143 161.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 43.63 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 130.948 3.699 . . . . 74.43 110.92 168.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 178.97 178.08 0.47 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.317 1.847 . . . . 71.5 111.233 155.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.78 -18.62 56.96 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.867 1.222 . . . . 64.14 114.202 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 m -148.97 -179.03 6.7 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.671 1.589 . . . . 74.43 108.719 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.9 164.21 35.52 Favored Glycine 0 N--CA 1.465 0.621 0 O-C-N 120.385 -1.447 . . . . 63.54 111.164 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.36 131.98 51.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 124.119 0.968 . . . . 75.41 108.518 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.6 t -144.0 154.98 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.328 -1.36 . . . . 71.4 107.328 -160.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -139.07 131.95 29.3 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.763 -1.569 . . . . 72.13 106.763 -172.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -101.8 -178.11 3.62 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.703 1.201 . . . . 70.3 108.056 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.47 -51.78 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.809 -1.182 . . . . 73.14 107.809 170.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.47 163.49 32.8 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 114.507 1.299 . . . . 71.1 114.507 -164.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -61.32 -33.18 73.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.586 -1.643 . . . . 73.0 112.076 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.87 -56.63 13.91 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.522 -0.918 . . . . 70.11 108.522 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -61.52 -45.31 94.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.533 0.733 . . . . 64.13 109.58 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -51.05 -55.43 17.58 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.772 -0.58 . . . . 74.03 112.259 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.1 m -57.11 -48.92 77.45 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.586 1.084 . . . . 74.31 110.347 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -55.16 -33.3 62.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.206 1.002 . . . . 74.31 111.494 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.11 -44.78 75.26 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.623 1.169 . . . . 73.31 110.498 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.78 -10.18 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.252 -0.905 . . . . 74.34 110.884 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -104.65 -31.95 9.14 Favored 'General case' 0 CA--C 1.527 0.089 0 O-C-N 121.413 -0.804 . . . . 73.32 110.914 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.03 -0.29 6.53 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.364 1.246 . . . . 72.54 114.364 -169.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -133.69 -4.87 2.87 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.284 1.402 . . . . 54.14 111.873 -172.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.04 161.17 21.78 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.356 -1.465 . . . . 74.2 111.998 165.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.8 t30 70.89 20.2 5.5 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.776 2.031 . . . . 74.53 112.26 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.6 p -85.35 142.18 29.5 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.06 -0.719 . . . . 73.22 109.06 -169.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -77.77 101.31 6.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.103 -1.443 . . . . 73.43 107.103 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -85.9 141.69 29.39 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.935 1.294 . . . . 74.34 113.134 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -99.42 139.24 35.36 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.66 1.984 . . . . 72.52 110.643 -176.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.4 p -108.89 174.25 5.95 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.137 0.975 . . . . 73.42 109.609 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -92.34 18.18 8.73 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.841 -1.072 . . . . 75.2 111.095 165.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -98.8 18.11 17.8 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.537 -1.352 . . . . 63.1 110.599 169.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.02 7.1 75.6 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 126.406 1.955 . . . . 63.3 112.845 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -176.66 4.13 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 117.627 0.714 . . . . 64.31 110.209 -166.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 48.0 p -141.76 138.11 32.07 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 106.65 -1.611 . . . . 73.54 106.65 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.39 135.23 47.8 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.989 1.268 . . . . 64.11 109.326 172.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -69.93 156.51 38.99 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.982 0.81 . . . . 74.4 110.296 -168.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.96 166.46 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.711 0.767 . . . . 72.42 111.146 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -127.43 152.51 47.43 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.666 -1.235 . . . . 64.14 107.666 159.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.6 p -109.79 149.59 12.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.758 1.223 . . . . 73.21 109.142 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.92 166.69 23.96 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.661 1.184 . . . . 72.11 108.803 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.9 t -81.69 144.16 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.689 -1.967 . . . . 75.04 105.689 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 C--O 1.256 1.395 0 CA-C-O 117.853 -1.07 . . . . 73.21 109.726 169.517 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.189 0 N-CA-C 110.864 -0.894 . . . . 72.22 110.864 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.56 165.55 20.6 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 118.79 1.295 . . . . 72.11 109.863 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -74.8 -169.89 0.69 Allowed 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 124.07 3.18 . . . . 75.4 112.33 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -146.36 174.29 11.5 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.325 1.85 . . . . 72.54 109.234 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.83 79.12 0.02 OUTLIER Glycine 0 C--N 1.336 0.582 0 CA-C-O 118.963 -0.91 . . . . 71.33 113.704 163.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -146.83 123.97 11.47 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 119.404 1.602 . . . . 75.14 109.689 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -163.39 147.66 10.83 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.21 2.204 . . . . 72.21 105.319 166.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.9 165.5 11.02 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.704 1.145 . . . . 42.31 110.765 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.65 170.79 13.12 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.208 2.605 . . . . 71.23 111.695 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.61 64.36 8.07 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.979 2.453 . . . . 54.0 111.573 -174.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.18 163.57 33.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.882 1.273 . . . . 72.24 110.043 -173.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.45 -169.25 3.27 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.281 2.632 . . . . 72.22 106.424 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -130.99 -78.19 0.53 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.006 -1.479 . . . . 73.3 107.006 164.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m -140.91 164.81 29.23 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.122 0.969 . . . . 70.1 108.597 174.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -72.62 25.79 0.06 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.418 2.287 . . . . 65.34 113.137 -170.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.52 14.49 2.96 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.075 -1.641 . . . . 72.21 110.292 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -95.78 145.07 25.62 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.644 -1.285 . . . . 65.53 110.676 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.0 m -133.75 160.26 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.834 -0.802 . . . . 73.54 108.834 164.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.97 149.0 27.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 106.557 -1.646 . . . . 72.54 106.557 164.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.01 153.65 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.705 -1.591 . . . . 74.51 106.705 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -144.45 162.36 36.71 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 120.119 -1.613 . . . . 43.43 112.244 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.14 12.52 80.76 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.733 1.635 . . . . 73.42 112.71 -177.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mt -63.89 144.3 98.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.023 -0.989 . . . . 74.14 111.789 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -71.88 165.13 33.49 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.238 3.292 . . . . 74.33 113.583 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.29 -32.89 25.39 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.978 2.452 . . . . 51.41 113.427 -172.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -97.85 41.39 1.13 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.991 0.916 . . . . 63.24 109.381 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.35 124.48 8.25 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 108.179 -1.968 . . . . 73.24 108.179 173.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.6 m -125.02 169.67 11.9 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.24 1.416 . . . . 73.15 109.48 167.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -61.95 -20.14 63.51 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 113.511 0.93 . . . . 73.23 113.511 -174.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -60.84 2.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.071 -0.966 . . . . 74.54 108.548 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.08 -34.78 73.91 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.837 0.744 . . . . 64.11 109.171 177.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.4 -53.43 36.72 Favored 'General case' 0 C--N 1.345 0.397 0 O-C-N 121.452 -0.78 . . . . 74.44 111.149 173.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.505 ' HE3' ' HB ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -80.18 -20.46 44.72 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.762 1.165 . . . . 72.12 112.343 -176.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.45 -29.92 66.62 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.645 -0.66 . . . . 70.35 110.911 169.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -93.52 -51.48 4.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.035 1.334 . . . . 74.43 110.131 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.8 ttt -79.92 66.8 5.51 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 128.546 2.738 . . . . 74.51 110.382 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.66 -1.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 120.709 -1.244 . . . . 74.52 113.712 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.06 -44.94 94.42 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 119.572 1.078 . . . . 72.15 108.89 168.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.05 16.65 0.22 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.935 2.494 . . . . 70.21 114.293 -171.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.22 -147.9 16.66 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.282 -0.727 . . . . 72.43 111.282 162.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.43 99.94 8.24 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.846 0.832 . . . . 74.31 109.714 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.505 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 44.0 t -98.7 96.38 5.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 105.586 -2.005 . . . . 74.13 105.586 171.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.5 t -75.13 -22.97 57.82 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.408 0.442 . . . . 71.31 112.038 -174.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -124.39 149.73 46.37 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 125.545 1.538 . . . . 74.03 109.506 -170.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.38 129.97 10.74 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.237 0.926 . . . . 70.13 109.082 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.68 147.45 28.09 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.138 0.881 . . . . 61.33 110.356 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.4 t -145.65 151.65 14.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.234 -1.765 . . . . 73.33 106.234 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.7 168.68 19.27 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.88 2.072 . . . . 73.31 109.193 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.495 ' HG3' ' H ' ' A' ' 50' ' ' ASP . 9.0 ptm180 42.86 -87.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 129.821 3.248 . . . . 74.33 112.674 163.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.495 ' H ' ' HG3' ' A' ' 49' ' ' ARG . 1.9 p-10 -178.61 -176.92 0.5 Allowed 'General case' 0 N--CA 1.436 -1.128 1 C-N-CA 132.684 4.394 . . . . 74.4 107.728 162.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.28 -24.65 5.37 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-O 119.214 -0.77 . . . . 71.33 113.452 163.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.93 165.08 35.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.854 1.327 . . . . 72.32 108.676 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.0 140.58 6.68 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.089 -2.404 . . . . 73.12 107.089 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -111.57 134.98 52.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 118.781 1.29 . . . . 73.4 108.04 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.0 161.87 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 105.98 -1.859 . . . . 74.54 105.98 -172.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -143.52 139.88 30.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.371 -2.085 . . . . 72.4 105.371 170.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -107.34 164.26 12.34 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.959 -1.867 . . . . 74.53 105.959 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.1 t -63.98 -44.64 97.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.177 0.806 . . . . 72.44 113.177 -173.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -144.87 168.13 20.96 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.833 0.742 . . . . 74.52 109.506 -173.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -55.26 -28.88 56.38 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.19 -0.909 . . . . 71.52 110.197 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -64.8 -63.1 1.2 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.874 0.761 . . . . 65.35 108.99 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.46 -43.49 88.91 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.032 0.378 . . . . 74.34 110.033 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -57.16 -50.04 74.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.283 0.633 . . . . 71.43 111.228 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -59.51 -35.98 75.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.176 0.898 . . . . 73.24 111.229 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -54.78 -45.95 74.34 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.621 1.555 . . . . 74.24 110.013 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.43 -46.88 63.11 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.31 0.644 . . . . 74.44 111.68 -175.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -74.05 -7.42 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.571 0.749 . . . . 74.23 111.019 -169.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -123.89 -3.24 8.17 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.665 1.186 . . . . 72.54 113.452 -177.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -142.37 -0.91 1.21 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.029 0.932 . . . . 64.13 112.784 -175.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -149.08 10.18 0.78 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.093 1.315 . . . . 72.31 111.339 -167.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.69 163.65 14.02 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 119.009 -2.307 . . . . 40.45 112.302 171.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.418 ' H ' ' CB ' ' A' ' 86' ' ' ARG . 0.7 OUTLIER 68.5 12.96 8.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.356 1.862 . . . . 75.35 113.794 171.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 31.1 p -75.21 164.04 26.89 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.51 1.524 . . . . 72.21 111.388 -170.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.66 162.87 28.72 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.245 -1.535 . . . . 73.23 108.169 166.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -147.85 151.23 35.59 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 125.047 1.339 . . . . 73.43 110.227 171.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -138.03 138.91 39.3 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.722 2.009 . . . . 74.23 106.33 -160.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -144.14 156.34 44.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.044 0.938 . . . . 73.33 110.554 -164.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -71.69 60.95 0.36 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.914 1.686 . . . . 73.35 113.242 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -146.14 -2.09 0.72 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.306 2.243 . . . . 74.55 111.088 169.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.89 15.26 54.87 Favored Glycine 0 C--N 1.34 0.773 0 O-C-N 120.298 -1.501 . . . . 74.14 112.201 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.8 171.7 12.83 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.151 0.98 . . . . 72.54 111.369 -172.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.5 p -143.04 153.98 43.5 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.536 -1.211 . . . . 75.52 108.145 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.46 177.07 5.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.118 2.167 . . . . 74.35 108.496 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -97.81 153.99 17.92 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.015 -1.053 . . . . 74.33 108.709 147.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.7 pt -130.82 171.6 17.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 125.871 1.668 . . . . 75.53 107.165 171.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.418 ' CB ' ' H ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -143.69 165.75 26.79 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 120.998 -1.063 . . . . 71.52 108.874 156.467 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.24 163.85 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.98 1.312 . . . . 75.52 109.019 169.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -154.6 158.22 39.42 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.704 2.002 . . . . 74.4 107.264 163.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.02 83.87 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.224 -2.139 . . . . 70.24 105.224 164.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 t0 . . . . . 0 C--O 1.256 1.439 0 C-N-CA 127.894 2.478 . . . . 73.23 113.817 159.417 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.653 0 N-CA-C 109.483 -1.447 . . . . 74.45 109.483 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.21 152.62 90.38 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-N 118.041 0.92 . . . . 63.44 110.787 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -75.97 -179.74 5.5 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.394 2.729 . . . . 62.13 111.643 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -138.47 165.68 26.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.555 2.342 . . . . 74.52 107.955 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.48 -149.76 6.74 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 108.447 -1.861 . . . . 73.3 108.447 165.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.3 20.9 16.89 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.283 1.433 . . . . 74.31 110.862 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -148.14 154.03 39.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.356 1.462 . . . . 75.3 108.015 -172.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.78 54.89 28.27 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 117.78 -1.566 . . . . 72.52 113.669 170.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.01 159.2 26.54 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.007 2.472 . . . . 73.43 111.345 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -78.31 64.22 8.43 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.319 3.346 . . . . 74.34 112.1 -165.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 m -76.1 101.51 5.35 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.593 -1.632 . . . . 74.22 106.593 163.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.7 157.24 36.29 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.025 1.33 . . . . 73.41 107.476 163.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.9 mmt85 -140.22 96.05 2.98 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.572 -2.01 . . . . 75.3 105.572 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m -82.49 -175.93 5.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 122.059 0.933 . . . . 62.34 110.494 173.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -63.08 20.95 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 128.411 2.684 . . . . 73.14 113.095 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.04 28.4 4.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 119.328 -2.107 . . . . 73.24 108.481 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.618 HH21 ' CG1' ' A' ' 54' ' ' VAL . 42.1 ttt180 -112.83 129.56 56.4 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.753 1.221 . . . . 73.54 110.851 -177.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.7 159.86 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.703 -1.221 . . . . 71.42 107.703 168.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 12.5 m -124.3 -179.86 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.97 2.108 . . . . 75.11 107.042 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.11 155.15 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.496 1.918 . . . . 74.43 108.256 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.86 165.24 30.35 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.633 -1.292 . . . . 64.3 109.589 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.35 7.55 87.83 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.936 0.779 . . . . 72.52 113.003 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mt -60.82 155.02 55.1 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.065 1.346 . . . . 75.54 111.412 -173.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.58 167.54 23.92 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.913 3.742 . . . . 73.24 111.341 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.38 -27.87 39.78 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.358 2.038 . . . . 73.21 112.975 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.7 m -140.59 80.27 1.74 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 127.1 2.16 . . . . 72.43 107.445 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.22 138.96 10.47 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 105.112 -3.195 . . . . 64.54 105.112 157.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.78 179.23 4.18 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 117.747 0.774 . . . . 75.21 109.055 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -65.42 -19.18 65.83 Favored 'General case' 0 C--O 1.226 -0.153 0 O-C-N 121.606 -0.684 . . . . 75.51 110.648 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -59.5 4.2 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 117.775 -1.107 . . . . 64.23 108.555 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -35.9 78.82 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.598 -0.841 . . . . 54.34 109.477 177.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.97 -53.64 46.81 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.386 0.993 . . . . 74.31 110.708 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -69.74 -26.21 64.21 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.124 -0.985 . . . . 74.54 111.951 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -85.23 -12.91 51.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.938 0.895 . . . . 75.14 112.577 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -109.06 -57.61 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.522 1.129 . . . . 73.23 111.252 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.9 ttt -74.53 70.71 1.8 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.659 1.184 . . . . 71.22 108.588 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -140.64 -0.55 1.54 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.795 -1.191 . . . . 73.31 113.368 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -68.29 -21.57 64.77 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.602 0.637 . . . . 74.24 111.579 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.42 -6.88 58.82 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.359 1.244 . . . . 75.25 114.359 -171.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.26 -171.49 27.12 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 119.858 1.208 . . . . 71.11 111.357 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -86.19 85.03 7.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 106.965 -1.495 . . . . 73.42 106.965 -170.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.9 t -69.57 135.08 29.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.155 -1.054 . . . . 72.22 108.155 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.5 t -99.07 -11.55 21.35 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.076 -0.488 . . . . 75.13 111.954 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -159.45 146.79 17.01 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.555 1.071 . . . . 73.35 109.757 -162.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.7 143.25 32.21 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.727 -1.212 . . . . 73.14 107.727 165.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -152.47 134.24 14.71 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.488 0.715 . . . . 72.11 109.466 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 m -137.53 177.62 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.554 -1.276 . . . . 74.52 107.554 175.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -140.79 -169.24 2.76 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 126.167 1.787 . . . . 75.51 106.768 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -96.89 45.21 1.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.921 -1.112 . . . . 74.23 111.729 -176.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.93 -154.0 0.53 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.277 1.831 . . . . 63.13 107.324 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -111.02 28.65 9.58 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.772 2.13 . . . . 72.41 110.605 173.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 p -131.89 173.36 11.26 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.416 1.487 . . . . 74.23 109.508 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.86 172.66 44.4 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 107.743 -2.143 . . . . 75.51 107.743 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.618 ' CG1' HH21 ' A' ' 17' ' ' ARG . 37.5 t -145.59 144.34 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.483 -0.932 . . . . 72.4 108.483 -165.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.6 t -132.95 171.65 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.54 -0.911 . . . . 74.31 108.54 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -153.8 137.4 16.0 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 120.553 -1.342 . . . . 74.13 107.716 167.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.84 177.39 4.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.458 1.903 . . . . 75.24 108.104 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.3 m -86.38 -31.79 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.64 0.608 . . . . 75.21 112.64 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 ttm105 -156.37 160.32 39.56 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.362 0.665 . . . . 75.15 109.95 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -67.1 -22.92 65.8 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.568 1.147 . . . . 61.51 112.205 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.12 -54.01 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.112 0.869 . . . . 72.25 109.603 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.96 -41.21 87.25 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.563 -0.532 . . . . 63.33 109.563 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.3 ttp -53.22 -52.78 57.8 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 110.168 -0.308 . . . . 61.52 110.168 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -55.11 -40.26 70.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.537 -0.745 . . . . 73.43 111.08 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -55.84 -45.38 78.41 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.088 0.858 . . . . 60.12 109.446 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.5 -42.4 78.28 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.31 -0.869 . . . . 75.52 111.893 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 t -68.35 -18.18 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.503 0.721 . . . . 72.31 111.019 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -114.37 -15.81 12.06 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.833 1.049 . . . . 75.52 113.833 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm -134.1 -1.06 2.99 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.261 1.425 . . . . 72.35 112.681 -171.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.62 21.42 2.71 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.929 1.24 . . . . 74.45 110.753 -175.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.84 164.0 11.88 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.077 -1.64 . . . . 62.32 110.285 174.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 60.86 12.97 4.12 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.235 1.814 . . . . 75.43 112.202 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.3 p -74.06 168.2 20.01 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.883 -1.136 . . . . 71.12 110.724 -167.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -63.94 166.24 7.72 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 121.74 -0.6 . . . . 75.32 109.813 153.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -145.67 138.79 26.13 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.938 1.695 . . . . 75.41 107.791 166.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -96.09 136.61 36.33 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.822 -0.807 . . . . 75.32 108.822 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -109.9 174.39 5.89 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.086 -1.079 . . . . 60.1 108.086 -169.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.82 -11.3 55.98 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.839 -0.538 . . . . 72.31 111.882 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -102.02 34.24 2.77 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.079 1.351 . . . . 75.23 111.536 -166.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.08 15.99 68.11 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.782 1.182 . . . . 60.53 113.528 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -132.73 176.8 8.14 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.439 1.096 . . . . 60.24 110.252 -175.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.6 p -144.78 126.07 14.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.75 -1.204 . . . . 73.1 107.75 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.36 -176.49 4.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.861 0.865 . . . . 73.32 110.339 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -106.29 157.21 17.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.578 -0.897 . . . . 75.21 108.578 159.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 pt -141.61 163.78 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.551 1.141 . . . . 73.31 110.937 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -131.58 105.84 7.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.141 -1.429 . . . . 75.45 107.141 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.5 t -69.71 144.17 14.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.792 -1.188 . . . . 73.22 107.792 170.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.27 158.82 43.53 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.747 1.158 . . . . 71.21 111.724 166.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.75 137.37 22.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 106.184 -1.784 . . . . 64.24 106.184 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 C--O 1.25 1.119 0 C-N-CA 124.293 1.037 . . . . 74.43 110.487 175.656 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.656 0 N-CA-C 108.895 -1.682 . . . . 75.21 108.895 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.95 166.13 30.68 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 119.141 1.471 . . . . 63.14 111.141 -160.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -64.91 -179.54 1.04 Allowed 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 122.906 2.404 . . . . 72.3 111.724 164.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.8 163.95 38.65 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.344 1.058 . . . . 75.44 109.882 -175.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.88 67.01 0.01 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.998 -1.241 . . . . 74.44 109.998 174.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.89 159.21 37.93 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.969 0.908 . . . . 74.22 109.01 175.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.41 108.88 2.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.719 1.208 . . . . 74.24 109.391 177.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.96 81.69 1.59 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 108.453 -1.859 . . . . 53.34 108.453 -170.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.78 167.87 14.64 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.259 1.973 . . . . 71.12 111.118 171.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.57 84.09 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.085 2.523 . . . . 55.14 110.143 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.4 m -81.15 128.09 33.37 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.261 1.025 . . . . 75.3 110.035 170.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.7 164.72 26.31 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 128.614 2.765 . . . . 75.24 106.397 174.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -140.93 79.26 1.69 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.936 -1.505 . . . . 75.24 106.936 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 16' ' ' ASN . 72.7 m -67.96 175.62 3.01 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.81 0.814 . . . . 74.13 112.101 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.71 31.32 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.043 2.537 . . . . 73.51 111.541 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.467 ' H ' ' C ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -143.01 14.72 1.89 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.101 2.16 . . . . 74.5 108.284 -173.475 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.27 116.22 31.59 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.522 1.929 . . . . 75.34 110.13 -174.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.58 174.07 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.606 0.762 . . . . 75.12 111.522 173.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 10.7 m -136.1 -179.1 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.727 1.611 . . . . 64.41 106.967 170.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.0 t -135.7 153.52 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.134 2.174 . . . . 75.41 107.006 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.87 155.31 48.2 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.146 1.378 . . . . 71.21 108.88 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.02 4.8 57.58 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.419 1.961 . . . . 71.4 113.346 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mt -66.56 154.45 91.14 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 120.99 -1.3 . . . . 74.43 113.163 -166.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.47 166.36 20.03 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.169 2.579 . . . . 75.2 112.573 175.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.07 -6.03 18.29 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 124.12 3.213 . . . . 71.42 114.013 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -146.75 54.06 1.11 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.505 2.322 . . . . 74.3 108.926 -172.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.96 112.02 2.03 Favored Glycine 0 C--N 1.34 0.761 0 O-C-N 120.126 -1.608 . . . . 54.42 111.564 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -76.24 155.35 34.47 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 118.835 1.318 . . . . 74.14 112.361 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -59.04 -26.03 64.23 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.828 0.851 . . . . 75.1 113.217 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -65.22 -52.2 56.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.251 -1.018 . . . . 71.1 108.251 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -62.76 -27.56 69.37 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.109 1.363 . . . . 73.11 111.326 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -64.28 -61.34 2.3 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.067 -1.086 . . . . 72.02 108.067 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -61.28 -39.57 90.91 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.825 -0.607 . . . . 73.22 109.851 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -17.46 52.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.85 1.26 . . . . 73.33 112.688 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -100.72 -45.36 5.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.266 0.626 . . . . 75.01 111.23 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.0 tpt -57.75 -32.86 67.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.15 1.38 . . . . 75.4 113.396 -174.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -19.17 59.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.208 1.929 . . . . 73.0 116.208 -166.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.67 1.02 1.39 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.991 1.478 . . . . 64.01 114.991 -169.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.26 -10.09 31.31 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.754 1.222 . . . . 55.52 112.993 175.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.58 -101.74 0.21 Allowed Glycine 0 C--N 1.335 0.498 0 CA-C-N 119.68 1.127 . . . . 41.22 111.386 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.2 144.35 29.85 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.533 1.166 . . . . 72.32 109.84 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.493 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -131.7 139.53 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 126.379 1.872 . . . . 75.24 113.382 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -127.51 18.88 6.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.837 1.255 . . . . 71.22 111.36 -170.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -170.73 144.48 2.3 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.108 1.763 . . . . 72.42 108.318 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.69 139.26 16.91 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.861 -1.162 . . . . 75.2 107.861 168.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -155.14 129.22 8.82 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.421 1.089 . . . . 71.13 110.615 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 t -140.27 165.8 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.966 1.706 . . . . 72.04 107.285 -175.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.66 -162.76 1.3 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.775 2.83 . . . . 72.12 107.723 -169.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -105.25 63.53 0.7 Allowed 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.283 -1.511 . . . . 73.11 109.55 170.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -144.74 -176.33 5.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.26 -0.9 . . . . 64.04 108.592 169.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.38 13.73 20.11 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-O 118.312 -1.271 . . . . 52.33 113.433 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.32 163.54 30.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.163 1.982 . . . . 73.41 110.084 -174.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.45 167.84 38.52 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 107.788 -2.125 . . . . 72.24 107.788 -171.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 59.0 t -143.8 144.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 119.929 1.864 . . . . 73.1 110.395 -163.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.9 t -145.19 154.33 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.112 0.482 . . . . 74.34 110.849 -173.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -137.08 101.36 4.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.885 -1.524 . . . . 75.1 106.885 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.493 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 3.0 m-30 -72.37 179.37 3.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.533 1.933 . . . . 75.42 110.625 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.0 t -77.5 -63.43 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.627 -0.671 . . . . 72.11 110.98 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -140.37 157.36 45.66 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.27 0.941 . . . . 73.2 112.053 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -53.53 -27.13 24.19 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.247 1.019 . . . . 71.51 112.138 -166.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -53.16 -61.92 1.99 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.218 1.407 . . . . 72.44 108.376 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.56 -37.5 71.08 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.05 1.34 . . . . 75.54 110.667 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -56.86 -54.85 41.8 Favored 'General case' 0 C--O 1.228 -0.047 0 CA-C-O 118.829 -0.605 . . . . 74.42 110.178 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.6 m -54.73 -40.64 69.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.634 -0.698 . . . . 74.42 110.508 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -60.02 -49.77 76.34 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.02 0.928 . . . . 72.24 110.661 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.46 -25.1 68.12 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.739 -1.226 . . . . 75.3 112.68 -176.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.3 t -76.77 -5.75 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 O-C-N 120.853 -1.155 . . . . 75.23 110.125 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -129.41 0.45 5.06 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.537 1.31 . . . . 44.34 114.537 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.39 5.26 0.82 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.499 1.519 . . . . 64.14 112.563 -171.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.01 4.05 0.62 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.404 1.082 . . . . 71.13 109.765 -173.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -99.42 157.69 16.24 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.079 1.751 . . . . 74.44 111.372 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.452 ' H ' ' CB ' ' A' ' 86' ' ' ARG . 0.6 OUTLIER 44.42 64.41 1.34 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.496 1.519 . . . . 75.44 110.359 -168.255 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.4 p -121.06 174.19 6.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.203 2.601 . . . . 73.02 109.278 -174.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.89 161.98 14.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.952 -1.093 . . . . 75.42 109.633 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -151.68 120.66 6.66 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 126.647 1.979 . . . . 64.23 111.483 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -102.74 119.82 39.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.665 -1.235 . . . . 64.44 107.665 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.54 168.41 16.45 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.799 1.64 . . . . 74.11 110.309 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -65.07 -14.17 59.81 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.33 1.233 . . . . 73.11 114.33 174.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -86.56 6.02 32.79 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.692 1.997 . . . . 72.2 112.51 -172.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.15 14.39 82.31 Favored Glycine 0 C--N 1.337 0.635 0 O-C-N 121.572 -0.705 . . . . 43.34 112.061 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -125.08 171.71 10.05 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 123.961 0.904 . . . . 74.14 110.566 -177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.5 p -139.42 146.03 39.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.967 1.307 . . . . 75.33 108.05 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.7 129.97 19.83 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.729 -1.582 . . . . 64.44 106.729 172.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -69.74 159.49 33.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.968 0.804 . . . . 75.23 110.126 -164.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.69 155.73 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 123.414 0.686 . . . . 74.2 109.165 -173.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.452 ' CB ' ' H ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -134.99 143.05 46.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.849 -1.157 . . . . 54.41 109.728 163.119 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.94 151.2 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.377 1.471 . . . . 73.04 108.347 166.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -146.3 161.61 39.93 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.423 -0.955 . . . . 73.12 108.423 152.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 t -70.18 143.93 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 106.358 -1.719 . . . . 74.33 106.358 169.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.604 -1.189 . . . . 63.4 110.487 -177.743 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.236 0.369 0 N-CA-C 108.953 -0.758 . . . . 63.43 108.953 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -72.28 37.98 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.371 -0.831 . . . . 72.209999999999994 112.295 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.64 28.75 2.41 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 119.349 -2.094 . . . . 72.340000000000003 109.797 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.13 143.03 51.03 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.867 -1.145 . . . . 74.030000000000001 112.395 -167.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 m -140.51 167.69 17.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 124.491 1.117 . . . . 62.140000000000001 110.527 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.2 t -129.72 153.67 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.15 -1.796 . . . . 73.150000000000006 106.15 170.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -121.98 136.58 58.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 105.821 -1.918 . . . . 62.140000000000001 105.821 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 p -134.53 145.08 48.4 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.927 0.785 . . . . 61.340000000000003 111.678 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.9 27.66 23.25 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 125.147 1.356 . . . . 15.42 112.619 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.454 HD22 HG21 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -58.71 152.7 45.82 Favored Pre-proline 0 N--CA 1.467 0.419 0 CA-C-N 118.443 1.121 . . . . 60.420000000000002 110.393 -177.591 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.07 168.59 17.01 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.813 2.342 . . . . 73.409999999999997 110.882 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.02 -12.6 35.43 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.65 2.234 . . . . 75.450000000000003 113.831 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -151.16 57.03 0.89 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.379 1.445 . . . . 72.140000000000001 111.92 -171.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.19 -166.51 32.7 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.273 1.416 . . . . 72.150000000000006 111.11 172.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.8 p -157.69 173.85 16.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.402 1.081 . . . . 53.119999999999997 109.718 169.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -70.06 -18.4 63.27 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.97 0.908 . . . . 71.319999999999993 111.38 171.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.44 -54.11 10.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.834 -1.173 . . . . 63.520000000000003 107.834 -177.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.51 -32.84 74.41 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 118.55 -0.738 . . . . 71.120000000000005 110.249 172.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.35 -57.08 13.8 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.558 1.072 . . . . 73.450000000000003 110.57 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -61.81 -42.99 99.71 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 118.785 0.72 . . . . 74.239999999999995 110.087 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.25 -25.66 64.39 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.224 1.01 . . . . 75.420000000000002 111.92 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -81.39 -60.04 2.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.589 0.756 . . . . 72.299999999999997 110.046 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.485 ' HG3' HD11 ' A' ' 70' ' ' LEU . 15.0 ttt -68.09 -8.8 41.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.791 1.636 . . . . 62.009999999999998 114.348 -159.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.18 20.97 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 131.218 3.807 . . . . 62.530000000000001 115.848 175.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -100.59 0.79 39.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.98 1.712 . . . . 74.340000000000003 112.604 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.92 17.08 6.79 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 125.846 1.658 . . . . 74.319999999999993 112.797 -167.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 -107.73 1.04 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 125.762 1.648 . . . . 75.239999999999995 109.304 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -143.96 139.61 29.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 117.764 0.782 . . . . 71.239999999999995 109.922 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 t -128.44 81.13 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 126.451 1.9 . . . . 75.5 107.167 -170.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.7 t -72.66 -15.12 61.71 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.277 0.473 . . . . 51.409999999999997 112.277 -174.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -132.83 135.14 45.47 Favored 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 121.038 -1.039 . . . . 64.109999999999999 108.413 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.42 138.83 41.93 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.218 -1.03 . . . . 73.420000000000002 108.218 166.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -145.92 156.68 43.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.843 -1.169 . . . . 74.420000000000002 107.843 169.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.35 -178.41 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 O-C-N 120.826 -1.171 . . . . 51.130000000000003 108.162 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -103.34 -163.09 0.96 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.417 1.487 . . . . 74.310000000000002 107.283 166.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 mtm-85 -52.71 -53.98 40.08 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.975 -1.011 . . . . 72.25 109.885 159.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -170.68 -179.91 3.05 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.083 0.856 . . . . 62.310000000000002 112.82 -171.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.69 -39.85 2.73 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 127.147 2.308 . . . . 72.439999999999998 113.445 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.01 170.58 16.82 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.759 1.279 . . . . 44.229999999999997 109.429 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.86 159.66 28.09 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.543 -1.823 . . . . 60.409999999999997 108.543 165.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.3 p -130.23 131.3 65.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.396 1.098 . . . . 62.030000000000001 109.292 -170.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.7 t -144.32 151.83 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.632 -0.877 . . . . 75.430000000000007 108.632 -157.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -135.13 133.7 39.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.5 -1.296 . . . . 73.409999999999997 107.5 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -101.6 -176.77 3.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.117 1.767 . . . . 74.120000000000005 108.626 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.2 t -81.72 -50.96 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 118.256 -0.878 . . . . 54.210000000000001 110.57 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.1 ttt85 -145.17 164.5 31.1 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 120.526 1.512 . . . . 75.299999999999997 111.79 -171.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -62.7 -30.31 71.31 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 117.867 -1.063 . . . . 64.239999999999995 111.673 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -65.38 -50.98 63.47 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.645 -0.872 . . . . 60.0 108.645 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -59.36 -53.11 61.99 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 126.786 2.034 . . . . 75.120000000000005 109.25 176.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -51.94 -51.56 56.18 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.485 -0.759 . . . . 75.019999999999996 112.457 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.7 m -55.29 -53.56 54.53 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.536 -0.745 . . . . 73.019999999999996 109.584 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -56.96 -32.43 66.02 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.321 1.048 . . . . 72.299999999999997 111.588 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.25 -42.77 77.91 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.438 1.017 . . . . 72.310000000000002 110.863 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t -69.3 -14.31 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.951 -0.468 . . . . 64.120000000000005 111.091 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -100.58 -33.55 10.26 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.314 -1.492 . . . . 73.409999999999997 112.349 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' O ' ' HE2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -137.7 9.01 2.85 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.844 0.858 . . . . 71.030000000000001 113.19 -165.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.485 HD11 ' HG3' ' A' ' 36' ' ' MET . 1.0 OUTLIER -134.36 3.24 3.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.798 0.726 . . . . 75.329999999999998 111.132 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.611 ' HB2' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -95.85 162.16 13.7 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 119.315 -2.116 . . . . 72.329999999999998 114.501 171.349 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.4 t30 66.2 15.38 10.07 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.007 2.523 . . . . 62.229999999999997 113.003 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 31.1 p -78.46 171.21 15.43 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.495 -0.753 . . . . 54.219999999999999 109.747 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.08 151.65 21.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.029 1.332 . . . . 63.219999999999999 109.034 166.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -125.15 130.18 51.66 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 127.709 2.404 . . . . 75.299999999999997 108.896 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.472 ' HA ' HG22 ' A' ' 82' ' ' THR . 73.9 mtm180 -87.03 153.83 21.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.108 0.963 . . . . 61.409999999999997 110.541 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.7 p -124.39 176.73 6.28 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.077 0.951 . . . . 71.540000000000006 110.451 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -85.6 5.15 33.01 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.569 1.148 . . . . 72.129999999999995 111.268 167.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.74 13.42 14.17 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.729 2.012 . . . . 62.210000000000001 112.595 -162.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.24 12.85 81.7 Favored Glycine 0 C--N 1.336 0.561 0 O-C-N 121.762 -0.586 . . . . 55.020000000000003 113.489 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -134.59 162.99 30.74 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.227 1.011 . . . . 52.240000000000002 109.593 -173.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 76' ' ' ARG . 43.6 p -148.75 119.61 7.6 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.678 -0.86 . . . . 71.209999999999994 108.678 -172.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.23 165.01 13.68 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.418 0.687 . . . . 72.150000000000006 110.033 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -84.65 157.23 21.21 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.569 -0.9 . . . . 64.219999999999999 108.569 160.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.454 HG21 HD22 ' A' ' 23' ' ' LEU . 25.3 pt -137.47 152.94 27.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.895 0.855 . . . . 71.010000000000005 109.364 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -123.9 119.19 28.92 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.043 -1.836 . . . . 51.439999999999998 106.043 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.611 HG12 ' HB2' ' A' ' 71' ' ' ASP . 1.4 p -75.62 163.25 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.262 -0.644 . . . . 53.439999999999998 109.262 175.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.49 163.84 39.48 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.922 1.689 . . . . 74.310000000000002 107.42 164.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.07 155.44 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.23 -1.767 . . . . 54.210000000000001 106.23 165.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 58.8 t0 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 124.567 1.147 . . . . 74.310000000000002 109.971 176.372 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 107.408 -1.33 . . . . 61.119999999999997 107.408 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -80.41 40.69 0.51 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.251 1.021 . . . . 62.420000000000002 111.976 173.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.94 15.05 1.91 Allowed 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.431 -1.418 . . . . 52.310000000000002 111.968 -178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.56 144.57 39.22 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.028 -1.045 . . . . 75.430000000000007 110.203 -171.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.437 ' CG1' ' HG3' ' A' ' 63' ' ' MET . 27.3 m -141.4 166.36 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.249 1.02 . . . . 62.219999999999999 110.496 -171.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.79 124.02 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 106.75 -1.574 . . . . 73.540000000000006 106.75 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.23 148.99 4.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.059 1.344 . . . . 53.240000000000002 107.601 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -136.6 163.1 31.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.591 -0.693 . . . . 74.129999999999995 109.635 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.5 9.87 68.66 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.062 -0.854 . . . . 51.109999999999999 113.81 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.81 150.99 45.29 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.481 1.141 . . . . 72.409999999999997 112.509 -172.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -71.52 169.65 20.42 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 125.163 3.909 . . . . 74.150000000000006 113.259 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.47 -4.23 11.56 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.576 3.517 . . . . 34.399999999999999 114.167 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.73 71.03 1.37 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.081 2.152 . . . . 44.039999999999999 106.579 171.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.18 127.08 6.66 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 125.344 1.449 . . . . 12.300000000000001 109.596 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.4 m -134.78 166.64 22.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.935 0.894 . . . . 60.109999999999999 110.644 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -65.05 -22.84 67.04 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.407 1.083 . . . . 74.439999999999998 111.711 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -58.38 -60.45 3.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.436 -1.269 . . . . 63.530000000000001 109.742 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.84 -42.69 94.13 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 108.875 -0.787 . . . . 53.450000000000003 108.875 176.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.78 -50.98 62.48 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.846 0.748 . . . . 61.509999999999998 111.072 -176.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -67.48 -31.88 72.33 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.263 -0.898 . . . . 74.310000000000002 112.406 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.78 -2.58 57.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.34 1.456 . . . . 74.420000000000002 112.003 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -122.17 -56.08 1.84 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.278 1.431 . . . . 52.520000000000003 110.45 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 17.2 ttt -75.74 72.11 2.64 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.435 -1.415 . . . . 64.420000000000002 108.473 171.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.3 ptm85 -136.81 -13.4 1.68 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.271 1.428 . . . . 65.329999999999998 111.734 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -76.39 3.41 11.13 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.423 -0.798 . . . . 72.420000000000002 112.315 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.7 64.29 0.74 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.814 1.645 . . . . 71.409999999999997 107.055 172.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.58 -136.38 33.87 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.249 -0.887 . . . . 74.349999999999994 111.528 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -109.43 117.87 35.16 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.212 0.53 . . . . 74.349999999999994 111.096 -159.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.23 95.99 4.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.092 0.957 . . . . 72.230000000000004 108.929 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.4 t -69.78 -29.58 66.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.003 -0.998 . . . . 41.130000000000003 112.064 -175.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -122.04 149.76 43.06 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.144 1.338 . . . . 73.510000000000005 110.916 -168.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.62 133.52 20.18 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.827 1.251 . . . . 65.319999999999993 109.231 169.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -151.63 125.28 8.99 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 107.5 -1.296 . . . . 71.140000000000001 107.5 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.9 t -142.62 96.9 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.018 -2.216 . . . . 43.32 105.018 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -64.89 -176.13 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.137 1.775 . . . . 74.140000000000001 108.818 161.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -115.15 78.51 1.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 O-C-N 120.585 -1.322 . . . . 75.540000000000006 107.793 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -158.41 42.0 0.26 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.945 1.298 . . . . 62.509999999999998 110.227 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.15 9.3 14.61 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.525 1.536 . . . . 42.409999999999997 116.385 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.2 p -134.7 168.13 19.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.977 1.889 . . . . 53.25 109.95 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -146.41 151.94 24.13 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 107.454 -2.258 . . . . 75.319999999999993 107.454 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.87 121.4 58.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.771 -1.566 . . . . 72.230000000000004 106.771 -172.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' HB ' HG23 ' A' ' 18' ' ' VAL . 76.4 t -135.81 147.84 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.387 -1.709 . . . . 74.530000000000001 106.387 -159.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -136.58 113.81 10.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 105.47 -2.048 . . . . 75.219999999999999 105.47 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -86.42 172.22 10.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.741 1.217 . . . . 72.230000000000004 108.424 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.7 t -70.65 -56.7 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 118.588 -0.72 . . . . 60.210000000000001 110.635 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -139.26 168.26 20.23 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 119.556 1.071 . . . . 63.149999999999999 111.034 -171.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -56.04 -36.34 67.89 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 117.479 -1.248 . . . . 61.520000000000003 110.343 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -67.01 -47.53 71.15 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.168 1.349 . . . . 63.549999999999997 109.847 -171.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.67 -51.67 68.59 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.837 1.655 . . . . 74.349999999999994 109.3 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.437 ' HG3' ' CG1' ' A' ' 18' ' ' VAL . 62.8 ttp -55.57 -50.57 69.73 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.825 0.85 . . . . 63.119999999999997 111.767 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.6 m -54.56 -53.53 53.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.963 -1.018 . . . . 64.430000000000007 109.258 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -49.84 -32.77 15.03 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.311 0.96 . . . . 75.420000000000002 111.527 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.2 -45.9 91.56 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.916 0.886 . . . . 72.549999999999997 111.033 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -68.52 -16.66 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.381 -0.824 . . . . 54.530000000000001 110.902 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -108.89 -19.58 13.35 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.216 -0.927 . . . . 72.430000000000007 113.147 -167.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -136.21 -9.03 2.0 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.579 1.151 . . . . 74.239999999999995 111.75 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.7 17.49 6.33 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.851 1.26 . . . . 75.340000000000003 110.385 -167.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.58 150.79 28.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.628 1.171 . . . . 73.420000000000002 112.099 -171.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.06 32.3 0.86 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.726 2.01 . . . . 71.150000000000006 113.202 -167.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.3 p -75.02 177.06 6.63 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.05 0.94 . . . . 45.020000000000003 109.631 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -72.97 176.49 5.68 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.564 0.345 . . . . 64.420000000000002 111.078 162.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -151.55 128.46 10.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 128.212 2.605 . . . . 74.120000000000005 108.639 168.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -75.84 124.45 27.33 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.378 1.071 . . . . 73.219999999999999 109.576 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.44 157.41 17.66 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.241 0.616 . . . . 72.120000000000005 110.475 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -80.63 -0.39 37.78 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.218 1.007 . . . . 55.119999999999997 112.097 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -86.1 4.67 37.21 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.573 1.949 . . . . 55.520000000000003 111.569 170.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.38 20.1 74.98 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 119.037 0.835 . . . . 65.430000000000007 111.886 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -120.91 177.85 4.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 127.302 2.241 . . . . 54.009999999999998 107.749 170.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.6 p -140.58 134.36 30.42 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.247 -1.39 . . . . 60.310000000000002 107.247 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.96 173.19 6.78 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.922 -1.111 . . . . 71.530000000000001 110.07 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -87.67 161.89 17.41 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.499 -0.926 . . . . 75.109999999999999 108.499 158.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.9 pt -137.93 141.46 38.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.414 1.086 . . . . 74.150000000000006 109.245 173.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -96.95 120.92 38.2 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.415 -1.698 . . . . 41.520000000000003 106.415 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.2 t -89.32 137.03 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.611 -1.255 . . . . 74.239999999999995 107.611 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -145.48 157.52 43.99 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.379 1.472 . . . . 64.230000000000004 109.545 169.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.21 143.41 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 126.19 1.796 . . . . 64.140000000000001 106.347 170.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 C--O 1.255 1.379 0 C-N-CA 124.281 1.032 . . . . 24.5 108.447 167.154 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 108.283 -1.006 . . . . 74.049999999999997 108.283 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -68.22 26.45 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.086 2.554 . . . . 53.310000000000002 114.925 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.9 23.35 3.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.29 1.436 . . . . 64.450000000000003 109.488 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.401 ' HG2' HH11 ' A' ' 17' ' ' ARG . 0.0 OUTLIER -119.27 143.75 47.16 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.568 1.147 . . . . 74.030000000000001 111.16 -168.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -144.97 156.47 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.877 1.271 . . . . 65.129999999999995 109.045 -165.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -141.3 120.4 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.992 1.269 . . . . 62.140000000000001 109.742 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.54 155.01 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.85 1.66 . . . . 73.120000000000005 109.867 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -143.87 167.58 21.98 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.379 1.072 . . . . 72.349999999999994 109.366 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.0 14.41 64.67 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.27 0.462 . . . . 55.530000000000001 112.778 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.96 148.68 87.12 Favored Pre-proline 0 CA--C 1.537 0.461 0 O-C-N 121.991 -0.711 . . . . 64.019999999999996 110.355 -168.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.18 167.44 23.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 124.996 3.798 . . . . 74.209999999999994 111.733 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.05 -21.19 56.6 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.791 2.327 . . . . 72.420000000000002 113.229 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.15 35.98 4.73 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.5 1.12 . . . . 62.32 111.314 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.99 156.42 51.65 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 107.503 -2.239 . . . . 42.009999999999998 107.503 158.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.4 m -152.47 173.24 15.37 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.771 0.828 . . . . 44.450000000000003 110.541 165.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -63.48 -21.8 66.52 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.227 1.011 . . . . 65.219999999999999 111.894 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -65.74 -63.83 1.0 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.383 1.073 . . . . 74.409999999999997 108.95 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -34.62 78.82 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 118.606 -1.238 . . . . 71.239999999999995 110.482 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -47.78 64.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.484 1.038 . . . . 73.219999999999999 111.017 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -66.94 -32.23 73.34 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.882 1.219 . . . . 54.530000000000001 111.557 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.23 -7.01 59.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.018 0.927 . . . . 65.019999999999996 113.194 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -106.09 -58.06 1.96 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.361 1.864 . . . . 73.439999999999998 108.1 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.6 ttt -79.23 73.05 5.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.312 1.445 . . . . 72.239999999999995 109.079 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -139.01 -0.32 1.88 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.892 0.877 . . . . 74.209999999999994 113.21 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -91.45 -1.11 57.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.5 1.52 . . . . 73.349999999999994 112.286 -169.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.2 -6.26 14.59 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.38 -0.825 . . . . 61.450000000000003 112.617 -170.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.3 -111.4 0.47 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.936 -1.48 . . . . 62.140000000000001 112.182 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -136.37 139.46 42.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.169 1.485 . . . . 74.120000000000005 109.817 169.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.495 HG22 ' CE1' ' A' ' 57' ' ' PHE . 8.7 t -124.13 97.77 4.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 124.847 1.259 . . . . 44.420000000000002 107.686 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 t -67.39 -54.84 16.92 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.119 -0.363 . . . . 73.030000000000001 110.054 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -83.8 175.92 9.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.316 1.846 . . . . 54.32 111.816 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -167.08 130.73 1.86 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.542 1.137 . . . . 73.409999999999997 111.398 166.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -157.36 136.99 12.2 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.793 1.178 . . . . 64.129999999999995 112.514 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.9 t -147.59 135.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.642 1.577 . . . . 75.25 107.492 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -112.12 152.85 27.81 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.241 1.416 . . . . 53.520000000000003 109.203 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -80.45 65.86 5.75 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.34 0.656 . . . . 64.430000000000007 110.338 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -130.45 -11.65 4.0 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.363 0.665 . . . . 71.140000000000001 112.361 168.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.86 17.36 7.96 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.756 -1.024 . . . . 61.25 112.531 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.97 158.46 43.87 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.939 1.37 . . . . 71.200000000000003 110.007 -171.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.67 107.98 0.34 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.42 -1.072 . . . . 74.030000000000001 110.42 -170.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.19 147.98 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 118.006 0.903 . . . . 71.430000000000007 109.634 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 18' ' ' VAL . 7.7 t -139.37 163.94 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 106.981 -1.488 . . . . 74.040000000000006 106.981 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -146.74 126.42 13.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.163 -1.421 . . . . 74.040000000000006 107.163 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.495 ' CE1' HG22 ' A' ' 42' ' ' VAL . 3.3 m-85 -99.3 170.49 8.62 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.183 -1.414 . . . . 72.450000000000003 107.183 172.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.93 -60.26 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.908 -0.775 . . . . 63.409999999999997 108.908 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -131.69 167.01 20.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.366 0.603 . . . . 74.230000000000004 110.155 -168.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -65.81 -27.38 68.22 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 118.138 -0.934 . . . . 71.340000000000003 110.377 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -57.46 -50.31 73.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.602 1.092 . . . . 70.409999999999997 109.745 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -67.68 -51.42 49.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.943 2.097 . . . . 74.340000000000003 107.833 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -57.33 -45.09 84.64 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.389 1.076 . . . . 71.129999999999995 112.755 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.6 m -59.15 -46.26 88.83 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.739 -1.226 . . . . 73.219999999999999 111.292 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -60.81 -29.95 69.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.07 0.548 . . . . 72.120000000000005 110.438 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.24 91.87 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.018 0.927 . . . . 74.209999999999994 111.519 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 83.6 t -72.69 -19.28 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 120.705 -1.247 . . . . 73.010000000000005 110.36 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -77.17 -57.55 3.77 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.018 -1.051 . . . . 64.319999999999993 109.56 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -100.21 -12.51 19.51 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.159 0.984 . . . . 54.43 113.225 -164.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.51 8.91 3.13 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.558 1.143 . . . . 72.150000000000006 111.899 -155.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -106.0 163.1 13.03 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.158 1.383 . . . . 72.340000000000003 110.017 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.321 6.8 p30 53.92 37.44 26.63 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 119.439 1.018 . . . . 62.229999999999997 110.808 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -93.77 172.55 8.18 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 131.625 3.97 . . . . 51.149999999999999 111.756 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -85.06 174.72 9.5 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.503 1.121 . . . . 73.310000000000002 109.881 160.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -155.81 133.43 11.07 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.756 1.222 . . . . 73.140000000000001 110.977 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HA ' HG22 ' A' ' 82' ' ' THR . 35.9 mmt180 -72.84 141.47 47.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.114 0.87 . . . . 73.140000000000001 110.988 177.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.79 171.79 7.54 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.961 0.886 . . . . 74.349999999999994 110.814 156.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -67.59 -22.66 65.36 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 113.613 -1.63 . . . . 75.140000000000001 112.33 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -87.69 14.2 8.99 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.176 0.99 . . . . 75.510000000000005 111.787 -169.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.11 30.77 74.06 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.454 -1.058 . . . . 72.129999999999995 110.454 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -132.13 159.34 39.23 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 127.076 2.15 . . . . 71.230000000000004 106.548 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 76' ' ' ARG . 31.6 p -142.63 113.71 7.65 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.045 0.926 . . . . 73.120000000000005 110.405 -171.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.75 177.4 8.91 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 125.909 1.683 . . . . 65.25 110.417 -173.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -106.31 144.78 32.51 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.488 -0.93 . . . . 64.310000000000002 108.488 158.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.2 pt -131.28 170.05 20.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 124.554 1.142 . . . . 64.120000000000005 108.94 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -125.02 151.87 45.01 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.966 -1.124 . . . . 71.319999999999993 107.966 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.1 t -114.9 114.8 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 128.341 2.656 . . . . 72.230000000000004 105.925 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -123.87 164.69 18.73 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 121.757 -0.589 . . . . 73.25 110.116 164.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.9 t -67.1 154.95 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 106.74 -1.578 . . . . 74.049999999999997 106.74 170.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.276 -1.009 . . . . 72.129999999999995 108.276 170.234 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.1 m . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 108.591 -0.892 . . . . 70.120000000000005 108.591 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -72.35 26.9 0.05 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.949 2.1 . . . . 65.329999999999998 113.664 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.43 41.18 3.49 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.925 -1.509 . . . . 62.219999999999999 106.925 174.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.19 136.43 49.23 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.848 1.259 . . . . 74.510000000000005 109.133 -172.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.528 HG23 ' HB ' ' A' ' 55' ' ' VAL . 33.7 m -137.61 169.08 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.008 0.923 . . . . 74.120000000000005 111.324 -169.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.44 156.31 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 104.604 -2.369 . . . . 73.140000000000001 104.604 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.3 t -130.89 151.27 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.047 -1.464 . . . . 70.209999999999994 107.047 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.4 p -136.56 167.89 20.53 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.542 1.064 . . . . 73.140000000000001 109.174 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.58 4.43 70.35 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.576 1.56 . . . . 72.109999999999999 113.557 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.58 148.1 67.53 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 119.528 1.664 . . . . 72.239999999999995 112.298 -169.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.58 163.22 36.43 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.142 1.894 . . . . 73.150000000000006 109.917 174.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.1 -8.49 20.29 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.898 3.066 . . . . 65.310000000000002 115.633 -165.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.53 19.64 2.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.781 1.232 . . . . 72.450000000000003 110.829 -175.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.87 103.52 2.0 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 108.594 -1.802 . . . . 65.209999999999994 108.594 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.9 m -85.9 169.73 13.01 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.128 0.964 . . . . 65.25 110.773 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -64.06 -24.46 67.71 Favored 'General case' 0 C--O 1.226 -0.136 0 O-C-N 121.86 -0.525 . . . . 72.319999999999993 110.77 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -50.45 72.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.472 1.509 . . . . 74.150000000000006 108.347 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.26 -41.91 80.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.249 0.477 . . . . 61.229999999999997 110.547 176.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -52.74 47.24 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.991 0.814 . . . . 71.430000000000007 109.884 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -65.14 -33.57 76.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.835 0.854 . . . . 74.329999999999998 110.827 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -80.01 -10.72 59.79 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.667 1.187 . . . . 74.329999999999998 113.263 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -112.68 -46.1 3.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.619 0.767 . . . . 74.340000000000003 109.866 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.66 ' HG3' HD11 ' A' ' 70' ' ' LEU . 17.2 ttt -67.04 -12.81 60.96 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.046 1.128 . . . . 74.409999999999997 114.046 -173.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -60.25 -11.5 6.51 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.893 1.277 . . . . 74.310000000000002 114.023 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -58.75 -27.92 65.4 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.47 1.032 . . . . 63.140000000000001 112.002 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.38 -9.83 59.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 113.822 1.045 . . . . 70.310000000000002 113.822 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.25 -148.83 17.39 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 119.941 1.246 . . . . 52.119999999999997 110.3 -171.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.45 91.65 8.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.579 1.657 . . . . 71.540000000000006 110.08 -166.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.45 144.61 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 113.524 -1.671 . . . . 74.400000000000006 106.608 161.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 2.3 t -138.13 -2.47 1.85 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.282 1.215 . . . . 65.430000000000007 114.282 172.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.439 ' HB3' ' CB ' ' A' ' 56' ' ' GLU . 3.8 t80 -138.25 145.43 41.32 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 121.125 1.784 . . . . 73.319999999999993 106.8 168.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.45 145.16 38.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.376 -0.972 . . . . 74.310000000000002 108.376 165.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -151.73 141.96 22.34 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.548 1.139 . . . . 74.420000000000002 109.238 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.9 m -144.33 176.11 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.368 1.467 . . . . 73.409999999999997 108.123 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -146.64 -177.24 5.54 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.704 1.202 . . . . 74.120000000000005 108.151 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -83.03 51.4 1.94 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.111 0.869 . . . . 64.25 109.083 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -139.65 176.24 8.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.405 -1.331 . . . . 70.340000000000003 107.405 167.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.75 53.61 4.86 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.331 -1.108 . . . . 70.310000000000002 110.331 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.03 154.56 32.67 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.354 1.077 . . . . 62.049999999999997 110.523 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.96 170.53 32.58 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.481 1.515 . . . . 65.120000000000005 110.394 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.7 t -146.13 142.93 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.094 1.757 . . . . 71.010000000000005 107.309 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.528 ' HB ' HG23 ' A' ' 18' ' ' VAL . 54.6 t -145.21 164.02 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.113 -1.069 . . . . 73.329999999999998 108.113 -161.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' CB ' ' HB3' ' A' ' 44' ' ' TYR . 15.2 tt0 -138.4 144.69 40.33 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.806 -1.553 . . . . 54.229999999999997 106.806 172.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -115.7 167.89 10.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.809 2.043 . . . . 74.420000000000002 107.638 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.4 m -73.42 -33.06 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.649 0.611 . . . . 64.530000000000001 112.649 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -156.95 159.74 38.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.74 0.7 . . . . 74.540000000000006 109.592 -171.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -64.85 -20.75 66.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 118.138 -0.934 . . . . 74.230000000000004 112.287 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.18 -64.14 0.94 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.391 1.076 . . . . 74.099999999999994 108.797 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.34 -42.18 81.43 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.881 0.872 . . . . 73.5 110.146 177.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.442 ' HG3' ' CG1' ' A' ' 18' ' ' VAL . 47.9 ttp -51.63 -57.94 7.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.541 0.336 . . . . 74.310000000000002 110.647 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.5 m -61.17 -38.33 86.1 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.96 0.904 . . . . 72.5 112.817 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -54.36 -34.97 62.23 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.224 0.92 . . . . 71.109999999999999 111.394 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.481 ' HB1' HD12 ' A' ' 70' ' ' LEU . . . -55.69 -43.43 76.39 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.657 -0.652 . . . . 72.219999999999999 112.08 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.33 -19.36 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.929 -1.107 . . . . 71.420000000000002 109.934 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -86.91 -36.46 18.36 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.513 1.125 . . . . 72.430000000000007 111.493 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.7 mmtm -132.72 0.95 3.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.648 0.981 . . . . 75.0 113.648 -160.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.66 HD11 ' HG3' ' A' ' 36' ' ' MET . 1.7 tm? -143.34 16.64 1.87 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.386 1.075 . . . . 75.040000000000006 110.369 -167.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HB2' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -102.25 156.32 17.65 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 119.294 -2.129 . . . . 74.310000000000002 112.561 173.58 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.2 t30 55.22 19.78 3.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.58 1.952 . . . . 75.239999999999995 114.059 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.5 p -70.31 173.32 6.93 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.958 1.703 . . . . 52.509999999999998 110.766 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -78.39 178.11 7.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.401 -0.592 . . . . 73.439999999999998 109.401 163.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -156.03 141.08 17.34 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.486 1.514 . . . . 73.310000000000002 112.102 168.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -94.5 109.48 21.36 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.133 2.173 . . . . 63.030000000000001 111.529 -170.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -93.39 165.5 12.74 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.53 1.514 . . . . 45.409999999999997 110.935 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.58 -17.56 44.44 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.085 -1.009 . . . . 53.450000000000003 113.112 176.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -80.97 22.94 0.58 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.233 1.413 . . . . 72.409999999999997 112.123 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.62 33.07 83.37 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.687 -0.633 . . . . 74.329999999999998 111.818 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.53 169.13 20.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.288 1.435 . . . . 72.010000000000005 110.275 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.6 p -148.87 131.06 15.48 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.331 1.052 . . . . 62.210000000000001 108.673 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.04 -178.94 3.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.653 0.781 . . . . 62.310000000000002 109.277 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -90.81 160.7 15.63 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.152 -0.684 . . . . 72.450000000000003 109.152 163.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.1 pt -136.54 167.1 24.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.546 1.138 . . . . 62.350000000000001 109.856 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -137.57 122.11 18.45 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.585 -1.265 . . . . 75.409999999999997 107.585 -170.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 71' ' ' ASP . 1.4 p -84.86 148.79 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 118.47 0.577 . . . . 62.100000000000001 109.708 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.89 177.2 10.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.565 0.746 . . . . 71.230000000000004 109.896 162.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.02 153.95 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.503 -1.666 . . . . 75.430000000000007 106.503 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.4 t0 . . . . . 0 C--O 1.252 1.187 0 N-CA-C 105.959 -1.867 . . . . 72.319999999999993 105.959 158.843 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 106.56 -1.644 . . . . 64.400000000000006 106.56 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' ' HE3' ' A' ' 60' ' ' LYS . 59.4 mt-10 -84.52 24.3 1.02 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.901 1.68 . . . . 75.219999999999999 112.27 -175.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.32 23.75 5.94 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 119.997 -1.689 . . . . 63.140000000000001 110.971 -169.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.2 122.02 40.04 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 121.376 -0.827 . . . . 74.120000000000005 111.132 -159.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 89' ' ' VAL . 3.2 m -127.07 159.96 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.24 1.816 . . . . 60.200000000000003 108.972 174.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 24.3 m -136.77 176.85 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 127.117 2.167 . . . . 74.129999999999995 108.139 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 53' ' ' GLY . 2.4 m -135.89 159.11 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.925 -1.139 . . . . 65.239999999999995 107.925 -162.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.88 169.52 22.63 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 123.912 0.885 . . . . 64.120000000000005 110.192 -176.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.09 11.1 69.96 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.008 0.813 . . . . 24.329999999999998 113.831 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.447 HD13 HG13 ' A' ' 47' ' ' VAL . 10.0 mt -60.31 148.83 78.49 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 118.845 1.323 . . . . 72.299999999999997 111.193 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -75.13 170.01 21.32 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.23 2.62 . . . . 72.0 110.39 168.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.93 -36.91 21.26 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.677 2.251 . . . . 70.430000000000007 113.969 -175.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.6 32.67 3.26 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 119.841 1.201 . . . . 64.319999999999993 110.918 -173.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.07 173.94 44.59 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-O 123.033 1.352 . . . . 61.039999999999999 109.776 164.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.4 p -159.43 168.88 25.18 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.063 1.745 . . . . 51.520000000000003 107.883 171.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -62.19 -27.34 68.9 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 122.116 -0.365 . . . . 74.099999999999994 111.26 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -65.02 -50.02 67.89 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.983 0.913 . . . . 73.010000000000005 109.807 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -67.45 -26.32 66.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.356 1.063 . . . . 73.430000000000007 111.02 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.08 -55.97 8.12 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.172 -1.047 . . . . 74.400000000000006 108.172 171.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -63.61 -35.75 81.56 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.299 -0.875 . . . . 72.040000000000006 111.85 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -75.3 -5.75 46.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.81 0.844 . . . . 64.319999999999993 113.244 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.501 ' CG ' HH21 ' A' ' 76' ' ' ARG . 2.2 t-160 -119.05 -43.7 2.63 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.262 1.025 . . . . 72.319999999999993 112.828 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.416 ' O ' HG21 ' A' ' 42' ' ' VAL . 8.8 ttt -76.27 41.83 0.25 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.452 -0.78 . . . . 74.099999999999994 110.752 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.2 ptm85 -111.28 -16.5 13.38 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.074 -1.641 . . . . 74.150000000000006 112.372 -170.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -84.58 -5.28 59.29 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.666 1.358 . . . . 55.240000000000002 114.666 -168.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.12 -13.73 24.82 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.755 0.822 . . . . 53.539999999999999 112.388 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.18 -176.23 24.33 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.767 -0.933 . . . . 72.310000000000002 110.767 -170.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.21 127.25 32.48 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.241 -0.564 . . . . 44.210000000000001 111.696 -166.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 36' ' ' MET . 30.2 t -118.05 123.29 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 C-N-CA 124.252 1.021 . . . . 74.430000000000007 108.948 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.82 -19.88 19.26 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 117.993 -1.003 . . . . 74.430000000000007 112.362 -177.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -130.02 166.98 19.0 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.362 1.437 . . . . 72.219999999999999 111.798 -170.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -163.29 139.73 7.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.412 1.085 . . . . 71.109999999999999 111.617 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -146.84 143.34 28.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.559 1.144 . . . . 64.129999999999995 109.741 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.447 HG13 HD13 ' A' ' 23' ' ' LEU . 42.4 t -144.41 148.4 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.074 1.35 . . . . 72.430000000000007 107.982 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -139.87 168.47 19.73 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.859 1.263 . . . . 72.420000000000002 110.554 175.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -84.06 40.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 127.294 2.237 . . . . 71.030000000000001 111.327 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -130.2 43.19 3.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.59 1.186 . . . . 71.239999999999995 109.205 170.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.14 12.34 30.16 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.357 -1.246 . . . . 33.439999999999998 114.523 172.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.3 p -143.12 157.45 44.51 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 120.429 2.115 . . . . 73.310000000000002 109.282 -169.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.542 ' N ' HG22 ' A' ' 20' ' ' VAL . . . -149.79 178.26 27.41 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 107.553 -2.219 . . . . 65.420000000000002 107.553 -172.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 31.0 t -155.96 137.79 5.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 105.393 -2.076 . . . . 74.040000000000006 105.393 -170.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.62 170.53 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.381 -1.34 . . . . 61.119999999999997 107.381 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -146.88 125.41 12.44 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.328 -2.101 . . . . 51.219999999999999 105.328 162.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -100.35 164.59 11.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.185 -1.783 . . . . 75.219999999999999 106.185 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.8 m -73.39 -29.5 27.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.307 -0.957 . . . . 73.209999999999994 112.266 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -151.82 165.41 34.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.526 0.603 . . . . 75.409999999999997 112.488 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 15' ' ' GLU . 8.7 ttmt -61.81 -28.38 69.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.884 -1.055 . . . . 74.329999999999998 110.944 176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.13 -59.76 4.33 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.17 0.896 . . . . 74.239999999999995 108.729 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.31 -46.52 86.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.586 1.555 . . . . 71.140000000000001 109.139 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -50.38 -55.46 15.6 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.253 1.021 . . . . 74.549999999999997 111.344 172.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.7 m -54.04 -44.2 70.84 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.779 0.718 . . . . 44.140000000000001 110.956 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -62.08 -40.88 97.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.11 -0.33 . . . . 75.239999999999995 110.11 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.95 -41.0 86.38 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.949 -0.469 . . . . 74.299999999999997 111.364 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.49 -10.24 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 121.497 -0.752 . . . . 53.109999999999999 110.975 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -119.12 -1.49 10.89 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.468 1.031 . . . . 71.140000000000001 113.721 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.0 -5.05 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.163 0.985 . . . . 53.009999999999998 112.586 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.99 24.24 3.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.633 1.173 . . . . 63.130000000000003 109.28 -171.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.34 156.83 17.59 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.796 -1.19 . . . . 71.129999999999995 110.361 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.13 20.96 1.96 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.389 2.276 . . . . 74.319999999999993 113.351 -174.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.3 p -74.31 174.62 8.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.528 1.931 . . . . 55.299999999999997 111.582 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -77.15 162.82 27.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.082 0.953 . . . . 73.430000000000007 110.116 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -148.18 121.13 8.77 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.726 1.611 . . . . 74.439999999999998 108.469 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.501 HH21 ' CG ' ' A' ' 35' ' ' HIS . 6.7 ptp180 -74.75 157.24 35.58 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.839 0.856 . . . . 72.030000000000001 109.747 173.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.9 p -141.42 163.26 33.42 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.13 0.572 . . . . 73.120000000000005 111.124 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -71.41 -12.43 61.41 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.579 1.551 . . . . 74.129999999999995 112.169 -174.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.75 8.58 2.32 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.755 1.222 . . . . 73.219999999999999 111.701 169.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.12 21.09 76.94 Favored Glycine 0 C--N 1.337 0.634 0 O-C-N 121.096 -1.002 . . . . 73.420000000000002 112.008 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -127.37 167.99 15.44 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.115 1.366 . . . . 74.340000000000003 109.065 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -140.27 145.6 37.51 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.387 -0.968 . . . . 73.019999999999996 108.387 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -127.26 -168.92 1.95 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.499 1.92 . . . . 72.200000000000003 107.022 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -103.72 161.94 13.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.785 -0.82 . . . . 63.340000000000003 108.785 165.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.8 pt -132.65 162.97 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-O 121.189 0.519 . . . . 73.200000000000003 109.793 169.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -120.09 103.01 8.92 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.543 1.537 . . . . 72.329999999999998 108.086 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 t -70.0 139.27 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.623 -1.251 . . . . 75.200000000000003 107.623 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -138.05 168.02 20.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.327 0.967 . . . . 62.5 110.467 159.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.546 ' HA ' HG12 ' A' ' 18' ' ' VAL . 90.7 t -78.57 140.8 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.047 -1.464 . . . . 61.530000000000001 107.047 170.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 44.5 t0 . . . . . 0 C--O 1.248 1.003 0 N-CA-C 107.273 -1.38 . . . . 53.240000000000002 107.273 167.521 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 107.43 -1.322 . . . . 74.209999999999994 107.43 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.56 25.72 0.05 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.229 2.612 . . . . 75.450000000000003 113.212 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.52 35.77 3.81 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.485 1.514 . . . . 75.230000000000004 108.326 -177.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -115.77 124.43 50.75 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.771 1.628 . . . . 73.209999999999994 108.436 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.55 166.26 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.336 1.854 . . . . 74.049999999999997 110.05 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -137.0 141.11 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.275 1.83 . . . . 71.310000000000002 106.506 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.7 t -112.99 152.16 14.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.792 1.237 . . . . 75.430000000000007 107.725 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.99 164.34 32.37 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.585 -1.265 . . . . 72.140000000000001 107.585 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.88 14.33 82.26 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.815 -0.992 . . . . 60.240000000000002 113.07 -173.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.792 HD23 ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -64.61 145.27 98.67 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 119.762 1.781 . . . . 65.049999999999997 110.94 -166.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.792 ' HD2' HD23 ' A' ' 23' ' ' LEU . 55.5 Cg_endo -64.33 169.86 10.29 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.095 2.53 . . . . 73.219999999999999 110.717 175.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.16 -13.92 39.28 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.761 1.641 . . . . 72.140000000000001 113.108 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -138.37 17.65 2.75 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.429 1.27 . . . . 64.010000000000005 114.429 -155.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.74 97.7 1.18 Allowed Glycine 0 C--N 1.335 0.507 0 N-CA-C 108.51 -1.836 . . . . 62.140000000000001 108.51 170.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.92 179.2 4.43 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.833 0.816 . . . . 45.450000000000003 110.876 172.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -61.93 -28.09 69.29 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.723 -1.235 . . . . 73.409999999999997 114.272 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.33 -51.8 64.47 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.245 -1.391 . . . . 53.229999999999997 107.245 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.3 -47.52 83.42 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.137 1.375 . . . . 73.030000000000001 110.056 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.519 HD23 HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -48.43 -58.22 4.95 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.638 0.775 . . . . 75.25 110.024 177.329 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.02 -37.86 78.87 Favored 'General case' 0 C--N 1.338 0.08 0 O-C-N 122.101 -0.374 . . . . 65.340000000000003 111.017 -171.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -7.71 14.2 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.284 0.846 . . . . 73.120000000000005 113.284 176.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -112.29 -49.32 2.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.173 0.989 . . . . 75.140000000000001 111.858 174.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.1 ttt -70.53 25.25 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.774 1.629 . . . . 64.319999999999993 112.945 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.51 -7.42 41.3 Favored 'General case' 0 C--O 1.222 -0.392 0 O-C-N 120.175 -1.578 . . . . 71.030000000000001 113.292 167.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.69 -23.05 67.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.83 1.65 . . . . 72.450000000000003 113.801 -172.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.48 -8.39 58.38 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.486 1.515 . . . . 20.030000000000001 113.951 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.21 -110.28 0.43 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 119.852 1.206 . . . . 60.229999999999997 111.448 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.99 138.31 22.86 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.34 1.067 . . . . 74.140000000000001 108.229 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.472 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.4 p -122.34 135.81 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 C-N-CA 127.42 2.288 . . . . 71.420000000000002 109.595 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.1 p -103.17 -25.88 13.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.386 -0.825 . . . . 42.539999999999999 110.104 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.424 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 8.8 t80 -130.67 136.9 49.26 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.74 1.616 . . . . 71.049999999999997 109.071 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.92 150.05 46.73 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.003 0.921 . . . . 34.43 108.635 158.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -148.05 132.69 17.82 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.458 1.903 . . . . 73.200000000000003 107.494 172.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.1 t -137.98 137.61 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.599 -2.0 . . . . 65.209999999999994 105.599 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.29 -163.83 0.22 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.0 1.72 . . . . 70.310000000000002 109.833 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 ptm85 -43.54 -57.49 3.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.532 -1.667 . . . . 65.099999999999994 111.118 159.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -172.7 168.76 5.12 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.803 1.638 . . . . 61.340000000000003 114.443 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.28 -39.95 3.06 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 128.152 2.787 . . . . 72.099999999999994 114.822 168.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.96 168.47 19.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.997 1.399 . . . . 61.210000000000001 109.242 -173.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.71 152.29 23.38 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.063 -1.615 . . . . 42.420000000000002 109.063 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -118.4 139.96 43.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.731 -1.211 . . . . 70.450000000000003 107.731 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.4 t -140.92 146.51 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.486 -1.672 . . . . 62.109999999999999 106.486 -168.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 44' ' ' TYR . 23.6 mt-10 -138.29 106.97 5.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 120.815 -1.178 . . . . 65.25 108.085 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.472 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 1.3 m-85 -76.51 163.76 26.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.201 1.801 . . . . 73.049999999999997 108.943 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.6 m -74.47 -39.17 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 120.955 -1.091 . . . . 63.329999999999998 112.499 -172.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -143.09 159.27 42.58 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.195 0.598 . . . . 75.420000000000002 110.412 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -67.26 -26.89 66.79 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 117.609 -1.186 . . . . 55.119999999999997 111.698 -174.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -51.72 -63.56 1.1 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 122.341 1.067 . . . . 75.010000000000005 108.429 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -73.2 -41.36 63.9 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.999 1.719 . . . . 72.439999999999998 108.446 -167.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.411 ' SD ' HG22 ' A' ' 89' ' ' VAL . 16.5 tmm? -52.62 -49.85 64.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.443 1.097 . . . . 75.319999999999993 111.245 170.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.4 m -61.19 -43.31 99.08 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.461 -0.774 . . . . 72.219999999999999 110.523 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -56.44 -41.31 76.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.93 0.786 . . . . 72.040000000000006 110.328 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.58 -43.49 68.56 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 123.729 0.812 . . . . 75.150000000000006 111.876 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.96 -34.94 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 120.596 1.543 . . . . 75.219999999999999 110.375 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.8 ptt85 -92.49 -16.32 25.96 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.145 1.165 . . . . 74.219999999999999 114.145 -170.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -117.18 -37.43 3.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.248 1.019 . . . . 54.119999999999997 111.482 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.04 22.57 12.05 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.367 1.467 . . . . 55.450000000000003 110.095 -167.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -101.16 154.96 18.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.306 1.412 . . . . 74.140000000000001 111.841 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.0 t30 63.7 14.88 8.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.148 2.579 . . . . 74.150000000000006 112.981 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.5 p -76.13 175.17 9.21 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.746 1.218 . . . . 73.430000000000007 110.832 -169.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -66.92 170.92 5.95 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.3 -0.875 . . . . 74.329999999999998 108.954 155.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -149.67 126.7 11.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.432 1.093 . . . . 74.040000000000006 109.553 166.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.5 mtt-85 -82.98 120.38 25.64 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.442 1.497 . . . . 75.25 111.511 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.8 p -76.25 -172.19 2.0 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.597 -0.89 . . . . 72.010000000000005 108.597 154.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -89.24 -8.16 54.02 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.006 -1.059 . . . . 71.140000000000001 110.99 165.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -76.82 5.55 7.59 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.84 -1.163 . . . . 73.340000000000003 113.64 -167.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.36 17.06 67.46 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 124.309 0.956 . . . . 74.150000000000006 110.845 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.6 167.14 20.58 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.139 1.376 . . . . 74.340000000000003 108.763 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.9 p -146.55 128.48 15.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.352 -0.981 . . . . 63.450000000000003 108.352 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.51 175.69 8.22 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.155 -1.054 . . . . 55.25 108.155 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -92.08 156.54 17.31 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.092 -1.818 . . . . 75.209999999999994 106.092 144.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.5 pt -131.64 173.74 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.558 -1.275 . . . . 72.150000000000006 107.558 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -128.94 150.4 50.4 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.231 -1.396 . . . . 75.25 107.231 168.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.8 t -122.62 137.21 56.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 126.081 1.752 . . . . 75.439999999999998 107.664 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.61 158.84 43.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.04 1.336 . . . . 62.25 108.902 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.411 HG22 ' SD ' ' A' ' 63' ' ' MET . 11.3 t -70.43 149.89 10.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.45 -1.685 . . . . 64.510000000000005 106.45 162.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.3 t70 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.813 -1.089 . . . . 75.409999999999997 110.369 172.445 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 108.509 -0.922 . . . . 72.209999999999994 108.509 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -73.42 44.65 0.16 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.446 1.898 . . . . 72.519999999999996 111.9 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.23 22.3 3.22 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.125 -1.609 . . . . 75.129999999999995 110.861 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -121.61 136.79 54.93 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.937 -1.102 . . . . 64.120000000000005 109.285 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.51 155.99 16.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.112 -0.699 . . . . 51.119999999999997 109.112 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.97 141.26 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 124.893 1.277 . . . . 72.409999999999997 107.671 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.0 t -101.88 147.27 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 126.727 2.011 . . . . 75.349999999999994 107.805 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.08 156.45 48.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.726 0.694 . . . . 74.439999999999998 110.632 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.94 3.53 70.3 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.674 1.13 . . . . 74.230000000000004 114.084 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.9 mt -58.26 147.12 68.23 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.449 1.1 . . . . 72.409999999999997 113.448 -164.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.22 165.6 31.91 Favored 'Trans proline' 0 CA--C 1.538 0.694 1 C-N-CA 126.051 4.501 . . . . 74.219999999999999 112.841 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -67.61 -15.76 45.43 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.669 2.913 . . . . 62.530000000000001 114.754 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.04 22.72 9.48 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.536 1.134 . . . . 73.200000000000003 110.023 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.45 72.75 2.71 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.56 -1.016 . . . . 74.239999999999995 110.56 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -69.68 162.8 26.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 124.423 0.72 . . . . 72.129999999999995 111.126 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.0 p-90 -61.55 -19.54 62.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.714 0.806 . . . . 74.239999999999995 111.467 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -60.49 3.28 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 117.093 -1.432 . . . . 74.030000000000001 109.385 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -64.46 -39.9 94.69 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.128 0.893 . . . . 54.420000000000002 109.544 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -48.6 52.37 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 123.247 0.619 . . . . 64.510000000000005 110.866 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -67.77 -44.15 78.14 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.708 0.685 . . . . 75.230000000000004 110.81 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.41 -13.07 62.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.767 1.227 . . . . 63.219999999999999 112.499 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -108.74 -43.85 4.16 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.986 1.314 . . . . 75.430000000000007 112.455 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.5 ttt -77.59 42.72 0.37 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.59 -1.319 . . . . 61.140000000000001 111.198 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.5 -5.65 12.83 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.092 -1.63 . . . . 64.120000000000005 113.366 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -63.19 -22.55 66.94 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.565 1.529 . . . . 72.329999999999998 113.833 -172.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.47 -5.44 59.16 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.06 1.504 . . . . 74.349999999999994 115.06 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.27 -98.6 0.21 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-O 118.349 -1.251 . . . . 44.140000000000001 111.034 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.15 149.53 31.19 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.579 1.189 . . . . 71.430000000000007 112.188 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.4 t -130.55 148.22 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.79 1.636 . . . . 72.239999999999995 109.509 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.9 t -129.76 8.19 5.29 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.525 0.73 . . . . 64.439999999999998 112.293 -170.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -154.08 162.88 40.89 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.593 1.557 . . . . 74.120000000000005 108.81 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -162.04 129.9 4.04 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.867 0.867 . . . . 73.010000000000005 109.583 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -155.75 128.61 7.99 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.268 0.94 . . . . 72.140000000000001 111.184 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.01 177.38 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 O-C-N 120.522 -1.361 . . . . 71.329999999999998 107.398 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.21 161.04 42.27 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.312 -1.366 . . . . 63.329999999999998 107.312 168.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 42.36 -86.87 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.426 1 C-N-CA 132.116 4.166 . . . . 72.209999999999994 112.114 162.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -165.48 -178.02 4.73 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 128.002 2.521 . . . . 71.120000000000005 110.209 153.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.74 -21.12 31.47 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-O 117.879 -1.512 . . . . 74.099999999999994 114.293 161.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.02 164.82 37.28 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 120.154 1.977 . . . . 73.430000000000007 108.448 168.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.0 143.05 8.17 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 107.816 -2.114 . . . . 72.140000000000001 107.816 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.7 p -107.99 144.9 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.726 1.263 . . . . 75.530000000000001 109.567 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.2 t -142.81 156.58 18.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 107.152 -1.425 . . . . 71.540000000000006 107.152 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -136.49 112.85 9.91 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.93 -1.507 . . . . 73.019999999999996 106.93 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -80.0 177.81 8.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.977 -1.465 . . . . 73.530000000000001 107.237 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.54 -60.99 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.046 -0.979 . . . . 64.230000000000004 110.399 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -139.19 169.17 18.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 124.24 1.016 . . . . 75.310000000000002 109.671 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -59.45 -29.73 68.0 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 116.875 -1.536 . . . . 63.520000000000003 111.791 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -60.55 -60.01 4.48 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.086 1.312 . . . . 63.25 109.877 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.64 -42.45 98.15 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.904 0.882 . . . . 71.540000000000006 109.695 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -58.31 -50.61 73.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.282 1.033 . . . . 70.439999999999998 110.721 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.9 m -57.57 -52.76 64.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.255 -0.646 . . . . 70.25 109.255 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -56.57 -32.13 64.89 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.627 0.771 . . . . 74.549999999999997 112.077 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.54 93.64 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 123.304 0.641 . . . . 63.329999999999998 110.024 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 t -70.29 -12.99 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.229 -0.919 . . . . 52.219999999999999 110.84 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -105.35 -33.1 8.29 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 120.875 -1.141 . . . . 64.209999999999994 111.957 -174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -121.51 -12.42 8.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.377 1.071 . . . . 72.540000000000006 112.759 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.1 18.24 10.81 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.246 1.818 . . . . 73.549999999999997 109.434 -172.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -112.57 148.71 33.97 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.725 -1.234 . . . . 74.239999999999995 110.836 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.77 27.84 16.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.395 1.078 . . . . 72.329999999999998 111.032 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.1 p -90.44 175.93 6.9 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.85 1.26 . . . . 44.329999999999998 109.807 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.86 167.82 21.11 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.831 -0.803 . . . . 62.350000000000001 108.831 158.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -146.05 160.79 41.4 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 127.328 2.251 . . . . 64.340000000000003 110.656 173.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -114.93 126.18 54.49 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.313 0.96 . . . . 60.439999999999998 109.16 -173.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.7 t -93.33 163.58 13.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.874 -0.787 . . . . 75.5 108.874 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.52 -8.37 56.56 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 119.112 -0.47 . . . . 73.200000000000003 111.749 166.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -78.43 -12.99 60.04 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.927 1.239 . . . . 73.219999999999999 113.339 -169.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.65 31.69 4.77 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 124.327 0.965 . . . . 74.239999999999995 111.864 -173.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.1 168.29 26.41 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.036 0.934 . . . . 73.109999999999999 110.936 -169.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.5 p -145.2 122.53 11.59 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.566 -1.197 . . . . 73.439999999999998 108.565 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.02 -174.17 2.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.603 1.961 . . . . 61.399999999999999 108.392 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -105.1 156.37 18.14 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 120.477 1.489 . . . . 72.430000000000007 110.59 172.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.6 pt -129.8 170.37 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 122.115 0.96 . . . . 65.129999999999995 108.987 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -130.61 155.51 46.42 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 104.791 -2.299 . . . . 71.140000000000001 104.791 172.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.8 t -125.97 137.33 58.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.982 -1.118 . . . . 72.530000000000001 107.982 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -130.41 147.7 52.14 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 123.853 0.861 . . . . 65.400000000000006 110.592 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.66 127.61 24.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 105.722 -1.955 . . . . 61.350000000000001 105.722 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 127.678 2.391 . . . . 51.210000000000001 111.09 -172.992 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 106.97 -1.493 . . . . 71.120000000000005 106.97 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -76.34 37.15 0.16 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.709 1.603 . . . . 53.439999999999998 112.301 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.8 14.94 3.63 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.465 1.906 . . . . 71.340000000000003 110.746 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.33 121.39 42.66 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.512 1.525 . . . . 73.019999999999996 107.526 -162.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.457 HG23 ' HB ' ' A' ' 55' ' ' VAL . 20.8 m -115.14 166.12 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 118.504 0.593 . . . . 52.32 111.455 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.3 t -132.74 153.01 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.092 -1.818 . . . . 72.340000000000003 106.092 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 t -134.11 141.03 44.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 106.955 -1.498 . . . . 74.420000000000002 106.955 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.3 m -137.31 141.81 41.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 123.127 1.442 . . . . 74.329999999999998 113.266 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.19 37.43 48.8 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 128.578 2.99 . . . . 52.240000000000002 112.773 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.63 160.77 3.67 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.853 1.661 . . . . 73.409999999999997 113.021 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.83 171.02 14.13 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.612 3.541 . . . . 70.510000000000005 112.014 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.76 -4.89 16.18 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.739 2.293 . . . . 73.230000000000004 114.239 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.8 t -141.58 51.66 1.55 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.615 1.166 . . . . 70.430000000000007 109.08 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.95 164.55 13.22 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.365 -1.494 . . . . 54.409999999999997 109.365 168.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 m -151.66 168.41 25.09 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.405 1.482 . . . . 51.409999999999997 108.426 167.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -53.0 -29.3 28.39 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.203 0.816 . . . . 62.310000000000002 113.203 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -62.79 -58.24 8.11 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.424 1.089 . . . . 72.439999999999998 108.911 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.3 -30.6 67.64 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.453 -0.573 . . . . 70.129999999999995 109.453 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -51.29 -56.05 15.05 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.33 -0.856 . . . . 54.119999999999997 109.78 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -70.47 -35.62 73.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.919 1.288 . . . . 65.530000000000001 110.034 -175.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -59.63 -23.04 62.68 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.245 1.018 . . . . 73.329999999999998 112.953 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -102.59 -42.89 5.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.153 0.981 . . . . 72.329999999999998 111.431 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.19 -20.42 65.4 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.154 -0.966 . . . . 74.430000000000007 113.244 -174.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -52.55 -26.2 12.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.827 1.417 . . . . 74.400000000000006 114.827 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -71.06 3.08 3.69 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.687 1.736 . . . . 65.430000000000007 115.687 -161.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.75 -0.96 28.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.642 1.177 . . . . 65.439999999999998 111.955 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.47 -97.95 0.16 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.617 -1.793 . . . . 50.020000000000003 108.617 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -157.76 162.53 38.51 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.795 1.283 . . . . 62.520000000000003 107.789 166.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.477 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -131.81 129.73 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 126.738 2.015 . . . . 64.319999999999993 109.818 -175.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.7 t -86.85 -32.62 20.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.577 -1.192 . . . . 61.409999999999997 109.341 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -138.47 137.16 36.9 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.156 -0.965 . . . . 74.319999999999993 110.638 -160.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.76 149.43 37.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.203 1.001 . . . . 65.219999999999999 110.771 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -161.63 106.97 1.3 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.879 2.072 . . . . 63.109999999999999 108.821 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.93 -176.71 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.282 -1.511 . . . . 72.510000000000005 107.985 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -143.16 155.17 44.5 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.892 -0.781 . . . . 74.519999999999996 108.892 156.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 43.37 -86.13 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 130.666 3.587 . . . . 63.109999999999999 111.838 166.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -159.38 173.97 15.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 125.231 1.582 . . . . 72.239999999999995 107.52 147.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.08 -8.92 63.27 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 118.605 -1.108 . . . . 71.439999999999998 113.343 161.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.56 164.84 33.93 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.635 1.717 . . . . 74.099999999999994 108.294 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -155.8 163.21 31.65 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.174 -1.17 . . . . 72.530000000000001 110.174 167.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.6 147.54 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.493 1.917 . . . . 31.140000000000001 108.23 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.457 ' HB ' HG23 ' A' ' 18' ' ' VAL . 72.1 t -144.0 166.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.943 -1.132 . . . . 73.439999999999998 107.943 -165.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -135.81 109.68 8.16 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.249 -1.389 . . . . 74.439999999999998 107.249 165.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.477 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -79.12 167.11 21.49 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.495 1.518 . . . . 53.219999999999999 108.336 172.049 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.71 -29.98 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.212 1.19 . . . . 70.129999999999995 114.212 -166.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -156.31 164.39 38.38 Favored 'General case' 0 CA--C 1.515 -0.381 0 O-C-N 121.262 -0.899 . . . . 74.200000000000003 109.894 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -61.72 -31.95 72.15 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 117.448 -1.263 . . . . 63.409999999999997 111.632 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.29 -51.92 65.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 120.379 1.445 . . . . 72.420000000000002 109.724 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.46 -40.69 66.8 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.258 1.423 . . . . 61.219999999999999 108.706 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.415 ' HG3' ' CG1' ' A' ' 18' ' ' VAL . 36.2 ttp -52.25 -53.82 38.95 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 123.338 0.655 . . . . 65.040000000000006 109.98 169.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.4 m -55.31 -47.46 75.57 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.306 -0.854 . . . . 54.399999999999999 109.977 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -57.53 -28.34 63.4 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.866 1.212 . . . . 71.510000000000005 112.113 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.1 -44.91 83.0 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.469 1.108 . . . . 72.230000000000004 109.227 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.8 t -65.09 -21.76 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 121.192 -0.942 . . . . 53.340000000000003 110.778 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -91.9 -43.78 9.29 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 120.964 -1.085 . . . . 74.409999999999997 111.317 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -114.44 -15.62 12.05 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.069 1.348 . . . . 63.439999999999998 111.998 -165.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.32 22.15 9.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.478 1.911 . . . . 63.299999999999997 108.95 -171.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -111.83 154.53 24.98 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.45 -1.407 . . . . 72.420000000000002 110.87 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.269 5.8 p-10 45.25 41.67 6.31 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.103 2.161 . . . . 72.420000000000002 112.327 -170.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.0 p -95.97 175.15 6.59 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.545 1.138 . . . . 54.439999999999998 111.668 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 171.78 4.09 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.078 0.551 . . . . 51.329999999999998 109.541 158.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -150.97 124.78 9.14 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.104 1.361 . . . . 74.200000000000003 109.328 166.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.453 ' HA ' HG22 ' A' ' 82' ' ' THR . 70.5 mtp180 -70.46 142.2 51.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.84 1.2 . . . . 43.329999999999998 110.47 177.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -109.11 -170.97 1.75 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.17 1.788 . . . . 65.200000000000003 107.507 176.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -99.6 -3.21 33.74 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.303 0.853 . . . . 71.239999999999995 113.303 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.73 41.46 1.39 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.494 1.117 . . . . 62.439999999999998 111.465 -171.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.41 18.48 55.78 Favored Glycine 0 N--CA 1.464 0.538 0 C-N-CA 124.924 1.249 . . . . 51.210000000000001 113.408 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -142.99 174.09 10.98 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 125.492 1.517 . . . . 74.510000000000005 108.894 -166.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 76' ' ' ARG . 52.5 p -147.19 143.35 28.14 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.813 -0.81 . . . . 71.540000000000006 108.813 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.21 176.81 8.13 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.619 0.768 . . . . 70.510000000000005 110.565 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -104.13 154.79 19.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.984 -1.487 . . . . 61.439999999999998 106.984 141.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 pt -133.4 166.43 29.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 124.828 1.251 . . . . 74.519999999999996 108.603 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -126.51 133.5 51.13 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 105.822 -1.918 . . . . 73.340000000000003 105.822 165.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.5 t -84.44 165.96 2.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 125.779 1.632 . . . . 72.109999999999999 107.703 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.77 156.43 31.55 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.552 1.541 . . . . 73.329999999999998 107.967 162.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.78 138.51 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 105.18 -2.156 . . . . 50.109999999999999 105.18 156.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--O 1.245 0.853 0 C-N-CA 124.044 0.938 . . . . 65.310000000000002 110.568 177.361 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 108.319 -0.993 . . . . 72.420000000000002 108.319 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -70.53 24.35 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.054 2.541 . . . . 74.140000000000001 113.949 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.51 18.24 5.3 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.473 -1.392 . . . . 65.400000000000006 110.465 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.93 146.56 34.98 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.057 1.743 . . . . 64.310000000000002 111.106 -170.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.517 HG23 ' HB ' ' A' ' 55' ' ' VAL . 31.0 m -142.01 171.92 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 118.956 0.798 . . . . 74.430000000000007 111.012 -175.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 39.5 t -140.96 148.15 21.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.188 -2.153 . . . . 71.140000000000001 105.188 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 t -118.83 154.88 21.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 125.006 1.322 . . . . 71.340000000000003 107.683 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.6 m -149.45 158.49 44.22 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 119.955 -1.716 . . . . 73.310000000000002 110.525 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.39 61.42 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.889 0.757 . . . . 64.420000000000002 112.895 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.405 HD11 HD23 ' A' ' 32' ' ' LEU . 4.1 mm? -59.1 154.85 37.49 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 124.866 1.267 . . . . 73.049999999999997 112.238 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.63 174.54 12.06 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.45 3.434 . . . . 73.109999999999999 112.8 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.89 -8.08 21.74 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.625 2.217 . . . . 64.010000000000005 114.676 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.68 59.84 1.65 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.997 1.726 . . . . 51.240000000000002 109.685 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.97 149.12 16.87 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 108.199 -1.96 . . . . 63.119999999999997 108.199 172.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.1 m -137.6 -179.69 5.89 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 122.513 1.149 . . . . 72.140000000000001 108.144 168.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.3 p-90 -63.56 -18.53 63.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.92 1.288 . . . . 70.409999999999997 112.239 -176.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -69.89 -57.18 5.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.082 -1.081 . . . . 71.120000000000005 108.082 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -64.39 -26.91 68.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.548 0.69 . . . . 71.319999999999993 110.455 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.405 HD23 HD11 ' A' ' 23' ' ' LEU . 1.3 tm? -64.74 -54.05 37.46 Favored 'General case' 0 C--O 1.224 -0.264 0 O-C-N 120.235 -1.54 . . . . 50.219999999999999 110.653 174.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -65.51 -25.83 67.63 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.864 0.866 . . . . 73.310000000000002 110.865 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -31.89 64.97 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.808 -0.812 . . . . 74.310000000000002 108.808 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -83.82 -53.41 5.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.231 1.813 . . . . 72.510000000000005 112.088 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.9 ttt -81.64 39.42 0.54 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.64 1.176 . . . . 72.140000000000001 112.069 -167.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.81 2.28 14.33 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.229 1.412 . . . . 74.340000000000003 111.874 -175.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -85.78 -8.56 58.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.418 1.487 . . . . 64.5 113.174 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.61 25.22 11.88 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.979 1.312 . . . . 52.0 112.926 -166.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.51 -104.03 0.82 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 108.818 -1.713 . . . . 73.099999999999994 108.818 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -139.73 133.9 31.13 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.812 0.845 . . . . 64.329999999999998 110.64 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.6 t -127.97 136.04 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 126.195 1.798 . . . . 71.299999999999997 107.587 173.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.2 t -110.08 -26.13 9.86 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.462 0.541 . . . . 72.140000000000001 112.462 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -116.01 146.13 42.4 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.238 1.015 . . . . 72.420000000000002 109.721 -173.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.74 152.19 43.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.112 0.965 . . . . 71.25 108.463 163.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -148.58 144.66 27.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.569 0.748 . . . . 74.510000000000005 109.557 160.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -147.4 144.91 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 105.768 -1.938 . . . . 73.219999999999999 105.768 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -138.22 178.79 6.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.599 1.16 . . . . 73.340000000000003 109.343 -171.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -89.42 66.47 7.43 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.203 -1.036 . . . . 64.430000000000007 108.203 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -151.49 31.68 0.58 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.625 0.77 . . . . 63.420000000000002 110.414 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.75 18.75 40.22 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.062 -1.024 . . . . 61.450000000000003 113.616 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.7 p -146.93 170.22 17.52 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.222 1.511 . . . . 45.450000000000003 110.242 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.42 164.01 34.27 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.841 1.21 . . . . 72.230000000000004 110.469 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 28.7 t -131.4 156.01 42.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.572 1.549 . . . . 70.150000000000006 109.025 172.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.517 ' HB ' HG23 ' A' ' 18' ' ' VAL . 45.5 t -147.1 158.4 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.093 -1.447 . . . . 62.420000000000002 107.093 -175.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -145.0 114.45 7.14 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.325 -0.991 . . . . 50.420000000000002 108.325 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.78 174.77 7.01 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.822 2.449 . . . . 71.5 107.941 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.81 -49.25 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 117.606 -1.188 . . . . 53.210000000000001 111.11 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -137.09 157.84 45.79 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 120.471 1.487 . . . . 74.420000000000002 110.721 -167.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -62.88 -25.85 68.5 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 118.303 -0.856 . . . . 53.200000000000003 111.133 -170.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.66 -42.76 40.67 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 119.242 0.928 . . . . 73.109999999999999 111.299 -174.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -67.84 -44.44 77.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.082 0.855 . . . . 64.519999999999996 109.104 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.488 ' HG2' ' CG1' ' A' ' 18' ' ' VAL . 16.9 tmm? -50.6 -50.94 52.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.926 0.491 . . . . 33.43 110.938 173.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.9 m -56.58 -52.84 63.28 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.715 -0.659 . . . . 74.510000000000005 110.344 172.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -49.52 -40.84 39.26 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.489 1.515 . . . . 72.400000000000006 111.158 -174.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.39 93.35 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.102 1.361 . . . . 52.5 111.259 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.5 t -58.67 -25.77 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 121.413 -0.804 . . . . 75.120000000000005 110.269 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -106.87 -9.85 16.2 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.399 1.479 . . . . 71.329999999999998 111.852 -167.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -20.23 1.54 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 117.283 -1.341 . . . . 71.010000000000005 113.587 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.0 18.83 10.08 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.882 1.673 . . . . 74.420000000000002 109.737 -164.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -104.12 159.0 16.04 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.921 -1.112 . . . . 73.319999999999993 111.91 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 44.98 43.24 7.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.782 2.433 . . . . 74.430000000000007 112.044 -168.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.2 p -86.54 164.35 16.95 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.509 0.723 . . . . 75.450000000000003 110.731 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -88.07 157.62 18.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.553 1.141 . . . . 75.120000000000005 108.99 169.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -140.29 133.1 29.09 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.65 1.58 . . . . 64.219999999999999 109.519 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HA ' HG22 ' A' ' 82' ' ' THR . 62.6 mtt180 -81.82 112.28 18.81 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 123.692 0.797 . . . . 74.329999999999998 110.52 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.15 156.66 29.77 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.961 -1.125 . . . . 73.349999999999994 107.961 165.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -72.77 -11.36 60.58 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.94 -0.475 . . . . 74.540000000000006 111.196 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -70.05 3.64 2.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.778 2.031 . . . . 74.129999999999995 113.545 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.19 15.97 78.67 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 119.121 0.873 . . . . 50.539999999999999 111.525 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.13 170.88 14.36 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 126.841 2.056 . . . . 75.420000000000002 108.011 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.425 HG22 ' HA ' ' A' ' 76' ' ' ARG . 30.6 p -137.54 154.71 49.78 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.295 -1.743 . . . . 63.130000000000003 106.295 -177.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.07 -179.09 5.2 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.871 -0.789 . . . . 61.219999999999999 108.871 166.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -95.56 156.53 16.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.453 -0.573 . . . . 62.049999999999997 109.453 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.1 pt -124.95 168.83 17.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.552 1.141 . . . . 74.340000000000003 108.873 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -125.39 147.18 49.28 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.154 -1.424 . . . . 64.030000000000001 107.154 165.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.1 t -104.79 146.39 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 125.909 1.684 . . . . 74.409999999999997 108.794 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 160.61 43.77 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.211 1.805 . . . . 71.430000000000007 108.815 173.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.9 150.49 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 105.688 -1.967 . . . . 64.010000000000005 105.688 167.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t70 . . . . . 0 C--O 1.248 1.005 0 C-N-CA 125.477 1.511 . . . . 74.129999999999995 109.854 171.022 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.447 -0.597 0 CA-C-O 123.053 1.406 . . . . 70.129999999999995 111.156 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -62.34 15.26 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 131.138 3.775 . . . . 71.519999999999996 113.17 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.43 14.85 3.46 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 119.093 -2.254 . . . . 44.240000000000002 111.314 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -104.49 142.61 34.32 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.63 1.172 . . . . 52.130000000000003 111.3 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.503 HG23 ' HB ' ' A' ' 55' ' ' VAL . 31.1 m -131.7 169.41 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.095 1.358 . . . . 63.439999999999998 111.601 173.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.7 t -133.86 151.3 32.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.948 2.099 . . . . 73.430000000000007 106.008 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.42 153.9 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.379 -0.971 . . . . 65.400000000000006 108.379 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.0 p -132.14 168.83 17.31 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 121.286 -0.884 . . . . 54.100000000000001 109.04 168.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.69 -6.45 58.88 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.713 -1.049 . . . . 70.430000000000007 113.644 168.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.83 152.58 26.56 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 125.082 1.353 . . . . 74.530000000000001 113.892 -165.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.26 173.55 12.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.763 2.975 . . . . 64.109999999999999 111.788 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.45 -7.55 12.7 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.071 3.181 . . . . 73.230000000000004 115.329 168.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.29 68.16 1.23 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 121.25 1.841 . . . . 64.430000000000007 110.787 172.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.92 115.51 3.49 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.35 -1.5 . . . . 64.319999999999993 109.35 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 m -111.06 164.05 13.23 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.324 1.05 . . . . 54.229999999999997 109.83 -174.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -66.48 -25.26 66.62 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.171 -0.956 . . . . 74.430000000000007 112.097 -168.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -68.75 -52.08 34.43 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.729 -0.841 . . . . 73.439999999999998 108.729 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -58.56 -41.32 85.36 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.772 -0.825 . . . . 73.25 108.772 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.95 -60.75 2.94 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-O 117.707 -1.139 . . . . 73.530000000000001 110.264 174.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -65.86 -32.83 74.58 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 120.904 1.683 . . . . 72.540000000000006 111.758 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.31 -30.02 71.24 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.458 1.103 . . . . 74.129999999999995 111.351 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.34 -48.56 6.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.774 0.43 . . . . 72.150000000000006 110.803 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.4 ttt -72.25 30.64 0.06 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.454 2.302 . . . . 65.129999999999995 112.843 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -108.92 -10.07 15.09 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 120.125 -1.609 . . . . 74.140000000000001 112.091 172.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -72.3 -9.75 58.89 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.269 -1.52 . . . . 64.439999999999998 113.828 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.03 8.34 43.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.335 1.054 . . . . 71.519999999999996 113.048 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.44 -127.25 3.28 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 109.334 -1.507 . . . . 71.439999999999998 109.334 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -142.02 131.82 24.26 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.247 0.523 . . . . 70.319999999999993 109.92 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -127.57 138.76 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 C-N-CA 126.095 1.758 . . . . 62.409999999999997 112.37 -175.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.1 t -112.51 -35.57 5.51 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.929 -1.032 . . . . 73.310000000000002 111.46 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -109.55 136.35 49.07 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.499 1.045 . . . . 73.329999999999998 108.887 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.69 143.88 31.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.256 -1.387 . . . . 13.42 107.256 166.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -158.6 129.44 6.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.482 -1.303 . . . . 43.340000000000003 107.482 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.82 163.02 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 120.798 -1.189 . . . . 74.140000000000001 109.286 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -149.38 169.23 21.32 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.437 0.637 . . . . 70.129999999999995 110.151 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -74.61 48.8 0.37 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.869 2.468 . . . . 72.310000000000002 113.059 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -138.56 15.78 2.73 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.851 -1.155 . . . . 63.229999999999997 112.283 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.55 20.46 66.3 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 120.761 -1.212 . . . . 45.340000000000003 113.016 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 p -138.45 177.43 7.89 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 119.036 1.418 . . . . 54.340000000000003 111.963 -169.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.6 168.53 40.16 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.817 1.198 . . . . 72.329999999999998 111.007 167.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 p -133.97 139.38 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.497 1.519 . . . . 72.319999999999993 108.115 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.503 ' HB ' HG23 ' A' ' 18' ' ' VAL . 55.2 t -146.41 148.36 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 107.78 -1.192 . . . . 72.329999999999998 107.78 -161.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -137.37 109.5 7.26 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.686 1.232 . . . . 65.239999999999995 108.979 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.461 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 3.6 m-30 -69.19 -179.52 1.6 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.952 1.701 . . . . 64.209999999999994 109.666 171.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.92 -50.55 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 O-C-N 121.238 -0.914 . . . . 72.549999999999997 110.068 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -142.6 159.07 42.95 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 119.281 0.946 . . . . 73.329999999999998 111.447 -169.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -59.31 -30.91 68.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.211 -0.9 . . . . 74.209999999999994 111.458 -173.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.6 -29.65 68.22 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.886 1.221 . . . . 70.310000000000002 112.296 -174.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -85.12 -40.83 16.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.725 0.81 . . . . 73.409999999999997 108.907 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -52.79 -51.94 58.74 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.769 -0.582 . . . . 70.409999999999997 110.626 171.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.6 m -48.64 -46.55 40.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.475 1.51 . . . . 45.439999999999998 110.728 171.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -59.46 -40.32 86.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.223 0.609 . . . . 70.530000000000001 110.221 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.53 -39.01 78.95 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.054 0.843 . . . . 44.43 111.677 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.79 -27.76 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.812 0.733 . . . . 65.400000000000006 109.897 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -106.39 -9.1 16.87 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 114.101 1.148 . . . . 74.230000000000004 114.101 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -133.78 -1.74 3.03 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 117.673 -1.156 . . . . 72.329999999999998 113.195 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.439 HD13 HG21 ' A' ' 73' ' ' THR . 0.1 OUTLIER -144.89 17.81 1.61 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 120.067 1.303 . . . . 72.310000000000002 111.97 -165.399 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.48 153.1 18.65 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.705 1.593 . . . . 62.420000000000002 114.432 173.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 52.68 33.09 13.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 128.488 2.715 . . . . 63.329999999999998 114.494 -173.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.439 HG21 HD13 ' A' ' 70' ' ' LEU . 75.2 p -82.38 172.78 12.69 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.4 -0.813 . . . . 74.219999999999999 110.748 -177.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.74 171.23 15.41 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.66 1.184 . . . . 74.540000000000006 109.356 168.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -144.87 122.63 11.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.746 2.018 . . . . 70.140000000000001 109.489 167.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -69.64 122.22 18.68 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.814 1.646 . . . . 54.329999999999998 109.436 170.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.0 p -87.45 172.87 9.48 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.752 0.705 . . . . 64.310000000000002 109.565 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -73.28 -9.87 59.16 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.336 -0.393 . . . . 71.25 111.919 165.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.62 23.33 10.54 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.539 1.536 . . . . 74.299999999999997 112.78 -164.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.43 4.5 38.27 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 123.344 0.497 . . . . 72.540000000000006 113.313 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -119.71 165.87 13.95 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.302 1.441 . . . . 64.120000000000005 108.752 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.2 p -140.77 142.05 34.76 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.561 -1.644 . . . . 51.020000000000003 106.561 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.09 169.08 12.04 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.915 1.686 . . . . 53.409999999999997 107.392 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -93.25 158.0 15.97 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.65 1.114 . . . . 71.209999999999994 109.256 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 pt -126.89 168.92 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.677 0.791 . . . . 74.5 110.644 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -129.28 120.32 25.48 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 105.162 -2.162 . . . . 71.409999999999997 105.162 163.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.5 t -67.66 149.18 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.575 -1.269 . . . . 74.430000000000007 107.575 162.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -144.28 165.72 27.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 123.872 0.869 . . . . 71.319999999999993 109.93 156.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 t -73.36 149.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.728 -1.582 . . . . 52.109999999999999 106.728 166.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.0 t0 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 124.785 1.234 . . . . 72.540000000000006 108.399 167.543 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 C--O 1.235 0.319 0 N-CA-C 108.144 -1.058 . . . . 72.150000000000006 108.144 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -80.74 33.87 0.33 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.439 1.895 . . . . 74.239999999999995 112.039 -170.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.38 29.08 3.33 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.158 -1.589 . . . . 55.450000000000003 108.948 175.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.77 145.2 44.67 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.746 -1.221 . . . . 64.209999999999994 109.77 -167.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.455 ' CG1' ' HG2' ' A' ' 63' ' ' MET . 18.3 m -141.18 175.37 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.554 0.741 . . . . 74.450000000000003 110.326 -173.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.1 t -135.08 155.48 37.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 107.674 -1.232 . . . . 74.25 107.674 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.7 140.44 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.903 1.681 . . . . 70.349999999999994 106.528 170.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -135.58 165.03 26.47 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.874 -0.787 . . . . 64.019999999999996 108.874 170.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.58 7.04 72.5 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.616 -0.547 . . . . 71.219999999999999 113.04 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.9 mt -63.85 156.52 72.66 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 119.136 1.468 . . . . 73.010000000000005 111.189 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.99 170.46 19.75 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.049 3.166 . . . . 65.239999999999995 110.534 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.28 -5.11 16.26 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.04 2.493 . . . . 72.319999999999993 114.932 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.53 34.78 4.75 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.886 1.221 . . . . 72.140000000000001 111.398 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.9 146.66 21.44 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.265 -1.134 . . . . 74.310000000000002 110.265 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 t -137.75 168.08 20.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.61 1.195 . . . . 64.329999999999998 113.428 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -67.19 -26.1 66.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.989 1.716 . . . . 74.030000000000001 111.455 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -61.82 2.35 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.6 -1.259 . . . . 73.310000000000002 107.6 175.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -63.73 -35.46 80.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.1 0.875 . . . . 64.0 109.72 -176.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -54.38 46.95 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.48 0.582 . . . . 75.099999999999994 109.834 175.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -67.57 -27.51 67.0 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 111.563 0.208 . . . . 75.239999999999995 111.563 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.01 -20.53 52.37 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.729 -0.607 . . . . 75.019999999999996 112.069 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -88.33 -60.6 1.92 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.628 1.571 . . . . 73.299999999999997 111.171 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -69.44 -13.4 62.34 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.372 1.249 . . . . 60.350000000000001 114.372 -160.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -8.9 0.06 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.848 2.859 . . . . 71.319999999999993 113.757 170.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.415 ' HB3' HD23 ' A' ' 70' ' ' LEU . 18.3 tt0 -58.75 -30.55 67.6 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.489 1.04 . . . . 73.409999999999997 112.256 173.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.35 0.94 57.44 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.28 1.215 . . . . 64.349999999999994 114.28 -170.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.71 -104.21 0.33 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 108.855 -1.698 . . . . 54.140000000000001 108.855 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -147.03 152.31 38.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.661 0.73 . . . . 74.239999999999995 109.451 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.2 t -141.74 120.36 9.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 127.245 2.218 . . . . 64.409999999999997 106.273 -165.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -102.43 -44.43 5.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.96 0.8 . . . . 72.409999999999997 110.926 -175.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -73.22 160.26 32.2 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.596 0.759 . . . . 73.340000000000003 110.607 174.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.94 128.35 5.56 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.269 0.94 . . . . 75.019999999999996 112.105 166.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -158.17 127.02 5.58 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.342 1.057 . . . . 52.420000000000002 111.309 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.8 t -143.81 158.89 16.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.467 -1.679 . . . . 63.130000000000003 106.467 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -138.51 171.01 14.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.735 0.814 . . . . 63.210000000000001 109.908 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -75.32 68.66 2.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.707 1.603 . . . . 63.229999999999997 108.245 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -148.61 174.03 12.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.978 2.911 . . . . 71.409999999999997 106.354 166.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.07 22.81 0.45 Allowed Glycine 0 CA--C 1.537 1.458 0 CA-C-O 117.379 -1.789 . . . . 74.439999999999998 114.597 165.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.3 p -133.46 158.08 43.97 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 121.01 2.405 . . . . 74.420000000000002 112.504 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.41 151.95 23.69 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 105.676 -2.97 . . . . 54.350000000000001 105.676 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.09 148.97 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.705 -1.961 . . . . 72.450000000000003 105.705 168.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.422 ' HB ' HG23 ' A' ' 18' ' ' VAL . 12.9 t -137.47 160.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.112 -1.44 . . . . 62.219999999999999 107.112 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -140.99 149.92 42.4 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.826 -1.916 . . . . 74.219999999999999 105.826 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -122.3 176.77 5.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.251 1.82 . . . . 74.120000000000005 108.573 -168.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -82.7 -39.21 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.314 -0.857 . . . . 64.010000000000005 111.36 -174.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -151.88 163.99 38.05 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.744 0.702 . . . . 71.030000000000001 110.1 -176.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -68.97 -27.41 65.69 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 117.773 -1.108 . . . . 60.25 110.944 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -58.68 -51.84 68.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.941 1.246 . . . . 75.129999999999995 109.39 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.31 -47.83 75.19 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.541 1.936 . . . . 74.430000000000007 109.012 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.455 ' HG2' ' CG1' ' A' ' 18' ' ' VAL . 12.0 tmm? -54.54 -58.47 7.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.453 0.701 . . . . 64.120000000000005 112.061 176.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.4 m -55.3 -44.93 76.22 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 118.013 -0.994 . . . . 73.340000000000003 110.31 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.1 -32.83 71.35 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.245 0.929 . . . . 73.430000000000007 111.211 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 70' ' ' LEU . . . -58.35 -41.64 85.12 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.813 0.845 . . . . 72.340000000000003 110.739 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.04 -18.77 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 O-C-N 121.008 -1.058 . . . . 70.329999999999998 109.842 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.08 -16.16 14.34 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.807 1.643 . . . . 71.120000000000005 114.129 -173.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -144.72 12.94 1.49 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.034 1.124 . . . . 74.120000000000005 114.034 -174.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.429 HD12 ' HB1' ' A' ' 66' ' ' ALA . 1.6 tm? -149.69 -1.66 0.44 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.874 1.216 . . . . 73.450000000000003 112.735 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.473 ' CB ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.86 156.23 19.95 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 119.134 -2.229 . . . . 65.200000000000003 112.884 172.368 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.4 t30 57.82 58.19 3.79 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.109 1.764 . . . . 73.129999999999995 109.98 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.6 p -128.7 168.24 16.09 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.39 1.076 . . . . 74.120000000000005 110.436 -172.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -80.43 161.56 24.87 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.731 -0.605 . . . . 73.219999999999999 111.521 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -146.89 127.17 13.89 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.231 1.413 . . . . 75.140000000000001 111.457 171.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -78.75 125.39 29.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.192 2.197 . . . . 73.099999999999994 111.203 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.2 t -94.79 169.75 9.93 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.062 0.945 . . . . 74.230000000000004 109.442 172.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -65.36 -30.37 71.19 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 123.898 0.879 . . . . 73.400000000000006 112.498 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.64 9.7 3.21 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.762 0.825 . . . . 63.109999999999999 112.104 -173.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.17 4.93 57.74 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 120.866 -1.146 . . . . 73.310000000000002 113.577 -175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 81' ' ' GLU . 23.3 pt-20 -88.04 172.22 9.71 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 124.709 1.204 . . . . 50.539999999999999 109.107 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.2 p -142.06 160.37 40.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.207 -1.405 . . . . 53.439999999999998 107.207 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.32 -177.44 4.24 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.644 -0.873 . . . . 41.200000000000003 108.644 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -108.88 148.75 30.17 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.046 -1.094 . . . . 71.109999999999999 108.046 165.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.6 pt -134.15 162.36 39.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 122.208 1.004 . . . . 70.420000000000002 111.331 -171.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -136.29 109.34 7.7 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.978 1.711 . . . . 54.210000000000001 107.509 -162.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.473 HG12 ' CB ' ' A' ' 71' ' ' ASP . 2.3 p -77.69 156.21 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 124.834 1.334 . . . . 71.209999999999994 108.815 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -152.16 161.66 42.29 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.567 -1.271 . . . . 74.140000000000001 107.567 160.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.0 141.49 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.826 -1.916 . . . . 65.310000000000002 105.826 168.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 59.2 t0 . . . . . 0 C--O 1.256 1.445 0 N-CA-C 107.465 -1.309 . . . . 73.439999999999998 107.465 168.144 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 108.539 -0.912 . . . . 51.509999999999998 108.539 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -75.44 21.07 0.14 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.29 1.436 . . . . 71.030000000000001 112.966 -173.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.69 17.94 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.316 -1.49 . . . . 64.329999999999998 110.853 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 124.9 50.33 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.414 1.086 . . . . 74.120000000000005 112.273 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.609 HG13 ' HG2' ' A' ' 63' ' ' MET . 4.4 m -129.48 162.31 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.661 1.585 . . . . 63.100000000000001 109.592 171.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.28 171.09 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.782 1.633 . . . . 61.200000000000003 109.708 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.17 148.8 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.524 1.129 . . . . 62.32 108.102 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.92 164.96 25.78 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.53 1.932 . . . . 61.329999999999998 107.676 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.25 -2.12 47.05 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 124.892 1.234 . . . . 72.349999999999994 113.676 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.58 147.73 98.68 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 118.758 1.279 . . . . 44.310000000000002 111.666 -161.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.2 169.13 22.26 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.481 2.788 . . . . 75.409999999999997 110.24 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.63 -4.27 11.8 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.707 2.938 . . . . 64.349999999999994 114.173 174.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.29 41.7 3.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.081 1.353 . . . . 74.310000000000002 108.777 -174.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.44 106.36 1.31 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.756 1.646 . . . . 61.119999999999997 110.567 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 m -103.35 174.26 5.94 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.754 1.277 . . . . 73.129999999999995 111.683 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -67.33 -18.94 65.37 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.502 1.121 . . . . 74.319999999999993 112.688 -170.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -74.77 -53.82 8.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.346 -0.983 . . . . 70.209999999999994 108.346 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -58.09 -37.33 74.28 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.269 0.627 . . . . 64.25 110.187 173.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -56.76 17.63 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.92 0.888 . . . . 72.019999999999996 110.257 173.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -61.19 -37.8 84.23 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.692 1.133 . . . . 73.25 110.069 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.39 -8.29 56.29 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.035 0.934 . . . . 71.230000000000004 113.225 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.457 ' CE1' ' HA ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -92.36 -54.49 3.78 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.764 1.226 . . . . 74.439999999999998 110.763 163.724 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -80.02 77.85 6.69 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.988 1.315 . . . . 72.319999999999993 108.656 -169.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.77 -21.47 0.46 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.293 1.437 . . . . 72.439999999999998 112.386 176.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.4 -14.09 61.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.064 0.946 . . . . 74.010000000000005 113.304 -172.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.13 -27.8 35.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.201 0.6 . . . . 71.040000000000006 112.414 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.35 -170.88 17.26 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.19 -0.764 . . . . 65.319999999999993 111.19 -154.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.76 127.94 33.92 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 113.183 0.809 . . . . 62.420000000000002 113.183 -146.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.548 HG22 ' CE1' ' A' ' 57' ' ' PHE . 24.5 t -119.33 130.45 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 125.278 1.431 . . . . 63.130000000000003 108.446 -178.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.2 t -130.63 11.59 5.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.126 0.97 . . . . 65.099999999999994 111.243 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -152.99 139.63 18.83 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.076 2.15 . . . . 71.430000000000007 107.239 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.73 147.78 41.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.839 0.856 . . . . 72.150000000000006 109.471 163.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -162.16 142.38 10.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.946 2.098 . . . . 73.019999999999996 109.194 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.41 -172.35 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 125.849 1.66 . . . . 70.420000000000002 107.089 173.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -150.54 156.2 40.93 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.788 -1.56 . . . . 71.010000000000005 106.788 171.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.318 0.3 OUTLIER 41.45 -85.75 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 129.142 2.977 . . . . 63.450000000000003 112.654 152.152 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.94 174.73 14.52 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.181 0.991 . . . . 73.049999999999997 112.589 169.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.39 -41.33 3.06 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 125.677 1.608 . . . . 35.109999999999999 113.672 159.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.25 169.68 17.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.419 1.61 . . . . 72.409999999999997 110.285 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.55 167.98 35.9 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.578 1.561 . . . . 64.129999999999995 109.46 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.77 119.85 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 118.399 1.1 . . . . 73.150000000000006 110.303 -168.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -113.27 174.23 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.619 -0.882 . . . . 63.439999999999998 108.619 -166.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.39 125.99 11.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.609 1.55 . . . . 73.340000000000003 108.774 164.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.548 ' CE1' HG22 ' A' ' 42' ' ' VAL . 3.2 m-85 -99.48 177.5 5.15 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.251 1.82 . . . . 65.299999999999997 108.874 -175.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.4 -64.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 O-C-N 122.14 -0.35 . . . . 73.340000000000003 110.206 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -133.49 168.53 18.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.358 0.599 . . . . 65.129999999999995 111.637 -169.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -54.18 -33.56 58.39 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 114.353 -1.294 . . . . 71.219999999999999 110.706 176.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -54.16 -64.12 0.93 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.76 0.824 . . . . 65.109999999999999 110.265 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.64 -41.45 79.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.594 1.558 . . . . 73.120000000000005 109.387 -173.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.609 ' HG2' HG13 ' A' ' 18' ' ' VAL . 16.6 tmm? -53.47 -50.59 65.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.599 1.159 . . . . 73.329999999999998 111.198 174.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -66.42 -45.55 79.5 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.156 0.583 . . . . 54.530000000000001 110.602 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -56.7 -38.62 72.53 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.805 0.729 . . . . 74.420000000000002 110.134 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.62 -39.89 74.43 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.643 -0.694 . . . . 63.299999999999997 112.053 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.11 -26.3 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.102 1.319 . . . . 61.43 109.587 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -105.53 4.38 30.4 Favored 'General case' 0 C--N 1.343 0.305 0 N-CA-C 114.779 1.4 . . . . 63.420000000000002 114.779 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -148.4 -9.71 0.37 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.423 1.268 . . . . 72.319999999999993 114.423 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 70' ' ' LEU . 1.8 tm? -130.71 11.88 5.26 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.684 -1.26 . . . . 75.200000000000003 109.928 -167.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.426 ' HB2' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -96.53 159.98 14.64 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 120.679 -1.263 . . . . 74.299999999999997 113.723 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.5 t30 60.58 14.4 4.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.854 1.662 . . . . 75.030000000000001 113.61 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.3 p -76.68 174.99 9.77 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.261 1.824 . . . . 53.140000000000001 112.298 -169.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -67.39 171.0 6.48 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.235 1.014 . . . . 63.409999999999997 110.798 167.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.457 ' HA ' ' CE1' ' A' ' 35' ' ' HIS . 46.4 t80 -145.3 124.35 12.82 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.759 1.624 . . . . 75.439999999999998 112.015 164.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -72.08 126.32 29.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.486 1.115 . . . . 75.010000000000005 109.484 172.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.0 p -98.86 177.75 5.17 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.978 0.894 . . . . 71.349999999999994 110.303 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -76.17 -19.94 57.99 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.811 -0.556 . . . . 73.239999999999995 110.723 167.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -84.79 16.34 3.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.878 1.217 . . . . 64.010000000000005 113.429 -169.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.08 21.51 78.38 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.214 -0.754 . . . . 72.319999999999993 111.214 176.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.29 -175.01 3.91 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.176 1.79 . . . . 63.25 108.224 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 p -143.86 148.61 35.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.34 -0.615 . . . . 52.340000000000003 109.34 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -110.31 -163.69 0.87 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.407 1.083 . . . . 63.030000000000001 109.13 167.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -121.24 164.47 16.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.482 1.113 . . . . 74.150000000000006 108.681 164.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 pt -136.94 165.38 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.944 1.297 . . . . 73.140000000000001 110.547 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -132.29 128.62 38.17 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.625 1.97 . . . . 74.150000000000006 106.56 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 71' ' ' ASP . 1.3 p -94.68 150.72 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.831 1.196 . . . . 33.409999999999997 108.593 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 164.61 34.3 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.83 1.196 . . . . 75.430000000000007 110.067 160.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.534 ' HA ' HG12 ' A' ' 18' ' ' VAL . 30.7 t -61.58 136.13 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 105.277 -2.12 . . . . 75.239999999999995 105.277 163.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.8 t0 . . . . . 0 C--O 1.26 1.615 0 N-CA-C 107.165 -1.421 . . . . 74.239999999999995 107.165 175.708 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 107.459 -1.312 . . . . 72.340000000000003 107.459 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.411 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 5.1 pt-20 -78.8 22.04 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.269 1.828 . . . . 64.549999999999997 113.088 176.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.64 50.82 1.99 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.286 -1.509 . . . . 74.329999999999998 107.046 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -130.06 137.49 50.25 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.667 1.587 . . . . 74.109999999999999 109.772 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.633 HG23 ' HB ' ' A' ' 55' ' ' VAL . 4.2 m -136.04 169.95 19.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 124.793 1.237 . . . . 73.540000000000006 110.952 -176.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.8 144.3 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 125.891 1.676 . . . . 60.439999999999998 106.879 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.69 146.07 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.613 -1.625 . . . . 72.310000000000002 106.613 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -137.42 160.68 38.41 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.114 -0.991 . . . . 64.209999999999994 109.193 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.47 12.96 84.04 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.427 -0.652 . . . . 64.140000000000001 113.491 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 mt -59.27 144.63 83.16 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 117.643 0.722 . . . . 72.409999999999997 109.694 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HB2' ' HD2' ' A' ' 25' ' ' PRO . 51.2 Cg_endo -73.57 171.94 16.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.387 2.058 . . . . 73.329999999999998 108.907 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 24' ' ' PRO . 35.5 Cg_endo -67.12 -15.85 47.51 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 CA-C-N 119.923 1.008 . . . . 42.539999999999999 112.822 -168.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.64 21.02 13.23 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.404 1.482 . . . . 53.439999999999998 111.643 -170.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.47 99.5 1.93 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.207 1.384 . . . . 72.239999999999995 111.688 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -94.87 179.57 5.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.644 1.577 . . . . 62.310000000000002 111.599 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.9 p-90 -62.26 -33.65 75.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.511 1.124 . . . . 74.209999999999994 112.397 -175.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -46.64 63.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.885 -0.783 . . . . 75.140000000000001 108.885 -173.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.71 -33.16 75.31 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.718 -0.658 . . . . 74.040000000000006 109.764 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -53.51 56.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.481 1.037 . . . . 73.319999999999993 109.39 174.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -63.45 -39.4 94.38 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.344 1.058 . . . . 74.400000000000006 110.36 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.19 -12.24 60.25 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.921 1.082 . . . . 64.310000000000002 113.921 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -99.95 -59.27 1.74 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.149 1.78 . . . . 72.310000000000002 112.78 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.522 ' HE2' ' CE1' ' A' ' 57' ' ' PHE . 11.5 ttt -72.83 37.91 0.08 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.777 2.431 . . . . 63.420000000000002 110.579 -171.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -107.38 -9.75 15.93 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 119.087 -2.258 . . . . 74.319999999999993 111.006 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -79.06 -27.96 43.11 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.091 -1.005 . . . . 64.340000000000003 111.997 -163.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.42 -10.97 58.08 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.028 1.331 . . . . 44.200000000000003 112.224 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.48 173.69 13.25 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.495 -1.442 . . . . 51.229999999999997 109.495 -165.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -97.25 153.86 17.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.2 1.0 . . . . 74.299999999999997 111.508 -160.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.457 HG22 ' CE1' ' A' ' 57' ' ' PHE . 64.9 t -125.49 147.76 30.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 125.408 1.483 . . . . 72.530000000000001 107.831 -166.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.8 t -111.41 -53.29 2.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.418 -0.956 . . . . 71.200000000000003 108.418 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -86.45 150.01 24.58 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.505 0.722 . . . . 75.340000000000003 110.155 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.72 125.72 15.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.641 -0.874 . . . . 64.409999999999997 108.641 168.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -156.55 124.44 5.56 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.864 0.84 . . . . 71.140000000000001 110.599 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.28 156.95 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.886 -2.264 . . . . 74.209999999999994 104.886 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -124.64 162.83 23.29 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 127.126 2.17 . . . . 73.129999999999995 107.618 170.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 43.55 -86.6 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 130.768 3.627 . . . . 70.140000000000001 112.612 153.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -170.91 168.87 6.96 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 127.206 2.202 . . . . 71.450000000000003 110.625 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.85 -15.39 32.08 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.757 1.17 . . . . 52.340000000000003 115.432 156.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.77 168.52 22.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 120.022 1.911 . . . . 72.25 108.492 164.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.2 167.66 35.6 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 108.878 -1.689 . . . . 75.319999999999993 108.878 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.12 144.09 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.083 -1.08 . . . . 71.450000000000003 108.083 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.633 ' HB ' HG23 ' A' ' 18' ' ' VAL . 38.3 t -146.62 157.53 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 106.706 -1.59 . . . . 61.210000000000001 106.706 -163.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -143.46 129.51 19.63 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.165 -1.05 . . . . 54.130000000000003 108.165 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.522 ' CE1' ' HE2' ' A' ' 36' ' ' MET . 3.6 m-85 -100.54 170.19 8.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.869 1.668 . . . . 75.340000000000003 109.257 -175.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.0 m -75.85 -31.15 21.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 71.200000000000003 112.315 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 43.2 ttt85 -154.9 155.74 34.85 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.664 -0.495 . . . . 60.509999999999998 109.664 -172.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.445 ' HE2' ' CE ' ' A' ' 63' ' ' MET . 14.6 ttmt -63.18 -26.46 68.81 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 117.723 -1.132 . . . . 73.510000000000005 110.931 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.0 -55.59 15.94 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 120.487 1.494 . . . . 74.230000000000004 109.285 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.15 -47.75 77.61 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.798 1.239 . . . . 72.209999999999994 109.525 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.445 ' CE ' ' HE2' ' A' ' 60' ' ' LYS . 59.7 ttp -54.04 -53.29 55.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.162 0.585 . . . . 61.32 112.047 176.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.7 m -54.33 -48.32 71.52 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.508 1.123 . . . . 64.129999999999995 109.102 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.534 ' CZ ' ' HE3' ' A' ' 69' ' ' LYS . 16.4 t80 -53.59 -38.98 64.47 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.315 1.046 . . . . 75.219999999999999 111.641 -175.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.04 -33.04 75.09 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.75 0.82 . . . . 72.319999999999993 110.832 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.4 t -70.09 -14.15 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 O-C-N 120.532 -1.355 . . . . 72.310000000000002 110.813 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -108.41 -37.73 5.89 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.04 -1.037 . . . . 72.319999999999993 111.469 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.534 ' HE3' ' CZ ' ' A' ' 65' ' ' TYR . 3.6 mptp? -108.87 -16.9 14.06 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.278 1.031 . . . . 71.040000000000006 111.743 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.9 7.53 8.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.24 -0.886 . . . . 74.439999999999998 111.17 -164.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.26 153.72 19.38 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 121.088 1.767 . . . . 64.439999999999998 111.164 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 t30 57.5 40.29 27.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.953 1.701 . . . . 70.099999999999994 111.591 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.4 p -103.39 -179.22 3.89 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.883 2.073 . . . . 71.019999999999996 111.287 -169.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.13 158.63 15.38 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.436 1.016 . . . . 61.439999999999998 110.305 171.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -137.26 146.22 44.48 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 125.588 1.555 . . . . 61.340000000000003 110.417 167.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -112.95 118.0 33.64 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.545 1.538 . . . . 75.030000000000001 110.908 -173.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 m -78.3 156.5 29.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 119.079 0.854 . . . . 62.009999999999998 109.3 167.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -62.61 -13.14 28.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.36 0.874 . . . . 75.299999999999997 113.36 168.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.87 12.23 0.72 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.944 1.697 . . . . 64.109999999999999 112.104 172.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.85 26.33 74.67 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 121.118 -0.989 . . . . 65.319999999999993 111.258 170.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -139.14 160.97 38.55 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 125.808 1.643 . . . . 61.43 108.684 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.8 p -145.84 149.81 34.98 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.154 -1.054 . . . . 74.030000000000001 108.154 -168.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.55 169.17 15.34 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.973 -1.121 . . . . 65.430000000000007 107.973 166.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -82.81 151.81 25.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.984 -1.117 . . . . 64.239999999999995 107.984 168.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.7 pt -125.16 166.27 21.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.418 1.487 . . . . 75.140000000000001 109.093 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -123.75 144.07 49.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.373 -2.084 . . . . 71.349999999999994 105.373 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.8 t -127.88 124.26 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.758 -1.571 . . . . 55.530000000000001 106.758 -172.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.38 153.33 51.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.446 1.098 . . . . 73.230000000000004 108.261 -170.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.423 ' HA ' HG12 ' A' ' 18' ' ' VAL . 12.1 t -71.34 153.18 8.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 106.08 -1.822 . . . . 54.450000000000003 106.08 162.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.881 1.272 . . . . 61.509999999999998 111.295 170.884 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 109.051 -0.722 . . . . 53.520000000000003 109.051 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -65.34 11.92 0.06 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.504 2.322 . . . . 52.530000000000001 114.802 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.72 26.7 7.07 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 119.729 -1.857 . . . . 71.340000000000003 109.199 -178.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -109.26 133.56 52.88 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.664 1.185 . . . . 71.230000000000004 109.107 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -129.32 168.81 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 126.009 1.724 . . . . 73.340000000000003 109.533 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.92 154.3 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.934 1.694 . . . . 61.119999999999997 106.809 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.3 t -130.12 152.07 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.229 -1.397 . . . . 42.130000000000003 107.229 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.6 154.97 48.71 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.268 1.027 . . . . 73.120000000000005 108.733 -175.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.75 6.4 52.53 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 117.905 -1.497 . . . . 34.009999999999998 114.176 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.46 149.87 91.06 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 120.037 1.918 . . . . 62.219999999999999 112.412 -160.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.07 170.03 13.88 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.966 3.111 . . . . 75.129999999999995 111.022 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.29 -8.3 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.675 2.25 . . . . 62.130000000000003 113.833 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.35 52.05 1.27 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.345 1.458 . . . . 72.430000000000007 109.204 -176.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.03 130.6 10.24 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 108.626 -1.79 . . . . 65.219999999999999 108.626 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -116.42 163.62 15.77 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.811 0.845 . . . . 71.230000000000004 111.221 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.3 p-90 -66.37 -23.96 66.42 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.838 0.681 . . . . 73.230000000000004 112.838 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -56.04 14.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.883 -0.784 . . . . 74.040000000000006 108.883 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -60.17 -35.61 75.73 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.847 0.859 . . . . 73.25 109.656 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -58.36 8.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 117.28 -1.343 . . . . 71.150000000000006 110.014 174.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -68.67 -37.62 79.74 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 120.066 1.303 . . . . 73.239999999999995 110.763 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.02 -24.78 64.77 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.562 1.545 . . . . 73.409999999999997 112.874 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -95.22 -46.64 6.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.636 0.374 . . . . 75.120000000000005 111.061 170.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.6 ttt -77.02 32.31 0.14 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.336 1.454 . . . . 75.120000000000005 113.086 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.2 -5.28 14.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 121.03 1.741 . . . . 63.140000000000001 114.308 171.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -61.27 -31.16 70.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.099 1.318 . . . . 62.450000000000003 113.874 -173.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.26 -0.88 13.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.839 1.256 . . . . 73.329999999999998 114.33 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.87 -100.97 0.21 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 108.153 -1.979 . . . . 71.400000000000006 108.153 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -154.11 163.57 39.88 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.021 0.928 . . . . 72.299999999999997 108.999 176.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.77 135.93 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.518 2.327 . . . . 73.310000000000002 109.822 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.3 t -90.81 -56.17 3.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.846 -0.798 . . . . 74.329999999999998 108.846 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -96.01 146.99 24.16 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.795 1.238 . . . . 73.310000000000002 109.588 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.55 136.18 21.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.846 -1.168 . . . . 45.200000000000003 107.846 168.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -148.86 131.2 15.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.436 -0.95 . . . . 74.310000000000002 108.436 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 91.9 t -140.75 140.73 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.086 -2.19 . . . . 71.0 105.086 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -77.32 -164.08 0.44 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.985 1.714 . . . . 71.329999999999998 109.996 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -44.4 -50.94 9.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.464 -1.698 . . . . 72.409999999999997 112.078 158.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -179.67 -179.11 0.49 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.195 1.398 . . . . 61.149999999999999 112.391 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.3 -34.39 3.46 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 128.226 2.822 . . . . 42.530000000000001 114.407 166.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.26 -179.05 6.75 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.772 1.286 . . . . 63.030000000000001 108.529 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.74 171.71 40.26 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 125.246 1.403 . . . . 63.299999999999997 109.67 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -141.75 135.11 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.738 0.78 . . . . 43.109999999999999 108.982 -173.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.52 145.13 25.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 108.405 -0.961 . . . . 73.319999999999993 108.405 -156.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -133.83 106.54 7.37 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.543 -1.651 . . . . 64.140000000000001 106.543 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.89 168.1 16.38 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 130.258 3.423 . . . . 71.400000000000006 109.876 -176.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -72.47 -42.3 64.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 121.305 -0.872 . . . . 73.120000000000005 111.573 -171.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -152.88 160.24 43.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.961 0.8 . . . . 61.200000000000003 109.462 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -63.96 -19.31 65.04 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.492 -1.242 . . . . 71.200000000000003 111.025 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -52.97 -65.95 0.47 Allowed 'General case' 0 C--N 1.345 0.407 0 C-N-CA 125.581 1.553 . . . . 62.43 108.684 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -75.33 -36.18 61.08 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.751 1.62 . . . . 73.299999999999997 108.836 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.428 ' SD ' HG13 ' A' ' 18' ' ' VAL . 39.2 ttp -51.33 -52.27 46.87 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.881 -0.414 . . . . 74.129999999999995 109.881 169.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.7 m -68.42 -12.16 60.74 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.939 -1.101 . . . . 64.140000000000001 113.359 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -79.95 -35.57 37.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 122.539 2.427 . . . . 74.239999999999995 110.083 169.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.65 -35.39 80.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.094 0.958 . . . . 75.200000000000003 110.198 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.73 -17.45 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.651 0.78 . . . . 73.0 111.163 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -120.24 -16.88 8.41 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.49 -1.381 . . . . 74.200000000000003 112.059 -163.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -132.35 -19.06 2.49 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.24 1.416 . . . . 64.230000000000004 113.807 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.23 11.99 16.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 120.081 1.31 . . . . 75.409999999999997 110.356 -168.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.48 161.44 13.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.893 1.224 . . . . 73.340000000000003 112.437 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.0 t30 56.96 17.86 3.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.523 3.129 . . . . 73.409999999999997 114.177 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.6 p -71.74 175.15 5.95 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.817 2.847 . . . . 71.120000000000005 112.731 -172.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.48 169.69 15.23 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.709 1.604 . . . . 71.129999999999995 109.656 171.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -150.58 135.16 17.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.972 1.709 . . . . 71.239999999999995 109.46 170.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -82.69 119.14 23.92 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 118.652 0.66 . . . . 72.25 109.977 176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 t -81.05 154.57 26.78 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.3 -1.0 . . . . 74.319999999999993 108.3 165.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -62.45 -16.68 56.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.892 -0.575 . . . . 63.009999999999998 111.644 164.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.58 17.41 0.11 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.248 1.419 . . . . 74.349999999999994 112.413 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.26 21.18 71.92 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 124.31 0.957 . . . . 71.329999999999998 112.496 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.93 175.4 10.46 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.327 1.851 . . . . 72.420000000000002 108.412 -172.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.0 p -137.07 148.86 47.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.689 -0.856 . . . . 74.239999999999995 108.689 -174.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.01 176.74 7.82 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.776 -1.194 . . . . 74.030000000000001 107.776 172.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -102.25 154.74 18.75 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.721 0.691 . . . . 74.150000000000006 109.932 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 pt -133.34 160.39 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 O-C-N 121.924 -0.485 . . . . 55.140000000000001 110.457 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -131.65 106.98 8.51 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.101 1.36 . . . . 53.229999999999997 107.697 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.53 154.46 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 124.219 0.949 . . . . 74.340000000000003 108.83 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -145.82 173.36 12.18 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.708 2.403 . . . . 72.010000000000005 107.505 162.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.541 ' HA ' HG12 ' A' ' 18' ' ' VAL . 58.8 t -97.81 151.18 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 125.624 1.57 . . . . 72.439999999999998 107.742 173.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.381 1.072 . . . . 40.119999999999997 108.788 167.133 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.446 -0.661 0 CA-C-O 121.038 0.447 . . . . 43.219999999999999 109.947 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.41 30.96 0.06 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.379 1.471 . . . . 71.310000000000002 113.093 -167.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.84 20.58 3.28 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.751 2.02 . . . . 74.049999999999997 108.754 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.09 139.25 47.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.768 1.227 . . . . 74.319999999999993 111.907 -171.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.464 HG23 ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -147.94 170.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 126.078 1.751 . . . . 44.219999999999999 109.633 -172.751 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 19.6 m -136.14 174.31 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.014 1.726 . . . . 71.439999999999998 108.386 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -137.26 162.35 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.024 1.329 . . . . 72.25 108.297 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.75 165.07 37.17 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.458 -1.401 . . . . 75.310000000000002 108.424 -174.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.84 9.37 86.95 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 119.156 0.889 . . . . 74.099999999999994 113.239 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.19 150.84 69.77 Favored Pre-proline 0 N--CA 1.445 -0.681 0 CA-C-N 119.097 1.448 . . . . 75.400000000000006 112.194 -175.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.54 161.07 36.76 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.358 2.705 . . . . 75.340000000000003 111.516 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.44 -34.22 44.13 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.233 1.955 . . . . 63.5 111.563 173.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.81 60.51 0.71 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 122.488 1.137 . . . . 71.109999999999999 110.549 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -132.3 159.53 23.39 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 107.565 -2.214 . . . . 71.409999999999997 107.565 159.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m -128.39 -175.86 3.64 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.295 1.038 . . . . 63.009999999999998 109.059 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -62.08 -21.39 64.92 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.958 1.303 . . . . 72.329999999999998 111.057 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -57.24 11.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.929 -1.137 . . . . 73.129999999999995 107.929 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.82 -32.38 73.88 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.394 0.434 . . . . 71.0 110.894 175.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.39 -54.9 37.97 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.867 0.758 . . . . 61.240000000000002 110.303 176.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -64.28 -33.61 76.23 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.553 0.615 . . . . 75.209999999999994 110.827 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -74.5 -25.62 59.48 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.834 1.254 . . . . 62.420000000000002 113.526 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -102.26 -41.43 6.37 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.599 1.56 . . . . 75.439999999999998 111.545 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.3 ttt -81.59 53.39 2.1 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.334 -1.479 . . . . 74.319999999999993 109.884 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.29 47.5 2.48 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.332 1.453 . . . . 75.010000000000005 110.604 -170.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -135.65 -5.77 2.22 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.258 1.207 . . . . 75.239999999999995 114.258 -172.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.94 45.88 1.99 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.792 1.637 . . . . 63.43 110.726 -170.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.11 -107.32 1.95 Allowed Glycine 0 N--CA 1.47 0.967 0 N-CA-C 108.581 -1.808 . . . . 60.450000000000003 108.581 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.9 167.09 25.72 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.426 1.613 . . . . 64.239999999999995 111.761 158.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.01 135.73 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.505 1.522 . . . . 72.310000000000002 109.775 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.9 t -113.88 -24.06 9.3 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.53 0.567 . . . . 63.210000000000001 112.53 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -123.66 143.35 50.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.816 1.189 . . . . 53.219999999999999 109.263 -173.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.61 133.96 15.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.228 0.922 . . . . 54.420000000000002 110.688 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -149.48 131.21 15.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.17 1.388 . . . . 75.040000000000006 108.881 -177.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.93 171.31 16.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.946 1.298 . . . . 62.439999999999998 109.137 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -154.3 -177.89 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.115 0.966 . . . . 62.119999999999997 109.768 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -81.58 40.1 0.57 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.88 2.072 . . . . 55.100000000000001 111.833 -164.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -117.62 -25.67 6.83 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.836 0.854 . . . . 73.129999999999995 112.309 -171.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.38 6.48 64.42 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.452 -0.659 . . . . 72.129999999999995 111.452 -162.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -119.26 165.58 14.07 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.989 1.394 . . . . 74.040000000000006 110.448 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.75 174.61 28.34 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.64 -1.784 . . . . 34.210000000000001 108.64 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 70.1 t -146.69 134.53 15.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.619 1.568 . . . . 74.120000000000005 107.964 -173.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HB ' HG23 ' A' ' 18' ' ' VAL . 5.4 t -132.64 164.06 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.046 -0.724 . . . . 73.010000000000005 109.046 -169.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -142.5 124.51 15.29 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 120.433 -1.417 . . . . 73.049999999999997 107.45 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -94.11 174.64 7.05 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.604 1.562 . . . . 75.040000000000006 108.066 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.2 -64.01 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 118.69 -0.672 . . . . 54.149999999999999 110.901 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -139.85 172.13 13.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.628 1.104 . . . . 75.409999999999997 109.865 -166.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -62.85 -29.57 70.84 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.058 -1.026 . . . . 74.439999999999998 110.092 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -52.7 -63.43 1.15 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.862 0.865 . . . . 62.420000000000002 109.497 173.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.1 -47.99 83.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.771 1.229 . . . . 63.43 108.336 -175.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -57.32 -53.19 60.93 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.208 0.603 . . . . 60.420000000000002 110.914 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.4 m -59.3 -41.03 88.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.284 0.634 . . . . 44.340000000000003 110.282 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -56.96 -33.16 66.77 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 118.898 0.772 . . . . 74.129999999999995 111.741 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.61 83.16 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.392 -0.818 . . . . 73.209999999999994 109.971 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -71.81 -7.66 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 121.349 -0.845 . . . . 75.040000000000006 110.868 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.4 mtt180 -109.34 -31.96 7.35 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.855 0.862 . . . . 72.109999999999999 113.234 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -124.87 -6.16 7.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.843 1.257 . . . . 75.030000000000001 113.686 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.64 21.85 3.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.12 1.327 . . . . 64.129999999999995 110.86 -167.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.44 153.85 30.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.666 1.586 . . . . 75.450000000000003 109.777 170.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 62.27 11.35 4.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.572 2.749 . . . . 62.530000000000001 113.62 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.0 p -75.79 172.23 13.01 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.309 -0.869 . . . . 73.510000000000005 110.526 -172.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.469 ' HE3' ' OG1' ' A' ' 82' ' ' THR . 17.8 tttp -78.6 168.7 19.37 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 122.038 -0.414 . . . . 42.200000000000003 109.973 166.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -147.43 159.72 43.39 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 125.208 1.403 . . . . 73.040000000000006 111.866 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -116.46 148.04 41.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.747 1.158 . . . . 64.439999999999998 111.647 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.23 153.81 45.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.86 1.664 . . . . 74.099999999999994 109.284 -174.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -70.67 -12.54 61.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.175 1.176 . . . . 75.129999999999995 114.175 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.95 1.4 7.26 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.395 1.078 . . . . 75.400000000000006 112.728 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.26 9.1 63.79 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 124.08 0.848 . . . . 72.340000000000003 112.084 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -128.0 168.31 15.47 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 112.793 0.664 . . . . 64.430000000000007 112.793 -165.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.469 ' OG1' ' HE3' ' A' ' 74' ' ' LYS . 57.2 p -141.65 117.41 10.41 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.148 -0.933 . . . . 44.219999999999999 111.053 -175.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.83 173.19 7.8 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.584 1.953 . . . . 53.420000000000002 108.491 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -93.32 152.39 19.18 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.615 1.098 . . . . 72.420000000000002 108.478 159.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.5 pt -122.2 170.61 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.936 1.351 . . . . 74.109999999999999 108.839 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -125.33 143.19 51.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.751 -1.944 . . . . 74.219999999999999 105.751 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -110.8 146.34 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.325 -1.361 . . . . 55.530000000000001 107.325 168.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -142.98 159.94 41.29 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 122.109 -0.37 . . . . 62.450000000000003 111.156 163.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.4 t -61.16 138.96 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.603 -1.629 . . . . 61.32 106.603 165.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 43.1 t0 . . . . . 0 C--O 1.259 1.577 0 N-CA-C 105.257 -2.127 . . . . 75.239999999999995 105.257 166.22 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 108.13 -1.063 . . . . 73.310000000000002 108.13 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 31.44 0.07 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.992 2.117 . . . . 52.340000000000003 113.272 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -132.7 24.28 4.34 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 119.334 -2.104 . . . . 73.150000000000006 110.317 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.0 139.35 47.57 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.346 -1.471 . . . . 71.349999999999994 110.704 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.43 159.99 22.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 126.455 1.902 . . . . 72.340000000000003 108.881 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 95.4 t -132.8 140.85 46.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 127.232 2.213 . . . . 53.119999999999997 106.147 -170.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.424 ' HB ' HD11 ' A' ' 23' ' ' LEU . 24.9 t -104.73 145.37 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.782 1.633 . . . . 70.439999999999998 108.414 177.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -131.97 160.62 35.27 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.779 -1.201 . . . . 74.420000000000002 109.197 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.02 5.58 67.83 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.695 1.141 . . . . 73.430000000000007 113.866 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.426 HD13 ' CG2' ' A' ' 47' ' ' VAL . 5.2 mt -64.65 151.49 92.03 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.133 0.973 . . . . 65.450000000000003 112.304 -165.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -76.21 161.29 35.38 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.93 2.42 . . . . 50.119999999999997 110.662 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -67.55 -39.17 12.74 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.4 2.733 . . . . 50.149999999999999 110.567 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.0 p -67.19 -0.3 3.29 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.65 1.98 . . . . 74.430000000000007 112.303 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.42 121.42 7.08 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 126.078 1.799 . . . . 50.439999999999998 109.416 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.769 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -142.07 -179.6 6.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.855 1.262 . . . . 71.209999999999994 108.482 171.367 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -62.01 -29.44 70.27 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.181 -0.914 . . . . 71.439999999999998 111.974 -158.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -58.69 -62.1 2.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.809 -1.182 . . . . 63.509999999999998 107.809 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.71 -47.11 74.13 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.589 0.755 . . . . 73.430000000000007 109.867 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.03 -45.03 87.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.954 1.702 . . . . 64.209999999999994 111.537 -176.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -69.36 -30.25 68.22 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 72.120000000000005 111.15 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -92.52 1.44 57.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.565 1.146 . . . . 53.329999999999998 112.778 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -121.46 -56.55 1.88 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.664 1.586 . . . . 64.329999999999998 112.285 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.5 ttt -75.01 79.72 2.2 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.378 -1.342 . . . . 74.5 107.378 170.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.39 -7.71 0.78 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.423 1.889 . . . . 71.200000000000003 111.873 173.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.59 -3.08 25.71 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.585 0.63 . . . . 72.140000000000001 111.88 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.38 -0.41 41.06 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 119.322 0.965 . . . . 61.420000000000002 112.913 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.27 -156.52 15.58 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.444 -1.062 . . . . 50.140000000000001 110.444 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.37 114.91 21.15 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.32 1.057 . . . . 53.43 110.694 -163.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.3 t -101.9 151.52 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.458 -1.312 . . . . 73.200000000000003 107.458 171.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.7 t -131.37 0.93 4.11 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.033 0.753 . . . . 74.519999999999996 113.033 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -161.81 144.82 12.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.7 1.6 . . . . 63.439999999999998 107.7 -169.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.61 139.44 22.92 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.8 -0.815 . . . . 63.219999999999999 108.8 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -155.51 107.48 2.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.508 1.049 . . . . 72.109999999999999 109.202 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.769 HG13 ' HA ' ' A' ' 28' ' ' SER . 1.3 p -135.71 144.82 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.228 1.811 . . . . 70.519999999999996 111.976 -171.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -135.27 156.57 48.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.429 1.092 . . . . 74.150000000000006 109.697 -164.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -81.37 35.38 0.39 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.996 1.318 . . . . 70.140000000000001 111.53 -169.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -115.42 9.58 15.57 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.959 1.703 . . . . 73.239999999999995 108.486 173.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.26 23.98 60.05 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 125.672 1.606 . . . . 73.439999999999998 112.886 174.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.96 162.91 34.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.28 1.04 . . . . 64.129999999999995 108.498 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.26 160.11 32.7 Favored Glycine 0 C--O 1.224 -0.469 0 N-CA-C 109.13 -1.588 . . . . 62.450000000000003 109.13 -169.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 88.7 t -132.53 155.36 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 125.595 1.558 . . . . 51.340000000000003 108.351 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.19 170.73 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 127.415 2.286 . . . . 53.420000000000002 106.032 -174.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -144.41 124.28 13.46 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.12 -1.808 . . . . 74.540000000000006 106.12 167.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -94.29 166.05 12.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.408 -0.96 . . . . 74.450000000000003 108.408 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -73.08 -37.86 54.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.378 -1.283 . . . . 51.43 111.835 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.4 ttm105 -154.04 156.69 37.81 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.328 0.651 . . . . 64.510000000000005 109.4 -168.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -61.12 -27.99 68.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 117.639 -1.172 . . . . 72.200000000000003 111.567 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.12 -50.32 74.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.839 1.2 . . . . 74.239999999999995 110.749 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -77.7 -41.58 37.46 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.539 -0.912 . . . . 74.299999999999997 108.539 -175.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -47.77 -50.86 24.41 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.615 1.166 . . . . 71.530000000000001 111.237 169.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.1 m -64.9 -47.47 77.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.369 -0.824 . . . . 70.540000000000006 111.216 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -54.84 -32.75 60.91 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.559 1.072 . . . . 74.310000000000002 111.324 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.34 -42.29 86.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.448 0.567 . . . . 51.0 111.681 178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.89 -25.21 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.281 -0.887 . . . . 72.129999999999995 110.248 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -79.49 -41.84 26.57 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 117.519 -1.229 . . . . 71.299999999999997 112.553 -177.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -124.27 -16.98 6.26 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.186 1.18 . . . . 70.310000000000002 114.186 -170.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.32 1.44 32.77 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.779 1.232 . . . . 64.430000000000007 110.151 -171.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.11 147.97 25.08 Favored 'General case' 0 CA--C 1.527 0.078 0 O-C-N 120.27 -1.519 . . . . 65.319999999999993 113.65 -172.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 69.68 11.15 7.83 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.034 2.134 . . . . 64.200000000000003 111.531 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.4 p -83.97 163.07 20.2 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.032 1.333 . . . . 71.299999999999997 110.161 -169.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -77.81 156.92 30.18 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 120.892 -1.13 . . . . 71.430000000000007 109.706 168.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -107.72 -175.73 2.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.215 2.206 . . . . 73.120000000000005 110.768 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.1 mtt-85 -146.65 146.54 30.42 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 124.85 1.26 . . . . 73.200000000000003 107.681 169.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 p -142.3 159.98 41.15 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.794 1.238 . . . . 65.439999999999998 110.537 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -73.76 37.9 0.1 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.218 1.807 . . . . 72.420000000000002 113.551 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.4 16.43 4.48 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.557 2.343 . . . . 71.150000000000006 110.617 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.39 29.41 69.05 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 124.284 0.945 . . . . 64.230000000000004 112.227 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.52 173.9 11.17 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 125.82 1.648 . . . . 71.129999999999995 111.002 -173.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.7 p -144.8 147.72 33.21 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.255 -1.017 . . . . 73.310000000000002 108.255 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.02 176.43 5.3 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.504 1.122 . . . . 74.409999999999997 108.495 161.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -109.0 150.15 28.18 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 120.256 1.389 . . . . 74.319999999999993 110.45 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 pt -124.91 158.76 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 122.08 0.943 . . . . 71.209999999999994 112.207 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.0 mmm-85 -117.27 136.91 52.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.46 -1.681 . . . . 74.239999999999995 106.46 165.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 89.7 t -108.4 131.12 59.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.053 -1.832 . . . . 64.310000000000002 106.053 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -138.33 168.06 20.56 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.182 1.393 . . . . 73.230000000000004 108.332 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.4 t -87.82 161.34 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.046 -1.464 . . . . 74.549999999999997 107.046 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.1 t0 . . . . . 0 C--O 1.252 1.197 0 N-CA-C 104.368 -2.456 . . . . 73.219999999999999 104.368 156.818 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 104.2 -2.519 . . . . 73.400000000000006 104.2 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -74.1 38.84 0.11 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.52 0.728 . . . . 74.209999999999994 111.748 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.6 28.27 2.71 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 119.52 -1.987 . . . . 71.209999999999994 110.053 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -130.2 154.85 47.13 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.954 -1.091 . . . . 72.310000000000002 112.704 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.525 HG23 ' HB ' ' A' ' 55' ' ' VAL . 2.1 m -144.01 168.49 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.296 1.438 . . . . 61.0 112.32 -171.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.24 136.09 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.638 -1.615 . . . . 43.329999999999998 106.638 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 98.3 t -105.26 150.7 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.63 -1.248 . . . . 41.140000000000001 107.63 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 p -150.17 153.09 35.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.443 1.019 . . . . 73.310000000000002 109.714 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.11 6.97 38.89 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.301 1.429 . . . . 64.310000000000002 113.311 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 mt -65.91 156.44 83.73 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.347 1.059 . . . . 74.219999999999999 113.171 -164.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.09 175.7 8.03 Favored 'Trans proline' 0 CA--C 1.537 0.674 1 C-N-CA 125.493 4.129 . . . . 64.519999999999996 113.294 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.31 -7.96 15.43 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.766 2.977 . . . . 62.130000000000003 115.238 172.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 t -148.81 56.6 1.02 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 120.531 1.514 . . . . 72.230000000000004 110.296 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.38 79.5 0.58 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.319 -1.113 . . . . 74.109999999999999 110.319 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -74.8 155.46 37.57 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 119.395 -0.922 . . . . 44.420000000000002 110.32 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -60.08 -25.38 65.35 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.932 -1.105 . . . . 75.540000000000006 112.205 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -59.3 -46.03 89.69 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.59 1.556 . . . . 75.409999999999997 109.579 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -71.14 -37.5 72.26 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.032 0.933 . . . . 63.399999999999999 109.074 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.418 HD22 ' ND1' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -56.65 -52.16 65.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.863 0.756 . . . . 62.399999999999999 111.164 177.585 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -62.06 -39.67 93.2 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.154 -0.684 . . . . 72.319999999999993 109.154 -174.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.97 -17.38 64.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.569 1.548 . . . . 54.0 112.066 175.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.418 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -91.84 -45.03 8.6 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 104.817 -2.29 . . . . 74.530000000000001 104.817 -174.23 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.43 ' SD ' HG11 ' A' ' 55' ' ' VAL . 7.8 ttt -82.26 -14.1 55.99 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.238 0.459 . . . . 63.439999999999998 112.238 -150.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.6 -0.91 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 130.77 3.628 . . . . 73.200000000000003 116.446 174.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -81.65 -16.14 52.33 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 120.704 -1.247 . . . . 70.099999999999994 112.315 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.13 1.74 57.03 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.078 0.77 . . . . 44.310000000000002 113.078 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.19 -161.15 15.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.027 -2.029 . . . . 74.129999999999995 108.027 -157.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.83 145.3 32.84 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.593 0.357 . . . . 72.239999999999995 111.002 -165.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 t -130.33 131.01 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.397 -2.075 . . . . 72.340000000000003 105.397 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.5 t -116.69 5.61 13.2 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.748 0.647 . . . . 70.439999999999998 112.748 -167.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -162.94 158.21 22.09 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 126.435 1.894 . . . . 73.099999999999994 106.737 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.04 150.04 34.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 119.579 1.081 . . . . 73.310000000000002 108.396 163.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -158.89 129.7 6.1 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 117.965 0.348 . . . . 64.319999999999993 110.721 167.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -128.8 114.44 33.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.868 -2.271 . . . . 73.430000000000007 104.868 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -77.52 153.8 33.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.081 0.952 . . . . 74.409999999999997 109.143 161.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 43.63 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 130.948 3.699 . . . . 74.430000000000007 110.92 168.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 178.97 178.08 0.47 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.317 1.847 . . . . 71.5 111.233 155.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.78 -18.62 56.96 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.867 1.222 . . . . 64.140000000000001 114.202 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 m -148.97 -179.03 6.7 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.671 1.589 . . . . 74.430000000000007 108.719 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.9 164.21 35.52 Favored Glycine 0 N--CA 1.465 0.621 0 O-C-N 120.385 -1.447 . . . . 63.200000000000003 111.164 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.36 131.98 51.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 124.119 0.968 . . . . 75.409999999999997 108.518 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.525 ' HB ' HG23 ' A' ' 18' ' ' VAL . 67.6 t -144.0 154.98 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.328 -1.36 . . . . 71.400000000000006 107.328 -160.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -139.07 131.95 29.3 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.763 -1.569 . . . . 72.099999999999994 106.763 -172.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -101.8 -178.11 3.62 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.703 1.201 . . . . 70.299999999999997 108.056 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.47 -51.78 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.809 -1.182 . . . . 73.140000000000001 107.809 170.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.47 163.49 32.8 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 114.507 1.299 . . . . 71.099999999999994 114.507 -164.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -61.32 -33.18 73.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.586 -1.643 . . . . 65.099999999999994 112.076 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.87 -56.63 13.91 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.522 -0.918 . . . . 70.109999999999999 108.522 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -61.52 -45.31 94.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.533 0.733 . . . . 64.129999999999995 109.58 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -51.05 -55.43 17.58 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.772 -0.58 . . . . 73.409999999999997 112.259 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.1 m -57.11 -48.92 77.45 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.586 1.084 . . . . 74.310000000000002 110.347 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -55.16 -33.3 62.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.206 1.002 . . . . 74.310000000000002 111.494 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.11 -44.78 75.26 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.623 1.169 . . . . 73.310000000000002 110.498 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.78 -10.18 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.252 -0.905 . . . . 73.319999999999993 110.884 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -104.65 -31.95 9.14 Favored 'General case' 0 CA--C 1.527 0.089 0 O-C-N 121.413 -0.804 . . . . 63.020000000000003 110.914 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.03 -0.29 6.53 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.364 1.246 . . . . 72.540000000000006 114.364 -169.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -133.69 -4.87 2.87 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.284 1.402 . . . . 52.140000000000001 111.873 -172.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.54 ' HB2' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -83.04 161.17 21.78 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.356 -1.465 . . . . 73.329999999999998 111.998 165.747 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.8 t30 70.89 20.2 5.5 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.776 2.031 . . . . 74.530000000000001 112.26 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.6 p -85.35 142.18 29.5 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.06 -0.719 . . . . 72.5 109.06 -169.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -77.77 101.31 6.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.103 -1.443 . . . . 73.430000000000007 107.103 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -85.9 141.69 29.39 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.935 1.294 . . . . 72.140000000000001 113.134 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HA ' HG22 ' A' ' 82' ' ' THR . 30.5 ptt180 -99.42 139.24 35.36 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.66 1.984 . . . . 72.519999999999996 110.643 -176.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.4 p -108.89 174.25 5.95 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.137 0.975 . . . . 42.119999999999997 109.609 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -92.34 18.18 8.73 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.841 -1.072 . . . . 75.200000000000003 111.095 165.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -98.8 18.11 17.8 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.537 -1.352 . . . . 63.100000000000001 110.599 169.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.02 7.1 75.6 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 126.406 1.955 . . . . 63.299999999999997 112.845 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -176.66 4.13 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 117.627 0.714 . . . . 64.310000000000002 110.209 -166.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 76' ' ' ARG . 48.0 p -141.76 138.11 32.07 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 106.65 -1.611 . . . . 73.540000000000006 106.65 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.39 135.23 47.8 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.989 1.268 . . . . 64.109999999999999 109.326 172.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -69.93 156.51 38.99 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.982 0.81 . . . . 74.400000000000006 110.296 -168.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.96 166.46 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.711 0.767 . . . . 72.420000000000002 111.146 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -127.43 152.51 47.43 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.666 -1.235 . . . . 64.140000000000001 107.666 159.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 71' ' ' ASP . 2.6 p -109.79 149.59 12.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.758 1.223 . . . . 72.200000000000003 109.142 177.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.92 166.69 23.96 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.661 1.184 . . . . 72.109999999999999 108.803 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.9 t -81.69 144.16 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.689 -1.967 . . . . 72.010000000000005 105.689 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 C--O 1.256 1.395 0 CA-C-O 117.853 -1.07 . . . . 73.209999999999994 109.726 169.517 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 108.597 -0.89 . . . . 70.099999999999994 108.597 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -72.62 25.79 0.06 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.418 2.287 . . . . 65.340000000000003 113.137 -170.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.52 14.49 2.96 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.075 -1.641 . . . . 70.5 110.292 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -95.78 145.07 25.62 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.644 -1.285 . . . . 65.530000000000001 110.676 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.0 m -133.75 160.26 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.834 -0.802 . . . . 73.540000000000006 108.834 164.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.97 149.0 27.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 106.557 -1.646 . . . . 72.540000000000006 106.557 164.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.01 153.65 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.705 -1.591 . . . . 53.399999999999999 106.705 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -144.45 162.36 36.71 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 120.119 -1.613 . . . . 43.43 112.244 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.14 12.52 80.76 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.733 1.635 . . . . 73.420000000000002 112.71 -177.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mt -63.89 144.3 98.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.023 -0.989 . . . . 54.020000000000003 111.789 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -71.88 165.13 33.49 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.238 3.292 . . . . 63.219999999999999 113.583 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.29 -32.89 25.39 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.978 2.452 . . . . 51.109999999999999 113.427 -172.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -97.85 41.39 1.13 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.991 0.916 . . . . 63.240000000000002 109.381 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.35 124.48 8.25 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 108.179 -1.968 . . . . 72.140000000000001 108.179 173.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.6 m -125.02 169.67 11.9 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.24 1.416 . . . . 73.150000000000006 109.48 167.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -61.95 -20.14 63.51 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 113.511 0.93 . . . . 73.230000000000004 113.511 -174.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -60.84 2.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.071 -0.966 . . . . 72.510000000000005 108.548 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.08 -34.78 73.91 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.837 0.744 . . . . 62.329999999999998 109.171 177.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.4 -53.43 36.72 Favored 'General case' 0 C--N 1.345 0.397 0 O-C-N 121.452 -0.78 . . . . 64.549999999999997 111.149 173.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.49 ' HE3' ' HB ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -80.18 -20.46 44.72 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.762 1.165 . . . . 63.43 112.343 -176.856 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.45 -29.92 66.62 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.645 -0.66 . . . . 70.349999999999994 110.911 169.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -93.52 -51.48 4.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.035 1.334 . . . . 72.129999999999995 110.131 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.482 ' HG3' HD11 ' A' ' 70' ' ' LEU . 4.8 ttt -79.92 66.8 5.51 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 128.546 2.738 . . . . 74.25 110.382 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.66 -1.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 120.709 -1.244 . . . . 72.129999999999995 113.712 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.06 -44.94 94.42 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 119.572 1.078 . . . . 65.150000000000006 108.89 168.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.05 16.65 0.22 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.935 2.494 . . . . 70.209999999999994 114.293 -171.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.22 -147.9 16.66 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.282 -0.727 . . . . 64.129999999999995 111.282 162.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.43 99.94 8.24 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.846 0.832 . . . . 74.310000000000002 109.714 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.49 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 44.0 t -98.7 96.38 5.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 105.586 -2.005 . . . . 72.209999999999994 105.586 171.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.5 t -75.13 -22.97 57.82 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.408 0.442 . . . . 71.310000000000002 112.038 -174.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -124.39 149.73 46.37 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 125.545 1.538 . . . . 74.030000000000001 109.506 -170.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.38 129.97 10.74 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.237 0.926 . . . . 70.129999999999995 109.082 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.68 147.45 28.09 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.138 0.881 . . . . 61.329999999999998 110.356 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.4 t -145.65 151.65 14.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.234 -1.765 . . . . 64.239999999999995 106.234 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.7 168.68 19.27 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.88 2.072 . . . . 73.310000000000002 109.193 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.452 ' HG3' ' H ' ' A' ' 50' ' ' ASP . 9.0 ptm180 42.86 -87.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 129.821 3.248 . . . . 65.420000000000002 112.674 163.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.452 ' H ' ' HG3' ' A' ' 49' ' ' ARG . 1.9 p-10 -178.61 -176.92 0.5 Allowed 'General case' 0 N--CA 1.436 -1.128 1 C-N-CA 132.684 4.394 . . . . 74.400000000000006 107.728 162.638 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.28 -24.65 5.37 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-O 119.214 -0.77 . . . . 71.329999999999998 113.452 163.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.93 165.08 35.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.854 1.327 . . . . 61.140000000000001 108.676 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.0 140.58 6.68 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.089 -2.404 . . . . 73.120000000000005 107.089 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -111.57 134.98 52.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 118.781 1.29 . . . . 70.109999999999999 108.04 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.0 161.87 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 105.98 -1.859 . . . . 74.430000000000007 105.98 -172.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -143.52 139.88 30.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.371 -2.085 . . . . 62.43 105.371 170.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -107.34 164.26 12.34 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.959 -1.867 . . . . 74.530000000000001 105.959 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.1 t -63.98 -44.64 97.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.177 0.806 . . . . 65.230000000000004 113.177 -173.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -144.87 168.13 20.96 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.833 0.742 . . . . 74.519999999999996 109.506 -173.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -55.26 -28.88 56.38 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.19 -0.909 . . . . 42.009999999999998 110.197 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -64.8 -63.1 1.2 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.874 0.761 . . . . 65.349999999999994 108.99 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.46 -43.49 88.91 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.032 0.378 . . . . 74.340000000000003 110.033 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -57.16 -50.04 74.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.283 0.633 . . . . 53.140000000000001 111.228 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -59.51 -35.98 75.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.176 0.898 . . . . 72.340000000000003 111.229 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -54.78 -45.95 74.34 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.621 1.555 . . . . 74.239999999999995 110.013 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.43 -46.88 63.11 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.31 0.644 . . . . 71.409999999999997 111.68 -175.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -74.05 -7.42 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.571 0.749 . . . . 53.329999999999998 111.019 -169.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -123.89 -3.24 8.17 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.665 1.186 . . . . 64.109999999999999 113.452 -177.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -142.37 -0.91 1.21 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.029 0.932 . . . . 63.140000000000001 112.784 -175.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.482 HD11 ' HG3' ' A' ' 36' ' ' MET . 1.1 tm? -149.08 10.18 0.78 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.093 1.315 . . . . 63.350000000000001 111.339 -167.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.69 163.65 14.02 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 119.009 -2.307 . . . . 40.450000000000003 112.302 171.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.57 ' H ' ' HA ' ' A' ' 86' ' ' ARG . 0.7 OUTLIER 68.5 12.96 8.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.356 1.862 . . . . 64.409999999999997 113.794 171.92 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 31.1 p -75.21 164.04 26.89 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.51 1.524 . . . . 71.319999999999993 111.388 -170.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.66 162.87 28.72 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.245 -1.535 . . . . 73.230000000000004 108.169 166.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -147.85 151.23 35.59 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 125.047 1.339 . . . . 73.430000000000007 110.227 171.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -138.03 138.91 39.3 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.722 2.009 . . . . 74.209999999999994 106.33 -160.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -144.14 156.34 44.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.044 0.938 . . . . 73.329999999999998 110.554 -164.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -71.69 60.95 0.36 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.914 1.686 . . . . 73.349999999999994 113.242 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -146.14 -2.09 0.72 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.306 2.243 . . . . 74.549999999999997 111.088 169.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.89 15.26 54.87 Favored Glycine 0 C--N 1.34 0.773 0 O-C-N 120.298 -1.501 . . . . 74.140000000000001 112.201 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.8 171.7 12.83 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.151 0.98 . . . . 72.540000000000006 111.369 -172.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.5 p -143.04 153.98 43.5 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.536 -1.211 . . . . 74.239999999999995 108.145 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.46 177.07 5.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.118 2.167 . . . . 74.349999999999994 108.496 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -97.81 153.99 17.92 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.015 -1.053 . . . . 60.32 108.709 147.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.7 pt -130.82 171.6 17.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 125.871 1.668 . . . . 75.530000000000001 107.165 171.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.57 ' HA ' ' H ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -143.69 165.75 26.79 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 120.998 -1.063 . . . . 71.519999999999996 108.874 156.467 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.24 163.85 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.98 1.312 . . . . 73.340000000000003 109.019 169.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -154.6 158.22 39.42 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.704 2.002 . . . . 74.400000000000006 107.264 163.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.02 83.87 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.224 -2.139 . . . . 70.239999999999995 105.224 164.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 t0 . . . . . 0 C--O 1.256 1.439 0 C-N-CA 127.894 2.478 . . . . 73.230000000000004 113.817 159.417 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 122.059 0.933 . . . . 62.340000000000003 110.494 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -63.08 20.95 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 128.411 2.684 . . . . 60.549999999999997 113.095 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.04 28.4 4.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 119.328 -2.107 . . . . 51.310000000000002 108.481 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.654 HH21 HG11 ' A' ' 54' ' ' VAL . 42.1 ttt180 -112.83 129.56 56.4 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.753 1.221 . . . . 72.430000000000007 110.851 -177.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.7 159.86 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.703 -1.221 . . . . 71.420000000000002 107.703 168.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 12.5 m -124.3 -179.86 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.97 2.108 . . . . 75.109999999999999 107.042 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.11 155.15 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.496 1.918 . . . . 64.5 108.256 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.86 165.24 30.35 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.633 -1.292 . . . . 64.209999999999994 109.589 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.35 7.55 87.83 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.936 0.779 . . . . 72.519999999999996 113.003 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mt -60.82 155.02 55.1 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.065 1.346 . . . . 75.540000000000006 111.412 -173.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.58 167.54 23.92 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.913 3.742 . . . . 72.230000000000004 111.341 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.38 -27.87 39.78 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.358 2.038 . . . . 73.209999999999994 112.975 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.42 ' HB2' ' HG3' ' A' ' 79' ' ' GLU . 7.7 m -140.59 80.27 1.74 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 127.1 2.16 . . . . 64.230000000000004 107.445 -177.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.22 138.96 10.47 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 105.112 -3.195 . . . . 64.540000000000006 105.112 157.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.78 179.23 4.18 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 117.747 0.774 . . . . 74.420000000000002 109.055 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -65.42 -19.18 65.83 Favored 'General case' 0 C--O 1.226 -0.153 0 O-C-N 121.606 -0.684 . . . . 75.510000000000005 110.648 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -59.5 4.2 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 117.775 -1.107 . . . . 63.520000000000003 108.555 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -35.9 78.82 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.598 -0.841 . . . . 54.340000000000003 109.477 177.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.97 -53.64 46.81 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.386 0.993 . . . . 33.520000000000003 110.708 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -69.74 -26.21 64.21 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.124 -0.985 . . . . 55.329999999999998 111.951 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -85.23 -12.91 51.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.938 0.895 . . . . 75.140000000000001 112.577 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -109.06 -57.61 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.522 1.129 . . . . 61.520000000000003 111.252 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.9 ttt -74.53 70.71 1.8 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.659 1.184 . . . . 71.219999999999999 108.588 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -140.64 -0.55 1.54 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.795 -1.191 . . . . 73.310000000000002 113.368 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -68.29 -21.57 64.77 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.602 0.637 . . . . 74.239999999999995 111.579 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.42 -6.88 58.82 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.359 1.244 . . . . 75.25 114.359 -171.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.26 -171.49 27.12 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 119.858 1.208 . . . . 54.310000000000002 111.357 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -86.19 85.03 7.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 106.965 -1.495 . . . . 73.420000000000002 106.965 -170.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.9 t -69.57 135.08 29.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.155 -1.054 . . . . 72.219999999999999 108.155 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.5 t -99.07 -11.55 21.35 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.076 -0.488 . . . . 75.129999999999995 111.954 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -159.45 146.79 17.01 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.555 1.071 . . . . 73.349999999999994 109.757 -162.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.7 143.25 32.21 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.727 -1.212 . . . . 73.140000000000001 107.727 165.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -152.47 134.24 14.71 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.488 0.715 . . . . 64.299999999999997 109.466 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 m -137.53 177.62 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.554 -1.276 . . . . 74.519999999999996 107.554 175.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -140.79 -169.24 2.76 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 126.167 1.787 . . . . 74.400000000000006 106.768 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -96.89 45.21 1.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.921 -1.112 . . . . 54.240000000000002 111.729 -176.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.93 -154.0 0.53 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.277 1.831 . . . . 63.130000000000003 107.324 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -111.02 28.65 9.58 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.772 2.13 . . . . 72.409999999999997 110.605 173.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 p -131.89 173.36 11.26 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.416 1.487 . . . . 74.230000000000004 109.508 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.86 172.66 44.4 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 107.743 -2.143 . . . . 75.510000000000005 107.743 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.654 HG11 HH21 ' A' ' 17' ' ' ARG . 37.5 t -145.59 144.34 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.483 -0.932 . . . . 72.400000000000006 108.483 -165.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.6 t -132.95 171.65 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.54 -0.911 . . . . 63.310000000000002 108.54 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -153.8 137.4 16.0 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 120.553 -1.342 . . . . 61.340000000000003 107.716 167.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.84 177.39 4.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.458 1.903 . . . . 75.239999999999995 108.104 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.3 m -86.38 -31.79 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.64 0.608 . . . . 55.310000000000002 112.64 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 ttm105 -156.37 160.32 39.56 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.362 0.665 . . . . 64.540000000000006 109.95 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -67.1 -22.92 65.8 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.568 1.147 . . . . 61.509999999999998 112.205 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.12 -54.01 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.112 0.869 . . . . 72.25 109.603 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.96 -41.21 87.25 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.563 -0.532 . . . . 63.329999999999998 109.563 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.3 ttp -53.22 -52.78 57.8 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 110.168 -0.308 . . . . 55.130000000000003 110.168 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -55.11 -40.26 70.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.537 -0.745 . . . . 73.430000000000007 111.08 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -55.84 -45.38 78.41 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.088 0.858 . . . . 60.119999999999997 109.446 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.5 -42.4 78.28 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.31 -0.869 . . . . 74.239999999999995 111.893 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 t -68.35 -18.18 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.503 0.721 . . . . 72.310000000000002 111.019 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -114.37 -15.81 12.06 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.833 1.049 . . . . 75.519999999999996 113.833 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm -134.1 -1.06 2.99 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.261 1.425 . . . . 72.349999999999994 112.681 -171.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.62 21.42 2.71 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.929 1.24 . . . . 44.049999999999997 110.753 -175.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.84 164.0 11.88 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.077 -1.64 . . . . 62.32 110.285 174.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.86 12.97 4.12 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.235 1.814 . . . . 61.210000000000001 112.202 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.3 p -74.06 168.2 20.01 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.883 -1.136 . . . . 44.25 110.724 -167.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -63.94 166.24 7.72 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 121.74 -0.6 . . . . 71.319999999999993 109.813 153.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -145.67 138.79 26.13 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.938 1.695 . . . . 73.150000000000006 107.791 166.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -96.09 136.61 36.33 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.822 -0.807 . . . . 74.25 108.822 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -109.9 174.39 5.89 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.086 -1.079 . . . . 60.100000000000001 108.086 -169.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.82 -11.3 55.98 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.839 -0.538 . . . . 72.310000000000002 111.882 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG3' ' HB2' ' A' ' 26' ' ' SER . 6.0 mm-40 -102.02 34.24 2.77 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.079 1.351 . . . . 72.129999999999995 111.536 -166.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.08 15.99 68.11 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.782 1.182 . . . . 24.140000000000001 113.528 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -132.73 176.8 8.14 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.439 1.096 . . . . 52.399999999999999 110.252 -175.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.6 p -144.78 126.07 14.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.75 -1.204 . . . . 73.099999999999994 107.75 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.36 -176.49 4.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.861 0.865 . . . . 73.319999999999993 110.339 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -106.29 157.21 17.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.578 -0.897 . . . . 75.209999999999994 108.578 159.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 pt -141.61 163.78 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.551 1.141 . . . . 73.310000000000002 110.937 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -131.58 105.84 7.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.141 -1.429 . . . . 75.450000000000003 107.141 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.5 t -69.71 144.17 14.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.792 -1.188 . . . . 62.210000000000001 107.792 170.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.27 158.82 43.53 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.747 1.158 . . . . 44.119999999999997 111.724 166.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.75 137.37 22.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 106.184 -1.784 . . . . 64.239999999999995 106.184 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 C--O 1.25 1.119 0 C-N-CA 124.293 1.037 . . . . 72.099999999999994 110.487 175.656 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 16' ' ' ASN . 72.7 m . . . . . 0 C--O 1.238 0.459 0 CA-C-O 121.81 0.814 . . . . 55.109999999999999 112.101 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.71 31.32 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.043 2.537 . . . . 73.510000000000005 111.541 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -143.01 14.72 1.89 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.101 2.16 . . . . 62.32 108.284 -173.475 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.27 116.22 31.59 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.522 1.929 . . . . 75.340000000000003 110.13 -174.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -122.58 174.07 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.606 0.762 . . . . 62.509999999999998 111.522 173.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.578 HG23 ' HG3' ' A' ' 88' ' ' LYS . 10.7 m -136.1 -179.1 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.727 1.611 . . . . 64.409999999999997 106.967 170.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.0 t -135.7 153.52 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.134 2.174 . . . . 75.409999999999997 107.006 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.87 155.31 48.2 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.146 1.378 . . . . 43.210000000000001 108.88 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.02 4.8 57.58 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.419 1.961 . . . . 71.400000000000006 113.346 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mt -66.56 154.45 91.14 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 120.99 -1.3 . . . . 74.430000000000007 113.163 -166.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.47 166.36 20.03 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.169 2.579 . . . . 71.019999999999996 112.573 175.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.07 -6.03 18.29 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 124.12 3.213 . . . . 71.420000000000002 114.013 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -146.75 54.06 1.11 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.505 2.322 . . . . 74.299999999999997 108.926 -172.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.96 112.02 2.03 Favored Glycine 0 C--N 1.34 0.761 0 O-C-N 120.126 -1.608 . . . . 35.030000000000001 111.564 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -76.24 155.35 34.47 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 118.835 1.318 . . . . 74.140000000000001 112.361 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -59.04 -26.03 64.23 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.828 0.851 . . . . 75.099999999999994 113.217 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -65.22 -52.2 56.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.251 -1.018 . . . . 71.099999999999994 108.251 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -62.76 -27.56 69.37 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.109 1.363 . . . . 73.109999999999999 111.326 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -64.28 -61.34 2.3 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.067 -1.086 . . . . 72.019999999999996 108.067 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -61.28 -39.57 90.91 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.825 -0.607 . . . . 55.399999999999999 109.851 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -17.46 52.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.85 1.26 . . . . 73.329999999999998 112.688 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -100.72 -45.36 5.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.266 0.626 . . . . 75.010000000000005 111.23 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.0 tpt -57.75 -32.86 67.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.15 1.38 . . . . 72.299999999999997 113.396 -174.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -19.17 59.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.208 1.929 . . . . 73.0 116.208 -166.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.67 1.02 1.39 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.991 1.478 . . . . 64.010000000000005 114.991 -169.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.448 ' CB ' ' HB2' ' A' ' 66' ' ' ALA . . . -95.26 -10.09 31.31 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.754 1.222 . . . . 53.200000000000003 112.993 175.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.58 -101.74 0.21 Allowed Glycine 0 C--N 1.335 0.498 0 CA-C-N 119.68 1.127 . . . . 41.219999999999999 111.386 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.2 144.35 29.85 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.533 1.166 . . . . 72.319999999999993 109.84 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.511 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -131.7 139.53 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 126.379 1.872 . . . . 51.200000000000003 113.382 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -127.51 18.88 6.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.837 1.255 . . . . 71.219999999999999 111.36 -170.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.415 ' HB3' ' CB ' ' A' ' 56' ' ' GLU . 73.5 t80 -170.73 144.48 2.3 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.108 1.763 . . . . 64.329999999999998 108.318 172.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.69 139.26 16.91 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.861 -1.162 . . . . 74.019999999999996 107.861 168.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -155.14 129.22 8.82 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.421 1.089 . . . . 71.129999999999995 110.615 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 t -140.27 165.8 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.966 1.706 . . . . 54.43 107.285 -175.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.66 -162.76 1.3 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.775 2.83 . . . . 72.120000000000005 107.723 -169.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -105.25 63.53 0.7 Allowed 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.283 -1.511 . . . . 72.109999999999999 109.55 170.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -144.74 -176.33 5.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.26 -0.9 . . . . 64.040000000000006 108.592 169.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.38 13.73 20.11 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-O 118.312 -1.271 . . . . 52.329999999999998 113.433 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.32 163.54 30.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.163 1.982 . . . . 73.409999999999997 110.084 -174.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.45 167.84 38.52 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 107.788 -2.125 . . . . 51.530000000000001 107.788 -171.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 59.0 t -143.8 144.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 119.929 1.864 . . . . 73.099999999999994 110.395 -163.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.9 t -145.19 154.33 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.112 0.482 . . . . 73.519999999999996 110.849 -173.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.415 ' CB ' ' HB3' ' A' ' 44' ' ' TYR . 3.9 tt0 -137.08 101.36 4.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.885 -1.524 . . . . 75.099999999999994 106.885 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.511 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 3.0 m-30 -72.37 179.37 3.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.533 1.933 . . . . 71.140000000000001 110.625 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.0 t -77.5 -63.43 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.627 -0.671 . . . . 64.540000000000006 110.98 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -140.37 157.36 45.66 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.27 0.941 . . . . 63.520000000000003 112.053 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -53.53 -27.13 24.19 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.247 1.019 . . . . 71.510000000000005 112.138 -166.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -53.16 -61.92 1.99 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.218 1.407 . . . . 71.409999999999997 108.376 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.56 -37.5 71.08 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.05 1.34 . . . . 75.540000000000006 110.667 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -56.86 -54.85 41.8 Favored 'General case' 0 C--O 1.228 -0.047 0 CA-C-O 118.829 -0.605 . . . . 74.420000000000002 110.178 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.6 m -54.73 -40.64 69.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.634 -0.698 . . . . 72.209999999999994 110.508 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -60.02 -49.77 76.34 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.02 0.928 . . . . 71.430000000000007 110.661 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.448 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . . . -63.46 -25.1 68.12 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.739 -1.226 . . . . 64.400000000000006 112.68 -176.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.3 t -76.77 -5.75 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 O-C-N 120.853 -1.155 . . . . 60.240000000000002 110.125 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -129.41 0.45 5.06 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.537 1.31 . . . . 44.299999999999997 114.537 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.39 5.26 0.82 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.499 1.519 . . . . 64.140000000000001 112.563 -171.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.01 4.05 0.62 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.404 1.082 . . . . 71.129999999999995 109.765 -173.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -99.42 157.69 16.24 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.079 1.751 . . . . 74.439999999999998 111.372 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.59 ' H ' ' HB3' ' A' ' 86' ' ' ARG . 0.6 OUTLIER 44.42 64.41 1.34 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.496 1.519 . . . . 75.439999999999998 110.359 -168.255 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.4 p -121.06 174.19 6.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.203 2.601 . . . . 73.019999999999996 109.278 -174.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.89 161.98 14.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.952 -1.093 . . . . 74.420000000000002 109.633 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -151.68 120.66 6.66 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 126.647 1.979 . . . . 64.230000000000004 111.483 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -102.74 119.82 39.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.665 -1.235 . . . . 63.219999999999999 107.665 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.54 168.41 16.45 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.799 1.64 . . . . 74.109999999999999 110.309 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -65.07 -14.17 59.81 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.33 1.233 . . . . 73.109999999999999 114.33 174.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -86.56 6.02 32.79 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.692 1.997 . . . . 72.200000000000003 112.51 -172.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.15 14.39 82.31 Favored Glycine 0 C--N 1.337 0.635 0 O-C-N 121.572 -0.705 . . . . 43.340000000000003 112.061 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -125.08 171.71 10.05 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 123.961 0.904 . . . . 74.140000000000001 110.566 -177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.5 p -139.42 146.03 39.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.967 1.307 . . . . 74.219999999999999 108.05 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.7 129.97 19.83 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.729 -1.582 . . . . 64.439999999999998 106.729 172.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -69.74 159.49 33.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.968 0.804 . . . . 75.230000000000004 110.126 -164.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.69 155.73 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 123.414 0.686 . . . . 74.200000000000003 109.165 -173.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.59 ' HB3' ' H ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -134.99 143.05 46.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.849 -1.157 . . . . 53.420000000000002 109.728 163.119 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.94 151.2 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.377 1.471 . . . . 73.040000000000006 108.347 166.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.578 ' HG3' HG23 ' A' ' 19' ' ' VAL . 6.4 ptmt -146.3 161.61 39.93 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.423 -0.955 . . . . 61.119999999999997 108.423 152.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.576 ' HA ' HG12 ' A' ' 18' ' ' VAL . 7.4 t -70.18 143.93 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 106.358 -1.719 . . . . 73.239999999999995 106.358 169.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.604 -1.189 . . . . 63.399999999999999 110.487 -177.743 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.701 0 N-CA-C 109.956 -1.258 . . . . 61.549999999999997 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.91 155.13 33.82 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 123.843 0.857 . . . . 75.150000000000006 110.86 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.91 174.26 8.03 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.437 2.758 . . . . 74.549999999999997 112.187 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -137.52 -179.32 5.67 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.233 1.013 . . . . 71.219999999999999 110.089 -174.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.57 -179.51 24.7 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.616 1.579 . . . . 62.520000000000003 110.391 167.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.85 122.07 45.21 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.463 1.505 . . . . 75.219999999999999 108.99 -167.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -154.09 160.61 42.03 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.265 0.626 . . . . 75.120000000000005 110.479 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.21 67.35 0.23 Allowed Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.03 -0.872 . . . . 53.509999999999998 113.265 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.8 155.66 67.98 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 CA-C-N 120.953 2.377 . . . . 75.019999999999996 112.695 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.92 91.99 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.997 3.132 . . . . 51.240000000000002 111.377 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.4 m -103.36 172.23 6.93 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.197 2.199 . . . . 73.019999999999996 111.957 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 167.68 1.85 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.398 1.079 . . . . 73.239999999999995 110.943 169.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -127.73 110.32 12.52 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.205 -2.146 . . . . 71.150000000000006 105.205 174.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -68.61 174.4 4.26 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.953 -0.758 . . . . 63.43 108.953 168.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -72.28 37.98 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.371 -0.831 . . . . 72.209999999999994 112.295 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.64 28.75 2.41 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 119.349 -2.094 . . . . 72.340000000000003 109.797 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.13 143.03 51.03 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.867 -1.145 . . . . 74.030000000000001 112.395 -167.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 m -140.51 167.69 17.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 124.491 1.117 . . . . 62.140000000000001 110.527 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.2 t -129.72 153.67 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.15 -1.796 . . . . 73.150000000000006 106.15 170.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -121.98 136.58 58.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 105.821 -1.918 . . . . 62.140000000000001 105.821 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 p -134.53 145.08 48.4 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.927 0.785 . . . . 61.340000000000003 111.678 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.9 27.66 23.25 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 125.147 1.356 . . . . 15.42 112.619 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.454 HD22 HG21 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -58.71 152.7 45.82 Favored Pre-proline 0 N--CA 1.467 0.419 0 CA-C-N 118.443 1.121 . . . . 60.420000000000002 110.393 -177.591 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.07 168.59 17.01 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.813 2.342 . . . . 73.409999999999997 110.882 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.02 -12.6 35.43 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.65 2.234 . . . . 75.450000000000003 113.831 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -151.16 57.03 0.89 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.379 1.445 . . . . 72.140000000000001 111.92 -171.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.19 -166.51 32.7 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.273 1.416 . . . . 72.150000000000006 111.11 172.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.8 p -157.69 173.85 16.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.402 1.081 . . . . 53.119999999999997 109.718 169.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -70.06 -18.4 63.27 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.97 0.908 . . . . 71.319999999999993 111.38 171.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.44 -54.11 10.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.834 -1.173 . . . . 63.520000000000003 107.834 -177.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.51 -32.84 74.41 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 118.55 -0.738 . . . . 71.120000000000005 110.249 172.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.35 -57.08 13.8 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.558 1.072 . . . . 73.450000000000003 110.57 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -61.81 -42.99 99.71 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 118.785 0.72 . . . . 74.239999999999995 110.087 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.25 -25.66 64.39 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.224 1.01 . . . . 75.420000000000002 111.92 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -81.39 -60.04 2.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.589 0.756 . . . . 72.299999999999997 110.046 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.485 ' HG3' HD11 ' A' ' 70' ' ' LEU . 15.0 ttt -68.09 -8.8 41.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.791 1.636 . . . . 62.009999999999998 114.348 -159.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.18 20.97 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 131.218 3.807 . . . . 62.530000000000001 115.848 175.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -100.59 0.79 39.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.98 1.712 . . . . 74.340000000000003 112.604 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.92 17.08 6.79 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 125.846 1.658 . . . . 74.319999999999993 112.797 -167.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 -107.73 1.04 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 125.762 1.648 . . . . 75.239999999999995 109.304 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -143.96 139.61 29.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 117.764 0.782 . . . . 71.239999999999995 109.922 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 t -128.44 81.13 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 126.451 1.9 . . . . 75.5 107.167 -170.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.7 t -72.66 -15.12 61.71 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.277 0.473 . . . . 51.409999999999997 112.277 -174.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -132.83 135.14 45.47 Favored 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 121.038 -1.039 . . . . 64.109999999999999 108.413 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.42 138.83 41.93 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.218 -1.03 . . . . 73.420000000000002 108.218 166.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -145.92 156.68 43.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.843 -1.169 . . . . 74.420000000000002 107.843 169.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.35 -178.41 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 O-C-N 120.826 -1.171 . . . . 51.130000000000003 108.162 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -103.34 -163.09 0.96 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.417 1.487 . . . . 74.310000000000002 107.283 166.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 mtm-85 -52.71 -53.98 40.08 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.975 -1.011 . . . . 72.25 109.885 159.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -170.68 -179.91 3.05 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.083 0.856 . . . . 62.310000000000002 112.82 -171.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.69 -39.85 2.73 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 127.147 2.308 . . . . 72.439999999999998 113.445 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.01 170.58 16.82 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.759 1.279 . . . . 44.229999999999997 109.429 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.86 159.66 28.09 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.543 -1.823 . . . . 60.409999999999997 108.543 165.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.3 p -130.23 131.3 65.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.396 1.098 . . . . 62.030000000000001 109.292 -170.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.7 t -144.32 151.83 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.632 -0.877 . . . . 75.430000000000007 108.632 -157.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -135.13 133.7 39.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.5 -1.296 . . . . 73.409999999999997 107.5 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -101.6 -176.77 3.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.117 1.767 . . . . 74.120000000000005 108.626 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.2 t -81.72 -50.96 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 118.256 -0.878 . . . . 54.210000000000001 110.57 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.1 ttt85 -145.17 164.5 31.1 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 120.526 1.512 . . . . 75.299999999999997 111.79 -171.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -62.7 -30.31 71.31 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 117.867 -1.063 . . . . 64.239999999999995 111.673 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -65.38 -50.98 63.47 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.645 -0.872 . . . . 60.0 108.645 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -59.36 -53.11 61.99 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 126.786 2.034 . . . . 75.120000000000005 109.25 176.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -51.94 -51.56 56.18 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.485 -0.759 . . . . 75.019999999999996 112.457 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.7 m -55.29 -53.56 54.53 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.536 -0.745 . . . . 73.019999999999996 109.584 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -56.96 -32.43 66.02 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.321 1.048 . . . . 72.299999999999997 111.588 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.25 -42.77 77.91 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.438 1.017 . . . . 72.310000000000002 110.863 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t -69.3 -14.31 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.951 -0.468 . . . . 64.120000000000005 111.091 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -100.58 -33.55 10.26 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.314 -1.492 . . . . 73.409999999999997 112.349 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' O ' ' HE2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -137.7 9.01 2.85 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.844 0.858 . . . . 71.030000000000001 113.19 -165.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.485 HD11 ' HG3' ' A' ' 36' ' ' MET . 1.0 OUTLIER -134.36 3.24 3.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.798 0.726 . . . . 75.329999999999998 111.132 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.611 ' HB2' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -95.85 162.16 13.7 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 119.315 -2.116 . . . . 72.329999999999998 114.501 171.349 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.4 t30 66.2 15.38 10.07 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.007 2.523 . . . . 62.229999999999997 113.003 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 31.1 p -78.46 171.21 15.43 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.495 -0.753 . . . . 54.219999999999999 109.747 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.08 151.65 21.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.029 1.332 . . . . 63.219999999999999 109.034 166.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -125.15 130.18 51.66 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 127.709 2.404 . . . . 75.299999999999997 108.896 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.472 ' HA ' HG22 ' A' ' 82' ' ' THR . 73.9 mtm180 -87.03 153.83 21.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.108 0.963 . . . . 61.409999999999997 110.541 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.7 p -124.39 176.73 6.28 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.077 0.951 . . . . 71.540000000000006 110.451 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -85.6 5.15 33.01 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.569 1.148 . . . . 72.129999999999995 111.268 167.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.74 13.42 14.17 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.729 2.012 . . . . 62.210000000000001 112.595 -162.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.24 12.85 81.7 Favored Glycine 0 C--N 1.336 0.561 0 O-C-N 121.762 -0.586 . . . . 55.020000000000003 113.489 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -134.59 162.99 30.74 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.227 1.011 . . . . 52.240000000000002 109.593 -173.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 76' ' ' ARG . 43.6 p -148.75 119.61 7.6 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.678 -0.86 . . . . 71.209999999999994 108.678 -172.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.23 165.01 13.68 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.418 0.687 . . . . 72.150000000000006 110.033 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -84.65 157.23 21.21 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.569 -0.9 . . . . 64.219999999999999 108.569 160.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.454 HG21 HD22 ' A' ' 23' ' ' LEU . 25.3 pt -137.47 152.94 27.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.895 0.855 . . . . 71.010000000000005 109.364 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -123.9 119.19 28.92 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.043 -1.836 . . . . 51.439999999999998 106.043 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.611 HG12 ' HB2' ' A' ' 71' ' ' ASP . 1.4 p -75.62 163.25 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.262 -0.644 . . . . 53.439999999999998 109.262 175.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.49 163.84 39.48 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.922 1.689 . . . . 74.310000000000002 107.42 164.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.07 155.44 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.23 -1.767 . . . . 54.210000000000001 106.23 165.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 58.8 t0 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 124.567 1.147 . . . . 74.310000000000002 109.971 176.372 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.504 0 N-CA-C 108.876 -1.69 . . . . 60.340000000000003 108.876 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.86 164.98 16.93 Favored Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 126.213 1.805 . . . . 74.239999999999995 106.323 170.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -67.41 156.1 67.57 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 CA-C-N 119.867 0.988 . . . . 62.310000000000002 110.011 169.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.31 136.03 41.26 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.022 2.129 . . . . 61.539999999999999 105.851 173.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.17 163.09 7.54 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.975 1.274 . . . . 60.409999999999997 114.886 173.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 38.32 0.76 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.581 1.152 . . . . 60.439999999999998 110.753 172.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -152.63 99.52 2.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.593 -2.003 . . . . 62.439999999999998 105.593 176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.45 -86.45 0.29 Allowed Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.117 -1.379 . . . . 42.020000000000003 111.574 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.72 167.73 16.68 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.442 2.761 . . . . 71.310000000000002 112.772 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.59 85.61 0.73 Allowed 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.178 2.585 . . . . 63.119999999999997 110.547 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.7 t -73.33 -158.86 0.06 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.761 2.025 . . . . 74.230000000000004 109.164 171.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 141.19 49.36 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.138 -1.601 . . . . 73.120000000000005 109.662 161.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.82 -88.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 130.553 3.541 . . . . 64.510000000000005 113.116 165.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.9 m -162.96 166.89 23.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.408 -1.33 . . . . 61.119999999999997 107.408 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -80.41 40.69 0.51 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.251 1.021 . . . . 62.420000000000002 111.976 173.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.94 15.05 1.91 Allowed 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.431 -1.418 . . . . 52.310000000000002 111.968 -178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.56 144.57 39.22 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.028 -1.045 . . . . 75.430000000000007 110.203 -171.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.437 ' CG1' ' HG3' ' A' ' 63' ' ' MET . 27.3 m -141.4 166.36 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.249 1.02 . . . . 62.219999999999999 110.496 -171.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.79 124.02 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 106.75 -1.574 . . . . 73.540000000000006 106.75 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.23 148.99 4.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.059 1.344 . . . . 53.240000000000002 107.601 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -136.6 163.1 31.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.591 -0.693 . . . . 74.129999999999995 109.635 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.5 9.87 68.66 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.062 -0.854 . . . . 51.109999999999999 113.81 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.81 150.99 45.29 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.481 1.141 . . . . 72.409999999999997 112.509 -172.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -71.52 169.65 20.42 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 125.163 3.909 . . . . 74.150000000000006 113.259 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.47 -4.23 11.56 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.576 3.517 . . . . 34.399999999999999 114.167 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.73 71.03 1.37 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.081 2.152 . . . . 44.039999999999999 106.579 171.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.18 127.08 6.66 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 125.344 1.449 . . . . 12.300000000000001 109.596 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.4 m -134.78 166.64 22.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.935 0.894 . . . . 60.109999999999999 110.644 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -65.05 -22.84 67.04 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.407 1.083 . . . . 74.439999999999998 111.711 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -58.38 -60.45 3.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.436 -1.269 . . . . 63.530000000000001 109.742 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.84 -42.69 94.13 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 108.875 -0.787 . . . . 53.450000000000003 108.875 176.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.78 -50.98 62.48 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.846 0.748 . . . . 61.509999999999998 111.072 -176.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -67.48 -31.88 72.33 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.263 -0.898 . . . . 74.310000000000002 112.406 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.78 -2.58 57.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.34 1.456 . . . . 74.420000000000002 112.003 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -122.17 -56.08 1.84 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.278 1.431 . . . . 52.520000000000003 110.45 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 17.2 ttt -75.74 72.11 2.64 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.435 -1.415 . . . . 64.420000000000002 108.473 171.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.3 ptm85 -136.81 -13.4 1.68 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.271 1.428 . . . . 65.329999999999998 111.734 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -76.39 3.41 11.13 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.423 -0.798 . . . . 72.420000000000002 112.315 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.7 64.29 0.74 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.814 1.645 . . . . 71.409999999999997 107.055 172.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.58 -136.38 33.87 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.249 -0.887 . . . . 74.349999999999994 111.528 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -109.43 117.87 35.16 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.212 0.53 . . . . 74.349999999999994 111.096 -159.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.23 95.99 4.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.092 0.957 . . . . 72.230000000000004 108.929 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.4 t -69.78 -29.58 66.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.003 -0.998 . . . . 41.130000000000003 112.064 -175.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -122.04 149.76 43.06 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.144 1.338 . . . . 73.510000000000005 110.916 -168.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.62 133.52 20.18 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.827 1.251 . . . . 65.319999999999993 109.231 169.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -151.63 125.28 8.99 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 107.5 -1.296 . . . . 71.140000000000001 107.5 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.9 t -142.62 96.9 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.018 -2.216 . . . . 43.32 105.018 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -64.89 -176.13 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.137 1.775 . . . . 74.140000000000001 108.818 161.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -115.15 78.51 1.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 O-C-N 120.585 -1.322 . . . . 75.540000000000006 107.793 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -158.41 42.0 0.26 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.945 1.298 . . . . 62.509999999999998 110.227 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.15 9.3 14.61 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.525 1.536 . . . . 42.409999999999997 116.385 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.2 p -134.7 168.13 19.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.977 1.889 . . . . 53.25 109.95 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -146.41 151.94 24.13 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 107.454 -2.258 . . . . 75.319999999999993 107.454 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.87 121.4 58.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.771 -1.566 . . . . 72.230000000000004 106.771 -172.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' HB ' HG23 ' A' ' 18' ' ' VAL . 76.4 t -135.81 147.84 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.387 -1.709 . . . . 74.530000000000001 106.387 -159.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -136.58 113.81 10.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 105.47 -2.048 . . . . 75.219999999999999 105.47 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -86.42 172.22 10.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.741 1.217 . . . . 72.230000000000004 108.424 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.7 t -70.65 -56.7 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 118.588 -0.72 . . . . 60.210000000000001 110.635 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -139.26 168.26 20.23 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 119.556 1.071 . . . . 63.149999999999999 111.034 -171.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -56.04 -36.34 67.89 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 117.479 -1.248 . . . . 61.520000000000003 110.343 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -67.01 -47.53 71.15 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.168 1.349 . . . . 63.549999999999997 109.847 -171.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.67 -51.67 68.59 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.837 1.655 . . . . 74.349999999999994 109.3 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.437 ' HG3' ' CG1' ' A' ' 18' ' ' VAL . 62.8 ttp -55.57 -50.57 69.73 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.825 0.85 . . . . 63.119999999999997 111.767 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.6 m -54.56 -53.53 53.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.963 -1.018 . . . . 64.430000000000007 109.258 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -49.84 -32.77 15.03 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.311 0.96 . . . . 75.420000000000002 111.527 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.2 -45.9 91.56 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.916 0.886 . . . . 72.549999999999997 111.033 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -68.52 -16.66 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.381 -0.824 . . . . 54.530000000000001 110.902 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -108.89 -19.58 13.35 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.216 -0.927 . . . . 72.430000000000007 113.147 -167.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -136.21 -9.03 2.0 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.579 1.151 . . . . 74.239999999999995 111.75 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.7 17.49 6.33 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.851 1.26 . . . . 75.340000000000003 110.385 -167.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.58 150.79 28.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.628 1.171 . . . . 73.420000000000002 112.099 -171.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.06 32.3 0.86 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.726 2.01 . . . . 71.150000000000006 113.202 -167.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.3 p -75.02 177.06 6.63 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.05 0.94 . . . . 45.020000000000003 109.631 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -72.97 176.49 5.68 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.564 0.345 . . . . 64.420000000000002 111.078 162.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -151.55 128.46 10.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 128.212 2.605 . . . . 74.120000000000005 108.639 168.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -75.84 124.45 27.33 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.378 1.071 . . . . 73.219999999999999 109.576 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.44 157.41 17.66 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.241 0.616 . . . . 72.120000000000005 110.475 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -80.63 -0.39 37.78 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.218 1.007 . . . . 55.119999999999997 112.097 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -86.1 4.67 37.21 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.573 1.949 . . . . 55.520000000000003 111.569 170.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.38 20.1 74.98 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 119.037 0.835 . . . . 65.430000000000007 111.886 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -120.91 177.85 4.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 127.302 2.241 . . . . 54.009999999999998 107.749 170.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.6 p -140.58 134.36 30.42 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.247 -1.39 . . . . 60.310000000000002 107.247 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.96 173.19 6.78 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.922 -1.111 . . . . 71.530000000000001 110.07 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -87.67 161.89 17.41 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.499 -0.926 . . . . 75.109999999999999 108.499 158.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.9 pt -137.93 141.46 38.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.414 1.086 . . . . 74.150000000000006 109.245 173.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -96.95 120.92 38.2 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.415 -1.698 . . . . 41.520000000000003 106.415 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.2 t -89.32 137.03 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.611 -1.255 . . . . 74.239999999999995 107.611 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -145.48 157.52 43.99 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.379 1.472 . . . . 64.230000000000004 109.545 169.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.21 143.41 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 126.19 1.796 . . . . 64.140000000000001 106.347 170.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 C--O 1.255 1.379 0 C-N-CA 124.281 1.032 . . . . 24.5 108.447 167.154 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.805 0 N-CA-C 110.927 -0.869 . . . . 61.329999999999998 110.927 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.5 155.15 94.07 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.111 0.964 . . . . 75.129999999999995 110.944 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.19 -168.63 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.102 3.201 . . . . 55.219999999999999 110.505 166.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -166.36 163.39 17.48 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 127.661 2.384 . . . . 75.439999999999998 107.486 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.63 -168.85 22.19 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 123.558 0.599 . . . . 64.010000000000005 111.864 173.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -135.76 148.33 48.74 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.392 -1.336 . . . . 73.120000000000005 107.392 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -129.9 155.71 45.59 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.518 1.127 . . . . 71.439999999999998 108.87 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.27 70.55 0.03 OUTLIER Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.107 -1.385 . . . . 61.140000000000001 112.333 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -67.43 166.17 24.59 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.693 2.928 . . . . 62.43 111.948 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.94 68.59 8.26 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.055 3.17 . . . . 64.340000000000003 112.65 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.5 t -156.83 164.16 38.39 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 120.591 -1.318 . . . . 62.240000000000002 110.681 152.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -124.95 155.06 40.19 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.452 1.501 . . . . 74.319999999999993 109.097 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -86.55 -86.2 0.15 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.14 -1.43 . . . . 63.130000000000003 107.14 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.5 m -161.37 174.17 13.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.035 2.134 . . . . 74.049999999999997 108.283 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -68.22 26.45 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.086 2.554 . . . . 53.310000000000002 114.925 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.9 23.35 3.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.29 1.436 . . . . 64.450000000000003 109.488 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.401 ' HG2' HH11 ' A' ' 17' ' ' ARG . 0.0 OUTLIER -119.27 143.75 47.16 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.568 1.147 . . . . 74.030000000000001 111.16 -168.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -144.97 156.47 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.877 1.271 . . . . 65.129999999999995 109.045 -165.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -141.3 120.4 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.992 1.269 . . . . 62.140000000000001 109.742 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.54 155.01 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.85 1.66 . . . . 73.120000000000005 109.867 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -143.87 167.58 21.98 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.379 1.072 . . . . 72.349999999999994 109.366 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.0 14.41 64.67 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.27 0.462 . . . . 55.530000000000001 112.778 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.96 148.68 87.12 Favored Pre-proline 0 CA--C 1.537 0.461 0 O-C-N 121.991 -0.711 . . . . 64.019999999999996 110.355 -168.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.18 167.44 23.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 124.996 3.798 . . . . 74.209999999999994 111.733 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.05 -21.19 56.6 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.791 2.327 . . . . 72.420000000000002 113.229 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.15 35.98 4.73 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.5 1.12 . . . . 62.32 111.314 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.99 156.42 51.65 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 107.503 -2.239 . . . . 42.009999999999998 107.503 158.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.4 m -152.47 173.24 15.37 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.771 0.828 . . . . 44.450000000000003 110.541 165.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -63.48 -21.8 66.52 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.227 1.011 . . . . 65.219999999999999 111.894 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -65.74 -63.83 1.0 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.383 1.073 . . . . 74.409999999999997 108.95 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -34.62 78.82 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 118.606 -1.238 . . . . 71.239999999999995 110.482 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -47.78 64.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.484 1.038 . . . . 73.219999999999999 111.017 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -66.94 -32.23 73.34 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.882 1.219 . . . . 54.530000000000001 111.557 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.23 -7.01 59.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.018 0.927 . . . . 65.019999999999996 113.194 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -106.09 -58.06 1.96 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.361 1.864 . . . . 73.439999999999998 108.1 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.6 ttt -79.23 73.05 5.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.312 1.445 . . . . 72.239999999999995 109.079 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -139.01 -0.32 1.88 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.892 0.877 . . . . 74.209999999999994 113.21 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -91.45 -1.11 57.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.5 1.52 . . . . 73.349999999999994 112.286 -169.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.2 -6.26 14.59 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.38 -0.825 . . . . 61.450000000000003 112.617 -170.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.3 -111.4 0.47 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.936 -1.48 . . . . 62.140000000000001 112.182 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -136.37 139.46 42.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.169 1.485 . . . . 74.120000000000005 109.817 169.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.495 HG22 ' CE1' ' A' ' 57' ' ' PHE . 8.7 t -124.13 97.77 4.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 124.847 1.259 . . . . 44.420000000000002 107.686 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 t -67.39 -54.84 16.92 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.119 -0.363 . . . . 73.030000000000001 110.054 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -83.8 175.92 9.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.316 1.846 . . . . 54.32 111.816 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -167.08 130.73 1.86 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.542 1.137 . . . . 73.409999999999997 111.398 166.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -157.36 136.99 12.2 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.793 1.178 . . . . 64.129999999999995 112.514 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.9 t -147.59 135.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.642 1.577 . . . . 75.25 107.492 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -112.12 152.85 27.81 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.241 1.416 . . . . 53.520000000000003 109.203 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -80.45 65.86 5.75 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.34 0.656 . . . . 64.430000000000007 110.338 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -130.45 -11.65 4.0 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.363 0.665 . . . . 71.140000000000001 112.361 168.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.86 17.36 7.96 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.756 -1.024 . . . . 61.25 112.531 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.97 158.46 43.87 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.939 1.37 . . . . 71.200000000000003 110.007 -171.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.67 107.98 0.34 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.42 -1.072 . . . . 74.030000000000001 110.42 -170.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.19 147.98 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 118.006 0.903 . . . . 71.430000000000007 109.634 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 18' ' ' VAL . 7.7 t -139.37 163.94 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 106.981 -1.488 . . . . 74.040000000000006 106.981 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -146.74 126.42 13.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.163 -1.421 . . . . 74.040000000000006 107.163 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.495 ' CE1' HG22 ' A' ' 42' ' ' VAL . 3.3 m-85 -99.3 170.49 8.62 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.183 -1.414 . . . . 72.450000000000003 107.183 172.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.93 -60.26 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.908 -0.775 . . . . 63.409999999999997 108.908 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -131.69 167.01 20.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.366 0.603 . . . . 74.230000000000004 110.155 -168.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -65.81 -27.38 68.22 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 118.138 -0.934 . . . . 71.340000000000003 110.377 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -57.46 -50.31 73.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.602 1.092 . . . . 70.409999999999997 109.745 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -67.68 -51.42 49.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.943 2.097 . . . . 74.340000000000003 107.833 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -57.33 -45.09 84.64 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.389 1.076 . . . . 71.129999999999995 112.755 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.6 m -59.15 -46.26 88.83 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.739 -1.226 . . . . 73.219999999999999 111.292 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -60.81 -29.95 69.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.07 0.548 . . . . 72.120000000000005 110.438 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.24 91.87 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.018 0.927 . . . . 74.209999999999994 111.519 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 83.6 t -72.69 -19.28 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 120.705 -1.247 . . . . 73.010000000000005 110.36 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -77.17 -57.55 3.77 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.018 -1.051 . . . . 64.319999999999993 109.56 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -100.21 -12.51 19.51 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.159 0.984 . . . . 54.43 113.225 -164.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.51 8.91 3.13 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.558 1.143 . . . . 72.150000000000006 111.899 -155.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -106.0 163.1 13.03 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.158 1.383 . . . . 72.340000000000003 110.017 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.321 6.8 p30 53.92 37.44 26.63 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 119.439 1.018 . . . . 62.229999999999997 110.808 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -93.77 172.55 8.18 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 131.625 3.97 . . . . 51.149999999999999 111.756 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -85.06 174.72 9.5 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.503 1.121 . . . . 73.310000000000002 109.881 160.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -155.81 133.43 11.07 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.756 1.222 . . . . 73.140000000000001 110.977 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HA ' HG22 ' A' ' 82' ' ' THR . 35.9 mmt180 -72.84 141.47 47.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.114 0.87 . . . . 73.140000000000001 110.988 177.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.79 171.79 7.54 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.961 0.886 . . . . 74.349999999999994 110.814 156.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -67.59 -22.66 65.36 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 113.613 -1.63 . . . . 75.140000000000001 112.33 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -87.69 14.2 8.99 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.176 0.99 . . . . 75.510000000000005 111.787 -169.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.11 30.77 74.06 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.454 -1.058 . . . . 72.129999999999995 110.454 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -132.13 159.34 39.23 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 127.076 2.15 . . . . 71.230000000000004 106.548 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 76' ' ' ARG . 31.6 p -142.63 113.71 7.65 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.045 0.926 . . . . 73.120000000000005 110.405 -171.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.75 177.4 8.91 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 125.909 1.683 . . . . 65.25 110.417 -173.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -106.31 144.78 32.51 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.488 -0.93 . . . . 64.310000000000002 108.488 158.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.2 pt -131.28 170.05 20.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 124.554 1.142 . . . . 64.120000000000005 108.94 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -125.02 151.87 45.01 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.966 -1.124 . . . . 71.319999999999993 107.966 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.1 t -114.9 114.8 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 128.341 2.656 . . . . 72.230000000000004 105.925 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -123.87 164.69 18.73 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 121.757 -0.589 . . . . 73.25 110.116 164.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.9 t -67.1 154.95 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 106.74 -1.578 . . . . 74.049999999999997 106.74 170.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.276 -1.009 . . . . 72.129999999999995 108.276 170.234 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.665 0 N-CA-C 109.879 -1.289 . . . . 42.439999999999998 109.879 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.39 152.26 45.69 Favored Pre-proline 0 C--O 1.235 0.293 0 O-C-N 121.647 -0.914 . . . . 71.519999999999996 109.902 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.98 167.23 27.72 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.802 2.335 . . . . 43.340000000000003 110.55 167.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.48 -170.99 2.32 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.29 1.836 . . . . 73.200000000000003 112.638 -159.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.97 26.32 37.86 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.249 -0.75 . . . . 42.130000000000003 113.812 170.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.81 10.31 2.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.14 1.376 . . . . 61.420000000000002 113.6 -171.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -149.99 144.56 25.91 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.213 1.405 . . . . 72.340000000000003 109.081 -172.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.2 -76.18 0.28 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 109.449 -1.46 . . . . 62.210000000000001 109.449 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -65.2 166.49 18.86 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.522 2.148 . . . . 74.109999999999999 110.756 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.58 64.72 7.42 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.425 2.75 . . . . 64.219999999999999 112.38 -172.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.1 m -94.45 151.46 19.36 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.285 -1.005 . . . . 63.100000000000001 108.285 152.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.451 ' H ' ' HD2' ' A' ' 12' ' ' ARG . 0.4 OUTLIER -69.44 -173.88 0.62 Allowed 'General case' 0 C--O 1.234 0.288 0 O-C-N 124.084 0.865 . . . . 72.519999999999996 110.394 162.352 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -118.55 -85.16 0.65 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.839 -1.541 . . . . 72.409999999999997 106.839 174.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.1 m -165.12 162.1 19.97 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.458 1.903 . . . . 70.120000000000005 108.591 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -72.35 26.9 0.05 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.949 2.1 . . . . 65.329999999999998 113.664 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.43 41.18 3.49 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.925 -1.509 . . . . 62.219999999999999 106.925 174.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.19 136.43 49.23 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.848 1.259 . . . . 74.510000000000005 109.133 -172.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.528 HG23 ' HB ' ' A' ' 55' ' ' VAL . 33.7 m -137.61 169.08 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.008 0.923 . . . . 74.120000000000005 111.324 -169.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.44 156.31 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 104.604 -2.369 . . . . 73.140000000000001 104.604 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.3 t -130.89 151.27 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.047 -1.464 . . . . 70.209999999999994 107.047 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.4 p -136.56 167.89 20.53 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.542 1.064 . . . . 73.140000000000001 109.174 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.58 4.43 70.35 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.576 1.56 . . . . 72.109999999999999 113.557 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.58 148.1 67.53 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 119.528 1.664 . . . . 72.239999999999995 112.298 -169.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.58 163.22 36.43 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.142 1.894 . . . . 73.150000000000006 109.917 174.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.1 -8.49 20.29 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.898 3.066 . . . . 65.310000000000002 115.633 -165.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.53 19.64 2.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.781 1.232 . . . . 72.450000000000003 110.829 -175.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.87 103.52 2.0 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 108.594 -1.802 . . . . 65.209999999999994 108.594 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.9 m -85.9 169.73 13.01 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.128 0.964 . . . . 65.25 110.773 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -64.06 -24.46 67.71 Favored 'General case' 0 C--O 1.226 -0.136 0 O-C-N 121.86 -0.525 . . . . 72.319999999999993 110.77 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -50.45 72.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.472 1.509 . . . . 74.150000000000006 108.347 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.26 -41.91 80.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.249 0.477 . . . . 61.229999999999997 110.547 176.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -52.74 47.24 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.991 0.814 . . . . 71.430000000000007 109.884 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -65.14 -33.57 76.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.835 0.854 . . . . 74.329999999999998 110.827 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -80.01 -10.72 59.79 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.667 1.187 . . . . 74.329999999999998 113.263 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -112.68 -46.1 3.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.619 0.767 . . . . 74.340000000000003 109.866 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.66 ' HG3' HD11 ' A' ' 70' ' ' LEU . 17.2 ttt -67.04 -12.81 60.96 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.046 1.128 . . . . 74.409999999999997 114.046 -173.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -60.25 -11.5 6.51 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.893 1.277 . . . . 74.310000000000002 114.023 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -58.75 -27.92 65.4 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.47 1.032 . . . . 63.140000000000001 112.002 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.38 -9.83 59.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 113.822 1.045 . . . . 70.310000000000002 113.822 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.25 -148.83 17.39 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 119.941 1.246 . . . . 52.119999999999997 110.3 -171.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.45 91.65 8.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.579 1.657 . . . . 71.540000000000006 110.08 -166.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.45 144.61 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 113.524 -1.671 . . . . 74.400000000000006 106.608 161.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 2.3 t -138.13 -2.47 1.85 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.282 1.215 . . . . 65.430000000000007 114.282 172.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.439 ' HB3' ' CB ' ' A' ' 56' ' ' GLU . 3.8 t80 -138.25 145.43 41.32 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 121.125 1.784 . . . . 73.319999999999993 106.8 168.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.45 145.16 38.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.376 -0.972 . . . . 74.310000000000002 108.376 165.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -151.73 141.96 22.34 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.548 1.139 . . . . 74.420000000000002 109.238 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.9 m -144.33 176.11 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.368 1.467 . . . . 73.409999999999997 108.123 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -146.64 -177.24 5.54 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.704 1.202 . . . . 74.120000000000005 108.151 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -83.03 51.4 1.94 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.111 0.869 . . . . 64.25 109.083 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -139.65 176.24 8.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.405 -1.331 . . . . 70.340000000000003 107.405 167.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.75 53.61 4.86 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.331 -1.108 . . . . 70.310000000000002 110.331 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.03 154.56 32.67 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.354 1.077 . . . . 62.049999999999997 110.523 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.96 170.53 32.58 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.481 1.515 . . . . 65.120000000000005 110.394 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.7 t -146.13 142.93 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.094 1.757 . . . . 71.010000000000005 107.309 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.528 ' HB ' HG23 ' A' ' 18' ' ' VAL . 54.6 t -145.21 164.02 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.113 -1.069 . . . . 73.329999999999998 108.113 -161.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' CB ' ' HB3' ' A' ' 44' ' ' TYR . 15.2 tt0 -138.4 144.69 40.33 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.806 -1.553 . . . . 54.229999999999997 106.806 172.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -115.7 167.89 10.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.809 2.043 . . . . 74.420000000000002 107.638 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.4 m -73.42 -33.06 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.649 0.611 . . . . 64.530000000000001 112.649 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -156.95 159.74 38.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.74 0.7 . . . . 74.540000000000006 109.592 -171.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -64.85 -20.75 66.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 118.138 -0.934 . . . . 74.230000000000004 112.287 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.18 -64.14 0.94 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.391 1.076 . . . . 74.099999999999994 108.797 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.34 -42.18 81.43 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.881 0.872 . . . . 73.5 110.146 177.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.442 ' HG3' ' CG1' ' A' ' 18' ' ' VAL . 47.9 ttp -51.63 -57.94 7.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.541 0.336 . . . . 74.310000000000002 110.647 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.5 m -61.17 -38.33 86.1 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.96 0.904 . . . . 72.5 112.817 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -54.36 -34.97 62.23 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.224 0.92 . . . . 71.109999999999999 111.394 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.481 ' HB1' HD12 ' A' ' 70' ' ' LEU . . . -55.69 -43.43 76.39 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.657 -0.652 . . . . 72.219999999999999 112.08 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.33 -19.36 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.929 -1.107 . . . . 71.420000000000002 109.934 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -86.91 -36.46 18.36 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.513 1.125 . . . . 72.430000000000007 111.493 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.7 mmtm -132.72 0.95 3.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.648 0.981 . . . . 75.0 113.648 -160.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.66 HD11 ' HG3' ' A' ' 36' ' ' MET . 1.7 tm? -143.34 16.64 1.87 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.386 1.075 . . . . 75.040000000000006 110.369 -167.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HB2' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -102.25 156.32 17.65 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 119.294 -2.129 . . . . 74.310000000000002 112.561 173.58 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.2 t30 55.22 19.78 3.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.58 1.952 . . . . 75.239999999999995 114.059 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.5 p -70.31 173.32 6.93 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.958 1.703 . . . . 52.509999999999998 110.766 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -78.39 178.11 7.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.401 -0.592 . . . . 73.439999999999998 109.401 163.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -156.03 141.08 17.34 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.486 1.514 . . . . 73.310000000000002 112.102 168.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -94.5 109.48 21.36 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.133 2.173 . . . . 63.030000000000001 111.529 -170.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -93.39 165.5 12.74 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.53 1.514 . . . . 45.409999999999997 110.935 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.58 -17.56 44.44 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.085 -1.009 . . . . 53.450000000000003 113.112 176.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -80.97 22.94 0.58 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.233 1.413 . . . . 72.409999999999997 112.123 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.62 33.07 83.37 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.687 -0.633 . . . . 74.329999999999998 111.818 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.53 169.13 20.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.288 1.435 . . . . 72.010000000000005 110.275 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.6 p -148.87 131.06 15.48 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.331 1.052 . . . . 62.210000000000001 108.673 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.04 -178.94 3.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.653 0.781 . . . . 62.310000000000002 109.277 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -90.81 160.7 15.63 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.152 -0.684 . . . . 72.450000000000003 109.152 163.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.1 pt -136.54 167.1 24.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.546 1.138 . . . . 62.350000000000001 109.856 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -137.57 122.11 18.45 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.585 -1.265 . . . . 75.409999999999997 107.585 -170.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 71' ' ' ASP . 1.4 p -84.86 148.79 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 118.47 0.577 . . . . 62.100000000000001 109.708 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.89 177.2 10.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.565 0.746 . . . . 71.230000000000004 109.896 162.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.02 153.95 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.503 -1.666 . . . . 75.430000000000007 106.503 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.4 t0 . . . . . 0 C--O 1.252 1.187 0 N-CA-C 105.959 -1.867 . . . . 72.319999999999993 105.959 158.843 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.901 0 N-CA-C 108.674 -1.77 . . . . 45.299999999999997 108.674 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.57 159.49 70.27 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 118.554 1.177 . . . . 72.299999999999997 110.233 -174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -70.89 161.36 46.34 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 N-CA-C 108.2 -1.5 . . . . 73.540000000000006 108.2 166.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -117.43 9.83 13.41 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 114.116 1.154 . . . . 73.340000000000003 114.116 -164.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.88 169.11 14.32 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 107.936 -2.066 . . . . 61.399999999999999 107.936 -157.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -151.08 129.44 12.04 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.302 -0.999 . . . . 73.129999999999995 108.302 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -150.98 146.48 26.26 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.195 -0.668 . . . . 73.340000000000003 109.195 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.3 -82.42 1.62 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.901 -1.28 . . . . 61.299999999999997 109.901 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -70.72 169.05 21.07 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.672 2.248 . . . . 61.109999999999999 112.974 -166.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.6 67.84 6.34 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.663 2.909 . . . . 72.299999999999997 111.339 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.5 m -132.48 152.76 51.42 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.415 1.486 . . . . 65.109999999999999 107.522 167.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -137.31 165.58 25.83 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.086 1.354 . . . . 73.120000000000005 108.851 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -82.43 -87.36 0.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.403 -0.962 . . . . 65.230000000000004 108.403 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -167.9 -178.55 3.83 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.661 2.384 . . . . 64.400000000000006 106.56 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' ' HE3' ' A' ' 60' ' ' LYS . 59.4 mt-10 -84.52 24.3 1.02 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.901 1.68 . . . . 75.219999999999999 112.27 -175.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.32 23.75 5.94 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 119.997 -1.689 . . . . 63.140000000000001 110.971 -169.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.2 122.02 40.04 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 121.376 -0.827 . . . . 74.120000000000005 111.132 -159.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 89' ' ' VAL . 3.2 m -127.07 159.96 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.24 1.816 . . . . 60.200000000000003 108.972 174.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 24.3 m -136.77 176.85 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 127.117 2.167 . . . . 74.129999999999995 108.139 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 53' ' ' GLY . 2.4 m -135.89 159.11 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.925 -1.139 . . . . 65.239999999999995 107.925 -162.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.88 169.52 22.63 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 123.912 0.885 . . . . 64.120000000000005 110.192 -176.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.09 11.1 69.96 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.008 0.813 . . . . 24.329999999999998 113.831 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.447 HD13 HG13 ' A' ' 47' ' ' VAL . 10.0 mt -60.31 148.83 78.49 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 118.845 1.323 . . . . 72.299999999999997 111.193 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -75.13 170.01 21.32 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.23 2.62 . . . . 72.0 110.39 168.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.93 -36.91 21.26 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.677 2.251 . . . . 70.430000000000007 113.969 -175.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.6 32.67 3.26 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 119.841 1.201 . . . . 64.319999999999993 110.918 -173.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.07 173.94 44.59 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-O 123.033 1.352 . . . . 61.039999999999999 109.776 164.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.4 p -159.43 168.88 25.18 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.063 1.745 . . . . 51.520000000000003 107.883 171.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -62.19 -27.34 68.9 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 122.116 -0.365 . . . . 74.099999999999994 111.26 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -65.02 -50.02 67.89 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.983 0.913 . . . . 73.010000000000005 109.807 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -67.45 -26.32 66.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.356 1.063 . . . . 73.430000000000007 111.02 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.08 -55.97 8.12 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.172 -1.047 . . . . 74.400000000000006 108.172 171.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -63.61 -35.75 81.56 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.299 -0.875 . . . . 72.040000000000006 111.85 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -75.3 -5.75 46.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.81 0.844 . . . . 64.319999999999993 113.244 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.501 ' CG ' HH21 ' A' ' 76' ' ' ARG . 2.2 t-160 -119.05 -43.7 2.63 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.262 1.025 . . . . 72.319999999999993 112.828 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.416 ' O ' HG21 ' A' ' 42' ' ' VAL . 8.8 ttt -76.27 41.83 0.25 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.452 -0.78 . . . . 74.099999999999994 110.752 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.2 ptm85 -111.28 -16.5 13.38 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.074 -1.641 . . . . 74.150000000000006 112.372 -170.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -84.58 -5.28 59.29 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.666 1.358 . . . . 55.240000000000002 114.666 -168.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.12 -13.73 24.82 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.755 0.822 . . . . 53.539999999999999 112.388 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.18 -176.23 24.33 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.767 -0.933 . . . . 72.310000000000002 110.767 -170.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.21 127.25 32.48 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.241 -0.564 . . . . 44.210000000000001 111.696 -166.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 36' ' ' MET . 30.2 t -118.05 123.29 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 C-N-CA 124.252 1.021 . . . . 74.430000000000007 108.948 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.82 -19.88 19.26 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 117.993 -1.003 . . . . 74.430000000000007 112.362 -177.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -130.02 166.98 19.0 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.362 1.437 . . . . 72.219999999999999 111.798 -170.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -163.29 139.73 7.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.412 1.085 . . . . 71.109999999999999 111.617 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -146.84 143.34 28.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.559 1.144 . . . . 64.129999999999995 109.741 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.447 HG13 HD13 ' A' ' 23' ' ' LEU . 42.4 t -144.41 148.4 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.074 1.35 . . . . 72.430000000000007 107.982 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -139.87 168.47 19.73 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.859 1.263 . . . . 72.420000000000002 110.554 175.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -84.06 40.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 127.294 2.237 . . . . 71.030000000000001 111.327 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -130.2 43.19 3.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.59 1.186 . . . . 71.239999999999995 109.205 170.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.14 12.34 30.16 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.357 -1.246 . . . . 33.439999999999998 114.523 172.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.3 p -143.12 157.45 44.51 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 120.429 2.115 . . . . 73.310000000000002 109.282 -169.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.542 ' N ' HG22 ' A' ' 20' ' ' VAL . . . -149.79 178.26 27.41 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 107.553 -2.219 . . . . 65.420000000000002 107.553 -172.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 31.0 t -155.96 137.79 5.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 105.393 -2.076 . . . . 74.040000000000006 105.393 -170.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.62 170.53 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.381 -1.34 . . . . 61.119999999999997 107.381 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -146.88 125.41 12.44 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.328 -2.101 . . . . 51.219999999999999 105.328 162.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -100.35 164.59 11.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.185 -1.783 . . . . 75.219999999999999 106.185 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.8 m -73.39 -29.5 27.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.307 -0.957 . . . . 73.209999999999994 112.266 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -151.82 165.41 34.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.526 0.603 . . . . 75.409999999999997 112.488 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 15' ' ' GLU . 8.7 ttmt -61.81 -28.38 69.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.884 -1.055 . . . . 74.329999999999998 110.944 176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.13 -59.76 4.33 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.17 0.896 . . . . 74.239999999999995 108.729 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.31 -46.52 86.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.586 1.555 . . . . 71.140000000000001 109.139 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -50.38 -55.46 15.6 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.253 1.021 . . . . 74.549999999999997 111.344 172.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.7 m -54.04 -44.2 70.84 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.779 0.718 . . . . 44.140000000000001 110.956 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -62.08 -40.88 97.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.11 -0.33 . . . . 75.239999999999995 110.11 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.95 -41.0 86.38 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.949 -0.469 . . . . 74.299999999999997 111.364 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.49 -10.24 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 121.497 -0.752 . . . . 53.109999999999999 110.975 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -119.12 -1.49 10.89 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.468 1.031 . . . . 71.140000000000001 113.721 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.0 -5.05 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.163 0.985 . . . . 53.009999999999998 112.586 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.99 24.24 3.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.633 1.173 . . . . 63.130000000000003 109.28 -171.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.34 156.83 17.59 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.796 -1.19 . . . . 71.129999999999995 110.361 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.13 20.96 1.96 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.389 2.276 . . . . 74.319999999999993 113.351 -174.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.3 p -74.31 174.62 8.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.528 1.931 . . . . 55.299999999999997 111.582 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -77.15 162.82 27.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.082 0.953 . . . . 73.430000000000007 110.116 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -148.18 121.13 8.77 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.726 1.611 . . . . 74.439999999999998 108.469 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.501 HH21 ' CG ' ' A' ' 35' ' ' HIS . 6.7 ptp180 -74.75 157.24 35.58 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.839 0.856 . . . . 72.030000000000001 109.747 173.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.9 p -141.42 163.26 33.42 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.13 0.572 . . . . 73.120000000000005 111.124 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -71.41 -12.43 61.41 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.579 1.551 . . . . 74.129999999999995 112.169 -174.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.75 8.58 2.32 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.755 1.222 . . . . 73.219999999999999 111.701 169.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.12 21.09 76.94 Favored Glycine 0 C--N 1.337 0.634 0 O-C-N 121.096 -1.002 . . . . 73.420000000000002 112.008 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -127.37 167.99 15.44 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.115 1.366 . . . . 74.340000000000003 109.065 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -140.27 145.6 37.51 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.387 -0.968 . . . . 73.019999999999996 108.387 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -127.26 -168.92 1.95 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.499 1.92 . . . . 72.200000000000003 107.022 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -103.72 161.94 13.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.785 -0.82 . . . . 63.340000000000003 108.785 165.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.8 pt -132.65 162.97 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-O 121.189 0.519 . . . . 73.200000000000003 109.793 169.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -120.09 103.01 8.92 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.543 1.537 . . . . 72.329999999999998 108.086 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 t -70.0 139.27 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.623 -1.251 . . . . 75.200000000000003 107.623 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -138.05 168.02 20.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.327 0.967 . . . . 62.5 110.467 159.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.546 ' HA ' HG12 ' A' ' 18' ' ' VAL . 90.7 t -78.57 140.8 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.047 -1.464 . . . . 61.530000000000001 107.047 170.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 44.5 t0 . . . . . 0 C--O 1.248 1.003 0 N-CA-C 107.273 -1.38 . . . . 53.240000000000002 107.273 167.521 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.815 0 N-CA-C 109.744 -1.342 . . . . 51.409999999999997 109.744 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.49 150.18 28.12 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 125.306 1.442 . . . . 64.099999999999994 107.934 165.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.42 158.2 56.51 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 121.98 1.786 . . . . 54.229999999999997 111.192 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.25 145.96 29.61 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.404 -0.962 . . . . 74.230000000000004 108.404 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.47 -157.69 53.44 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.404 -0.678 . . . . 52.32 111.404 175.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.02 -174.49 2.55 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.275 1.43 . . . . 73.019999999999996 109.416 -175.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -91.31 58.77 3.73 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.489 1.116 . . . . 74.420000000000002 108.346 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.49 175.05 47.03 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.879 1.228 . . . . 65.209999999999994 112.328 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -67.87 167.63 20.9 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.884 2.389 . . . . 74.329999999999998 110.047 170.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.51 66.48 5.55 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.849 3.033 . . . . 54.200000000000003 109.882 173.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.8 m -142.11 103.99 4.39 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.62 1.568 . . . . 73.239999999999995 107.107 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -70.54 177.84 3.27 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.128 -0.693 . . . . 73.040000000000006 109.128 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -136.88 -82.59 0.36 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.088 -1.078 . . . . 74.430000000000007 108.088 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.0 m -150.7 171.3 17.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.807 1.643 . . . . 74.209999999999994 107.43 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.56 25.72 0.05 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.229 2.612 . . . . 75.450000000000003 113.212 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.52 35.77 3.81 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.485 1.514 . . . . 75.230000000000004 108.326 -177.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -115.77 124.43 50.75 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.771 1.628 . . . . 73.209999999999994 108.436 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.55 166.26 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.336 1.854 . . . . 74.049999999999997 110.05 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -137.0 141.11 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.275 1.83 . . . . 71.310000000000002 106.506 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.7 t -112.99 152.16 14.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.792 1.237 . . . . 75.430000000000007 107.725 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.99 164.34 32.37 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.585 -1.265 . . . . 72.140000000000001 107.585 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.88 14.33 82.26 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.815 -0.992 . . . . 60.240000000000002 113.07 -173.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.792 HD23 ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -64.61 145.27 98.67 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 119.762 1.781 . . . . 65.049999999999997 110.94 -166.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.792 ' HD2' HD23 ' A' ' 23' ' ' LEU . 55.5 Cg_endo -64.33 169.86 10.29 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.095 2.53 . . . . 73.219999999999999 110.717 175.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.16 -13.92 39.28 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.761 1.641 . . . . 72.140000000000001 113.108 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -138.37 17.65 2.75 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.429 1.27 . . . . 64.010000000000005 114.429 -155.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.74 97.7 1.18 Allowed Glycine 0 C--N 1.335 0.507 0 N-CA-C 108.51 -1.836 . . . . 62.140000000000001 108.51 170.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.92 179.2 4.43 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.833 0.816 . . . . 45.450000000000003 110.876 172.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -61.93 -28.09 69.29 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.723 -1.235 . . . . 73.409999999999997 114.272 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.33 -51.8 64.47 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.245 -1.391 . . . . 53.229999999999997 107.245 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.3 -47.52 83.42 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.137 1.375 . . . . 73.030000000000001 110.056 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.519 HD23 HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -48.43 -58.22 4.95 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.638 0.775 . . . . 75.25 110.024 177.329 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.02 -37.86 78.87 Favored 'General case' 0 C--N 1.338 0.08 0 O-C-N 122.101 -0.374 . . . . 65.340000000000003 111.017 -171.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -7.71 14.2 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.284 0.846 . . . . 73.120000000000005 113.284 176.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -112.29 -49.32 2.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.173 0.989 . . . . 75.140000000000001 111.858 174.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.1 ttt -70.53 25.25 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.774 1.629 . . . . 64.319999999999993 112.945 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.51 -7.42 41.3 Favored 'General case' 0 C--O 1.222 -0.392 0 O-C-N 120.175 -1.578 . . . . 71.030000000000001 113.292 167.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.69 -23.05 67.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.83 1.65 . . . . 72.450000000000003 113.801 -172.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.48 -8.39 58.38 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.486 1.515 . . . . 20.030000000000001 113.951 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.21 -110.28 0.43 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 119.852 1.206 . . . . 60.229999999999997 111.448 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.99 138.31 22.86 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.34 1.067 . . . . 74.140000000000001 108.229 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.472 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.4 p -122.34 135.81 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 C-N-CA 127.42 2.288 . . . . 71.420000000000002 109.595 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.1 p -103.17 -25.88 13.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.386 -0.825 . . . . 42.539999999999999 110.104 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.424 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 8.8 t80 -130.67 136.9 49.26 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.74 1.616 . . . . 71.049999999999997 109.071 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.92 150.05 46.73 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.003 0.921 . . . . 34.43 108.635 158.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -148.05 132.69 17.82 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.458 1.903 . . . . 73.200000000000003 107.494 172.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.1 t -137.98 137.61 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.599 -2.0 . . . . 65.209999999999994 105.599 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.29 -163.83 0.22 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.0 1.72 . . . . 70.310000000000002 109.833 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 ptm85 -43.54 -57.49 3.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.532 -1.667 . . . . 65.099999999999994 111.118 159.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -172.7 168.76 5.12 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.803 1.638 . . . . 61.340000000000003 114.443 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.28 -39.95 3.06 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 128.152 2.787 . . . . 72.099999999999994 114.822 168.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.96 168.47 19.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.997 1.399 . . . . 61.210000000000001 109.242 -173.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.71 152.29 23.38 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.063 -1.615 . . . . 42.420000000000002 109.063 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -118.4 139.96 43.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.731 -1.211 . . . . 70.450000000000003 107.731 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.4 t -140.92 146.51 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.486 -1.672 . . . . 62.109999999999999 106.486 -168.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 44' ' ' TYR . 23.6 mt-10 -138.29 106.97 5.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 120.815 -1.178 . . . . 65.25 108.085 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.472 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 1.3 m-85 -76.51 163.76 26.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.201 1.801 . . . . 73.049999999999997 108.943 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.6 m -74.47 -39.17 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 120.955 -1.091 . . . . 63.329999999999998 112.499 -172.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -143.09 159.27 42.58 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.195 0.598 . . . . 75.420000000000002 110.412 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -67.26 -26.89 66.79 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 117.609 -1.186 . . . . 55.119999999999997 111.698 -174.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -51.72 -63.56 1.1 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 122.341 1.067 . . . . 75.010000000000005 108.429 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -73.2 -41.36 63.9 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.999 1.719 . . . . 72.439999999999998 108.446 -167.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.411 ' SD ' HG22 ' A' ' 89' ' ' VAL . 16.5 tmm? -52.62 -49.85 64.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.443 1.097 . . . . 75.319999999999993 111.245 170.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.4 m -61.19 -43.31 99.08 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.461 -0.774 . . . . 72.219999999999999 110.523 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -56.44 -41.31 76.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.93 0.786 . . . . 72.040000000000006 110.328 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.58 -43.49 68.56 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 123.729 0.812 . . . . 75.150000000000006 111.876 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.96 -34.94 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 120.596 1.543 . . . . 75.219999999999999 110.375 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.8 ptt85 -92.49 -16.32 25.96 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.145 1.165 . . . . 74.219999999999999 114.145 -170.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -117.18 -37.43 3.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.248 1.019 . . . . 54.119999999999997 111.482 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.04 22.57 12.05 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.367 1.467 . . . . 55.450000000000003 110.095 -167.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -101.16 154.96 18.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.306 1.412 . . . . 74.140000000000001 111.841 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.0 t30 63.7 14.88 8.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.148 2.579 . . . . 74.150000000000006 112.981 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.5 p -76.13 175.17 9.21 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.746 1.218 . . . . 73.430000000000007 110.832 -169.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -66.92 170.92 5.95 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.3 -0.875 . . . . 74.329999999999998 108.954 155.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -149.67 126.7 11.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.432 1.093 . . . . 74.040000000000006 109.553 166.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.5 mtt-85 -82.98 120.38 25.64 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.442 1.497 . . . . 75.25 111.511 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.8 p -76.25 -172.19 2.0 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.597 -0.89 . . . . 72.010000000000005 108.597 154.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -89.24 -8.16 54.02 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.006 -1.059 . . . . 71.140000000000001 110.99 165.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -76.82 5.55 7.59 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.84 -1.163 . . . . 73.340000000000003 113.64 -167.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.36 17.06 67.46 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 124.309 0.956 . . . . 74.150000000000006 110.845 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.6 167.14 20.58 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.139 1.376 . . . . 74.340000000000003 108.763 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.9 p -146.55 128.48 15.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.352 -0.981 . . . . 63.450000000000003 108.352 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.51 175.69 8.22 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.155 -1.054 . . . . 55.25 108.155 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -92.08 156.54 17.31 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.092 -1.818 . . . . 75.209999999999994 106.092 144.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.5 pt -131.64 173.74 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.558 -1.275 . . . . 72.150000000000006 107.558 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -128.94 150.4 50.4 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.231 -1.396 . . . . 75.25 107.231 168.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.8 t -122.62 137.21 56.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 126.081 1.752 . . . . 75.439999999999998 107.664 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.61 158.84 43.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.04 1.336 . . . . 62.25 108.902 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.411 HG22 ' SD ' ' A' ' 63' ' ' MET . 11.3 t -70.43 149.89 10.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.45 -1.685 . . . . 64.510000000000005 106.45 162.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.3 t70 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.813 -1.089 . . . . 75.409999999999997 110.369 172.445 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.948 0 N-CA-C 110.293 -1.123 . . . . 32.32 110.293 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.8 165.38 36.38 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.593 1.557 . . . . 64.450000000000003 108.733 -168.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.96 162.88 37.93 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.173 1.915 . . . . 75.230000000000004 110.903 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -146.89 104.57 3.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.235 -1.765 . . . . 75.040000000000006 106.235 -176.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.33 43.48 2.9 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.323 0.963 . . . . 42.100000000000001 112.569 -169.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.09 -176.3 5.04 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 125.162 1.385 . . . . 71.409999999999997 110.466 -173.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.72 -169.6 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.103 1.761 . . . . 74.310000000000002 109.952 165.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.33 -171.47 22.54 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 120.605 -1.309 . . . . 52.340000000000003 112.023 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.5 172.59 11.13 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 124.131 3.221 . . . . 65.219999999999999 112.955 -173.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -64.19 99.35 0.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.465 2.11 . . . . 74.239999999999995 109.202 160.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.57 166.12 12.47 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.548 1.539 . . . . 33.310000000000002 107.737 164.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.73 159.92 15.04 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.327 -0.62 . . . . 73.420000000000002 109.327 172.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -98.7 -79.28 0.48 Allowed 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.48 -1.304 . . . . 73.510000000000005 107.48 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.1 m -153.4 174.54 14.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.854 1.262 . . . . 72.209999999999994 108.509 165.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -73.42 44.65 0.16 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.446 1.898 . . . . 72.519999999999996 111.9 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.23 22.3 3.22 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.125 -1.609 . . . . 75.129999999999995 110.861 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -121.61 136.79 54.93 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.937 -1.102 . . . . 64.120000000000005 109.285 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.51 155.99 16.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.112 -0.699 . . . . 51.119999999999997 109.112 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.97 141.26 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 124.893 1.277 . . . . 72.409999999999997 107.671 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.0 t -101.88 147.27 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 126.727 2.011 . . . . 75.349999999999994 107.805 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.08 156.45 48.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.726 0.694 . . . . 74.439999999999998 110.632 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.94 3.53 70.3 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.674 1.13 . . . . 74.230000000000004 114.084 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.9 mt -58.26 147.12 68.23 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.449 1.1 . . . . 72.409999999999997 113.448 -164.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.22 165.6 31.91 Favored 'Trans proline' 0 CA--C 1.538 0.694 1 C-N-CA 126.051 4.501 . . . . 74.219999999999999 112.841 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -67.61 -15.76 45.43 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.669 2.913 . . . . 62.530000000000001 114.754 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.04 22.72 9.48 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.536 1.134 . . . . 73.200000000000003 110.023 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.45 72.75 2.71 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.56 -1.016 . . . . 74.239999999999995 110.56 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -69.68 162.8 26.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 124.423 0.72 . . . . 72.129999999999995 111.126 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.0 p-90 -61.55 -19.54 62.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.714 0.806 . . . . 74.239999999999995 111.467 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -60.49 3.28 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 117.093 -1.432 . . . . 74.030000000000001 109.385 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -64.46 -39.9 94.69 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.128 0.893 . . . . 54.420000000000002 109.544 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -48.6 52.37 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 123.247 0.619 . . . . 64.510000000000005 110.866 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -67.77 -44.15 78.14 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.708 0.685 . . . . 75.230000000000004 110.81 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.41 -13.07 62.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.767 1.227 . . . . 63.219999999999999 112.499 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -108.74 -43.85 4.16 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.986 1.314 . . . . 75.430000000000007 112.455 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.5 ttt -77.59 42.72 0.37 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.59 -1.319 . . . . 61.140000000000001 111.198 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.5 -5.65 12.83 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.092 -1.63 . . . . 64.120000000000005 113.366 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -63.19 -22.55 66.94 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.565 1.529 . . . . 72.329999999999998 113.833 -172.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.47 -5.44 59.16 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.06 1.504 . . . . 74.349999999999994 115.06 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.27 -98.6 0.21 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-O 118.349 -1.251 . . . . 44.140000000000001 111.034 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.15 149.53 31.19 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.579 1.189 . . . . 71.430000000000007 112.188 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.4 t -130.55 148.22 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.79 1.636 . . . . 72.239999999999995 109.509 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.9 t -129.76 8.19 5.29 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.525 0.73 . . . . 64.439999999999998 112.293 -170.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -154.08 162.88 40.89 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.593 1.557 . . . . 74.120000000000005 108.81 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -162.04 129.9 4.04 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.867 0.867 . . . . 73.010000000000005 109.583 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -155.75 128.61 7.99 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.268 0.94 . . . . 72.140000000000001 111.184 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.01 177.38 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 O-C-N 120.522 -1.361 . . . . 71.329999999999998 107.398 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.21 161.04 42.27 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.312 -1.366 . . . . 63.329999999999998 107.312 168.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 42.36 -86.87 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.426 1 C-N-CA 132.116 4.166 . . . . 72.209999999999994 112.114 162.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -165.48 -178.02 4.73 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 128.002 2.521 . . . . 71.120000000000005 110.209 153.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.74 -21.12 31.47 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-O 117.879 -1.512 . . . . 74.099999999999994 114.293 161.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.02 164.82 37.28 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 120.154 1.977 . . . . 73.430000000000007 108.448 168.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.0 143.05 8.17 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 107.816 -2.114 . . . . 72.140000000000001 107.816 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.7 p -107.99 144.9 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.726 1.263 . . . . 75.530000000000001 109.567 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.2 t -142.81 156.58 18.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 107.152 -1.425 . . . . 71.540000000000006 107.152 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -136.49 112.85 9.91 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.93 -1.507 . . . . 73.019999999999996 106.93 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -80.0 177.81 8.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.977 -1.465 . . . . 73.530000000000001 107.237 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.54 -60.99 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.046 -0.979 . . . . 64.230000000000004 110.399 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -139.19 169.17 18.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 124.24 1.016 . . . . 75.310000000000002 109.671 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -59.45 -29.73 68.0 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 116.875 -1.536 . . . . 63.520000000000003 111.791 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -60.55 -60.01 4.48 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.086 1.312 . . . . 63.25 109.877 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.64 -42.45 98.15 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.904 0.882 . . . . 71.540000000000006 109.695 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -58.31 -50.61 73.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.282 1.033 . . . . 70.439999999999998 110.721 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.9 m -57.57 -52.76 64.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.255 -0.646 . . . . 70.25 109.255 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -56.57 -32.13 64.89 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.627 0.771 . . . . 74.549999999999997 112.077 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.54 93.64 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 123.304 0.641 . . . . 63.329999999999998 110.024 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 t -70.29 -12.99 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.229 -0.919 . . . . 52.219999999999999 110.84 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -105.35 -33.1 8.29 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 120.875 -1.141 . . . . 64.209999999999994 111.957 -174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -121.51 -12.42 8.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.377 1.071 . . . . 72.540000000000006 112.759 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.1 18.24 10.81 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.246 1.818 . . . . 73.549999999999997 109.434 -172.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -112.57 148.71 33.97 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.725 -1.234 . . . . 74.239999999999995 110.836 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.77 27.84 16.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.395 1.078 . . . . 72.329999999999998 111.032 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.1 p -90.44 175.93 6.9 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.85 1.26 . . . . 44.329999999999998 109.807 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.86 167.82 21.11 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.831 -0.803 . . . . 62.350000000000001 108.831 158.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -146.05 160.79 41.4 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 127.328 2.251 . . . . 64.340000000000003 110.656 173.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -114.93 126.18 54.49 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.313 0.96 . . . . 60.439999999999998 109.16 -173.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.7 t -93.33 163.58 13.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.874 -0.787 . . . . 75.5 108.874 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.52 -8.37 56.56 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 119.112 -0.47 . . . . 73.200000000000003 111.749 166.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -78.43 -12.99 60.04 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.927 1.239 . . . . 73.219999999999999 113.339 -169.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.65 31.69 4.77 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 124.327 0.965 . . . . 74.239999999999995 111.864 -173.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.1 168.29 26.41 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.036 0.934 . . . . 73.109999999999999 110.936 -169.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.5 p -145.2 122.53 11.59 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.566 -1.197 . . . . 73.439999999999998 108.565 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.02 -174.17 2.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.603 1.961 . . . . 61.399999999999999 108.392 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -105.1 156.37 18.14 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 120.477 1.489 . . . . 72.430000000000007 110.59 172.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.6 pt -129.8 170.37 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 122.115 0.96 . . . . 65.129999999999995 108.987 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -130.61 155.51 46.42 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 104.791 -2.299 . . . . 71.140000000000001 104.791 172.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.8 t -125.97 137.33 58.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.982 -1.118 . . . . 72.530000000000001 107.982 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -130.41 147.7 52.14 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 123.853 0.861 . . . . 65.400000000000006 110.592 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.66 127.61 24.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 105.722 -1.955 . . . . 61.350000000000001 105.722 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 127.678 2.391 . . . . 51.210000000000001 111.09 -172.992 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.694 0 N-CA-C 110.356 -1.098 . . . . 70.5 110.356 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.81 164.77 19.92 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.827 2.051 . . . . 63.530000000000001 107.526 172.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -82.24 165.69 16.65 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.316 2.011 . . . . 73.519999999999996 112.476 -171.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -150.94 178.24 9.35 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.186 2.194 . . . . 65.099999999999994 109.145 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.52 85.14 0.06 OUTLIER Glycine 0 C--N 1.336 0.549 0 N-CA-C 109.523 -1.431 . . . . 52.329999999999998 109.523 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.96 78.48 1.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.285 1.043 . . . . 63.43 109.965 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -157.61 124.25 4.94 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 120.866 -1.146 . . . . 74.340000000000003 109.059 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.19 177.18 29.22 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.923 1.249 . . . . 63.229999999999997 112.627 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.6 172.41 10.47 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.198 2.599 . . . . 73.420000000000002 109.976 164.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.78 78.51 2.8 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.337 2.691 . . . . 70.010000000000005 110.464 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.4 m -90.49 157.0 17.78 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.062 -0.718 . . . . 72.319999999999993 109.062 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.84 -175.54 3.76 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.959 1.304 . . . . 74.0 110.474 -175.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -146.07 -81.08 0.15 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.817 0.847 . . . . 72.140000000000001 110.205 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.2 m -154.48 159.0 40.76 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 128.696 2.798 . . . . 71.120000000000005 106.97 -163.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -76.34 37.15 0.16 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.709 1.603 . . . . 53.439999999999998 112.301 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.8 14.94 3.63 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.465 1.906 . . . . 71.340000000000003 110.746 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.33 121.39 42.66 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.512 1.525 . . . . 73.019999999999996 107.526 -162.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.457 HG23 ' HB ' ' A' ' 55' ' ' VAL . 20.8 m -115.14 166.12 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 118.504 0.593 . . . . 52.32 111.455 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.3 t -132.74 153.01 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.092 -1.818 . . . . 72.340000000000003 106.092 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 t -134.11 141.03 44.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 106.955 -1.498 . . . . 74.420000000000002 106.955 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.3 m -137.31 141.81 41.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 123.127 1.442 . . . . 74.329999999999998 113.266 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.19 37.43 48.8 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 128.578 2.99 . . . . 52.240000000000002 112.773 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.63 160.77 3.67 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.853 1.661 . . . . 73.409999999999997 113.021 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.83 171.02 14.13 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.612 3.541 . . . . 70.510000000000005 112.014 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.76 -4.89 16.18 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.739 2.293 . . . . 73.230000000000004 114.239 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.8 t -141.58 51.66 1.55 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.615 1.166 . . . . 70.430000000000007 109.08 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.95 164.55 13.22 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.365 -1.494 . . . . 54.409999999999997 109.365 168.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 m -151.66 168.41 25.09 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.405 1.482 . . . . 51.409999999999997 108.426 167.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -53.0 -29.3 28.39 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.203 0.816 . . . . 62.310000000000002 113.203 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -62.79 -58.24 8.11 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.424 1.089 . . . . 72.439999999999998 108.911 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.3 -30.6 67.64 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.453 -0.573 . . . . 70.129999999999995 109.453 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -51.29 -56.05 15.05 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.33 -0.856 . . . . 54.119999999999997 109.78 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -70.47 -35.62 73.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.919 1.288 . . . . 65.530000000000001 110.034 -175.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -59.63 -23.04 62.68 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.245 1.018 . . . . 73.329999999999998 112.953 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -102.59 -42.89 5.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.153 0.981 . . . . 72.329999999999998 111.431 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.19 -20.42 65.4 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.154 -0.966 . . . . 74.430000000000007 113.244 -174.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -52.55 -26.2 12.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.827 1.417 . . . . 74.400000000000006 114.827 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -71.06 3.08 3.69 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.687 1.736 . . . . 65.430000000000007 115.687 -161.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.75 -0.96 28.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.642 1.177 . . . . 65.439999999999998 111.955 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.47 -97.95 0.16 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.617 -1.793 . . . . 50.020000000000003 108.617 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -157.76 162.53 38.51 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.795 1.283 . . . . 62.520000000000003 107.789 166.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.477 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -131.81 129.73 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 126.738 2.015 . . . . 64.319999999999993 109.818 -175.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.7 t -86.85 -32.62 20.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.577 -1.192 . . . . 61.409999999999997 109.341 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -138.47 137.16 36.9 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.156 -0.965 . . . . 74.319999999999993 110.638 -160.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.76 149.43 37.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.203 1.001 . . . . 65.219999999999999 110.771 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -161.63 106.97 1.3 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.879 2.072 . . . . 63.109999999999999 108.821 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.93 -176.71 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.282 -1.511 . . . . 72.510000000000005 107.985 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -143.16 155.17 44.5 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.892 -0.781 . . . . 74.519999999999996 108.892 156.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 43.37 -86.13 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 130.666 3.587 . . . . 63.109999999999999 111.838 166.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -159.38 173.97 15.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 125.231 1.582 . . . . 72.239999999999995 107.52 147.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.08 -8.92 63.27 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 118.605 -1.108 . . . . 71.439999999999998 113.343 161.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.56 164.84 33.93 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.635 1.717 . . . . 74.099999999999994 108.294 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -155.8 163.21 31.65 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.174 -1.17 . . . . 72.530000000000001 110.174 167.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.6 147.54 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.493 1.917 . . . . 31.140000000000001 108.23 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.457 ' HB ' HG23 ' A' ' 18' ' ' VAL . 72.1 t -144.0 166.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.943 -1.132 . . . . 73.439999999999998 107.943 -165.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -135.81 109.68 8.16 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.249 -1.389 . . . . 74.439999999999998 107.249 165.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.477 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -79.12 167.11 21.49 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.495 1.518 . . . . 53.219999999999999 108.336 172.049 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.71 -29.98 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.212 1.19 . . . . 70.129999999999995 114.212 -166.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -156.31 164.39 38.38 Favored 'General case' 0 CA--C 1.515 -0.381 0 O-C-N 121.262 -0.899 . . . . 74.200000000000003 109.894 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -61.72 -31.95 72.15 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 117.448 -1.263 . . . . 63.409999999999997 111.632 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.29 -51.92 65.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 120.379 1.445 . . . . 72.420000000000002 109.724 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.46 -40.69 66.8 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.258 1.423 . . . . 61.219999999999999 108.706 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.415 ' HG3' ' CG1' ' A' ' 18' ' ' VAL . 36.2 ttp -52.25 -53.82 38.95 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 123.338 0.655 . . . . 65.040000000000006 109.98 169.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.4 m -55.31 -47.46 75.57 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.306 -0.854 . . . . 54.399999999999999 109.977 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -57.53 -28.34 63.4 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.866 1.212 . . . . 71.510000000000005 112.113 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.1 -44.91 83.0 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.469 1.108 . . . . 72.230000000000004 109.227 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.8 t -65.09 -21.76 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 121.192 -0.942 . . . . 53.340000000000003 110.778 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -91.9 -43.78 9.29 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 120.964 -1.085 . . . . 74.409999999999997 111.317 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -114.44 -15.62 12.05 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.069 1.348 . . . . 63.439999999999998 111.998 -165.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.32 22.15 9.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.478 1.911 . . . . 63.299999999999997 108.95 -171.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -111.83 154.53 24.98 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.45 -1.407 . . . . 72.420000000000002 110.87 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.269 5.8 p-10 45.25 41.67 6.31 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.103 2.161 . . . . 72.420000000000002 112.327 -170.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.0 p -95.97 175.15 6.59 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.545 1.138 . . . . 54.439999999999998 111.668 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 171.78 4.09 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.078 0.551 . . . . 51.329999999999998 109.541 158.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -150.97 124.78 9.14 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.104 1.361 . . . . 74.200000000000003 109.328 166.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.453 ' HA ' HG22 ' A' ' 82' ' ' THR . 70.5 mtp180 -70.46 142.2 51.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.84 1.2 . . . . 43.329999999999998 110.47 177.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -109.11 -170.97 1.75 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.17 1.788 . . . . 65.200000000000003 107.507 176.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -99.6 -3.21 33.74 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.303 0.853 . . . . 71.239999999999995 113.303 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.73 41.46 1.39 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.494 1.117 . . . . 62.439999999999998 111.465 -171.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.41 18.48 55.78 Favored Glycine 0 N--CA 1.464 0.538 0 C-N-CA 124.924 1.249 . . . . 51.210000000000001 113.408 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -142.99 174.09 10.98 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 125.492 1.517 . . . . 74.510000000000005 108.894 -166.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 76' ' ' ARG . 52.5 p -147.19 143.35 28.14 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.813 -0.81 . . . . 71.540000000000006 108.813 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.21 176.81 8.13 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.619 0.768 . . . . 70.510000000000005 110.565 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -104.13 154.79 19.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.984 -1.487 . . . . 61.439999999999998 106.984 141.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 pt -133.4 166.43 29.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 124.828 1.251 . . . . 74.519999999999996 108.603 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -126.51 133.5 51.13 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 105.822 -1.918 . . . . 73.340000000000003 105.822 165.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.5 t -84.44 165.96 2.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 125.779 1.632 . . . . 72.109999999999999 107.703 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.77 156.43 31.55 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.552 1.541 . . . . 73.329999999999998 107.967 162.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.78 138.51 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 105.18 -2.156 . . . . 50.109999999999999 105.18 156.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--O 1.245 0.853 0 C-N-CA 124.044 0.938 . . . . 65.310000000000002 110.568 177.361 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.771 0 N-CA-C 111.609 -0.596 . . . . 55.229999999999997 111.609 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.49 158.1 57.19 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 125.877 1.671 . . . . 75.209999999999994 109.061 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.34 -55.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.559 2.173 . . . . 73.040000000000006 112.544 -171.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -172.54 165.94 5.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.121 -1.066 . . . . 74.340000000000003 108.121 -157.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.65 177.41 48.33 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 108.063 -2.015 . . . . 44.240000000000002 108.063 170.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -156.13 165.77 35.42 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.993 0.396 . . . . 73.450000000000003 110.415 161.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -148.51 -164.64 2.07 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.985 -1.117 . . . . 61.240000000000002 107.985 160.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.17 62.27 0.55 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.41 1.481 . . . . 64.420000000000002 110.886 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.17 170.81 9.98 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.271 1.98 . . . . 73.140000000000001 109.662 166.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.7 79.25 1.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.9 2.4 . . . . 74.519999999999996 110.148 174.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.0 p -145.35 164.56 31.09 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.911 1.284 . . . . 71.430000000000007 109.68 165.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.1 179.52 6.58 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.148 1.779 . . . . 73.140000000000001 108.143 169.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -134.92 -84.97 0.41 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.942 -1.133 . . . . 71.140000000000001 107.942 165.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.4 m -149.32 167.72 25.32 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.372 1.869 . . . . 72.420000000000002 108.319 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -70.53 24.35 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.054 2.541 . . . . 74.140000000000001 113.949 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.51 18.24 5.3 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.473 -1.392 . . . . 65.400000000000006 110.465 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.93 146.56 34.98 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.057 1.743 . . . . 64.310000000000002 111.106 -170.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.517 HG23 ' HB ' ' A' ' 55' ' ' VAL . 31.0 m -142.01 171.92 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 118.956 0.798 . . . . 74.430000000000007 111.012 -175.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 39.5 t -140.96 148.15 21.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.188 -2.153 . . . . 71.140000000000001 105.188 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 t -118.83 154.88 21.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 125.006 1.322 . . . . 71.340000000000003 107.683 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.6 m -149.45 158.49 44.22 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 119.955 -1.716 . . . . 73.310000000000002 110.525 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.39 61.42 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.889 0.757 . . . . 64.420000000000002 112.895 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.405 HD11 HD23 ' A' ' 32' ' ' LEU . 4.1 mm? -59.1 154.85 37.49 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 124.866 1.267 . . . . 73.049999999999997 112.238 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.63 174.54 12.06 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.45 3.434 . . . . 73.109999999999999 112.8 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.89 -8.08 21.74 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.625 2.217 . . . . 64.010000000000005 114.676 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.68 59.84 1.65 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.997 1.726 . . . . 51.240000000000002 109.685 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.97 149.12 16.87 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 108.199 -1.96 . . . . 63.119999999999997 108.199 172.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.1 m -137.6 -179.69 5.89 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 122.513 1.149 . . . . 72.140000000000001 108.144 168.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.3 p-90 -63.56 -18.53 63.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.92 1.288 . . . . 70.409999999999997 112.239 -176.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -69.89 -57.18 5.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.082 -1.081 . . . . 71.120000000000005 108.082 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -64.39 -26.91 68.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.548 0.69 . . . . 71.319999999999993 110.455 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.405 HD23 HD11 ' A' ' 23' ' ' LEU . 1.3 tm? -64.74 -54.05 37.46 Favored 'General case' 0 C--O 1.224 -0.264 0 O-C-N 120.235 -1.54 . . . . 50.219999999999999 110.653 174.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -65.51 -25.83 67.63 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.864 0.866 . . . . 73.310000000000002 110.865 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -31.89 64.97 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.808 -0.812 . . . . 74.310000000000002 108.808 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -83.82 -53.41 5.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.231 1.813 . . . . 72.510000000000005 112.088 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.9 ttt -81.64 39.42 0.54 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.64 1.176 . . . . 72.140000000000001 112.069 -167.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.81 2.28 14.33 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.229 1.412 . . . . 74.340000000000003 111.874 -175.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -85.78 -8.56 58.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.418 1.487 . . . . 64.5 113.174 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.61 25.22 11.88 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.979 1.312 . . . . 52.0 112.926 -166.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.51 -104.03 0.82 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 108.818 -1.713 . . . . 73.099999999999994 108.818 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -139.73 133.9 31.13 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.812 0.845 . . . . 64.329999999999998 110.64 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.6 t -127.97 136.04 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 126.195 1.798 . . . . 71.299999999999997 107.587 173.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.2 t -110.08 -26.13 9.86 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.462 0.541 . . . . 72.140000000000001 112.462 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -116.01 146.13 42.4 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.238 1.015 . . . . 72.420000000000002 109.721 -173.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.74 152.19 43.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.112 0.965 . . . . 71.25 108.463 163.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -148.58 144.66 27.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.569 0.748 . . . . 74.510000000000005 109.557 160.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -147.4 144.91 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 105.768 -1.938 . . . . 73.219999999999999 105.768 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -138.22 178.79 6.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.599 1.16 . . . . 73.340000000000003 109.343 -171.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -89.42 66.47 7.43 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.203 -1.036 . . . . 64.430000000000007 108.203 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -151.49 31.68 0.58 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.625 0.77 . . . . 63.420000000000002 110.414 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.75 18.75 40.22 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.062 -1.024 . . . . 61.450000000000003 113.616 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.7 p -146.93 170.22 17.52 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.222 1.511 . . . . 45.450000000000003 110.242 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.42 164.01 34.27 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.841 1.21 . . . . 72.230000000000004 110.469 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 28.7 t -131.4 156.01 42.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.572 1.549 . . . . 70.150000000000006 109.025 172.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.517 ' HB ' HG23 ' A' ' 18' ' ' VAL . 45.5 t -147.1 158.4 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.093 -1.447 . . . . 62.420000000000002 107.093 -175.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -145.0 114.45 7.14 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.325 -0.991 . . . . 50.420000000000002 108.325 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.78 174.77 7.01 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.822 2.449 . . . . 71.5 107.941 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.81 -49.25 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 117.606 -1.188 . . . . 53.210000000000001 111.11 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -137.09 157.84 45.79 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 120.471 1.487 . . . . 74.420000000000002 110.721 -167.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -62.88 -25.85 68.5 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 118.303 -0.856 . . . . 53.200000000000003 111.133 -170.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.66 -42.76 40.67 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 119.242 0.928 . . . . 73.109999999999999 111.299 -174.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -67.84 -44.44 77.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.082 0.855 . . . . 64.519999999999996 109.104 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.488 ' HG2' ' CG1' ' A' ' 18' ' ' VAL . 16.9 tmm? -50.6 -50.94 52.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.926 0.491 . . . . 33.43 110.938 173.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.9 m -56.58 -52.84 63.28 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.715 -0.659 . . . . 74.510000000000005 110.344 172.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -49.52 -40.84 39.26 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.489 1.515 . . . . 72.400000000000006 111.158 -174.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.39 93.35 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.102 1.361 . . . . 52.5 111.259 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.5 t -58.67 -25.77 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 121.413 -0.804 . . . . 75.120000000000005 110.269 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -106.87 -9.85 16.2 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.399 1.479 . . . . 71.329999999999998 111.852 -167.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -20.23 1.54 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 117.283 -1.341 . . . . 71.010000000000005 113.587 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.0 18.83 10.08 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.882 1.673 . . . . 74.420000000000002 109.737 -164.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -104.12 159.0 16.04 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.921 -1.112 . . . . 73.319999999999993 111.91 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 44.98 43.24 7.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.782 2.433 . . . . 74.430000000000007 112.044 -168.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.2 p -86.54 164.35 16.95 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.509 0.723 . . . . 75.450000000000003 110.731 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -88.07 157.62 18.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.553 1.141 . . . . 75.120000000000005 108.99 169.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -140.29 133.1 29.09 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.65 1.58 . . . . 64.219999999999999 109.519 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HA ' HG22 ' A' ' 82' ' ' THR . 62.6 mtt180 -81.82 112.28 18.81 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 123.692 0.797 . . . . 74.329999999999998 110.52 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.15 156.66 29.77 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.961 -1.125 . . . . 73.349999999999994 107.961 165.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -72.77 -11.36 60.58 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.94 -0.475 . . . . 74.540000000000006 111.196 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -70.05 3.64 2.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.778 2.031 . . . . 74.129999999999995 113.545 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.19 15.97 78.67 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 119.121 0.873 . . . . 50.539999999999999 111.525 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.13 170.88 14.36 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 126.841 2.056 . . . . 75.420000000000002 108.011 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.425 HG22 ' HA ' ' A' ' 76' ' ' ARG . 30.6 p -137.54 154.71 49.78 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.295 -1.743 . . . . 63.130000000000003 106.295 -177.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.07 -179.09 5.2 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.871 -0.789 . . . . 61.219999999999999 108.871 166.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -95.56 156.53 16.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.453 -0.573 . . . . 62.049999999999997 109.453 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.1 pt -124.95 168.83 17.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.552 1.141 . . . . 74.340000000000003 108.873 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -125.39 147.18 49.28 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.154 -1.424 . . . . 64.030000000000001 107.154 165.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.1 t -104.79 146.39 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 125.909 1.684 . . . . 74.409999999999997 108.794 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 160.61 43.77 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.211 1.805 . . . . 71.430000000000007 108.815 173.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.9 150.49 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 105.688 -1.967 . . . . 64.010000000000005 105.688 167.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t70 . . . . . 0 C--O 1.248 1.005 0 C-N-CA 125.477 1.511 . . . . 74.129999999999995 109.854 171.022 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.141 0 N-CA-C 110.113 -1.195 . . . . 62.119999999999997 110.113 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.04 160.69 34.48 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 118.188 0.994 . . . . 65.129999999999995 109.963 170.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -68.98 -175.76 1.07 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.083 2.522 . . . . 61.100000000000001 110.968 164.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.48 161.31 42.37 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.269 1.027 . . . . 52.109999999999999 110.2 -170.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.64 -168.04 26.43 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.354 -1.098 . . . . 72.209999999999994 110.354 169.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.55 164.96 34.71 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.164 1.386 . . . . 74.219999999999999 108.163 166.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -156.6 162.73 39.86 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.315 0.507 . . . . 74.239999999999995 110.908 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.1 67.82 0.03 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.859 1.218 . . . . 44.119999999999997 110.112 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.63 163.89 25.82 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.552 2.168 . . . . 72.519999999999996 111.341 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.6 78.38 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.302 3.335 . . . . 72.409999999999997 111.09 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 p -145.58 167.79 22.2 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 126.403 1.881 . . . . 63.43 109.621 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.83 167.56 25.31 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 127.538 2.335 . . . . 71.519999999999996 105.269 169.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 mtp-105 -127.26 -75.95 0.57 Allowed 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.2 -1.407 . . . . 52.219999999999999 107.2 165.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.3 m -146.74 165.66 28.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 123.053 1.406 . . . . 70.129999999999995 111.156 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -62.34 15.26 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 131.138 3.775 . . . . 71.519999999999996 113.17 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.43 14.85 3.46 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 119.093 -2.254 . . . . 44.240000000000002 111.314 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -104.49 142.61 34.32 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.63 1.172 . . . . 52.130000000000003 111.3 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.503 HG23 ' HB ' ' A' ' 55' ' ' VAL . 31.1 m -131.7 169.41 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.095 1.358 . . . . 63.439999999999998 111.601 173.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.7 t -133.86 151.3 32.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.948 2.099 . . . . 73.430000000000007 106.008 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.42 153.9 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.379 -0.971 . . . . 65.400000000000006 108.379 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.0 p -132.14 168.83 17.31 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 121.286 -0.884 . . . . 54.100000000000001 109.04 168.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.69 -6.45 58.88 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.713 -1.049 . . . . 70.430000000000007 113.644 168.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.83 152.58 26.56 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 125.082 1.353 . . . . 74.530000000000001 113.892 -165.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.26 173.55 12.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.763 2.975 . . . . 64.109999999999999 111.788 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.45 -7.55 12.7 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.071 3.181 . . . . 73.230000000000004 115.329 168.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.29 68.16 1.23 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 121.25 1.841 . . . . 64.430000000000007 110.787 172.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.92 115.51 3.49 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.35 -1.5 . . . . 64.319999999999993 109.35 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 m -111.06 164.05 13.23 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.324 1.05 . . . . 54.229999999999997 109.83 -174.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -66.48 -25.26 66.62 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.171 -0.956 . . . . 74.430000000000007 112.097 -168.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -68.75 -52.08 34.43 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.729 -0.841 . . . . 73.439999999999998 108.729 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -58.56 -41.32 85.36 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.772 -0.825 . . . . 73.25 108.772 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.95 -60.75 2.94 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-O 117.707 -1.139 . . . . 73.530000000000001 110.264 174.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -65.86 -32.83 74.58 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 120.904 1.683 . . . . 72.540000000000006 111.758 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.31 -30.02 71.24 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.458 1.103 . . . . 74.129999999999995 111.351 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.34 -48.56 6.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.774 0.43 . . . . 72.150000000000006 110.803 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.4 ttt -72.25 30.64 0.06 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.454 2.302 . . . . 65.129999999999995 112.843 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -108.92 -10.07 15.09 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 120.125 -1.609 . . . . 74.140000000000001 112.091 172.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -72.3 -9.75 58.89 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.269 -1.52 . . . . 64.439999999999998 113.828 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.03 8.34 43.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.335 1.054 . . . . 71.519999999999996 113.048 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.44 -127.25 3.28 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 109.334 -1.507 . . . . 71.439999999999998 109.334 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -142.02 131.82 24.26 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.247 0.523 . . . . 70.319999999999993 109.92 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -127.57 138.76 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 C-N-CA 126.095 1.758 . . . . 62.409999999999997 112.37 -175.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.1 t -112.51 -35.57 5.51 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.929 -1.032 . . . . 73.310000000000002 111.46 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -109.55 136.35 49.07 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.499 1.045 . . . . 73.329999999999998 108.887 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.69 143.88 31.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.256 -1.387 . . . . 13.42 107.256 166.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -158.6 129.44 6.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.482 -1.303 . . . . 43.340000000000003 107.482 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.82 163.02 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 120.798 -1.189 . . . . 74.140000000000001 109.286 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -149.38 169.23 21.32 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.437 0.637 . . . . 70.129999999999995 110.151 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -74.61 48.8 0.37 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.869 2.468 . . . . 72.310000000000002 113.059 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -138.56 15.78 2.73 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.851 -1.155 . . . . 63.229999999999997 112.283 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.55 20.46 66.3 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 120.761 -1.212 . . . . 45.340000000000003 113.016 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 p -138.45 177.43 7.89 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 119.036 1.418 . . . . 54.340000000000003 111.963 -169.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.6 168.53 40.16 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.817 1.198 . . . . 72.329999999999998 111.007 167.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 p -133.97 139.38 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.497 1.519 . . . . 72.319999999999993 108.115 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.503 ' HB ' HG23 ' A' ' 18' ' ' VAL . 55.2 t -146.41 148.36 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 107.78 -1.192 . . . . 72.329999999999998 107.78 -161.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -137.37 109.5 7.26 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.686 1.232 . . . . 65.239999999999995 108.979 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.461 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 3.6 m-30 -69.19 -179.52 1.6 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.952 1.701 . . . . 64.209999999999994 109.666 171.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.92 -50.55 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 O-C-N 121.238 -0.914 . . . . 72.549999999999997 110.068 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -142.6 159.07 42.95 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 119.281 0.946 . . . . 73.329999999999998 111.447 -169.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -59.31 -30.91 68.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.211 -0.9 . . . . 74.209999999999994 111.458 -173.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.6 -29.65 68.22 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.886 1.221 . . . . 70.310000000000002 112.296 -174.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -85.12 -40.83 16.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.725 0.81 . . . . 73.409999999999997 108.907 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -52.79 -51.94 58.74 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.769 -0.582 . . . . 70.409999999999997 110.626 171.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.6 m -48.64 -46.55 40.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.475 1.51 . . . . 45.439999999999998 110.728 171.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -59.46 -40.32 86.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.223 0.609 . . . . 70.530000000000001 110.221 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.53 -39.01 78.95 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.054 0.843 . . . . 44.43 111.677 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.79 -27.76 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.812 0.733 . . . . 65.400000000000006 109.897 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -106.39 -9.1 16.87 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 114.101 1.148 . . . . 74.230000000000004 114.101 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -133.78 -1.74 3.03 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 117.673 -1.156 . . . . 72.329999999999998 113.195 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.439 HD13 HG21 ' A' ' 73' ' ' THR . 0.1 OUTLIER -144.89 17.81 1.61 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 120.067 1.303 . . . . 72.310000000000002 111.97 -165.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.48 153.1 18.65 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.705 1.593 . . . . 62.420000000000002 114.432 173.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 52.68 33.09 13.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 128.488 2.715 . . . . 63.329999999999998 114.494 -173.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.439 HG21 HD13 ' A' ' 70' ' ' LEU . 75.2 p -82.38 172.78 12.69 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.4 -0.813 . . . . 74.219999999999999 110.748 -177.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.74 171.23 15.41 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.66 1.184 . . . . 74.540000000000006 109.356 168.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -144.87 122.63 11.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.746 2.018 . . . . 70.140000000000001 109.489 167.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -69.64 122.22 18.68 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.814 1.646 . . . . 54.329999999999998 109.436 170.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.0 p -87.45 172.87 9.48 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.752 0.705 . . . . 64.310000000000002 109.565 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -73.28 -9.87 59.16 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.336 -0.393 . . . . 71.25 111.919 165.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.62 23.33 10.54 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.539 1.536 . . . . 74.299999999999997 112.78 -164.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.43 4.5 38.27 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 123.344 0.497 . . . . 72.540000000000006 113.313 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -119.71 165.87 13.95 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.302 1.441 . . . . 64.120000000000005 108.752 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.2 p -140.77 142.05 34.76 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.561 -1.644 . . . . 51.020000000000003 106.561 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.09 169.08 12.04 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.915 1.686 . . . . 53.409999999999997 107.392 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -93.25 158.0 15.97 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.65 1.114 . . . . 71.209999999999994 109.256 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 pt -126.89 168.92 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.677 0.791 . . . . 74.5 110.644 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -129.28 120.32 25.48 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 105.162 -2.162 . . . . 71.409999999999997 105.162 163.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.5 t -67.66 149.18 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.575 -1.269 . . . . 74.430000000000007 107.575 162.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -144.28 165.72 27.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 123.872 0.869 . . . . 71.319999999999993 109.93 156.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 t -73.36 149.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.728 -1.582 . . . . 52.109999999999999 106.728 166.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.0 t0 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 124.785 1.234 . . . . 72.540000000000006 108.399 167.543 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.661 0 N-CA-C 111.777 -0.529 . . . . 62.240000000000002 111.777 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.25 161.96 50.24 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 126.321 1.848 . . . . 43.329999999999998 107.871 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.91 -57.05 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 120.648 1.267 . . . . 74.310000000000002 111.493 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 175.42 173.66 0.27 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.941 -1.133 . . . . 63.310000000000002 107.941 -157.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.2 -163.3 5.33 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.889 1.709 . . . . 73.040000000000006 112.022 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.62 169.51 24.14 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.505 1.522 . . . . 64.040000000000006 108.239 158.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.32 120.83 4.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 104.913 -2.254 . . . . 74.319999999999993 104.913 168.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.5 -170.05 24.07 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.453 -1.193 . . . . 72.319999999999993 111.909 -176.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -64.12 175.54 3.14 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.65 2.9 . . . . 74.319999999999993 113.105 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -55.66 -164.55 0.01 OUTLIER 'Trans proline' 0 CA--C 1.555 1.566 0 CA-C-O 124.726 1.886 . . . . 64.239999999999995 112.4 146.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 174.89 144.81 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 1 C-N-CA 132.565 4.346 . . . . 45.130000000000003 108.499 -168.127 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.474 ' HD3' ' H ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -78.95 178.02 8.32 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.548 1.139 . . . . 71.120000000000005 110.646 168.481 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -128.2 -83.2 0.59 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 118.774 -0.632 . . . . 75.030000000000001 109.687 162.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 m -152.39 173.25 15.32 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.812 1.645 . . . . 72.150000000000006 108.144 -169.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -80.74 33.87 0.33 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.439 1.895 . . . . 74.239999999999995 112.039 -170.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.38 29.08 3.33 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.158 -1.589 . . . . 55.450000000000003 108.948 175.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.77 145.2 44.67 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.746 -1.221 . . . . 64.209999999999994 109.77 -167.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.455 ' CG1' ' HG2' ' A' ' 63' ' ' MET . 18.3 m -141.18 175.37 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.554 0.741 . . . . 74.450000000000003 110.326 -173.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.1 t -135.08 155.48 37.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 107.674 -1.232 . . . . 74.25 107.674 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.7 140.44 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.903 1.681 . . . . 70.349999999999994 106.528 170.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -135.58 165.03 26.47 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.874 -0.787 . . . . 64.019999999999996 108.874 170.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.58 7.04 72.5 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.616 -0.547 . . . . 71.219999999999999 113.04 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.9 mt -63.85 156.52 72.66 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 119.136 1.468 . . . . 73.010000000000005 111.189 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.99 170.46 19.75 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.049 3.166 . . . . 65.239999999999995 110.534 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.28 -5.11 16.26 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.04 2.493 . . . . 72.319999999999993 114.932 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.53 34.78 4.75 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.886 1.221 . . . . 72.140000000000001 111.398 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.9 146.66 21.44 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.265 -1.134 . . . . 74.310000000000002 110.265 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 t -137.75 168.08 20.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.61 1.195 . . . . 64.329999999999998 113.428 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -67.19 -26.1 66.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.989 1.716 . . . . 74.030000000000001 111.455 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -61.82 2.35 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.6 -1.259 . . . . 73.310000000000002 107.6 175.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -63.73 -35.46 80.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.1 0.875 . . . . 64.0 109.72 -176.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -54.38 46.95 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.48 0.582 . . . . 75.099999999999994 109.834 175.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -67.57 -27.51 67.0 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 111.563 0.208 . . . . 75.239999999999995 111.563 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.01 -20.53 52.37 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.729 -0.607 . . . . 75.019999999999996 112.069 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -88.33 -60.6 1.92 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.628 1.571 . . . . 73.299999999999997 111.171 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -69.44 -13.4 62.34 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.372 1.249 . . . . 60.350000000000001 114.372 -160.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -8.9 0.06 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.848 2.859 . . . . 71.319999999999993 113.757 170.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.415 ' HB3' HD23 ' A' ' 70' ' ' LEU . 18.3 tt0 -58.75 -30.55 67.6 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.489 1.04 . . . . 73.409999999999997 112.256 173.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.35 0.94 57.44 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.28 1.215 . . . . 64.349999999999994 114.28 -170.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.71 -104.21 0.33 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 108.855 -1.698 . . . . 54.140000000000001 108.855 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -147.03 152.31 38.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.661 0.73 . . . . 74.239999999999995 109.451 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.2 t -141.74 120.36 9.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 127.245 2.218 . . . . 64.409999999999997 106.273 -165.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -102.43 -44.43 5.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.96 0.8 . . . . 72.409999999999997 110.926 -175.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -73.22 160.26 32.2 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.596 0.759 . . . . 73.340000000000003 110.607 174.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.94 128.35 5.56 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.269 0.94 . . . . 75.019999999999996 112.105 166.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -158.17 127.02 5.58 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.342 1.057 . . . . 52.420000000000002 111.309 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.8 t -143.81 158.89 16.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.467 -1.679 . . . . 63.130000000000003 106.467 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -138.51 171.01 14.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.735 0.814 . . . . 63.210000000000001 109.908 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -75.32 68.66 2.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.707 1.603 . . . . 63.229999999999997 108.245 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -148.61 174.03 12.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.978 2.911 . . . . 71.409999999999997 106.354 166.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.07 22.81 0.45 Allowed Glycine 0 CA--C 1.537 1.458 0 CA-C-O 117.379 -1.789 . . . . 74.439999999999998 114.597 165.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.3 p -133.46 158.08 43.97 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 121.01 2.405 . . . . 74.420000000000002 112.504 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.41 151.95 23.69 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 105.676 -2.97 . . . . 54.350000000000001 105.676 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.09 148.97 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.705 -1.961 . . . . 72.450000000000003 105.705 168.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.422 ' HB ' HG23 ' A' ' 18' ' ' VAL . 12.9 t -137.47 160.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.112 -1.44 . . . . 62.219999999999999 107.112 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -140.99 149.92 42.4 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.826 -1.916 . . . . 74.219999999999999 105.826 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -122.3 176.77 5.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.251 1.82 . . . . 74.120000000000005 108.573 -168.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -82.7 -39.21 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.314 -0.857 . . . . 64.010000000000005 111.36 -174.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -151.88 163.99 38.05 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.744 0.702 . . . . 71.030000000000001 110.1 -176.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -68.97 -27.41 65.69 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 117.773 -1.108 . . . . 60.25 110.944 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -58.68 -51.84 68.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.941 1.246 . . . . 75.129999999999995 109.39 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.31 -47.83 75.19 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.541 1.936 . . . . 74.430000000000007 109.012 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.455 ' HG2' ' CG1' ' A' ' 18' ' ' VAL . 12.0 tmm? -54.54 -58.47 7.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.453 0.701 . . . . 64.120000000000005 112.061 176.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.4 m -55.3 -44.93 76.22 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 118.013 -0.994 . . . . 73.340000000000003 110.31 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.1 -32.83 71.35 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.245 0.929 . . . . 73.430000000000007 111.211 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 70' ' ' LEU . . . -58.35 -41.64 85.12 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.813 0.845 . . . . 72.340000000000003 110.739 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.04 -18.77 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 O-C-N 121.008 -1.058 . . . . 70.329999999999998 109.842 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.08 -16.16 14.34 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.807 1.643 . . . . 71.120000000000005 114.129 -173.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -144.72 12.94 1.49 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.034 1.124 . . . . 74.120000000000005 114.034 -174.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.429 HD12 ' HB1' ' A' ' 66' ' ' ALA . 1.6 tm? -149.69 -1.66 0.44 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.874 1.216 . . . . 73.450000000000003 112.735 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.473 ' CB ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.86 156.23 19.95 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 119.134 -2.229 . . . . 65.200000000000003 112.884 172.368 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.4 t30 57.82 58.19 3.79 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.109 1.764 . . . . 73.129999999999995 109.98 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.6 p -128.7 168.24 16.09 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.39 1.076 . . . . 74.120000000000005 110.436 -172.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -80.43 161.56 24.87 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.731 -0.605 . . . . 73.219999999999999 111.521 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -146.89 127.17 13.89 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.231 1.413 . . . . 75.140000000000001 111.457 171.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -78.75 125.39 29.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.192 2.197 . . . . 73.099999999999994 111.203 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.2 t -94.79 169.75 9.93 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.062 0.945 . . . . 74.230000000000004 109.442 172.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -65.36 -30.37 71.19 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 123.898 0.879 . . . . 73.400000000000006 112.498 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.64 9.7 3.21 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.762 0.825 . . . . 63.109999999999999 112.104 -173.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.17 4.93 57.74 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 120.866 -1.146 . . . . 73.310000000000002 113.577 -175.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 81' ' ' GLU . 23.3 pt-20 -88.04 172.22 9.71 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 124.709 1.204 . . . . 50.539999999999999 109.107 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.2 p -142.06 160.37 40.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.207 -1.405 . . . . 53.439999999999998 107.207 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.32 -177.44 4.24 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.644 -0.873 . . . . 41.200000000000003 108.644 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -108.88 148.75 30.17 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.046 -1.094 . . . . 71.109999999999999 108.046 165.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.6 pt -134.15 162.36 39.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 122.208 1.004 . . . . 70.420000000000002 111.331 -171.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -136.29 109.34 7.7 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.978 1.711 . . . . 54.210000000000001 107.509 -162.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.473 HG12 ' CB ' ' A' ' 71' ' ' ASP . 2.3 p -77.69 156.21 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 124.834 1.334 . . . . 71.209999999999994 108.815 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -152.16 161.66 42.29 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.567 -1.271 . . . . 74.140000000000001 107.567 160.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.0 141.49 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.826 -1.916 . . . . 65.310000000000002 105.826 168.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 59.2 t0 . . . . . 0 C--O 1.256 1.445 0 N-CA-C 107.465 -1.309 . . . . 73.439999999999998 107.465 168.144 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.757 0 N-CA-C 108.647 -1.781 . . . . 73.25 108.647 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.22 155.03 28.52 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 108.402 -0.962 . . . . 64.340000000000003 108.402 162.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.17 163.6 34.65 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.937 2.424 . . . . 71.120000000000005 111.434 175.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -145.12 133.11 21.34 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.126 0.97 . . . . 74.450000000000003 108.823 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.29 -135.3 20.86 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 108.954 -1.659 . . . . 62.310000000000002 108.954 -172.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.51 -178.93 5.28 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.291 1.436 . . . . 74.409999999999997 109.306 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -115.22 155.89 26.36 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.223 1.009 . . . . 75.439999999999998 108.662 167.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.75 -179.53 5.03 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.928 1.393 . . . . 61.119999999999997 113.39 171.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.33 157.53 49.6 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.162 1.908 . . . . 62.229999999999997 110.185 163.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.54 66.82 6.46 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.855 3.037 . . . . 75.0 109.398 164.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -85.88 157.19 20.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.268 -1.012 . . . . 71.109999999999999 108.268 166.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -139.51 165.55 26.95 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.425 0.69 . . . . 64.0 110.346 -172.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.67 -67.26 0.8 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.671 0.788 . . . . 73.420000000000002 110.78 -167.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.9 m -156.55 167.99 28.76 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.554 1.941 . . . . 51.509999999999998 108.539 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -75.44 21.07 0.14 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.29 1.436 . . . . 71.030000000000001 112.966 -173.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.69 17.94 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.316 -1.49 . . . . 64.329999999999998 110.853 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 124.9 50.33 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.414 1.086 . . . . 74.120000000000005 112.273 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.609 HG13 ' HG2' ' A' ' 63' ' ' MET . 4.4 m -129.48 162.31 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.661 1.585 . . . . 63.100000000000001 109.592 171.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.28 171.09 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.782 1.633 . . . . 61.200000000000003 109.708 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.17 148.8 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.524 1.129 . . . . 62.32 108.102 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.92 164.96 25.78 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.53 1.932 . . . . 61.329999999999998 107.676 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.25 -2.12 47.05 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 124.892 1.234 . . . . 72.349999999999994 113.676 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.58 147.73 98.68 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 118.758 1.279 . . . . 44.310000000000002 111.666 -161.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.2 169.13 22.26 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.481 2.788 . . . . 75.409999999999997 110.24 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.63 -4.27 11.8 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.707 2.938 . . . . 64.349999999999994 114.173 174.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.29 41.7 3.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.081 1.353 . . . . 74.310000000000002 108.777 -174.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.44 106.36 1.31 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.756 1.646 . . . . 61.119999999999997 110.567 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 m -103.35 174.26 5.94 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.754 1.277 . . . . 73.129999999999995 111.683 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -67.33 -18.94 65.37 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.502 1.121 . . . . 74.319999999999993 112.688 -170.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -74.77 -53.82 8.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.346 -0.983 . . . . 70.209999999999994 108.346 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -58.09 -37.33 74.28 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.269 0.627 . . . . 64.25 110.187 173.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -56.76 17.63 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.92 0.888 . . . . 72.019999999999996 110.257 173.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -61.19 -37.8 84.23 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.692 1.133 . . . . 73.25 110.069 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.39 -8.29 56.29 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.035 0.934 . . . . 71.230000000000004 113.225 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.457 ' CE1' ' HA ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -92.36 -54.49 3.78 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.764 1.226 . . . . 74.439999999999998 110.763 163.724 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -80.02 77.85 6.69 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.988 1.315 . . . . 72.319999999999993 108.656 -169.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.77 -21.47 0.46 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.293 1.437 . . . . 72.439999999999998 112.386 176.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.4 -14.09 61.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.064 0.946 . . . . 74.010000000000005 113.304 -172.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.13 -27.8 35.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.201 0.6 . . . . 71.040000000000006 112.414 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.35 -170.88 17.26 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.19 -0.764 . . . . 65.319999999999993 111.19 -154.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.76 127.94 33.92 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 113.183 0.809 . . . . 62.420000000000002 113.183 -146.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.548 HG22 ' CE1' ' A' ' 57' ' ' PHE . 24.5 t -119.33 130.45 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 125.278 1.431 . . . . 63.130000000000003 108.446 -178.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.2 t -130.63 11.59 5.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.126 0.97 . . . . 65.099999999999994 111.243 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -152.99 139.63 18.83 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.076 2.15 . . . . 71.430000000000007 107.239 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.73 147.78 41.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.839 0.856 . . . . 72.150000000000006 109.471 163.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -162.16 142.38 10.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.946 2.098 . . . . 73.019999999999996 109.194 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.41 -172.35 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 125.849 1.66 . . . . 70.420000000000002 107.089 173.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -150.54 156.2 40.93 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.788 -1.56 . . . . 71.010000000000005 106.788 171.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.318 0.3 OUTLIER 41.45 -85.75 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 129.142 2.977 . . . . 63.450000000000003 112.654 152.152 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.94 174.73 14.52 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.181 0.991 . . . . 73.049999999999997 112.589 169.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.39 -41.33 3.06 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 125.677 1.608 . . . . 35.109999999999999 113.672 159.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.25 169.68 17.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.419 1.61 . . . . 72.409999999999997 110.285 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.55 167.98 35.9 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.578 1.561 . . . . 64.129999999999995 109.46 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.77 119.85 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 118.399 1.1 . . . . 73.150000000000006 110.303 -168.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -113.27 174.23 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.619 -0.882 . . . . 63.439999999999998 108.619 -166.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.39 125.99 11.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.609 1.55 . . . . 73.340000000000003 108.774 164.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.548 ' CE1' HG22 ' A' ' 42' ' ' VAL . 3.2 m-85 -99.48 177.5 5.15 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.251 1.82 . . . . 65.299999999999997 108.874 -175.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.4 -64.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 O-C-N 122.14 -0.35 . . . . 73.340000000000003 110.206 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -133.49 168.53 18.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.358 0.599 . . . . 65.129999999999995 111.637 -169.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -54.18 -33.56 58.39 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 114.353 -1.294 . . . . 71.219999999999999 110.706 176.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -54.16 -64.12 0.93 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.76 0.824 . . . . 65.109999999999999 110.265 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.64 -41.45 79.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.594 1.558 . . . . 73.120000000000005 109.387 -173.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.609 ' HG2' HG13 ' A' ' 18' ' ' VAL . 16.6 tmm? -53.47 -50.59 65.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.599 1.159 . . . . 73.329999999999998 111.198 174.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -66.42 -45.55 79.5 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.156 0.583 . . . . 54.530000000000001 110.602 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -56.7 -38.62 72.53 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.805 0.729 . . . . 74.420000000000002 110.134 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.62 -39.89 74.43 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.643 -0.694 . . . . 63.299999999999997 112.053 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.11 -26.3 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.102 1.319 . . . . 61.43 109.587 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -105.53 4.38 30.4 Favored 'General case' 0 C--N 1.343 0.305 0 N-CA-C 114.779 1.4 . . . . 63.420000000000002 114.779 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -148.4 -9.71 0.37 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.423 1.268 . . . . 72.319999999999993 114.423 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 70' ' ' LEU . 1.8 tm? -130.71 11.88 5.26 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.684 -1.26 . . . . 75.200000000000003 109.928 -167.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.426 ' HB2' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -96.53 159.98 14.64 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 120.679 -1.263 . . . . 74.299999999999997 113.723 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.5 t30 60.58 14.4 4.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.854 1.662 . . . . 75.030000000000001 113.61 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.3 p -76.68 174.99 9.77 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.261 1.824 . . . . 53.140000000000001 112.298 -169.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -67.39 171.0 6.48 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.235 1.014 . . . . 63.409999999999997 110.798 167.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.457 ' HA ' ' CE1' ' A' ' 35' ' ' HIS . 46.4 t80 -145.3 124.35 12.82 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.759 1.624 . . . . 75.439999999999998 112.015 164.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -72.08 126.32 29.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.486 1.115 . . . . 75.010000000000005 109.484 172.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.0 p -98.86 177.75 5.17 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.978 0.894 . . . . 71.349999999999994 110.303 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -76.17 -19.94 57.99 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.811 -0.556 . . . . 73.239999999999995 110.723 167.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -84.79 16.34 3.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.878 1.217 . . . . 64.010000000000005 113.429 -169.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.08 21.51 78.38 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.214 -0.754 . . . . 72.319999999999993 111.214 176.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.29 -175.01 3.91 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.176 1.79 . . . . 63.25 108.224 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 p -143.86 148.61 35.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.34 -0.615 . . . . 52.340000000000003 109.34 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -110.31 -163.69 0.87 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.407 1.083 . . . . 63.030000000000001 109.13 167.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -121.24 164.47 16.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.482 1.113 . . . . 74.150000000000006 108.681 164.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 pt -136.94 165.38 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.944 1.297 . . . . 73.140000000000001 110.547 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -132.29 128.62 38.17 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.625 1.97 . . . . 74.150000000000006 106.56 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 71' ' ' ASP . 1.3 p -94.68 150.72 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.831 1.196 . . . . 33.409999999999997 108.593 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 164.61 34.3 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.83 1.196 . . . . 75.430000000000007 110.067 160.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.534 ' HA ' HG12 ' A' ' 18' ' ' VAL . 30.7 t -61.58 136.13 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 105.277 -2.12 . . . . 75.239999999999995 105.277 163.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.8 t0 . . . . . 0 C--O 1.26 1.615 0 N-CA-C 107.165 -1.421 . . . . 74.239999999999995 107.165 175.708 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.573 0 N-CA-C 108.256 -1.938 . . . . 70.030000000000001 108.256 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.58 165.76 18.01 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.712 1.205 . . . . 74.030000000000001 109.705 -169.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.43 -174.9 1.36 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.988 2.459 . . . . 71.439999999999998 111.946 172.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.07 160.56 39.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.009 2.124 . . . . 73.329999999999998 107.195 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.79 -174.67 47.22 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.946 -0.861 . . . . 71.209999999999994 110.946 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.03 153.24 23.77 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 127.776 2.43 . . . . 65.25 107.205 -176.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -156.71 171.34 20.53 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.51 1.05 . . . . 53.350000000000001 110.545 -176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.83 85.08 0.07 OUTLIER Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.248 0.927 . . . . 72.310000000000002 111.88 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.2 164.25 35.83 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.523 2.148 . . . . 75.349999999999994 111.025 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.21 73.91 5.8 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.852 2.368 . . . . 61.549999999999997 111.556 -173.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.9 m -152.21 160.57 43.35 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 119.962 -1.711 . . . . 64.25 110.466 171.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.85 171.0 14.98 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 128.348 2.659 . . . . 64.349999999999994 108.694 173.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -132.97 -74.67 0.49 Allowed 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.209 1.003 . . . . 72.530000000000001 108.32 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 m -145.38 -175.59 4.77 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.362 1.865 . . . . 72.340000000000003 107.459 166.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 5.1 pt-20 -78.8 22.04 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.269 1.828 . . . . 64.549999999999997 113.088 176.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.64 50.82 1.99 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.286 -1.509 . . . . 74.329999999999998 107.046 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -130.06 137.49 50.25 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.667 1.587 . . . . 74.109999999999999 109.772 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.633 HG23 ' HB ' ' A' ' 55' ' ' VAL . 4.2 m -136.04 169.95 19.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 124.793 1.237 . . . . 73.540000000000006 110.952 -176.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.8 144.3 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 125.891 1.676 . . . . 60.439999999999998 106.879 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.69 146.07 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.613 -1.625 . . . . 72.310000000000002 106.613 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -137.42 160.68 38.41 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.114 -0.991 . . . . 64.209999999999994 109.193 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.47 12.96 84.04 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.427 -0.652 . . . . 64.140000000000001 113.491 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 mt -59.27 144.63 83.16 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 117.643 0.722 . . . . 72.409999999999997 109.694 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HB2' ' HD2' ' A' ' 25' ' ' PRO . 51.2 Cg_endo -73.57 171.94 16.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.387 2.058 . . . . 73.329999999999998 108.907 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 24' ' ' PRO . 35.5 Cg_endo -67.12 -15.85 47.51 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 CA-C-N 119.923 1.008 . . . . 42.539999999999999 112.822 -168.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.64 21.02 13.23 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.404 1.482 . . . . 53.439999999999998 111.643 -170.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.47 99.5 1.93 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.207 1.384 . . . . 72.239999999999995 111.688 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -94.87 179.57 5.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.644 1.577 . . . . 62.310000000000002 111.599 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.9 p-90 -62.26 -33.65 75.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.511 1.124 . . . . 74.209999999999994 112.397 -175.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -46.64 63.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.885 -0.783 . . . . 75.140000000000001 108.885 -173.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.71 -33.16 75.31 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.718 -0.658 . . . . 74.040000000000006 109.764 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -53.51 56.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.481 1.037 . . . . 73.319999999999993 109.39 174.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -63.45 -39.4 94.38 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.344 1.058 . . . . 74.400000000000006 110.36 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.19 -12.24 60.25 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.921 1.082 . . . . 64.310000000000002 113.921 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -99.95 -59.27 1.74 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.149 1.78 . . . . 72.310000000000002 112.78 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.522 ' HE2' ' CE1' ' A' ' 57' ' ' PHE . 11.5 ttt -72.83 37.91 0.08 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.777 2.431 . . . . 63.420000000000002 110.579 -171.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -107.38 -9.75 15.93 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 119.087 -2.258 . . . . 74.319999999999993 111.006 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -79.06 -27.96 43.11 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.091 -1.005 . . . . 64.340000000000003 111.997 -163.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.42 -10.97 58.08 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.028 1.331 . . . . 44.200000000000003 112.224 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.48 173.69 13.25 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.495 -1.442 . . . . 51.229999999999997 109.495 -165.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -97.25 153.86 17.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.2 1.0 . . . . 74.299999999999997 111.508 -160.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.457 HG22 ' CE1' ' A' ' 57' ' ' PHE . 64.9 t -125.49 147.76 30.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 125.408 1.483 . . . . 72.530000000000001 107.831 -166.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.8 t -111.41 -53.29 2.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.418 -0.956 . . . . 71.200000000000003 108.418 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -86.45 150.01 24.58 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.505 0.722 . . . . 75.340000000000003 110.155 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.72 125.72 15.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.641 -0.874 . . . . 64.409999999999997 108.641 168.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -156.55 124.44 5.56 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.864 0.84 . . . . 71.140000000000001 110.599 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.28 156.95 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.886 -2.264 . . . . 74.209999999999994 104.886 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -124.64 162.83 23.29 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 127.126 2.17 . . . . 73.129999999999995 107.618 170.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 43.55 -86.6 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 130.768 3.627 . . . . 70.140000000000001 112.612 153.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -170.91 168.87 6.96 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 127.206 2.202 . . . . 71.450000000000003 110.625 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.85 -15.39 32.08 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.757 1.17 . . . . 52.340000000000003 115.432 156.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.77 168.52 22.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 120.022 1.911 . . . . 72.25 108.492 164.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.2 167.66 35.6 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 108.878 -1.689 . . . . 75.319999999999993 108.878 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.12 144.09 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.083 -1.08 . . . . 71.450000000000003 108.083 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.633 ' HB ' HG23 ' A' ' 18' ' ' VAL . 38.3 t -146.62 157.53 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 106.706 -1.59 . . . . 61.210000000000001 106.706 -163.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -143.46 129.51 19.63 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.165 -1.05 . . . . 54.130000000000003 108.165 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.522 ' CE1' ' HE2' ' A' ' 36' ' ' MET . 3.6 m-85 -100.54 170.19 8.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.869 1.668 . . . . 75.340000000000003 109.257 -175.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.0 m -75.85 -31.15 21.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 71.200000000000003 112.315 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 43.2 ttt85 -154.9 155.74 34.85 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.664 -0.495 . . . . 60.509999999999998 109.664 -172.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.445 ' HE2' ' CE ' ' A' ' 63' ' ' MET . 14.6 ttmt -63.18 -26.46 68.81 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 117.723 -1.132 . . . . 73.510000000000005 110.931 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.0 -55.59 15.94 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 120.487 1.494 . . . . 74.230000000000004 109.285 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.15 -47.75 77.61 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.798 1.239 . . . . 72.209999999999994 109.525 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.445 ' CE ' ' HE2' ' A' ' 60' ' ' LYS . 59.7 ttp -54.04 -53.29 55.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.162 0.585 . . . . 61.32 112.047 176.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.7 m -54.33 -48.32 71.52 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.508 1.123 . . . . 64.129999999999995 109.102 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.534 ' CZ ' ' HE3' ' A' ' 69' ' ' LYS . 16.4 t80 -53.59 -38.98 64.47 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.315 1.046 . . . . 75.219999999999999 111.641 -175.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.04 -33.04 75.09 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.75 0.82 . . . . 72.319999999999993 110.832 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.4 t -70.09 -14.15 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 O-C-N 120.532 -1.355 . . . . 72.310000000000002 110.813 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -108.41 -37.73 5.89 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.04 -1.037 . . . . 72.319999999999993 111.469 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.534 ' HE3' ' CZ ' ' A' ' 65' ' ' TYR . 3.6 mptp? -108.87 -16.9 14.06 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.278 1.031 . . . . 71.040000000000006 111.743 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.9 7.53 8.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.24 -0.886 . . . . 74.439999999999998 111.17 -164.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.26 153.72 19.38 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 121.088 1.767 . . . . 64.439999999999998 111.164 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 t30 57.5 40.29 27.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.953 1.701 . . . . 70.099999999999994 111.591 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.4 p -103.39 -179.22 3.89 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.883 2.073 . . . . 71.019999999999996 111.287 -169.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.13 158.63 15.38 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.436 1.016 . . . . 61.439999999999998 110.305 171.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -137.26 146.22 44.48 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 125.588 1.555 . . . . 61.340000000000003 110.417 167.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -112.95 118.0 33.64 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.545 1.538 . . . . 75.030000000000001 110.908 -173.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 m -78.3 156.5 29.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 119.079 0.854 . . . . 62.009999999999998 109.3 167.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -62.61 -13.14 28.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.36 0.874 . . . . 75.299999999999997 113.36 168.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.87 12.23 0.72 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.944 1.697 . . . . 64.109999999999999 112.104 172.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.85 26.33 74.67 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 121.118 -0.989 . . . . 65.319999999999993 111.258 170.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -139.14 160.97 38.55 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 125.808 1.643 . . . . 61.43 108.684 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.8 p -145.84 149.81 34.98 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.154 -1.054 . . . . 74.030000000000001 108.154 -168.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.55 169.17 15.34 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.973 -1.121 . . . . 65.430000000000007 107.973 166.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -82.81 151.81 25.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.984 -1.117 . . . . 64.239999999999995 107.984 168.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.7 pt -125.16 166.27 21.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.418 1.487 . . . . 75.140000000000001 109.093 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -123.75 144.07 49.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.373 -2.084 . . . . 71.349999999999994 105.373 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.8 t -127.88 124.26 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.758 -1.571 . . . . 55.530000000000001 106.758 -172.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.38 153.33 51.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.446 1.098 . . . . 73.230000000000004 108.261 -170.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.423 ' HA ' HG12 ' A' ' 18' ' ' VAL . 12.1 t -71.34 153.18 8.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 106.08 -1.822 . . . . 54.450000000000003 106.08 162.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.881 1.272 . . . . 61.509999999999998 111.295 170.884 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.068 0 N-CA-C 109.908 -1.277 . . . . 72.140000000000001 109.908 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.66 156.53 24.94 Favored Pre-proline 0 C--O 1.24 0.554 0 CA-C-N 118.608 1.204 . . . . 73.25 109.069 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.84 -56.93 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.913 1.742 . . . . 71.040000000000006 110.55 168.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 178.85 150.12 0.26 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.987 1.267 . . . . 75.120000000000005 111.391 -168.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -116.82 150.17 18.6 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.044 1.307 . . . . 65.340000000000003 110.992 166.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 -168.18 109.11 0.55 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.826 2.05 . . . . 70.420000000000002 107.934 169.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CE1' ' HD3' ' A' ' 9' ' ' PRO . 9.8 t80 -164.73 -179.5 5.91 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.875 2.07 . . . . 63.329999999999998 106.557 168.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.21 85.62 0.73 Allowed Glycine 0 C--N 1.345 1.036 0 CA-C-O 118.138 -1.368 . . . . 65.239999999999995 113.206 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HD3' ' CE1' ' A' ' 7' ' ' TYR . 97.7 Cg_endo -74.99 154.39 42.52 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 121.215 2.507 . . . . 65.109999999999999 110.003 173.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.89 64.01 8.18 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.63 2.886 . . . . 64.200000000000003 111.149 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.0 m -125.37 108.86 12.1 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 128.176 2.59 . . . . 34.329999999999998 106.08 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -90.83 172.34 8.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.474 1.11 . . . . 74.230000000000004 110.768 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -125.69 -80.67 0.62 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.191 -1.04 . . . . 72.0 108.191 166.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -156.76 162.06 39.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 124.264 0.978 . . . . 53.520000000000003 109.051 -156.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -65.34 11.92 0.06 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.504 2.322 . . . . 52.530000000000001 114.802 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.72 26.7 7.07 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 119.729 -1.857 . . . . 71.340000000000003 109.199 -178.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -109.26 133.56 52.88 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.664 1.185 . . . . 71.230000000000004 109.107 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -129.32 168.81 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 126.009 1.724 . . . . 73.340000000000003 109.533 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.92 154.3 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.934 1.694 . . . . 61.119999999999997 106.809 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.3 t -130.12 152.07 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.229 -1.397 . . . . 42.130000000000003 107.229 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.6 154.97 48.71 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.268 1.027 . . . . 73.120000000000005 108.733 -175.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.75 6.4 52.53 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 117.905 -1.497 . . . . 34.009999999999998 114.176 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.46 149.87 91.06 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 120.037 1.918 . . . . 62.219999999999999 112.412 -160.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.07 170.03 13.88 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.966 3.111 . . . . 75.129999999999995 111.022 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.29 -8.3 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.675 2.25 . . . . 62.130000000000003 113.833 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.35 52.05 1.27 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.345 1.458 . . . . 72.430000000000007 109.204 -176.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.03 130.6 10.24 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 108.626 -1.79 . . . . 65.219999999999999 108.626 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -116.42 163.62 15.77 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.811 0.845 . . . . 71.230000000000004 111.221 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.3 p-90 -66.37 -23.96 66.42 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.838 0.681 . . . . 73.230000000000004 112.838 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -56.04 14.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.883 -0.784 . . . . 74.040000000000006 108.883 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -60.17 -35.61 75.73 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.847 0.859 . . . . 73.25 109.656 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -58.36 8.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 117.28 -1.343 . . . . 71.150000000000006 110.014 174.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -68.67 -37.62 79.74 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 120.066 1.303 . . . . 73.239999999999995 110.763 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.02 -24.78 64.77 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.562 1.545 . . . . 73.409999999999997 112.874 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -95.22 -46.64 6.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.636 0.374 . . . . 75.120000000000005 111.061 170.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.6 ttt -77.02 32.31 0.14 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.336 1.454 . . . . 75.120000000000005 113.086 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.2 -5.28 14.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 121.03 1.741 . . . . 63.140000000000001 114.308 171.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -61.27 -31.16 70.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.099 1.318 . . . . 62.450000000000003 113.874 -173.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.26 -0.88 13.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.839 1.256 . . . . 73.329999999999998 114.33 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.87 -100.97 0.21 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 108.153 -1.979 . . . . 71.400000000000006 108.153 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -154.11 163.57 39.88 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.021 0.928 . . . . 72.299999999999997 108.999 176.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.77 135.93 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.518 2.327 . . . . 73.310000000000002 109.822 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.3 t -90.81 -56.17 3.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.846 -0.798 . . . . 74.329999999999998 108.846 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -96.01 146.99 24.16 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.795 1.238 . . . . 73.310000000000002 109.588 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.55 136.18 21.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.846 -1.168 . . . . 45.200000000000003 107.846 168.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -148.86 131.2 15.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.436 -0.95 . . . . 74.310000000000002 108.436 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 91.9 t -140.75 140.73 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.086 -2.19 . . . . 71.0 105.086 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -77.32 -164.08 0.44 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.985 1.714 . . . . 71.329999999999998 109.996 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -44.4 -50.94 9.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.464 -1.698 . . . . 72.409999999999997 112.078 158.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -179.67 -179.11 0.49 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.195 1.398 . . . . 61.149999999999999 112.391 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.3 -34.39 3.46 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 128.226 2.822 . . . . 42.530000000000001 114.407 166.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.26 -179.05 6.75 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.772 1.286 . . . . 63.030000000000001 108.529 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.74 171.71 40.26 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 125.246 1.403 . . . . 63.299999999999997 109.67 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -141.75 135.11 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.738 0.78 . . . . 43.109999999999999 108.982 -173.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.52 145.13 25.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 108.405 -0.961 . . . . 73.319999999999993 108.405 -156.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -133.83 106.54 7.37 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.543 -1.651 . . . . 64.140000000000001 106.543 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.89 168.1 16.38 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 130.258 3.423 . . . . 71.400000000000006 109.876 -176.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -72.47 -42.3 64.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 121.305 -0.872 . . . . 73.120000000000005 111.573 -171.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -152.88 160.24 43.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.961 0.8 . . . . 61.200000000000003 109.462 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -63.96 -19.31 65.04 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.492 -1.242 . . . . 71.200000000000003 111.025 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -52.97 -65.95 0.47 Allowed 'General case' 0 C--N 1.345 0.407 0 C-N-CA 125.581 1.553 . . . . 62.43 108.684 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -75.33 -36.18 61.08 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.751 1.62 . . . . 73.299999999999997 108.836 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.428 ' SD ' HG13 ' A' ' 18' ' ' VAL . 39.2 ttp -51.33 -52.27 46.87 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.881 -0.414 . . . . 74.129999999999995 109.881 169.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.7 m -68.42 -12.16 60.74 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.939 -1.101 . . . . 64.140000000000001 113.359 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -79.95 -35.57 37.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 122.539 2.427 . . . . 74.239999999999995 110.083 169.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.65 -35.39 80.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.094 0.958 . . . . 75.200000000000003 110.198 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.73 -17.45 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.651 0.78 . . . . 73.0 111.163 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -120.24 -16.88 8.41 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.49 -1.381 . . . . 74.200000000000003 112.059 -163.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -132.35 -19.06 2.49 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.24 1.416 . . . . 64.230000000000004 113.807 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.23 11.99 16.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 120.081 1.31 . . . . 75.409999999999997 110.356 -168.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.48 161.44 13.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.893 1.224 . . . . 73.340000000000003 112.437 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.0 t30 56.96 17.86 3.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.523 3.129 . . . . 73.409999999999997 114.177 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.6 p -71.74 175.15 5.95 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.817 2.847 . . . . 71.120000000000005 112.731 -172.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.48 169.69 15.23 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.709 1.604 . . . . 71.129999999999995 109.656 171.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -150.58 135.16 17.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.972 1.709 . . . . 71.239999999999995 109.46 170.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -82.69 119.14 23.92 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 118.652 0.66 . . . . 72.25 109.977 176.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 t -81.05 154.57 26.78 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.3 -1.0 . . . . 74.319999999999993 108.3 165.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -62.45 -16.68 56.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.892 -0.575 . . . . 63.009999999999998 111.644 164.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.58 17.41 0.11 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.248 1.419 . . . . 74.349999999999994 112.413 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.26 21.18 71.92 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 124.31 0.957 . . . . 71.329999999999998 112.496 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.93 175.4 10.46 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.327 1.851 . . . . 72.420000000000002 108.412 -172.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.0 p -137.07 148.86 47.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.689 -0.856 . . . . 74.239999999999995 108.689 -174.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.01 176.74 7.82 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.776 -1.194 . . . . 74.030000000000001 107.776 172.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -102.25 154.74 18.75 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.721 0.691 . . . . 74.150000000000006 109.932 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 pt -133.34 160.39 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 O-C-N 121.924 -0.485 . . . . 55.140000000000001 110.457 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -131.65 106.98 8.51 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.101 1.36 . . . . 53.229999999999997 107.697 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.53 154.46 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 124.219 0.949 . . . . 74.340000000000003 108.83 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -145.82 173.36 12.18 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.708 2.403 . . . . 72.010000000000005 107.505 162.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.541 ' HA ' HG12 ' A' ' 18' ' ' VAL . 58.8 t -97.81 151.18 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 125.624 1.57 . . . . 72.439999999999998 107.742 173.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.381 1.072 . . . . 40.119999999999997 108.788 167.133 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.116 0 N-CA-C 111.063 -0.815 . . . . 44.149999999999999 111.063 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.71 154.18 58.95 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 124.341 1.057 . . . . 64.349999999999994 109.714 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -76.96 177.33 9.01 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.884 3.056 . . . . 75.040000000000006 110.86 174.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -146.05 164.55 31.77 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.9 0.88 . . . . 74.310000000000002 109.831 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.77 -161.95 36.63 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.212 1.386 . . . . 61.409999999999997 109.934 166.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 tpp85 -100.79 138.7 37.49 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.449 1.099 . . . . 73.140000000000001 108.818 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -156.1 -179.83 8.53 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.969 0.508 . . . . 75.439999999999998 110.085 148.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.32 70.45 0.46 Allowed Glycine 0 CA--C 1.536 1.396 0 CA-C-O 118.406 -1.219 . . . . 40.119999999999997 113.303 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.15 167.93 17.02 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.55 3.5 . . . . 51.210000000000001 115.079 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.48 91.82 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 125.016 3.811 . . . . 64.340000000000003 111.35 170.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.7 m -106.33 148.57 27.88 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.215 1.406 . . . . 71.450000000000003 110.19 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.76 174.2 9.48 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.559 0.744 . . . . 75.310000000000002 111.167 175.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.565 ' HG3' HH11 ' A' ' 17' ' ' ARG . 0.8 OUTLIER -118.45 77.81 1.2 Allowed 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 106.212 -1.774 . . . . 64.439999999999998 106.212 175.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.0 m -59.51 164.85 3.19 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.442 -1.254 . . . . 43.219999999999999 109.947 169.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.41 30.96 0.06 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.379 1.471 . . . . 71.310000000000002 113.093 -167.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.84 20.58 3.28 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.751 2.02 . . . . 74.049999999999997 108.754 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.565 HH11 ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -112.09 139.25 47.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.768 1.227 . . . . 74.319999999999993 111.907 -171.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.464 HG23 ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -147.94 170.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 126.078 1.751 . . . . 44.219999999999999 109.633 -172.751 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 19.6 m -136.14 174.31 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.014 1.726 . . . . 71.439999999999998 108.386 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -137.26 162.35 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.024 1.329 . . . . 72.25 108.297 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.75 165.07 37.17 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.458 -1.401 . . . . 75.310000000000002 108.424 -174.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.84 9.37 86.95 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 119.156 0.889 . . . . 74.099999999999994 113.239 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.19 150.84 69.77 Favored Pre-proline 0 N--CA 1.445 -0.681 0 CA-C-N 119.097 1.448 . . . . 75.400000000000006 112.194 -175.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.54 161.07 36.76 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.358 2.705 . . . . 75.340000000000003 111.516 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.44 -34.22 44.13 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.233 1.955 . . . . 63.5 111.563 173.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.81 60.51 0.71 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 122.488 1.137 . . . . 71.109999999999999 110.549 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -132.3 159.53 23.39 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 107.565 -2.214 . . . . 71.409999999999997 107.565 159.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m -128.39 -175.86 3.64 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.295 1.038 . . . . 63.009999999999998 109.059 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -62.08 -21.39 64.92 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.958 1.303 . . . . 72.329999999999998 111.057 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -57.24 11.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.929 -1.137 . . . . 73.129999999999995 107.929 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.82 -32.38 73.88 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.394 0.434 . . . . 71.0 110.894 175.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.39 -54.9 37.97 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.867 0.758 . . . . 61.240000000000002 110.303 176.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -64.28 -33.61 76.23 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.553 0.615 . . . . 75.209999999999994 110.827 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -74.5 -25.62 59.48 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.834 1.254 . . . . 62.420000000000002 113.526 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -102.26 -41.43 6.37 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.599 1.56 . . . . 75.439999999999998 111.545 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.3 ttt -81.59 53.39 2.1 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.334 -1.479 . . . . 74.319999999999993 109.884 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.29 47.5 2.48 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.332 1.453 . . . . 75.010000000000005 110.604 -170.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -135.65 -5.77 2.22 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.258 1.207 . . . . 75.239999999999995 114.258 -172.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.94 45.88 1.99 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.792 1.637 . . . . 63.43 110.726 -170.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.11 -107.32 1.95 Allowed Glycine 0 N--CA 1.47 0.967 0 N-CA-C 108.581 -1.808 . . . . 60.450000000000003 108.581 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.9 167.09 25.72 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.426 1.613 . . . . 64.239999999999995 111.761 158.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.01 135.73 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.505 1.522 . . . . 72.310000000000002 109.775 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.9 t -113.88 -24.06 9.3 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.53 0.567 . . . . 63.210000000000001 112.53 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -123.66 143.35 50.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.816 1.189 . . . . 53.219999999999999 109.263 -173.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.61 133.96 15.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.228 0.922 . . . . 54.420000000000002 110.688 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -149.48 131.21 15.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.17 1.388 . . . . 75.040000000000006 108.881 -177.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.93 171.31 16.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.946 1.298 . . . . 62.439999999999998 109.137 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -154.3 -177.89 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.115 0.966 . . . . 62.119999999999997 109.768 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -81.58 40.1 0.57 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.88 2.072 . . . . 55.100000000000001 111.833 -164.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -117.62 -25.67 6.83 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.836 0.854 . . . . 73.129999999999995 112.309 -171.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.38 6.48 64.42 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.452 -0.659 . . . . 72.129999999999995 111.452 -162.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -119.26 165.58 14.07 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.989 1.394 . . . . 74.040000000000006 110.448 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.75 174.61 28.34 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.64 -1.784 . . . . 34.210000000000001 108.64 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 70.1 t -146.69 134.53 15.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.619 1.568 . . . . 74.120000000000005 107.964 -173.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HB ' HG23 ' A' ' 18' ' ' VAL . 5.4 t -132.64 164.06 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.046 -0.724 . . . . 73.010000000000005 109.046 -169.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -142.5 124.51 15.29 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 120.433 -1.417 . . . . 73.049999999999997 107.45 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -94.11 174.64 7.05 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.604 1.562 . . . . 75.040000000000006 108.066 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.2 -64.01 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 118.69 -0.672 . . . . 54.149999999999999 110.901 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -139.85 172.13 13.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.628 1.104 . . . . 75.409999999999997 109.865 -166.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -62.85 -29.57 70.84 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.058 -1.026 . . . . 74.439999999999998 110.092 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -52.7 -63.43 1.15 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.862 0.865 . . . . 62.420000000000002 109.497 173.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.1 -47.99 83.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.771 1.229 . . . . 63.43 108.336 -175.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -57.32 -53.19 60.93 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.208 0.603 . . . . 60.420000000000002 110.914 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.4 m -59.3 -41.03 88.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.284 0.634 . . . . 44.340000000000003 110.282 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -56.96 -33.16 66.77 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 118.898 0.772 . . . . 74.129999999999995 111.741 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.61 83.16 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.392 -0.818 . . . . 73.209999999999994 109.971 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -71.81 -7.66 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 121.349 -0.845 . . . . 75.040000000000006 110.868 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.4 mtt180 -109.34 -31.96 7.35 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.855 0.862 . . . . 72.109999999999999 113.234 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -124.87 -6.16 7.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.843 1.257 . . . . 75.030000000000001 113.686 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.64 21.85 3.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.12 1.327 . . . . 64.129999999999995 110.86 -167.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.44 153.85 30.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.666 1.586 . . . . 75.450000000000003 109.777 170.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 62.27 11.35 4.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.572 2.749 . . . . 62.530000000000001 113.62 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.0 p -75.79 172.23 13.01 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.309 -0.869 . . . . 73.510000000000005 110.526 -172.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.469 ' HE3' ' OG1' ' A' ' 82' ' ' THR . 17.8 tttp -78.6 168.7 19.37 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 122.038 -0.414 . . . . 42.200000000000003 109.973 166.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -147.43 159.72 43.39 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 125.208 1.403 . . . . 73.040000000000006 111.866 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -116.46 148.04 41.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.747 1.158 . . . . 64.439999999999998 111.647 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.23 153.81 45.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.86 1.664 . . . . 74.099999999999994 109.284 -174.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -70.67 -12.54 61.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.175 1.176 . . . . 75.129999999999995 114.175 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.95 1.4 7.26 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.395 1.078 . . . . 75.400000000000006 112.728 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.26 9.1 63.79 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 124.08 0.848 . . . . 72.340000000000003 112.084 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -128.0 168.31 15.47 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 112.793 0.664 . . . . 64.430000000000007 112.793 -165.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.469 ' OG1' ' HE3' ' A' ' 74' ' ' LYS . 57.2 p -141.65 117.41 10.41 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.148 -0.933 . . . . 44.219999999999999 111.053 -175.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.83 173.19 7.8 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.584 1.953 . . . . 53.420000000000002 108.491 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -93.32 152.39 19.18 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.615 1.098 . . . . 72.420000000000002 108.478 159.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.5 pt -122.2 170.61 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.936 1.351 . . . . 74.109999999999999 108.839 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -125.33 143.19 51.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.751 -1.944 . . . . 74.219999999999999 105.751 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -110.8 146.34 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.325 -1.361 . . . . 55.530000000000001 107.325 168.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -142.98 159.94 41.29 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 122.109 -0.37 . . . . 62.450000000000003 111.156 163.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.4 t -61.16 138.96 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.603 -1.629 . . . . 61.32 106.603 165.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 43.1 t0 . . . . . 0 C--O 1.259 1.577 0 N-CA-C 105.257 -2.127 . . . . 75.239999999999995 105.257 166.22 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.517 0 N-CA-C 110.253 -1.139 . . . . 71.319999999999993 110.253 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.78 156.66 43.4 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 124.665 1.186 . . . . 33.210000000000001 110.421 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -76.14 -164.18 0.24 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 124.708 3.605 . . . . 70.150000000000006 110.554 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -146.86 -176.14 5.08 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.363 1.065 . . . . 74.349999999999994 108.67 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.95 7.78 71.56 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 116.809 -2.106 . . . . 65.310000000000002 116.893 161.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.34 142.1 23.71 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 121.096 2.448 . . . . 72.230000000000004 110.18 -176.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -62.23 171.8 1.7 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 127.092 2.157 . . . . 74.439999999999998 112.857 176.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.58 84.76 0.16 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.861 1.696 . . . . 72.510000000000005 109.264 170.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.43 169.85 18.78 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.424 2.749 . . . . 72.540000000000006 112.765 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.48 101.82 0.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.882 2.388 . . . . 54.409999999999997 109.632 163.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 m -130.49 116.4 18.14 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.808 0.843 . . . . 74.209999999999994 109.983 170.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.406 HH21 ' C ' ' A' ' 90' ' ' ASP . 27.7 mmm-85 -75.59 -167.96 0.76 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.535 0.683 . . . . 45.439999999999998 109.232 169.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -123.57 -85.43 0.65 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.729 -1.211 . . . . 65.430000000000007 107.729 167.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -147.45 172.39 14.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.528 1.531 . . . . 73.310000000000002 108.13 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 31.44 0.07 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.992 2.117 . . . . 52.340000000000003 113.272 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -132.7 24.28 4.34 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 119.334 -2.104 . . . . 73.150000000000006 110.317 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.0 139.35 47.57 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.346 -1.471 . . . . 71.349999999999994 110.704 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.43 159.99 22.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 126.455 1.902 . . . . 72.340000000000003 108.881 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 95.4 t -132.8 140.85 46.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 127.232 2.213 . . . . 53.119999999999997 106.147 -170.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.424 ' HB ' HD11 ' A' ' 23' ' ' LEU . 24.9 t -104.73 145.37 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.782 1.633 . . . . 70.439999999999998 108.414 177.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -131.97 160.62 35.27 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.779 -1.201 . . . . 74.420000000000002 109.197 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.02 5.58 67.83 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.695 1.141 . . . . 73.430000000000007 113.866 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.426 HD13 ' CG2' ' A' ' 47' ' ' VAL . 5.2 mt -64.65 151.49 92.03 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.133 0.973 . . . . 65.450000000000003 112.304 -165.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -76.21 161.29 35.38 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.93 2.42 . . . . 50.119999999999997 110.662 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -67.55 -39.17 12.74 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.4 2.733 . . . . 50.149999999999999 110.567 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.0 p -67.19 -0.3 3.29 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.65 1.98 . . . . 74.430000000000007 112.303 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.42 121.42 7.08 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 126.078 1.799 . . . . 50.439999999999998 109.416 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.769 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -142.07 -179.6 6.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.855 1.262 . . . . 71.209999999999994 108.482 171.367 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -62.01 -29.44 70.27 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.181 -0.914 . . . . 71.439999999999998 111.974 -158.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -58.69 -62.1 2.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.809 -1.182 . . . . 63.509999999999998 107.809 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.71 -47.11 74.13 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.589 0.755 . . . . 73.430000000000007 109.867 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.03 -45.03 87.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.954 1.702 . . . . 64.209999999999994 111.537 -176.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -69.36 -30.25 68.22 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 72.120000000000005 111.15 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -92.52 1.44 57.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.565 1.146 . . . . 53.329999999999998 112.778 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -121.46 -56.55 1.88 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.664 1.586 . . . . 64.329999999999998 112.285 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.5 ttt -75.01 79.72 2.2 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.378 -1.342 . . . . 74.5 107.378 170.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.39 -7.71 0.78 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.423 1.889 . . . . 71.200000000000003 111.873 173.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.59 -3.08 25.71 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.585 0.63 . . . . 72.140000000000001 111.88 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.38 -0.41 41.06 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 119.322 0.965 . . . . 61.420000000000002 112.913 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.27 -156.52 15.58 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.444 -1.062 . . . . 50.140000000000001 110.444 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.37 114.91 21.15 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.32 1.057 . . . . 53.43 110.694 -163.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.3 t -101.9 151.52 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.458 -1.312 . . . . 73.200000000000003 107.458 171.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.7 t -131.37 0.93 4.11 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.033 0.753 . . . . 74.519999999999996 113.033 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -161.81 144.82 12.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.7 1.6 . . . . 63.439999999999998 107.7 -169.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.61 139.44 22.92 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.8 -0.815 . . . . 63.219999999999999 108.8 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -155.51 107.48 2.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.508 1.049 . . . . 72.109999999999999 109.202 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.769 HG13 ' HA ' ' A' ' 28' ' ' SER . 1.3 p -135.71 144.82 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.228 1.811 . . . . 70.519999999999996 111.976 -171.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -135.27 156.57 48.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.429 1.092 . . . . 74.150000000000006 109.697 -164.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -81.37 35.38 0.39 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.996 1.318 . . . . 70.140000000000001 111.53 -169.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -115.42 9.58 15.57 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.959 1.703 . . . . 73.239999999999995 108.486 173.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.26 23.98 60.05 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 125.672 1.606 . . . . 73.439999999999998 112.886 174.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.96 162.91 34.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.28 1.04 . . . . 64.129999999999995 108.498 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.26 160.11 32.7 Favored Glycine 0 C--O 1.224 -0.469 0 N-CA-C 109.13 -1.588 . . . . 62.450000000000003 109.13 -169.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 88.7 t -132.53 155.36 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 125.595 1.558 . . . . 51.340000000000003 108.351 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.19 170.73 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 127.415 2.286 . . . . 53.420000000000002 106.032 -174.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -144.41 124.28 13.46 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.12 -1.808 . . . . 74.540000000000006 106.12 167.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -94.29 166.05 12.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.408 -0.96 . . . . 74.450000000000003 108.408 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -73.08 -37.86 54.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.378 -1.283 . . . . 51.43 111.835 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.4 ttm105 -154.04 156.69 37.81 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.328 0.651 . . . . 64.510000000000005 109.4 -168.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -61.12 -27.99 68.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 117.639 -1.172 . . . . 72.200000000000003 111.567 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.12 -50.32 74.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.839 1.2 . . . . 74.239999999999995 110.749 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -77.7 -41.58 37.46 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.539 -0.912 . . . . 74.299999999999997 108.539 -175.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -47.77 -50.86 24.41 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.615 1.166 . . . . 71.530000000000001 111.237 169.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.1 m -64.9 -47.47 77.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.369 -0.824 . . . . 70.540000000000006 111.216 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -54.84 -32.75 60.91 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.559 1.072 . . . . 74.310000000000002 111.324 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.34 -42.29 86.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.448 0.567 . . . . 51.0 111.681 178.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.89 -25.21 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.281 -0.887 . . . . 72.129999999999995 110.248 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -79.49 -41.84 26.57 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 117.519 -1.229 . . . . 71.299999999999997 112.553 -177.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -124.27 -16.98 6.26 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.186 1.18 . . . . 70.310000000000002 114.186 -170.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.32 1.44 32.77 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.779 1.232 . . . . 64.430000000000007 110.151 -171.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.11 147.97 25.08 Favored 'General case' 0 CA--C 1.527 0.078 0 O-C-N 120.27 -1.519 . . . . 65.319999999999993 113.65 -172.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 69.68 11.15 7.83 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.034 2.134 . . . . 64.200000000000003 111.531 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.4 p -83.97 163.07 20.2 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.032 1.333 . . . . 71.299999999999997 110.161 -169.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -77.81 156.92 30.18 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 120.892 -1.13 . . . . 71.430000000000007 109.706 168.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -107.72 -175.73 2.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.215 2.206 . . . . 73.120000000000005 110.768 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.1 mtt-85 -146.65 146.54 30.42 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 124.85 1.26 . . . . 73.200000000000003 107.681 169.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 p -142.3 159.98 41.15 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.794 1.238 . . . . 65.439999999999998 110.537 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -73.76 37.9 0.1 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.218 1.807 . . . . 72.420000000000002 113.551 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.4 16.43 4.48 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.557 2.343 . . . . 71.150000000000006 110.617 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.39 29.41 69.05 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 124.284 0.945 . . . . 64.230000000000004 112.227 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.52 173.9 11.17 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 125.82 1.648 . . . . 71.129999999999995 111.002 -173.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.7 p -144.8 147.72 33.21 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.255 -1.017 . . . . 73.310000000000002 108.255 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.02 176.43 5.3 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.504 1.122 . . . . 74.409999999999997 108.495 161.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -109.0 150.15 28.18 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 120.256 1.389 . . . . 74.319999999999993 110.45 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 pt -124.91 158.76 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 122.08 0.943 . . . . 71.209999999999994 112.207 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.0 mmm-85 -117.27 136.91 52.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.46 -1.681 . . . . 74.239999999999995 106.46 165.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 89.7 t -108.4 131.12 59.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.053 -1.832 . . . . 64.310000000000002 106.053 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -138.33 168.06 20.56 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.182 1.393 . . . . 73.230000000000004 108.332 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.4 t -87.82 161.34 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.046 -1.464 . . . . 74.549999999999997 107.046 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.406 ' C ' HH21 ' A' ' 12' ' ' ARG . 25.1 t0 . . . . . 0 C--O 1.252 1.197 0 N-CA-C 104.368 -2.456 . . . . 73.219999999999999 104.368 156.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.744 0 N-CA-C 110.5 -1.04 . . . . 40.119999999999997 110.5 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.33 155.28 28.72 Favored Pre-proline 0 C--O 1.237 0.443 0 CA-C-N 118.412 1.106 . . . . 75.0 111.85 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.05 -179.62 5.61 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.28 3.32 . . . . 73.030000000000001 111.847 163.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.4 mtm-85 -142.54 4.15 1.53 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.667 1.729 . . . . 75.120000000000005 115.667 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -123.76 -124.22 2.87 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 126.476 1.989 . . . . 51.310000000000002 110.777 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -139.72 136.84 34.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.469 1.634 . . . . 75.230000000000004 108.591 171.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -155.79 -174.88 5.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.273 1.829 . . . . 75.310000000000002 106.835 167.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.58 69.0 0.48 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 109.587 -1.405 . . . . 73.0 109.587 174.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -69.17 168.49 20.63 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.997 2.465 . . . . 64.400000000000006 110.705 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.55 83.01 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.534 2.823 . . . . 72.120000000000005 110.662 173.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -156.17 155.91 33.3 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.997 1.719 . . . . 72.010000000000005 106.59 170.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -53.76 166.51 0.32 Allowed 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.887 0.875 . . . . 75.420000000000002 110.066 156.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.4 mtt-85 -122.76 -83.12 0.66 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.234 -0.654 . . . . 74.430000000000007 109.234 167.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.6 m -151.48 152.46 33.03 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 104.2 -2.519 . . . . 73.400000000000006 104.2 -160.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -74.1 38.84 0.11 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.52 0.728 . . . . 74.209999999999994 111.748 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.6 28.27 2.71 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 119.52 -1.987 . . . . 71.209999999999994 110.053 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -130.2 154.85 47.13 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.954 -1.091 . . . . 72.310000000000002 112.704 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.525 HG23 ' HB ' ' A' ' 55' ' ' VAL . 2.1 m -144.01 168.49 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.296 1.438 . . . . 61.0 112.32 -171.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.24 136.09 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.638 -1.615 . . . . 43.329999999999998 106.638 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 98.3 t -105.26 150.7 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.63 -1.248 . . . . 41.140000000000001 107.63 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 p -150.17 153.09 35.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.443 1.019 . . . . 73.310000000000002 109.714 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.11 6.97 38.89 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.301 1.429 . . . . 64.310000000000002 113.311 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 mt -65.91 156.44 83.73 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.347 1.059 . . . . 74.219999999999999 113.171 -164.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.09 175.7 8.03 Favored 'Trans proline' 0 CA--C 1.537 0.674 1 C-N-CA 125.493 4.129 . . . . 64.519999999999996 113.294 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.31 -7.96 15.43 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.766 2.977 . . . . 62.130000000000003 115.238 172.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 t -148.81 56.6 1.02 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 120.531 1.514 . . . . 72.230000000000004 110.296 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.38 79.5 0.58 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.319 -1.113 . . . . 74.109999999999999 110.319 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -74.8 155.46 37.57 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 119.395 -0.922 . . . . 44.420000000000002 110.32 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -60.08 -25.38 65.35 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.932 -1.105 . . . . 75.540000000000006 112.205 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -59.3 -46.03 89.69 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.59 1.556 . . . . 75.409999999999997 109.579 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -71.14 -37.5 72.26 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.032 0.933 . . . . 63.399999999999999 109.074 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.418 HD22 ' ND1' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -56.65 -52.16 65.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.863 0.756 . . . . 62.399999999999999 111.164 177.585 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -62.06 -39.67 93.2 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.154 -0.684 . . . . 72.319999999999993 109.154 -174.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.97 -17.38 64.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.569 1.548 . . . . 54.0 112.066 175.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.418 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -91.84 -45.03 8.6 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 104.817 -2.29 . . . . 74.530000000000001 104.817 -174.23 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.43 ' SD ' HG11 ' A' ' 55' ' ' VAL . 7.8 ttt -82.26 -14.1 55.99 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.238 0.459 . . . . 63.439999999999998 112.238 -150.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.6 -0.91 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 130.77 3.628 . . . . 73.200000000000003 116.446 174.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -81.65 -16.14 52.33 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 120.704 -1.247 . . . . 70.099999999999994 112.315 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.13 1.74 57.03 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.078 0.77 . . . . 44.310000000000002 113.078 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.19 -161.15 15.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.027 -2.029 . . . . 74.129999999999995 108.027 -157.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.83 145.3 32.84 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.593 0.357 . . . . 72.239999999999995 111.002 -165.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 t -130.33 131.01 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.397 -2.075 . . . . 72.340000000000003 105.397 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.5 t -116.69 5.61 13.2 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.748 0.647 . . . . 70.439999999999998 112.748 -167.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -162.94 158.21 22.09 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 126.435 1.894 . . . . 73.099999999999994 106.737 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.04 150.04 34.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 119.579 1.081 . . . . 73.310000000000002 108.396 163.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -158.89 129.7 6.1 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 117.965 0.348 . . . . 64.319999999999993 110.721 167.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -128.8 114.44 33.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.868 -2.271 . . . . 73.430000000000007 104.868 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -77.52 153.8 33.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.081 0.952 . . . . 74.409999999999997 109.143 161.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 43.63 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 130.948 3.699 . . . . 74.430000000000007 110.92 168.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 178.97 178.08 0.47 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.317 1.847 . . . . 71.5 111.233 155.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.78 -18.62 56.96 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.867 1.222 . . . . 64.140000000000001 114.202 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 m -148.97 -179.03 6.7 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.671 1.589 . . . . 74.430000000000007 108.719 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.9 164.21 35.52 Favored Glycine 0 N--CA 1.465 0.621 0 O-C-N 120.385 -1.447 . . . . 63.200000000000003 111.164 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.36 131.98 51.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 124.119 0.968 . . . . 75.409999999999997 108.518 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.525 ' HB ' HG23 ' A' ' 18' ' ' VAL . 67.6 t -144.0 154.98 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.328 -1.36 . . . . 71.400000000000006 107.328 -160.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -139.07 131.95 29.3 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.763 -1.569 . . . . 72.099999999999994 106.763 -172.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -101.8 -178.11 3.62 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.703 1.201 . . . . 70.299999999999997 108.056 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.47 -51.78 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.809 -1.182 . . . . 73.140000000000001 107.809 170.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.47 163.49 32.8 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 114.507 1.299 . . . . 71.099999999999994 114.507 -164.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -61.32 -33.18 73.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.586 -1.643 . . . . 65.099999999999994 112.076 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.87 -56.63 13.91 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.522 -0.918 . . . . 70.109999999999999 108.522 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -61.52 -45.31 94.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.533 0.733 . . . . 64.129999999999995 109.58 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -51.05 -55.43 17.58 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.772 -0.58 . . . . 73.409999999999997 112.259 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.1 m -57.11 -48.92 77.45 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.586 1.084 . . . . 74.310000000000002 110.347 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -55.16 -33.3 62.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.206 1.002 . . . . 74.310000000000002 111.494 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.11 -44.78 75.26 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.623 1.169 . . . . 73.310000000000002 110.498 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.78 -10.18 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.252 -0.905 . . . . 73.319999999999993 110.884 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -104.65 -31.95 9.14 Favored 'General case' 0 CA--C 1.527 0.089 0 O-C-N 121.413 -0.804 . . . . 63.020000000000003 110.914 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.03 -0.29 6.53 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.364 1.246 . . . . 72.540000000000006 114.364 -169.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -133.69 -4.87 2.87 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.284 1.402 . . . . 52.140000000000001 111.873 -172.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.54 ' HB2' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -83.04 161.17 21.78 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.356 -1.465 . . . . 73.329999999999998 111.998 165.747 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.8 t30 70.89 20.2 5.5 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.776 2.031 . . . . 74.530000000000001 112.26 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.6 p -85.35 142.18 29.5 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.06 -0.719 . . . . 72.5 109.06 -169.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -77.77 101.31 6.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.103 -1.443 . . . . 73.430000000000007 107.103 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -85.9 141.69 29.39 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.935 1.294 . . . . 72.140000000000001 113.134 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HA ' HG22 ' A' ' 82' ' ' THR . 30.5 ptt180 -99.42 139.24 35.36 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.66 1.984 . . . . 72.519999999999996 110.643 -176.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.4 p -108.89 174.25 5.95 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.137 0.975 . . . . 42.119999999999997 109.609 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -92.34 18.18 8.73 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.841 -1.072 . . . . 75.200000000000003 111.095 165.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -98.8 18.11 17.8 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.537 -1.352 . . . . 63.100000000000001 110.599 169.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.02 7.1 75.6 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 126.406 1.955 . . . . 63.299999999999997 112.845 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -176.66 4.13 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 117.627 0.714 . . . . 64.310000000000002 110.209 -166.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 76' ' ' ARG . 48.0 p -141.76 138.11 32.07 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 106.65 -1.611 . . . . 73.540000000000006 106.65 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.39 135.23 47.8 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.989 1.268 . . . . 64.109999999999999 109.326 172.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -69.93 156.51 38.99 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.982 0.81 . . . . 74.400000000000006 110.296 -168.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.96 166.46 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.711 0.767 . . . . 72.420000000000002 111.146 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -127.43 152.51 47.43 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.666 -1.235 . . . . 64.140000000000001 107.666 159.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 71' ' ' ASP . 2.6 p -109.79 149.59 12.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.758 1.223 . . . . 72.200000000000003 109.142 177.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.92 166.69 23.96 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.661 1.184 . . . . 72.109999999999999 108.803 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.9 t -81.69 144.16 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.689 -1.967 . . . . 72.010000000000005 105.689 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 C--O 1.256 1.395 0 CA-C-O 117.853 -1.07 . . . . 73.209999999999994 109.726 169.517 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.189 0 N-CA-C 110.864 -0.894 . . . . 72.219999999999999 110.864 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.4 ' HB1' ' HD2' ' A' ' 3' ' ' PRO . . . -91.56 165.55 20.6 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 118.79 1.295 . . . . 72.109999999999999 109.863 176.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 2' ' ' ALA . 93.5 Cg_endo -74.8 -169.89 0.69 Allowed 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 124.07 3.18 . . . . 75.400000000000006 112.33 177.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -146.36 174.29 11.5 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.325 1.85 . . . . 63.439999999999998 109.234 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.83 79.12 0.02 OUTLIER Glycine 0 C--N 1.336 0.582 0 CA-C-O 118.963 -0.91 . . . . 71.329999999999998 113.704 163.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -146.83 123.97 11.47 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 119.404 1.602 . . . . 73.209999999999994 109.689 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -163.39 147.66 10.83 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.21 2.204 . . . . 64.510000000000005 105.319 166.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.9 165.5 11.02 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.704 1.145 . . . . 42.310000000000002 110.765 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.65 170.79 13.12 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.208 2.605 . . . . 70.430000000000007 111.695 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.61 64.36 8.07 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.979 2.453 . . . . 54.0 111.573 -174.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.18 163.57 33.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.882 1.273 . . . . 72.239999999999995 110.043 -173.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.45 -169.25 3.27 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.281 2.632 . . . . 72.219999999999999 106.424 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -130.99 -78.19 0.53 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.006 -1.479 . . . . 73.299999999999997 107.006 164.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m -140.91 164.81 29.23 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.122 0.969 . . . . 70.099999999999994 108.597 174.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -72.62 25.79 0.06 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.418 2.287 . . . . 65.340000000000003 113.137 -170.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.52 14.49 2.96 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.075 -1.641 . . . . 70.5 110.292 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -95.78 145.07 25.62 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.644 -1.285 . . . . 65.530000000000001 110.676 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.0 m -133.75 160.26 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.834 -0.802 . . . . 73.540000000000006 108.834 164.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.97 149.0 27.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 106.557 -1.646 . . . . 72.540000000000006 106.557 164.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.01 153.65 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.705 -1.591 . . . . 53.399999999999999 106.705 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -144.45 162.36 36.71 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 120.119 -1.613 . . . . 43.43 112.244 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.14 12.52 80.76 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.733 1.635 . . . . 73.420000000000002 112.71 -177.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mt -63.89 144.3 98.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.023 -0.989 . . . . 54.020000000000003 111.789 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -71.88 165.13 33.49 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.238 3.292 . . . . 63.219999999999999 113.583 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.29 -32.89 25.39 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.978 2.452 . . . . 51.109999999999999 113.427 -172.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -97.85 41.39 1.13 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.991 0.916 . . . . 63.240000000000002 109.381 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.35 124.48 8.25 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 108.179 -1.968 . . . . 72.140000000000001 108.179 173.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.6 m -125.02 169.67 11.9 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.24 1.416 . . . . 73.150000000000006 109.48 167.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -61.95 -20.14 63.51 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 113.511 0.93 . . . . 73.230000000000004 113.511 -174.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -60.84 2.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.071 -0.966 . . . . 72.510000000000005 108.548 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.08 -34.78 73.91 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.837 0.744 . . . . 62.329999999999998 109.171 177.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.4 -53.43 36.72 Favored 'General case' 0 C--N 1.345 0.397 0 O-C-N 121.452 -0.78 . . . . 64.549999999999997 111.149 173.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.49 ' HE3' ' HB ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -80.18 -20.46 44.72 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.762 1.165 . . . . 63.43 112.343 -176.856 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.45 -29.92 66.62 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.645 -0.66 . . . . 70.349999999999994 110.911 169.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -93.52 -51.48 4.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.035 1.334 . . . . 72.129999999999995 110.131 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.482 ' HG3' HD11 ' A' ' 70' ' ' LEU . 4.8 ttt -79.92 66.8 5.51 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 128.546 2.738 . . . . 74.25 110.382 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.66 -1.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 120.709 -1.244 . . . . 72.129999999999995 113.712 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.06 -44.94 94.42 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 119.572 1.078 . . . . 65.150000000000006 108.89 168.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.05 16.65 0.22 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.935 2.494 . . . . 70.209999999999994 114.293 -171.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.22 -147.9 16.66 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.282 -0.727 . . . . 64.129999999999995 111.282 162.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.43 99.94 8.24 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.846 0.832 . . . . 74.310000000000002 109.714 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.49 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 44.0 t -98.7 96.38 5.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 105.586 -2.005 . . . . 72.209999999999994 105.586 171.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.5 t -75.13 -22.97 57.82 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.408 0.442 . . . . 71.310000000000002 112.038 -174.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -124.39 149.73 46.37 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 125.545 1.538 . . . . 74.030000000000001 109.506 -170.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.38 129.97 10.74 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.237 0.926 . . . . 70.129999999999995 109.082 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.68 147.45 28.09 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.138 0.881 . . . . 61.329999999999998 110.356 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.4 t -145.65 151.65 14.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.234 -1.765 . . . . 64.239999999999995 106.234 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.7 168.68 19.27 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.88 2.072 . . . . 73.310000000000002 109.193 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.452 ' HG3' ' H ' ' A' ' 50' ' ' ASP . 9.0 ptm180 42.86 -87.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 129.821 3.248 . . . . 65.420000000000002 112.674 163.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.452 ' H ' ' HG3' ' A' ' 49' ' ' ARG . 1.9 p-10 -178.61 -176.92 0.5 Allowed 'General case' 0 N--CA 1.436 -1.128 1 C-N-CA 132.684 4.394 . . . . 74.400000000000006 107.728 162.638 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.28 -24.65 5.37 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-O 119.214 -0.77 . . . . 71.329999999999998 113.452 163.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.93 165.08 35.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.854 1.327 . . . . 61.140000000000001 108.676 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.0 140.58 6.68 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.089 -2.404 . . . . 73.120000000000005 107.089 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -111.57 134.98 52.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 118.781 1.29 . . . . 70.109999999999999 108.04 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.0 161.87 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 105.98 -1.859 . . . . 74.430000000000007 105.98 -172.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -143.52 139.88 30.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.371 -2.085 . . . . 62.43 105.371 170.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -107.34 164.26 12.34 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.959 -1.867 . . . . 74.530000000000001 105.959 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.1 t -63.98 -44.64 97.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.177 0.806 . . . . 65.230000000000004 113.177 -173.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -144.87 168.13 20.96 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.833 0.742 . . . . 74.519999999999996 109.506 -173.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -55.26 -28.88 56.38 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.19 -0.909 . . . . 42.009999999999998 110.197 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -64.8 -63.1 1.2 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.874 0.761 . . . . 65.349999999999994 108.99 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.46 -43.49 88.91 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.032 0.378 . . . . 74.340000000000003 110.033 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -57.16 -50.04 74.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.283 0.633 . . . . 53.140000000000001 111.228 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -59.51 -35.98 75.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.176 0.898 . . . . 72.340000000000003 111.229 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -54.78 -45.95 74.34 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.621 1.555 . . . . 74.239999999999995 110.013 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.43 -46.88 63.11 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.31 0.644 . . . . 71.409999999999997 111.68 -175.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -74.05 -7.42 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.571 0.749 . . . . 53.329999999999998 111.019 -169.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -123.89 -3.24 8.17 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.665 1.186 . . . . 64.109999999999999 113.452 -177.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -142.37 -0.91 1.21 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.029 0.932 . . . . 63.140000000000001 112.784 -175.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.482 HD11 ' HG3' ' A' ' 36' ' ' MET . 1.1 tm? -149.08 10.18 0.78 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.093 1.315 . . . . 63.350000000000001 111.339 -167.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.69 163.65 14.02 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 119.009 -2.307 . . . . 40.450000000000003 112.302 171.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.57 ' H ' ' HA ' ' A' ' 86' ' ' ARG . 0.7 OUTLIER 68.5 12.96 8.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.356 1.862 . . . . 64.409999999999997 113.794 171.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 31.1 p -75.21 164.04 26.89 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.51 1.524 . . . . 71.319999999999993 111.388 -170.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.66 162.87 28.72 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.245 -1.535 . . . . 73.230000000000004 108.169 166.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -147.85 151.23 35.59 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 125.047 1.339 . . . . 73.430000000000007 110.227 171.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -138.03 138.91 39.3 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.722 2.009 . . . . 74.209999999999994 106.33 -160.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -144.14 156.34 44.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.044 0.938 . . . . 73.329999999999998 110.554 -164.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -71.69 60.95 0.36 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.914 1.686 . . . . 73.349999999999994 113.242 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -146.14 -2.09 0.72 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.306 2.243 . . . . 74.549999999999997 111.088 169.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.89 15.26 54.87 Favored Glycine 0 C--N 1.34 0.773 0 O-C-N 120.298 -1.501 . . . . 74.140000000000001 112.201 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.8 171.7 12.83 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.151 0.98 . . . . 72.540000000000006 111.369 -172.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.5 p -143.04 153.98 43.5 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.536 -1.211 . . . . 74.239999999999995 108.145 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.46 177.07 5.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.118 2.167 . . . . 74.349999999999994 108.496 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -97.81 153.99 17.92 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.015 -1.053 . . . . 60.32 108.709 147.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.7 pt -130.82 171.6 17.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 125.871 1.668 . . . . 75.530000000000001 107.165 171.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.57 ' HA ' ' H ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -143.69 165.75 26.79 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 120.998 -1.063 . . . . 71.519999999999996 108.874 156.467 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.24 163.85 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.98 1.312 . . . . 73.340000000000003 109.019 169.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -154.6 158.22 39.42 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.704 2.002 . . . . 74.400000000000006 107.264 163.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.02 83.87 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.224 -2.139 . . . . 70.239999999999995 105.224 164.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 t0 . . . . . 0 C--O 1.256 1.439 0 C-N-CA 127.894 2.478 . . . . 73.230000000000004 113.817 159.417 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.653 0 N-CA-C 109.483 -1.447 . . . . 74.450000000000003 109.483 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.21 152.62 90.38 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-N 118.041 0.92 . . . . 63.439999999999998 110.787 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -75.97 -179.74 5.5 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.394 2.729 . . . . 61.240000000000002 111.643 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -138.47 165.68 26.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.555 2.342 . . . . 74.519999999999996 107.955 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.48 -149.76 6.74 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 108.447 -1.861 . . . . 55.200000000000003 108.447 165.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.3 20.9 16.89 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.283 1.433 . . . . 74.310000000000002 110.862 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -148.14 154.03 39.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.356 1.462 . . . . 64.439999999999998 108.015 -172.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.78 54.89 28.27 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 117.78 -1.566 . . . . 72.519999999999996 113.669 170.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.01 159.2 26.54 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.007 2.472 . . . . 62.340000000000003 111.345 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -78.31 64.22 8.43 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.319 3.346 . . . . 74.340000000000003 112.1 -165.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 m -76.1 101.51 5.35 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.593 -1.632 . . . . 74.219999999999999 106.593 163.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.7 157.24 36.29 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.025 1.33 . . . . 73.409999999999997 107.476 163.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.9 mmt85 -140.22 96.05 2.98 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.572 -2.01 . . . . 71.340000000000003 105.572 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m -82.49 -175.93 5.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 122.059 0.933 . . . . 62.340000000000003 110.494 173.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -63.08 20.95 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 128.411 2.684 . . . . 60.549999999999997 113.095 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -133.04 28.4 4.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 119.328 -2.107 . . . . 51.310000000000002 108.481 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.654 HH21 HG11 ' A' ' 54' ' ' VAL . 42.1 ttt180 -112.83 129.56 56.4 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.753 1.221 . . . . 72.430000000000007 110.851 -177.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.7 159.86 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.703 -1.221 . . . . 71.420000000000002 107.703 168.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 12.5 m -124.3 -179.86 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.97 2.108 . . . . 75.109999999999999 107.042 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.11 155.15 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.496 1.918 . . . . 64.5 108.256 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.86 165.24 30.35 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.633 -1.292 . . . . 64.209999999999994 109.589 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.35 7.55 87.83 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.936 0.779 . . . . 72.519999999999996 113.003 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mt -60.82 155.02 55.1 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.065 1.346 . . . . 75.540000000000006 111.412 -173.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.58 167.54 23.92 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.913 3.742 . . . . 72.230000000000004 111.341 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.38 -27.87 39.78 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.358 2.038 . . . . 73.209999999999994 112.975 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.42 ' HB2' ' HG3' ' A' ' 79' ' ' GLU . 7.7 m -140.59 80.27 1.74 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 127.1 2.16 . . . . 64.230000000000004 107.445 -177.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.22 138.96 10.47 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 105.112 -3.195 . . . . 64.540000000000006 105.112 157.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.78 179.23 4.18 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 117.747 0.774 . . . . 74.420000000000002 109.055 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -65.42 -19.18 65.83 Favored 'General case' 0 C--O 1.226 -0.153 0 O-C-N 121.606 -0.684 . . . . 75.510000000000005 110.648 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -64.66 -59.5 4.2 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 117.775 -1.107 . . . . 63.520000000000003 108.555 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -35.9 78.82 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.598 -0.841 . . . . 54.340000000000003 109.477 177.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.97 -53.64 46.81 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.386 0.993 . . . . 33.520000000000003 110.708 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -69.74 -26.21 64.21 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.124 -0.985 . . . . 55.329999999999998 111.951 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -85.23 -12.91 51.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.938 0.895 . . . . 75.140000000000001 112.577 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -109.06 -57.61 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.522 1.129 . . . . 61.520000000000003 111.252 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.9 ttt -74.53 70.71 1.8 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.659 1.184 . . . . 71.219999999999999 108.588 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -140.64 -0.55 1.54 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.795 -1.191 . . . . 73.310000000000002 113.368 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -68.29 -21.57 64.77 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.602 0.637 . . . . 74.239999999999995 111.579 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.42 -6.88 58.82 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.359 1.244 . . . . 75.25 114.359 -171.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.26 -171.49 27.12 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 119.858 1.208 . . . . 54.310000000000002 111.357 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -86.19 85.03 7.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 106.965 -1.495 . . . . 73.420000000000002 106.965 -170.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.9 t -69.57 135.08 29.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.155 -1.054 . . . . 72.219999999999999 108.155 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.5 t -99.07 -11.55 21.35 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.076 -0.488 . . . . 75.129999999999995 111.954 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -159.45 146.79 17.01 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.555 1.071 . . . . 73.349999999999994 109.757 -162.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.7 143.25 32.21 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.727 -1.212 . . . . 73.140000000000001 107.727 165.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -152.47 134.24 14.71 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.488 0.715 . . . . 64.299999999999997 109.466 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 m -137.53 177.62 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.554 -1.276 . . . . 74.519999999999996 107.554 175.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -140.79 -169.24 2.76 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 126.167 1.787 . . . . 74.400000000000006 106.768 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -96.89 45.21 1.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.921 -1.112 . . . . 54.240000000000002 111.729 -176.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.93 -154.0 0.53 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.277 1.831 . . . . 63.130000000000003 107.324 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -111.02 28.65 9.58 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.772 2.13 . . . . 72.409999999999997 110.605 173.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 p -131.89 173.36 11.26 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.416 1.487 . . . . 74.230000000000004 109.508 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.86 172.66 44.4 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 107.743 -2.143 . . . . 75.510000000000005 107.743 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.654 HG11 HH21 ' A' ' 17' ' ' ARG . 37.5 t -145.59 144.34 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.483 -0.932 . . . . 72.400000000000006 108.483 -165.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.6 t -132.95 171.65 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.54 -0.911 . . . . 63.310000000000002 108.54 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -153.8 137.4 16.0 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 120.553 -1.342 . . . . 61.340000000000003 107.716 167.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.84 177.39 4.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.458 1.903 . . . . 75.239999999999995 108.104 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.3 m -86.38 -31.79 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.64 0.608 . . . . 55.310000000000002 112.64 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 ttm105 -156.37 160.32 39.56 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.362 0.665 . . . . 64.540000000000006 109.95 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -67.1 -22.92 65.8 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.568 1.147 . . . . 61.509999999999998 112.205 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.12 -54.01 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.112 0.869 . . . . 72.25 109.603 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.96 -41.21 87.25 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.563 -0.532 . . . . 63.329999999999998 109.563 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.3 ttp -53.22 -52.78 57.8 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 110.168 -0.308 . . . . 55.130000000000003 110.168 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -55.11 -40.26 70.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.537 -0.745 . . . . 73.430000000000007 111.08 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -55.84 -45.38 78.41 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.088 0.858 . . . . 60.119999999999997 109.446 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.5 -42.4 78.28 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.31 -0.869 . . . . 74.239999999999995 111.893 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 t -68.35 -18.18 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.503 0.721 . . . . 72.310000000000002 111.019 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -114.37 -15.81 12.06 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.833 1.049 . . . . 75.519999999999996 113.833 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm -134.1 -1.06 2.99 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.261 1.425 . . . . 72.349999999999994 112.681 -171.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.62 21.42 2.71 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.929 1.24 . . . . 44.049999999999997 110.753 -175.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.84 164.0 11.88 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.077 -1.64 . . . . 62.32 110.285 174.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.86 12.97 4.12 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.235 1.814 . . . . 61.210000000000001 112.202 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.3 p -74.06 168.2 20.01 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.883 -1.136 . . . . 44.25 110.724 -167.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -63.94 166.24 7.72 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 121.74 -0.6 . . . . 71.319999999999993 109.813 153.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -145.67 138.79 26.13 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.938 1.695 . . . . 73.150000000000006 107.791 166.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -96.09 136.61 36.33 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.822 -0.807 . . . . 74.25 108.822 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -109.9 174.39 5.89 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.086 -1.079 . . . . 60.100000000000001 108.086 -169.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.82 -11.3 55.98 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.839 -0.538 . . . . 72.310000000000002 111.882 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG3' ' HB2' ' A' ' 26' ' ' SER . 6.0 mm-40 -102.02 34.24 2.77 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.079 1.351 . . . . 72.129999999999995 111.536 -166.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.08 15.99 68.11 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.782 1.182 . . . . 24.140000000000001 113.528 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -132.73 176.8 8.14 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.439 1.096 . . . . 52.399999999999999 110.252 -175.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.6 p -144.78 126.07 14.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.75 -1.204 . . . . 73.099999999999994 107.75 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.36 -176.49 4.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.861 0.865 . . . . 73.319999999999993 110.339 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -106.29 157.21 17.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.578 -0.897 . . . . 75.209999999999994 108.578 159.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 pt -141.61 163.78 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.551 1.141 . . . . 73.310000000000002 110.937 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -131.58 105.84 7.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.141 -1.429 . . . . 75.450000000000003 107.141 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.5 t -69.71 144.17 14.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.792 -1.188 . . . . 62.210000000000001 107.792 170.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.27 158.82 43.53 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.747 1.158 . . . . 44.119999999999997 111.724 166.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.75 137.37 22.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 106.184 -1.784 . . . . 64.239999999999995 106.184 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 C--O 1.25 1.119 0 C-N-CA 124.293 1.037 . . . . 72.099999999999994 110.487 175.656 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.656 0 N-CA-C 108.895 -1.682 . . . . 63.409999999999997 108.895 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.95 166.13 30.68 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 119.141 1.471 . . . . 35.140000000000001 111.141 -160.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -64.91 -179.54 1.04 Allowed 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 122.906 2.404 . . . . 72.299999999999997 111.724 164.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.8 163.95 38.65 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.344 1.058 . . . . 75.439999999999998 109.882 -175.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.88 67.01 0.01 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.998 -1.241 . . . . 73.209999999999994 109.998 174.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.89 159.21 37.93 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.969 0.908 . . . . 74.219999999999999 109.01 175.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.41 108.88 2.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.719 1.208 . . . . 72.200000000000003 109.391 177.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.96 81.69 1.59 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 108.453 -1.859 . . . . 42.100000000000001 108.453 -170.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.78 167.87 14.64 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.259 1.973 . . . . 71.120000000000005 111.118 171.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.57 84.09 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.085 2.523 . . . . 53.399999999999999 110.143 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.4 m -81.15 128.09 33.37 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.261 1.025 . . . . 75.299999999999997 110.035 170.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.7 164.72 26.31 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 128.614 2.765 . . . . 75.239999999999995 106.397 174.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -140.93 79.26 1.69 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.936 -1.505 . . . . 74.430000000000007 106.936 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 16' ' ' ASN . 72.7 m -67.96 175.62 3.01 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.81 0.814 . . . . 55.109999999999999 112.101 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.71 31.32 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.043 2.537 . . . . 73.510000000000005 111.541 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -143.01 14.72 1.89 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.101 2.16 . . . . 62.32 108.284 -173.475 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.27 116.22 31.59 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.522 1.929 . . . . 75.340000000000003 110.13 -174.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -122.58 174.07 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.606 0.762 . . . . 62.509999999999998 111.522 173.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.578 HG23 ' HG3' ' A' ' 88' ' ' LYS . 10.7 m -136.1 -179.1 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.727 1.611 . . . . 64.409999999999997 106.967 170.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.0 t -135.7 153.52 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.134 2.174 . . . . 75.409999999999997 107.006 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.87 155.31 48.2 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.146 1.378 . . . . 43.210000000000001 108.88 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.02 4.8 57.58 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.419 1.961 . . . . 71.400000000000006 113.346 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mt -66.56 154.45 91.14 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 120.99 -1.3 . . . . 74.430000000000007 113.163 -166.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.47 166.36 20.03 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.169 2.579 . . . . 71.019999999999996 112.573 175.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.07 -6.03 18.29 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 124.12 3.213 . . . . 71.420000000000002 114.013 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -146.75 54.06 1.11 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.505 2.322 . . . . 74.299999999999997 108.926 -172.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.96 112.02 2.03 Favored Glycine 0 C--N 1.34 0.761 0 O-C-N 120.126 -1.608 . . . . 35.030000000000001 111.564 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -76.24 155.35 34.47 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 118.835 1.318 . . . . 74.140000000000001 112.361 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -59.04 -26.03 64.23 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.828 0.851 . . . . 75.099999999999994 113.217 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -65.22 -52.2 56.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.251 -1.018 . . . . 71.099999999999994 108.251 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -62.76 -27.56 69.37 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.109 1.363 . . . . 73.109999999999999 111.326 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -64.28 -61.34 2.3 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.067 -1.086 . . . . 72.019999999999996 108.067 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -61.28 -39.57 90.91 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.825 -0.607 . . . . 55.399999999999999 109.851 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -17.46 52.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.85 1.26 . . . . 73.329999999999998 112.688 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -100.72 -45.36 5.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.266 0.626 . . . . 75.010000000000005 111.23 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.0 tpt -57.75 -32.86 67.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.15 1.38 . . . . 72.299999999999997 113.396 -174.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -19.17 59.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.208 1.929 . . . . 73.0 116.208 -166.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.67 1.02 1.39 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.991 1.478 . . . . 64.010000000000005 114.991 -169.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.448 ' CB ' ' HB2' ' A' ' 66' ' ' ALA . . . -95.26 -10.09 31.31 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.754 1.222 . . . . 53.200000000000003 112.993 175.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.58 -101.74 0.21 Allowed Glycine 0 C--N 1.335 0.498 0 CA-C-N 119.68 1.127 . . . . 41.219999999999999 111.386 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.2 144.35 29.85 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.533 1.166 . . . . 72.319999999999993 109.84 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.511 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -131.7 139.53 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 126.379 1.872 . . . . 51.200000000000003 113.382 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -127.51 18.88 6.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.837 1.255 . . . . 71.219999999999999 111.36 -170.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.415 ' HB3' ' CB ' ' A' ' 56' ' ' GLU . 73.5 t80 -170.73 144.48 2.3 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.108 1.763 . . . . 64.329999999999998 108.318 172.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.69 139.26 16.91 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.861 -1.162 . . . . 74.019999999999996 107.861 168.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -155.14 129.22 8.82 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.421 1.089 . . . . 71.129999999999995 110.615 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 t -140.27 165.8 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.966 1.706 . . . . 54.43 107.285 -175.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.66 -162.76 1.3 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.775 2.83 . . . . 72.120000000000005 107.723 -169.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -105.25 63.53 0.7 Allowed 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.283 -1.511 . . . . 72.109999999999999 109.55 170.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -144.74 -176.33 5.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.26 -0.9 . . . . 64.040000000000006 108.592 169.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.38 13.73 20.11 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-O 118.312 -1.271 . . . . 52.329999999999998 113.433 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.32 163.54 30.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.163 1.982 . . . . 73.409999999999997 110.084 -174.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.45 167.84 38.52 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 107.788 -2.125 . . . . 51.530000000000001 107.788 -171.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 59.0 t -143.8 144.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 119.929 1.864 . . . . 73.099999999999994 110.395 -163.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.9 t -145.19 154.33 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.112 0.482 . . . . 73.519999999999996 110.849 -173.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.415 ' CB ' ' HB3' ' A' ' 44' ' ' TYR . 3.9 tt0 -137.08 101.36 4.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.885 -1.524 . . . . 75.099999999999994 106.885 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.511 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 3.0 m-30 -72.37 179.37 3.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.533 1.933 . . . . 71.140000000000001 110.625 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.0 t -77.5 -63.43 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.627 -0.671 . . . . 64.540000000000006 110.98 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -140.37 157.36 45.66 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.27 0.941 . . . . 63.520000000000003 112.053 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -53.53 -27.13 24.19 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.247 1.019 . . . . 71.510000000000005 112.138 -166.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -53.16 -61.92 1.99 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.218 1.407 . . . . 71.409999999999997 108.376 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.56 -37.5 71.08 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.05 1.34 . . . . 75.540000000000006 110.667 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -56.86 -54.85 41.8 Favored 'General case' 0 C--O 1.228 -0.047 0 CA-C-O 118.829 -0.605 . . . . 74.420000000000002 110.178 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.6 m -54.73 -40.64 69.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.634 -0.698 . . . . 72.209999999999994 110.508 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -60.02 -49.77 76.34 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.02 0.928 . . . . 71.430000000000007 110.661 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.448 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . . . -63.46 -25.1 68.12 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.739 -1.226 . . . . 64.400000000000006 112.68 -176.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.3 t -76.77 -5.75 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 O-C-N 120.853 -1.155 . . . . 60.240000000000002 110.125 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -129.41 0.45 5.06 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.537 1.31 . . . . 44.299999999999997 114.537 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.39 5.26 0.82 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.499 1.519 . . . . 64.140000000000001 112.563 -171.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.01 4.05 0.62 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.404 1.082 . . . . 71.129999999999995 109.765 -173.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -99.42 157.69 16.24 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.079 1.751 . . . . 74.439999999999998 111.372 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.59 ' H ' ' HB3' ' A' ' 86' ' ' ARG . 0.6 OUTLIER 44.42 64.41 1.34 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.496 1.519 . . . . 75.439999999999998 110.359 -168.255 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.4 p -121.06 174.19 6.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.203 2.601 . . . . 73.019999999999996 109.278 -174.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.89 161.98 14.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.952 -1.093 . . . . 74.420000000000002 109.633 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -151.68 120.66 6.66 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 126.647 1.979 . . . . 64.230000000000004 111.483 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -102.74 119.82 39.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.665 -1.235 . . . . 63.219999999999999 107.665 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.54 168.41 16.45 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.799 1.64 . . . . 74.109999999999999 110.309 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -65.07 -14.17 59.81 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.33 1.233 . . . . 73.109999999999999 114.33 174.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -86.56 6.02 32.79 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.692 1.997 . . . . 72.200000000000003 112.51 -172.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.15 14.39 82.31 Favored Glycine 0 C--N 1.337 0.635 0 O-C-N 121.572 -0.705 . . . . 43.340000000000003 112.061 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -125.08 171.71 10.05 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 123.961 0.904 . . . . 74.140000000000001 110.566 -177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.5 p -139.42 146.03 39.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.967 1.307 . . . . 74.219999999999999 108.05 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.7 129.97 19.83 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.729 -1.582 . . . . 64.439999999999998 106.729 172.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -69.74 159.49 33.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.968 0.804 . . . . 75.230000000000004 110.126 -164.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.69 155.73 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 123.414 0.686 . . . . 74.200000000000003 109.165 -173.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.59 ' HB3' ' H ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -134.99 143.05 46.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.849 -1.157 . . . . 53.420000000000002 109.728 163.119 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.94 151.2 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.377 1.471 . . . . 73.040000000000006 108.347 166.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.578 ' HG3' HG23 ' A' ' 19' ' ' VAL . 6.4 ptmt -146.3 161.61 39.93 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.423 -0.955 . . . . 61.119999999999997 108.423 152.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.576 ' HA ' HG12 ' A' ' 18' ' ' VAL . 7.4 t -70.18 143.93 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 106.358 -1.719 . . . . 73.239999999999995 106.358 169.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.604 -1.189 . . . . 63.399999999999999 110.487 -177.743 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.236 0.369 0 N-CA-C 108.953 -0.758 . . . . 63.43 108.953 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -72.28 37.98 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.371 -0.831 . . . . 72.21 112.295 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.64 28.75 2.41 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 119.349 -2.094 . . . . 72.34 109.797 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.13 143.03 51.03 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.867 -1.145 . . . . 74.03 112.395 -167.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 m -140.51 167.69 17.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 124.491 1.117 . . . . 62.14 110.527 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.2 t -129.72 153.67 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.15 -1.796 . . . . 73.15 106.15 170.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -121.98 136.58 58.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 105.821 -1.918 . . . . 62.14 105.821 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 p -134.53 145.08 48.4 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.927 0.785 . . . . 61.34 111.678 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.9 27.66 23.25 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 125.147 1.356 . . . . 15.42 112.619 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.454 HD22 HG21 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -58.71 152.7 45.82 Favored Pre-proline 0 N--CA 1.467 0.419 0 CA-C-N 118.443 1.121 . . . . 60.42 110.393 -177.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.07 168.59 17.01 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.813 2.342 . . . . 73.41 110.882 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.02 -12.6 35.43 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.65 2.234 . . . . 75.45 113.831 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -151.16 57.03 0.89 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.379 1.445 . . . . 72.14 111.92 -171.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.19 -166.51 32.7 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.273 1.416 . . . . 72.15 111.11 172.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.8 p -157.69 173.85 16.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.402 1.081 . . . . 53.12 109.718 169.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -70.06 -18.4 63.27 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.97 0.908 . . . . 71.32 111.38 171.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.44 -54.11 10.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.834 -1.173 . . . . 63.52 107.834 -177.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.51 -32.84 74.41 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 118.55 -0.738 . . . . 71.12 110.249 172.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.35 -57.08 13.8 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.558 1.072 . . . . 73.45 110.57 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -61.81 -42.99 99.71 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 118.785 0.72 . . . . 74.24 110.087 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.25 -25.66 64.39 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.224 1.01 . . . . 75.42 111.92 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -81.39 -60.04 2.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.589 0.756 . . . . 72.3 110.046 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.485 ' HG3' HD11 ' A' ' 70' ' ' LEU . 15.0 ttt -68.09 -8.8 41.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.791 1.636 . . . . 62.01 114.348 -159.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.18 20.97 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 131.218 3.807 . . . . 62.53 115.848 175.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -100.59 0.79 39.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.98 1.712 . . . . 74.34 112.604 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.92 17.08 6.79 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 125.846 1.658 . . . . 74.32 112.797 -167.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 -107.73 1.04 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 125.762 1.648 . . . . 75.24 109.304 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -143.96 139.61 29.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 117.764 0.782 . . . . 71.24 109.922 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 t -128.44 81.13 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 126.451 1.9 . . . . 75.5 107.167 -170.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.7 t -72.66 -15.12 61.71 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.277 0.473 . . . . 51.41 112.277 -174.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -132.83 135.14 45.47 Favored 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 121.038 -1.039 . . . . 64.11 108.413 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.42 138.83 41.93 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.218 -1.03 . . . . 73.42 108.218 166.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -145.92 156.68 43.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.843 -1.169 . . . . 74.42 107.843 169.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.35 -178.41 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 O-C-N 120.826 -1.171 . . . . 51.13 108.162 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -103.34 -163.09 0.96 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.417 1.487 . . . . 74.31 107.283 166.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 mtm-85 -52.71 -53.98 40.08 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.975 -1.011 . . . . 72.25 109.885 159.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -170.68 -179.91 3.05 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.083 0.856 . . . . 62.31 112.82 -171.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.69 -39.85 2.73 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 127.147 2.308 . . . . 72.44 113.445 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.01 170.58 16.82 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.759 1.279 . . . . 44.23 109.429 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.86 159.66 28.09 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.543 -1.823 . . . . 60.41 108.543 165.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.3 p -130.23 131.3 65.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.396 1.098 . . . . 62.03 109.292 -170.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.7 t -144.32 151.83 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.632 -0.877 . . . . 75.43 108.632 -157.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -135.13 133.7 39.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.5 -1.296 . . . . 73.41 107.5 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -101.6 -176.77 3.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.117 1.767 . . . . 74.12 108.626 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.2 t -81.72 -50.96 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 118.256 -0.878 . . . . 54.21 110.57 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.1 ttt85 -145.17 164.5 31.1 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 120.526 1.512 . . . . 75.3 111.79 -171.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -62.7 -30.31 71.31 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 117.867 -1.063 . . . . 64.24 111.673 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -65.38 -50.98 63.47 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.645 -0.872 . . . . 60.0 108.645 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -59.36 -53.11 61.99 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 126.786 2.034 . . . . 75.12 109.25 176.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -51.94 -51.56 56.18 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.485 -0.759 . . . . 75.02 112.457 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.7 m -55.29 -53.56 54.53 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.536 -0.745 . . . . 73.02 109.584 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -56.96 -32.43 66.02 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.321 1.048 . . . . 72.3 111.588 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.25 -42.77 77.91 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.438 1.017 . . . . 72.31 110.863 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t -69.3 -14.31 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.951 -0.468 . . . . 64.12 111.091 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -100.58 -33.55 10.26 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.314 -1.492 . . . . 73.41 112.349 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.413 ' O ' ' HE2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -137.7 9.01 2.85 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.844 0.858 . . . . 71.03 113.19 -165.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.485 HD11 ' HG3' ' A' ' 36' ' ' MET . 1.0 OUTLIER -134.36 3.24 3.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.798 0.726 . . . . 75.33 111.132 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.611 ' HB2' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -95.85 162.16 13.7 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 119.315 -2.116 . . . . 72.33 114.501 171.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.4 t30 66.2 15.38 10.07 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.007 2.523 . . . . 62.23 113.003 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 31.1 p -78.46 171.21 15.43 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.495 -0.753 . . . . 54.22 109.747 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.08 151.65 21.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.029 1.332 . . . . 63.22 109.034 166.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -125.15 130.18 51.66 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 127.709 2.404 . . . . 75.3 108.896 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.472 ' HA ' HG22 ' A' ' 82' ' ' THR . 73.9 mtm180 -87.03 153.83 21.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.108 0.963 . . . . 61.41 110.541 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.7 p -124.39 176.73 6.28 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.077 0.951 . . . . 71.54 110.451 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -85.6 5.15 33.01 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.569 1.148 . . . . 72.13 111.268 167.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.74 13.42 14.17 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.729 2.012 . . . . 62.21 112.595 -162.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.24 12.85 81.7 Favored Glycine 0 C--N 1.336 0.561 0 O-C-N 121.762 -0.586 . . . . 55.02 113.489 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -134.59 162.99 30.74 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.227 1.011 . . . . 52.24 109.593 -173.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 76' ' ' ARG . 43.6 p -148.75 119.61 7.6 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.678 -0.86 . . . . 71.21 108.678 -172.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.23 165.01 13.68 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.418 0.687 . . . . 72.15 110.033 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -84.65 157.23 21.21 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.569 -0.9 . . . . 64.22 108.569 160.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.454 HG21 HD22 ' A' ' 23' ' ' LEU . 25.3 pt -137.47 152.94 27.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.895 0.855 . . . . 71.01 109.364 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -123.9 119.19 28.92 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.043 -1.836 . . . . 51.44 106.043 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.611 HG12 ' HB2' ' A' ' 71' ' ' ASP . 1.4 p -75.62 163.25 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.262 -0.644 . . . . 53.44 109.262 175.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.49 163.84 39.48 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.922 1.689 . . . . 74.31 107.42 164.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.07 155.44 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.23 -1.767 . . . . 54.21 106.23 165.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 58.8 t0 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 124.567 1.147 . . . . 74.31 109.971 176.372 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 107.408 -1.33 . . . . 61.12 107.408 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -80.41 40.69 0.51 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.251 1.021 . . . . 62.42 111.976 173.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.94 15.05 1.91 Allowed 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.431 -1.418 . . . . 52.31 111.968 -178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.56 144.57 39.22 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.028 -1.045 . . . . 75.43 110.203 -171.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.437 ' CG1' ' HG3' ' A' ' 63' ' ' MET . 27.3 m -141.4 166.36 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.249 1.02 . . . . 62.22 110.496 -171.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.79 124.02 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 106.75 -1.574 . . . . 73.54 106.75 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.23 148.99 4.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.059 1.344 . . . . 53.24 107.601 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -136.6 163.1 31.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.591 -0.693 . . . . 74.13 109.635 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.5 9.87 68.66 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.062 -0.854 . . . . 51.11 113.81 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.81 150.99 45.29 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.481 1.141 . . . . 72.41 112.509 -172.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -71.52 169.65 20.42 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 125.163 3.909 . . . . 74.15 113.259 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.47 -4.23 11.56 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.576 3.517 . . . . 34.4 114.167 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.73 71.03 1.37 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.081 2.152 . . . . 44.04 106.579 171.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.18 127.08 6.66 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 125.344 1.449 . . . . 12.3 109.596 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.4 m -134.78 166.64 22.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.935 0.894 . . . . 60.11 110.644 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -65.05 -22.84 67.04 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.407 1.083 . . . . 74.44 111.711 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -58.38 -60.45 3.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.436 -1.269 . . . . 63.53 109.742 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.84 -42.69 94.13 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 108.875 -0.787 . . . . 53.45 108.875 176.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.78 -50.98 62.48 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.846 0.748 . . . . 61.51 111.072 -176.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -67.48 -31.88 72.33 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.263 -0.898 . . . . 74.31 112.406 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.78 -2.58 57.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.34 1.456 . . . . 74.42 112.003 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -122.17 -56.08 1.84 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.278 1.431 . . . . 52.52 110.45 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 17.2 ttt -75.74 72.11 2.64 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.435 -1.415 . . . . 64.42 108.473 171.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.3 ptm85 -136.81 -13.4 1.68 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.271 1.428 . . . . 65.33 111.734 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -76.39 3.41 11.13 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.423 -0.798 . . . . 72.42 112.315 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.7 64.29 0.74 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.814 1.645 . . . . 71.41 107.055 172.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.58 -136.38 33.87 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.249 -0.887 . . . . 74.35 111.528 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -109.43 117.87 35.16 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.212 0.53 . . . . 74.35 111.096 -159.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.23 95.99 4.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.092 0.957 . . . . 72.23 108.929 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.4 t -69.78 -29.58 66.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.003 -0.998 . . . . 41.13 112.064 -175.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -122.04 149.76 43.06 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.144 1.338 . . . . 73.51 110.916 -168.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.62 133.52 20.18 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.827 1.251 . . . . 65.32 109.231 169.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -151.63 125.28 8.99 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 107.5 -1.296 . . . . 71.14 107.5 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.9 t -142.62 96.9 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.018 -2.216 . . . . 43.32 105.018 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -64.89 -176.13 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.137 1.775 . . . . 74.14 108.818 161.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -115.15 78.51 1.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 O-C-N 120.585 -1.322 . . . . 75.54 107.793 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -158.41 42.0 0.26 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.945 1.298 . . . . 62.51 110.227 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.15 9.3 14.61 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.525 1.536 . . . . 42.41 116.385 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.2 p -134.7 168.13 19.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.977 1.889 . . . . 53.25 109.95 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -146.41 151.94 24.13 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 107.454 -2.258 . . . . 75.32 107.454 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.87 121.4 58.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.771 -1.566 . . . . 72.23 106.771 -172.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.425 ' HB ' HG23 ' A' ' 18' ' ' VAL . 76.4 t -135.81 147.84 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.387 -1.709 . . . . 74.53 106.387 -159.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -136.58 113.81 10.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 105.47 -2.048 . . . . 75.22 105.47 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -86.42 172.22 10.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.741 1.217 . . . . 72.23 108.424 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.7 t -70.65 -56.7 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 118.588 -0.72 . . . . 60.21 110.635 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -139.26 168.26 20.23 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 119.556 1.071 . . . . 63.15 111.034 -171.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -56.04 -36.34 67.89 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 117.479 -1.248 . . . . 61.52 110.343 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -67.01 -47.53 71.15 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.168 1.349 . . . . 63.55 109.847 -171.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.67 -51.67 68.59 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.837 1.655 . . . . 74.35 109.3 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.437 ' HG3' ' CG1' ' A' ' 18' ' ' VAL . 62.8 ttp -55.57 -50.57 69.73 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.825 0.85 . . . . 63.12 111.767 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.6 m -54.56 -53.53 53.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.963 -1.018 . . . . 64.43 109.258 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -49.84 -32.77 15.03 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.311 0.96 . . . . 75.42 111.527 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.2 -45.9 91.56 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.916 0.886 . . . . 72.55 111.033 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -68.52 -16.66 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.381 -0.824 . . . . 54.53 110.902 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -108.89 -19.58 13.35 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.216 -0.927 . . . . 72.43 113.147 -167.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -136.21 -9.03 2.0 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.579 1.151 . . . . 74.24 111.75 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.7 17.49 6.33 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.851 1.26 . . . . 75.34 110.385 -167.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.58 150.79 28.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.628 1.171 . . . . 73.42 112.099 -171.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.06 32.3 0.86 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.726 2.01 . . . . 71.15 113.202 -167.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.3 p -75.02 177.06 6.63 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.05 0.94 . . . . 45.02 109.631 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -72.97 176.49 5.68 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.564 0.345 . . . . 64.42 111.078 162.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -151.55 128.46 10.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 128.212 2.605 . . . . 74.12 108.639 168.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -75.84 124.45 27.33 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.378 1.071 . . . . 73.22 109.576 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.44 157.41 17.66 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.241 0.616 . . . . 72.12 110.475 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -80.63 -0.39 37.78 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.218 1.007 . . . . 55.12 112.097 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -86.1 4.67 37.21 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.573 1.949 . . . . 55.52 111.569 170.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.38 20.1 74.98 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 119.037 0.835 . . . . 65.43 111.886 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -120.91 177.85 4.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 127.302 2.241 . . . . 54.01 107.749 170.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.6 p -140.58 134.36 30.42 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.247 -1.39 . . . . 60.31 107.247 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.96 173.19 6.78 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.922 -1.111 . . . . 71.53 110.07 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -87.67 161.89 17.41 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.499 -0.926 . . . . 75.11 108.499 158.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.9 pt -137.93 141.46 38.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.414 1.086 . . . . 74.15 109.245 173.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -96.95 120.92 38.2 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.415 -1.698 . . . . 41.52 106.415 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.2 t -89.32 137.03 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.611 -1.255 . . . . 74.24 107.611 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -145.48 157.52 43.99 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.379 1.472 . . . . 64.23 109.545 169.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.21 143.41 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 126.19 1.796 . . . . 64.14 106.347 170.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 C--O 1.255 1.379 0 C-N-CA 124.281 1.032 . . . . 24.5 108.447 167.154 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.451 -0.425 0 N-CA-C 108.283 -1.006 . . . . 74.05 108.283 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -68.22 26.45 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.086 2.554 . . . . 53.31 114.925 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.9 23.35 3.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.29 1.436 . . . . 64.45 109.488 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.401 ' HG2' HH11 ' A' ' 17' ' ' ARG . 0.0 OUTLIER -119.27 143.75 47.16 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.568 1.147 . . . . 74.03 111.16 -168.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -144.97 156.47 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.877 1.271 . . . . 65.13 109.045 -165.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -141.3 120.4 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.992 1.269 . . . . 62.14 109.742 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.54 155.01 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.85 1.66 . . . . 73.12 109.867 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -143.87 167.58 21.98 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.379 1.072 . . . . 72.35 109.366 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.0 14.41 64.67 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.27 0.462 . . . . 55.53 112.778 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.96 148.68 87.12 Favored Pre-proline 0 CA--C 1.537 0.461 0 O-C-N 121.991 -0.711 . . . . 64.02 110.355 -168.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.18 167.44 23.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 124.996 3.798 . . . . 74.21 111.733 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.05 -21.19 56.6 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.791 2.327 . . . . 72.42 113.229 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.15 35.98 4.73 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.5 1.12 . . . . 62.32 111.314 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.99 156.42 51.65 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 107.503 -2.239 . . . . 42.01 107.503 158.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.4 m -152.47 173.24 15.37 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.771 0.828 . . . . 44.45 110.541 165.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -63.48 -21.8 66.52 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.227 1.011 . . . . 65.22 111.894 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -65.74 -63.83 1.0 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.383 1.073 . . . . 74.41 108.95 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -34.62 78.82 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 118.606 -1.238 . . . . 71.24 110.482 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -47.78 64.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.484 1.038 . . . . 73.22 111.017 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -66.94 -32.23 73.34 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.882 1.219 . . . . 54.53 111.557 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.23 -7.01 59.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.018 0.927 . . . . 65.02 113.194 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -106.09 -58.06 1.96 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.361 1.864 . . . . 73.44 108.1 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.6 ttt -79.23 73.05 5.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.312 1.445 . . . . 72.24 109.079 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -139.01 -0.32 1.88 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.892 0.877 . . . . 74.21 113.21 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -91.45 -1.11 57.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.5 1.52 . . . . 73.35 112.286 -169.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.2 -6.26 14.59 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.38 -0.825 . . . . 61.45 112.617 -170.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.3 -111.4 0.47 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.936 -1.48 . . . . 62.14 112.182 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -136.37 139.46 42.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.169 1.485 . . . . 74.12 109.817 169.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.495 HG22 ' CE1' ' A' ' 57' ' ' PHE . 8.7 t -124.13 97.77 4.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 124.847 1.259 . . . . 44.42 107.686 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 t -67.39 -54.84 16.92 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.119 -0.363 . . . . 73.03 110.054 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -83.8 175.92 9.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.316 1.846 . . . . 54.32 111.816 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -167.08 130.73 1.86 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.542 1.137 . . . . 73.41 111.398 166.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -157.36 136.99 12.2 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.793 1.178 . . . . 64.13 112.514 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.9 t -147.59 135.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.642 1.577 . . . . 75.25 107.492 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -112.12 152.85 27.81 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.241 1.416 . . . . 53.52 109.203 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -80.45 65.86 5.75 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.34 0.656 . . . . 64.43 110.338 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -130.45 -11.65 4.0 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.363 0.665 . . . . 71.14 112.361 168.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.86 17.36 7.96 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.756 -1.024 . . . . 61.25 112.531 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.97 158.46 43.87 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.939 1.37 . . . . 71.2 110.007 -171.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.67 107.98 0.34 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.42 -1.072 . . . . 74.03 110.42 -170.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.19 147.98 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 118.006 0.903 . . . . 71.43 109.634 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 18' ' ' VAL . 7.7 t -139.37 163.94 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 106.981 -1.488 . . . . 74.04 106.981 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -146.74 126.42 13.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.163 -1.421 . . . . 74.04 107.163 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.495 ' CE1' HG22 ' A' ' 42' ' ' VAL . 3.3 m-85 -99.3 170.49 8.62 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.183 -1.414 . . . . 72.45 107.183 172.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.93 -60.26 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.908 -0.775 . . . . 63.41 108.908 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -131.69 167.01 20.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.366 0.603 . . . . 74.23 110.155 -168.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -65.81 -27.38 68.22 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 118.138 -0.934 . . . . 71.34 110.377 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -57.46 -50.31 73.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.602 1.092 . . . . 70.41 109.745 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -67.68 -51.42 49.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.943 2.097 . . . . 74.34 107.833 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -57.33 -45.09 84.64 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.389 1.076 . . . . 71.13 112.755 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.6 m -59.15 -46.26 88.83 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.739 -1.226 . . . . 73.22 111.292 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -60.81 -29.95 69.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.07 0.548 . . . . 72.12 110.438 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.24 91.87 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.018 0.927 . . . . 74.21 111.519 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 83.6 t -72.69 -19.28 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 120.705 -1.247 . . . . 73.01 110.36 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -77.17 -57.55 3.77 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.018 -1.051 . . . . 64.32 109.56 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -100.21 -12.51 19.51 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.159 0.984 . . . . 54.43 113.225 -164.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.51 8.91 3.13 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.558 1.143 . . . . 72.15 111.899 -155.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -106.0 163.1 13.03 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.158 1.383 . . . . 72.34 110.017 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.321 6.8 p30 53.92 37.44 26.63 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 119.439 1.018 . . . . 62.23 110.808 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -93.77 172.55 8.18 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 131.625 3.97 . . . . 51.15 111.756 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -85.06 174.72 9.5 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.503 1.121 . . . . 73.31 109.881 160.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -155.81 133.43 11.07 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.756 1.222 . . . . 73.14 110.977 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HA ' HG22 ' A' ' 82' ' ' THR . 35.9 mmt180 -72.84 141.47 47.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.114 0.87 . . . . 73.14 110.988 177.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.79 171.79 7.54 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.961 0.886 . . . . 74.35 110.814 156.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -67.59 -22.66 65.36 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 113.613 -1.63 . . . . 75.14 112.33 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -87.69 14.2 8.99 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.176 0.99 . . . . 75.51 111.787 -169.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.11 30.77 74.06 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.454 -1.058 . . . . 72.13 110.454 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -132.13 159.34 39.23 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 127.076 2.15 . . . . 71.23 106.548 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 76' ' ' ARG . 31.6 p -142.63 113.71 7.65 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.045 0.926 . . . . 73.12 110.405 -171.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.75 177.4 8.91 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 125.909 1.683 . . . . 65.25 110.417 -173.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -106.31 144.78 32.51 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.488 -0.93 . . . . 64.31 108.488 158.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.2 pt -131.28 170.05 20.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 124.554 1.142 . . . . 64.12 108.94 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -125.02 151.87 45.01 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.966 -1.124 . . . . 71.32 107.966 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.1 t -114.9 114.8 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 128.341 2.656 . . . . 72.23 105.925 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -123.87 164.69 18.73 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 121.757 -0.589 . . . . 73.25 110.116 164.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.9 t -67.1 154.95 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 106.74 -1.578 . . . . 74.05 106.74 170.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.276 -1.009 . . . . 72.13 108.276 170.234 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.1 m . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 108.591 -0.892 . . . . 70.12 108.591 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -72.35 26.9 0.05 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.949 2.1 . . . . 65.33 113.664 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.43 41.18 3.49 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.925 -1.509 . . . . 62.22 106.925 174.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.19 136.43 49.23 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.848 1.259 . . . . 74.51 109.133 -172.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.528 HG23 ' HB ' ' A' ' 55' ' ' VAL . 33.7 m -137.61 169.08 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.008 0.923 . . . . 74.12 111.324 -169.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.44 156.31 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 104.604 -2.369 . . . . 73.14 104.604 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.3 t -130.89 151.27 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.047 -1.464 . . . . 70.21 107.047 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.4 p -136.56 167.89 20.53 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.542 1.064 . . . . 73.14 109.174 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.58 4.43 70.35 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.576 1.56 . . . . 72.11 113.557 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.58 148.1 67.53 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 119.528 1.664 . . . . 72.24 112.298 -169.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.58 163.22 36.43 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.142 1.894 . . . . 73.15 109.917 174.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.1 -8.49 20.29 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.898 3.066 . . . . 65.31 115.633 -165.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.53 19.64 2.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.781 1.232 . . . . 72.45 110.829 -175.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.87 103.52 2.0 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 108.594 -1.802 . . . . 65.21 108.594 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.9 m -85.9 169.73 13.01 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.128 0.964 . . . . 65.25 110.773 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -64.06 -24.46 67.71 Favored 'General case' 0 C--O 1.226 -0.136 0 O-C-N 121.86 -0.525 . . . . 72.32 110.77 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -50.45 72.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.472 1.509 . . . . 74.15 108.347 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.26 -41.91 80.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.249 0.477 . . . . 61.23 110.547 176.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -52.74 47.24 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.991 0.814 . . . . 71.43 109.884 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -65.14 -33.57 76.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.835 0.854 . . . . 74.33 110.827 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -80.01 -10.72 59.79 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.667 1.187 . . . . 74.33 113.263 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -112.68 -46.1 3.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.619 0.767 . . . . 74.34 109.866 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.66 ' HG3' HD11 ' A' ' 70' ' ' LEU . 17.2 ttt -67.04 -12.81 60.96 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.046 1.128 . . . . 74.41 114.046 -173.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -60.25 -11.5 6.51 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.893 1.277 . . . . 74.31 114.023 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -58.75 -27.92 65.4 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.47 1.032 . . . . 63.14 112.002 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.38 -9.83 59.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 113.822 1.045 . . . . 70.31 113.822 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.25 -148.83 17.39 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 119.941 1.246 . . . . 52.12 110.3 -171.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.45 91.65 8.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.579 1.657 . . . . 71.54 110.08 -166.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.45 144.61 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 113.524 -1.671 . . . . 74.4 106.608 161.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 2.3 t -138.13 -2.47 1.85 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.282 1.215 . . . . 65.43 114.282 172.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.439 ' HB3' ' CB ' ' A' ' 56' ' ' GLU . 3.8 t80 -138.25 145.43 41.32 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 121.125 1.784 . . . . 73.32 106.8 168.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.45 145.16 38.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.376 -0.972 . . . . 74.31 108.376 165.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -151.73 141.96 22.34 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.548 1.139 . . . . 74.42 109.238 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.9 m -144.33 176.11 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.368 1.467 . . . . 73.41 108.123 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -146.64 -177.24 5.54 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.704 1.202 . . . . 74.12 108.151 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -83.03 51.4 1.94 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.111 0.869 . . . . 64.25 109.083 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -139.65 176.24 8.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.405 -1.331 . . . . 70.34 107.405 167.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.75 53.61 4.86 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.331 -1.108 . . . . 70.31 110.331 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.03 154.56 32.67 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.354 1.077 . . . . 62.05 110.523 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.96 170.53 32.58 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.481 1.515 . . . . 65.12 110.394 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.7 t -146.13 142.93 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.094 1.757 . . . . 71.01 107.309 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.528 ' HB ' HG23 ' A' ' 18' ' ' VAL . 54.6 t -145.21 164.02 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.113 -1.069 . . . . 73.33 108.113 -161.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.439 ' CB ' ' HB3' ' A' ' 44' ' ' TYR . 15.2 tt0 -138.4 144.69 40.33 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.806 -1.553 . . . . 54.23 106.806 172.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -115.7 167.89 10.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.809 2.043 . . . . 74.42 107.638 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.4 m -73.42 -33.06 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.649 0.611 . . . . 64.53 112.649 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -156.95 159.74 38.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.74 0.7 . . . . 74.54 109.592 -171.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -64.85 -20.75 66.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 118.138 -0.934 . . . . 74.23 112.287 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.18 -64.14 0.94 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.391 1.076 . . . . 74.1 108.797 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.34 -42.18 81.43 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.881 0.872 . . . . 73.5 110.146 177.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.442 ' HG3' ' CG1' ' A' ' 18' ' ' VAL . 47.9 ttp -51.63 -57.94 7.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.541 0.336 . . . . 74.31 110.647 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.5 m -61.17 -38.33 86.1 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.96 0.904 . . . . 72.5 112.817 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -54.36 -34.97 62.23 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.224 0.92 . . . . 71.11 111.394 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.481 ' HB1' HD12 ' A' ' 70' ' ' LEU . . . -55.69 -43.43 76.39 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.657 -0.652 . . . . 72.22 112.08 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.33 -19.36 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.929 -1.107 . . . . 71.42 109.934 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -86.91 -36.46 18.36 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.513 1.125 . . . . 72.43 111.493 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.7 mmtm -132.72 0.95 3.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.648 0.981 . . . . 75.0 113.648 -160.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.66 HD11 ' HG3' ' A' ' 36' ' ' MET . 1.7 tm? -143.34 16.64 1.87 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.386 1.075 . . . . 75.04 110.369 -167.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HB2' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -102.25 156.32 17.65 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 119.294 -2.129 . . . . 74.31 112.561 173.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.2 t30 55.22 19.78 3.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.58 1.952 . . . . 75.24 114.059 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.5 p -70.31 173.32 6.93 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.958 1.703 . . . . 52.51 110.766 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -78.39 178.11 7.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.401 -0.592 . . . . 73.44 109.401 163.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -156.03 141.08 17.34 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.486 1.514 . . . . 73.31 112.102 168.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -94.5 109.48 21.36 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.133 2.173 . . . . 63.03 111.529 -170.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -93.39 165.5 12.74 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.53 1.514 . . . . 45.41 110.935 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.58 -17.56 44.44 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.085 -1.009 . . . . 53.45 113.112 176.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -80.97 22.94 0.58 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.233 1.413 . . . . 72.41 112.123 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.62 33.07 83.37 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.687 -0.633 . . . . 74.33 111.818 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.53 169.13 20.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.288 1.435 . . . . 72.01 110.275 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.6 p -148.87 131.06 15.48 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.331 1.052 . . . . 62.21 108.673 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.04 -178.94 3.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.653 0.781 . . . . 62.31 109.277 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -90.81 160.7 15.63 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.152 -0.684 . . . . 72.45 109.152 163.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.1 pt -136.54 167.1 24.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.546 1.138 . . . . 62.35 109.856 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -137.57 122.11 18.45 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.585 -1.265 . . . . 75.41 107.585 -170.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 71' ' ' ASP . 1.4 p -84.86 148.79 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 118.47 0.577 . . . . 62.1 109.708 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.89 177.2 10.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.565 0.746 . . . . 71.23 109.896 162.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.02 153.95 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.503 -1.666 . . . . 75.43 106.503 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.4 t0 . . . . . 0 C--O 1.252 1.187 0 N-CA-C 105.959 -1.867 . . . . 72.32 105.959 158.843 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 106.56 -1.644 . . . . 64.4 106.56 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' ' HE3' ' A' ' 60' ' ' LYS . 59.4 mt-10 -84.52 24.3 1.02 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.901 1.68 . . . . 75.22 112.27 -175.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.32 23.75 5.94 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 119.997 -1.689 . . . . 63.14 110.971 -169.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.2 122.02 40.04 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 121.376 -0.827 . . . . 74.12 111.132 -159.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 89' ' ' VAL . 3.2 m -127.07 159.96 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.24 1.816 . . . . 60.2 108.972 174.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 24.3 m -136.77 176.85 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 127.117 2.167 . . . . 74.13 108.139 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 53' ' ' GLY . 2.4 m -135.89 159.11 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.925 -1.139 . . . . 65.24 107.925 -162.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.88 169.52 22.63 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 123.912 0.885 . . . . 64.12 110.192 -176.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.09 11.1 69.96 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.008 0.813 . . . . 24.33 113.831 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.447 HD13 HG13 ' A' ' 47' ' ' VAL . 10.0 mt -60.31 148.83 78.49 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 118.845 1.323 . . . . 72.3 111.193 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -75.13 170.01 21.32 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.23 2.62 . . . . 72.0 110.39 168.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.93 -36.91 21.26 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.677 2.251 . . . . 70.43 113.969 -175.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.6 32.67 3.26 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 119.841 1.201 . . . . 64.32 110.918 -173.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.07 173.94 44.59 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-O 123.033 1.352 . . . . 61.04 109.776 164.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.4 p -159.43 168.88 25.18 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.063 1.745 . . . . 51.52 107.883 171.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -62.19 -27.34 68.9 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 122.116 -0.365 . . . . 74.1 111.26 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -65.02 -50.02 67.89 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.983 0.913 . . . . 73.01 109.807 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -67.45 -26.32 66.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.356 1.063 . . . . 73.43 111.02 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.08 -55.97 8.12 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.172 -1.047 . . . . 74.4 108.172 171.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -63.61 -35.75 81.56 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.299 -0.875 . . . . 72.04 111.85 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -75.3 -5.75 46.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.81 0.844 . . . . 64.32 113.244 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.501 ' CG ' HH21 ' A' ' 76' ' ' ARG . 2.2 t-160 -119.05 -43.7 2.63 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.262 1.025 . . . . 72.32 112.828 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.416 ' O ' HG21 ' A' ' 42' ' ' VAL . 8.8 ttt -76.27 41.83 0.25 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.452 -0.78 . . . . 74.1 110.752 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.2 ptm85 -111.28 -16.5 13.38 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.074 -1.641 . . . . 74.15 112.372 -170.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -84.58 -5.28 59.29 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.666 1.358 . . . . 55.24 114.666 -168.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.12 -13.73 24.82 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.755 0.822 . . . . 53.54 112.388 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.18 -176.23 24.33 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.767 -0.933 . . . . 72.31 110.767 -170.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.21 127.25 32.48 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.241 -0.564 . . . . 44.21 111.696 -166.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 36' ' ' MET . 30.2 t -118.05 123.29 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 C-N-CA 124.252 1.021 . . . . 74.43 108.948 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.82 -19.88 19.26 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 117.993 -1.003 . . . . 74.43 112.362 -177.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -130.02 166.98 19.0 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.362 1.437 . . . . 72.22 111.798 -170.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -163.29 139.73 7.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.412 1.085 . . . . 71.11 111.617 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -146.84 143.34 28.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.559 1.144 . . . . 64.13 109.741 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.447 HG13 HD13 ' A' ' 23' ' ' LEU . 42.4 t -144.41 148.4 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.074 1.35 . . . . 72.43 107.982 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -139.87 168.47 19.73 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.859 1.263 . . . . 72.42 110.554 175.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -84.06 40.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 127.294 2.237 . . . . 71.03 111.327 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -130.2 43.19 3.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.59 1.186 . . . . 71.24 109.205 170.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.14 12.34 30.16 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.357 -1.246 . . . . 33.44 114.523 172.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.3 p -143.12 157.45 44.51 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 120.429 2.115 . . . . 73.31 109.282 -169.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.542 ' N ' HG22 ' A' ' 20' ' ' VAL . . . -149.79 178.26 27.41 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 107.553 -2.219 . . . . 65.42 107.553 -172.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 31.0 t -155.96 137.79 5.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 105.393 -2.076 . . . . 74.04 105.393 -170.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.62 170.53 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.381 -1.34 . . . . 61.12 107.381 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -146.88 125.41 12.44 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.328 -2.101 . . . . 51.22 105.328 162.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -100.35 164.59 11.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.185 -1.783 . . . . 75.22 106.185 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.8 m -73.39 -29.5 27.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.307 -0.957 . . . . 73.21 112.266 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -151.82 165.41 34.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.526 0.603 . . . . 75.41 112.488 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 15' ' ' GLU . 8.7 ttmt -61.81 -28.38 69.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.884 -1.055 . . . . 74.33 110.944 176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.13 -59.76 4.33 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.17 0.896 . . . . 74.24 108.729 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.31 -46.52 86.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.586 1.555 . . . . 71.14 109.139 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -50.38 -55.46 15.6 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.253 1.021 . . . . 74.55 111.344 172.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.7 m -54.04 -44.2 70.84 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.779 0.718 . . . . 44.14 110.956 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -62.08 -40.88 97.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.11 -0.33 . . . . 75.24 110.11 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.95 -41.0 86.38 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.949 -0.469 . . . . 74.3 111.364 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.49 -10.24 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 121.497 -0.752 . . . . 53.11 110.975 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -119.12 -1.49 10.89 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.468 1.031 . . . . 71.14 113.721 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.0 -5.05 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.163 0.985 . . . . 53.01 112.586 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.99 24.24 3.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.633 1.173 . . . . 63.13 109.28 -171.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.34 156.83 17.59 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.796 -1.19 . . . . 71.13 110.361 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.13 20.96 1.96 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.389 2.276 . . . . 74.32 113.351 -174.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.3 p -74.31 174.62 8.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.528 1.931 . . . . 55.3 111.582 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -77.15 162.82 27.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.082 0.953 . . . . 73.43 110.116 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -148.18 121.13 8.77 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.726 1.611 . . . . 74.44 108.469 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.501 HH21 ' CG ' ' A' ' 35' ' ' HIS . 6.7 ptp180 -74.75 157.24 35.58 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.839 0.856 . . . . 72.03 109.747 173.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.9 p -141.42 163.26 33.42 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.13 0.572 . . . . 73.12 111.124 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -71.41 -12.43 61.41 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.579 1.551 . . . . 74.13 112.169 -174.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.75 8.58 2.32 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.755 1.222 . . . . 73.22 111.701 169.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.12 21.09 76.94 Favored Glycine 0 C--N 1.337 0.634 0 O-C-N 121.096 -1.002 . . . . 73.42 112.008 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -127.37 167.99 15.44 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.115 1.366 . . . . 74.34 109.065 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -140.27 145.6 37.51 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.387 -0.968 . . . . 73.02 108.387 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -127.26 -168.92 1.95 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.499 1.92 . . . . 72.2 107.022 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -103.72 161.94 13.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.785 -0.82 . . . . 63.34 108.785 165.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.8 pt -132.65 162.97 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-O 121.189 0.519 . . . . 73.2 109.793 169.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -120.09 103.01 8.92 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.543 1.537 . . . . 72.33 108.086 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 t -70.0 139.27 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.623 -1.251 . . . . 75.2 107.623 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -138.05 168.02 20.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.327 0.967 . . . . 62.5 110.467 159.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.546 ' HA ' HG12 ' A' ' 18' ' ' VAL . 90.7 t -78.57 140.8 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.047 -1.464 . . . . 61.53 107.047 170.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 44.5 t0 . . . . . 0 C--O 1.248 1.003 0 N-CA-C 107.273 -1.38 . . . . 53.24 107.273 167.521 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 107.43 -1.322 . . . . 74.21 107.43 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.56 25.72 0.05 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.229 2.612 . . . . 75.45 113.212 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.52 35.77 3.81 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.485 1.514 . . . . 75.23 108.326 -177.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -115.77 124.43 50.75 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.771 1.628 . . . . 73.21 108.436 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.55 166.26 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.336 1.854 . . . . 74.05 110.05 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -137.0 141.11 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.275 1.83 . . . . 71.31 106.506 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.7 t -112.99 152.16 14.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.792 1.237 . . . . 75.43 107.725 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.99 164.34 32.37 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.585 -1.265 . . . . 72.14 107.585 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.88 14.33 82.26 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.815 -0.992 . . . . 60.24 113.07 -173.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.792 HD23 ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -64.61 145.27 98.67 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 119.762 1.781 . . . . 65.05 110.94 -166.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.792 ' HD2' HD23 ' A' ' 23' ' ' LEU . 55.5 Cg_endo -64.33 169.86 10.29 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.095 2.53 . . . . 73.22 110.717 175.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.16 -13.92 39.28 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.761 1.641 . . . . 72.14 113.108 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -138.37 17.65 2.75 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.429 1.27 . . . . 64.01 114.429 -155.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.74 97.7 1.18 Allowed Glycine 0 C--N 1.335 0.507 0 N-CA-C 108.51 -1.836 . . . . 62.14 108.51 170.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.92 179.2 4.43 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.833 0.816 . . . . 45.45 110.876 172.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -61.93 -28.09 69.29 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.723 -1.235 . . . . 73.41 114.272 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.33 -51.8 64.47 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.245 -1.391 . . . . 53.23 107.245 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.3 -47.52 83.42 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.137 1.375 . . . . 73.03 110.056 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.519 HD23 HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -48.43 -58.22 4.95 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.638 0.775 . . . . 75.25 110.024 177.329 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.02 -37.86 78.87 Favored 'General case' 0 C--N 1.338 0.08 0 O-C-N 122.101 -0.374 . . . . 65.34 111.017 -171.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -7.71 14.2 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.284 0.846 . . . . 73.12 113.284 176.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -112.29 -49.32 2.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.173 0.989 . . . . 75.14 111.858 174.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.1 ttt -70.53 25.25 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.774 1.629 . . . . 64.32 112.945 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.51 -7.42 41.3 Favored 'General case' 0 C--O 1.222 -0.392 0 O-C-N 120.175 -1.578 . . . . 71.03 113.292 167.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.69 -23.05 67.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.83 1.65 . . . . 72.45 113.801 -172.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.48 -8.39 58.38 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.486 1.515 . . . . 20.03 113.951 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.21 -110.28 0.43 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 119.852 1.206 . . . . 60.23 111.448 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.99 138.31 22.86 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.34 1.067 . . . . 74.14 108.229 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.472 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.4 p -122.34 135.81 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 C-N-CA 127.42 2.288 . . . . 71.42 109.595 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.1 p -103.17 -25.88 13.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.386 -0.825 . . . . 42.54 110.104 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.424 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 8.8 t80 -130.67 136.9 49.26 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.74 1.616 . . . . 71.05 109.071 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.92 150.05 46.73 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.003 0.921 . . . . 34.43 108.635 158.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -148.05 132.69 17.82 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.458 1.903 . . . . 73.2 107.494 172.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.1 t -137.98 137.61 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.599 -2.0 . . . . 65.21 105.599 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.29 -163.83 0.22 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.0 1.72 . . . . 70.31 109.833 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 ptm85 -43.54 -57.49 3.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.532 -1.667 . . . . 65.1 111.118 159.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -172.7 168.76 5.12 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.803 1.638 . . . . 61.34 114.443 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.28 -39.95 3.06 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 128.152 2.787 . . . . 72.1 114.822 168.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.96 168.47 19.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.997 1.399 . . . . 61.21 109.242 -173.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.71 152.29 23.38 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.063 -1.615 . . . . 42.42 109.063 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -118.4 139.96 43.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.731 -1.211 . . . . 70.45 107.731 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.4 t -140.92 146.51 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.486 -1.672 . . . . 62.11 106.486 -168.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 44' ' ' TYR . 23.6 mt-10 -138.29 106.97 5.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 120.815 -1.178 . . . . 65.25 108.085 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.472 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 1.3 m-85 -76.51 163.76 26.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.201 1.801 . . . . 73.05 108.943 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.6 m -74.47 -39.17 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 120.955 -1.091 . . . . 63.33 112.499 -172.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -143.09 159.27 42.58 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.195 0.598 . . . . 75.42 110.412 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -67.26 -26.89 66.79 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 117.609 -1.186 . . . . 55.12 111.698 -174.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -51.72 -63.56 1.1 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 122.341 1.067 . . . . 75.01 108.429 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -73.2 -41.36 63.9 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.999 1.719 . . . . 72.44 108.446 -167.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.411 ' SD ' HG22 ' A' ' 89' ' ' VAL . 16.5 tmm? -52.62 -49.85 64.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.443 1.097 . . . . 75.32 111.245 170.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.4 m -61.19 -43.31 99.08 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.461 -0.774 . . . . 72.22 110.523 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -56.44 -41.31 76.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.93 0.786 . . . . 72.04 110.328 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.58 -43.49 68.56 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 123.729 0.812 . . . . 75.15 111.876 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.96 -34.94 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 120.596 1.543 . . . . 75.22 110.375 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.8 ptt85 -92.49 -16.32 25.96 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.145 1.165 . . . . 74.22 114.145 -170.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -117.18 -37.43 3.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.248 1.019 . . . . 54.12 111.482 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.04 22.57 12.05 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.367 1.467 . . . . 55.45 110.095 -167.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -101.16 154.96 18.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.306 1.412 . . . . 74.14 111.841 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.0 t30 63.7 14.88 8.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.148 2.579 . . . . 74.15 112.981 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.5 p -76.13 175.17 9.21 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.746 1.218 . . . . 73.43 110.832 -169.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -66.92 170.92 5.95 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.3 -0.875 . . . . 74.33 108.954 155.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -149.67 126.7 11.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.432 1.093 . . . . 74.04 109.553 166.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.5 mtt-85 -82.98 120.38 25.64 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.442 1.497 . . . . 75.25 111.511 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.8 p -76.25 -172.19 2.0 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.597 -0.89 . . . . 72.01 108.597 154.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -89.24 -8.16 54.02 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.006 -1.059 . . . . 71.14 110.99 165.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -76.82 5.55 7.59 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.84 -1.163 . . . . 73.34 113.64 -167.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.36 17.06 67.46 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 124.309 0.956 . . . . 74.15 110.845 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.6 167.14 20.58 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.139 1.376 . . . . 74.34 108.763 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.9 p -146.55 128.48 15.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.352 -0.981 . . . . 63.45 108.352 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.51 175.69 8.22 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.155 -1.054 . . . . 55.25 108.155 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -92.08 156.54 17.31 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.092 -1.818 . . . . 75.21 106.092 144.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.5 pt -131.64 173.74 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.558 -1.275 . . . . 72.15 107.558 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -128.94 150.4 50.4 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.231 -1.396 . . . . 75.25 107.231 168.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.8 t -122.62 137.21 56.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 126.081 1.752 . . . . 75.44 107.664 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.61 158.84 43.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.04 1.336 . . . . 62.25 108.902 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.411 HG22 ' SD ' ' A' ' 63' ' ' MET . 11.3 t -70.43 149.89 10.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.45 -1.685 . . . . 64.51 106.45 162.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.3 t70 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.813 -1.089 . . . . 75.41 110.369 172.445 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 108.509 -0.922 . . . . 72.21 108.509 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -73.42 44.65 0.16 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.446 1.898 . . . . 72.52 111.9 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.23 22.3 3.22 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.125 -1.609 . . . . 75.13 110.861 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -121.61 136.79 54.93 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.937 -1.102 . . . . 64.12 109.285 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.51 155.99 16.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.112 -0.699 . . . . 51.12 109.112 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.97 141.26 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 124.893 1.277 . . . . 72.41 107.671 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.0 t -101.88 147.27 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 126.727 2.011 . . . . 75.35 107.805 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.08 156.45 48.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.726 0.694 . . . . 74.44 110.632 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.94 3.53 70.3 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.674 1.13 . . . . 74.23 114.084 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.9 mt -58.26 147.12 68.23 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.449 1.1 . . . . 72.41 113.448 -164.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.22 165.6 31.91 Favored 'Trans proline' 0 CA--C 1.538 0.694 1 C-N-CA 126.051 4.501 . . . . 74.22 112.841 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -67.61 -15.76 45.43 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.669 2.913 . . . . 62.53 114.754 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.04 22.72 9.48 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.536 1.134 . . . . 73.2 110.023 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.45 72.75 2.71 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.56 -1.016 . . . . 74.24 110.56 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -69.68 162.8 26.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 124.423 0.72 . . . . 72.13 111.126 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.0 p-90 -61.55 -19.54 62.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.714 0.806 . . . . 74.24 111.467 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -60.49 3.28 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 117.093 -1.432 . . . . 74.03 109.385 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -64.46 -39.9 94.69 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.128 0.893 . . . . 54.42 109.544 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -48.6 52.37 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 123.247 0.619 . . . . 64.51 110.866 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -67.77 -44.15 78.14 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.708 0.685 . . . . 75.23 110.81 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.41 -13.07 62.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.767 1.227 . . . . 63.22 112.499 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -108.74 -43.85 4.16 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.986 1.314 . . . . 75.43 112.455 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.5 ttt -77.59 42.72 0.37 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.59 -1.319 . . . . 61.14 111.198 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.5 -5.65 12.83 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.092 -1.63 . . . . 64.12 113.366 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -63.19 -22.55 66.94 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.565 1.529 . . . . 72.33 113.833 -172.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.47 -5.44 59.16 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.06 1.504 . . . . 74.35 115.06 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.27 -98.6 0.21 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-O 118.349 -1.251 . . . . 44.14 111.034 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.15 149.53 31.19 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.579 1.189 . . . . 71.43 112.188 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.4 t -130.55 148.22 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.79 1.636 . . . . 72.24 109.509 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.9 t -129.76 8.19 5.29 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.525 0.73 . . . . 64.44 112.293 -170.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -154.08 162.88 40.89 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.593 1.557 . . . . 74.12 108.81 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -162.04 129.9 4.04 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.867 0.867 . . . . 73.01 109.583 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -155.75 128.61 7.99 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.268 0.94 . . . . 72.14 111.184 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.01 177.38 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 O-C-N 120.522 -1.361 . . . . 71.33 107.398 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.21 161.04 42.27 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.312 -1.366 . . . . 63.33 107.312 168.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 42.36 -86.87 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.426 1 C-N-CA 132.116 4.166 . . . . 72.21 112.114 162.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -165.48 -178.02 4.73 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 128.002 2.521 . . . . 71.12 110.209 153.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.74 -21.12 31.47 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-O 117.879 -1.512 . . . . 74.1 114.293 161.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.02 164.82 37.28 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 120.154 1.977 . . . . 73.43 108.448 168.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.0 143.05 8.17 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 107.816 -2.114 . . . . 72.14 107.816 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.7 p -107.99 144.9 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.726 1.263 . . . . 75.53 109.567 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.2 t -142.81 156.58 18.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 107.152 -1.425 . . . . 71.54 107.152 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -136.49 112.85 9.91 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.93 -1.507 . . . . 73.02 106.93 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -80.0 177.81 8.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.977 -1.465 . . . . 73.53 107.237 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.54 -60.99 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.046 -0.979 . . . . 64.23 110.399 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -139.19 169.17 18.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 124.24 1.016 . . . . 75.31 109.671 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -59.45 -29.73 68.0 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 116.875 -1.536 . . . . 63.52 111.791 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -60.55 -60.01 4.48 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.086 1.312 . . . . 63.25 109.877 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.64 -42.45 98.15 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.904 0.882 . . . . 71.54 109.695 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -58.31 -50.61 73.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.282 1.033 . . . . 70.44 110.721 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.9 m -57.57 -52.76 64.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.255 -0.646 . . . . 70.25 109.255 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -56.57 -32.13 64.89 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.627 0.771 . . . . 74.55 112.077 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.54 93.64 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 123.304 0.641 . . . . 63.33 110.024 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 t -70.29 -12.99 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.229 -0.919 . . . . 52.22 110.84 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -105.35 -33.1 8.29 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 120.875 -1.141 . . . . 64.21 111.957 -174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -121.51 -12.42 8.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.377 1.071 . . . . 72.54 112.759 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.1 18.24 10.81 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.246 1.818 . . . . 73.55 109.434 -172.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -112.57 148.71 33.97 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.725 -1.234 . . . . 74.24 110.836 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.77 27.84 16.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.395 1.078 . . . . 72.33 111.032 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.1 p -90.44 175.93 6.9 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.85 1.26 . . . . 44.33 109.807 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.86 167.82 21.11 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.831 -0.803 . . . . 62.35 108.831 158.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -146.05 160.79 41.4 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 127.328 2.251 . . . . 64.34 110.656 173.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -114.93 126.18 54.49 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.313 0.96 . . . . 60.44 109.16 -173.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.7 t -93.33 163.58 13.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.874 -0.787 . . . . 75.5 108.874 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.52 -8.37 56.56 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 119.112 -0.47 . . . . 73.2 111.749 166.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -78.43 -12.99 60.04 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.927 1.239 . . . . 73.22 113.339 -169.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.65 31.69 4.77 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 124.327 0.965 . . . . 74.24 111.864 -173.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.1 168.29 26.41 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.036 0.934 . . . . 73.11 110.936 -169.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.5 p -145.2 122.53 11.59 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.566 -1.197 . . . . 73.44 108.565 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.02 -174.17 2.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.603 1.961 . . . . 61.4 108.392 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -105.1 156.37 18.14 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 120.477 1.489 . . . . 72.43 110.59 172.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.6 pt -129.8 170.37 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 122.115 0.96 . . . . 65.13 108.987 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -130.61 155.51 46.42 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 104.791 -2.299 . . . . 71.14 104.791 172.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.8 t -125.97 137.33 58.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.982 -1.118 . . . . 72.53 107.982 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -130.41 147.7 52.14 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 123.853 0.861 . . . . 65.4 110.592 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.66 127.61 24.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 105.722 -1.955 . . . . 61.35 105.722 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 127.678 2.391 . . . . 51.21 111.09 -172.992 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 106.97 -1.493 . . . . 71.12 106.97 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -76.34 37.15 0.16 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.709 1.603 . . . . 53.44 112.301 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.8 14.94 3.63 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.465 1.906 . . . . 71.34 110.746 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.33 121.39 42.66 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.512 1.525 . . . . 73.02 107.526 -162.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.457 HG23 ' HB ' ' A' ' 55' ' ' VAL . 20.8 m -115.14 166.12 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 118.504 0.593 . . . . 52.32 111.455 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.3 t -132.74 153.01 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.092 -1.818 . . . . 72.34 106.092 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 t -134.11 141.03 44.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 106.955 -1.498 . . . . 74.42 106.955 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.3 m -137.31 141.81 41.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 123.127 1.442 . . . . 74.33 113.266 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.19 37.43 48.8 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 128.578 2.99 . . . . 52.24 112.773 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.63 160.77 3.67 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.853 1.661 . . . . 73.41 113.021 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.83 171.02 14.13 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.612 3.541 . . . . 70.51 112.014 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.76 -4.89 16.18 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.739 2.293 . . . . 73.23 114.239 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.8 t -141.58 51.66 1.55 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.615 1.166 . . . . 70.43 109.08 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.95 164.55 13.22 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.365 -1.494 . . . . 54.41 109.365 168.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 m -151.66 168.41 25.09 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.405 1.482 . . . . 51.41 108.426 167.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -53.0 -29.3 28.39 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.203 0.816 . . . . 62.31 113.203 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -62.79 -58.24 8.11 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.424 1.089 . . . . 72.44 108.911 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.3 -30.6 67.64 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.453 -0.573 . . . . 70.13 109.453 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -51.29 -56.05 15.05 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.33 -0.856 . . . . 54.12 109.78 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -70.47 -35.62 73.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.919 1.288 . . . . 65.53 110.034 -175.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -59.63 -23.04 62.68 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.245 1.018 . . . . 73.33 112.953 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -102.59 -42.89 5.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.153 0.981 . . . . 72.33 111.431 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.19 -20.42 65.4 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.154 -0.966 . . . . 74.43 113.244 -174.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -52.55 -26.2 12.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.827 1.417 . . . . 74.4 114.827 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -71.06 3.08 3.69 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.687 1.736 . . . . 65.43 115.687 -161.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.75 -0.96 28.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.642 1.177 . . . . 65.44 111.955 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.47 -97.95 0.16 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.617 -1.793 . . . . 50.02 108.617 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -157.76 162.53 38.51 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.795 1.283 . . . . 62.52 107.789 166.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.477 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -131.81 129.73 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 126.738 2.015 . . . . 64.32 109.818 -175.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.7 t -86.85 -32.62 20.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.577 -1.192 . . . . 61.41 109.341 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -138.47 137.16 36.9 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.156 -0.965 . . . . 74.32 110.638 -160.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.76 149.43 37.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.203 1.001 . . . . 65.22 110.771 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -161.63 106.97 1.3 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.879 2.072 . . . . 63.11 108.821 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.93 -176.71 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.282 -1.511 . . . . 72.51 107.985 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -143.16 155.17 44.5 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.892 -0.781 . . . . 74.52 108.892 156.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 43.37 -86.13 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 130.666 3.587 . . . . 63.11 111.838 166.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -159.38 173.97 15.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 125.231 1.582 . . . . 72.24 107.52 147.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.08 -8.92 63.27 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 118.605 -1.108 . . . . 71.44 113.343 161.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.56 164.84 33.93 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.635 1.717 . . . . 74.1 108.294 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -155.8 163.21 31.65 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.174 -1.17 . . . . 72.53 110.174 167.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.6 147.54 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.493 1.917 . . . . 31.14 108.23 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.457 ' HB ' HG23 ' A' ' 18' ' ' VAL . 72.1 t -144.0 166.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.943 -1.132 . . . . 73.44 107.943 -165.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -135.81 109.68 8.16 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.249 -1.389 . . . . 74.44 107.249 165.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.477 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -79.12 167.11 21.49 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.495 1.518 . . . . 53.22 108.336 172.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.71 -29.98 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.212 1.19 . . . . 70.13 114.212 -166.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -156.31 164.39 38.38 Favored 'General case' 0 CA--C 1.515 -0.381 0 O-C-N 121.262 -0.899 . . . . 74.2 109.894 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -61.72 -31.95 72.15 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 117.448 -1.263 . . . . 63.41 111.632 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.29 -51.92 65.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 120.379 1.445 . . . . 72.42 109.724 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.46 -40.69 66.8 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.258 1.423 . . . . 61.22 108.706 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.415 ' HG3' ' CG1' ' A' ' 18' ' ' VAL . 36.2 ttp -52.25 -53.82 38.95 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 123.338 0.655 . . . . 65.04 109.98 169.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.4 m -55.31 -47.46 75.57 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.306 -0.854 . . . . 54.4 109.977 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -57.53 -28.34 63.4 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.866 1.212 . . . . 71.51 112.113 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.1 -44.91 83.0 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.469 1.108 . . . . 72.23 109.227 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.8 t -65.09 -21.76 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 121.192 -0.942 . . . . 53.34 110.778 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -91.9 -43.78 9.29 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 120.964 -1.085 . . . . 74.41 111.317 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -114.44 -15.62 12.05 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.069 1.348 . . . . 63.44 111.998 -165.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.32 22.15 9.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.478 1.911 . . . . 63.3 108.95 -171.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -111.83 154.53 24.98 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.45 -1.407 . . . . 72.42 110.87 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.269 5.8 p-10 45.25 41.67 6.31 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.103 2.161 . . . . 72.42 112.327 -170.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.0 p -95.97 175.15 6.59 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.545 1.138 . . . . 54.44 111.668 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 171.78 4.09 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.078 0.551 . . . . 51.33 109.541 158.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -150.97 124.78 9.14 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.104 1.361 . . . . 74.2 109.328 166.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.453 ' HA ' HG22 ' A' ' 82' ' ' THR . 70.5 mtp180 -70.46 142.2 51.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.84 1.2 . . . . 43.33 110.47 177.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -109.11 -170.97 1.75 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.17 1.788 . . . . 65.2 107.507 176.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -99.6 -3.21 33.74 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.303 0.853 . . . . 71.24 113.303 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.73 41.46 1.39 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.494 1.117 . . . . 62.44 111.465 -171.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.41 18.48 55.78 Favored Glycine 0 N--CA 1.464 0.538 0 C-N-CA 124.924 1.249 . . . . 51.21 113.408 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -142.99 174.09 10.98 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 125.492 1.517 . . . . 74.51 108.894 -166.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 76' ' ' ARG . 52.5 p -147.19 143.35 28.14 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.813 -0.81 . . . . 71.54 108.813 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.21 176.81 8.13 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.619 0.768 . . . . 70.51 110.565 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -104.13 154.79 19.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.984 -1.487 . . . . 61.44 106.984 141.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 pt -133.4 166.43 29.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 124.828 1.251 . . . . 74.52 108.603 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -126.51 133.5 51.13 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 105.822 -1.918 . . . . 73.34 105.822 165.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.5 t -84.44 165.96 2.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 125.779 1.632 . . . . 72.11 107.703 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.77 156.43 31.55 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.552 1.541 . . . . 73.33 107.967 162.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.78 138.51 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 105.18 -2.156 . . . . 50.11 105.18 156.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--O 1.245 0.853 0 C-N-CA 124.044 0.938 . . . . 65.31 110.568 177.361 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 108.319 -0.993 . . . . 72.42 108.319 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -70.53 24.35 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.054 2.541 . . . . 74.14 113.949 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.51 18.24 5.3 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.473 -1.392 . . . . 65.4 110.465 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.93 146.56 34.98 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.057 1.743 . . . . 64.31 111.106 -170.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.517 HG23 ' HB ' ' A' ' 55' ' ' VAL . 31.0 m -142.01 171.92 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 118.956 0.798 . . . . 74.43 111.012 -175.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 39.5 t -140.96 148.15 21.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.188 -2.153 . . . . 71.14 105.188 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 t -118.83 154.88 21.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 125.006 1.322 . . . . 71.34 107.683 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.6 m -149.45 158.49 44.22 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 119.955 -1.716 . . . . 73.31 110.525 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.39 61.42 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.889 0.757 . . . . 64.42 112.895 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.405 HD11 HD23 ' A' ' 32' ' ' LEU . 4.1 mm? -59.1 154.85 37.49 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 124.866 1.267 . . . . 73.05 112.238 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.63 174.54 12.06 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.45 3.434 . . . . 73.11 112.8 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.89 -8.08 21.74 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.625 2.217 . . . . 64.01 114.676 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.68 59.84 1.65 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.997 1.726 . . . . 51.24 109.685 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.97 149.12 16.87 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 108.199 -1.96 . . . . 63.12 108.199 172.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.1 m -137.6 -179.69 5.89 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 122.513 1.149 . . . . 72.14 108.144 168.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.3 p-90 -63.56 -18.53 63.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.92 1.288 . . . . 70.41 112.239 -176.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -69.89 -57.18 5.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.082 -1.081 . . . . 71.12 108.082 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -64.39 -26.91 68.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.548 0.69 . . . . 71.32 110.455 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.405 HD23 HD11 ' A' ' 23' ' ' LEU . 1.3 tm? -64.74 -54.05 37.46 Favored 'General case' 0 C--O 1.224 -0.264 0 O-C-N 120.235 -1.54 . . . . 50.22 110.653 174.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -65.51 -25.83 67.63 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.864 0.866 . . . . 73.31 110.865 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -31.89 64.97 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.808 -0.812 . . . . 74.31 108.808 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -83.82 -53.41 5.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.231 1.813 . . . . 72.51 112.088 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.9 ttt -81.64 39.42 0.54 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.64 1.176 . . . . 72.14 112.069 -167.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.81 2.28 14.33 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.229 1.412 . . . . 74.34 111.874 -175.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -85.78 -8.56 58.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.418 1.487 . . . . 64.5 113.174 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.61 25.22 11.88 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.979 1.312 . . . . 52.0 112.926 -166.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.51 -104.03 0.82 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 108.818 -1.713 . . . . 73.1 108.818 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -139.73 133.9 31.13 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.812 0.845 . . . . 64.33 110.64 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.6 t -127.97 136.04 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 126.195 1.798 . . . . 71.3 107.587 173.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.2 t -110.08 -26.13 9.86 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.462 0.541 . . . . 72.14 112.462 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -116.01 146.13 42.4 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.238 1.015 . . . . 72.42 109.721 -173.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.74 152.19 43.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.112 0.965 . . . . 71.25 108.463 163.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -148.58 144.66 27.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.569 0.748 . . . . 74.51 109.557 160.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -147.4 144.91 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 105.768 -1.938 . . . . 73.22 105.768 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -138.22 178.79 6.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.599 1.16 . . . . 73.34 109.343 -171.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -89.42 66.47 7.43 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.203 -1.036 . . . . 64.43 108.203 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -151.49 31.68 0.58 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.625 0.77 . . . . 63.42 110.414 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.75 18.75 40.22 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.062 -1.024 . . . . 61.45 113.616 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.7 p -146.93 170.22 17.52 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.222 1.511 . . . . 45.45 110.242 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.42 164.01 34.27 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.841 1.21 . . . . 72.23 110.469 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 28.7 t -131.4 156.01 42.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.572 1.549 . . . . 70.15 109.025 172.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.517 ' HB ' HG23 ' A' ' 18' ' ' VAL . 45.5 t -147.1 158.4 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.093 -1.447 . . . . 62.42 107.093 -175.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -145.0 114.45 7.14 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.325 -0.991 . . . . 50.42 108.325 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.78 174.77 7.01 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.822 2.449 . . . . 71.5 107.941 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.81 -49.25 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 117.606 -1.188 . . . . 53.21 111.11 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -137.09 157.84 45.79 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 120.471 1.487 . . . . 74.42 110.721 -167.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -62.88 -25.85 68.5 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 118.303 -0.856 . . . . 53.2 111.133 -170.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.66 -42.76 40.67 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 119.242 0.928 . . . . 73.11 111.299 -174.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -67.84 -44.44 77.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.082 0.855 . . . . 64.52 109.104 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.488 ' HG2' ' CG1' ' A' ' 18' ' ' VAL . 16.9 tmm? -50.6 -50.94 52.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.926 0.491 . . . . 33.43 110.938 173.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.9 m -56.58 -52.84 63.28 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.715 -0.659 . . . . 74.51 110.344 172.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -49.52 -40.84 39.26 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.489 1.515 . . . . 72.4 111.158 -174.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.39 93.35 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.102 1.361 . . . . 52.5 111.259 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.5 t -58.67 -25.77 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 121.413 -0.804 . . . . 75.12 110.269 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -106.87 -9.85 16.2 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.399 1.479 . . . . 71.33 111.852 -167.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -20.23 1.54 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 117.283 -1.341 . . . . 71.01 113.587 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.0 18.83 10.08 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.882 1.673 . . . . 74.42 109.737 -164.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -104.12 159.0 16.04 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.921 -1.112 . . . . 73.32 111.91 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 44.98 43.24 7.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.782 2.433 . . . . 74.43 112.044 -168.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.2 p -86.54 164.35 16.95 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.509 0.723 . . . . 75.45 110.731 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -88.07 157.62 18.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.553 1.141 . . . . 75.12 108.99 169.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -140.29 133.1 29.09 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.65 1.58 . . . . 64.22 109.519 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HA ' HG22 ' A' ' 82' ' ' THR . 62.6 mtt180 -81.82 112.28 18.81 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 123.692 0.797 . . . . 74.33 110.52 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.15 156.66 29.77 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.961 -1.125 . . . . 73.35 107.961 165.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -72.77 -11.36 60.58 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.94 -0.475 . . . . 74.54 111.196 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -70.05 3.64 2.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.778 2.031 . . . . 74.13 113.545 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.19 15.97 78.67 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 119.121 0.873 . . . . 50.54 111.525 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.13 170.88 14.36 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 126.841 2.056 . . . . 75.42 108.011 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.425 HG22 ' HA ' ' A' ' 76' ' ' ARG . 30.6 p -137.54 154.71 49.78 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.295 -1.743 . . . . 63.13 106.295 -177.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.07 -179.09 5.2 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.871 -0.789 . . . . 61.22 108.871 166.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -95.56 156.53 16.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.453 -0.573 . . . . 62.05 109.453 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.1 pt -124.95 168.83 17.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.552 1.141 . . . . 74.34 108.873 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -125.39 147.18 49.28 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.154 -1.424 . . . . 64.03 107.154 165.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.1 t -104.79 146.39 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 125.909 1.684 . . . . 74.41 108.794 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 160.61 43.77 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.211 1.805 . . . . 71.43 108.815 173.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.9 150.49 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 105.688 -1.967 . . . . 64.01 105.688 167.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t70 . . . . . 0 C--O 1.248 1.005 0 C-N-CA 125.477 1.511 . . . . 74.13 109.854 171.022 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.3 m . . . . . 0 N--CA 1.447 -0.597 0 CA-C-O 123.053 1.406 . . . . 70.13 111.156 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -62.34 15.26 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 131.138 3.775 . . . . 71.52 113.17 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.43 14.85 3.46 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 119.093 -2.254 . . . . 44.24 111.314 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -104.49 142.61 34.32 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.63 1.172 . . . . 52.13 111.3 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.503 HG23 ' HB ' ' A' ' 55' ' ' VAL . 31.1 m -131.7 169.41 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.095 1.358 . . . . 63.44 111.601 173.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.7 t -133.86 151.3 32.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.948 2.099 . . . . 73.43 106.008 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.42 153.9 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.379 -0.971 . . . . 65.4 108.379 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.0 p -132.14 168.83 17.31 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 121.286 -0.884 . . . . 54.1 109.04 168.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.69 -6.45 58.88 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.713 -1.049 . . . . 70.43 113.644 168.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.83 152.58 26.56 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 125.082 1.353 . . . . 74.53 113.892 -165.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.26 173.55 12.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.763 2.975 . . . . 64.11 111.788 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.45 -7.55 12.7 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.071 3.181 . . . . 73.23 115.329 168.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.29 68.16 1.23 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 121.25 1.841 . . . . 64.43 110.787 172.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.92 115.51 3.49 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.35 -1.5 . . . . 64.32 109.35 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 m -111.06 164.05 13.23 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.324 1.05 . . . . 54.23 109.83 -174.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -66.48 -25.26 66.62 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.171 -0.956 . . . . 74.43 112.097 -168.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -68.75 -52.08 34.43 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.729 -0.841 . . . . 73.44 108.729 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -58.56 -41.32 85.36 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.772 -0.825 . . . . 73.25 108.772 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.95 -60.75 2.94 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-O 117.707 -1.139 . . . . 73.53 110.264 174.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -65.86 -32.83 74.58 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 120.904 1.683 . . . . 72.54 111.758 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.31 -30.02 71.24 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.458 1.103 . . . . 74.13 111.351 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.34 -48.56 6.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.774 0.43 . . . . 72.15 110.803 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.4 ttt -72.25 30.64 0.06 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.454 2.302 . . . . 65.13 112.843 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -108.92 -10.07 15.09 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 120.125 -1.609 . . . . 74.14 112.091 172.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -72.3 -9.75 58.89 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.269 -1.52 . . . . 64.44 113.828 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.03 8.34 43.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.335 1.054 . . . . 71.52 113.048 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.44 -127.25 3.28 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 109.334 -1.507 . . . . 71.44 109.334 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -142.02 131.82 24.26 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.247 0.523 . . . . 70.32 109.92 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -127.57 138.76 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 C-N-CA 126.095 1.758 . . . . 62.41 112.37 -175.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.1 t -112.51 -35.57 5.51 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.929 -1.032 . . . . 73.31 111.46 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -109.55 136.35 49.07 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.499 1.045 . . . . 73.33 108.887 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.69 143.88 31.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.256 -1.387 . . . . 13.42 107.256 166.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -158.6 129.44 6.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.482 -1.303 . . . . 43.34 107.482 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.82 163.02 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 120.798 -1.189 . . . . 74.14 109.286 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -149.38 169.23 21.32 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.437 0.637 . . . . 70.13 110.151 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -74.61 48.8 0.37 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.869 2.468 . . . . 72.31 113.059 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -138.56 15.78 2.73 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.851 -1.155 . . . . 63.23 112.283 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.55 20.46 66.3 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 120.761 -1.212 . . . . 45.34 113.016 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 p -138.45 177.43 7.89 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 119.036 1.418 . . . . 54.34 111.963 -169.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.6 168.53 40.16 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.817 1.198 . . . . 72.33 111.007 167.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 p -133.97 139.38 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.497 1.519 . . . . 72.32 108.115 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.503 ' HB ' HG23 ' A' ' 18' ' ' VAL . 55.2 t -146.41 148.36 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 107.78 -1.192 . . . . 72.33 107.78 -161.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -137.37 109.5 7.26 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.686 1.232 . . . . 65.24 108.979 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.461 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 3.6 m-30 -69.19 -179.52 1.6 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.952 1.701 . . . . 64.21 109.666 171.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.92 -50.55 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 O-C-N 121.238 -0.914 . . . . 72.55 110.068 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -142.6 159.07 42.95 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 119.281 0.946 . . . . 73.33 111.447 -169.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -59.31 -30.91 68.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.211 -0.9 . . . . 74.21 111.458 -173.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.6 -29.65 68.22 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.886 1.221 . . . . 70.31 112.296 -174.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -85.12 -40.83 16.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.725 0.81 . . . . 73.41 108.907 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -52.79 -51.94 58.74 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.769 -0.582 . . . . 70.41 110.626 171.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.6 m -48.64 -46.55 40.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.475 1.51 . . . . 45.44 110.728 171.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -59.46 -40.32 86.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.223 0.609 . . . . 70.53 110.221 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.53 -39.01 78.95 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.054 0.843 . . . . 44.43 111.677 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.79 -27.76 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.812 0.733 . . . . 65.4 109.897 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -106.39 -9.1 16.87 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 114.101 1.148 . . . . 74.23 114.101 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -133.78 -1.74 3.03 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 117.673 -1.156 . . . . 72.33 113.195 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.439 HD13 HG21 ' A' ' 73' ' ' THR . 0.1 OUTLIER -144.89 17.81 1.61 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 120.067 1.303 . . . . 72.31 111.97 -165.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.48 153.1 18.65 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.705 1.593 . . . . 62.42 114.432 173.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 52.68 33.09 13.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 128.488 2.715 . . . . 63.33 114.494 -173.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.439 HG21 HD13 ' A' ' 70' ' ' LEU . 75.2 p -82.38 172.78 12.69 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.4 -0.813 . . . . 74.22 110.748 -177.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.74 171.23 15.41 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.66 1.184 . . . . 74.54 109.356 168.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -144.87 122.63 11.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.746 2.018 . . . . 70.14 109.489 167.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -69.64 122.22 18.68 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.814 1.646 . . . . 54.33 109.436 170.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.0 p -87.45 172.87 9.48 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.752 0.705 . . . . 64.31 109.565 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -73.28 -9.87 59.16 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.336 -0.393 . . . . 71.25 111.919 165.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.62 23.33 10.54 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.539 1.536 . . . . 74.3 112.78 -164.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.43 4.5 38.27 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 123.344 0.497 . . . . 72.54 113.313 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -119.71 165.87 13.95 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.302 1.441 . . . . 64.12 108.752 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.2 p -140.77 142.05 34.76 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.561 -1.644 . . . . 51.02 106.561 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.09 169.08 12.04 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.915 1.686 . . . . 53.41 107.392 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -93.25 158.0 15.97 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.65 1.114 . . . . 71.21 109.256 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 pt -126.89 168.92 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.677 0.791 . . . . 74.5 110.644 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -129.28 120.32 25.48 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 105.162 -2.162 . . . . 71.41 105.162 163.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.5 t -67.66 149.18 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.575 -1.269 . . . . 74.43 107.575 162.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -144.28 165.72 27.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 123.872 0.869 . . . . 71.32 109.93 156.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 t -73.36 149.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.728 -1.582 . . . . 52.11 106.728 166.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.0 t0 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 124.785 1.234 . . . . 72.54 108.399 167.543 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 m . . . . . 0 C--O 1.235 0.319 0 N-CA-C 108.144 -1.058 . . . . 72.15 108.144 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -80.74 33.87 0.33 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.439 1.895 . . . . 74.24 112.039 -170.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.38 29.08 3.33 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.158 -1.589 . . . . 55.45 108.948 175.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.77 145.2 44.67 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.746 -1.221 . . . . 64.21 109.77 -167.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.455 ' CG1' ' HG2' ' A' ' 63' ' ' MET . 18.3 m -141.18 175.37 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.554 0.741 . . . . 74.45 110.326 -173.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.1 t -135.08 155.48 37.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 107.674 -1.232 . . . . 74.25 107.674 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.7 140.44 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.903 1.681 . . . . 70.35 106.528 170.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -135.58 165.03 26.47 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.874 -0.787 . . . . 64.02 108.874 170.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.58 7.04 72.5 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.616 -0.547 . . . . 71.22 113.04 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.9 mt -63.85 156.52 72.66 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 119.136 1.468 . . . . 73.01 111.189 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.99 170.46 19.75 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.049 3.166 . . . . 65.24 110.534 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.28 -5.11 16.26 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.04 2.493 . . . . 72.32 114.932 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.53 34.78 4.75 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.886 1.221 . . . . 72.14 111.398 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.9 146.66 21.44 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.265 -1.134 . . . . 74.31 110.265 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 t -137.75 168.08 20.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.61 1.195 . . . . 64.33 113.428 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -67.19 -26.1 66.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.989 1.716 . . . . 74.03 111.455 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -61.82 2.35 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.6 -1.259 . . . . 73.31 107.6 175.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -63.73 -35.46 80.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.1 0.875 . . . . 64.0 109.72 -176.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -54.38 46.95 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.48 0.582 . . . . 75.1 109.834 175.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -67.57 -27.51 67.0 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 111.563 0.208 . . . . 75.24 111.563 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.01 -20.53 52.37 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.729 -0.607 . . . . 75.02 112.069 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -88.33 -60.6 1.92 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.628 1.571 . . . . 73.3 111.171 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -69.44 -13.4 62.34 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.372 1.249 . . . . 60.35 114.372 -160.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -8.9 0.06 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.848 2.859 . . . . 71.32 113.757 170.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.415 ' HB3' HD23 ' A' ' 70' ' ' LEU . 18.3 tt0 -58.75 -30.55 67.6 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.489 1.04 . . . . 73.41 112.256 173.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.35 0.94 57.44 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.28 1.215 . . . . 64.35 114.28 -170.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.71 -104.21 0.33 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 108.855 -1.698 . . . . 54.14 108.855 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -147.03 152.31 38.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.661 0.73 . . . . 74.24 109.451 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.2 t -141.74 120.36 9.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 127.245 2.218 . . . . 64.41 106.273 -165.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -102.43 -44.43 5.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.96 0.8 . . . . 72.41 110.926 -175.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -73.22 160.26 32.2 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.596 0.759 . . . . 73.34 110.607 174.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.94 128.35 5.56 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.269 0.94 . . . . 75.02 112.105 166.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -158.17 127.02 5.58 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.342 1.057 . . . . 52.42 111.309 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.8 t -143.81 158.89 16.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.467 -1.679 . . . . 63.13 106.467 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -138.51 171.01 14.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.735 0.814 . . . . 63.21 109.908 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -75.32 68.66 2.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.707 1.603 . . . . 63.23 108.245 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -148.61 174.03 12.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.978 2.911 . . . . 71.41 106.354 166.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.07 22.81 0.45 Allowed Glycine 0 CA--C 1.537 1.458 0 CA-C-O 117.379 -1.789 . . . . 74.44 114.597 165.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.3 p -133.46 158.08 43.97 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 121.01 2.405 . . . . 74.42 112.504 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.41 151.95 23.69 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 105.676 -2.97 . . . . 54.35 105.676 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.09 148.97 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.705 -1.961 . . . . 72.45 105.705 168.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.422 ' HB ' HG23 ' A' ' 18' ' ' VAL . 12.9 t -137.47 160.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.112 -1.44 . . . . 62.22 107.112 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -140.99 149.92 42.4 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.826 -1.916 . . . . 74.22 105.826 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -122.3 176.77 5.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.251 1.82 . . . . 74.12 108.573 -168.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -82.7 -39.21 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.314 -0.857 . . . . 64.01 111.36 -174.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -151.88 163.99 38.05 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.744 0.702 . . . . 71.03 110.1 -176.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -68.97 -27.41 65.69 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 117.773 -1.108 . . . . 60.25 110.944 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -58.68 -51.84 68.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.941 1.246 . . . . 75.13 109.39 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.31 -47.83 75.19 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.541 1.936 . . . . 74.43 109.012 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.455 ' HG2' ' CG1' ' A' ' 18' ' ' VAL . 12.0 tmm? -54.54 -58.47 7.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.453 0.701 . . . . 64.12 112.061 176.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.4 m -55.3 -44.93 76.22 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 118.013 -0.994 . . . . 73.34 110.31 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.1 -32.83 71.35 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.245 0.929 . . . . 73.43 111.211 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 70' ' ' LEU . . . -58.35 -41.64 85.12 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.813 0.845 . . . . 72.34 110.739 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.04 -18.77 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 O-C-N 121.008 -1.058 . . . . 70.33 109.842 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.08 -16.16 14.34 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.807 1.643 . . . . 71.12 114.129 -173.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -144.72 12.94 1.49 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.034 1.124 . . . . 74.12 114.034 -174.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.429 HD12 ' HB1' ' A' ' 66' ' ' ALA . 1.6 tm? -149.69 -1.66 0.44 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.874 1.216 . . . . 73.45 112.735 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.473 ' CB ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.86 156.23 19.95 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 119.134 -2.229 . . . . 65.2 112.884 172.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.4 t30 57.82 58.19 3.79 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.109 1.764 . . . . 73.13 109.98 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.6 p -128.7 168.24 16.09 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.39 1.076 . . . . 74.12 110.436 -172.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -80.43 161.56 24.87 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.731 -0.605 . . . . 73.22 111.521 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -146.89 127.17 13.89 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.231 1.413 . . . . 75.14 111.457 171.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -78.75 125.39 29.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.192 2.197 . . . . 73.1 111.203 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.2 t -94.79 169.75 9.93 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.062 0.945 . . . . 74.23 109.442 172.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -65.36 -30.37 71.19 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 123.898 0.879 . . . . 73.4 112.498 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.64 9.7 3.21 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.762 0.825 . . . . 63.11 112.104 -173.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.17 4.93 57.74 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 120.866 -1.146 . . . . 73.31 113.577 -175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 81' ' ' GLU . 23.3 pt-20 -88.04 172.22 9.71 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 124.709 1.204 . . . . 50.54 109.107 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.2 p -142.06 160.37 40.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.207 -1.405 . . . . 53.44 107.207 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.32 -177.44 4.24 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.644 -0.873 . . . . 41.2 108.644 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -108.88 148.75 30.17 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.046 -1.094 . . . . 71.11 108.046 165.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.6 pt -134.15 162.36 39.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 122.208 1.004 . . . . 70.42 111.331 -171.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -136.29 109.34 7.7 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.978 1.711 . . . . 54.21 107.509 -162.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.473 HG12 ' CB ' ' A' ' 71' ' ' ASP . 2.3 p -77.69 156.21 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 124.834 1.334 . . . . 71.21 108.815 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -152.16 161.66 42.29 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.567 -1.271 . . . . 74.14 107.567 160.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.0 141.49 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.826 -1.916 . . . . 65.31 105.826 168.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 59.2 t0 . . . . . 0 C--O 1.256 1.445 0 N-CA-C 107.465 -1.309 . . . . 73.44 107.465 168.144 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 N--CA 1.453 -0.311 0 N-CA-C 108.539 -0.912 . . . . 51.51 108.539 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -75.44 21.07 0.14 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.29 1.436 . . . . 71.03 112.966 -173.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.69 17.94 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.316 -1.49 . . . . 64.33 110.853 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 124.9 50.33 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.414 1.086 . . . . 74.12 112.273 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.609 HG13 ' HG2' ' A' ' 63' ' ' MET . 4.4 m -129.48 162.31 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.661 1.585 . . . . 63.1 109.592 171.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.28 171.09 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.782 1.633 . . . . 61.2 109.708 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.17 148.8 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.524 1.129 . . . . 62.32 108.102 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.92 164.96 25.78 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.53 1.932 . . . . 61.33 107.676 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.25 -2.12 47.05 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 124.892 1.234 . . . . 72.35 113.676 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.58 147.73 98.68 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 118.758 1.279 . . . . 44.31 111.666 -161.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.2 169.13 22.26 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.481 2.788 . . . . 75.41 110.24 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.63 -4.27 11.8 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.707 2.938 . . . . 64.35 114.173 174.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.29 41.7 3.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.081 1.353 . . . . 74.31 108.777 -174.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.44 106.36 1.31 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.756 1.646 . . . . 61.12 110.567 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 m -103.35 174.26 5.94 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.754 1.277 . . . . 73.13 111.683 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -67.33 -18.94 65.37 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.502 1.121 . . . . 74.32 112.688 -170.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -74.77 -53.82 8.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.346 -0.983 . . . . 70.21 108.346 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -58.09 -37.33 74.28 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.269 0.627 . . . . 64.25 110.187 173.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -56.76 17.63 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.92 0.888 . . . . 72.02 110.257 173.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -61.19 -37.8 84.23 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.692 1.133 . . . . 73.25 110.069 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.39 -8.29 56.29 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.035 0.934 . . . . 71.23 113.225 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.536 ' CE1' ' H ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -92.36 -54.49 3.78 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.764 1.226 . . . . 74.44 110.763 163.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -80.02 77.85 6.69 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.988 1.315 . . . . 72.32 108.656 -169.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.77 -21.47 0.46 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.293 1.437 . . . . 72.44 112.386 176.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.4 -14.09 61.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.064 0.946 . . . . 74.01 113.304 -172.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.13 -27.8 35.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.201 0.6 . . . . 71.04 112.414 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.35 -170.88 17.26 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.19 -0.764 . . . . 65.32 111.19 -154.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.76 127.94 33.92 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 113.183 0.809 . . . . 62.42 113.183 -146.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.548 HG22 ' CE1' ' A' ' 57' ' ' PHE . 24.5 t -119.33 130.45 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 125.278 1.431 . . . . 63.13 108.446 -178.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.2 t -130.63 11.59 5.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.126 0.97 . . . . 65.1 111.243 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -152.99 139.63 18.83 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.076 2.15 . . . . 71.43 107.239 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.73 147.78 41.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.839 0.856 . . . . 72.15 109.471 163.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -162.16 142.38 10.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.946 2.098 . . . . 73.02 109.194 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.41 -172.35 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 125.849 1.66 . . . . 70.42 107.089 173.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -150.54 156.2 40.93 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.788 -1.56 . . . . 71.01 106.788 171.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.318 0.3 OUTLIER 41.45 -85.75 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 129.142 2.977 . . . . 63.45 112.654 152.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.94 174.73 14.52 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.181 0.991 . . . . 73.05 112.589 169.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.39 -41.33 3.06 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 125.677 1.608 . . . . 35.11 113.672 159.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.25 169.68 17.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.419 1.61 . . . . 72.41 110.285 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.55 167.98 35.9 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.578 1.561 . . . . 64.13 109.46 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.77 119.85 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 118.399 1.1 . . . . 73.15 110.303 -168.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -113.27 174.23 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.619 -0.882 . . . . 63.44 108.619 -166.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.39 125.99 11.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.609 1.55 . . . . 73.34 108.774 164.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.548 ' CE1' HG22 ' A' ' 42' ' ' VAL . 3.2 m-85 -99.48 177.5 5.15 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.251 1.82 . . . . 65.3 108.874 -175.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.4 -64.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 O-C-N 122.14 -0.35 . . . . 73.34 110.206 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -133.49 168.53 18.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.358 0.599 . . . . 65.13 111.637 -169.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -54.18 -33.56 58.39 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 114.353 -1.294 . . . . 71.22 110.706 176.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -54.16 -64.12 0.93 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.76 0.824 . . . . 65.11 110.265 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.64 -41.45 79.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.594 1.558 . . . . 73.12 109.387 -173.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.609 ' HG2' HG13 ' A' ' 18' ' ' VAL . 16.6 tmm? -53.47 -50.59 65.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.599 1.159 . . . . 73.33 111.198 174.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -66.42 -45.55 79.5 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.156 0.583 . . . . 54.53 110.602 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -56.7 -38.62 72.53 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.805 0.729 . . . . 74.42 110.134 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.62 -39.89 74.43 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.643 -0.694 . . . . 63.3 112.053 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.11 -26.3 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.102 1.319 . . . . 61.43 109.587 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -105.53 4.38 30.4 Favored 'General case' 0 C--N 1.343 0.305 0 N-CA-C 114.779 1.4 . . . . 63.42 114.779 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -148.4 -9.71 0.37 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.423 1.268 . . . . 72.32 114.423 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.5 ' O ' HD13 ' A' ' 70' ' ' LEU . 1.8 tm? -130.71 11.88 5.26 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.684 -1.26 . . . . 75.2 109.928 -167.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.426 ' HB2' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -96.53 159.98 14.64 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 120.679 -1.263 . . . . 74.3 113.723 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.5 t30 60.58 14.4 4.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.854 1.662 . . . . 75.03 113.61 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.3 p -76.68 174.99 9.77 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.261 1.824 . . . . 53.14 112.298 -169.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -67.39 171.0 6.48 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.235 1.014 . . . . 63.41 110.798 167.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -145.3 124.35 12.82 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.759 1.624 . . . . 75.44 112.015 164.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.536 ' H ' ' CE1' ' A' ' 35' ' ' HIS . 7.3 ptp180 -72.08 126.32 29.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.486 1.115 . . . . 75.01 109.484 172.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.0 p -98.86 177.75 5.17 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.978 0.894 . . . . 71.35 110.303 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -76.17 -19.94 57.99 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.811 -0.556 . . . . 73.24 110.723 167.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -84.79 16.34 3.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.878 1.217 . . . . 64.01 113.429 -169.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.08 21.51 78.38 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.214 -0.754 . . . . 72.32 111.214 176.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.29 -175.01 3.91 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.176 1.79 . . . . 63.25 108.224 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 p -143.86 148.61 35.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.34 -0.615 . . . . 52.34 109.34 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -110.31 -163.69 0.87 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.407 1.083 . . . . 63.03 109.13 167.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -121.24 164.47 16.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.482 1.113 . . . . 74.15 108.681 164.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 pt -136.94 165.38 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.944 1.297 . . . . 73.14 110.547 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -132.29 128.62 38.17 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.625 1.97 . . . . 74.15 106.56 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 71' ' ' ASP . 1.3 p -94.68 150.72 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.831 1.196 . . . . 33.41 108.593 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 164.61 34.3 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.83 1.196 . . . . 75.43 110.067 160.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.534 ' HA ' HG12 ' A' ' 18' ' ' VAL . 30.7 t -61.58 136.13 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 105.277 -2.12 . . . . 75.24 105.277 163.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.8 t0 . . . . . 0 C--O 1.26 1.615 0 N-CA-C 107.165 -1.421 . . . . 74.24 107.165 175.708 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.532 0.284 0 N-CA-C 107.459 -1.312 . . . . 72.34 107.459 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.411 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 5.1 pt-20 -78.8 22.04 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.269 1.828 . . . . 64.55 113.088 176.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.64 50.82 1.99 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.286 -1.509 . . . . 74.33 107.046 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -130.06 137.49 50.25 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.667 1.587 . . . . 74.11 109.772 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.633 HG23 ' HB ' ' A' ' 55' ' ' VAL . 4.2 m -136.04 169.95 19.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 124.793 1.237 . . . . 73.54 110.952 -176.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.8 144.3 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 125.891 1.676 . . . . 60.44 106.879 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.69 146.07 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.613 -1.625 . . . . 72.31 106.613 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -137.42 160.68 38.41 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.114 -0.991 . . . . 64.21 109.193 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.47 12.96 84.04 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.427 -0.652 . . . . 64.14 113.491 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 mt -59.27 144.63 83.16 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 117.643 0.722 . . . . 72.41 109.694 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HB2' ' HD2' ' A' ' 25' ' ' PRO . 51.2 Cg_endo -73.57 171.94 16.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.387 2.058 . . . . 73.33 108.907 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 24' ' ' PRO . 35.5 Cg_endo -67.12 -15.85 47.51 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 CA-C-N 119.923 1.008 . . . . 42.54 112.822 -168.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.64 21.02 13.23 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.404 1.482 . . . . 53.44 111.643 -170.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.47 99.5 1.93 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.207 1.384 . . . . 72.24 111.688 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -94.87 179.57 5.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.644 1.577 . . . . 62.31 111.599 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.9 p-90 -62.26 -33.65 75.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.511 1.124 . . . . 74.21 112.397 -175.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -46.64 63.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.885 -0.783 . . . . 75.14 108.885 -173.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.71 -33.16 75.31 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.718 -0.658 . . . . 74.04 109.764 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -53.51 56.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.481 1.037 . . . . 73.32 109.39 174.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -63.45 -39.4 94.38 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.344 1.058 . . . . 74.4 110.36 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.19 -12.24 60.25 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.921 1.082 . . . . 64.31 113.921 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -99.95 -59.27 1.74 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.149 1.78 . . . . 72.31 112.78 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.522 ' HE2' ' CE1' ' A' ' 57' ' ' PHE . 11.5 ttt -72.83 37.91 0.08 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.777 2.431 . . . . 63.42 110.579 -171.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -107.38 -9.75 15.93 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 119.087 -2.258 . . . . 74.32 111.006 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -79.06 -27.96 43.11 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.091 -1.005 . . . . 64.34 111.997 -163.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.42 -10.97 58.08 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.028 1.331 . . . . 44.2 112.224 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.48 173.69 13.25 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.495 -1.442 . . . . 51.23 109.495 -165.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -97.25 153.86 17.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.2 1.0 . . . . 74.3 111.508 -160.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.457 HG22 ' CE1' ' A' ' 57' ' ' PHE . 64.9 t -125.49 147.76 30.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 125.408 1.483 . . . . 72.53 107.831 -166.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.8 t -111.41 -53.29 2.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.418 -0.956 . . . . 71.2 108.418 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -86.45 150.01 24.58 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.505 0.722 . . . . 75.34 110.155 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.72 125.72 15.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.641 -0.874 . . . . 64.41 108.641 168.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -156.55 124.44 5.56 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.864 0.84 . . . . 71.14 110.599 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.28 156.95 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.886 -2.264 . . . . 74.21 104.886 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -124.64 162.83 23.29 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 127.126 2.17 . . . . 73.13 107.618 170.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 43.55 -86.6 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 130.768 3.627 . . . . 70.14 112.612 153.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -170.91 168.87 6.96 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 127.206 2.202 . . . . 71.45 110.625 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.85 -15.39 32.08 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.757 1.17 . . . . 52.34 115.432 156.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.77 168.52 22.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 120.022 1.911 . . . . 72.25 108.492 164.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.2 167.66 35.6 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 108.878 -1.689 . . . . 75.32 108.878 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.12 144.09 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.083 -1.08 . . . . 71.45 108.083 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.633 ' HB ' HG23 ' A' ' 18' ' ' VAL . 38.3 t -146.62 157.53 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 106.706 -1.59 . . . . 61.21 106.706 -163.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -143.46 129.51 19.63 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.165 -1.05 . . . . 54.13 108.165 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.522 ' CE1' ' HE2' ' A' ' 36' ' ' MET . 3.6 m-85 -100.54 170.19 8.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.869 1.668 . . . . 75.34 109.257 -175.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.0 m -75.85 -31.15 21.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 71.2 112.315 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 43.2 ttt85 -154.9 155.74 34.85 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.664 -0.495 . . . . 60.51 109.664 -172.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.445 ' HE2' ' CE ' ' A' ' 63' ' ' MET . 14.6 ttmt -63.18 -26.46 68.81 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 117.723 -1.132 . . . . 73.51 110.931 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.0 -55.59 15.94 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 120.487 1.494 . . . . 74.23 109.285 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.15 -47.75 77.61 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.798 1.239 . . . . 72.21 109.525 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.445 ' CE ' ' HE2' ' A' ' 60' ' ' LYS . 59.7 ttp -54.04 -53.29 55.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.162 0.585 . . . . 61.32 112.047 176.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.7 m -54.33 -48.32 71.52 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.508 1.123 . . . . 64.13 109.102 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.534 ' CZ ' ' HE3' ' A' ' 69' ' ' LYS . 16.4 t80 -53.59 -38.98 64.47 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.315 1.046 . . . . 75.22 111.641 -175.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.04 -33.04 75.09 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.75 0.82 . . . . 72.32 110.832 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.4 t -70.09 -14.15 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 O-C-N 120.532 -1.355 . . . . 72.31 110.813 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -108.41 -37.73 5.89 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.04 -1.037 . . . . 72.32 111.469 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.534 ' HE3' ' CZ ' ' A' ' 65' ' ' TYR . 3.6 mptp? -108.87 -16.9 14.06 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.278 1.031 . . . . 71.04 111.743 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.9 7.53 8.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.24 -0.886 . . . . 74.44 111.17 -164.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.26 153.72 19.38 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 121.088 1.767 . . . . 64.44 111.164 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 t30 57.5 40.29 27.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.953 1.701 . . . . 70.1 111.591 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.4 p -103.39 -179.22 3.89 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.883 2.073 . . . . 71.02 111.287 -169.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.13 158.63 15.38 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.436 1.016 . . . . 61.44 110.305 171.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -137.26 146.22 44.48 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 125.588 1.555 . . . . 61.34 110.417 167.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -112.95 118.0 33.64 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.545 1.538 . . . . 75.03 110.908 -173.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 m -78.3 156.5 29.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 119.079 0.854 . . . . 62.01 109.3 167.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -62.61 -13.14 28.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.36 0.874 . . . . 75.3 113.36 168.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.87 12.23 0.72 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.944 1.697 . . . . 64.11 112.104 172.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.85 26.33 74.67 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 121.118 -0.989 . . . . 65.32 111.258 170.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -139.14 160.97 38.55 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 125.808 1.643 . . . . 61.43 108.684 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.8 p -145.84 149.81 34.98 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.154 -1.054 . . . . 74.03 108.154 -168.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.55 169.17 15.34 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.973 -1.121 . . . . 65.43 107.973 166.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -82.81 151.81 25.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.984 -1.117 . . . . 64.24 107.984 168.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.7 pt -125.16 166.27 21.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.418 1.487 . . . . 75.14 109.093 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -123.75 144.07 49.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.373 -2.084 . . . . 71.35 105.373 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.8 t -127.88 124.26 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.758 -1.571 . . . . 55.53 106.758 -172.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.38 153.33 51.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.446 1.098 . . . . 73.23 108.261 -170.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.423 ' HA ' HG12 ' A' ' 18' ' ' VAL . 12.1 t -71.34 153.18 8.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 106.08 -1.822 . . . . 54.45 106.08 162.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.881 1.272 . . . . 61.51 111.295 170.884 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 109.051 -0.722 . . . . 53.52 109.051 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -65.34 11.92 0.06 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.504 2.322 . . . . 52.53 114.802 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.72 26.7 7.07 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 119.729 -1.857 . . . . 71.34 109.199 -178.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -109.26 133.56 52.88 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.664 1.185 . . . . 71.23 109.107 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -129.32 168.81 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 126.009 1.724 . . . . 73.34 109.533 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.92 154.3 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.934 1.694 . . . . 61.12 106.809 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.3 t -130.12 152.07 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.229 -1.397 . . . . 42.13 107.229 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.6 154.97 48.71 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.268 1.027 . . . . 73.12 108.733 -175.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.75 6.4 52.53 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 117.905 -1.497 . . . . 34.01 114.176 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.46 149.87 91.06 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 120.037 1.918 . . . . 62.22 112.412 -160.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.07 170.03 13.88 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.966 3.111 . . . . 75.13 111.022 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.29 -8.3 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.675 2.25 . . . . 62.13 113.833 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.35 52.05 1.27 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.345 1.458 . . . . 72.43 109.204 -176.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.03 130.6 10.24 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 108.626 -1.79 . . . . 65.22 108.626 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -116.42 163.62 15.77 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.811 0.845 . . . . 71.23 111.221 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.3 p-90 -66.37 -23.96 66.42 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.838 0.681 . . . . 73.23 112.838 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -56.04 14.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.883 -0.784 . . . . 74.04 108.883 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -60.17 -35.61 75.73 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.847 0.859 . . . . 73.25 109.656 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -58.36 8.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 117.28 -1.343 . . . . 71.15 110.014 174.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -68.67 -37.62 79.74 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 120.066 1.303 . . . . 73.24 110.763 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.02 -24.78 64.77 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.562 1.545 . . . . 73.41 112.874 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -95.22 -46.64 6.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.636 0.374 . . . . 75.12 111.061 170.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.6 ttt -77.02 32.31 0.14 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.336 1.454 . . . . 75.12 113.086 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.2 -5.28 14.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 121.03 1.741 . . . . 63.14 114.308 171.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -61.27 -31.16 70.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.099 1.318 . . . . 62.45 113.874 -173.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.26 -0.88 13.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.839 1.256 . . . . 73.33 114.33 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.87 -100.97 0.21 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 108.153 -1.979 . . . . 71.4 108.153 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -154.11 163.57 39.88 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.021 0.928 . . . . 72.3 108.999 176.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.77 135.93 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.518 2.327 . . . . 73.31 109.822 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.3 t -90.81 -56.17 3.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.846 -0.798 . . . . 74.33 108.846 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -96.01 146.99 24.16 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.795 1.238 . . . . 73.31 109.588 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.55 136.18 21.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.846 -1.168 . . . . 45.2 107.846 168.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -148.86 131.2 15.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.436 -0.95 . . . . 74.31 108.436 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 91.9 t -140.75 140.73 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.086 -2.19 . . . . 71.0 105.086 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -77.32 -164.08 0.44 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.985 1.714 . . . . 71.33 109.996 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -44.4 -50.94 9.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.464 -1.698 . . . . 72.41 112.078 158.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -179.67 -179.11 0.49 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.195 1.398 . . . . 61.15 112.391 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.3 -34.39 3.46 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 128.226 2.822 . . . . 42.53 114.407 166.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.26 -179.05 6.75 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.772 1.286 . . . . 63.03 108.529 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.74 171.71 40.26 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 125.246 1.403 . . . . 63.3 109.67 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -141.75 135.11 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.738 0.78 . . . . 43.11 108.982 -173.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.52 145.13 25.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 108.405 -0.961 . . . . 73.32 108.405 -156.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -133.83 106.54 7.37 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.543 -1.651 . . . . 64.14 106.543 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.89 168.1 16.38 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 130.258 3.423 . . . . 71.4 109.876 -176.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -72.47 -42.3 64.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 121.305 -0.872 . . . . 73.12 111.573 -171.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -152.88 160.24 43.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.961 0.8 . . . . 61.2 109.462 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -63.96 -19.31 65.04 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.492 -1.242 . . . . 71.2 111.025 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -52.97 -65.95 0.47 Allowed 'General case' 0 C--N 1.345 0.407 0 C-N-CA 125.581 1.553 . . . . 62.43 108.684 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -75.33 -36.18 61.08 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.751 1.62 . . . . 73.3 108.836 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.428 ' SD ' HG13 ' A' ' 18' ' ' VAL . 39.2 ttp -51.33 -52.27 46.87 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.881 -0.414 . . . . 74.13 109.881 169.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.7 m -68.42 -12.16 60.74 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.939 -1.101 . . . . 64.14 113.359 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -79.95 -35.57 37.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 122.539 2.427 . . . . 74.24 110.083 169.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.65 -35.39 80.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.094 0.958 . . . . 75.2 110.198 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.73 -17.45 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.651 0.78 . . . . 73.0 111.163 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -120.24 -16.88 8.41 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.49 -1.381 . . . . 74.2 112.059 -163.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -132.35 -19.06 2.49 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.24 1.416 . . . . 64.23 113.807 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.23 11.99 16.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 120.081 1.31 . . . . 75.41 110.356 -168.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.48 161.44 13.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.893 1.224 . . . . 73.34 112.437 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.0 t30 56.96 17.86 3.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.523 3.129 . . . . 73.41 114.177 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.6 p -71.74 175.15 5.95 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.817 2.847 . . . . 71.12 112.731 -172.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.48 169.69 15.23 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.709 1.604 . . . . 71.13 109.656 171.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -150.58 135.16 17.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.972 1.709 . . . . 71.24 109.46 170.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -82.69 119.14 23.92 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 118.652 0.66 . . . . 72.25 109.977 176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 t -81.05 154.57 26.78 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.3 -1.0 . . . . 74.32 108.3 165.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -62.45 -16.68 56.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.892 -0.575 . . . . 63.01 111.644 164.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.58 17.41 0.11 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.248 1.419 . . . . 74.35 112.413 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.26 21.18 71.92 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 124.31 0.957 . . . . 71.33 112.496 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.93 175.4 10.46 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.327 1.851 . . . . 72.42 108.412 -172.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.0 p -137.07 148.86 47.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.689 -0.856 . . . . 74.24 108.689 -174.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.01 176.74 7.82 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.776 -1.194 . . . . 74.03 107.776 172.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -102.25 154.74 18.75 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.721 0.691 . . . . 74.15 109.932 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 pt -133.34 160.39 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 O-C-N 121.924 -0.485 . . . . 55.14 110.457 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -131.65 106.98 8.51 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.101 1.36 . . . . 53.23 107.697 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.53 154.46 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 124.219 0.949 . . . . 74.34 108.83 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -145.82 173.36 12.18 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.708 2.403 . . . . 72.01 107.505 162.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.541 ' HA ' HG12 ' A' ' 18' ' ' VAL . 58.8 t -97.81 151.18 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 125.624 1.57 . . . . 72.44 107.742 173.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.381 1.072 . . . . 40.12 108.788 167.133 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 N--CA 1.446 -0.661 0 CA-C-O 121.038 0.447 . . . . 43.22 109.947 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.41 30.96 0.06 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.379 1.471 . . . . 71.31 113.093 -167.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.84 20.58 3.28 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.751 2.02 . . . . 74.05 108.754 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.09 139.25 47.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.768 1.227 . . . . 74.32 111.907 -171.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.464 HG23 ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -147.94 170.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 126.078 1.751 . . . . 44.22 109.633 -172.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 19.6 m -136.14 174.31 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.014 1.726 . . . . 71.44 108.386 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -137.26 162.35 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.024 1.329 . . . . 72.25 108.297 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.75 165.07 37.17 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.458 -1.401 . . . . 75.31 108.424 -174.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.84 9.37 86.95 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 119.156 0.889 . . . . 74.1 113.239 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.19 150.84 69.77 Favored Pre-proline 0 N--CA 1.445 -0.681 0 CA-C-N 119.097 1.448 . . . . 75.4 112.194 -175.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.54 161.07 36.76 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.358 2.705 . . . . 75.34 111.516 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.44 -34.22 44.13 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.233 1.955 . . . . 63.5 111.563 173.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.81 60.51 0.71 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 122.488 1.137 . . . . 71.11 110.549 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -132.3 159.53 23.39 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 107.565 -2.214 . . . . 71.41 107.565 159.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m -128.39 -175.86 3.64 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.295 1.038 . . . . 63.01 109.059 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -62.08 -21.39 64.92 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.958 1.303 . . . . 72.33 111.057 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -57.24 11.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.929 -1.137 . . . . 73.13 107.929 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.82 -32.38 73.88 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.394 0.434 . . . . 71.0 110.894 175.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.39 -54.9 37.97 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.867 0.758 . . . . 61.24 110.303 176.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -64.28 -33.61 76.23 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.553 0.615 . . . . 75.21 110.827 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -74.5 -25.62 59.48 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.834 1.254 . . . . 62.42 113.526 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -102.26 -41.43 6.37 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.599 1.56 . . . . 75.44 111.545 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.3 ttt -81.59 53.39 2.1 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.334 -1.479 . . . . 74.32 109.884 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.29 47.5 2.48 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.332 1.453 . . . . 75.01 110.604 -170.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -135.65 -5.77 2.22 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.258 1.207 . . . . 75.24 114.258 -172.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.94 45.88 1.99 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.792 1.637 . . . . 63.43 110.726 -170.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.11 -107.32 1.95 Allowed Glycine 0 N--CA 1.47 0.967 0 N-CA-C 108.581 -1.808 . . . . 60.45 108.581 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.9 167.09 25.72 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.426 1.613 . . . . 64.24 111.761 158.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.01 135.73 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.505 1.522 . . . . 72.31 109.775 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.9 t -113.88 -24.06 9.3 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.53 0.567 . . . . 63.21 112.53 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -123.66 143.35 50.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.816 1.189 . . . . 53.22 109.263 -173.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.61 133.96 15.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.228 0.922 . . . . 54.42 110.688 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -149.48 131.21 15.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.17 1.388 . . . . 75.04 108.881 -177.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.93 171.31 16.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.946 1.298 . . . . 62.44 109.137 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -154.3 -177.89 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.115 0.966 . . . . 62.12 109.768 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -81.58 40.1 0.57 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.88 2.072 . . . . 55.1 111.833 -164.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -117.62 -25.67 6.83 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.836 0.854 . . . . 73.13 112.309 -171.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.38 6.48 64.42 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.452 -0.659 . . . . 72.13 111.452 -162.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -119.26 165.58 14.07 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.989 1.394 . . . . 74.04 110.448 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.75 174.61 28.34 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.64 -1.784 . . . . 34.21 108.64 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 70.1 t -146.69 134.53 15.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.619 1.568 . . . . 74.12 107.964 -173.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HB ' HG23 ' A' ' 18' ' ' VAL . 5.4 t -132.64 164.06 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.046 -0.724 . . . . 73.01 109.046 -169.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -142.5 124.51 15.29 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 120.433 -1.417 . . . . 73.05 107.45 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -94.11 174.64 7.05 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.604 1.562 . . . . 75.04 108.066 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.2 -64.01 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 118.69 -0.672 . . . . 54.15 110.901 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -139.85 172.13 13.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.628 1.104 . . . . 75.41 109.865 -166.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -62.85 -29.57 70.84 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.058 -1.026 . . . . 74.44 110.092 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -52.7 -63.43 1.15 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.862 0.865 . . . . 62.42 109.497 173.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.1 -47.99 83.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.771 1.229 . . . . 63.43 108.336 -175.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -57.32 -53.19 60.93 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.208 0.603 . . . . 60.42 110.914 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.4 m -59.3 -41.03 88.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.284 0.634 . . . . 44.34 110.282 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -56.96 -33.16 66.77 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 118.898 0.772 . . . . 74.13 111.741 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.61 83.16 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.392 -0.818 . . . . 73.21 109.971 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -71.81 -7.66 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 121.349 -0.845 . . . . 75.04 110.868 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.4 mtt180 -109.34 -31.96 7.35 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.855 0.862 . . . . 72.11 113.234 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -124.87 -6.16 7.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.843 1.257 . . . . 75.03 113.686 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.64 21.85 3.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.12 1.327 . . . . 64.13 110.86 -167.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.44 153.85 30.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.666 1.586 . . . . 75.45 109.777 170.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 62.27 11.35 4.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.572 2.749 . . . . 62.53 113.62 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.0 p -75.79 172.23 13.01 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.309 -0.869 . . . . 73.51 110.526 -172.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.469 ' HE3' ' OG1' ' A' ' 82' ' ' THR . 17.8 tttp -78.6 168.7 19.37 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 122.038 -0.414 . . . . 42.2 109.973 166.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -147.43 159.72 43.39 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 125.208 1.403 . . . . 73.04 111.866 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -116.46 148.04 41.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.747 1.158 . . . . 64.44 111.647 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.23 153.81 45.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.86 1.664 . . . . 74.1 109.284 -174.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -70.67 -12.54 61.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.175 1.176 . . . . 75.13 114.175 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.95 1.4 7.26 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.395 1.078 . . . . 75.4 112.728 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.26 9.1 63.79 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 124.08 0.848 . . . . 72.34 112.084 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -128.0 168.31 15.47 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 112.793 0.664 . . . . 64.43 112.793 -165.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.469 ' OG1' ' HE3' ' A' ' 74' ' ' LYS . 57.2 p -141.65 117.41 10.41 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.148 -0.933 . . . . 44.22 111.053 -175.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.83 173.19 7.8 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.584 1.953 . . . . 53.42 108.491 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -93.32 152.39 19.18 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.615 1.098 . . . . 72.42 108.478 159.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.5 pt -122.2 170.61 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.936 1.351 . . . . 74.11 108.839 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -125.33 143.19 51.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.751 -1.944 . . . . 74.22 105.751 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -110.8 146.34 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.325 -1.361 . . . . 55.53 107.325 168.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -142.98 159.94 41.29 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 122.109 -0.37 . . . . 62.45 111.156 163.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.4 t -61.16 138.96 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.603 -1.629 . . . . 61.32 106.603 165.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 43.1 t0 . . . . . 0 C--O 1.259 1.577 0 N-CA-C 105.257 -2.127 . . . . 75.24 105.257 166.22 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 108.13 -1.063 . . . . 73.31 108.13 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 31.44 0.07 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.992 2.117 . . . . 52.34 113.272 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -132.7 24.28 4.34 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 119.334 -2.104 . . . . 73.15 110.317 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.0 139.35 47.57 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.346 -1.471 . . . . 71.35 110.704 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.43 159.99 22.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 126.455 1.902 . . . . 72.34 108.881 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 95.4 t -132.8 140.85 46.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 127.232 2.213 . . . . 53.12 106.147 -170.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.424 ' HB ' HD11 ' A' ' 23' ' ' LEU . 24.9 t -104.73 145.37 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.782 1.633 . . . . 70.44 108.414 177.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -131.97 160.62 35.27 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.779 -1.201 . . . . 74.42 109.197 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.02 5.58 67.83 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.695 1.141 . . . . 73.43 113.866 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.426 HD13 ' CG2' ' A' ' 47' ' ' VAL . 5.2 mt -64.65 151.49 92.03 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.133 0.973 . . . . 65.45 112.304 -165.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -76.21 161.29 35.38 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.93 2.42 . . . . 50.12 110.662 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -67.55 -39.17 12.74 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.4 2.733 . . . . 50.15 110.567 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.0 p -67.19 -0.3 3.29 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.65 1.98 . . . . 74.43 112.303 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.42 121.42 7.08 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 126.078 1.799 . . . . 50.44 109.416 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.769 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -142.07 -179.6 6.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.855 1.262 . . . . 71.21 108.482 171.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -62.01 -29.44 70.27 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.181 -0.914 . . . . 71.44 111.974 -158.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -58.69 -62.1 2.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.809 -1.182 . . . . 63.51 107.809 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.71 -47.11 74.13 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.589 0.755 . . . . 73.43 109.867 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.03 -45.03 87.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.954 1.702 . . . . 64.21 111.537 -176.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -69.36 -30.25 68.22 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 72.12 111.15 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -92.52 1.44 57.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.565 1.146 . . . . 53.33 112.778 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -121.46 -56.55 1.88 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.664 1.586 . . . . 64.33 112.285 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.5 ttt -75.01 79.72 2.2 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.378 -1.342 . . . . 74.5 107.378 170.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.39 -7.71 0.78 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.423 1.889 . . . . 71.2 111.873 173.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.59 -3.08 25.71 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.585 0.63 . . . . 72.14 111.88 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.38 -0.41 41.06 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 119.322 0.965 . . . . 61.42 112.913 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.27 -156.52 15.58 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.444 -1.062 . . . . 50.14 110.444 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.37 114.91 21.15 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.32 1.057 . . . . 53.43 110.694 -163.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.3 t -101.9 151.52 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.458 -1.312 . . . . 73.2 107.458 171.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.7 t -131.37 0.93 4.11 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.033 0.753 . . . . 74.52 113.033 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -161.81 144.82 12.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.7 1.6 . . . . 63.44 107.7 -169.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.61 139.44 22.92 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.8 -0.815 . . . . 63.22 108.8 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -155.51 107.48 2.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.508 1.049 . . . . 72.11 109.202 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.769 HG13 ' HA ' ' A' ' 28' ' ' SER . 1.3 p -135.71 144.82 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.228 1.811 . . . . 70.52 111.976 -171.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -135.27 156.57 48.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.429 1.092 . . . . 74.15 109.697 -164.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -81.37 35.38 0.39 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.996 1.318 . . . . 70.14 111.53 -169.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -115.42 9.58 15.57 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.959 1.703 . . . . 73.24 108.486 173.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.26 23.98 60.05 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 125.672 1.606 . . . . 73.44 112.886 174.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.96 162.91 34.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.28 1.04 . . . . 64.13 108.498 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.26 160.11 32.7 Favored Glycine 0 C--O 1.224 -0.469 0 N-CA-C 109.13 -1.588 . . . . 62.45 109.13 -169.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 88.7 t -132.53 155.36 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 125.595 1.558 . . . . 51.34 108.351 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.19 170.73 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 127.415 2.286 . . . . 53.42 106.032 -174.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -144.41 124.28 13.46 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.12 -1.808 . . . . 74.54 106.12 167.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -94.29 166.05 12.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.408 -0.96 . . . . 74.45 108.408 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -73.08 -37.86 54.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.378 -1.283 . . . . 51.43 111.835 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.4 ttm105 -154.04 156.69 37.81 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.328 0.651 . . . . 64.51 109.4 -168.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -61.12 -27.99 68.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 117.639 -1.172 . . . . 72.2 111.567 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.12 -50.32 74.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.839 1.2 . . . . 74.24 110.749 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -77.7 -41.58 37.46 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.539 -0.912 . . . . 74.3 108.539 -175.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -47.77 -50.86 24.41 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.615 1.166 . . . . 71.53 111.237 169.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.1 m -64.9 -47.47 77.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.369 -0.824 . . . . 70.54 111.216 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -54.84 -32.75 60.91 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.559 1.072 . . . . 74.31 111.324 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.34 -42.29 86.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.448 0.567 . . . . 51.0 111.681 178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.89 -25.21 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.281 -0.887 . . . . 72.13 110.248 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -79.49 -41.84 26.57 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 117.519 -1.229 . . . . 71.3 112.553 -177.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -124.27 -16.98 6.26 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.186 1.18 . . . . 70.31 114.186 -170.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.32 1.44 32.77 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.779 1.232 . . . . 64.43 110.151 -171.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.11 147.97 25.08 Favored 'General case' 0 CA--C 1.527 0.078 0 O-C-N 120.27 -1.519 . . . . 65.32 113.65 -172.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 69.68 11.15 7.83 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.034 2.134 . . . . 64.2 111.531 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.4 p -83.97 163.07 20.2 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.032 1.333 . . . . 71.3 110.161 -169.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -77.81 156.92 30.18 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 120.892 -1.13 . . . . 71.43 109.706 168.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -107.72 -175.73 2.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.215 2.206 . . . . 73.12 110.768 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.1 mtt-85 -146.65 146.54 30.42 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 124.85 1.26 . . . . 73.2 107.681 169.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 p -142.3 159.98 41.15 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.794 1.238 . . . . 65.44 110.537 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -73.76 37.9 0.1 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.218 1.807 . . . . 72.42 113.551 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.4 16.43 4.48 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.557 2.343 . . . . 71.15 110.617 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.39 29.41 69.05 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 124.284 0.945 . . . . 64.23 112.227 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.52 173.9 11.17 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 125.82 1.648 . . . . 71.13 111.002 -173.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.7 p -144.8 147.72 33.21 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.255 -1.017 . . . . 73.31 108.255 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.02 176.43 5.3 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.504 1.122 . . . . 74.41 108.495 161.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -109.0 150.15 28.18 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 120.256 1.389 . . . . 74.32 110.45 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 pt -124.91 158.76 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 122.08 0.943 . . . . 71.21 112.207 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.0 mmm-85 -117.27 136.91 52.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.46 -1.681 . . . . 74.24 106.46 165.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 89.7 t -108.4 131.12 59.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.053 -1.832 . . . . 64.31 106.053 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -138.33 168.06 20.56 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.182 1.393 . . . . 73.23 108.332 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.4 t -87.82 161.34 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.046 -1.464 . . . . 74.55 107.046 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.1 t0 . . . . . 0 C--O 1.252 1.197 0 N-CA-C 104.368 -2.456 . . . . 73.22 104.368 156.818 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.6 m . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 104.2 -2.519 . . . . 73.4 104.2 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -74.1 38.84 0.11 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.52 0.728 . . . . 74.21 111.748 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.6 28.27 2.71 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 119.52 -1.987 . . . . 71.21 110.053 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -130.2 154.85 47.13 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.954 -1.091 . . . . 72.31 112.704 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.525 HG23 ' HB ' ' A' ' 55' ' ' VAL . 2.1 m -144.01 168.49 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.296 1.438 . . . . 61.0 112.32 -171.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.24 136.09 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.638 -1.615 . . . . 43.33 106.638 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 98.3 t -105.26 150.7 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.63 -1.248 . . . . 41.14 107.63 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 p -150.17 153.09 35.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.443 1.019 . . . . 73.31 109.714 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.11 6.97 38.89 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.301 1.429 . . . . 64.31 113.311 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 mt -65.91 156.44 83.73 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.347 1.059 . . . . 74.22 113.171 -164.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.09 175.7 8.03 Favored 'Trans proline' 0 CA--C 1.537 0.674 1 C-N-CA 125.493 4.129 . . . . 64.52 113.294 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.31 -7.96 15.43 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.766 2.977 . . . . 62.13 115.238 172.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 t -148.81 56.6 1.02 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 120.531 1.514 . . . . 72.23 110.296 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.38 79.5 0.58 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.319 -1.113 . . . . 74.11 110.319 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -74.8 155.46 37.57 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 119.395 -0.922 . . . . 44.42 110.32 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -60.08 -25.38 65.35 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.932 -1.105 . . . . 75.54 112.205 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -59.3 -46.03 89.69 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.59 1.556 . . . . 75.41 109.579 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -71.14 -37.5 72.26 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.032 0.933 . . . . 63.4 109.074 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.418 HD22 ' ND1' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -56.65 -52.16 65.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.863 0.756 . . . . 62.4 111.164 177.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -62.06 -39.67 93.2 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.154 -0.684 . . . . 72.32 109.154 -174.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.97 -17.38 64.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.569 1.548 . . . . 54.0 112.066 175.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.418 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -91.84 -45.03 8.6 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 104.817 -2.29 . . . . 74.53 104.817 -174.23 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.43 ' SD ' HG11 ' A' ' 55' ' ' VAL . 7.8 ttt -82.26 -14.1 55.99 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.238 0.459 . . . . 63.44 112.238 -150.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.6 -0.91 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 130.77 3.628 . . . . 73.2 116.446 174.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -81.65 -16.14 52.33 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 120.704 -1.247 . . . . 70.1 112.315 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.13 1.74 57.03 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.078 0.77 . . . . 44.31 113.078 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.19 -161.15 15.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.027 -2.029 . . . . 74.13 108.027 -157.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.83 145.3 32.84 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.593 0.357 . . . . 72.24 111.002 -165.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 t -130.33 131.01 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.397 -2.075 . . . . 72.34 105.397 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.5 t -116.69 5.61 13.2 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.748 0.647 . . . . 70.44 112.748 -167.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -162.94 158.21 22.09 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 126.435 1.894 . . . . 73.1 106.737 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.04 150.04 34.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 119.579 1.081 . . . . 73.31 108.396 163.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -158.89 129.7 6.1 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 117.965 0.348 . . . . 64.32 110.721 167.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -128.8 114.44 33.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.868 -2.271 . . . . 73.43 104.868 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -77.52 153.8 33.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.081 0.952 . . . . 74.41 109.143 161.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 43.63 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 130.948 3.699 . . . . 74.43 110.92 168.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 178.97 178.08 0.47 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.317 1.847 . . . . 71.5 111.233 155.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.78 -18.62 56.96 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.867 1.222 . . . . 64.14 114.202 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 m -148.97 -179.03 6.7 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.671 1.589 . . . . 74.43 108.719 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.9 164.21 35.52 Favored Glycine 0 N--CA 1.465 0.621 0 O-C-N 120.385 -1.447 . . . . 63.2 111.164 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.36 131.98 51.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 124.119 0.968 . . . . 75.41 108.518 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.525 ' HB ' HG23 ' A' ' 18' ' ' VAL . 67.6 t -144.0 154.98 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.328 -1.36 . . . . 71.4 107.328 -160.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -139.07 131.95 29.3 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.763 -1.569 . . . . 72.1 106.763 -172.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -101.8 -178.11 3.62 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.703 1.201 . . . . 70.3 108.056 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.47 -51.78 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.809 -1.182 . . . . 73.14 107.809 170.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.47 163.49 32.8 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 114.507 1.299 . . . . 71.1 114.507 -164.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -61.32 -33.18 73.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.586 -1.643 . . . . 65.1 112.076 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.87 -56.63 13.91 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.522 -0.918 . . . . 70.11 108.522 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -61.52 -45.31 94.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.533 0.733 . . . . 64.13 109.58 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -51.05 -55.43 17.58 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.772 -0.58 . . . . 73.41 112.259 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.1 m -57.11 -48.92 77.45 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.586 1.084 . . . . 74.31 110.347 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -55.16 -33.3 62.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.206 1.002 . . . . 74.31 111.494 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.11 -44.78 75.26 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.623 1.169 . . . . 73.31 110.498 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.78 -10.18 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.252 -0.905 . . . . 73.32 110.884 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -104.65 -31.95 9.14 Favored 'General case' 0 CA--C 1.527 0.089 0 O-C-N 121.413 -0.804 . . . . 63.02 110.914 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.03 -0.29 6.53 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.364 1.246 . . . . 72.54 114.364 -169.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -133.69 -4.87 2.87 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.284 1.402 . . . . 52.14 111.873 -172.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.54 ' HB2' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -83.04 161.17 21.78 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.356 -1.465 . . . . 73.33 111.998 165.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.8 t30 70.89 20.2 5.5 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.776 2.031 . . . . 74.53 112.26 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.6 p -85.35 142.18 29.5 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.06 -0.719 . . . . 72.5 109.06 -169.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -77.77 101.31 6.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.103 -1.443 . . . . 73.43 107.103 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -85.9 141.69 29.39 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.935 1.294 . . . . 72.14 113.134 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HA ' HG22 ' A' ' 82' ' ' THR . 30.5 ptt180 -99.42 139.24 35.36 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.66 1.984 . . . . 72.52 110.643 -176.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.4 p -108.89 174.25 5.95 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.137 0.975 . . . . 42.12 109.609 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -92.34 18.18 8.73 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.841 -1.072 . . . . 75.2 111.095 165.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -98.8 18.11 17.8 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.537 -1.352 . . . . 63.1 110.599 169.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.02 7.1 75.6 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 126.406 1.955 . . . . 63.3 112.845 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -176.66 4.13 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 117.627 0.714 . . . . 64.31 110.209 -166.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 76' ' ' ARG . 48.0 p -141.76 138.11 32.07 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 106.65 -1.611 . . . . 73.54 106.65 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.39 135.23 47.8 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.989 1.268 . . . . 64.11 109.326 172.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -69.93 156.51 38.99 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.982 0.81 . . . . 74.4 110.296 -168.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.96 166.46 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.711 0.767 . . . . 72.42 111.146 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -127.43 152.51 47.43 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.666 -1.235 . . . . 64.14 107.666 159.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 71' ' ' ASP . 2.6 p -109.79 149.59 12.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.758 1.223 . . . . 72.2 109.142 177.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.92 166.69 23.96 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.661 1.184 . . . . 72.11 108.803 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.9 t -81.69 144.16 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.689 -1.967 . . . . 72.01 105.689 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 C--O 1.256 1.395 0 CA-C-O 117.853 -1.07 . . . . 73.21 109.726 169.517 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 108.597 -0.89 . . . . 70.1 108.597 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -72.62 25.79 0.06 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.418 2.287 . . . . 65.34 113.137 -170.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.52 14.49 2.96 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.075 -1.641 . . . . 70.5 110.292 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -95.78 145.07 25.62 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.644 -1.285 . . . . 65.53 110.676 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.0 m -133.75 160.26 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.834 -0.802 . . . . 73.54 108.834 164.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.97 149.0 27.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 106.557 -1.646 . . . . 72.54 106.557 164.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.01 153.65 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.705 -1.591 . . . . 53.4 106.705 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -144.45 162.36 36.71 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 120.119 -1.613 . . . . 43.43 112.244 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.14 12.52 80.76 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.733 1.635 . . . . 73.42 112.71 -177.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mt -63.89 144.3 98.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.023 -0.989 . . . . 54.02 111.789 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -71.88 165.13 33.49 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.238 3.292 . . . . 63.22 113.583 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.29 -32.89 25.39 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.978 2.452 . . . . 51.11 113.427 -172.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -97.85 41.39 1.13 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.991 0.916 . . . . 63.24 109.381 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.35 124.48 8.25 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 108.179 -1.968 . . . . 72.14 108.179 173.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.6 m -125.02 169.67 11.9 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.24 1.416 . . . . 73.15 109.48 167.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -61.95 -20.14 63.51 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 113.511 0.93 . . . . 73.23 113.511 -174.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -60.84 2.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.071 -0.966 . . . . 72.51 108.548 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.08 -34.78 73.91 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.837 0.744 . . . . 62.33 109.171 177.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.4 -53.43 36.72 Favored 'General case' 0 C--N 1.345 0.397 0 O-C-N 121.452 -0.78 . . . . 64.55 111.149 173.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.49 ' HE3' ' HB ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -80.18 -20.46 44.72 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.762 1.165 . . . . 63.43 112.343 -176.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.45 -29.92 66.62 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.645 -0.66 . . . . 70.35 110.911 169.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -93.52 -51.48 4.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.035 1.334 . . . . 72.13 110.131 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.482 ' HG3' HD11 ' A' ' 70' ' ' LEU . 4.8 ttt -79.92 66.8 5.51 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 128.546 2.738 . . . . 74.25 110.382 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.66 -1.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 120.709 -1.244 . . . . 72.13 113.712 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.06 -44.94 94.42 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 119.572 1.078 . . . . 65.15 108.89 168.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.05 16.65 0.22 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.935 2.494 . . . . 70.21 114.293 -171.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.22 -147.9 16.66 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.282 -0.727 . . . . 64.13 111.282 162.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.43 99.94 8.24 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.846 0.832 . . . . 74.31 109.714 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.49 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 44.0 t -98.7 96.38 5.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 105.586 -2.005 . . . . 72.21 105.586 171.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.5 t -75.13 -22.97 57.82 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.408 0.442 . . . . 71.31 112.038 -174.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -124.39 149.73 46.37 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 125.545 1.538 . . . . 74.03 109.506 -170.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.38 129.97 10.74 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.237 0.926 . . . . 70.13 109.082 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.68 147.45 28.09 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.138 0.881 . . . . 61.33 110.356 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.4 t -145.65 151.65 14.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.234 -1.765 . . . . 64.24 106.234 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.7 168.68 19.27 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.88 2.072 . . . . 73.31 109.193 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.452 ' HG3' ' H ' ' A' ' 50' ' ' ASP . 9.0 ptm180 42.86 -87.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 129.821 3.248 . . . . 65.42 112.674 163.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.452 ' H ' ' HG3' ' A' ' 49' ' ' ARG . 1.9 p-10 -178.61 -176.92 0.5 Allowed 'General case' 0 N--CA 1.436 -1.128 1 C-N-CA 132.684 4.394 . . . . 74.4 107.728 162.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.28 -24.65 5.37 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-O 119.214 -0.77 . . . . 71.33 113.452 163.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.93 165.08 35.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.854 1.327 . . . . 61.14 108.676 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.0 140.58 6.68 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.089 -2.404 . . . . 73.12 107.089 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -111.57 134.98 52.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 118.781 1.29 . . . . 70.11 108.04 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.0 161.87 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 105.98 -1.859 . . . . 74.43 105.98 -172.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -143.52 139.88 30.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.371 -2.085 . . . . 62.43 105.371 170.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -107.34 164.26 12.34 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.959 -1.867 . . . . 74.53 105.959 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.1 t -63.98 -44.64 97.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.177 0.806 . . . . 65.23 113.177 -173.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -144.87 168.13 20.96 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.833 0.742 . . . . 74.52 109.506 -173.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -55.26 -28.88 56.38 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.19 -0.909 . . . . 42.01 110.197 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -64.8 -63.1 1.2 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.874 0.761 . . . . 65.35 108.99 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.46 -43.49 88.91 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.032 0.378 . . . . 74.34 110.033 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -57.16 -50.04 74.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.283 0.633 . . . . 53.14 111.228 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -59.51 -35.98 75.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.176 0.898 . . . . 72.34 111.229 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -54.78 -45.95 74.34 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.621 1.555 . . . . 74.24 110.013 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.43 -46.88 63.11 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.31 0.644 . . . . 71.41 111.68 -175.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -74.05 -7.42 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.571 0.749 . . . . 53.33 111.019 -169.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -123.89 -3.24 8.17 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.665 1.186 . . . . 64.11 113.452 -177.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -142.37 -0.91 1.21 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.029 0.932 . . . . 63.14 112.784 -175.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.482 HD11 ' HG3' ' A' ' 36' ' ' MET . 1.1 tm? -149.08 10.18 0.78 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.093 1.315 . . . . 63.35 111.339 -167.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.69 163.65 14.02 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 119.009 -2.307 . . . . 40.45 112.302 171.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.57 ' H ' ' HA ' ' A' ' 86' ' ' ARG . 0.7 OUTLIER 68.5 12.96 8.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.356 1.862 . . . . 64.41 113.794 171.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 31.1 p -75.21 164.04 26.89 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.51 1.524 . . . . 71.32 111.388 -170.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.66 162.87 28.72 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.245 -1.535 . . . . 73.23 108.169 166.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -147.85 151.23 35.59 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 125.047 1.339 . . . . 73.43 110.227 171.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -138.03 138.91 39.3 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.722 2.009 . . . . 74.21 106.33 -160.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -144.14 156.34 44.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.044 0.938 . . . . 73.33 110.554 -164.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -71.69 60.95 0.36 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.914 1.686 . . . . 73.35 113.242 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -146.14 -2.09 0.72 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.306 2.243 . . . . 74.55 111.088 169.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.89 15.26 54.87 Favored Glycine 0 C--N 1.34 0.773 0 O-C-N 120.298 -1.501 . . . . 74.14 112.201 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.8 171.7 12.83 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.151 0.98 . . . . 72.54 111.369 -172.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.5 p -143.04 153.98 43.5 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.536 -1.211 . . . . 74.24 108.145 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.46 177.07 5.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.118 2.167 . . . . 74.35 108.496 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -97.81 153.99 17.92 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.015 -1.053 . . . . 60.32 108.709 147.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.7 pt -130.82 171.6 17.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 125.871 1.668 . . . . 75.53 107.165 171.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.57 ' HA ' ' H ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -143.69 165.75 26.79 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 120.998 -1.063 . . . . 71.52 108.874 156.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.24 163.85 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.98 1.312 . . . . 73.34 109.019 169.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -154.6 158.22 39.42 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.704 2.002 . . . . 74.4 107.264 163.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.02 83.87 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.224 -2.139 . . . . 70.24 105.224 164.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 t0 . . . . . 0 C--O 1.256 1.439 0 C-N-CA 127.894 2.478 . . . . 73.23 113.817 159.417 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 122.059 0.933 . . . . 62.34 110.494 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -63.08 20.95 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 128.411 2.684 . . . . 60.55 113.095 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.04 28.4 4.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 119.328 -2.107 . . . . 51.31 108.481 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.654 HH21 HG11 ' A' ' 54' ' ' VAL . 42.1 ttt180 -112.83 129.56 56.4 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.753 1.221 . . . . 72.43 110.851 -177.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.7 159.86 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.703 -1.221 . . . . 71.42 107.703 168.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 12.5 m -124.3 -179.86 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.97 2.108 . . . . 75.11 107.042 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.11 155.15 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.496 1.918 . . . . 64.5 108.256 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.86 165.24 30.35 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.633 -1.292 . . . . 64.21 109.589 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.35 7.55 87.83 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.936 0.779 . . . . 72.52 113.003 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mt -60.82 155.02 55.1 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.065 1.346 . . . . 75.54 111.412 -173.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.58 167.54 23.92 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.913 3.742 . . . . 72.23 111.341 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.38 -27.87 39.78 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.358 2.038 . . . . 73.21 112.975 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.42 ' HB2' ' HG3' ' A' ' 79' ' ' GLU . 7.7 m -140.59 80.27 1.74 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 127.1 2.16 . . . . 64.23 107.445 -177.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.22 138.96 10.47 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 105.112 -3.195 . . . . 64.54 105.112 157.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.78 179.23 4.18 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 117.747 0.774 . . . . 74.42 109.055 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -65.42 -19.18 65.83 Favored 'General case' 0 C--O 1.226 -0.153 0 O-C-N 121.606 -0.684 . . . . 75.51 110.648 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -59.5 4.2 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 117.775 -1.107 . . . . 63.52 108.555 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -35.9 78.82 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.598 -0.841 . . . . 54.34 109.477 177.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.97 -53.64 46.81 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.386 0.993 . . . . 33.52 110.708 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -69.74 -26.21 64.21 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.124 -0.985 . . . . 55.33 111.951 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -85.23 -12.91 51.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.938 0.895 . . . . 75.14 112.577 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -109.06 -57.61 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.522 1.129 . . . . 61.52 111.252 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.9 ttt -74.53 70.71 1.8 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.659 1.184 . . . . 71.22 108.588 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -140.64 -0.55 1.54 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.795 -1.191 . . . . 73.31 113.368 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -68.29 -21.57 64.77 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.602 0.637 . . . . 74.24 111.579 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.42 -6.88 58.82 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.359 1.244 . . . . 75.25 114.359 -171.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.26 -171.49 27.12 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 119.858 1.208 . . . . 54.31 111.357 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -86.19 85.03 7.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 106.965 -1.495 . . . . 73.42 106.965 -170.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.9 t -69.57 135.08 29.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.155 -1.054 . . . . 72.22 108.155 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.5 t -99.07 -11.55 21.35 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.076 -0.488 . . . . 75.13 111.954 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -159.45 146.79 17.01 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.555 1.071 . . . . 73.35 109.757 -162.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.7 143.25 32.21 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.727 -1.212 . . . . 73.14 107.727 165.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -152.47 134.24 14.71 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.488 0.715 . . . . 64.3 109.466 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 m -137.53 177.62 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.554 -1.276 . . . . 74.52 107.554 175.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -140.79 -169.24 2.76 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 126.167 1.787 . . . . 74.4 106.768 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -96.89 45.21 1.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.921 -1.112 . . . . 54.24 111.729 -176.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.93 -154.0 0.53 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.277 1.831 . . . . 63.13 107.324 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -111.02 28.65 9.58 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.772 2.13 . . . . 72.41 110.605 173.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 p -131.89 173.36 11.26 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.416 1.487 . . . . 74.23 109.508 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.86 172.66 44.4 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 107.743 -2.143 . . . . 75.51 107.743 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.654 HG11 HH21 ' A' ' 17' ' ' ARG . 37.5 t -145.59 144.34 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.483 -0.932 . . . . 72.4 108.483 -165.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.6 t -132.95 171.65 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.54 -0.911 . . . . 63.31 108.54 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -153.8 137.4 16.0 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 120.553 -1.342 . . . . 61.34 107.716 167.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.84 177.39 4.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.458 1.903 . . . . 75.24 108.104 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.3 m -86.38 -31.79 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.64 0.608 . . . . 55.31 112.64 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 ttm105 -156.37 160.32 39.56 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.362 0.665 . . . . 64.54 109.95 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -67.1 -22.92 65.8 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.568 1.147 . . . . 61.51 112.205 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.12 -54.01 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.112 0.869 . . . . 72.25 109.603 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.96 -41.21 87.25 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.563 -0.532 . . . . 63.33 109.563 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.3 ttp -53.22 -52.78 57.8 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 110.168 -0.308 . . . . 55.13 110.168 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -55.11 -40.26 70.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.537 -0.745 . . . . 73.43 111.08 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -55.84 -45.38 78.41 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.088 0.858 . . . . 60.12 109.446 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.5 -42.4 78.28 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.31 -0.869 . . . . 74.24 111.893 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 t -68.35 -18.18 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.503 0.721 . . . . 72.31 111.019 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -114.37 -15.81 12.06 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.833 1.049 . . . . 75.52 113.833 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm -134.1 -1.06 2.99 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.261 1.425 . . . . 72.35 112.681 -171.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.62 21.42 2.71 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.929 1.24 . . . . 44.05 110.753 -175.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.84 164.0 11.88 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.077 -1.64 . . . . 62.32 110.285 174.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 60.86 12.97 4.12 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.235 1.814 . . . . 61.21 112.202 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.3 p -74.06 168.2 20.01 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.883 -1.136 . . . . 44.25 110.724 -167.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -63.94 166.24 7.72 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 121.74 -0.6 . . . . 71.32 109.813 153.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -145.67 138.79 26.13 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.938 1.695 . . . . 73.15 107.791 166.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -96.09 136.61 36.33 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.822 -0.807 . . . . 74.25 108.822 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -109.9 174.39 5.89 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.086 -1.079 . . . . 60.1 108.086 -169.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.82 -11.3 55.98 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.839 -0.538 . . . . 72.31 111.882 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG3' ' HB2' ' A' ' 26' ' ' SER . 6.0 mm-40 -102.02 34.24 2.77 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.079 1.351 . . . . 72.13 111.536 -166.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.08 15.99 68.11 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.782 1.182 . . . . 24.14 113.528 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -132.73 176.8 8.14 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.439 1.096 . . . . 52.4 110.252 -175.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.6 p -144.78 126.07 14.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.75 -1.204 . . . . 73.1 107.75 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.36 -176.49 4.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.861 0.865 . . . . 73.32 110.339 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -106.29 157.21 17.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.578 -0.897 . . . . 75.21 108.578 159.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 pt -141.61 163.78 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.551 1.141 . . . . 73.31 110.937 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -131.58 105.84 7.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.141 -1.429 . . . . 75.45 107.141 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.5 t -69.71 144.17 14.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.792 -1.188 . . . . 62.21 107.792 170.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.27 158.82 43.53 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.747 1.158 . . . . 44.12 111.724 166.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.75 137.37 22.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 106.184 -1.784 . . . . 64.24 106.184 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 C--O 1.25 1.119 0 C-N-CA 124.293 1.037 . . . . 72.1 110.487 175.656 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 16' ' ' ASN . 72.7 m . . . . . 0 C--O 1.238 0.459 0 CA-C-O 121.81 0.814 . . . . 55.11 112.101 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.71 31.32 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.043 2.537 . . . . 73.51 111.541 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -143.01 14.72 1.89 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.101 2.16 . . . . 62.32 108.284 -173.475 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.27 116.22 31.59 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.522 1.929 . . . . 75.34 110.13 -174.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -122.58 174.07 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.606 0.762 . . . . 62.51 111.522 173.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.578 HG23 ' HG3' ' A' ' 88' ' ' LYS . 10.7 m -136.1 -179.1 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.727 1.611 . . . . 64.41 106.967 170.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.0 t -135.7 153.52 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.134 2.174 . . . . 75.41 107.006 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.87 155.31 48.2 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.146 1.378 . . . . 43.21 108.88 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.02 4.8 57.58 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.419 1.961 . . . . 71.4 113.346 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mt -66.56 154.45 91.14 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 120.99 -1.3 . . . . 74.43 113.163 -166.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.47 166.36 20.03 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.169 2.579 . . . . 71.02 112.573 175.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.07 -6.03 18.29 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 124.12 3.213 . . . . 71.42 114.013 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -146.75 54.06 1.11 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.505 2.322 . . . . 74.3 108.926 -172.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.96 112.02 2.03 Favored Glycine 0 C--N 1.34 0.761 0 O-C-N 120.126 -1.608 . . . . 35.03 111.564 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -76.24 155.35 34.47 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 118.835 1.318 . . . . 74.14 112.361 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -59.04 -26.03 64.23 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.828 0.851 . . . . 75.1 113.217 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -65.22 -52.2 56.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.251 -1.018 . . . . 71.1 108.251 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -62.76 -27.56 69.37 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.109 1.363 . . . . 73.11 111.326 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -64.28 -61.34 2.3 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.067 -1.086 . . . . 72.02 108.067 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -61.28 -39.57 90.91 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.825 -0.607 . . . . 55.4 109.851 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -17.46 52.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.85 1.26 . . . . 73.33 112.688 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -100.72 -45.36 5.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.266 0.626 . . . . 75.01 111.23 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.0 tpt -57.75 -32.86 67.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.15 1.38 . . . . 72.3 113.396 -174.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -19.17 59.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.208 1.929 . . . . 73.0 116.208 -166.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.67 1.02 1.39 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.991 1.478 . . . . 64.01 114.991 -169.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.448 ' CB ' ' HB2' ' A' ' 66' ' ' ALA . . . -95.26 -10.09 31.31 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.754 1.222 . . . . 53.2 112.993 175.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.58 -101.74 0.21 Allowed Glycine 0 C--N 1.335 0.498 0 CA-C-N 119.68 1.127 . . . . 41.22 111.386 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.2 144.35 29.85 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.533 1.166 . . . . 72.32 109.84 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.511 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -131.7 139.53 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 126.379 1.872 . . . . 51.2 113.382 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -127.51 18.88 6.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.837 1.255 . . . . 71.22 111.36 -170.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.415 ' HB3' ' CB ' ' A' ' 56' ' ' GLU . 73.5 t80 -170.73 144.48 2.3 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.108 1.763 . . . . 64.33 108.318 172.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.69 139.26 16.91 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.861 -1.162 . . . . 74.02 107.861 168.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -155.14 129.22 8.82 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.421 1.089 . . . . 71.13 110.615 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 t -140.27 165.8 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.966 1.706 . . . . 54.43 107.285 -175.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.66 -162.76 1.3 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.775 2.83 . . . . 72.12 107.723 -169.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -105.25 63.53 0.7 Allowed 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.283 -1.511 . . . . 72.11 109.55 170.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -144.74 -176.33 5.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.26 -0.9 . . . . 64.04 108.592 169.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.38 13.73 20.11 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-O 118.312 -1.271 . . . . 52.33 113.433 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.32 163.54 30.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.163 1.982 . . . . 73.41 110.084 -174.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.45 167.84 38.52 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 107.788 -2.125 . . . . 51.53 107.788 -171.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 59.0 t -143.8 144.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 119.929 1.864 . . . . 73.1 110.395 -163.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.9 t -145.19 154.33 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.112 0.482 . . . . 73.52 110.849 -173.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.415 ' CB ' ' HB3' ' A' ' 44' ' ' TYR . 3.9 tt0 -137.08 101.36 4.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.885 -1.524 . . . . 75.1 106.885 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.511 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 3.0 m-30 -72.37 179.37 3.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.533 1.933 . . . . 71.14 110.625 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.0 t -77.5 -63.43 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.627 -0.671 . . . . 64.54 110.98 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -140.37 157.36 45.66 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.27 0.941 . . . . 63.52 112.053 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -53.53 -27.13 24.19 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.247 1.019 . . . . 71.51 112.138 -166.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -53.16 -61.92 1.99 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.218 1.407 . . . . 71.41 108.376 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.56 -37.5 71.08 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.05 1.34 . . . . 75.54 110.667 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -56.86 -54.85 41.8 Favored 'General case' 0 C--O 1.228 -0.047 0 CA-C-O 118.829 -0.605 . . . . 74.42 110.178 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.6 m -54.73 -40.64 69.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.634 -0.698 . . . . 72.21 110.508 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -60.02 -49.77 76.34 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.02 0.928 . . . . 71.43 110.661 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.448 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . . . -63.46 -25.1 68.12 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.739 -1.226 . . . . 64.4 112.68 -176.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.3 t -76.77 -5.75 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 O-C-N 120.853 -1.155 . . . . 60.24 110.125 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -129.41 0.45 5.06 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.537 1.31 . . . . 44.3 114.537 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.39 5.26 0.82 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.499 1.519 . . . . 64.14 112.563 -171.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.01 4.05 0.62 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.404 1.082 . . . . 71.13 109.765 -173.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -99.42 157.69 16.24 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.079 1.751 . . . . 74.44 111.372 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.59 ' H ' ' HB3' ' A' ' 86' ' ' ARG . 0.6 OUTLIER 44.42 64.41 1.34 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.496 1.519 . . . . 75.44 110.359 -168.255 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.4 p -121.06 174.19 6.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.203 2.601 . . . . 73.02 109.278 -174.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.89 161.98 14.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.952 -1.093 . . . . 74.42 109.633 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -151.68 120.66 6.66 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 126.647 1.979 . . . . 64.23 111.483 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -102.74 119.82 39.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.665 -1.235 . . . . 63.22 107.665 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.54 168.41 16.45 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.799 1.64 . . . . 74.11 110.309 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -65.07 -14.17 59.81 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.33 1.233 . . . . 73.11 114.33 174.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -86.56 6.02 32.79 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.692 1.997 . . . . 72.2 112.51 -172.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.15 14.39 82.31 Favored Glycine 0 C--N 1.337 0.635 0 O-C-N 121.572 -0.705 . . . . 43.34 112.061 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -125.08 171.71 10.05 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 123.961 0.904 . . . . 74.14 110.566 -177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.5 p -139.42 146.03 39.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.967 1.307 . . . . 74.22 108.05 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.7 129.97 19.83 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.729 -1.582 . . . . 64.44 106.729 172.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -69.74 159.49 33.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.968 0.804 . . . . 75.23 110.126 -164.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.69 155.73 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 123.414 0.686 . . . . 74.2 109.165 -173.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.59 ' HB3' ' H ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -134.99 143.05 46.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.849 -1.157 . . . . 53.42 109.728 163.119 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.94 151.2 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.377 1.471 . . . . 73.04 108.347 166.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.578 ' HG3' HG23 ' A' ' 19' ' ' VAL . 6.4 ptmt -146.3 161.61 39.93 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.423 -0.955 . . . . 61.12 108.423 152.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.576 ' HA ' HG12 ' A' ' 18' ' ' VAL . 7.4 t -70.18 143.93 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 106.358 -1.719 . . . . 73.24 106.358 169.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.604 -1.189 . . . . 63.4 110.487 -177.743 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.701 0 N-CA-C 109.956 -1.258 . . . . 61.55 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.91 155.13 33.82 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 123.843 0.857 . . . . 75.15 110.86 178.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.91 174.26 8.03 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.437 2.758 . . . . 74.55 112.187 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -137.52 -179.32 5.67 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.233 1.013 . . . . 71.22 110.089 -174.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.57 -179.51 24.7 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.616 1.579 . . . . 62.52 110.391 167.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.85 122.07 45.21 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.463 1.505 . . . . 75.22 108.99 -167.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -154.09 160.61 42.03 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.265 0.626 . . . . 75.12 110.479 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -111.21 67.35 0.23 Allowed Glycine 0 CA--C 1.534 1.255 0 CA-C-O 119.03 -0.872 . . . . 53.51 113.265 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.8 155.66 67.98 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 CA-C-N 120.953 2.377 . . . . 75.02 112.695 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.92 91.99 0.44 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.997 3.132 . . . . 51.24 111.377 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.4 m -103.36 172.23 6.93 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.197 2.199 . . . . 73.02 111.957 176.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.48 167.68 1.85 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.398 1.079 . . . . 73.24 110.943 169.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.2 mmt85 -127.73 110.32 12.52 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.205 -2.146 . . . . 71.15 105.205 174.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.0 m -68.61 174.4 4.26 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.953 -0.758 . . . . 63.43 108.953 168.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -72.28 37.98 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.371 -0.831 . . . . 72.21 112.295 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -138.64 28.75 2.41 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 119.349 -2.094 . . . . 72.34 109.797 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.13 143.03 51.03 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.867 -1.145 . . . . 74.03 112.395 -167.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.2 m -140.51 167.69 17.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 124.491 1.117 . . . . 62.14 110.527 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.2 t -129.72 153.67 39.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.15 -1.796 . . . . 73.15 106.15 170.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -121.98 136.58 58.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 105.821 -1.918 . . . . 62.14 105.821 -178.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 p -134.53 145.08 48.4 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 118.927 0.785 . . . . 61.34 111.678 -170.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.9 27.66 23.25 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 125.147 1.356 . . . . 15.42 112.619 -178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.454 HD22 HG21 ' A' ' 85' ' ' ILE . 0.1 OUTLIER -58.71 152.7 45.82 Favored Pre-proline 0 N--CA 1.467 0.419 0 CA-C-N 118.443 1.121 . . . . 60.42 110.393 -177.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -67.07 168.59 17.01 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.813 2.342 . . . . 73.41 110.882 177.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.02 -12.6 35.43 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.65 2.234 . . . . 75.45 113.831 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 t -151.16 57.03 0.89 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.379 1.445 . . . . 72.14 111.92 -171.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.19 -166.51 32.7 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.273 1.416 . . . . 72.15 111.11 172.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 86.8 p -157.69 173.85 16.21 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.402 1.081 . . . . 53.12 109.718 169.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -70.06 -18.4 63.27 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.97 0.908 . . . . 71.32 111.38 171.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.44 -54.11 10.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 107.834 -1.173 . . . . 63.52 107.834 -177.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.51 -32.84 74.41 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 118.55 -0.738 . . . . 71.12 110.249 172.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.35 -57.08 13.8 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.558 1.072 . . . . 73.45 110.57 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.4 ttmt -61.81 -42.99 99.71 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 118.785 0.72 . . . . 74.24 110.087 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -69.25 -25.66 64.39 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.224 1.01 . . . . 75.42 111.92 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -81.39 -60.04 2.41 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.589 0.756 . . . . 72.3 110.046 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.485 ' HG3' HD11 ' A' ' 70' ' ' LEU . 15.0 ttt -68.09 -8.8 41.2 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.791 1.636 . . . . 62.01 114.348 -159.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.18 20.97 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 131.218 3.807 . . . . 62.53 115.848 175.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -100.59 0.79 39.97 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.98 1.712 . . . . 74.34 112.604 179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.92 17.08 6.79 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 125.846 1.658 . . . . 74.32 112.797 -167.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.71 -107.73 1.04 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 125.762 1.648 . . . . 75.24 109.304 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -143.96 139.61 29.19 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 117.764 0.782 . . . . 71.24 109.922 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 t -128.44 81.13 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.342 0 C-N-CA 126.451 1.9 . . . . 75.5 107.167 -170.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.7 t -72.66 -15.12 61.71 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.277 0.473 . . . . 51.41 112.277 -174.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -132.83 135.14 45.47 Favored 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 121.038 -1.039 . . . . 64.11 108.413 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.42 138.83 41.93 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.218 -1.03 . . . . 73.42 108.218 166.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -145.92 156.68 43.69 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.843 -1.169 . . . . 74.42 107.843 169.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.8 m -143.35 -178.41 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 O-C-N 120.826 -1.171 . . . . 51.13 108.162 175.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -103.34 -163.09 0.96 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.417 1.487 . . . . 74.31 107.283 166.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 19.0 mtm-85 -52.71 -53.98 40.08 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.975 -1.011 . . . . 72.25 109.885 159.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -170.68 -179.91 3.05 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 119.083 0.856 . . . . 62.31 112.82 -171.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.69 -39.85 2.73 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 127.147 2.308 . . . . 72.44 113.445 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -147.01 170.58 16.82 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.759 1.279 . . . . 44.23 109.429 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.86 159.66 28.09 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 108.543 -1.823 . . . . 60.41 108.543 165.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.3 p -130.23 131.3 65.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 118.396 1.098 . . . . 62.03 109.292 -170.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.7 t -144.32 151.83 15.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 108.632 -0.877 . . . . 75.43 108.632 -157.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.0 tt0 -135.13 133.7 39.45 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.5 -1.296 . . . . 73.41 107.5 175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -101.6 -176.77 3.23 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.117 1.767 . . . . 74.12 108.626 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.2 t -81.72 -50.96 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 118.256 -0.878 . . . . 54.21 110.57 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.1 ttt85 -145.17 164.5 31.1 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 120.526 1.512 . . . . 75.3 111.79 -171.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -62.7 -30.31 71.31 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 117.867 -1.063 . . . . 64.24 111.673 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -65.38 -50.98 63.47 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 108.645 -0.872 . . . . 60.0 108.645 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -59.36 -53.11 61.99 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 126.786 2.034 . . . . 75.12 109.25 176.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 12.4 tmm? -51.94 -51.56 56.18 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.485 -0.759 . . . . 75.02 112.457 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.7 m -55.29 -53.56 54.53 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 118.536 -0.745 . . . . 73.02 109.584 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -56.96 -32.43 66.02 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.321 1.048 . . . . 72.3 111.588 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.25 -42.77 77.91 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 119.438 1.017 . . . . 72.31 110.863 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t -69.3 -14.31 18.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 O-C-N 121.951 -0.468 . . . . 64.12 111.091 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -100.58 -33.55 10.26 Favored 'General case' 0 C--N 1.331 -0.206 0 O-C-N 120.314 -1.492 . . . . 73.41 112.349 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.413 ' O ' ' HE2' ' A' ' 69' ' ' LYS . 0.0 OUTLIER -137.7 9.01 2.85 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.844 0.858 . . . . 71.03 113.19 -165.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.485 HD11 ' HG3' ' A' ' 36' ' ' MET . 1.0 OUTLIER -134.36 3.24 3.34 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.798 0.726 . . . . 75.33 111.132 179.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.611 ' HB2' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -95.85 162.16 13.7 Favored 'General case' 0 N--CA 1.466 0.334 0 O-C-N 119.315 -2.116 . . . . 72.33 114.501 171.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 43.4 t30 66.2 15.38 10.07 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.007 2.523 . . . . 62.23 113.003 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 31.1 p -78.46 171.21 15.43 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.495 -0.753 . . . . 54.22 109.747 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -90.08 151.65 21.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.029 1.332 . . . . 63.22 109.034 166.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -125.15 130.18 51.66 Favored 'General case' 0 CA--C 1.519 -0.227 0 C-N-CA 127.709 2.404 . . . . 75.3 108.896 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.472 ' HA ' HG22 ' A' ' 82' ' ' THR . 73.9 mtm180 -87.03 153.83 21.23 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.108 0.963 . . . . 61.41 110.541 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 80.7 p -124.39 176.73 6.28 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.077 0.951 . . . . 71.54 110.451 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -85.6 5.15 33.01 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.569 1.148 . . . . 72.13 111.268 167.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.74 13.42 14.17 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.729 2.012 . . . . 62.21 112.595 -162.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.24 12.85 81.7 Favored Glycine 0 C--N 1.336 0.561 0 O-C-N 121.762 -0.586 . . . . 55.02 113.489 176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -134.59 162.99 30.74 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.227 1.011 . . . . 52.24 109.593 -173.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 76' ' ' ARG . 43.6 p -148.75 119.61 7.6 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.678 -0.86 . . . . 71.21 108.678 -172.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.23 165.01 13.68 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 123.418 0.687 . . . . 72.15 110.033 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -84.65 157.23 21.21 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.569 -0.9 . . . . 64.22 108.569 160.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.454 HG21 HD22 ' A' ' 23' ' ' LEU . 25.3 pt -137.47 152.94 27.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.895 0.855 . . . . 71.01 109.364 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.2 mmm-85 -123.9 119.19 28.92 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.043 -1.836 . . . . 51.44 106.043 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.611 HG12 ' HB2' ' A' ' 71' ' ' ASP . 1.4 p -75.62 163.25 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 109.262 -0.644 . . . . 53.44 109.262 175.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.49 163.84 39.48 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.922 1.689 . . . . 74.31 107.42 164.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.3 t -69.07 155.44 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.23 -1.767 . . . . 54.21 106.23 165.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 58.8 t0 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 124.567 1.147 . . . . 74.31 109.971 176.372 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.504 0 N-CA-C 108.876 -1.69 . . . . 60.34 108.876 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.86 164.98 16.93 Favored Pre-proline 0 C--O 1.239 0.502 0 C-N-CA 126.213 1.805 . . . . 74.24 106.323 170.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -67.41 156.1 67.57 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 CA-C-N 119.867 0.988 . . . . 62.31 110.011 169.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -135.31 136.03 41.26 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.022 2.129 . . . . 61.54 105.851 173.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.17 163.09 7.54 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.975 1.274 . . . . 60.41 114.886 173.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.64 38.32 0.76 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.581 1.152 . . . . 60.44 110.753 172.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -152.63 99.52 2.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.593 -2.003 . . . . 62.44 105.593 176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.45 -86.45 0.29 Allowed Glycine 0 CA--C 1.53 0.993 0 CA-C-O 118.117 -1.379 . . . . 42.02 111.574 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.72 167.73 16.68 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.442 2.761 . . . . 71.31 112.772 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.59 85.61 0.73 Allowed 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.178 2.585 . . . . 63.12 110.547 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.7 t -73.33 -158.86 0.06 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.761 2.025 . . . . 74.23 109.164 171.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 141.19 49.36 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 120.138 -1.601 . . . . 73.12 109.662 161.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 43.82 -88.37 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 130.553 3.541 . . . . 64.51 113.116 165.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.9 m -162.96 166.89 23.31 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.408 -1.33 . . . . 61.12 107.408 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -80.41 40.69 0.51 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.251 1.021 . . . . 62.42 111.976 173.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.94 15.05 1.91 Allowed 'General case' 0 N--CA 1.472 0.658 0 O-C-N 120.431 -1.418 . . . . 52.31 111.968 -178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.56 144.57 39.22 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.028 -1.045 . . . . 75.43 110.203 -171.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.437 ' CG1' ' HG3' ' A' ' 63' ' ' MET . 27.3 m -141.4 166.36 17.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 124.249 1.02 . . . . 62.22 110.496 -171.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 25.1 t -144.79 124.02 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 106.75 -1.574 . . . . 73.54 106.75 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.23 148.99 4.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.059 1.344 . . . . 53.24 107.601 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -136.6 163.1 31.33 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.591 -0.693 . . . . 74.13 109.635 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.5 9.87 68.66 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.062 -0.854 . . . . 51.11 113.81 176.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -57.81 150.99 45.29 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 118.481 1.141 . . . . 72.41 112.509 -172.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -71.52 169.65 20.42 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 125.163 3.909 . . . . 74.15 113.259 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.47 -4.23 11.56 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 124.576 3.517 . . . . 34.4 114.167 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -139.73 71.03 1.37 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.081 2.152 . . . . 44.04 106.579 171.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -122.18 127.08 6.66 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 125.344 1.449 . . . . 12.3 109.596 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.4 m -134.78 166.64 22.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.935 0.894 . . . . 60.11 110.644 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.8 p-90 -65.05 -22.84 67.04 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.407 1.083 . . . . 74.44 111.711 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -58.38 -60.45 3.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 117.436 -1.269 . . . . 63.53 109.742 177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.84 -42.69 94.13 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 108.875 -0.787 . . . . 53.45 108.875 176.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.78 -50.98 62.48 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 118.846 0.748 . . . . 61.51 111.072 -176.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.6 tttm -67.48 -31.88 72.33 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.263 -0.898 . . . . 74.31 112.406 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.78 -2.58 57.87 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.34 1.456 . . . . 74.42 112.003 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -122.17 -56.08 1.84 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.278 1.431 . . . . 52.52 110.45 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 17.2 ttt -75.74 72.11 2.64 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 120.435 -1.415 . . . . 64.42 108.473 171.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.3 ptm85 -136.81 -13.4 1.68 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.271 1.428 . . . . 65.33 111.734 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -76.39 3.41 11.13 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.423 -0.798 . . . . 72.42 112.315 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.7 64.29 0.74 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.814 1.645 . . . . 71.41 107.055 172.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.58 -136.38 33.87 Favored Glycine 0 CA--C 1.523 0.558 0 CA-C-N 115.249 -0.887 . . . . 74.35 111.528 172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -109.43 117.87 35.16 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.212 0.53 . . . . 74.35 111.096 -159.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.23 95.99 4.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 C-N-CA 124.092 0.957 . . . . 72.23 108.929 -176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.4 t -69.78 -29.58 66.93 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 118.003 -0.998 . . . . 41.13 112.064 -175.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -122.04 149.76 43.06 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.144 1.338 . . . . 73.51 110.916 -168.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -146.62 133.52 20.18 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.827 1.251 . . . . 65.32 109.231 169.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -151.63 125.28 8.99 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 107.5 -1.296 . . . . 71.14 107.5 172.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.9 t -142.62 96.9 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.018 -2.216 . . . . 43.32 105.018 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -64.89 -176.13 0.24 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 126.137 1.775 . . . . 74.14 108.818 161.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -115.15 78.51 1.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 O-C-N 120.585 -1.322 . . . . 75.54 107.793 -174.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -158.41 42.0 0.26 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.945 1.298 . . . . 62.51 110.227 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.15 9.3 14.61 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.525 1.536 . . . . 42.41 116.385 176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.2 p -134.7 168.13 19.57 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.977 1.889 . . . . 53.25 109.95 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -146.41 151.94 24.13 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 107.454 -2.258 . . . . 75.32 107.454 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.87 121.4 58.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.771 -1.566 . . . . 72.23 106.771 -172.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.425 ' HB ' HG23 ' A' ' 18' ' ' VAL . 76.4 t -135.81 147.84 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 106.387 -1.709 . . . . 74.53 106.387 -159.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -136.58 113.81 10.71 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 105.47 -2.048 . . . . 75.22 105.47 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -86.42 172.22 10.54 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.741 1.217 . . . . 72.23 108.424 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.7 t -70.65 -56.7 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 118.588 -0.72 . . . . 60.21 110.635 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -139.26 168.26 20.23 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 119.556 1.071 . . . . 63.15 111.034 -171.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 ttmt -56.04 -36.34 67.89 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 117.479 -1.248 . . . . 61.52 110.343 175.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -67.01 -47.53 71.15 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 120.168 1.349 . . . . 63.55 109.847 -171.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.67 -51.67 68.59 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.837 1.655 . . . . 74.35 109.3 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.437 ' HG3' ' CG1' ' A' ' 18' ' ' VAL . 62.8 ttp -55.57 -50.57 69.73 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.825 0.85 . . . . 63.12 111.767 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.6 m -54.56 -53.53 53.28 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 117.963 -1.018 . . . . 64.43 109.258 173.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -49.84 -32.77 15.03 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.311 0.96 . . . . 75.42 111.527 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.2 -45.9 91.56 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.916 0.886 . . . . 72.55 111.033 178.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -68.52 -16.66 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.381 -0.824 . . . . 54.53 110.902 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -108.89 -19.58 13.35 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 121.216 -0.927 . . . . 72.43 113.147 -167.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 5.7 mmpt? -136.21 -9.03 2.0 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 124.579 1.151 . . . . 74.24 111.75 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.7 17.49 6.33 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.851 1.26 . . . . 75.34 110.385 -167.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.58 150.79 28.45 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.628 1.171 . . . . 73.42 112.099 -171.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.06 32.3 0.86 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.726 2.01 . . . . 71.15 113.202 -167.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.3 p -75.02 177.06 6.63 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.05 0.94 . . . . 45.02 109.631 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -72.97 176.49 5.68 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.564 0.345 . . . . 64.42 111.078 162.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -151.55 128.46 10.99 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 128.212 2.605 . . . . 74.12 108.639 168.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -75.84 124.45 27.33 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.378 1.071 . . . . 73.22 109.576 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.44 157.41 17.66 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.241 0.616 . . . . 72.12 110.475 -176.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -80.63 -0.39 37.78 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.218 1.007 . . . . 55.12 112.097 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -86.1 4.67 37.21 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.573 1.949 . . . . 55.52 111.569 170.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.38 20.1 74.98 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 119.037 0.835 . . . . 65.43 111.886 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -120.91 177.85 4.94 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 127.302 2.241 . . . . 54.01 107.749 170.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.6 p -140.58 134.36 30.42 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.247 -1.39 . . . . 60.31 107.247 179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.96 173.19 6.78 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 120.922 -1.111 . . . . 71.53 110.07 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -87.67 161.89 17.41 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.499 -0.926 . . . . 75.11 108.499 158.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.9 pt -137.93 141.46 38.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 124.414 1.086 . . . . 74.15 109.245 173.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.9 mmt85 -96.95 120.92 38.2 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 106.415 -1.698 . . . . 41.52 106.415 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 30.2 t -89.32 137.03 22.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.611 -1.255 . . . . 74.24 107.611 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -145.48 157.52 43.99 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.379 1.472 . . . . 64.23 109.545 169.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.21 143.41 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 126.19 1.796 . . . . 64.14 106.347 170.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 16.2 t70 . . . . . 0 C--O 1.255 1.379 0 C-N-CA 124.281 1.032 . . . . 24.5 108.447 167.154 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.805 0 N-CA-C 110.927 -0.869 . . . . 61.33 110.927 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.5 155.15 94.07 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 124.111 0.964 . . . . 75.13 110.944 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.19 -168.63 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 124.102 3.201 . . . . 55.22 110.505 166.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -166.36 163.39 17.48 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 127.661 2.384 . . . . 75.44 107.486 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.63 -168.85 22.19 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 123.558 0.599 . . . . 64.01 111.864 173.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -135.76 148.33 48.74 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.392 -1.336 . . . . 73.12 107.392 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -129.9 155.71 45.59 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.518 1.127 . . . . 71.44 108.87 175.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.27 70.55 0.03 OUTLIER Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.107 -1.385 . . . . 61.14 112.333 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -67.43 166.17 24.59 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.693 2.928 . . . . 62.43 111.948 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.94 68.59 8.26 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.055 3.17 . . . . 64.34 112.65 -173.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.5 t -156.83 164.16 38.39 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 120.591 -1.318 . . . . 62.24 110.681 152.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -124.95 155.06 40.19 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.452 1.501 . . . . 74.32 109.097 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -86.55 -86.2 0.15 Allowed 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.14 -1.43 . . . . 63.13 107.14 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.5 m -161.37 174.17 13.89 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.035 2.134 . . . . 74.05 108.283 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -68.22 26.45 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.086 2.554 . . . . 53.31 114.925 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.9 23.35 3.9 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.29 1.436 . . . . 64.45 109.488 -178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.401 ' HG2' HH11 ' A' ' 17' ' ' ARG . 0.0 OUTLIER -119.27 143.75 47.16 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.568 1.147 . . . . 74.03 111.16 -168.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.52 HG23 ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -144.97 156.47 13.99 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 124.877 1.271 . . . . 65.13 109.045 -165.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.8 t -141.3 120.4 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 119.992 1.269 . . . . 62.14 109.742 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.54 155.01 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.85 1.66 . . . . 73.12 109.867 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -143.87 167.58 21.98 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.379 1.072 . . . . 72.35 109.366 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.0 14.41 64.67 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 123.27 0.462 . . . . 55.53 112.778 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 mt -73.96 148.68 87.12 Favored Pre-proline 0 CA--C 1.537 0.461 0 O-C-N 121.991 -0.711 . . . . 64.02 110.355 -168.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.18 167.44 23.28 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 124.996 3.798 . . . . 74.21 111.733 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.05 -21.19 56.6 Favored 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 122.791 2.327 . . . . 72.42 113.229 -175.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -121.15 35.98 4.73 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 124.5 1.12 . . . . 62.32 111.314 175.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.99 156.42 51.65 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 107.503 -2.239 . . . . 42.01 107.503 158.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.4 m -152.47 173.24 15.37 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.771 0.828 . . . . 44.45 110.541 165.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 34.8 p-90 -63.48 -21.8 66.52 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 124.227 1.011 . . . . 65.22 111.894 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -65.74 -63.83 1.0 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.383 1.073 . . . . 74.41 108.95 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.15 -34.62 78.82 Favored 'General case' 0 C--O 1.219 -0.511 0 C-N-CA 118.606 -1.238 . . . . 71.24 110.482 177.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -47.78 64.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.484 1.038 . . . . 73.22 111.017 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.0 tttm -66.94 -32.23 73.34 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 119.882 1.219 . . . . 54.53 111.557 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.23 -7.01 59.62 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.018 0.927 . . . . 65.02 113.194 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -106.09 -58.06 1.96 Allowed 'General case' 0 C--O 1.235 0.338 0 C-N-CA 126.361 1.864 . . . . 73.44 108.1 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 16.6 ttt -79.23 73.05 5.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.312 1.445 . . . . 72.24 109.079 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -139.01 -0.32 1.88 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.892 0.877 . . . . 74.21 113.21 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -91.45 -1.11 57.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.5 1.52 . . . . 73.35 112.286 -169.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.2 -6.26 14.59 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.38 -0.825 . . . . 61.45 112.617 -170.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.3 -111.4 0.47 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 117.936 -1.48 . . . . 62.14 112.182 177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -136.37 139.46 42.52 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.169 1.485 . . . . 74.12 109.817 169.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.495 HG22 ' CE1' ' A' ' 57' ' ' PHE . 8.7 t -124.13 97.77 4.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 124.847 1.259 . . . . 44.42 107.686 -175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 15.1 t -67.39 -54.84 16.92 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.119 -0.363 . . . . 73.03 110.054 -177.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -83.8 175.92 9.3 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.316 1.846 . . . . 54.32 111.816 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -167.08 130.73 1.86 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.542 1.137 . . . . 73.41 111.398 166.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -157.36 136.99 12.2 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.793 1.178 . . . . 64.13 112.514 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.9 t -147.59 135.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.642 1.577 . . . . 75.25 107.492 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -112.12 152.85 27.81 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 125.241 1.416 . . . . 53.52 109.203 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -80.45 65.86 5.75 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.34 0.656 . . . . 64.43 110.338 -175.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -130.45 -11.65 4.0 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 123.363 0.665 . . . . 71.14 112.361 168.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.86 17.36 7.96 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.756 -1.024 . . . . 61.25 112.531 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.97 158.46 43.87 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.939 1.37 . . . . 71.2 110.007 -171.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -159.67 107.98 0.34 Allowed Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.42 -1.072 . . . . 74.03 110.42 -170.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.19 147.98 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 118.006 0.903 . . . . 71.43 109.634 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.52 ' HB ' HG23 ' A' ' 18' ' ' VAL . 7.7 t -139.37 163.94 25.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 106.981 -1.488 . . . . 74.04 106.981 177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -146.74 126.42 13.39 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.163 -1.421 . . . . 74.04 107.163 174.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.495 ' CE1' HG22 ' A' ' 42' ' ' VAL . 3.3 m-85 -99.3 170.49 8.62 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.183 -1.414 . . . . 72.45 107.183 172.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -68.93 -60.26 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 108.908 -0.775 . . . . 63.41 108.908 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -131.69 167.01 20.21 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.366 0.603 . . . . 74.23 110.155 -168.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -65.81 -27.38 68.22 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-O 118.138 -0.934 . . . . 71.34 110.377 -176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -57.46 -50.31 73.44 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.602 1.092 . . . . 70.41 109.745 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -67.68 -51.42 49.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.943 2.097 . . . . 74.34 107.833 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.4 tmm? -57.33 -45.09 84.64 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.389 1.076 . . . . 71.13 112.755 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.6 m -59.15 -46.26 88.83 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 120.739 -1.226 . . . . 73.22 111.292 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -60.81 -29.95 69.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.07 0.548 . . . . 72.12 110.438 -174.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.24 91.87 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.018 0.927 . . . . 74.21 111.519 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 83.6 t -72.69 -19.28 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 120.705 -1.247 . . . . 73.01 110.36 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 31.2 mtm180 -77.17 -57.55 3.77 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.018 -1.051 . . . . 64.32 109.56 174.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -100.21 -12.51 19.51 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.159 0.984 . . . . 54.43 113.225 -164.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.51 8.91 3.13 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.558 1.143 . . . . 72.15 111.899 -155.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -106.0 163.1 13.03 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.158 1.383 . . . . 72.34 110.017 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.321 6.8 p30 53.92 37.44 26.63 Favored 'General case' 0 C--N 1.349 0.566 0 CA-C-N 119.439 1.018 . . . . 62.23 110.808 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.5 p -93.77 172.55 8.18 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 131.625 3.97 . . . . 51.15 111.756 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.5 tttp -85.06 174.72 9.5 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 124.503 1.121 . . . . 73.31 109.881 160.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -155.81 133.43 11.07 Favored 'General case' 0 N--CA 1.461 0.082 0 C-N-CA 124.756 1.222 . . . . 73.14 110.977 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HA ' HG22 ' A' ' 82' ' ' THR . 35.9 mmt180 -72.84 141.47 47.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.114 0.87 . . . . 73.14 110.988 177.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.79 171.79 7.54 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.961 0.886 . . . . 74.35 110.814 156.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.0 t-80 -67.59 -22.66 65.36 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 113.613 -1.63 . . . . 75.14 112.33 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -87.69 14.2 8.99 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.176 0.99 . . . . 75.51 111.787 -169.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.11 30.77 74.06 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.454 -1.058 . . . . 72.13 110.454 177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -132.13 159.34 39.23 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 127.076 2.15 . . . . 71.23 106.548 177.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 76' ' ' ARG . 31.6 p -142.63 113.71 7.65 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.045 0.926 . . . . 73.12 110.405 -171.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.75 177.4 8.91 Favored 'General case' 0 C--O 1.226 -0.137 0 C-N-CA 125.909 1.683 . . . . 65.25 110.417 -173.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -106.31 144.78 32.51 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.488 -0.93 . . . . 64.31 108.488 158.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.2 pt -131.28 170.05 20.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 C-N-CA 124.554 1.142 . . . . 64.12 108.94 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 mtm180 -125.02 151.87 45.01 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.966 -1.124 . . . . 71.32 107.966 170.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.1 t -114.9 114.8 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 128.341 2.656 . . . . 72.23 105.925 173.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -123.87 164.69 18.73 Favored 'General case' 0 CA--C 1.513 -0.48 0 O-C-N 121.757 -0.589 . . . . 73.25 110.116 164.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.9 t -67.1 154.95 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 106.74 -1.578 . . . . 74.05 106.74 170.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--O 1.251 1.144 0 N-CA-C 108.276 -1.009 . . . . 72.13 108.276 170.234 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.665 0 N-CA-C 109.879 -1.289 . . . . 42.44 109.879 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.39 152.26 45.69 Favored Pre-proline 0 C--O 1.235 0.293 0 O-C-N 121.647 -0.914 . . . . 71.52 109.902 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -73.98 167.23 27.72 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.802 2.335 . . . . 43.34 110.55 167.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.48 -170.99 2.32 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.29 1.836 . . . . 73.2 112.638 -159.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.97 26.32 37.86 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 119.249 -0.75 . . . . 42.13 113.812 170.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.81 10.31 2.42 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.14 1.376 . . . . 61.42 113.6 -171.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -149.99 144.56 25.91 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.213 1.405 . . . . 72.34 109.081 -172.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.2 -76.18 0.28 Allowed Glycine 0 CA--C 1.52 0.384 0 N-CA-C 109.449 -1.46 . . . . 62.21 109.449 175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -65.2 166.49 18.86 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 122.522 2.148 . . . . 74.11 110.756 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -76.58 64.72 7.42 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.425 2.75 . . . . 64.22 112.38 -172.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.1 m -94.45 151.46 19.36 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.285 -1.005 . . . . 63.1 108.285 152.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.451 ' HD2' ' H ' ' A' ' 12' ' ' ARG . 0.4 OUTLIER -69.44 -173.88 0.62 Allowed 'General case' 0 C--O 1.234 0.288 0 O-C-N 124.084 0.865 . . . . 72.52 110.394 162.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -118.55 -85.16 0.65 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.839 -1.541 . . . . 72.41 106.839 174.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 63.1 m -165.12 162.1 19.97 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 126.458 1.903 . . . . 70.12 108.591 174.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -72.35 26.9 0.05 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.949 2.1 . . . . 65.33 113.664 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.43 41.18 3.49 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 106.925 -1.509 . . . . 62.22 106.925 174.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.19 136.43 49.23 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 124.848 1.259 . . . . 74.51 109.133 -172.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.528 HG23 ' HB ' ' A' ' 55' ' ' VAL . 33.7 m -137.61 169.08 19.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.008 0.923 . . . . 74.12 111.324 -169.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.44 156.31 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 N-CA-C 104.604 -2.369 . . . . 73.14 104.604 179.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.3 t -130.89 151.27 35.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 107.047 -1.464 . . . . 70.21 107.047 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.4 p -136.56 167.89 20.53 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 119.542 1.064 . . . . 73.14 109.174 175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.58 4.43 70.35 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.576 1.56 . . . . 72.11 113.557 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.58 148.1 67.53 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 119.528 1.664 . . . . 72.24 112.298 -169.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.58 163.22 36.43 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.142 1.894 . . . . 73.15 109.917 174.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.1 -8.49 20.29 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.898 3.066 . . . . 65.31 115.633 -165.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.53 19.64 2.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.781 1.232 . . . . 72.45 110.829 -175.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.87 103.52 2.0 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 108.594 -1.802 . . . . 65.21 108.594 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.9 m -85.9 169.73 13.01 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 118.128 0.964 . . . . 65.25 110.773 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 41.0 p-90 -64.06 -24.46 67.71 Favored 'General case' 0 C--O 1.226 -0.136 0 O-C-N 121.86 -0.525 . . . . 72.32 110.77 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.36 -50.45 72.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.472 1.509 . . . . 74.15 108.347 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.26 -41.91 80.39 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.249 0.477 . . . . 61.23 110.547 176.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.85 -52.74 47.24 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.991 0.814 . . . . 71.43 109.884 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.3 tttt -65.14 -33.57 76.32 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.835 0.854 . . . . 74.33 110.827 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -80.01 -10.72 59.79 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.667 1.187 . . . . 74.33 113.263 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -112.68 -46.1 3.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.619 0.767 . . . . 74.34 109.866 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.66 ' HG3' HD11 ' A' ' 70' ' ' LEU . 17.2 ttt -67.04 -12.81 60.96 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.046 1.128 . . . . 74.41 114.046 -173.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -60.25 -11.5 6.51 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 124.893 1.277 . . . . 74.31 114.023 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -58.75 -27.92 65.4 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.47 1.032 . . . . 63.14 112.002 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.38 -9.83 59.09 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 113.822 1.045 . . . . 70.31 113.822 177.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.25 -148.83 17.39 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 119.941 1.246 . . . . 52.12 110.3 -171.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -90.45 91.65 8.55 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 123.579 1.657 . . . . 71.54 110.08 -166.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 53.5 t -72.45 144.61 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-N 113.524 -1.671 . . . . 74.4 106.608 161.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 2.3 t -138.13 -2.47 1.85 Allowed 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 114.282 1.215 . . . . 65.43 114.282 172.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.439 ' HB3' ' CB ' ' A' ' 56' ' ' GLU . 3.8 t80 -138.25 145.43 41.32 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 121.125 1.784 . . . . 73.32 106.8 168.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.45 145.16 38.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.376 -0.972 . . . . 74.31 108.376 165.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -151.73 141.96 22.34 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.548 1.139 . . . . 74.42 109.238 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.9 m -144.33 176.11 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 125.368 1.467 . . . . 73.41 108.123 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -146.64 -177.24 5.54 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.704 1.202 . . . . 74.12 108.151 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -83.03 51.4 1.94 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.111 0.869 . . . . 64.25 109.083 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -139.65 176.24 8.89 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.405 -1.331 . . . . 70.34 107.405 167.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -82.75 53.61 4.86 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 110.331 -1.108 . . . . 70.31 110.331 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.03 154.56 32.67 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.354 1.077 . . . . 62.05 110.523 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.96 170.53 32.58 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.481 1.515 . . . . 65.12 110.394 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.7 t -146.13 142.93 21.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.094 1.757 . . . . 71.01 107.309 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.528 ' HB ' HG23 ' A' ' 18' ' ' VAL . 54.6 t -145.21 164.02 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 108.113 -1.069 . . . . 73.33 108.113 -161.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.439 ' CB ' ' HB3' ' A' ' 44' ' ' TYR . 15.2 tt0 -138.4 144.69 40.33 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.806 -1.553 . . . . 54.23 106.806 172.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -115.7 167.89 10.52 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.809 2.043 . . . . 74.42 107.638 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.4 m -73.42 -33.06 39.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.649 0.611 . . . . 64.53 112.649 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -156.95 159.74 38.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 118.74 0.7 . . . . 74.54 109.592 -171.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.8 tttm -64.85 -20.75 66.58 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 118.138 -0.934 . . . . 74.23 112.287 178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.18 -64.14 0.94 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.391 1.076 . . . . 74.1 108.797 176.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.34 -42.18 81.43 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.881 0.872 . . . . 73.5 110.146 177.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.442 ' HG3' ' CG1' ' A' ' 18' ' ' VAL . 47.9 ttp -51.63 -57.94 7.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.541 0.336 . . . . 74.31 110.647 174.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.5 m -61.17 -38.33 86.1 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.96 0.904 . . . . 72.5 112.817 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -54.36 -34.97 62.23 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 119.224 0.92 . . . . 71.11 111.394 177.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.481 ' HB1' HD12 ' A' ' 70' ' ' LEU . . . -55.69 -43.43 76.39 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.657 -0.652 . . . . 72.22 112.08 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.33 -19.36 25.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 O-C-N 120.929 -1.107 . . . . 71.42 109.934 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -86.91 -36.46 18.36 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.513 1.125 . . . . 72.43 111.493 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 25.7 mmtm -132.72 0.95 3.62 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.648 0.981 . . . . 75.0 113.648 -160.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.66 HD11 ' HG3' ' A' ' 36' ' ' MET . 1.7 tm? -143.34 16.64 1.87 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.386 1.075 . . . . 75.04 110.369 -167.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HB2' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -102.25 156.32 17.65 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 119.294 -2.129 . . . . 74.31 112.561 173.58 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 13.2 t30 55.22 19.78 3.09 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.58 1.952 . . . . 75.24 114.059 -176.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.5 p -70.31 173.32 6.93 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.958 1.703 . . . . 52.51 110.766 -176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -78.39 178.11 7.96 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.401 -0.592 . . . . 73.44 109.401 163.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -156.03 141.08 17.34 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.486 1.514 . . . . 73.31 112.102 168.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -94.5 109.48 21.36 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.133 2.173 . . . . 63.03 111.529 -170.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 t -93.39 165.5 12.74 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 120.53 1.514 . . . . 45.41 110.935 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.58 -17.56 44.44 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.085 -1.009 . . . . 53.45 113.112 176.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -80.97 22.94 0.58 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.233 1.413 . . . . 72.41 112.123 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.62 33.07 83.37 Favored Glycine 0 CA--C 1.525 0.694 0 O-C-N 121.687 -0.633 . . . . 74.33 111.818 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -147.53 169.13 20.23 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 125.288 1.435 . . . . 72.01 110.275 -177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.6 p -148.87 131.06 15.48 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.331 1.052 . . . . 62.21 108.673 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.04 -178.94 3.71 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.653 0.781 . . . . 62.31 109.277 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -90.81 160.7 15.63 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.152 -0.684 . . . . 72.45 109.152 163.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.1 pt -136.54 167.1 24.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 124.546 1.138 . . . . 62.35 109.856 173.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -137.57 122.11 18.45 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 107.585 -1.265 . . . . 75.41 107.585 -170.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' A' ' 71' ' ' ASP . 1.4 p -84.86 148.79 4.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-N 118.47 0.577 . . . . 62.1 109.708 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.89 177.2 10.05 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.565 0.746 . . . . 71.23 109.896 162.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 19.3 t -95.02 153.95 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.503 -1.666 . . . . 75.43 106.503 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.4 t0 . . . . . 0 C--O 1.252 1.187 0 N-CA-C 105.959 -1.867 . . . . 72.32 105.959 158.843 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.901 0 N-CA-C 108.674 -1.77 . . . . 45.3 108.674 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.57 159.49 70.27 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 118.554 1.177 . . . . 72.3 110.233 -174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -70.89 161.36 46.34 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 N-CA-C 108.2 -1.5 . . . . 73.54 108.2 166.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 27.0 ptt180 -117.43 9.83 13.41 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 114.116 1.154 . . . . 73.34 114.116 -164.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 118.88 169.11 14.32 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 107.936 -2.066 . . . . 61.4 107.936 -157.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -151.08 129.44 12.04 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.302 -0.999 . . . . 73.13 108.302 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -150.98 146.48 26.26 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.195 -0.668 . . . . 73.34 109.195 176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.3 -82.42 1.62 Allowed Glycine 0 CA--C 1.527 0.81 0 N-CA-C 109.901 -1.28 . . . . 61.3 109.901 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -70.72 169.05 21.07 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.672 2.248 . . . . 61.11 112.974 -166.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -75.6 67.84 6.34 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.663 2.909 . . . . 72.3 111.339 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.5 m -132.48 152.76 51.42 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.415 1.486 . . . . 65.11 107.522 167.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -137.31 165.58 25.83 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.086 1.354 . . . . 73.12 108.851 176.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -82.43 -87.36 0.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.403 -0.962 . . . . 65.23 108.403 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -167.9 -178.55 3.83 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.661 2.384 . . . . 64.4 106.56 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' ' HE3' ' A' ' 60' ' ' LYS . 59.4 mt-10 -84.52 24.3 1.02 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.901 1.68 . . . . 75.22 112.27 -175.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -128.32 23.75 5.94 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 119.997 -1.689 . . . . 63.14 110.971 -169.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.2 122.02 40.04 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 121.376 -0.827 . . . . 74.12 111.132 -159.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 89' ' ' VAL . 3.2 m -127.07 159.96 36.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 126.24 1.816 . . . . 60.2 108.972 174.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 24.3 m -136.77 176.85 7.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 C-N-CA 127.117 2.167 . . . . 74.13 108.139 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.542 HG22 ' N ' ' A' ' 53' ' ' GLY . 2.4 m -135.89 159.11 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 107.925 -1.139 . . . . 65.24 107.925 -162.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.88 169.52 22.63 Favored 'General case' 0 C--O 1.227 -0.101 0 C-N-CA 123.912 0.885 . . . . 64.12 110.192 -176.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.09 11.1 69.96 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 124.008 0.813 . . . . 24.33 113.831 179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.447 HD13 HG13 ' A' ' 47' ' ' VAL . 10.0 mt -60.31 148.83 78.49 Favored Pre-proline 0 C--O 1.233 0.222 0 CA-C-N 118.845 1.323 . . . . 72.3 111.193 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -75.13 170.01 21.32 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.23 2.62 . . . . 72.0 110.39 168.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -66.93 -36.91 21.26 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.677 2.251 . . . . 70.43 113.969 -175.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.6 32.67 3.26 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 119.841 1.201 . . . . 64.32 110.918 -173.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.07 173.94 44.59 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-O 123.033 1.352 . . . . 61.04 109.776 164.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 62.4 p -159.43 168.88 25.18 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.063 1.745 . . . . 51.52 107.883 171.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -62.19 -27.34 68.9 Favored 'General case' 0 C--O 1.225 -0.22 0 O-C-N 122.116 -0.365 . . . . 74.1 111.26 174.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -65.02 -50.02 67.89 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.983 0.913 . . . . 73.01 109.807 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -67.45 -26.32 66.33 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.356 1.063 . . . . 73.43 111.02 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.08 -55.97 8.12 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.172 -1.047 . . . . 74.4 108.172 171.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.9 tttm -63.61 -35.75 81.56 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.299 -0.875 . . . . 72.04 111.85 -172.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -75.3 -5.75 46.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.81 0.844 . . . . 64.32 113.244 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.501 ' CG ' HH21 ' A' ' 76' ' ' ARG . 2.2 t-160 -119.05 -43.7 2.63 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.262 1.025 . . . . 72.32 112.828 -178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.416 ' O ' HG21 ' A' ' 42' ' ' VAL . 8.8 ttt -76.27 41.83 0.25 Allowed 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.452 -0.78 . . . . 74.1 110.752 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.2 ptm85 -111.28 -16.5 13.38 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 120.074 -1.641 . . . . 74.15 112.372 -170.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -84.58 -5.28 59.29 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 114.666 1.358 . . . . 55.24 114.666 -168.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.12 -13.73 24.82 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.755 0.822 . . . . 53.54 112.388 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 145.18 -176.23 24.33 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.767 -0.933 . . . . 72.31 110.767 -170.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -81.21 127.25 32.48 Favored 'General case' 0 C--O 1.236 0.376 0 O-C-N 122.241 -0.564 . . . . 44.21 111.696 -166.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 36' ' ' MET . 30.2 t -118.05 123.29 71.44 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 C-N-CA 124.252 1.021 . . . . 74.43 108.948 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.82 -19.88 19.26 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 117.993 -1.003 . . . . 74.43 112.362 -177.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -130.02 166.98 19.0 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 120.362 1.437 . . . . 72.22 111.798 -170.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -163.29 139.73 7.1 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.412 1.085 . . . . 71.11 111.617 167.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -146.84 143.34 28.51 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.559 1.144 . . . . 64.13 109.741 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.447 HG13 HD13 ' A' ' 23' ' ' LEU . 42.4 t -144.41 148.4 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.074 1.35 . . . . 72.43 107.982 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -139.87 168.47 19.73 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.859 1.263 . . . . 72.42 110.554 175.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -84.06 40.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 127.294 2.237 . . . . 71.03 111.327 -168.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -130.2 43.19 3.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.59 1.186 . . . . 71.24 109.205 170.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.14 12.34 30.16 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-O 118.357 -1.246 . . . . 33.44 114.523 172.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.3 p -143.12 157.45 44.51 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 120.429 2.115 . . . . 73.31 109.282 -169.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.542 ' N ' HG22 ' A' ' 20' ' ' VAL . . . -149.79 178.26 27.41 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 107.553 -2.219 . . . . 65.42 107.553 -172.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 31.0 t -155.96 137.79 5.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 105.393 -2.076 . . . . 74.04 105.393 -170.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 t -123.62 170.53 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.381 -1.34 . . . . 61.12 107.381 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -146.88 125.41 12.44 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.328 -2.101 . . . . 51.22 105.328 162.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -100.35 164.59 11.86 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 106.185 -1.783 . . . . 75.22 106.185 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.8 m -73.39 -29.5 27.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 119.307 -0.957 . . . . 73.21 112.266 -174.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -151.82 165.41 34.59 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.526 0.603 . . . . 75.41 112.488 -176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 15' ' ' GLU . 8.7 ttmt -61.81 -28.38 69.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 117.884 -1.055 . . . . 74.33 110.944 176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.13 -59.76 4.33 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.17 0.896 . . . . 74.24 108.729 -176.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.31 -46.52 86.33 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.586 1.555 . . . . 71.14 109.139 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -50.38 -55.46 15.6 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 124.253 1.021 . . . . 74.55 111.344 172.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.7 m -54.04 -44.2 70.84 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 118.779 0.718 . . . . 44.14 110.956 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -62.08 -40.88 97.33 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.11 -0.33 . . . . 75.24 110.11 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.95 -41.0 86.38 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 121.949 -0.469 . . . . 74.3 111.364 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.7 t -72.49 -10.24 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 O-C-N 121.497 -0.752 . . . . 53.11 110.975 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -119.12 -1.49 10.89 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.468 1.031 . . . . 71.14 113.721 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.0 -5.05 0.62 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.163 0.985 . . . . 53.01 112.586 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.99 24.24 3.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.633 1.173 . . . . 63.13 109.28 -171.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.34 156.83 17.59 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 120.796 -1.19 . . . . 71.13 110.361 175.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.13 20.96 1.96 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.389 2.276 . . . . 74.32 113.351 -174.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.3 p -74.31 174.62 8.58 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.528 1.931 . . . . 55.3 111.582 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -77.15 162.82 27.13 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.082 0.953 . . . . 73.43 110.116 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -148.18 121.13 8.77 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 125.726 1.611 . . . . 74.44 108.469 174.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.501 HH21 ' CG ' ' A' ' 35' ' ' HIS . 6.7 ptp180 -74.75 157.24 35.58 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.839 0.856 . . . . 72.03 109.747 173.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.9 p -141.42 163.26 33.42 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.13 0.572 . . . . 73.12 111.124 171.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -71.41 -12.43 61.41 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.579 1.551 . . . . 74.13 112.169 -174.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.75 8.58 2.32 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.755 1.222 . . . . 73.22 111.701 169.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.12 21.09 76.94 Favored Glycine 0 C--N 1.337 0.634 0 O-C-N 121.096 -1.002 . . . . 73.42 112.008 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -127.37 167.99 15.44 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 125.115 1.366 . . . . 74.34 109.065 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -140.27 145.6 37.51 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.387 -0.968 . . . . 73.02 108.387 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -127.26 -168.92 1.95 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.499 1.92 . . . . 72.2 107.022 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -103.72 161.94 13.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.785 -0.82 . . . . 63.34 108.785 165.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.8 pt -132.65 162.97 39.01 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 CA-C-O 121.189 0.519 . . . . 73.2 109.793 169.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -120.09 103.01 8.92 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.543 1.537 . . . . 72.33 108.086 -173.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 34.5 t -70.0 139.27 20.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.623 -1.251 . . . . 75.2 107.623 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -138.05 168.02 20.58 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 119.327 0.967 . . . . 62.5 110.467 159.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.546 ' HA ' HG12 ' A' ' 18' ' ' VAL . 90.7 t -78.57 140.8 16.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.047 -1.464 . . . . 61.53 107.047 170.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 44.5 t0 . . . . . 0 C--O 1.248 1.003 0 N-CA-C 107.273 -1.38 . . . . 53.24 107.273 167.521 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.815 0 N-CA-C 109.744 -1.342 . . . . 51.41 109.744 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.49 150.18 28.12 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 125.306 1.442 . . . . 64.1 107.934 165.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -66.42 158.2 56.51 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 121.98 1.786 . . . . 54.23 111.192 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.25 145.96 29.61 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.404 -0.962 . . . . 74.23 108.404 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 69.47 -157.69 53.44 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.404 -0.678 . . . . 52.32 111.404 175.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.02 -174.49 2.55 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.275 1.43 . . . . 73.02 109.416 -175.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -91.31 58.77 3.73 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.489 1.116 . . . . 74.42 108.346 174.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.49 175.05 47.03 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.879 1.228 . . . . 65.21 112.328 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -67.87 167.63 20.9 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.884 2.389 . . . . 74.33 110.047 170.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.51 66.48 5.55 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.849 3.033 . . . . 54.2 109.882 173.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.8 m -142.11 103.99 4.39 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.62 1.568 . . . . 73.24 107.107 -176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -70.54 177.84 3.27 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 109.128 -0.693 . . . . 73.04 109.128 171.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -136.88 -82.59 0.36 Allowed 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.088 -1.078 . . . . 74.43 108.088 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.0 m -150.7 171.3 17.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.807 1.643 . . . . 74.21 107.43 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.56 25.72 0.05 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 128.229 2.612 . . . . 75.45 113.212 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -131.52 35.77 3.81 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.485 1.514 . . . . 75.23 108.326 -177.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -115.77 124.43 50.75 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.771 1.628 . . . . 73.21 108.436 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.55 166.26 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.336 1.854 . . . . 74.05 110.05 177.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.8 t -137.0 141.11 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 C-N-CA 126.275 1.83 . . . . 71.31 106.506 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.7 t -112.99 152.16 14.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.792 1.237 . . . . 75.43 107.725 174.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.99 164.34 32.37 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.585 -1.265 . . . . 72.14 107.585 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.88 14.33 82.26 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.815 -0.992 . . . . 60.24 113.07 -173.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.792 HD23 ' HD2' ' A' ' 24' ' ' PRO . 0.2 OUTLIER -64.61 145.27 98.67 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 119.762 1.781 . . . . 65.05 110.94 -166.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.792 ' HD2' HD23 ' A' ' 23' ' ' LEU . 55.5 Cg_endo -64.33 169.86 10.29 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.095 2.53 . . . . 73.22 110.717 175.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.16 -13.92 39.28 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.761 1.641 . . . . 72.14 113.108 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -138.37 17.65 2.75 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.429 1.27 . . . . 64.01 114.429 -155.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.74 97.7 1.18 Allowed Glycine 0 C--N 1.335 0.507 0 N-CA-C 108.51 -1.836 . . . . 62.14 108.51 170.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -73.92 179.2 4.43 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 117.833 0.816 . . . . 45.45 110.876 172.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -61.93 -28.09 69.29 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.723 -1.235 . . . . 73.41 114.272 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.33 -51.8 64.47 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.245 -1.391 . . . . 53.23 107.245 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.3 -47.52 83.42 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.137 1.375 . . . . 73.03 110.056 177.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.519 HD23 HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -48.43 -58.22 4.95 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 123.638 0.775 . . . . 75.25 110.024 177.329 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.02 -37.86 78.87 Favored 'General case' 0 C--N 1.338 0.08 0 O-C-N 122.101 -0.374 . . . . 65.34 111.017 -171.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.23 -7.71 14.2 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.284 0.846 . . . . 73.12 113.284 176.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -112.29 -49.32 2.97 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.173 0.989 . . . . 75.14 111.858 174.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.1 ttt -70.53 25.25 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.774 1.629 . . . . 64.32 112.945 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.51 -7.42 41.3 Favored 'General case' 0 C--O 1.222 -0.392 0 O-C-N 120.175 -1.578 . . . . 71.03 113.292 167.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -63.69 -23.05 67.22 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.83 1.65 . . . . 72.45 113.801 -172.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.48 -8.39 58.38 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.486 1.515 . . . . 20.03 113.951 175.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 162.21 -110.28 0.43 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 119.852 1.206 . . . . 60.23 111.448 176.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.99 138.31 22.86 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 122.34 1.067 . . . . 74.14 108.229 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.472 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.4 p -122.34 135.81 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 C-N-CA 127.42 2.288 . . . . 71.42 109.595 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 31.1 p -103.17 -25.88 13.21 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.386 -0.825 . . . . 42.54 110.104 -176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.424 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 8.8 t80 -130.67 136.9 49.26 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.74 1.616 . . . . 71.05 109.071 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.92 150.05 46.73 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.003 0.921 . . . . 34.43 108.635 158.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -148.05 132.69 17.82 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 126.458 1.903 . . . . 73.2 107.494 172.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.1 t -137.98 137.61 44.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.599 -2.0 . . . . 65.21 105.599 175.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.29 -163.83 0.22 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.0 1.72 . . . . 70.31 109.833 177.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.6 ptm85 -43.54 -57.49 3.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.532 -1.667 . . . . 65.1 111.118 159.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -172.7 168.76 5.12 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 120.803 1.638 . . . . 61.34 114.443 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.28 -39.95 3.06 Favored Glycine 0 C--N 1.339 0.721 0 C-N-CA 128.152 2.787 . . . . 72.1 114.822 168.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.96 168.47 19.68 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.997 1.399 . . . . 61.21 109.242 -173.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -158.71 152.29 23.38 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 109.063 -1.615 . . . . 42.42 109.063 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 1.2 p -118.4 139.96 43.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.731 -1.211 . . . . 70.45 107.731 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 42.4 t -140.92 146.51 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.486 -1.672 . . . . 62.11 106.486 -168.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 44' ' ' TYR . 23.6 mt-10 -138.29 106.97 5.89 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 120.815 -1.178 . . . . 65.25 108.085 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.472 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 1.3 m-85 -76.51 163.76 26.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.201 1.801 . . . . 73.05 108.943 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.6 m -74.47 -39.17 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 O-C-N 120.955 -1.091 . . . . 63.33 112.499 -172.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.0 ttm-85 -143.09 159.27 42.58 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 123.195 0.598 . . . . 75.42 110.412 -173.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -67.26 -26.89 66.79 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 117.609 -1.186 . . . . 55.12 111.698 -174.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -51.72 -63.56 1.1 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 122.341 1.067 . . . . 75.01 108.429 175.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -73.2 -41.36 63.9 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.999 1.719 . . . . 72.44 108.446 -167.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.411 ' SD ' HG22 ' A' ' 89' ' ' VAL . 16.5 tmm? -52.62 -49.85 64.28 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.443 1.097 . . . . 75.32 111.245 170.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.4 m -61.19 -43.31 99.08 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.461 -0.774 . . . . 72.22 110.523 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -56.44 -41.31 76.21 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.93 0.786 . . . . 72.04 110.328 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.58 -43.49 68.56 Favored 'General case' 0 C--O 1.223 -0.335 0 C-N-CA 123.729 0.812 . . . . 75.15 111.876 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.96 -34.94 66.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 120.596 1.543 . . . . 75.22 110.375 -177.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.8 ptt85 -92.49 -16.32 25.96 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 114.145 1.165 . . . . 74.22 114.145 -170.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.4 mmtm -117.18 -37.43 3.55 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.248 1.019 . . . . 54.12 111.482 175.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.04 22.57 12.05 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.367 1.467 . . . . 55.45 110.095 -167.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -101.16 154.96 18.3 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 120.306 1.412 . . . . 74.14 111.841 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 19.0 t30 63.7 14.88 8.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.148 2.579 . . . . 74.15 112.981 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 39.5 p -76.13 175.17 9.21 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.746 1.218 . . . . 73.43 110.832 -169.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.5 tptt -66.92 170.92 5.95 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.3 -0.875 . . . . 74.33 108.954 155.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -149.67 126.7 11.23 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.432 1.093 . . . . 74.04 109.553 166.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.5 mtt-85 -82.98 120.38 25.64 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.442 1.497 . . . . 75.25 111.511 173.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 87.8 p -76.25 -172.19 2.0 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.597 -0.89 . . . . 72.01 108.597 154.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -89.24 -8.16 54.02 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.006 -1.059 . . . . 71.14 110.99 165.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -76.82 5.55 7.59 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 120.84 -1.163 . . . . 73.34 113.64 -167.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.36 17.06 67.46 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 124.309 0.956 . . . . 74.15 110.845 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.6 167.14 20.58 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.139 1.376 . . . . 74.34 108.763 -176.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.9 p -146.55 128.48 15.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.352 -0.981 . . . . 63.45 108.352 -177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.51 175.69 8.22 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.155 -1.054 . . . . 55.25 108.155 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -92.08 156.54 17.31 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.092 -1.818 . . . . 75.21 106.092 144.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.5 pt -131.64 173.74 14.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 107.558 -1.275 . . . . 72.15 107.558 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.7 mmt85 -128.94 150.4 50.4 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.231 -1.396 . . . . 75.25 107.231 168.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.8 t -122.62 137.21 56.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 126.081 1.752 . . . . 75.44 107.664 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.61 158.84 43.36 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.04 1.336 . . . . 62.25 108.902 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.411 HG22 ' SD ' ' A' ' 63' ' ' MET . 11.3 t -70.43 149.89 10.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 106.45 -1.685 . . . . 64.51 106.45 162.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.3 t70 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.813 -1.089 . . . . 75.41 110.369 172.445 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.948 0 N-CA-C 110.293 -1.123 . . . . 32.32 110.293 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.8 165.38 36.38 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 125.593 1.557 . . . . 64.45 108.733 -168.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.96 162.88 37.93 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.173 1.915 . . . . 75.23 110.903 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -146.89 104.57 3.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.235 -1.765 . . . . 75.04 106.235 -176.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -81.33 43.48 2.9 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.323 0.963 . . . . 42.1 112.569 -169.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.09 -176.3 5.04 Favored 'General case' 0 C--O 1.241 0.627 0 C-N-CA 125.162 1.385 . . . . 71.41 110.466 -173.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.72 -169.6 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.103 1.761 . . . . 74.31 109.952 165.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 135.33 -171.47 22.54 Favored Glycine 0 CA--C 1.529 0.969 0 O-C-N 120.605 -1.309 . . . . 52.34 112.023 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.5 172.59 11.13 Favored 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 124.131 3.221 . . . . 65.22 112.955 -173.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -64.19 99.35 0.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.465 2.11 . . . . 74.24 109.202 160.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -116.57 166.12 12.47 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 125.548 1.539 . . . . 33.31 107.737 164.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.73 159.92 15.04 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 109.327 -0.62 . . . . 73.42 109.327 172.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.0 mtp180 -98.7 -79.28 0.48 Allowed 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.48 -1.304 . . . . 73.51 107.48 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.1 m -153.4 174.54 14.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.854 1.262 . . . . 72.21 108.509 165.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -73.42 44.65 0.16 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.446 1.898 . . . . 72.52 111.9 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.23 22.3 3.22 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 120.125 -1.609 . . . . 75.13 110.861 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.6 ttt85 -121.61 136.79 54.93 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 120.937 -1.102 . . . . 64.12 109.285 -169.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.51 155.99 16.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.112 -0.699 . . . . 51.12 109.112 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.9 t -125.97 141.26 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 124.893 1.277 . . . . 72.41 107.671 179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.0 t -101.88 147.27 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 C-N-CA 126.727 2.011 . . . . 75.35 107.805 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.08 156.45 48.71 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 118.726 0.694 . . . . 74.44 110.632 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.94 3.53 70.3 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.674 1.13 . . . . 74.23 114.084 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.9 mt -58.26 147.12 68.23 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.449 1.1 . . . . 72.41 113.448 -164.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.22 165.6 31.91 Favored 'Trans proline' 0 CA--C 1.538 0.694 1 C-N-CA 126.051 4.501 . . . . 74.22 112.841 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -67.61 -15.76 45.43 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.669 2.913 . . . . 62.53 114.754 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.04 22.72 9.48 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.536 1.134 . . . . 73.2 110.023 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -81.45 72.75 2.71 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.56 -1.016 . . . . 74.24 110.56 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -69.68 162.8 26.98 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 124.423 0.72 . . . . 72.13 111.126 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.0 p-90 -61.55 -19.54 62.27 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.714 0.806 . . . . 74.24 111.467 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -60.49 3.28 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 117.093 -1.432 . . . . 74.03 109.385 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -64.46 -39.9 94.69 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 124.128 0.893 . . . . 54.42 109.544 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.0 -48.6 52.37 Favored 'General case' 0 C--O 1.225 -0.212 0 C-N-CA 123.247 0.619 . . . . 64.51 110.866 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 tttm -67.77 -44.15 78.14 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.708 0.685 . . . . 75.23 110.81 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.41 -13.07 62.16 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.767 1.227 . . . . 63.22 112.499 -176.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -108.74 -43.85 4.16 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.986 1.314 . . . . 75.43 112.455 178.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.5 ttt -77.59 42.72 0.37 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 120.59 -1.319 . . . . 61.14 111.198 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.5 -5.65 12.83 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.092 -1.63 . . . . 64.12 113.366 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -63.19 -22.55 66.94 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 120.565 1.529 . . . . 72.33 113.833 -172.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.47 -5.44 59.16 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 115.06 1.504 . . . . 74.35 115.06 -170.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.27 -98.6 0.21 Allowed Glycine 0 CA--C 1.523 0.548 0 CA-C-O 118.349 -1.251 . . . . 44.14 111.034 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -149.15 149.53 31.19 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.579 1.189 . . . . 71.43 112.188 176.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.4 t -130.55 148.22 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 125.79 1.636 . . . . 72.24 109.509 177.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.9 t -129.76 8.19 5.29 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.525 0.73 . . . . 64.44 112.293 -170.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -154.08 162.88 40.89 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.593 1.557 . . . . 74.12 108.81 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -162.04 129.9 4.04 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.867 0.867 . . . . 73.01 109.583 175.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -155.75 128.61 7.99 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 119.268 0.94 . . . . 72.14 111.184 175.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.4 m -130.01 177.38 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 O-C-N 120.522 -1.361 . . . . 71.33 107.398 174.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -148.21 161.04 42.27 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 107.312 -1.366 . . . . 63.33 107.312 168.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 42.36 -86.87 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.426 1 C-N-CA 132.116 4.166 . . . . 72.21 112.114 162.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -165.48 -178.02 4.73 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 128.002 2.521 . . . . 71.12 110.209 153.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.74 -21.12 31.47 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-O 117.879 -1.512 . . . . 74.1 114.293 161.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.02 164.82 37.28 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 120.154 1.977 . . . . 73.43 108.448 168.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.0 143.05 8.17 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 107.816 -2.114 . . . . 72.14 107.816 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.7 p -107.99 144.9 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 CA-C-N 118.726 1.263 . . . . 75.53 109.567 -177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.2 t -142.81 156.58 18.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 107.152 -1.425 . . . . 71.54 107.152 -173.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -136.49 112.85 9.91 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 106.93 -1.507 . . . . 73.02 106.93 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -80.0 177.81 8.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.977 -1.465 . . . . 73.53 107.237 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.5 t -72.54 -60.99 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.046 -0.979 . . . . 64.23 110.399 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -139.19 169.17 18.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 124.24 1.016 . . . . 75.31 109.671 -168.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -59.45 -29.73 68.0 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-O 116.875 -1.536 . . . . 63.52 111.791 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 58.3 mm-40 -60.55 -60.01 4.48 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 120.086 1.312 . . . . 63.25 109.877 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -63.64 -42.45 98.15 Favored 'General case' 0 N--CA 1.462 0.15 0 C-N-CA 123.904 0.882 . . . . 71.54 109.695 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -58.31 -50.61 73.0 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.282 1.033 . . . . 70.44 110.721 176.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.9 m -57.57 -52.76 64.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.255 -0.646 . . . . 70.25 109.255 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -56.57 -32.13 64.89 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.627 0.771 . . . . 74.55 112.077 -177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.43 -39.54 93.64 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 123.304 0.641 . . . . 63.33 110.024 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 t -70.29 -12.99 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.229 -0.919 . . . . 52.22 110.84 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -105.35 -33.1 8.29 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 120.875 -1.141 . . . . 64.21 111.957 -174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -121.51 -12.42 8.55 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.377 1.071 . . . . 72.54 112.759 -174.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.1 18.24 10.81 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.246 1.818 . . . . 73.55 109.434 -172.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -112.57 148.71 33.97 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 120.725 -1.234 . . . . 74.24 110.836 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.77 27.84 16.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.395 1.078 . . . . 72.33 111.032 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 28.1 p -90.44 175.93 6.9 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.85 1.26 . . . . 44.33 109.807 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.86 167.82 21.11 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.831 -0.803 . . . . 62.35 108.831 158.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -146.05 160.79 41.4 Favored 'General case' 0 C--O 1.22 -0.483 0 C-N-CA 127.328 2.251 . . . . 64.34 110.656 173.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 50.2 mtt180 -114.93 126.18 54.49 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.313 0.96 . . . . 60.44 109.16 -173.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 18.7 t -93.33 163.58 13.55 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.874 -0.787 . . . . 75.5 108.874 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -75.52 -8.37 56.56 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 119.112 -0.47 . . . . 73.2 111.749 166.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -78.43 -12.99 60.04 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.927 1.239 . . . . 73.22 113.339 -169.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.65 31.69 4.77 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 124.327 0.965 . . . . 74.24 111.864 -173.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.1 168.29 26.41 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.036 0.934 . . . . 73.11 110.936 -169.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.5 p -145.2 122.53 11.59 Favored 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.566 -1.197 . . . . 73.44 108.565 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -111.02 -174.17 2.41 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.603 1.961 . . . . 61.4 108.392 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -105.1 156.37 18.14 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 120.477 1.489 . . . . 72.43 110.59 172.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 14.6 pt -129.8 170.37 19.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 122.115 0.96 . . . . 65.13 108.987 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -130.61 155.51 46.42 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 104.791 -2.299 . . . . 71.14 104.791 172.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 92.8 t -125.97 137.33 58.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.982 -1.118 . . . . 72.53 107.982 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -130.41 147.7 52.14 Favored 'General case' 0 CA--C 1.511 -0.557 0 C-N-CA 123.853 0.861 . . . . 65.4 110.592 173.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.66 127.61 24.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 105.722 -1.955 . . . . 61.35 105.722 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.7 t70 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 127.678 2.391 . . . . 51.21 111.09 -172.992 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.694 0 N-CA-C 110.356 -1.098 . . . . 70.5 110.356 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.81 164.77 19.92 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 126.827 2.051 . . . . 63.53 107.526 172.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -82.24 165.69 16.65 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.316 2.011 . . . . 73.52 112.476 -171.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -150.94 178.24 9.35 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.186 2.194 . . . . 65.1 109.145 -178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.52 85.14 0.06 OUTLIER Glycine 0 C--N 1.336 0.549 0 N-CA-C 109.523 -1.431 . . . . 52.33 109.523 172.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.96 78.48 1.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 118.285 1.043 . . . . 63.43 109.965 -176.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -157.61 124.25 4.94 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 120.866 -1.146 . . . . 74.34 109.059 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.19 177.18 29.22 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 124.923 1.249 . . . . 63.23 112.627 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.6 172.41 10.47 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.198 2.599 . . . . 73.42 109.976 164.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.78 78.51 2.8 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.337 2.691 . . . . 70.01 110.464 173.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.4 m -90.49 157.0 17.78 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.062 -0.718 . . . . 72.32 109.062 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.84 -175.54 3.76 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.959 1.304 . . . . 74.0 110.474 -175.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -146.07 -81.08 0.15 Allowed 'General case' 0 C--N 1.339 0.134 0 C-N-CA 123.817 0.847 . . . . 72.14 110.205 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.2 m -154.48 159.0 40.76 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 128.696 2.798 . . . . 71.12 106.97 -163.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -76.34 37.15 0.16 Allowed 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.709 1.603 . . . . 53.44 112.301 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.8 14.94 3.63 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.465 1.906 . . . . 71.34 110.746 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -103.33 121.39 42.66 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.512 1.525 . . . . 73.02 107.526 -162.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.457 HG23 ' HB ' ' A' ' 55' ' ' VAL . 20.8 m -115.14 166.12 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 CA-C-N 118.504 0.593 . . . . 52.32 111.455 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.3 t -132.74 153.01 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 106.092 -1.818 . . . . 72.34 106.092 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.8 t -134.11 141.03 44.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 N-CA-C 106.955 -1.498 . . . . 74.42 106.955 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.3 m -137.31 141.81 41.88 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 123.127 1.442 . . . . 74.33 113.266 -165.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.19 37.43 48.8 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 128.578 2.99 . . . . 52.24 112.773 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.63 160.77 3.67 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.853 1.661 . . . . 73.41 113.021 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -68.83 171.02 14.13 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.612 3.541 . . . . 70.51 112.014 -174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.76 -4.89 16.18 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.739 2.293 . . . . 73.23 114.239 176.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.8 t -141.58 51.66 1.55 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.615 1.166 . . . . 70.43 109.08 -177.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.95 164.55 13.22 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 109.365 -1.494 . . . . 54.41 109.365 168.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 29.8 m -151.66 168.41 25.09 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.405 1.482 . . . . 51.41 108.426 167.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -53.0 -29.3 28.39 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.203 0.816 . . . . 62.31 113.203 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -62.79 -58.24 8.11 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.424 1.089 . . . . 72.44 108.911 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -70.3 -30.6 67.64 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.453 -0.573 . . . . 70.13 109.453 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -51.29 -56.05 15.05 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.33 -0.856 . . . . 54.12 109.78 172.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -70.47 -35.62 73.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.919 1.288 . . . . 65.53 110.034 -175.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -59.63 -23.04 62.68 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.245 1.018 . . . . 73.33 112.953 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -102.59 -42.89 5.78 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 124.153 0.981 . . . . 72.33 111.431 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.19 -20.42 65.4 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.154 -0.966 . . . . 74.43 113.244 -174.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -52.55 -26.2 12.58 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 114.827 1.417 . . . . 74.4 114.827 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -71.06 3.08 3.69 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.687 1.736 . . . . 65.43 115.687 -161.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.75 -0.96 28.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.642 1.177 . . . . 65.44 111.955 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 159.47 -97.95 0.16 Allowed Glycine 0 C--N 1.335 0.474 0 N-CA-C 108.617 -1.793 . . . . 50.02 108.617 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -157.76 162.53 38.51 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.795 1.283 . . . . 62.52 107.789 166.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.477 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -131.81 129.73 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 C-N-CA 126.738 2.015 . . . . 64.32 109.818 -175.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.7 t -86.85 -32.62 20.16 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 114.577 -1.192 . . . . 61.41 109.341 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -138.47 137.16 36.9 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.156 -0.965 . . . . 74.32 110.638 -160.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.76 149.43 37.09 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.203 1.001 . . . . 65.22 110.771 170.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -161.63 106.97 1.3 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.879 2.072 . . . . 63.11 108.821 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.93 -176.71 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 O-C-N 120.282 -1.511 . . . . 72.51 107.985 172.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -143.16 155.17 44.5 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.892 -0.781 . . . . 74.52 108.892 156.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 43.37 -86.13 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 130.666 3.587 . . . . 63.11 111.838 166.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -159.38 173.97 15.44 Favored 'General case' 0 N--CA 1.434 -1.254 0 O-C-N 125.231 1.582 . . . . 72.24 107.52 147.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.08 -8.92 63.27 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 118.605 -1.108 . . . . 71.44 113.343 161.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -159.56 164.84 33.93 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 119.635 1.717 . . . . 74.1 108.294 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -155.8 163.21 31.65 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.174 -1.17 . . . . 72.53 110.174 167.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 p -124.6 147.54 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.493 1.917 . . . . 31.14 108.23 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.457 ' HB ' HG23 ' A' ' 18' ' ' VAL . 72.1 t -144.0 166.14 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.943 -1.132 . . . . 73.44 107.943 -165.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -135.81 109.68 8.16 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 107.249 -1.389 . . . . 74.44 107.249 165.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.477 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -79.12 167.11 21.49 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.495 1.518 . . . . 53.22 108.336 172.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.7 m -77.71 -29.98 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 114.212 1.19 . . . . 70.13 114.212 -166.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -156.31 164.39 38.38 Favored 'General case' 0 CA--C 1.515 -0.381 0 O-C-N 121.262 -0.899 . . . . 74.2 109.894 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.3 ttmt -61.72 -31.95 72.15 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 117.448 -1.263 . . . . 63.41 111.632 176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -62.29 -51.92 65.77 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 120.379 1.445 . . . . 72.42 109.724 -174.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -72.46 -40.69 66.8 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.258 1.423 . . . . 61.22 108.706 -174.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.415 ' HG3' ' CG1' ' A' ' 18' ' ' VAL . 36.2 ttp -52.25 -53.82 38.95 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 123.338 0.655 . . . . 65.04 109.98 169.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.4 m -55.31 -47.46 75.57 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.306 -0.854 . . . . 54.4 109.977 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -57.53 -28.34 63.4 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 119.866 1.212 . . . . 71.51 112.113 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.1 -44.91 83.0 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 124.469 1.108 . . . . 72.23 109.227 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.8 t -65.09 -21.76 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 O-C-N 121.192 -0.942 . . . . 53.34 110.778 177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -91.9 -43.78 9.29 Favored 'General case' 0 N--CA 1.462 0.154 0 O-C-N 120.964 -1.085 . . . . 74.41 111.317 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -114.44 -15.62 12.05 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.069 1.348 . . . . 63.44 111.998 -165.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.32 22.15 9.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.478 1.911 . . . . 63.3 108.95 -171.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -111.83 154.53 24.98 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 120.45 -1.407 . . . . 72.42 110.87 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . 0.269 5.8 p-10 45.25 41.67 6.31 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 127.103 2.161 . . . . 72.42 112.327 -170.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 38.0 p -95.97 175.15 6.59 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.545 1.138 . . . . 54.44 111.668 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 171.78 4.09 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.078 0.551 . . . . 51.33 109.541 158.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -150.97 124.78 9.14 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 125.104 1.361 . . . . 74.2 109.328 166.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.453 ' HA ' HG22 ' A' ' 82' ' ' THR . 70.5 mtp180 -70.46 142.2 51.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.84 1.2 . . . . 43.33 110.47 177.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.7 t -109.11 -170.97 1.75 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 126.17 1.788 . . . . 65.2 107.507 176.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -99.6 -3.21 33.74 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.303 0.853 . . . . 71.24 113.303 172.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.73 41.46 1.39 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.494 1.117 . . . . 62.44 111.465 -171.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.41 18.48 55.78 Favored Glycine 0 N--CA 1.464 0.538 0 C-N-CA 124.924 1.249 . . . . 51.21 113.408 176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -142.99 174.09 10.98 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 125.492 1.517 . . . . 74.51 108.894 -166.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 76' ' ' ARG . 52.5 p -147.19 143.35 28.14 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.813 -0.81 . . . . 71.54 108.813 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.21 176.81 8.13 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.619 0.768 . . . . 70.51 110.565 174.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -104.13 154.79 19.31 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.984 -1.487 . . . . 61.44 106.984 141.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 16.3 pt -133.4 166.43 29.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 C-N-CA 124.828 1.251 . . . . 74.52 108.603 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -126.51 133.5 51.13 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 105.822 -1.918 . . . . 73.34 105.822 165.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.5 t -84.44 165.96 2.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 C-N-CA 125.779 1.632 . . . . 72.11 107.703 170.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.77 156.43 31.55 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.552 1.541 . . . . 73.33 107.967 162.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.8 t -66.78 138.51 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 105.18 -2.156 . . . . 50.11 105.18 156.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 24.0 t70 . . . . . 0 C--O 1.245 0.853 0 C-N-CA 124.044 0.938 . . . . 65.31 110.568 177.361 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.771 0 N-CA-C 111.609 -0.596 . . . . 55.23 111.609 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.49 158.1 57.19 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 125.877 1.671 . . . . 75.21 109.061 175.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.34 -55.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.559 2.173 . . . . 73.04 112.544 -171.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -172.54 165.94 5.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 108.121 -1.066 . . . . 74.34 108.121 -157.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.65 177.41 48.33 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 108.063 -2.015 . . . . 44.24 108.063 170.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.7 ptt180 -156.13 165.77 35.42 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 116.993 0.396 . . . . 73.45 110.415 161.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -148.51 -164.64 2.07 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.985 -1.117 . . . . 61.24 107.985 160.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 108.17 62.27 0.55 Allowed Glycine 0 CA--C 1.527 0.844 0 C-N-CA 125.41 1.481 . . . . 64.42 110.886 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.17 170.81 9.98 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.271 1.98 . . . . 73.14 109.662 166.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -72.7 79.25 1.94 Allowed 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.9 2.4 . . . . 74.52 110.148 174.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.0 p -145.35 164.56 31.09 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.911 1.284 . . . . 71.43 109.68 165.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.1 179.52 6.58 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.148 1.779 . . . . 73.14 108.143 169.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -134.92 -84.97 0.41 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.942 -1.133 . . . . 71.14 107.942 165.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.4 m -149.32 167.72 25.32 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.372 1.869 . . . . 72.42 108.319 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -70.53 24.35 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 128.054 2.541 . . . . 74.14 113.949 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -130.51 18.24 5.3 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 120.473 -1.392 . . . . 65.4 110.465 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.93 146.56 34.98 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.057 1.743 . . . . 64.31 111.106 -170.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.517 HG23 ' HB ' ' A' ' 55' ' ' VAL . 31.0 m -142.01 171.92 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 118.956 0.798 . . . . 74.43 111.012 -175.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 39.5 t -140.96 148.15 21.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 105.188 -2.153 . . . . 71.14 105.188 -178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 t -118.83 154.88 21.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 C-N-CA 125.006 1.322 . . . . 71.34 107.683 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.6 m -149.45 158.49 44.22 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 119.955 -1.716 . . . . 73.31 110.525 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.62 9.39 61.42 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 123.889 0.757 . . . . 64.42 112.895 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.405 HD11 HD23 ' A' ' 32' ' ' LEU . 4.1 mm? -59.1 154.85 37.49 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 124.866 1.267 . . . . 73.05 112.238 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.63 174.54 12.06 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.45 3.434 . . . . 73.11 112.8 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.89 -8.08 21.74 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.625 2.217 . . . . 64.01 114.676 171.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.68 59.84 1.65 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 120.997 1.726 . . . . 51.24 109.685 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.97 149.12 16.87 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 108.199 -1.96 . . . . 63.12 108.199 172.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.1 m -137.6 -179.69 5.89 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 122.513 1.149 . . . . 72.14 108.144 168.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.3 p-90 -63.56 -18.53 63.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.92 1.288 . . . . 70.41 112.239 -176.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -69.89 -57.18 5.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.082 -1.081 . . . . 71.12 108.082 -179.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -64.39 -26.91 68.67 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.548 0.69 . . . . 71.32 110.455 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.405 HD23 HD11 ' A' ' 23' ' ' LEU . 1.3 tm? -64.74 -54.05 37.46 Favored 'General case' 0 C--O 1.224 -0.264 0 O-C-N 120.235 -1.54 . . . . 50.22 110.653 174.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -65.51 -25.83 67.63 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 123.864 0.866 . . . . 73.31 110.865 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -31.89 64.97 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.808 -0.812 . . . . 74.31 108.808 -178.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -83.82 -53.41 5.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.231 1.813 . . . . 72.51 112.088 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 9.9 ttt -81.64 39.42 0.54 Allowed 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.64 1.176 . . . . 72.14 112.069 -167.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.81 2.28 14.33 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.229 1.412 . . . . 74.34 111.874 -175.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -85.78 -8.56 58.04 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.418 1.487 . . . . 64.5 113.174 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -111.61 25.22 11.88 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.979 1.312 . . . . 52.0 112.926 -166.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.51 -104.03 0.82 Allowed Glycine 0 C--N 1.332 0.345 0 N-CA-C 108.818 -1.713 . . . . 73.1 108.818 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -139.73 133.9 31.13 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 123.812 0.845 . . . . 64.33 110.64 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 57.6 t -127.97 136.04 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 126.195 1.798 . . . . 71.3 107.587 173.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.2 t -110.08 -26.13 9.86 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.462 0.541 . . . . 72.14 112.462 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -116.01 146.13 42.4 Favored 'General case' 0 N--CA 1.463 0.181 0 C-N-CA 124.238 1.015 . . . . 72.42 109.721 -173.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -141.74 152.19 43.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.112 0.965 . . . . 71.25 108.463 163.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -148.58 144.66 27.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.569 0.748 . . . . 74.51 109.557 160.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.7 t -147.4 144.91 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 105.768 -1.938 . . . . 73.22 105.768 176.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -138.22 178.79 6.86 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.599 1.16 . . . . 73.34 109.343 -171.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -89.42 66.47 7.43 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.203 -1.036 . . . . 64.43 108.203 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -151.49 31.68 0.58 Allowed 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.625 0.77 . . . . 63.42 110.414 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.75 18.75 40.22 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.062 -1.024 . . . . 61.45 113.616 178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.7 p -146.93 170.22 17.52 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 119.222 1.511 . . . . 45.45 110.242 -169.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.42 164.01 34.27 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.841 1.21 . . . . 72.23 110.469 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 28.7 t -131.4 156.01 42.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.572 1.549 . . . . 70.15 109.025 172.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.517 ' HB ' HG23 ' A' ' 18' ' ' VAL . 45.5 t -147.1 158.4 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.093 -1.447 . . . . 62.42 107.093 -175.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -145.0 114.45 7.14 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 108.325 -0.991 . . . . 50.42 108.325 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.78 174.77 7.01 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.822 2.449 . . . . 71.5 107.941 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.7 t -81.81 -49.25 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 CA-C-O 117.606 -1.188 . . . . 53.21 111.11 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -137.09 157.84 45.79 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 120.471 1.487 . . . . 74.42 110.721 -167.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -62.88 -25.85 68.5 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 118.303 -0.856 . . . . 53.2 111.133 -170.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -76.66 -42.76 40.67 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 119.242 0.928 . . . . 73.11 111.299 -174.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -67.84 -44.44 77.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.082 0.855 . . . . 64.52 109.104 172.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.488 ' HG2' ' CG1' ' A' ' 18' ' ' VAL . 16.9 tmm? -50.6 -50.94 52.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.926 0.491 . . . . 33.43 110.938 173.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.9 m -56.58 -52.84 63.28 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 118.715 -0.659 . . . . 74.51 110.344 172.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -49.52 -40.84 39.26 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 125.489 1.515 . . . . 72.4 111.158 -174.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.39 93.35 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.102 1.361 . . . . 52.5 111.259 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.5 t -58.67 -25.77 29.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 121.413 -0.804 . . . . 75.12 110.269 175.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -106.87 -9.85 16.2 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 125.399 1.479 . . . . 71.33 111.852 -167.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.77 -20.23 1.54 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 117.283 -1.341 . . . . 71.01 113.587 -174.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.0 18.83 10.08 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.882 1.673 . . . . 74.42 109.737 -164.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -104.12 159.0 16.04 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 120.921 -1.112 . . . . 73.32 111.91 -176.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 44.98 43.24 7.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 127.782 2.433 . . . . 74.43 112.044 -168.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.2 p -86.54 164.35 16.95 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.509 0.723 . . . . 75.45 110.731 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -88.07 157.62 18.82 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.553 1.141 . . . . 75.12 108.99 169.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -140.29 133.1 29.09 Favored 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 125.65 1.58 . . . . 64.22 109.519 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.425 ' HA ' HG22 ' A' ' 82' ' ' THR . 62.6 mtt180 -81.82 112.28 18.81 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 123.692 0.797 . . . . 74.33 110.52 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -78.15 156.66 29.77 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.961 -1.125 . . . . 73.35 107.961 165.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -72.77 -11.36 60.58 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.94 -0.475 . . . . 74.54 111.196 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -70.05 3.64 2.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.778 2.031 . . . . 74.13 113.545 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.19 15.97 78.67 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-N 119.121 0.873 . . . . 50.54 111.525 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.13 170.88 14.36 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 126.841 2.056 . . . . 75.42 108.011 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.425 HG22 ' HA ' ' A' ' 76' ' ' ARG . 30.6 p -137.54 154.71 49.78 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 106.295 -1.743 . . . . 63.13 106.295 -177.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -132.07 -179.09 5.2 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.871 -0.789 . . . . 61.22 108.871 166.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -95.56 156.53 16.29 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.453 -0.573 . . . . 62.05 109.453 175.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 13.1 pt -124.95 168.83 17.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 124.552 1.141 . . . . 74.34 108.873 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.3 mmm180 -125.39 147.18 49.28 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.154 -1.424 . . . . 64.03 107.154 165.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 26.1 t -104.79 146.39 12.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 125.909 1.684 . . . . 74.41 108.794 175.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.83 160.61 43.77 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 126.211 1.805 . . . . 71.43 108.815 173.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.9 t -75.9 150.49 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 105.688 -1.967 . . . . 64.01 105.688 167.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 4.0 t70 . . . . . 0 C--O 1.248 1.005 0 C-N-CA 125.477 1.511 . . . . 74.13 109.854 171.022 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.141 0 N-CA-C 110.113 -1.195 . . . . 62.12 110.113 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.04 160.69 34.48 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 118.188 0.994 . . . . 65.13 109.963 170.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -68.98 -175.76 1.07 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.083 2.522 . . . . 61.1 110.968 164.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.48 161.31 42.37 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.269 1.027 . . . . 52.11 110.2 -170.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -102.64 -168.04 26.43 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.354 -1.098 . . . . 72.21 110.354 169.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.55 164.96 34.71 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.164 1.386 . . . . 74.22 108.163 166.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 12.2 t80 -156.6 162.73 39.86 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 118.315 0.507 . . . . 74.24 110.908 -176.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.1 67.82 0.03 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.859 1.218 . . . . 44.12 110.112 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.63 163.89 25.82 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.552 2.168 . . . . 72.52 111.341 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -71.6 78.38 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.302 3.335 . . . . 72.41 111.09 -177.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 p -145.58 167.79 22.2 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 126.403 1.881 . . . . 63.43 109.621 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.83 167.56 25.31 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 127.538 2.335 . . . . 71.52 105.269 169.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.5 mtp-105 -127.26 -75.95 0.57 Allowed 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 107.2 -1.407 . . . . 52.22 107.2 165.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.3 m -146.74 165.66 28.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 123.053 1.406 . . . . 70.13 111.156 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -62.34 15.26 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 131.138 3.775 . . . . 71.52 113.17 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.43 14.85 3.46 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 119.093 -2.254 . . . . 44.24 111.314 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -104.49 142.61 34.32 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.63 1.172 . . . . 52.13 111.3 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.503 HG23 ' HB ' ' A' ' 55' ' ' VAL . 31.1 m -131.7 169.41 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.095 1.358 . . . . 63.44 111.601 173.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.7 t -133.86 151.3 32.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 126.948 2.099 . . . . 73.43 106.008 177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 t -122.42 153.9 27.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 108.379 -0.971 . . . . 65.4 108.379 176.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.0 p -132.14 168.83 17.31 Favored 'General case' 0 CA--C 1.519 -0.23 0 O-C-N 121.286 -0.884 . . . . 54.1 109.04 168.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.69 -6.45 58.88 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.713 -1.049 . . . . 70.43 113.644 168.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.83 152.58 26.56 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 125.082 1.353 . . . . 74.53 113.892 -165.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.26 173.55 12.11 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.763 2.975 . . . . 64.11 111.788 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -63.45 -7.55 12.7 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.071 3.181 . . . . 73.23 115.329 168.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.29 68.16 1.23 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 121.25 1.841 . . . . 64.43 110.787 172.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -114.92 115.51 3.49 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 109.35 -1.5 . . . . 64.32 109.35 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.9 m -111.06 164.05 13.23 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.324 1.05 . . . . 54.23 109.83 -174.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -66.48 -25.26 66.62 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.171 -0.956 . . . . 74.43 112.097 -168.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -68.75 -52.08 34.43 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 108.729 -0.841 . . . . 73.44 108.729 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -58.56 -41.32 85.36 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 108.772 -0.825 . . . . 73.25 108.772 175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.95 -60.75 2.94 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-O 117.707 -1.139 . . . . 73.53 110.264 174.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -65.86 -32.83 74.58 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 120.904 1.683 . . . . 72.54 111.758 -176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -63.31 -30.02 71.24 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.458 1.103 . . . . 74.13 111.351 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -92.34 -48.56 6.6 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.774 0.43 . . . . 72.15 110.803 176.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.4 ttt -72.25 30.64 0.06 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.454 2.302 . . . . 65.13 112.843 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -108.92 -10.07 15.09 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 120.125 -1.609 . . . . 74.14 112.091 172.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -72.3 -9.75 58.89 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 120.269 -1.52 . . . . 64.44 113.828 -176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -101.03 8.34 43.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.335 1.054 . . . . 71.52 113.048 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.44 -127.25 3.28 Favored Glycine 0 C--N 1.334 0.435 0 N-CA-C 109.334 -1.507 . . . . 71.44 109.334 -175.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -142.02 131.82 24.26 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 117.247 0.523 . . . . 70.32 109.92 -169.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.461 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -127.57 138.76 53.83 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 C-N-CA 126.095 1.758 . . . . 62.41 112.37 -175.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 11.1 t -112.51 -35.57 5.51 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.929 -1.032 . . . . 73.31 111.46 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -109.55 136.35 49.07 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 119.499 1.045 . . . . 73.33 108.887 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.69 143.88 31.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.256 -1.387 . . . . 13.42 107.256 166.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -158.6 129.44 6.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.482 -1.303 . . . . 43.34 107.482 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.5 m -134.82 163.02 37.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 O-C-N 120.798 -1.189 . . . . 74.14 109.286 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -149.38 169.23 21.32 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 121.437 0.637 . . . . 70.13 110.151 177.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -74.61 48.8 0.37 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.869 2.468 . . . . 72.31 113.059 -170.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -138.56 15.78 2.73 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.851 -1.155 . . . . 63.23 112.283 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.55 20.46 66.3 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 120.761 -1.212 . . . . 45.34 113.016 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.7 p -138.45 177.43 7.89 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 119.036 1.418 . . . . 54.34 111.963 -169.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -166.6 168.53 40.16 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 124.817 1.198 . . . . 72.33 111.007 167.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.5 p -133.97 139.38 48.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.497 1.519 . . . . 72.32 108.115 177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.503 ' HB ' HG23 ' A' ' 18' ' ' VAL . 55.2 t -146.41 148.36 17.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 107.78 -1.192 . . . . 72.33 107.78 -161.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -137.37 109.5 7.26 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 122.686 1.232 . . . . 65.24 108.979 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.461 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 3.6 m-30 -69.19 -179.52 1.6 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.952 1.701 . . . . 64.21 109.666 171.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.1 t -80.92 -50.55 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 O-C-N 121.238 -0.914 . . . . 72.55 110.068 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.9 ttm180 -142.6 159.07 42.95 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 119.281 0.946 . . . . 73.33 111.447 -169.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.4 tttt -59.31 -30.91 68.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 118.211 -0.9 . . . . 74.21 111.458 -173.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -68.6 -29.65 68.22 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.886 1.221 . . . . 70.31 112.296 -174.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -85.12 -40.83 16.31 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.725 0.81 . . . . 73.41 108.907 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.3 tmm? -52.79 -51.94 58.74 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.769 -0.582 . . . . 70.41 110.626 171.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.6 m -48.64 -46.55 40.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.475 1.51 . . . . 45.44 110.728 171.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -59.46 -40.32 86.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.223 0.609 . . . . 70.53 110.221 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.53 -39.01 78.95 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.054 0.843 . . . . 44.43 111.677 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.79 -27.76 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.812 0.733 . . . . 65.4 109.897 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.1 ptt85 -106.39 -9.1 16.87 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 114.101 1.148 . . . . 74.23 114.101 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt -133.78 -1.74 3.03 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 117.673 -1.156 . . . . 72.33 113.195 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.439 HD13 HG21 ' A' ' 73' ' ' THR . 0.1 OUTLIER -144.89 17.81 1.61 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 120.067 1.303 . . . . 72.31 111.97 -165.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -93.48 153.1 18.65 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 120.705 1.593 . . . . 62.42 114.432 173.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 52.68 33.09 13.1 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 128.488 2.715 . . . . 63.33 114.494 -173.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.439 HG21 HD13 ' A' ' 70' ' ' LEU . 75.2 p -82.38 172.78 12.69 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.4 -0.813 . . . . 74.22 110.748 -177.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.74 171.23 15.41 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.66 1.184 . . . . 74.54 109.356 168.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -144.87 122.63 11.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.746 2.018 . . . . 70.14 109.489 167.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 68.5 mtt180 -69.64 122.22 18.68 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 125.814 1.646 . . . . 54.33 109.436 170.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 57.0 p -87.45 172.87 9.48 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.752 0.705 . . . . 64.31 109.565 169.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -73.28 -9.87 59.16 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.336 -0.393 . . . . 71.25 111.919 165.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.62 23.33 10.54 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.539 1.536 . . . . 74.3 112.78 -164.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.43 4.5 38.27 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 123.344 0.497 . . . . 72.54 113.313 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -119.71 165.87 13.95 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.302 1.441 . . . . 64.12 108.752 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.2 p -140.77 142.05 34.76 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 106.561 -1.644 . . . . 51.02 106.561 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -124.09 169.08 12.04 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 125.915 1.686 . . . . 53.41 107.392 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -93.25 158.0 15.97 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.65 1.114 . . . . 71.21 109.256 174.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 11.8 pt -126.89 168.92 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.677 0.791 . . . . 74.5 110.644 173.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.4 mmt180 -129.28 120.32 25.48 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 105.162 -2.162 . . . . 71.41 105.162 163.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 88.5 t -67.66 149.18 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 107.575 -1.269 . . . . 74.43 107.575 162.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -144.28 165.72 27.08 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 123.872 0.869 . . . . 71.32 109.93 156.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.5 t -73.36 149.82 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 106.728 -1.582 . . . . 52.11 106.728 166.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.0 t0 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 124.785 1.234 . . . . 72.54 108.399 167.543 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.661 0 N-CA-C 111.777 -0.529 . . . . 62.24 111.777 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.25 161.96 50.24 Favored Pre-proline 0 C--O 1.239 0.501 0 C-N-CA 126.321 1.848 . . . . 43.33 107.871 176.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.91 -57.05 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 120.648 1.267 . . . . 74.31 111.493 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 175.42 173.66 0.27 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 107.941 -1.133 . . . . 63.31 107.941 -157.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.2 -163.3 5.33 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 125.889 1.709 . . . . 73.04 112.022 176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.62 169.51 24.14 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 125.505 1.522 . . . . 64.04 108.239 158.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -157.32 120.83 4.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 104.913 -2.254 . . . . 74.32 104.913 168.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.5 -170.05 24.07 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-O 118.453 -1.193 . . . . 72.32 111.909 -176.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -64.12 175.54 3.14 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 123.65 2.9 . . . . 74.32 113.105 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -55.66 -164.55 0.01 OUTLIER 'Trans proline' 0 CA--C 1.555 1.566 0 CA-C-O 124.726 1.886 . . . . 64.24 112.4 146.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 174.89 144.81 0.06 Allowed 'General case' 0 C--N 1.318 -0.766 1 C-N-CA 132.565 4.346 . . . . 45.13 108.499 -168.127 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.474 ' H ' ' HD3' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -78.95 178.02 8.32 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.548 1.139 . . . . 71.12 110.646 168.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -128.2 -83.2 0.59 Allowed 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 118.774 -0.632 . . . . 75.03 109.687 162.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.3 m -152.39 173.25 15.32 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.812 1.645 . . . . 72.15 108.144 -169.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -80.74 33.87 0.33 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.439 1.895 . . . . 74.24 112.039 -170.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.38 29.08 3.33 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 120.158 -1.589 . . . . 55.45 108.948 175.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.77 145.2 44.67 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 120.746 -1.221 . . . . 64.21 109.77 -167.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.455 ' CG1' ' HG2' ' A' ' 63' ' ' MET . 18.3 m -141.18 175.37 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 123.554 0.741 . . . . 74.45 110.326 -173.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.1 t -135.08 155.48 37.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 107.674 -1.232 . . . . 74.25 107.674 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 89.9 t -114.7 140.44 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 125.903 1.681 . . . . 70.35 106.528 170.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.8 p -135.58 165.03 26.47 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.874 -0.787 . . . . 64.02 108.874 170.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.58 7.04 72.5 Favored Glycine 0 CA--C 1.527 0.791 0 CA-C-O 119.616 -0.547 . . . . 71.22 113.04 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.9 mt -63.85 156.52 72.66 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 119.136 1.468 . . . . 73.01 111.189 -175.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.99 170.46 19.75 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 124.049 3.166 . . . . 65.24 110.534 174.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.28 -5.11 16.26 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.04 2.493 . . . . 72.32 114.932 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.53 34.78 4.75 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 119.886 1.221 . . . . 72.14 111.398 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.9 146.66 21.44 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.265 -1.134 . . . . 74.31 110.265 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 t -137.75 168.08 20.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.61 1.195 . . . . 64.33 113.428 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 51.7 p-90 -67.19 -26.1 66.46 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.989 1.716 . . . . 74.03 111.455 -178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.94 -61.82 2.35 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.6 -1.259 . . . . 73.31 107.6 175.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -63.73 -35.46 80.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 124.1 0.875 . . . . 64.0 109.72 -176.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -54.38 46.95 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.48 0.582 . . . . 75.1 109.834 175.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -67.57 -27.51 67.0 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 111.563 0.208 . . . . 75.24 111.563 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -78.01 -20.53 52.37 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.729 -0.607 . . . . 75.02 112.069 176.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 -88.33 -60.6 1.92 Allowed 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.628 1.571 . . . . 73.3 111.171 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -69.44 -13.4 62.34 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 114.372 1.249 . . . . 60.35 114.372 -160.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.44 -8.9 0.06 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.848 2.859 . . . . 71.32 113.757 170.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.415 ' HB3' HD23 ' A' ' 70' ' ' LEU . 18.3 tt0 -58.75 -30.55 67.6 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 119.489 1.04 . . . . 73.41 112.256 173.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.35 0.94 57.44 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 114.28 1.215 . . . . 64.35 114.28 -170.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.71 -104.21 0.33 Allowed Glycine 0 C--N 1.336 0.539 0 N-CA-C 108.855 -1.698 . . . . 54.14 108.855 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -147.03 152.31 38.36 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.661 0.73 . . . . 74.24 109.451 173.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 45.2 t -141.74 120.36 9.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 127.245 2.218 . . . . 64.41 106.273 -165.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -102.43 -44.43 5.37 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.96 0.8 . . . . 72.41 110.926 -175.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -73.22 160.26 32.2 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.596 0.759 . . . . 73.34 110.607 174.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -158.94 128.35 5.56 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.269 0.94 . . . . 75.02 112.105 166.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -158.17 127.02 5.58 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 124.342 1.057 . . . . 52.42 111.309 -173.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.8 t -143.81 158.89 16.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 106.467 -1.679 . . . . 63.13 106.467 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -138.51 171.01 14.99 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 123.735 0.814 . . . . 63.21 109.908 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -75.32 68.66 2.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.707 1.603 . . . . 63.23 108.245 179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -148.61 174.03 12.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.978 2.911 . . . . 71.41 106.354 166.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.07 22.81 0.45 Allowed Glycine 0 CA--C 1.537 1.458 0 CA-C-O 117.379 -1.789 . . . . 74.44 114.597 165.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.3 p -133.46 158.08 43.97 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 121.01 2.405 . . . . 74.42 112.504 177.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.41 151.95 23.69 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 105.676 -2.97 . . . . 54.35 105.676 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -105.09 148.97 8.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 105.705 -1.961 . . . . 72.45 105.705 168.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.422 ' HB ' HG23 ' A' ' 18' ' ' VAL . 12.9 t -137.47 160.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.112 -1.44 . . . . 62.22 107.112 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -140.99 149.92 42.4 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 105.826 -1.916 . . . . 74.22 105.826 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -122.3 176.77 5.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.251 1.82 . . . . 74.12 108.573 -168.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.6 m -82.7 -39.21 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 115.314 -0.857 . . . . 64.01 111.36 -174.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -151.88 163.99 38.05 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 118.744 0.702 . . . . 71.03 110.1 -176.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 19.8 tttm -68.97 -27.41 65.69 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 117.773 -1.108 . . . . 60.25 110.944 -175.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -58.68 -51.84 68.25 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.941 1.246 . . . . 75.13 109.39 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.31 -47.83 75.19 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 126.541 1.936 . . . . 74.43 109.012 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.455 ' HG2' ' CG1' ' A' ' 18' ' ' VAL . 12.0 tmm? -54.54 -58.47 7.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.453 0.701 . . . . 64.12 112.061 176.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 92.4 m -55.3 -44.93 76.22 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 118.013 -0.994 . . . . 73.34 110.31 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -60.1 -32.83 71.35 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 119.245 0.929 . . . . 73.43 111.211 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 70' ' ' LEU . . . -58.35 -41.64 85.12 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.813 0.845 . . . . 72.34 110.739 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.6 t -64.04 -18.77 23.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 O-C-N 121.008 -1.058 . . . . 70.33 109.842 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -108.08 -16.16 14.34 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.807 1.643 . . . . 71.12 114.129 -173.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 mmtm -144.72 12.94 1.49 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.034 1.124 . . . . 74.12 114.034 -174.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.429 HD12 ' HB1' ' A' ' 66' ' ' ALA . 1.6 tm? -149.69 -1.66 0.44 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 119.874 1.216 . . . . 73.45 112.735 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.473 ' CB ' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.86 156.23 19.95 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 119.134 -2.229 . . . . 65.2 112.884 172.368 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.4 t30 57.82 58.19 3.79 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.109 1.764 . . . . 73.13 109.98 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.6 p -128.7 168.24 16.09 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 124.39 1.076 . . . . 74.12 110.436 -172.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -80.43 161.56 24.87 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.731 -0.605 . . . . 73.22 111.521 -175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -146.89 127.17 13.89 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.231 1.413 . . . . 75.14 111.457 171.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -78.75 125.39 29.3 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.192 2.197 . . . . 73.1 111.203 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.2 t -94.79 169.75 9.93 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.062 0.945 . . . . 74.23 109.442 172.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -65.36 -30.37 71.19 Favored 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 123.898 0.879 . . . . 73.4 112.498 173.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -77.64 9.7 3.21 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.762 0.825 . . . . 63.11 112.104 -173.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.17 4.93 57.74 Favored Glycine 0 C--N 1.337 0.611 0 O-C-N 120.866 -1.146 . . . . 73.31 113.577 -175.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 81' ' ' GLU . 23.3 pt-20 -88.04 172.22 9.71 Favored 'General case' 0 N--CA 1.437 -1.119 0 C-N-CA 124.709 1.204 . . . . 50.54 109.107 172.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.2 p -142.06 160.37 40.37 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.207 -1.405 . . . . 53.44 107.207 172.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.32 -177.44 4.24 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.644 -0.873 . . . . 41.2 108.644 170.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -108.88 148.75 30.17 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.046 -1.094 . . . . 71.11 108.046 165.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.6 pt -134.15 162.36 39.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 122.208 1.004 . . . . 70.42 111.331 -171.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 -136.29 109.34 7.7 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.978 1.711 . . . . 54.21 107.509 -162.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.473 HG12 ' CB ' ' A' ' 71' ' ' ASP . 2.3 p -77.69 156.21 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 124.834 1.334 . . . . 71.21 108.815 178.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.4 ptpt -152.16 161.66 42.29 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 107.567 -1.271 . . . . 74.14 107.567 160.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.0 t -72.0 141.49 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.826 -1.916 . . . . 65.31 105.826 168.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 59.2 t0 . . . . . 0 C--O 1.256 1.445 0 N-CA-C 107.465 -1.309 . . . . 73.44 107.465 168.144 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.757 0 N-CA-C 108.647 -1.781 . . . . 73.25 108.647 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.22 155.03 28.52 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 108.402 -0.962 . . . . 64.34 108.402 162.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -75.17 163.6 34.65 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.937 2.424 . . . . 71.12 111.434 175.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -145.12 133.11 21.34 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.126 0.97 . . . . 74.45 108.823 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.29 -135.3 20.86 Favored Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 108.954 -1.659 . . . . 62.31 108.954 -172.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.51 -178.93 5.28 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.291 1.436 . . . . 74.41 109.306 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -115.22 155.89 26.36 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.223 1.009 . . . . 75.44 108.662 167.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.75 -179.53 5.03 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.928 1.393 . . . . 61.12 113.39 171.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.33 157.53 49.6 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.162 1.908 . . . . 62.23 110.185 163.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.54 66.82 6.46 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.855 3.037 . . . . 75.0 109.398 164.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.0 m -85.88 157.19 20.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.268 -1.012 . . . . 71.11 108.268 166.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -139.51 165.55 26.95 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.425 0.69 . . . . 64.0 110.346 -172.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.67 -67.26 0.8 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.671 0.788 . . . . 73.42 110.78 -167.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.9 m -156.55 167.99 28.76 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 126.554 1.941 . . . . 51.51 108.539 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -75.44 21.07 0.14 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.29 1.436 . . . . 71.03 112.966 -173.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.69 17.94 3.08 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.316 -1.49 . . . . 64.33 110.853 178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.03 124.9 50.33 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.414 1.086 . . . . 74.12 112.273 -174.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.609 HG13 ' HG2' ' A' ' 63' ' ' MET . 4.4 m -129.48 162.31 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.661 1.585 . . . . 63.1 109.592 171.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.1 m -131.28 171.09 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 125.782 1.633 . . . . 61.2 109.708 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.6 t -129.17 148.8 33.28 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 124.524 1.129 . . . . 62.32 108.102 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.92 164.96 25.78 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.53 1.932 . . . . 61.33 107.676 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.25 -2.12 47.05 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 124.892 1.234 . . . . 72.35 113.676 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.58 147.73 98.68 Favored Pre-proline 0 C--O 1.239 0.504 0 CA-C-N 118.758 1.279 . . . . 44.31 111.666 -161.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.2 169.13 22.26 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.481 2.788 . . . . 75.41 110.24 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.63 -4.27 11.8 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.707 2.938 . . . . 64.35 114.173 174.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.29 41.7 3.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.081 1.353 . . . . 74.31 108.777 -174.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.44 106.36 1.31 Allowed Glycine 0 C--N 1.336 0.541 0 C-N-CA 125.756 1.646 . . . . 61.12 110.567 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.1 m -103.35 174.26 5.94 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 118.754 1.277 . . . . 73.13 111.683 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -67.33 -18.94 65.37 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.502 1.121 . . . . 74.32 112.688 -170.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -74.77 -53.82 8.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.346 -0.983 . . . . 70.21 108.346 -179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -58.09 -37.33 74.28 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.269 0.627 . . . . 64.25 110.187 173.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.36 -56.76 17.63 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 123.92 0.888 . . . . 72.02 110.257 173.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.8 ttpt -61.19 -37.8 84.23 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 119.692 1.133 . . . . 73.25 110.069 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.39 -8.29 56.29 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.035 0.934 . . . . 71.23 113.225 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.536 ' CE1' ' H ' ' A' ' 76' ' ' ARG . 0.4 OUTLIER -92.36 -54.49 3.78 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.764 1.226 . . . . 74.44 110.763 163.724 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.2 ttt -80.02 77.85 6.69 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.988 1.315 . . . . 72.32 108.656 -169.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.77 -21.47 0.46 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.293 1.437 . . . . 72.44 112.386 176.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.4 -14.09 61.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.064 0.946 . . . . 74.01 113.304 -172.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.13 -27.8 35.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 123.201 0.6 . . . . 71.04 112.414 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.35 -170.88 17.26 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.19 -0.764 . . . . 65.32 111.19 -154.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.76 127.94 33.92 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 113.183 0.809 . . . . 62.42 113.183 -146.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.548 HG22 ' CE1' ' A' ' 57' ' ' PHE . 24.5 t -119.33 130.45 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 C-N-CA 125.278 1.431 . . . . 63.13 108.446 -178.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 5.2 t -130.63 11.59 5.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.126 0.97 . . . . 65.1 111.243 -171.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -152.99 139.63 18.83 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 127.076 2.15 . . . . 71.43 107.239 173.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -139.73 147.78 41.37 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.839 0.856 . . . . 72.15 109.471 163.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -162.16 142.38 10.07 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 126.946 2.098 . . . . 73.02 109.194 173.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.5 m -142.41 -172.35 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 C-N-CA 125.849 1.66 . . . . 70.42 107.089 173.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -150.54 156.2 40.93 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.788 -1.56 . . . . 71.01 106.788 171.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . 0.318 0.3 OUTLIER 41.45 -85.75 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 129.142 2.977 . . . . 63.45 112.654 152.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.94 174.73 14.52 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.181 0.991 . . . . 73.05 112.589 169.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.39 -41.33 3.06 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 125.677 1.608 . . . . 35.11 113.672 159.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -145.25 169.68 17.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.419 1.61 . . . . 72.41 110.285 -177.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.55 167.98 35.9 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.578 1.561 . . . . 64.13 109.46 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.77 119.85 4.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 118.399 1.1 . . . . 73.15 110.303 -168.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.9 t -113.27 174.23 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.619 -0.882 . . . . 63.44 108.619 -166.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.39 125.99 11.0 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 120.609 1.55 . . . . 73.34 108.774 164.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.548 ' CE1' HG22 ' A' ' 42' ' ' VAL . 3.2 m-85 -99.48 177.5 5.15 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 126.251 1.82 . . . . 65.3 108.874 -175.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.4 -64.84 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 O-C-N 122.14 -0.35 . . . . 73.34 110.206 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -133.49 168.53 18.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.358 0.599 . . . . 65.13 111.637 -169.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -54.18 -33.56 58.39 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 114.353 -1.294 . . . . 71.22 110.706 176.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -54.16 -64.12 0.93 Allowed 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.76 0.824 . . . . 65.11 110.265 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -68.64 -41.45 79.37 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.594 1.558 . . . . 73.12 109.387 -173.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.609 ' HG2' HG13 ' A' ' 18' ' ' VAL . 16.6 tmm? -53.47 -50.59 65.01 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.599 1.159 . . . . 73.33 111.198 174.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -66.42 -45.55 79.5 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.156 0.583 . . . . 54.53 110.602 176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -56.7 -38.62 72.53 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.805 0.729 . . . . 74.42 110.134 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.62 -39.89 74.43 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 118.643 -0.694 . . . . 63.3 112.053 175.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.11 -26.3 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 120.102 1.319 . . . . 61.43 109.587 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -105.53 4.38 30.4 Favored 'General case' 0 C--N 1.343 0.305 0 N-CA-C 114.779 1.4 . . . . 63.42 114.779 -176.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -148.4 -9.71 0.37 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.423 1.268 . . . . 72.32 114.423 -179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.5 ' O ' HD13 ' A' ' 70' ' ' LEU . 1.8 tm? -130.71 11.88 5.26 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 120.684 -1.26 . . . . 75.2 109.928 -167.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.426 ' HB2' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -96.53 159.98 14.64 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 120.679 -1.263 . . . . 74.3 113.723 -177.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 16.5 t30 60.58 14.4 4.9 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.854 1.662 . . . . 75.03 113.61 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 36.3 p -76.68 174.99 9.77 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 126.261 1.824 . . . . 53.14 112.298 -169.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -67.39 171.0 6.48 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.235 1.014 . . . . 63.41 110.798 167.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -145.3 124.35 12.82 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 125.759 1.624 . . . . 75.44 112.015 164.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.536 ' H ' ' CE1' ' A' ' 35' ' ' HIS . 7.3 ptp180 -72.08 126.32 29.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.486 1.115 . . . . 75.01 109.484 172.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.0 p -98.86 177.75 5.17 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.978 0.894 . . . . 71.35 110.303 175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -76.17 -19.94 57.99 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 121.811 -0.556 . . . . 73.24 110.723 167.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -84.79 16.34 3.37 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 119.878 1.217 . . . . 64.01 113.429 -169.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 71.08 21.51 78.38 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 111.214 -0.754 . . . . 72.32 111.214 176.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.29 -175.01 3.91 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.176 1.79 . . . . 63.25 108.224 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.1 p -143.86 148.61 35.73 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.34 -0.615 . . . . 52.34 109.34 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -110.31 -163.69 0.87 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.407 1.083 . . . . 63.03 109.13 167.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -121.24 164.47 16.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.482 1.113 . . . . 74.15 108.681 164.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 pt -136.94 165.38 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.944 1.297 . . . . 73.14 110.547 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -132.29 128.62 38.17 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.625 1.97 . . . . 74.15 106.56 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 71' ' ' ASP . 1.3 p -94.68 150.72 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 119.831 1.196 . . . . 33.41 108.593 177.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.23 164.61 34.3 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.83 1.196 . . . . 75.43 110.067 160.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.534 ' HA ' HG12 ' A' ' 18' ' ' VAL . 30.7 t -61.58 136.13 25.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 105.277 -2.12 . . . . 75.24 105.277 163.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 56.8 t0 . . . . . 0 C--O 1.26 1.615 0 N-CA-C 107.165 -1.421 . . . . 74.24 107.165 175.708 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.573 0 N-CA-C 108.256 -1.938 . . . . 70.03 108.256 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.58 165.76 18.01 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.712 1.205 . . . . 74.03 109.705 -169.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -71.43 -174.9 1.36 Allowed 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.988 2.459 . . . . 71.44 111.946 172.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.07 160.56 39.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.009 2.124 . . . . 73.33 107.195 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.79 -174.67 47.22 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.946 -0.861 . . . . 71.21 110.946 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -159.03 153.24 23.77 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 127.776 2.43 . . . . 65.25 107.205 -176.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -156.71 171.34 20.53 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.51 1.05 . . . . 53.35 110.545 -176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.83 85.08 0.07 OUTLIER Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.248 0.927 . . . . 72.31 111.88 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.2 164.25 35.83 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 122.523 2.148 . . . . 75.35 111.025 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -79.21 73.91 5.8 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.852 2.368 . . . . 61.55 111.556 -173.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.9 m -152.21 160.57 43.35 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 119.962 -1.711 . . . . 64.25 110.466 171.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.85 171.0 14.98 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 128.348 2.659 . . . . 64.35 108.694 173.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -132.97 -74.67 0.49 Allowed 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.209 1.003 . . . . 72.53 108.32 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.1 m -145.38 -175.59 4.77 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.362 1.865 . . . . 72.34 107.459 166.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 5.1 pt-20 -78.8 22.04 0.39 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.269 1.828 . . . . 64.55 113.088 176.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -127.64 50.82 1.99 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 120.286 -1.509 . . . . 74.33 107.046 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -130.06 137.49 50.25 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.667 1.587 . . . . 74.11 109.772 -176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.633 HG23 ' HB ' ' A' ' 55' ' ' VAL . 4.2 m -136.04 169.95 19.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 C-N-CA 124.793 1.237 . . . . 73.54 110.952 -176.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.6 t -132.8 144.3 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 125.891 1.676 . . . . 60.44 106.879 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.6 t -117.69 146.07 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 106.613 -1.625 . . . . 72.31 106.613 171.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.2 m -137.42 160.68 38.41 Favored 'General case' 0 CA--C 1.518 -0.254 0 O-C-N 121.114 -0.991 . . . . 64.21 109.193 -177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.47 12.96 84.04 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.427 -0.652 . . . . 64.14 113.491 176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 mt -59.27 144.63 83.16 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 117.643 0.722 . . . . 72.41 109.694 -178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.432 ' HB2' ' HD2' ' A' ' 25' ' ' PRO . 51.2 Cg_endo -73.57 171.94 16.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.387 2.058 . . . . 73.33 108.907 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 24' ' ' PRO . 35.5 Cg_endo -67.12 -15.85 47.51 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 CA-C-N 119.923 1.008 . . . . 42.54 112.822 -168.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.64 21.02 13.23 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.404 1.482 . . . . 53.44 111.643 -170.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.47 99.5 1.93 Allowed Glycine 0 C--N 1.338 0.683 0 C-N-CA 125.207 1.384 . . . . 72.24 111.688 176.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -94.87 179.57 5.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.644 1.577 . . . . 62.31 111.599 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.9 p-90 -62.26 -33.65 75.02 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.511 1.124 . . . . 74.21 112.397 -175.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.29 -46.64 63.9 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.885 -0.783 . . . . 75.14 108.885 -173.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.71 -33.16 75.31 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 118.718 -0.658 . . . . 74.04 109.764 173.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.18 -53.51 56.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 119.481 1.037 . . . . 73.32 109.39 174.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -63.45 -39.4 94.38 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.344 1.058 . . . . 74.4 110.36 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.19 -12.24 60.25 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.921 1.082 . . . . 64.31 113.921 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -99.95 -59.27 1.74 Allowed 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.149 1.78 . . . . 72.31 112.78 175.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.522 ' HE2' ' CE1' ' A' ' 57' ' ' PHE . 11.5 ttt -72.83 37.91 0.08 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.777 2.431 . . . . 63.42 110.579 -171.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -107.38 -9.75 15.93 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 119.087 -2.258 . . . . 74.32 111.006 -174.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -79.06 -27.96 43.11 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.091 -1.005 . . . . 64.34 111.997 -163.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -83.42 -10.97 58.08 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.028 1.331 . . . . 44.2 112.224 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 139.48 173.69 13.25 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 109.495 -1.442 . . . . 51.23 109.495 -165.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -97.25 153.86 17.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.2 1.0 . . . . 74.3 111.508 -160.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.457 HG22 ' CE1' ' A' ' 57' ' ' PHE . 64.9 t -125.49 147.76 30.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 125.408 1.483 . . . . 72.53 107.831 -166.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.8 t -111.41 -53.29 2.72 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.418 -0.956 . . . . 71.2 108.418 177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.5 t80 -86.45 150.01 24.58 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.505 0.722 . . . . 75.34 110.155 -175.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.72 125.72 15.35 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.641 -0.874 . . . . 64.41 108.641 168.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -156.55 124.44 5.56 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.864 0.84 . . . . 71.14 110.599 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.28 156.95 30.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 104.886 -2.264 . . . . 74.21 104.886 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -124.64 162.83 23.29 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 127.126 2.17 . . . . 73.13 107.618 170.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 12.9 mtt-85 43.55 -86.6 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.709 0 C-N-CA 130.768 3.627 . . . . 70.14 112.612 153.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -170.91 168.87 6.96 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 127.206 2.202 . . . . 71.45 110.625 172.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.85 -15.39 32.08 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.757 1.17 . . . . 52.34 115.432 156.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.77 168.52 22.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 120.022 1.911 . . . . 72.25 108.492 164.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.2 167.66 35.6 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 108.878 -1.689 . . . . 75.32 108.878 174.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.12 144.09 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 108.083 -1.08 . . . . 71.45 108.083 -175.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.633 ' HB ' HG23 ' A' ' 18' ' ' VAL . 38.3 t -146.62 157.53 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 106.706 -1.59 . . . . 61.21 106.706 -163.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -143.46 129.51 19.63 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.165 -1.05 . . . . 54.13 108.165 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.522 ' CE1' ' HE2' ' A' ' 36' ' ' MET . 3.6 m-85 -100.54 170.19 8.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.869 1.668 . . . . 75.34 109.257 -175.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.0 m -75.85 -31.15 21.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.001 -0.545 . . . . 71.2 112.315 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 43.2 ttt85 -154.9 155.74 34.85 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.664 -0.495 . . . . 60.51 109.664 -172.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.445 ' HE2' ' CE ' ' A' ' 63' ' ' MET . 14.6 ttmt -63.18 -26.46 68.81 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 117.723 -1.132 . . . . 73.51 110.931 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -66.0 -55.59 15.94 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 120.487 1.494 . . . . 74.23 109.285 -177.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.15 -47.75 77.61 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.798 1.239 . . . . 72.21 109.525 175.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.445 ' CE ' ' HE2' ' A' ' 60' ' ' LYS . 59.7 ttp -54.04 -53.29 55.13 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.162 0.585 . . . . 61.32 112.047 176.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 88.7 m -54.33 -48.32 71.52 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.508 1.123 . . . . 64.13 109.102 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.534 ' CZ ' ' HE3' ' A' ' 69' ' ' LYS . 16.4 t80 -53.59 -38.98 64.47 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.315 1.046 . . . . 75.22 111.641 -175.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.04 -33.04 75.09 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.75 0.82 . . . . 72.32 110.832 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.4 t -70.09 -14.15 17.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 O-C-N 120.532 -1.355 . . . . 72.31 110.813 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -108.41 -37.73 5.89 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.04 -1.037 . . . . 72.32 111.469 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.534 ' HE3' ' CZ ' ' A' ' 65' ' ' TYR . 3.6 mptp? -108.87 -16.9 14.06 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 124.278 1.031 . . . . 71.04 111.743 -176.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.9 7.53 8.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 118.24 -0.886 . . . . 74.44 111.17 -164.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.26 153.72 19.38 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 121.088 1.767 . . . . 64.44 111.164 178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.0 t30 57.5 40.29 27.23 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.953 1.701 . . . . 70.1 111.591 -171.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 11.4 p -103.39 -179.22 3.89 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.883 2.073 . . . . 71.02 111.287 -169.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.13 158.63 15.38 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 119.436 1.016 . . . . 61.44 110.305 171.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -137.26 146.22 44.48 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 125.588 1.555 . . . . 61.34 110.417 167.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -112.95 118.0 33.64 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.545 1.538 . . . . 75.03 110.908 -173.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 m -78.3 156.5 29.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 119.079 0.854 . . . . 62.01 109.3 167.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.0 p-80 -62.61 -13.14 28.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.36 0.874 . . . . 75.3 113.36 168.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.87 12.23 0.72 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.944 1.697 . . . . 64.11 112.104 172.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.85 26.33 74.67 Favored Glycine 0 C--N 1.339 0.709 0 O-C-N 121.118 -0.989 . . . . 65.32 111.258 170.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -139.14 160.97 38.55 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 125.808 1.643 . . . . 61.43 108.684 -175.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.8 p -145.84 149.81 34.98 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.154 -1.054 . . . . 74.03 108.154 -168.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -129.55 169.17 15.34 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.973 -1.121 . . . . 65.43 107.973 166.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 9.1 p90 -82.81 151.81 25.93 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.984 -1.117 . . . . 64.24 107.984 168.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.7 pt -125.16 166.27 21.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.418 1.487 . . . . 75.14 109.093 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 -123.75 144.07 49.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.373 -2.084 . . . . 71.35 105.373 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 96.8 t -127.88 124.26 62.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 106.758 -1.571 . . . . 55.53 106.758 -172.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.38 153.33 51.69 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 124.446 1.098 . . . . 73.23 108.261 -170.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.423 ' HA ' HG12 ' A' ' 18' ' ' VAL . 12.1 t -71.34 153.18 8.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 N-CA-C 106.08 -1.822 . . . . 54.45 106.08 162.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.881 1.272 . . . . 61.51 111.295 170.884 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.068 0 N-CA-C 109.908 -1.277 . . . . 72.14 109.908 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.66 156.53 24.94 Favored Pre-proline 0 C--O 1.24 0.554 0 CA-C-N 118.608 1.204 . . . . 73.25 109.069 172.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.84 -56.93 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.913 1.742 . . . . 71.04 110.55 168.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 ttp85 178.85 150.12 0.26 Allowed 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 119.987 1.267 . . . . 75.12 111.391 -168.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -116.82 150.17 18.6 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.044 1.307 . . . . 65.34 110.992 166.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.3 tpp85 -168.18 109.11 0.55 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.826 2.05 . . . . 70.42 107.934 169.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.447 ' CE1' ' HD3' ' A' ' 9' ' ' PRO . 9.8 t80 -164.73 -179.5 5.91 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.875 2.07 . . . . 63.33 106.557 168.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.21 85.62 0.73 Allowed Glycine 0 C--N 1.345 1.036 0 CA-C-O 118.138 -1.368 . . . . 65.24 113.206 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HD3' ' CE1' ' A' ' 7' ' ' TYR . 97.7 Cg_endo -74.99 154.39 42.52 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 CA-C-N 121.215 2.507 . . . . 65.11 110.003 173.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.89 64.01 8.18 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.63 2.886 . . . . 64.2 111.149 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.0 m -125.37 108.86 12.1 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 128.176 2.59 . . . . 34.33 106.08 -173.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 10.5 mtp180 -90.83 172.34 8.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.474 1.11 . . . . 74.23 110.768 177.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -125.69 -80.67 0.62 Allowed 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 108.191 -1.04 . . . . 72.0 108.191 166.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -156.76 162.06 39.77 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 124.264 0.978 . . . . 53.52 109.051 -156.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -65.34 11.92 0.06 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.504 2.322 . . . . 52.53 114.802 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.72 26.7 7.07 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 119.729 -1.857 . . . . 71.34 109.199 -178.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 43.5 ttt85 -109.26 133.56 52.88 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.664 1.185 . . . . 71.23 109.107 -176.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.541 HG12 ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -129.32 168.81 21.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 C-N-CA 126.009 1.724 . . . . 73.34 109.533 -179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 40.3 t -137.92 154.3 28.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 125.934 1.694 . . . . 61.12 106.809 -178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.3 t -130.12 152.07 36.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 107.229 -1.397 . . . . 42.13 107.229 -178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.6 154.97 48.71 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.268 1.027 . . . . 73.12 108.733 -175.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.75 6.4 52.53 Favored Glycine 0 CA--C 1.522 0.526 0 CA-C-O 117.905 -1.497 . . . . 34.01 114.176 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -63.46 149.87 91.06 Favored Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 120.037 1.918 . . . . 62.22 112.412 -160.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -67.07 170.03 13.88 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.966 3.111 . . . . 75.13 111.022 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.29 -8.3 23.22 Favored 'Trans proline' 0 CA--C 1.536 0.625 0 C-N-CA 122.675 2.25 . . . . 62.13 113.833 -176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.35 52.05 1.27 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.345 1.458 . . . . 72.43 109.204 -176.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.03 130.6 10.24 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 108.626 -1.79 . . . . 65.22 108.626 177.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.8 m -116.42 163.62 15.77 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.811 0.845 . . . . 71.23 111.221 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 35.3 p-90 -66.37 -23.96 66.42 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.838 0.681 . . . . 73.23 112.838 -175.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -56.04 14.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.883 -0.784 . . . . 74.04 108.883 178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -60.17 -35.61 75.73 Favored 'General case' 0 N--CA 1.461 0.12 0 C-N-CA 123.847 0.859 . . . . 73.25 109.656 178.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.64 -58.36 8.12 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 117.28 -1.343 . . . . 71.15 110.014 174.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.3 ttpm? -68.67 -37.62 79.74 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 120.066 1.303 . . . . 73.24 110.763 -174.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.02 -24.78 64.77 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.562 1.545 . . . . 73.41 112.874 176.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -95.22 -46.64 6.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.636 0.374 . . . . 75.12 111.061 170.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.6 ttt -77.02 32.31 0.14 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.336 1.454 . . . . 75.12 113.086 -174.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.2 -5.28 14.22 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 121.03 1.741 . . . . 63.14 114.308 171.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -61.27 -31.16 70.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.099 1.318 . . . . 62.45 113.874 -173.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.26 -0.88 13.3 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.839 1.256 . . . . 73.33 114.33 -177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.87 -100.97 0.21 Allowed Glycine 0 C--N 1.335 0.489 0 N-CA-C 108.153 -1.979 . . . . 71.4 108.153 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -154.11 163.57 39.88 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.021 0.928 . . . . 72.3 108.999 176.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -149.77 135.93 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.518 2.327 . . . . 73.31 109.822 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 49.3 t -90.81 -56.17 3.29 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.846 -0.798 . . . . 74.33 108.846 -179.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -96.01 146.99 24.16 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.795 1.238 . . . . 73.31 109.588 -168.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.55 136.18 21.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.846 -1.168 . . . . 45.2 107.846 168.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -148.86 131.2 15.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.436 -0.95 . . . . 74.31 108.436 176.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 91.9 t -140.75 140.73 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.086 -2.19 . . . . 71.0 105.086 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -77.32 -164.08 0.44 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.985 1.714 . . . . 71.33 109.996 -177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.3 ptt180 -44.4 -50.94 9.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.464 -1.698 . . . . 72.41 112.078 158.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.4 p30 -179.67 -179.11 0.49 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.195 1.398 . . . . 61.15 112.391 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.3 -34.39 3.46 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 128.226 2.822 . . . . 42.53 114.407 166.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.26 -179.05 6.75 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 118.772 1.286 . . . . 63.03 108.529 -177.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.74 171.71 40.26 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 125.246 1.403 . . . . 63.3 109.67 169.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -141.75 135.11 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-O 121.738 0.78 . . . . 43.11 108.982 -173.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.3 t -141.52 145.13 25.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 108.405 -0.961 . . . . 73.32 108.405 -156.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -133.83 106.54 7.37 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.543 -1.651 . . . . 64.14 106.543 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.89 168.1 16.38 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 130.258 3.423 . . . . 71.4 109.876 -176.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -72.47 -42.3 64.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 121.305 -0.872 . . . . 73.12 111.573 -171.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -152.88 160.24 43.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.961 0.8 . . . . 61.2 109.462 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -63.96 -19.31 65.04 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.492 -1.242 . . . . 71.2 111.025 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -52.97 -65.95 0.47 Allowed 'General case' 0 C--N 1.345 0.407 0 C-N-CA 125.581 1.553 . . . . 62.43 108.684 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -75.33 -36.18 61.08 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 125.751 1.62 . . . . 73.3 108.836 -171.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.428 ' SD ' HG13 ' A' ' 18' ' ' VAL . 39.2 ttp -51.33 -52.27 46.87 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.881 -0.414 . . . . 74.13 109.881 169.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.7 m -68.42 -12.16 60.74 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.939 -1.101 . . . . 64.14 113.359 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -79.95 -35.57 37.48 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 122.539 2.427 . . . . 74.24 110.083 169.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.65 -35.39 80.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.094 0.958 . . . . 75.2 110.198 -173.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 t -61.73 -17.45 17.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.651 0.78 . . . . 73.0 111.163 175.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -120.24 -16.88 8.41 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.49 -1.381 . . . . 74.2 112.059 -163.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -132.35 -19.06 2.49 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.24 1.416 . . . . 64.23 113.807 -178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.23 11.99 16.38 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 120.081 1.31 . . . . 75.41 110.356 -168.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.48 161.44 13.78 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 119.893 1.224 . . . . 73.34 112.437 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.0 t30 56.96 17.86 3.59 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.523 3.129 . . . . 73.41 114.177 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.6 p -71.74 175.15 5.95 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.817 2.847 . . . . 71.12 112.731 -172.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.48 169.69 15.23 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 125.709 1.604 . . . . 71.13 109.656 171.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -150.58 135.16 17.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.972 1.709 . . . . 71.24 109.46 170.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -82.69 119.14 23.92 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 118.652 0.66 . . . . 72.25 109.977 176.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.7 t -81.05 154.57 26.78 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.3 -1.0 . . . . 74.32 108.3 165.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -62.45 -16.68 56.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 118.892 -0.575 . . . . 63.01 111.644 164.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.58 17.41 0.11 Allowed 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.248 1.419 . . . . 74.35 112.413 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.26 21.18 71.92 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 124.31 0.957 . . . . 71.33 112.496 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.93 175.4 10.46 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 126.327 1.851 . . . . 72.42 108.412 -172.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.0 p -137.07 148.86 47.02 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.689 -0.856 . . . . 74.24 108.689 -174.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.01 176.74 7.82 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.776 -1.194 . . . . 74.03 107.776 172.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -102.25 154.74 18.75 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.721 0.691 . . . . 74.15 109.932 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 10.4 pt -133.34 160.39 42.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 O-C-N 121.924 -0.485 . . . . 55.14 110.457 -177.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -131.65 106.98 8.51 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 125.101 1.36 . . . . 53.23 107.697 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.53 154.46 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 124.219 0.949 . . . . 74.34 108.83 172.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -145.82 173.36 12.18 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 127.708 2.403 . . . . 72.01 107.505 162.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.541 ' HA ' HG12 ' A' ' 18' ' ' VAL . 58.8 t -97.81 151.18 4.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 125.624 1.57 . . . . 72.44 107.742 173.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 23.6 t70 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.381 1.072 . . . . 40.12 108.788 167.133 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.116 0 N-CA-C 111.063 -0.815 . . . . 44.15 111.063 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.71 154.18 58.95 Favored Pre-proline 0 C--O 1.239 0.525 0 C-N-CA 124.341 1.057 . . . . 64.35 109.714 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -76.96 177.33 9.01 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.884 3.056 . . . . 75.04 110.86 174.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -146.05 164.55 31.77 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 123.9 0.88 . . . . 74.31 109.831 176.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -92.77 -161.95 36.63 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.212 1.386 . . . . 61.41 109.934 166.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.4 tpp85 -100.79 138.7 37.49 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.449 1.099 . . . . 73.14 108.818 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -156.1 -179.83 8.53 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.969 0.508 . . . . 75.44 110.085 148.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -124.32 70.45 0.46 Allowed Glycine 0 CA--C 1.536 1.396 0 CA-C-O 118.406 -1.219 . . . . 40.12 113.303 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -66.15 167.93 17.02 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.55 3.5 . . . . 51.21 115.079 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -73.48 91.82 0.86 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 125.016 3.811 . . . . 64.34 111.35 170.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.7 m -106.33 148.57 27.88 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.215 1.406 . . . . 71.45 110.19 177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.76 174.2 9.48 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.559 0.744 . . . . 75.31 111.167 175.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.565 ' HG3' HH11 ' A' ' 17' ' ' ARG . 0.8 OUTLIER -118.45 77.81 1.2 Allowed 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 106.212 -1.774 . . . . 64.44 106.212 175.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.0 m -59.51 164.85 3.19 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.442 -1.254 . . . . 43.22 109.947 169.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -72.41 30.96 0.06 Allowed 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.379 1.471 . . . . 71.31 113.093 -167.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -135.84 20.58 3.28 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.751 2.02 . . . . 74.05 108.754 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.565 HH11 ' HG3' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -112.09 139.25 47.76 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.768 1.227 . . . . 74.32 111.907 -171.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.464 HG23 ' HB ' ' A' ' 55' ' ' VAL . 0.0 OUTLIER -147.94 170.11 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 C-N-CA 126.078 1.751 . . . . 44.22 109.633 -172.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 19.6 m -136.14 174.31 12.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 126.014 1.726 . . . . 71.44 108.386 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.0 t -137.26 162.35 33.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 125.024 1.329 . . . . 72.25 108.297 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -153.75 165.07 37.17 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 120.458 -1.401 . . . . 75.31 108.424 -174.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.84 9.37 86.95 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 119.156 0.889 . . . . 74.1 113.239 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.19 150.84 69.77 Favored Pre-proline 0 N--CA 1.445 -0.681 0 CA-C-N 119.097 1.448 . . . . 75.4 112.194 -175.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -64.54 161.07 36.76 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.358 2.705 . . . . 75.34 111.516 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -65.44 -34.22 44.13 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.233 1.955 . . . . 63.5 111.563 173.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.81 60.51 0.71 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 122.488 1.137 . . . . 71.11 110.549 -176.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -132.3 159.53 23.39 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 107.565 -2.214 . . . . 71.41 107.565 159.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.8 m -128.39 -175.86 3.64 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.295 1.038 . . . . 63.01 109.059 172.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.8 p-90 -62.08 -21.39 64.92 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 124.958 1.303 . . . . 72.33 111.057 176.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -57.24 11.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.929 -1.137 . . . . 73.13 107.929 179.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.82 -32.38 73.88 Favored 'General case' 0 C--O 1.223 -0.338 0 O-C-N 123.394 0.434 . . . . 71.0 110.894 175.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.39 -54.9 37.97 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 118.867 0.758 . . . . 61.24 110.303 176.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -64.28 -33.61 76.23 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.553 0.615 . . . . 75.21 110.827 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -74.5 -25.62 59.48 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.834 1.254 . . . . 62.42 113.526 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -102.26 -41.43 6.37 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.599 1.56 . . . . 75.44 111.545 -175.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 14.3 ttt -81.59 53.39 2.1 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 120.334 -1.479 . . . . 74.32 109.884 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.29 47.5 2.48 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.332 1.453 . . . . 75.01 110.604 -170.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -135.65 -5.77 2.22 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.258 1.207 . . . . 75.24 114.258 -172.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -118.94 45.88 1.99 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.792 1.637 . . . . 63.43 110.726 -170.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.11 -107.32 1.95 Allowed Glycine 0 N--CA 1.47 0.967 0 N-CA-C 108.581 -1.808 . . . . 60.45 108.581 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.9 167.09 25.72 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.426 1.613 . . . . 64.24 111.761 158.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.9 t -137.01 135.73 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.505 1.522 . . . . 72.31 109.775 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.9 t -113.88 -24.06 9.3 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.53 0.567 . . . . 63.21 112.53 -176.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -123.66 143.35 50.31 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.816 1.189 . . . . 53.22 109.263 -173.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -151.61 133.96 15.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.228 0.922 . . . . 54.42 110.688 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -149.48 131.21 15.03 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.17 1.388 . . . . 75.04 108.881 -177.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.7 m -136.93 171.31 16.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.946 1.298 . . . . 62.44 109.137 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -154.3 -177.89 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 124.115 0.966 . . . . 62.12 109.768 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 51.4 mmt-85 -81.58 40.1 0.57 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.88 2.072 . . . . 55.1 111.833 -164.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -117.62 -25.67 6.83 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.836 0.854 . . . . 73.13 112.309 -171.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.38 6.48 64.42 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.452 -0.659 . . . . 72.13 111.452 -162.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -119.26 165.58 14.07 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.989 1.394 . . . . 74.04 110.448 173.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -148.75 174.61 28.34 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.64 -1.784 . . . . 34.21 108.64 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 70.1 t -146.69 134.53 15.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 125.619 1.568 . . . . 74.12 107.964 -173.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HB ' HG23 ' A' ' 18' ' ' VAL . 5.4 t -132.64 164.06 36.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 109.046 -0.724 . . . . 73.01 109.046 -169.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -142.5 124.51 15.29 Favored 'General case' 0 C--O 1.238 0.454 0 O-C-N 120.433 -1.417 . . . . 73.05 107.45 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -94.11 174.64 7.05 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.604 1.562 . . . . 75.04 108.066 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.2 -64.01 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-O 118.69 -0.672 . . . . 54.15 110.901 175.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -139.85 172.13 13.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.628 1.104 . . . . 75.41 109.865 -166.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.7 ttmt -62.85 -29.57 70.84 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.058 -1.026 . . . . 74.44 110.092 -177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -52.7 -63.43 1.15 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.862 0.865 . . . . 62.42 109.497 173.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.1 -47.99 83.59 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 124.771 1.229 . . . . 63.43 108.336 -175.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -57.32 -53.19 60.93 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.208 0.603 . . . . 60.42 110.914 -175.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.4 m -59.3 -41.03 88.04 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.284 0.634 . . . . 44.34 110.282 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -56.96 -33.16 66.77 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 118.898 0.772 . . . . 74.13 111.741 -177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.49 -36.61 83.16 Favored 'General case' 0 C--N 1.331 -0.226 0 O-C-N 121.392 -0.818 . . . . 73.21 109.971 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -71.81 -7.66 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 O-C-N 121.349 -0.845 . . . . 75.04 110.868 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 24.4 mtt180 -109.34 -31.96 7.35 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.855 0.862 . . . . 72.11 113.234 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -124.87 -6.16 7.38 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.843 1.257 . . . . 75.03 113.686 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.64 21.85 3.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 120.12 1.327 . . . . 64.13 110.86 -167.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -115.44 153.85 30.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.666 1.586 . . . . 75.45 109.777 170.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 62.27 11.35 4.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.572 2.749 . . . . 62.53 113.62 -171.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.0 p -75.79 172.23 13.01 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.309 -0.869 . . . . 73.51 110.526 -172.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.469 ' HE3' ' OG1' ' A' ' 82' ' ' THR . 17.8 tttp -78.6 168.7 19.37 Favored 'General case' 0 C--O 1.239 0.529 0 O-C-N 122.038 -0.414 . . . . 42.2 109.973 166.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -147.43 159.72 43.39 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 125.208 1.403 . . . . 73.04 111.866 177.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.6 mmm-85 -116.46 148.04 41.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.747 1.158 . . . . 64.44 111.647 -175.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.23 153.81 45.46 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 125.86 1.664 . . . . 74.1 109.284 -174.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -70.67 -12.54 61.62 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 114.175 1.176 . . . . 75.13 114.175 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.95 1.4 7.26 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.395 1.078 . . . . 75.4 112.728 176.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.26 9.1 63.79 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 124.08 0.848 . . . . 72.34 112.084 -178.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -128.0 168.31 15.47 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 112.793 0.664 . . . . 64.43 112.793 -165.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.469 ' OG1' ' HE3' ' A' ' 74' ' ' LYS . 57.2 p -141.65 117.41 10.41 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.148 -0.933 . . . . 44.22 111.053 -175.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.83 173.19 7.8 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 126.584 1.953 . . . . 53.42 108.491 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -93.32 152.39 19.18 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 119.615 1.098 . . . . 72.42 108.478 159.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.5 pt -122.2 170.61 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.936 1.351 . . . . 74.11 108.839 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -125.33 143.19 51.09 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.751 -1.944 . . . . 74.22 105.751 168.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.1 t -110.8 146.34 16.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 107.325 -1.361 . . . . 55.53 107.325 168.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -142.98 159.94 41.29 Favored 'General case' 0 CA--C 1.516 -0.335 0 O-C-N 122.109 -0.37 . . . . 62.45 111.156 163.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.4 t -61.16 138.96 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 106.603 -1.629 . . . . 61.32 106.603 165.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 43.1 t0 . . . . . 0 C--O 1.259 1.577 0 N-CA-C 105.257 -2.127 . . . . 75.24 105.257 166.22 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.517 0 N-CA-C 110.253 -1.139 . . . . 71.32 110.253 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.78 156.66 43.4 Favored Pre-proline 0 C--O 1.237 0.401 0 C-N-CA 124.665 1.186 . . . . 33.21 110.421 -171.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -76.14 -164.18 0.24 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 124.708 3.605 . . . . 70.15 110.554 174.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -146.86 -176.14 5.08 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.363 1.065 . . . . 74.35 108.67 174.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.95 7.78 71.56 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 116.809 -2.106 . . . . 65.31 116.893 161.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.34 142.1 23.71 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 121.096 2.448 . . . . 72.23 110.18 -176.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -62.23 171.8 1.7 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 127.092 2.157 . . . . 74.44 112.857 176.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.58 84.76 0.16 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.861 1.696 . . . . 72.51 109.264 170.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.43 169.85 18.78 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.424 2.749 . . . . 72.54 112.765 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.48 101.82 0.56 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.882 2.388 . . . . 54.41 109.632 163.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.4 m -130.49 116.4 18.14 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.808 0.843 . . . . 74.21 109.983 170.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.406 HH21 ' C ' ' A' ' 90' ' ' ASP . 27.7 mmm-85 -75.59 -167.96 0.76 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.535 0.683 . . . . 45.44 109.232 169.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -123.57 -85.43 0.65 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 107.729 -1.211 . . . . 65.43 107.729 167.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.2 m -147.45 172.39 14.02 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.528 1.531 . . . . 73.31 108.13 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.64 31.44 0.07 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.992 2.117 . . . . 52.34 113.272 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -132.7 24.28 4.34 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 119.334 -2.104 . . . . 73.15 110.317 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.0 139.35 47.57 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 120.346 -1.471 . . . . 71.35 110.704 -177.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.43 159.99 22.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 126.455 1.902 . . . . 72.34 108.881 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 95.4 t -132.8 140.85 46.46 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 127.232 2.213 . . . . 53.12 106.147 -170.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.424 ' HB ' HD11 ' A' ' 23' ' ' LEU . 24.9 t -104.73 145.37 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 125.782 1.633 . . . . 70.44 108.414 177.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 m -131.97 160.62 35.27 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 120.779 -1.201 . . . . 74.42 109.197 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.02 5.58 67.83 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.695 1.141 . . . . 73.43 113.866 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.426 HD13 ' CG2' ' A' ' 47' ' ' VAL . 5.2 mt -64.65 151.49 92.03 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.133 0.973 . . . . 65.45 112.304 -165.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -76.21 161.29 35.38 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.93 2.42 . . . . 50.12 110.662 169.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -67.55 -39.17 12.74 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.4 2.733 . . . . 50.15 110.567 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 64.0 p -67.19 -0.3 3.29 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.65 1.98 . . . . 74.43 112.303 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -97.42 121.42 7.08 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 126.078 1.799 . . . . 50.44 109.416 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.769 ' HA ' HG13 ' A' ' 47' ' ' VAL . 0.1 OUTLIER -142.07 -179.6 6.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.855 1.262 . . . . 71.21 108.482 171.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -62.01 -29.44 70.27 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 118.181 -0.914 . . . . 71.44 111.974 -158.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -58.69 -62.1 2.12 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.809 -1.182 . . . . 63.51 107.809 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -54.71 -47.11 74.13 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.589 0.755 . . . . 73.43 109.867 177.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.03 -45.03 87.63 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.954 1.702 . . . . 64.21 111.537 -176.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.1 tttm -69.36 -30.25 68.22 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.315 1.046 . . . . 72.12 111.15 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -92.52 1.44 57.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.565 1.146 . . . . 53.33 112.778 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -121.46 -56.55 1.88 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.664 1.586 . . . . 64.33 112.285 178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 18.5 ttt -75.01 79.72 2.2 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.378 -1.342 . . . . 74.5 107.378 170.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -143.39 -7.71 0.78 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.423 1.889 . . . . 71.2 111.873 173.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.59 -3.08 25.71 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 118.585 0.63 . . . . 72.14 111.88 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.38 -0.41 41.06 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 119.322 0.965 . . . . 61.42 112.913 178.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 117.27 -156.52 15.58 Favored Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.444 -1.062 . . . . 50.14 110.444 -174.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.37 114.91 21.15 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 122.32 1.057 . . . . 53.43 110.694 -163.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 99.3 t -101.9 151.52 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 107.458 -1.312 . . . . 73.2 107.458 171.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 4.7 t -131.37 0.93 4.11 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.033 0.753 . . . . 74.52 113.033 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -161.81 144.82 12.02 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.7 1.6 . . . . 63.44 107.7 -169.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -148.61 139.44 22.92 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.8 -0.815 . . . . 63.22 108.8 169.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -155.51 107.48 2.63 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 119.508 1.049 . . . . 72.11 109.202 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.769 HG13 ' HA ' ' A' ' 28' ' ' SER . 1.3 p -135.71 144.82 32.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.228 1.811 . . . . 70.52 111.976 -171.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -135.27 156.57 48.74 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.429 1.092 . . . . 74.15 109.697 -164.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.3 mtm180 -81.37 35.38 0.39 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.996 1.318 . . . . 70.14 111.53 -169.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -115.42 9.58 15.57 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.959 1.703 . . . . 73.24 108.486 173.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.26 23.98 60.05 Favored Glycine 0 C--N 1.341 0.859 0 C-N-CA 125.672 1.606 . . . . 73.44 112.886 174.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.96 162.91 34.29 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.28 1.04 . . . . 64.13 108.498 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -163.26 160.11 32.7 Favored Glycine 0 C--O 1.224 -0.469 0 N-CA-C 109.13 -1.588 . . . . 62.45 109.13 -169.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 88.7 t -132.53 155.36 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 C-N-CA 125.595 1.558 . . . . 51.34 108.351 176.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.0 t -138.19 170.73 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 127.415 2.286 . . . . 53.42 106.032 -174.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -144.41 124.28 13.46 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.12 -1.808 . . . . 74.54 106.12 167.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -94.29 166.05 12.28 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.408 -0.96 . . . . 74.45 108.408 176.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.6 m -73.08 -37.86 54.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 114.378 -1.283 . . . . 51.43 111.835 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.4 ttm105 -154.04 156.69 37.81 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.328 0.651 . . . . 64.51 109.4 -168.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.4 tttt -61.12 -27.99 68.78 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 117.639 -1.172 . . . . 72.2 111.567 -176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.12 -50.32 74.17 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.839 1.2 . . . . 74.24 110.749 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -77.7 -41.58 37.46 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 108.539 -0.912 . . . . 74.3 108.539 -175.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 16.0 tmm? -47.77 -50.86 24.41 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.615 1.166 . . . . 71.53 111.237 169.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 24.1 m -64.9 -47.47 77.66 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 118.369 -0.824 . . . . 70.54 111.216 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.9 t80 -54.84 -32.75 60.91 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 119.559 1.072 . . . . 74.31 111.324 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.34 -42.29 86.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.448 0.567 . . . . 51.0 111.681 178.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.89 -25.21 27.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.281 -0.887 . . . . 72.13 110.248 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -79.49 -41.84 26.57 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-O 117.519 -1.229 . . . . 71.3 112.553 -177.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -124.27 -16.98 6.26 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.186 1.18 . . . . 70.31 114.186 -170.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.32 1.44 32.77 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.779 1.232 . . . . 64.43 110.151 -171.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -100.11 147.97 25.08 Favored 'General case' 0 CA--C 1.527 0.078 0 O-C-N 120.27 -1.519 . . . . 65.32 113.65 -172.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 69.68 11.15 7.83 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.034 2.134 . . . . 64.2 111.531 -176.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 61.4 p -83.97 163.07 20.2 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.032 1.333 . . . . 71.3 110.161 -169.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -77.81 156.92 30.18 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 120.892 -1.13 . . . . 71.43 109.706 168.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -107.72 -175.73 2.87 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.215 2.206 . . . . 73.12 110.768 176.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.1 mtt-85 -146.65 146.54 30.42 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 124.85 1.26 . . . . 73.2 107.681 169.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.5 p -142.3 159.98 41.15 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.794 1.238 . . . . 65.44 110.537 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -73.76 37.9 0.1 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.218 1.807 . . . . 72.42 113.551 -178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.4 16.43 4.48 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.557 2.343 . . . . 71.15 110.617 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.39 29.41 69.05 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 124.284 0.945 . . . . 64.23 112.227 178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.52 173.9 11.17 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 125.82 1.648 . . . . 71.13 111.002 -173.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.7 p -144.8 147.72 33.21 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.255 -1.017 . . . . 73.31 108.255 176.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.02 176.43 5.3 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.504 1.122 . . . . 74.41 108.495 161.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -109.0 150.15 28.18 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 120.256 1.389 . . . . 74.32 110.45 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 pt -124.91 158.76 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 122.08 0.943 . . . . 71.21 112.207 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.0 mmm-85 -117.27 136.91 52.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.46 -1.681 . . . . 74.24 106.46 165.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 89.7 t -108.4 131.12 59.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 106.053 -1.832 . . . . 64.31 106.053 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -138.33 168.06 20.56 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.182 1.393 . . . . 73.23 108.332 178.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.4 t -87.82 161.34 2.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.046 -1.464 . . . . 74.55 107.046 179.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.406 ' C ' HH21 ' A' ' 12' ' ' ARG . 25.1 t0 . . . . . 0 C--O 1.252 1.197 0 N-CA-C 104.368 -2.456 . . . . 73.22 104.368 156.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.744 0 N-CA-C 110.5 -1.04 . . . . 40.12 110.5 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.33 155.28 28.72 Favored Pre-proline 0 C--O 1.237 0.443 0 CA-C-N 118.412 1.106 . . . . 75.0 111.85 -176.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.05 -179.62 5.61 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 124.28 3.32 . . . . 73.03 111.847 163.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.4 mtm-85 -142.54 4.15 1.53 Allowed 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.667 1.729 . . . . 75.12 115.667 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -123.76 -124.22 2.87 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 126.476 1.989 . . . . 51.31 110.777 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -139.72 136.84 34.6 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 119.469 1.634 . . . . 75.23 108.591 171.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -155.79 -174.88 5.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.273 1.829 . . . . 75.31 106.835 167.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -139.58 69.0 0.48 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 109.587 -1.405 . . . . 73.0 109.587 174.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -69.17 168.49 20.63 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.997 2.465 . . . . 64.4 110.705 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -69.55 83.01 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.534 2.823 . . . . 72.12 110.662 173.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -156.17 155.91 33.3 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.997 1.719 . . . . 72.01 106.59 170.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.6 ptt180 -53.76 166.51 0.32 Allowed 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.887 0.875 . . . . 75.42 110.066 156.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.4 mtt-85 -122.76 -83.12 0.66 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.234 -0.654 . . . . 74.43 109.234 167.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.6 m -151.48 152.46 33.03 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 104.2 -2.519 . . . . 73.4 104.2 -160.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -74.1 38.84 0.11 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.52 0.728 . . . . 74.21 111.748 -174.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.6 28.27 2.71 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 119.52 -1.987 . . . . 71.21 110.053 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.3 ttt-85 -130.2 154.85 47.13 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 120.954 -1.091 . . . . 72.31 112.704 -172.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.525 HG23 ' HB ' ' A' ' 55' ' ' VAL . 2.1 m -144.01 168.49 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 125.296 1.438 . . . . 61.0 112.32 -171.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.4 t -137.24 136.09 47.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 N-CA-C 106.638 -1.615 . . . . 43.33 106.638 175.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 98.3 t -105.26 150.7 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.63 -1.248 . . . . 41.14 107.63 174.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.5 p -150.17 153.09 35.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 119.443 1.019 . . . . 73.31 109.714 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.11 6.97 38.89 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.301 1.429 . . . . 64.31 113.311 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 13.8 mt -65.91 156.44 83.73 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.347 1.059 . . . . 74.22 113.171 -164.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.09 175.7 8.03 Favored 'Trans proline' 0 CA--C 1.537 0.674 1 C-N-CA 125.493 4.129 . . . . 64.52 113.294 -175.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -64.31 -7.96 15.43 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.766 2.977 . . . . 62.13 115.238 172.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.6 t -148.81 56.6 1.02 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-N 120.531 1.514 . . . . 72.23 110.296 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.38 79.5 0.58 Allowed Glycine 0 C--N 1.332 0.35 0 N-CA-C 110.319 -1.113 . . . . 74.11 110.319 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 18.2 m -74.8 155.46 37.57 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 119.395 -0.922 . . . . 44.42 110.32 -175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 20.8 p-90 -60.08 -25.38 65.35 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 120.932 -1.105 . . . . 75.54 112.205 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -59.3 -46.03 89.69 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.59 1.556 . . . . 75.41 109.579 175.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -71.14 -37.5 72.26 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.032 0.933 . . . . 63.4 109.074 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.418 HD22 ' ND1' ' A' ' 35' ' ' HIS . 0.3 OUTLIER -56.65 -52.16 65.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 118.863 0.756 . . . . 62.4 111.164 177.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -62.06 -39.67 93.2 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 109.154 -0.684 . . . . 72.32 109.154 -174.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.97 -17.38 64.42 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.569 1.548 . . . . 54.0 112.066 175.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.418 ' ND1' HD22 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -91.84 -45.03 8.6 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 104.817 -2.29 . . . . 74.53 104.817 -174.23 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.43 ' SD ' HG11 ' A' ' 55' ' ' VAL . 7.8 ttt -82.26 -14.1 55.99 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.238 0.459 . . . . 63.44 112.238 -150.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.6 -0.91 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 130.77 3.628 . . . . 73.2 116.446 174.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -81.65 -16.14 52.33 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 120.704 -1.247 . . . . 70.1 112.315 179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.13 1.74 57.03 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.078 0.77 . . . . 44.31 113.078 -175.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.19 -161.15 15.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 108.027 -2.029 . . . . 74.13 108.027 -157.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -79.83 145.3 32.84 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 122.593 0.357 . . . . 72.24 111.002 -165.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 t -130.33 131.01 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 105.397 -2.075 . . . . 72.34 105.397 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.5 t -116.69 5.61 13.2 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.748 0.647 . . . . 70.44 112.748 -167.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -162.94 158.21 22.09 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 126.435 1.894 . . . . 73.1 106.737 -177.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.04 150.04 34.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 119.579 1.081 . . . . 73.31 108.396 163.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -158.89 129.7 6.1 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 117.965 0.348 . . . . 64.32 110.721 167.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -128.8 114.44 33.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.868 -2.271 . . . . 73.43 104.868 173.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -77.52 153.8 33.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.081 0.952 . . . . 74.41 109.143 161.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 43.63 -86.8 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 130.948 3.699 . . . . 74.43 110.92 168.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 178.97 178.08 0.47 Allowed 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.317 1.847 . . . . 71.5 111.233 155.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.78 -18.62 56.96 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.867 1.222 . . . . 64.14 114.202 175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 m -148.97 -179.03 6.7 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.671 1.589 . . . . 74.43 108.719 -175.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -173.9 164.21 35.52 Favored Glycine 0 N--CA 1.465 0.621 0 O-C-N 120.385 -1.447 . . . . 63.2 111.164 174.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 p -135.36 131.98 51.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 124.119 0.968 . . . . 75.41 108.518 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.525 ' HB ' HG23 ' A' ' 18' ' ' VAL . 67.6 t -144.0 154.98 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.328 -1.36 . . . . 71.4 107.328 -160.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -139.07 131.95 29.3 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.763 -1.569 . . . . 72.1 106.763 -172.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -101.8 -178.11 3.62 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.703 1.201 . . . . 70.3 108.056 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.47 -51.78 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 107.809 -1.182 . . . . 73.14 107.809 170.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.47 163.49 32.8 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 114.507 1.299 . . . . 71.1 114.507 -164.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.7 tttm -61.32 -33.18 73.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 113.586 -1.643 . . . . 65.1 112.076 -178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -63.87 -56.63 13.91 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.522 -0.918 . . . . 70.11 108.522 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -61.52 -45.31 94.72 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.533 0.733 . . . . 64.13 109.58 178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 15.3 tmm? -51.05 -55.43 17.58 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.772 -0.58 . . . . 73.41 112.259 174.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.1 m -57.11 -48.92 77.45 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.586 1.084 . . . . 74.31 110.347 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -55.16 -33.3 62.82 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.206 1.002 . . . . 74.31 111.494 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.11 -44.78 75.26 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 124.623 1.169 . . . . 73.31 110.498 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.78 -10.18 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 O-C-N 121.252 -0.905 . . . . 73.32 110.884 -176.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -104.65 -31.95 9.14 Favored 'General case' 0 CA--C 1.527 0.089 0 O-C-N 121.413 -0.804 . . . . 63.02 110.914 -178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.03 -0.29 6.53 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 114.364 1.246 . . . . 72.54 114.364 -169.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -133.69 -4.87 2.87 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 120.284 1.402 . . . . 52.14 111.873 -172.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.54 ' HB2' HG12 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -83.04 161.17 21.78 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 120.356 -1.465 . . . . 73.33 111.998 165.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.8 t30 70.89 20.2 5.5 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.776 2.031 . . . . 74.53 112.26 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.6 p -85.35 142.18 29.5 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.06 -0.719 . . . . 72.5 109.06 -169.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.9 tttp -77.77 101.31 6.63 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.103 -1.443 . . . . 73.43 107.103 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -85.9 141.69 29.39 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.935 1.294 . . . . 72.14 113.134 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.405 ' HA ' HG22 ' A' ' 82' ' ' THR . 30.5 ptt180 -99.42 139.24 35.36 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 126.66 1.984 . . . . 72.52 110.643 -176.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 73.4 p -108.89 174.25 5.95 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.137 0.975 . . . . 42.12 109.609 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -92.34 18.18 8.73 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.841 -1.072 . . . . 75.2 111.095 165.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -98.8 18.11 17.8 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 120.537 -1.352 . . . . 63.1 110.599 169.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.02 7.1 75.6 Favored Glycine 0 C--N 1.339 0.723 0 C-N-CA 126.406 1.955 . . . . 63.3 112.845 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.87 -176.66 4.13 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 117.627 0.714 . . . . 64.31 110.209 -166.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.405 HG22 ' HA ' ' A' ' 76' ' ' ARG . 48.0 p -141.76 138.11 32.07 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 106.65 -1.611 . . . . 73.54 106.65 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.39 135.23 47.8 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.989 1.268 . . . . 64.11 109.326 172.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -69.93 156.51 38.99 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.982 0.81 . . . . 74.4 110.296 -168.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 pt -122.96 166.46 17.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.711 0.767 . . . . 72.42 111.146 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -127.43 152.51 47.43 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.666 -1.235 . . . . 64.14 107.666 159.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 71' ' ' ASP . 2.6 p -109.79 149.59 12.78 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 124.758 1.223 . . . . 72.2 109.142 177.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -139.92 166.69 23.96 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.661 1.184 . . . . 72.11 108.803 168.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.9 t -81.69 144.16 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 105.689 -1.967 . . . . 72.01 105.689 173.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 37.4 t70 . . . . . 0 C--O 1.256 1.395 0 CA-C-O 117.853 -1.07 . . . . 73.21 109.726 169.517 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.189 0 N-CA-C 110.864 -0.894 . . . . 72.22 110.864 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.4 ' HB1' ' HD2' ' A' ' 3' ' ' PRO . . . -91.56 165.55 20.6 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-N 118.79 1.295 . . . . 72.11 109.863 176.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 2' ' ' ALA . 93.5 Cg_endo -74.8 -169.89 0.69 Allowed 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 124.07 3.18 . . . . 75.4 112.33 177.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -146.36 174.29 11.5 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.325 1.85 . . . . 63.44 109.234 177.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 155.83 79.12 0.02 OUTLIER Glycine 0 C--N 1.336 0.582 0 CA-C-O 118.963 -0.91 . . . . 71.33 113.704 163.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -146.83 123.97 11.47 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 119.404 1.602 . . . . 73.21 109.689 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -163.39 147.66 10.83 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 127.21 2.204 . . . . 64.51 105.319 166.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 133.9 165.5 11.02 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.704 1.145 . . . . 42.31 110.765 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.65 170.79 13.12 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.208 2.605 . . . . 70.43 111.695 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -77.61 64.36 8.07 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.979 2.453 . . . . 54.0 111.573 -174.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.18 163.57 33.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.882 1.273 . . . . 72.24 110.043 -173.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.45 -169.25 3.27 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.281 2.632 . . . . 72.22 106.424 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -130.99 -78.19 0.53 Allowed 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 107.006 -1.479 . . . . 73.3 107.006 164.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.0 m -140.91 164.81 29.23 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.122 0.969 . . . . 70.1 108.597 174.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -72.62 25.79 0.06 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 127.418 2.287 . . . . 65.34 113.137 -170.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -137.52 14.49 2.96 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 120.075 -1.641 . . . . 70.5 110.292 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -95.78 145.07 25.62 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 120.644 -1.285 . . . . 65.53 110.676 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.0 m -133.75 160.26 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.834 -0.802 . . . . 73.54 108.834 164.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.97 149.0 27.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 106.557 -1.646 . . . . 72.54 106.557 164.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -106.01 153.65 7.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 106.705 -1.591 . . . . 53.4 106.705 174.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.4 m -144.45 162.36 36.71 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 120.119 -1.613 . . . . 43.43 112.244 176.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.14 12.52 80.76 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.733 1.635 . . . . 73.42 112.71 -177.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 mt -63.89 144.3 98.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-O 118.023 -0.989 . . . . 54.02 111.789 -170.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -71.88 165.13 33.49 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 124.238 3.292 . . . . 63.22 113.583 -178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.29 -32.89 25.39 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 122.978 2.452 . . . . 51.11 113.427 -172.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -97.85 41.39 1.13 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.991 0.916 . . . . 63.24 109.381 175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -101.35 124.48 8.25 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 108.179 -1.968 . . . . 72.14 108.179 173.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.6 m -125.02 169.67 11.9 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.24 1.416 . . . . 73.15 109.48 167.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -61.95 -20.14 63.51 Favored 'General case' 0 CA--C 1.527 0.062 0 N-CA-C 113.511 0.93 . . . . 73.23 113.511 -174.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -60.84 2.21 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 118.071 -0.966 . . . . 72.51 108.548 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.08 -34.78 73.91 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.837 0.744 . . . . 62.33 109.171 177.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.4 -53.43 36.72 Favored 'General case' 0 C--N 1.345 0.397 0 O-C-N 121.452 -0.78 . . . . 64.55 111.149 173.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.49 ' HE3' ' HB ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -80.18 -20.46 44.72 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.762 1.165 . . . . 63.43 112.343 -176.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.45 -29.92 66.62 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.645 -0.66 . . . . 70.35 110.911 169.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -93.52 -51.48 4.93 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.035 1.334 . . . . 72.13 110.131 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.482 ' HG3' HD11 ' A' ' 70' ' ' LEU . 4.8 ttt -79.92 66.8 5.51 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 128.546 2.738 . . . . 74.25 110.382 -178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.66 -1.92 0.87 Allowed 'General case' 0 C--N 1.329 -0.325 0 O-C-N 120.709 -1.244 . . . . 72.13 113.712 -178.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.06 -44.94 94.42 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 119.572 1.078 . . . . 65.15 108.89 168.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.05 16.65 0.22 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 127.935 2.494 . . . . 70.21 114.293 -171.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.22 -147.9 16.66 Favored Glycine 0 CA--C 1.517 0.165 0 N-CA-C 111.282 -0.727 . . . . 64.13 111.282 162.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -80.43 99.94 8.24 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.846 0.832 . . . . 74.31 109.714 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.49 ' HB ' ' HE3' ' A' ' 33' ' ' LYS . 44.0 t -98.7 96.38 5.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 105.586 -2.005 . . . . 72.21 105.586 171.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 3.5 t -75.13 -22.97 57.82 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 123.408 0.442 . . . . 71.31 112.038 -174.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -124.39 149.73 46.37 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 125.545 1.538 . . . . 74.03 109.506 -170.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.38 129.97 10.74 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.237 0.926 . . . . 70.13 109.082 176.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -149.68 147.45 28.09 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 119.138 0.881 . . . . 61.33 110.356 169.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.4 t -145.65 151.65 14.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.234 -1.765 . . . . 64.24 106.234 175.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.7 168.68 19.27 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.88 2.072 . . . . 73.31 109.193 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.452 ' HG3' ' H ' ' A' ' 50' ' ' ASP . 9.0 ptm180 42.86 -87.19 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 129.821 3.248 . . . . 65.42 112.674 163.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.452 ' H ' ' HG3' ' A' ' 49' ' ' ARG . 1.9 p-10 -178.61 -176.92 0.5 Allowed 'General case' 0 N--CA 1.436 -1.128 1 C-N-CA 132.684 4.394 . . . . 74.4 107.728 162.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.28 -24.65 5.37 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-O 119.214 -0.77 . . . . 71.33 113.452 163.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.93 165.08 35.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.854 1.327 . . . . 61.14 108.676 178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -162.0 140.58 6.68 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 107.089 -2.404 . . . . 73.12 107.089 -176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -111.57 134.98 52.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 118.781 1.29 . . . . 70.11 108.04 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.3 t -140.0 161.87 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 105.98 -1.859 . . . . 74.43 105.98 -172.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -143.52 139.88 30.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 105.371 -2.085 . . . . 62.43 105.371 170.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -107.34 164.26 12.34 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.959 -1.867 . . . . 74.53 105.959 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.1 t -63.98 -44.64 97.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 113.177 0.806 . . . . 65.23 113.177 -173.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 40.7 ttm-85 -144.87 168.13 20.96 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 118.833 0.742 . . . . 74.52 109.506 -173.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -55.26 -28.88 56.38 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 118.19 -0.909 . . . . 42.01 110.197 171.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -64.8 -63.1 1.2 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 118.874 0.761 . . . . 65.35 108.99 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.46 -43.49 88.91 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 118.032 0.378 . . . . 74.34 110.033 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.8 tmm? -57.16 -50.04 74.08 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.283 0.633 . . . . 53.14 111.228 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.1 m -59.51 -35.98 75.21 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.176 0.898 . . . . 72.34 111.229 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -54.78 -45.95 74.34 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 120.621 1.555 . . . . 74.24 110.013 175.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.43 -46.88 63.11 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.31 0.644 . . . . 71.41 111.68 -175.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -74.05 -7.42 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 123.571 0.749 . . . . 53.33 111.019 -169.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 16.2 ptt180 -123.89 -3.24 8.17 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.665 1.186 . . . . 64.11 113.452 -177.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -142.37 -0.91 1.21 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.029 0.932 . . . . 63.14 112.784 -175.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.482 HD11 ' HG3' ' A' ' 36' ' ' MET . 1.1 tm? -149.08 10.18 0.78 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.093 1.315 . . . . 63.35 111.339 -167.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.69 163.65 14.02 Favored 'General case' 0 C--N 1.341 0.211 0 O-C-N 119.009 -2.307 . . . . 40.45 112.302 171.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.57 ' H ' ' HA ' ' A' ' 86' ' ' ARG . 0.7 OUTLIER 68.5 12.96 8.89 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.356 1.862 . . . . 64.41 113.794 171.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 31.1 p -75.21 164.04 26.89 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.51 1.524 . . . . 71.32 111.388 -170.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.66 162.87 28.72 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.245 -1.535 . . . . 73.23 108.169 166.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -147.85 151.23 35.59 Favored 'General case' 0 CA--C 1.504 -0.792 0 C-N-CA 125.047 1.339 . . . . 73.43 110.227 171.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -138.03 138.91 39.3 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.722 2.009 . . . . 74.21 106.33 -160.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -144.14 156.34 44.3 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.044 0.938 . . . . 73.33 110.554 -164.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -71.69 60.95 0.36 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.914 1.686 . . . . 73.35 113.242 178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -146.14 -2.09 0.72 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.306 2.243 . . . . 74.55 111.088 169.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.89 15.26 54.87 Favored Glycine 0 C--N 1.34 0.773 0 O-C-N 120.298 -1.501 . . . . 74.14 112.201 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -130.8 171.7 12.83 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 124.151 0.98 . . . . 72.54 111.369 -172.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 16.5 p -143.04 153.98 43.5 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 114.536 -1.211 . . . . 74.24 108.145 179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -119.46 177.07 5.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 127.118 2.167 . . . . 74.35 108.496 173.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -97.81 153.99 17.92 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 121.015 -1.053 . . . . 60.32 108.709 147.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.7 pt -130.82 171.6 17.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 125.871 1.668 . . . . 75.53 107.165 171.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.57 ' HA ' ' H ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -143.69 165.75 26.79 Favored 'General case' 0 N--CA 1.442 -0.869 0 O-C-N 120.998 -1.063 . . . . 71.52 108.874 156.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.4 p -89.24 163.85 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 C-N-CA 124.98 1.312 . . . . 73.34 109.019 169.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -154.6 158.22 39.42 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 126.704 2.002 . . . . 74.4 107.264 163.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.8 t -79.02 83.87 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 105.224 -2.139 . . . . 70.24 105.224 164.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 t0 . . . . . 0 C--O 1.256 1.439 0 C-N-CA 127.894 2.478 . . . . 73.23 113.817 159.417 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.653 0 N-CA-C 109.483 -1.447 . . . . 74.45 109.483 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.21 152.62 90.38 Favored Pre-proline 0 C--O 1.239 0.552 0 CA-C-N 118.041 0.92 . . . . 63.44 110.787 -178.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -75.97 -179.74 5.5 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.394 2.729 . . . . 61.24 111.643 173.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 43.2 mtp180 -138.47 165.68 26.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.555 2.342 . . . . 74.52 107.955 -178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.48 -149.76 6.74 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 108.447 -1.861 . . . . 55.2 108.447 165.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.3 20.9 16.89 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.283 1.433 . . . . 74.31 110.862 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -148.14 154.03 39.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.356 1.462 . . . . 64.44 108.015 -172.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 53.78 54.89 28.27 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 117.78 -1.566 . . . . 72.52 113.669 170.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.01 159.2 26.54 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.007 2.472 . . . . 62.34 111.345 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -78.31 64.22 8.43 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 124.319 3.346 . . . . 74.34 112.1 -165.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 m -76.1 101.51 5.35 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 106.593 -1.632 . . . . 74.22 106.593 163.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.7 157.24 36.29 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.025 1.33 . . . . 73.41 107.476 163.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.9 mmt85 -140.22 96.05 2.98 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 105.572 -2.01 . . . . 71.34 105.572 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.9 m -82.49 -175.93 5.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 122.059 0.933 . . . . 62.34 110.494 173.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -63.08 20.95 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 128.411 2.684 . . . . 60.55 113.095 169.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -133.04 28.4 4.15 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 119.328 -2.107 . . . . 51.31 108.481 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.654 HH21 HG11 ' A' ' 54' ' ' VAL . 42.1 ttt180 -112.83 129.56 56.4 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.753 1.221 . . . . 72.43 110.851 -177.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -127.7 159.86 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.703 -1.221 . . . . 71.42 107.703 168.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 12.5 m -124.3 -179.86 2.5 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 126.97 2.108 . . . . 75.11 107.042 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.8 t -136.11 155.15 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 126.496 1.918 . . . . 64.5 108.256 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.86 165.24 30.35 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 120.633 -1.292 . . . . 64.21 109.589 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.35 7.55 87.83 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.936 0.779 . . . . 72.52 113.003 -174.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.2 mt -60.82 155.02 55.1 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.065 1.346 . . . . 75.54 111.412 -173.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -69.58 167.54 23.92 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 124.913 3.742 . . . . 72.23 111.341 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -67.38 -27.87 39.78 Favored 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.358 2.038 . . . . 73.21 112.975 -176.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.42 ' HB2' ' HG3' ' A' ' 79' ' ' GLU . 7.7 m -140.59 80.27 1.74 Allowed 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 127.1 2.16 . . . . 64.23 107.445 -177.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.22 138.96 10.47 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 105.112 -3.195 . . . . 64.54 105.112 157.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.78 179.23 4.18 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 117.747 0.774 . . . . 74.42 109.055 -175.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.7 p-90 -65.42 -19.18 65.83 Favored 'General case' 0 C--O 1.226 -0.153 0 O-C-N 121.606 -0.684 . . . . 75.51 110.648 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -59.5 4.2 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 117.775 -1.107 . . . . 63.52 108.555 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.41 -35.9 78.82 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 119.598 -0.841 . . . . 54.34 109.477 177.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.97 -53.64 46.81 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.386 0.993 . . . . 33.52 110.708 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -69.74 -26.21 64.21 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.124 -0.985 . . . . 55.33 111.951 -178.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -85.23 -12.91 51.48 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.938 0.895 . . . . 75.14 112.577 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -109.06 -57.61 2.13 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.522 1.129 . . . . 61.52 111.252 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.9 ttt -74.53 70.71 1.8 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.659 1.184 . . . . 71.22 108.588 176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -140.64 -0.55 1.54 Allowed 'General case' 0 N--CA 1.466 0.362 0 O-C-N 120.795 -1.191 . . . . 73.31 113.368 176.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -68.29 -21.57 64.77 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 118.602 0.637 . . . . 74.24 111.579 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.42 -6.88 58.82 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 114.359 1.244 . . . . 75.25 114.359 -171.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.26 -171.49 27.12 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 119.858 1.208 . . . . 54.31 111.357 -176.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -86.19 85.03 7.35 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 106.965 -1.495 . . . . 73.42 106.965 -170.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.9 t -69.57 135.08 29.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 108.155 -1.054 . . . . 72.22 108.155 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 6.5 t -99.07 -11.55 21.35 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.076 -0.488 . . . . 75.13 111.954 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -159.45 146.79 17.01 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 119.555 1.071 . . . . 73.35 109.757 -162.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -142.7 143.25 32.21 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.727 -1.212 . . . . 73.14 107.727 165.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -152.47 134.24 14.71 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.488 0.715 . . . . 64.3 109.466 172.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.8 m -137.53 177.62 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.554 -1.276 . . . . 74.52 107.554 175.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -140.79 -169.24 2.76 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 126.167 1.787 . . . . 74.4 106.768 177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 20.7 mtm180 -96.89 45.21 1.05 Allowed 'General case' 0 N--CA 1.466 0.356 0 O-C-N 120.921 -1.112 . . . . 54.24 111.729 -176.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -110.93 -154.0 0.53 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.277 1.831 . . . . 63.13 107.324 170.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -111.02 28.65 9.58 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.772 2.13 . . . . 72.41 110.605 173.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 p -131.89 173.36 11.26 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.416 1.487 . . . . 74.23 109.508 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -170.86 172.66 44.4 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 107.743 -2.143 . . . . 75.51 107.743 -177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.654 HG11 HH21 ' A' ' 17' ' ' ARG . 37.5 t -145.59 144.34 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 108.483 -0.932 . . . . 72.4 108.483 -165.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.6 t -132.95 171.65 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.54 -0.911 . . . . 63.31 108.54 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -153.8 137.4 16.0 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 120.553 -1.342 . . . . 61.34 107.716 167.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -105.84 177.39 4.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.458 1.903 . . . . 75.24 108.104 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.3 m -86.38 -31.79 6.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.64 0.608 . . . . 55.31 112.64 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 ttm105 -156.37 160.32 39.56 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.362 0.665 . . . . 64.54 109.95 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -67.1 -22.92 65.8 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.568 1.147 . . . . 61.51 112.205 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -60.12 -54.01 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 119.112 0.869 . . . . 72.25 109.603 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.96 -41.21 87.25 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.563 -0.532 . . . . 63.33 109.563 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 48.3 ttp -53.22 -52.78 57.8 Favored 'General case' 0 C--N 1.342 0.252 0 N-CA-C 110.168 -0.308 . . . . 55.13 110.168 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.0 m -55.11 -40.26 70.26 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.537 -0.745 . . . . 73.43 111.08 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -55.84 -45.38 78.41 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.088 0.858 . . . . 60.12 109.446 177.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.5 -42.4 78.28 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.31 -0.869 . . . . 74.24 111.893 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 t -68.35 -18.18 23.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.503 0.721 . . . . 72.31 111.019 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -114.37 -15.81 12.06 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.833 1.049 . . . . 75.52 113.833 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.6 mmtm -134.1 -1.06 2.99 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.261 1.425 . . . . 72.35 112.681 -171.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.62 21.42 2.71 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 119.929 1.24 . . . . 44.05 110.753 -175.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.84 164.0 11.88 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.077 -1.64 . . . . 62.32 110.285 174.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 60.86 12.97 4.12 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.235 1.814 . . . . 61.21 112.202 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.3 p -74.06 168.2 20.01 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.883 -1.136 . . . . 44.25 110.724 -167.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -63.94 166.24 7.72 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 121.74 -0.6 . . . . 71.32 109.813 153.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -145.67 138.79 26.13 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.938 1.695 . . . . 73.15 107.791 166.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.8 ptt180 -96.09 136.61 36.33 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.822 -0.807 . . . . 74.25 108.822 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -109.9 174.39 5.89 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.086 -1.079 . . . . 60.1 108.086 -169.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.82 -11.3 55.98 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 121.839 -0.538 . . . . 72.31 111.882 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG3' ' HB2' ' A' ' 26' ' ' SER . 6.0 mm-40 -102.02 34.24 2.77 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.079 1.351 . . . . 72.13 111.536 -166.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 68.08 15.99 68.11 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 124.782 1.182 . . . . 24.14 113.528 177.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -132.73 176.8 8.14 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 124.439 1.096 . . . . 52.4 110.252 -175.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 31.6 p -144.78 126.07 14.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.75 -1.204 . . . . 73.1 107.75 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.36 -176.49 4.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.861 0.865 . . . . 73.32 110.339 175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -106.29 157.21 17.76 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.578 -0.897 . . . . 75.21 108.578 159.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 pt -141.61 163.78 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.551 1.141 . . . . 73.31 110.937 -174.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -131.58 105.84 7.8 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 107.141 -1.429 . . . . 75.45 107.141 -178.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 76.5 t -69.71 144.17 14.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 107.792 -1.188 . . . . 62.21 107.792 170.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.27 158.82 43.53 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.747 1.158 . . . . 44.12 111.724 166.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.3 t -77.75 137.37 22.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 106.184 -1.784 . . . . 64.24 106.184 174.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.8 t70 . . . . . 0 C--O 1.25 1.119 0 C-N-CA 124.293 1.037 . . . . 72.1 110.487 175.656 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.656 0 N-CA-C 108.895 -1.682 . . . . 63.41 108.895 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.95 166.13 30.68 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 119.141 1.471 . . . . 35.14 111.141 -160.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -64.91 -179.54 1.04 Allowed 'Trans proline' 0 C--O 1.242 0.695 0 C-N-CA 122.906 2.404 . . . . 72.3 111.724 164.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.8 163.95 38.65 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.344 1.058 . . . . 75.44 109.882 -175.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 151.88 67.01 0.01 OUTLIER Glycine 0 CA--C 1.523 0.564 0 N-CA-C 109.998 -1.241 . . . . 73.21 109.998 174.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.89 159.21 37.93 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 123.969 0.908 . . . . 74.22 109.01 175.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.41 108.88 2.52 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.719 1.208 . . . . 72.2 109.391 177.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.96 81.69 1.59 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 108.453 -1.859 . . . . 42.1 108.453 -170.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -64.78 167.87 14.64 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 122.259 1.973 . . . . 71.12 111.118 171.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -73.57 84.09 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.085 2.523 . . . . 53.4 110.143 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.4 m -81.15 128.09 33.37 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.261 1.025 . . . . 75.3 110.035 170.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.7 164.72 26.31 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 128.614 2.765 . . . . 75.24 106.397 174.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 16.9 mmt180 -140.93 79.26 1.69 Allowed 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.936 -1.505 . . . . 74.43 106.936 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 16' ' ' ASN . 72.7 m -67.96 175.62 3.01 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.81 0.814 . . . . 55.11 112.101 -175.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -66.71 31.32 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.043 2.537 . . . . 73.51 111.541 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.4 ' H ' ' C ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -143.01 14.72 1.89 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.101 2.16 . . . . 62.32 108.284 -173.475 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.27 116.22 31.59 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.522 1.929 . . . . 75.34 110.13 -174.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 89' ' ' VAL . 0.0 OUTLIER -122.58 174.07 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.606 0.762 . . . . 62.51 111.522 173.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.578 HG23 ' HG3' ' A' ' 88' ' ' LYS . 10.7 m -136.1 -179.1 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.727 1.611 . . . . 64.41 106.967 170.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 88.0 t -135.7 153.52 32.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 C-N-CA 127.134 2.174 . . . . 75.41 107.006 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.87 155.31 48.2 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.146 1.378 . . . . 43.21 108.88 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.02 4.8 57.58 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 126.419 1.961 . . . . 71.4 113.346 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mt -66.56 154.45 91.14 Favored Pre-proline 0 CA--C 1.54 0.558 0 O-C-N 120.99 -1.3 . . . . 74.43 113.163 -166.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.47 166.36 20.03 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.169 2.579 . . . . 71.02 112.573 175.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.07 -6.03 18.29 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 124.12 3.213 . . . . 71.42 114.013 -173.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -146.75 54.06 1.11 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.505 2.322 . . . . 74.3 108.926 -172.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.96 112.02 2.03 Favored Glycine 0 C--N 1.34 0.761 0 O-C-N 120.126 -1.608 . . . . 35.03 111.564 177.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.9 m -76.24 155.35 34.47 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 118.835 1.318 . . . . 74.14 112.361 -176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 37.8 p-90 -59.04 -26.03 64.23 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 123.828 0.851 . . . . 75.1 113.217 171.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -65.22 -52.2 56.15 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.251 -1.018 . . . . 71.1 108.251 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -62.76 -27.56 69.37 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 125.109 1.363 . . . . 73.11 111.326 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -64.28 -61.34 2.3 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.067 -1.086 . . . . 72.02 108.067 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -61.28 -39.57 90.91 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 118.825 -0.607 . . . . 55.4 109.851 -175.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -17.46 52.97 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.85 1.26 . . . . 73.33 112.688 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -100.72 -45.36 5.51 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.266 0.626 . . . . 75.01 111.23 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 13.0 tpt -57.75 -32.86 67.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.15 1.38 . . . . 72.3 113.396 -174.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -19.17 59.29 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 116.208 1.929 . . . . 73.0 116.208 -166.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.67 1.02 1.39 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.991 1.478 . . . . 64.01 114.991 -169.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.448 ' CB ' ' HB2' ' A' ' 66' ' ' ALA . . . -95.26 -10.09 31.31 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.754 1.222 . . . . 53.2 112.993 175.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.58 -101.74 0.21 Allowed Glycine 0 C--N 1.335 0.498 0 CA-C-N 119.68 1.127 . . . . 41.22 111.386 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.2 144.35 29.85 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 118.533 1.166 . . . . 72.32 109.84 178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.511 ' HB ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 p -131.7 139.53 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 126.379 1.872 . . . . 51.2 113.382 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -127.51 18.88 6.85 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.837 1.255 . . . . 71.22 111.36 -170.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.415 ' HB3' ' CB ' ' A' ' 56' ' ' GLU . 73.5 t80 -170.73 144.48 2.3 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.108 1.763 . . . . 64.33 108.318 172.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -154.69 139.26 16.91 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.861 -1.162 . . . . 74.02 107.861 168.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -155.14 129.22 8.82 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.421 1.089 . . . . 71.13 110.615 -175.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 t -140.27 165.8 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.966 1.706 . . . . 54.43 107.285 -175.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.66 -162.76 1.3 Allowed 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 128.775 2.83 . . . . 72.12 107.723 -169.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -105.25 63.53 0.7 Allowed 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.283 -1.511 . . . . 72.11 109.55 170.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -144.74 -176.33 5.02 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 121.26 -0.9 . . . . 64.04 108.592 169.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.38 13.73 20.11 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-O 118.312 -1.271 . . . . 52.33 113.433 -175.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.32 163.54 30.75 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 120.163 1.982 . . . . 73.41 110.084 -174.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -164.45 167.84 38.52 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 107.788 -2.125 . . . . 51.53 107.788 -171.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 59.0 t -143.8 144.23 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 119.929 1.864 . . . . 73.1 110.395 -163.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.9 t -145.19 154.33 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.112 0.482 . . . . 73.52 110.849 -173.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.415 ' CB ' ' HB3' ' A' ' 44' ' ' TYR . 3.9 tt0 -137.08 101.36 4.53 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 106.885 -1.524 . . . . 75.1 106.885 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.511 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 3.0 m-30 -72.37 179.37 3.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.533 1.933 . . . . 71.14 110.625 173.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.0 t -77.5 -63.43 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 121.627 -0.671 . . . . 64.54 110.98 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -140.37 157.36 45.66 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.27 0.941 . . . . 63.52 112.053 -175.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -53.53 -27.13 24.19 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.247 1.019 . . . . 71.51 112.138 -166.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -53.16 -61.92 1.99 Allowed 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.218 1.407 . . . . 71.41 108.376 179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.56 -37.5 71.08 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.05 1.34 . . . . 75.54 110.667 -173.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -56.86 -54.85 41.8 Favored 'General case' 0 C--O 1.228 -0.047 0 CA-C-O 118.829 -0.605 . . . . 74.42 110.178 173.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.6 m -54.73 -40.64 69.47 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 118.634 -0.698 . . . . 72.21 110.508 177.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -60.02 -49.77 76.34 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 124.02 0.928 . . . . 71.43 110.661 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.448 ' HB2' ' CB ' ' A' ' 39' ' ' ALA . . . -63.46 -25.1 68.12 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 120.739 -1.226 . . . . 64.4 112.68 -176.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.3 t -76.77 -5.75 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 O-C-N 120.853 -1.155 . . . . 60.24 110.125 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -129.41 0.45 5.06 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.537 1.31 . . . . 44.3 114.537 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.39 5.26 0.82 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.499 1.519 . . . . 64.14 112.563 -171.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.01 4.05 0.62 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.404 1.082 . . . . 71.13 109.765 -173.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -99.42 157.69 16.24 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.079 1.751 . . . . 74.44 111.372 -175.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.59 ' H ' ' HB3' ' A' ' 86' ' ' ARG . 0.6 OUTLIER 44.42 64.41 1.34 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.496 1.519 . . . . 75.44 110.359 -168.255 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 18.4 p -121.06 174.19 6.8 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.203 2.601 . . . . 73.02 109.278 -174.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.89 161.98 14.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 120.952 -1.093 . . . . 74.42 109.633 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -151.68 120.66 6.66 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 126.647 1.979 . . . . 64.23 111.483 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 39.8 mtm180 -102.74 119.82 39.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.665 -1.235 . . . . 63.22 107.665 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.54 168.41 16.45 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.799 1.64 . . . . 74.11 110.309 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -65.07 -14.17 59.81 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.33 1.233 . . . . 73.11 114.33 174.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -86.56 6.02 32.79 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.692 1.997 . . . . 72.2 112.51 -172.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.15 14.39 82.31 Favored Glycine 0 C--N 1.337 0.635 0 O-C-N 121.572 -0.705 . . . . 43.34 112.061 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -125.08 171.71 10.05 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 123.961 0.904 . . . . 74.14 110.566 -177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.5 p -139.42 146.03 39.62 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.967 1.307 . . . . 74.22 108.05 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -143.7 129.97 19.83 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 106.729 -1.582 . . . . 64.44 106.729 172.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -69.74 159.49 33.45 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.968 0.804 . . . . 75.23 110.126 -164.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.69 155.73 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 123.414 0.686 . . . . 74.2 109.165 -173.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.59 ' HB3' ' H ' ' A' ' 72' ' ' ASN . 0.0 OUTLIER -134.99 143.05 46.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 120.849 -1.157 . . . . 53.42 109.728 163.119 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 66.3 t -62.94 151.2 8.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.377 1.471 . . . . 73.04 108.347 166.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.578 ' HG3' HG23 ' A' ' 19' ' ' VAL . 6.4 ptmt -146.3 161.61 39.93 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.423 -0.955 . . . . 61.12 108.423 152.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.576 ' HA ' HG12 ' A' ' 18' ' ' VAL . 7.4 t -70.18 143.93 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 N-CA-C 106.358 -1.719 . . . . 73.24 106.358 169.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.604 -1.189 . . . . 63.4 110.487 -177.743 . . . . . . . . 0 0 . 1 stop_ save_